
<html lang="en"     class="pb-page"  data-request-id="9a435f64-71e6-4140-86fb-c96a108154d2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c00812;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Dienone Compounds: Targets and Pharmacological Responses" /></meta><meta name="dc.Creator" content="Martina  Bazzaro" /></meta><meta name="dc.Creator" content="Stig  Linder" /></meta><meta name="dc.Description" content="The biological responses to dienone compounds with a 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore have been studied extensively. Despite their expected general thiol reactivity, these compounds d..." /></meta><meta name="Description" content="The biological responses to dienone compounds with a 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore have been studied extensively. Despite their expected general thiol reactivity, these compounds d..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 4, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00812" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00812" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00812" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00812" /></link>
        
    
    

<title>Dienone Compounds: Targets and Pharmacological Responses | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00812" /></meta><meta property="og:title" content="Dienone Compounds: Targets and Pharmacological Responses" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0008.jpeg" /></meta><meta property="og:description" content="The biological responses to dienone compounds with a 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore have been studied extensively. Despite their expected general thiol reactivity, these compounds display considerable degrees of tumor cell selectivity. Here we review in vitro and preclinical studies of dienone compounds including b-AP15, VLX1570, RA-9, RA-190, EF24, HO-3867, and MCB-613. A common property of these compounds is their targeting of the ubiquitin–proteasome system (UPS), known to be essential for the viability of tumor cells. Gene expression profiling experiments have shown induction of responses characteristic of UPS inhibition, and experiments using cellular reporter proteins have shown that proteasome inhibition is associated with cell death. Other mechanisms of action such as reactivation of mutant p53, stimulation of steroid receptor coactivators, and induction of protein cross-linking have also been described. Although unsuitable as biological probes due to widespread reactivity, dienone compounds are cytotoxic to apoptosis-resistant tumor cells and show activity in animal tumor models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00812"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00812">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00812&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00812&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00812&amp;href=/doi/10.1021/acs.jmedchem.0c00812" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15075-15093</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01963" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00913" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dienone Compounds: Targets and Pharmacological Responses</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Martina Bazzaro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Bazzaro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Masonic Cancer Center and Department of Obstetrics, Gynecology and Women’s Heath, University of Minnesota, Minneapolis, Minnesota 55455, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Bazzaro">Martina Bazzaro</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Stig Linder</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stig Linder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biomedical and Clinical Sciences (BKV), Linköping University, SE-58183 Linköping, Sweden</div><div class="loa-info-affiliations-info">Department of Oncology and Pathology, Karolinska Institute, SE-17176 Stockholm, Sweden</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a0d3d4c9c78eccc9cec4c5d2e0ccc9d58ed3c5"><span class="__cf_email__" data-cfemail="d9aaadb0bef7b5b0b7bdbcab99b5b0acf7aabc">[email protected]</span></a> and <a href="/cdn-cgi/l/email-protection#50032439377e1c393e343522103b397e2335"><span class="__cf_email__" data-cfemail="1340677a743d5f7a7d77766153787a3d6076">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stig++Linder">Stig Linder</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4952-445X" title="Orcid link">http://orcid.org/0000-0002-4952-445X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00812&amp;href=/doi/10.1021%2Facs.jmedchem.0c00812" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15075–15093</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 4, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 May 2020</li><li><span class="item_label"><b>Published</b> online</span>4 November 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00812" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00812</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00812"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2497</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00812" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dienone Compounds: Targets and Pharmacological Responses&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Bazzaro&quot;},{&quot;first_name&quot;:&quot;Stig&quot;,&quot;last_name&quot;:&quot;Linder&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15075-15093&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00812&quot;},&quot;abstract&quot;:&quot;The biological responses to dienone compounds with a 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore have been studied extensively. Despite their expected general thiol reactivity, these compounds display considerable degrees of tumor cell selectivity. Here we review in vitro and preclinical studies of dienone compounds including b-AP15, VLX1570, RA-9, RA-190, EF24, HO-3867, and MCB-613. A common property of these compounds is their targeting of the ubiquitin–proteasome system (UPS), known to be essential for the viability of tumor cells. Gene expression profiling experiments have shown induction of responses characteristic of UPS inhibition, and experiments using cellular reporter proteins have shown that proteasome inhibition is associated with cell death. Other mechanisms of action such as reactivation of mutant p53, stimulation of steroid receptor coactivators, and induction of protein cross-linking have also been described. Although unsuitable as biological probes due to widespread reactivity, dienone com&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00812&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00812" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00812&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00812" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00812&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00812" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00812&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00812&amp;href=/doi/10.1021/acs.jmedchem.0c00812" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00812" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00812" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00812%26sid%3Dliteratum%253Aachs%26pmid%3D33146523%26genre%3Darticle%26aulast%3DBazzaro%26date%3D2020%26atitle%3DDienone%2BCompounds%253A%2BTargets%2Band%2BPharmacological%2BResponses%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15075%26epage%3D15093%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The biological responses to dienone compounds with a 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore have been studied extensively. Despite their expected general thiol reactivity, these compounds display considerable degrees of tumor cell selectivity. Here we review <i>in vitro</i> and preclinical studies of dienone compounds including b-AP15, VLX1570, RA-9, RA-190, EF24, HO-3867, and MCB-613. A common property of these compounds is their targeting of the ubiquitin–proteasome system (UPS), known to be essential for the viability of tumor cells. Gene expression profiling experiments have shown induction of responses characteristic of UPS inhibition, and experiments using cellular reporter proteins have shown that proteasome inhibition is associated with cell death. Other mechanisms of action such as reactivation of mutant p53, stimulation of steroid receptor coactivators, and induction of protein cross-linking have also been described. Although unsuitable as biological probes due to widespread reactivity, dienone compounds are cytotoxic to apoptosis-resistant tumor cells and show activity in animal tumor models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A considerable number of anticancer drugs have been discovered and developed using phenotypic screening.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Large numbers (in the order of 10<sup>3</sup>–10<sup>6</sup>) of molecules can be screened for identification of compounds that induce a desired biological response.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Screens can be set up using different strategies, using tumor cells that are resistant to conventional therapy, using cells with defined genetic makeups, using cellular reporter systems, etc.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A disadvantage of this approach is that identified compounds may be associated with extensive polypharmacology. Furthermore, it is generally difficult to define precise mechanisms of action of screening hits. The revolution of molecular biology has, however, resulted in substantially improved possibilities for elucidation of targets and of molecular mechanisms of action. Thus, methods such as gene expression profiling<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> (CMap), various proteomic techniques,<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> and knock-down and gene deletion technologies can be used to generate hypotheses with regard to molecular mechanisms of action, to identify and validate potential targets.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Investigators performing phenotypic screening are faced with the problem of how to manage projects where hit compounds display interesting features in terms of generating desired biological responses but are unattractive from a medicinal chemistry point of view. Should such projects be discontinued since, according to experience, such compounds can rarely be developed into useful drugs? Or is this a prejudiced view? Cancer is a disease characterized by the occurrence of a large number of genetic and epigenetic alterations.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> There is a considerable medical need for efficient drugs for improved treatment of diseases with dismal outcomes such as pancreatic cancer and glioblastoma. The clinical efficacy of many anticancer drugs is hampered by the development of clones expressing variant target proteins, resulting in treatment failure.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Perhaps no stone should be left unturned?</div><div class="NLM_p">Here we review the reported biological activities of substances containing 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophores such as 3,5-diarylidene-4-piperidones and dibenzylidene-acetone (DBA) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). These compounds are electrophiles, primarily reacting with thiols,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and will be referred to as “dienones”. Dienone compounds with completely different structures such as prostaglandins of the J-series will generally not be considered here. The general assumption is that molecules containing 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore will show similar mechanisms of action in biological systems by acting as Michael acceptors. This assumption is supported by the finding of common patterns of response in cells exposed to different compounds (see below).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of some of the compounds discussed in the text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Cancer Cells Are Selectively Sensitive to Dienone Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Early studies of compounds containing the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore were performed by Dimmock and colleagues at the University of Saskatchewan.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> These investigators documented interesting biological responses to these compounds, stimulating further interest. One of the early compounds described by Dimmock et al. was <b>1a</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a compound that inhibited the proliferation of cancer cells in the low μM range. Dimmock and colleagues have over the years studied a respectable number of compounds belonging to this class and have established structure–activity relationships (reviewed in refs <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>). The dienone has been found to be required for optimal cytotoxicity, and as expected, electron drawing groups on the aryls increase the antiproliferative effect.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">An interesting property of the compounds described by Dimmock and co-workers is their preferential cytotoxic to tumor cells.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18−21)</a> The Dimmock group reported selective indices (sensitivity of tumor cells relative to noncancerous cells) of >10-fold<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Selective antiproliferative activity to tumor cells has been verified by other laboratories<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25 ref26">(21−26)</a> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">Supplementary Table 1</a>). Analyses have not been restricted only to slowly proliferating primary cells but also to established immortalized noncancerous cell lines such as MCF-10A (a human breast cell line with a reported population doubling time of ∼19 h <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) and hTERT-RPE1 (an immortalized human epithelial cell line with a doubling time of ∼14 h <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a>). The proliferation rates of these cells are in the same range as those of many of the cancer cells listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">Supplementary Table 1</a>. It is therefore unlikely that the preferential cytotoxicities of dienones to tumor cells are solely due to their differences in proliferation rates.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Tumor cell selectivity of dienone compounds. The log<sub>10</sub> IC<sub>50</sub> values are shown on the <i>y</i>-axis in the upper graph and selectivity indices on the <i>y</i>-axis in the lower graph. Shown are the mean ± SD values where possible to calculate (i.e., where data from three or more cell lines were reported). The figure is based on the data in presented <a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">Supplementary Table 1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">EF24 (3,5-bis(2-fluorobenzylidene)piperidin-4-one) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was identified in a screen of different α,β-unsaturated ketones for their activities against cancer cell lines.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> EF24 was also suggested to exhibit antiangiogenic properties based on inhibition of the proliferation of endothelial cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> EF24 induces apoptosis as evidenced by activation of caspase-3, externalization of phosphatidylserine, and depolarization of mitochondrial membranes.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Inhibition of the proliferation of colon and gastric adenocarcinoma cells was observed at a concentration of 1 μM, whereas mouse embryo fibroblasts were not affected at 5 μM.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Selective cytotoxicity to tumor cells by EF24 was also reported by Santiago-Vazquez and co-workers (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">Supplementary Table 1</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Daily ip administration of EF24 suppressed the growth of colon cancer tumor xenografts in nude mice.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Administration of 100 mg/kg EF24 did not cause harmful side effects to animals.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> These findings have been repeated in later studies of EF24 using hepatocellular carcinoma,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> adrenocortical tumors,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> colorectal cancer,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> cholangiocellular carcinoma,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> oral squamous cell carcinoma<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and pancreatic cancer.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">H-4073 is a para-fluorinated variant of EF24 described to be more potent to ovarian cancer cells than the parental compound.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Yet another related compound, named HO-3867, was subsequently developed (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> HO-3867 showed a higher level of growth inhibitory activity to ovarian cancer cells compared to untransformed human ovarian surface epithelial cells.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> HO-3867 was effective in an ovarian cancer xenograft model using a schedule of oral administration. Further studies have shown that HO-3867 induces apoptosis of breast, colon, and liver cells whereas normal breast fibroblasts showed limited sensitivity.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> HO-3867 was also reported to show <i>in vitro</i> activity on pancreas cancer cell lines<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> and endometrial cancer cell lines.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> An EF24 analogue was recently described that showed a similar antiproliferative activity toward cancer cells as the parental compound but lower activity to normal cells.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> For a recent review on the biological activities of EF24, see ref <a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>.</div><div class="NLM_p">The group of Brancolini and co-workers at the University of Udine identified two compounds, F6 (NSC632839) and G5 (NSC144303) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), as capable of triggering caspase activation in cells with a mutated caspase-9.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> A prodrug version of G5 (2c-PE) that can be activated by esterases was developed and shown to suppress the growth of A549 lung carcinoma xenografts in mice.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">The compound NSC687852 (later named b-AP15) was originally identified in a screen for compounds that induce apoptosis of colon cancer cells independently of p53.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The compound was later found to elicit the lysosomal apoptosis pathway<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and to show antineoplastic activity in different tumor models including lung cancer and acute myelocytic leukemia.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Nontransformed hTERT-RPE1 epithelial cells showed limited sensitivity to b-AP15<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). VLX1570 is an analogue of b-AP15 with a central azepane ring (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) that induces an indistinguishable cellular response from b-AP15 while having a slightly improved solubility and potency.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> VLX1570 has been shown to have antitumor activity in multiple myeloma,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Ewings sarcoma,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Waldenströms macroglobulinemia,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and also other diseases (see<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a>).</div><div class="NLM_p">Bazzaro and colleagues<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> demonstrated cytotoxicity of a series of 3,5-diarylidene-4-piperidones (RA-1 to RA-9, RAMB1 to RAMB4) toward three cervical cancer cell lines, whereas the viability of primary human keratinocytes was only marginally affected. The compound RA-9 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) induced apoptosis of ovarian cancer cell lines but not of primary ovarian surface epithelial cells.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A related compound named RA-190 was later shown to preferentially kill HPV-transformed cells.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> RA-190 reduced the growth of both multiple myeloma and ovarian cancer xenografts and the growth of HPV-16 positive cells in a syngeneic mouse model.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div class="NLM_p">Ewing sarcoma is a bone malignancy that affects children.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Patients with metastatic disease have dismal outcomes despite aggressive treatment. Shukla et al. screened a library of >300 000 small molecules to identify compounds that selectively inhibit the growth of Ewing sarcoma cell lines.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The screen identified two benzyl-4-piperidone compounds, EWS-P (NSC666038) and EWS-W (NSC669441) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><div class="NLM_p">Wang et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> showed that the compound MCB-613 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) induced ER stress and reactive oxygen species (ROS) in tumor cell lines. The potency of the compound in proliferation assays was 3–6 μM on tumor cell lines, whereas primary hepatocytes and mouse embryo fibroblasts were less sensitive. MCB-613 was also identified in a screen for UPS inhibitors (as CB826) and was shown to be cytotoxic to melanoma, colon cancer, and multiple myeloma cells.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">A number of additional laboratories have synthesized and examined the biological responses to various dienone compounds, generally 3,5-bis(arylidene)-4-piperidones. Two different groups have reported activity of dienones on estrogen receptor negative breast cancer cells.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> Stronger antiproliferative activities were observed toward breast cancer cells compared to the noncancerous human breast cell line MCF-10A. Kalai et al. reported the antiproliferative activities of a number of 3,5-bis(arylidene)-4-piperidones, including <b>5e</b>, on two cancer cell lines and a noncancerous cardiomyoblast cell line<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">Supplementary Table 1</a>). Phosphonate derivatives of 3,5-bis(arylidene)-4-piperidones were found to display inhibitory properties toward four different human cancer cell lines with IC<sub>50</sub> values in the range of 2.5–8.5 μM.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> α,β-unsaturated piperidones were described that were active at <1 μM when tested on five cancer cell lines.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> One of the compounds (1b) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) displayed marked inhibitory effects in a lung carcinoma xenograft model with no apparent toxicity. Wei et al. synthesized 61 symmetrical dienone compounds and examined their anticancer activity toward three different cancer cell lines.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Two compounds containing sulfur or oxygen heteroatoms in the 4-position of the central six-carbon ring (E10, F10; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) exhibited antiproliferative activities at concentrations below 1 μM. Youssef et al. reported that amino acid conjugates of 3,5-bisarylmethylene-4-piperidones display improved cytostatic activities compared to compounds without N-substitutions.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Finally, Cheng et al. showed that the 3,5-bis(arylidene)-4-piperidone 7g decreased PSA promoter activity and lowered viability of LNCaP prostate cancer cells.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Molecules lacking the central ring structure (dibenzylideneacetone, DBA, and related molecules, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) have also been described to display antineoplastic activities. These compounds were shown to be less active than cycloketones.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A possible explanation for this difference is the larger flexibility of acyclic dienones compared to compounds with rigid piperidine rings.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The Arbiser laboratory at Emory University has examined the effects of Tris dibenzylideneacetone dipalladium (Tris DBA) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) in a number of studies. Tris DBA showed significant antiproliferative activity against melanoma cells, and ip injection of Tris DBA resulted in a 97% decreased tumor volume in the B16 murine melanoma model.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Tris DBA reduces cell proliferation and induces apoptosis in multiple myeloma cells while not exerting toxicity to normal peripheral blood mononuclear cells.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Antineoplastic activity of Tris DBA was also documented in an uveal melanoma xenograft model.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Finally and interestingly, considering the severity of the disease, Tris DBA was found to be effective in an orthotopic model of pancreatic cancer.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Similar results have been reported using similar compounds.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> Human mucoepidermoid carcinoma cell lines and tumor xenografts were found to be sensitive to DBA without reported systemic toxicity.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p last">We conclude from this overview that there is considerable evidence from different laboratories that dienone compounds containing the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore are cytotoxic to tumor cells and that a number of these compounds are less cytotoxic to nontransformed cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Other Activities of Dienones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In addition to the cytotoxic/antiproliferative activities to tumor cells, dienone compounds have been reported to have other biological effects, including anti-inflammatory and antiparasitic activity.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Anti-Inflammatory and Antiviral Activity</h3><div class="NLM_p">Zhao et al. showed that compound C12 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) showed low cytotoxicity to macrophages but potently inhibited the stimulation of proinflammatory cytokines such as TNF-α and IL-6 by LPS.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The activity of C12 was associated with inhibition of ERK/JNK phosphorylation and NF-κB activation.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> C12 suppresses proinflammatory cytokine production in LPS-exposed mice. The compound was administered by iv injection prior to injection of LPS. EF24 has also been reported to display anti-inflammatory activities, related to NF-κB inhibition.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a></div><div class="NLM_p last">3,5-Bis(arylidene)-4-piperidones have been reported to inhibit the Dengue virus NS3 protease.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Only <i>in vitro</i> biochemical data were reported, and the results should be viewed with some caution due to the PAINS nature of this class of compounds.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Antiparasitic Activity</h3><div class="NLM_p last">Independent research groups have reported that dienones are active against the malaria parasite <i>Plasmodium falciparum</i>. The dibenzylidene-acetone A9 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was found to display an IC<sub>50</sub> of 1.7 μM against a chloroquine-resistant isolate of <i>P. falciparum</i>.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Similar results were reported using b-AP15, shown to inhibit the growth of intraerythrocytic <i>P. falciparum</i> parasites.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> b-AP15 induced the accumulation of lysine-48-linked polyubiquitinylated proteasome substrates in the treated parasites. The data suggested effects on the ubiquitin–proteasome system, although not at the level of the 20S proteasome or by general inhibition of deubiquitinases.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> DBA was reported to arrest the growth of <i>Leishmania donovani</i> parasites and induce dissipation of mitochondrial membrane potential.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Targets Described for Dienone Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">3,5-Bis(arylidene)-4-piperidones and related compounds are often PAINS, and using these compounds in <i>in vitro</i> assays biochemical assays is potentially problematic.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Reactive compounds will score positive also in different bioassays,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> but problems such as inhibition of enzyme activity due to coprecipitation with insoluble compounds are likely to be less common. In the following we have primarily focused on data that have been validated using cellular assays.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Inhibition of the Ubiquitin–Proteasome System (UPS)</h3><div class="NLM_p last">A number of laboratories have reported that compounds with the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore induce the accumulation of lysine-48-linked polyubiquitinated proteins in cells.<a onclick="showRef(event, 'ref21 ref22 ref23 ref44 ref53 ref55'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref44 ref53 ref55">(21−23,44,53,55)</a> Lysine-48-linked polyubiquitinated proteins bind to, and are degraded by, the proteasome, and the accumulation of such proteins in cells is a characteristic feature of proteasome inhibitors. Experiments using glycerol gradient centrifugation<a onclick="showRef(event, 'ref49 ref57'); return false;" href="javascript:void(0);" class="ref ref49 ref57">(49,57)</a> and affinity purification of proteasomes<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> have demonstrated that polyubiquitinated proteins are associated with proteasomes in exposed cells. Further evidence of proteasome inhibition includes the accumulation of a proteasome-degradable reporter (Ub<sup>G76V</sup>-YFP) and proteins such as p53 and p21<sup>Cip1</sup>.<a onclick="showRef(event, 'ref22 ref30 ref37 ref45 ref55 ref81'); return false;" href="javascript:void(0);" class="ref ref22 ref30 ref37 ref45 ref55 ref81">(22,30,37,45,55,81)</a> These findings are interesting considering that the proteasome is a validated target of anticancer drugs and inhibitors of the 20S proteasome are in clinical use.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The compounds discussed here generally do not affect 20S proteasome activity, and different mechanisms have been proposed to explain the phenomenon of accumulation of proteasome substrates.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Inhibition of Deubiquitinases (DUBs)</h3><div class="NLM_p last">Brancolini et al. showed that compounds G5 and F6 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) induced strong accumulation of polyubiquitinated proteins in exposed cancer cells.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The same group<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> used a biotin conjugate as a probe to identify the cellular targets of the dienone compound 2c (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Importantly, the biotin modification did not alter the biological activity of 2c. The 2c-biotin probe was found to bind to a number of DUBs, USP1 and USP33 showing a higher affinity compared to USP14, USP18, and UCHL5.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> USP1 and USP33 were reported to be rare proteins, and their contribution to total cellular DUB activity may be limited. Other proteins were found to be modified by 2c-biotin, including AKT and a phosphorylated form of cofilin-1, and it was suggested that these targets contribute to the pharmacological effects of 2c.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Thus, cells exposed to 2c show alterations of the cytoskeleton that may be functionally linked to cofilin-1.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Inhibition of Proteasome-Associated DUBs</h3><div class="NLM_p">D’Arcy et al. showed that b-AP15 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) induces strong accumulation of polyubiquitin and inhibition of the degradation of a proteasome-degradable reporter in exposed cancer cells.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Polyubiquitinated proteins were found to be associated with proteasomes<a onclick="showRef(event, 'ref22 ref57'); return false;" href="javascript:void(0);" class="ref ref22 ref57">(22,57)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). b-AP15 does not inhibit 20S proteasome activity but inhibits the activity of the proteasome-associated DUBs USP14 and UCHL5, both <i>in vitro</i> and in cells.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Knock-down of both USP14 and UCHL5 is known to result in polyubiquitin accumulation and cytotoxicity,<a onclick="showRef(event, 'ref49 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref49 ref84 ref85">(49,84,85)</a> and inhibition of proteasome-associated DUBs represents an alternative strategy for inhibition of proteasome function.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Finally, Didier et al. demonstrated that adenoviral-mediated overexpression of USP14 results in decreased sensitivity to b-AP15.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. b-AP15 and structurally related compound induce accumulation of polyubiquitinated proteins on proteasomes. Lysates from cells exposed to different compounds were fractionated by glycerol gradient centrifugation, and fractions were collected and processed for immunoblotting. Compounds CID1381237, CID2247230, and CID2175947 were identified in a cell-based screen for compounds stimulate accumulation of Ub<sup>G76V</sup>-YFP in exposed cells.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> CID 2175947 (CB826 in ref <a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a>) is also known as MCB-613 and has been described to stimulate steroid receptor coactivator activity and to be preferentially cytotoxic to cancer cell lines.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> CID1381237 is also known as A9<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and C8.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Data reproduced from ref <a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a>, which licensed under <a href="https://creativecommons.org/licenses/by/4.0/" class="ext-link">CC BY 4.0</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the USP14 and UCHL5 DUBs are not structurally related, it would appear unlikely that a small molecule will inhibit both these enzymes. Inhibition of USP14 and UCHL5 has, however, been demonstrated in cells exposed to pharmacological concentrations of b-AP15.<a onclick="showRef(event, 'ref22 ref86'); return false;" href="javascript:void(0);" class="ref ref22 ref86">(22,86)</a> Most studies have shown that USP14 is inhibited at lower concentrations of b-AP15 (or VLX1570) than UCHL5.<a onclick="showRef(event, 'ref49 ref50 ref81 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref81 ref86 ref87">(49,50,81,86,87)</a> VLX1570 binds to USP14 and to proteasomes in surface plasmon resonance (SPR) experiments.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Binding of VLX1570 to the 26S proteasome was inhibited by pretreatment with ubiquitin vinylsulfone (an active site-specific DUB probe<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a>), consistent with binding to proteasome DUBs.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Furthermore, as discussed above, USP14 binds to biotin-conjugated 2c.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Incubation of recombinant USP14 with b-AP15 results in molecular weight shifts using MALDI.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In these <i>in vitro</i> experiments, the degree of binding (i.e., one or two bound b-AP15 molecules) depends on incubation time. Somewhat surprisingly, an apparent thermal stabilization of USP14 at ∼53 °C was observed in cells exposed to b-AP15/VLX1570.<a onclick="showRef(event, 'ref49 ref50 ref57'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref57">(49,50,57)</a> The proteasome is known to unfold this temperature,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and “thermal stabilization” is likely to result from a partial dissociation of USP14 from the proteasome, leading to an enrichment in the soluble fraction after heating. This effect has been observed under CETSA conditions (heating); USP14 does not dissociate from the proteasome at other conditions.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">UCHL5 appears to be less sensitive than USP14 to inhibition by dienones.<a onclick="showRef(event, 'ref49 ref81 ref87'); return false;" href="javascript:void(0);" class="ref ref49 ref81 ref87">(49,81,87)</a> Both G5 and RA-190 do, however, inhibit the activity of recombinant UCHL5.<a onclick="showRef(event, 'ref45 ref90'); return false;" href="javascript:void(0);" class="ref ref45 ref90">(45,90)</a> UCHL5 binds to a biotin-conjugated 2c probe,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and RA-190 binds to the catalytic domain of UCHL5/UCH37.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> In the latter study, four adducts were observed after incubation of His-UCHL5 with 20-fold excess of RA-190 for 8 h at 37 °C.</div><div class="NLM_p">RA-9 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was shown to induce accumulation of polyubiquitinated proteins in ovarian cancer and breast cancer cells.<a onclick="showRef(event, 'ref24 ref91'); return false;" href="javascript:void(0);" class="ref ref24 ref91">(24,91)</a> RA-9 inhibits proteasome-associated DUB activity, whereas total cellular DUB activity is not inhibited by it.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Similar to b-AP15, RA-9 induces autophagic flux and inhibition of autophagy increases RA-9-mediated cytotoxicity.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><div class="NLM_p">Since USP14 and UCHL5 are members of different families of DUB enzymes, it appears likely that compounds that inhibit the activities of both these enzymes will be general DUB inhibitors. Dienones have indeed been shown to inhibit DUB and also deSUMOylase activities.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> As discussed above, Ciotti et al. demonstrated widespread reactivity of compound 2c to cellular DUBs.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Inhibition of UCHL1, UCHL5, USP2, and USP18 was demonstrated by G5 and 2c.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> These results are in apparent conflict with the results from other laboratories showing that total cellular DUB activity is not inhibited by b-AP15/RA-9 at concentrations where proteasome DUB activity is inhibited.<a onclick="showRef(event, 'ref22 ref24 ref77'); return false;" href="javascript:void(0);" class="ref ref22 ref24 ref77">(22,24,77)</a> A possible explanation for this discrepancy is that the contribution of different DUBs to the total cleavage activity in total cell lysates may be quite disproportionate: a limited number of DUBs may be responsible for most of the cleavage activity in the lysates, and these DUBs may be dienone-insensitive. However, at a concentration of 20 μM, VLX1570 did not show general DUB inhibitory activity on a panel of recombinant DUBs.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> It was recently reported that total DUB activity in cell lysates is inhibited by 10 and 50 μM b-AP15.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The same authors reported inhibition of the activity of different recombinant DUBs using 100 μM b-AP15. This concentration is in the order of >100 times the IC<sub>50</sub> and difficult to interpret. In general, results obtained using biochemical <i>in vitro</i> assays of enzyme activity are unreliable. Thus, findings of no inhibition of DUB enzyme activity can be incorrect due to limited compound solubility (a common problem encountered with these compounds). Conversely, findings of DUB inhibition may be incorrect due to the PAINS nature of these compounds. Considering the reported ability of dienones to inhibit DUBs of both the USP and UCH families in exposed cells, it seems reasonable to conclude that dienones are very likely to be partially selective DUB inhibitors.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p last">Given that dienones are partially selective DUB inhibitors, the question arises with regard to the importance of inhibition of proteasome-associated DUBs, in relation to other DUBs, for the cytotoxicity of dienones. CRISPR deletion screening has demonstrated that the majority of DUB enzymes are nonessential for cell viability.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> In contrast, co-transfection with siRNA to both USP14 and UCHL5 is known to result in decreased processing of proteasome substrates<a onclick="showRef(event, 'ref84 ref87'); return false;" href="javascript:void(0);" class="ref ref84 ref87">(84,87)</a> and decreased cell viability.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> We have, so far, been unable to generate USP14/UCHL5 double knock-out cells to test their sensitivity to b-AP15.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Binding to the Ubiquitin Receptor Rpn13</h3><div class="NLM_p">Anchoori et al.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> reported that, similar to other dienones, RA-190 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) induces accumulation of polyubiquitin in exposed cancer cells. These authors found that RA-190 binds to Cys88 of the proteasome–ubiquitin receptor Rpn13 and suggested this to be the mechanism of action of the compound. A similar mechanism of action, involving Rpn13, has been suggested for EF24.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Rpn13 is known to bind and to activate the DUB UCHL5, and it was subsequently shown that RA-190 does not affect the interaction of Rpn13 with UCHL5 but directly inactivates UCHL5.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_p last">The studies of the role of Rpn13 and UCHL5 with regard to the mechanism of action of RA-190 are complicated by the fact that knock-out or knock-down of Rpn13 will lead to loss of UCHL5. In a recent study, Osei-Amponsa et al.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> showed that a cell line expressing an Rpn13 receptor lacking the Pru domain, necessary for proteasome and ubiquitin binding, is less sensitive to RA-190 compared to parental cells. Although these cells were not completely resistant to RA-190, the result demonstrates the involvement of the proteasome in conferring sensitivity to RA-190.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Organelle Stress</h3><div class="NLM_p">The robust induction of cell death by dienones (i.e., apoptosis-induction in Apaf-1 negative cells, BCL2 overexpressing cells, and p53<sup>null</sup> cells; see further below) can be interpreted in terms of major disruptions of cellular homeostasis. Many studies have shown that dienone compounds induce ER stress.<a onclick="showRef(event, 'ref98 ref23 ref99 ref39 ref57 ref81'); return false;" href="javascript:void(0);" class="ref ref98 ref23 ref99 ref39 ref57 ref81">(98,23,99,39,57,81)</a> This is expected considering the common finding of disturbancies of the ubiquitin–proteasome system observed by many investigators. Other types of organelle stress such as mitochondrial stress and lysosomal permeabilization have also been reported.</div><div class="NLM_p">In their initial study of G5/F6, Brancolini and co-workers<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> showed that these compounds induce mitochondrial fragmentation prior to induction of membrane permeabilization and cytochrome <i>c</i> release. The 20S proteasome inhibitor MG-132 induced a similar effect.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Dienones have been suggested to induce direct mitochondrial membrane permeability transition by oxidation or cross-linking of membrane proteins.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Zhang et al. showed that polyubiquitinated proteins become associated with mitochondrial outer membranes in cells exposed to b-AP15.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The amounts of misfolded proteins on mitochondrial membranes correlated with decreases in oxidative phosphorylation.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Dienone compounds, including b-AP15, were identified in a screen for compounds that induce the lysosomal pathway of apoptosis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Knock-down of the lysosomal enzyme cathepsin-D reduced caspase-cleavage in cells exposed to b-AP15 and also to other inhibitors of the UPS.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p last">An association between proteotoxic stress and organelle stress would offer an explanation for the selective sensitivity of tumor cells to dienones (due to high protein synthesis and a high production of misfolded proteins) and the robust induction of cell death.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Stimulation of Steroid Receptor Coactivators</h3><div class="NLM_p last">MCB-613 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was identified in a cell-based screen for compounds that stimulate the activity of SRC-1 and SRC-3 steroid receptor coactivators.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> MCB-613 increases the interactions of SRC proteins with other coactivators and induces ER stress and generation of reactive oxygen species. MCB-613 was also found to induce cellular accumulation polyubiquitinated proteins but this was not considered to be the primary mechanism of action of the compound.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> MCB-613 (CB826) was subsequently identified in a screen for compounds that inhibit the processing of a proteasome-degradable reporter and was found to increase the levels of polyubiquitinated proteins on proteasomes<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cross-Linking of Proteins</h3><div class="NLM_p">The dienone structure of 1,5-diaryl-3-oxo-1,4-pentadienes raises the possibility of protein cross-linking. Ward et al. recently raised the possibility of cross-linking being an important mechanism of action of b-AP15/VLX1570.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The distance between the carbonyls is approximately 5.1 Å apart in 3,5-bis(arylidene)-4-piperidones,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> arguably a short distance for a chemical cross-linker. Ward et al. did show that b-AP15 can bind two molecules of GSH. The thiols of GSH would, however, be expected to be more sterically available than most cysteine thiols on larger protein structures. Ward et al. demonstrated the formation of protein dimers in cells exposed to VLX1570.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Of particular interest was the finding of dimers of anamorsin/CIAPIN1, an apoptotic regulator, raising the possibility that functional depletion of this protein is important for the mechanism of action of VLX1570. The authors did, however, not detect direct cross-linking of anamorsin/CIAPIN1 involving thiols and the mechanism of dimer formation is unclear.</div><div class="NLM_p">Cross-linked protein material, detected as slowly migrating material using by SDS–PAGE and Coomassie Blue staining, was observed using 10 μM b-AP15/1570.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> We also observe high MW protein complexes in AML cells exposed to 10 μM b-AP15 (Selvaraju et al., unpublished data). It should be noted that 10 μM b-AP15 is a quite high concentration (10- to 100-fold the IC<sub>50</sub> in most cells) and that the cell death mode elicited by b-AP15 shifts from apoptosis to necrosis at concentrations of ≥5 μM.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> High molecular weight material is generally not observed using SDS–PAGE using IC<sub>50</sub> concentrations of dienone compounds (e.g., RAMB1 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), Figure 7A in Anchoori et al., 2011<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a>), and the molecular weights of various cellular proteins are not altered on immunoblots. However, the molecular weights of polyubiquitinated proteins gradually increase at pharmacologically more relevant concentrations of VLX1570 (0.5–1 μM, see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). We initially interpreted the increases in molecular weight in terms of DUB inhibition leading to longer polyubiquitin chains being attached to proteins.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> An alternative interpretation is that cysteines in unfolded proteasome substrates will be more available to adduction by dienones. The formation of high molecular weight complexes and aggregation of proteins by Michael acceptors need to be further studied to evaluate mechanisms of aggregation and whether protein aggregation is coupled to cytotoxicity.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration-dependent responses to VLX1570. (A) Induction of polyubiquitinated proteins in RS4;11 ALL cells. Note strong increases of polyubiquitin and induction of Hsp70 at 250 nM VLX1570. (B) Increases in p21<sup>Cip1</sup>, LYN, and HMOX1. RS4;11 cells were exposed to VLX1570, and different markers were analyzed in the same extracts using a PCR-based multiplex method (OLINK, Uppsala, Sweden). Note the increases of HMOX1 at 50–100 nM VLX1570 and the decreases of all markers at high concentrations. Figure from ref <a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a>, which licensed under <a href="https://creativecommons.org/licenses/by/3.0/" class="ext-link">CC BY 3.0</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cystic fibrosis transmembrane conductance regulator (CFTR) can be cross-linked into dimers after exposure of cells or microsomes to curcumin.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Cross-linking of the CFTR was observed also in the presence of high concentrations of reducing agents and using a cysteine-free CFTR construct, showing that oligomerization was not due to disulfide cross-linking. The authors suggested that cross-linking was associated with an oxidative reaction.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Protein cross-linking has been observed using also other compounds. Stanwell et al. tested the tyrosine kinase inhibitor erbstatin and related compounds for cross-linking of cellular proteins using an assay based on boiling cells for 10 min in 2% SDS/20 mM DTT and filtering through cellulose membranes.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Methyl 2,5-dihydroxycinnamate (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), containing a single Michael acceptor, was found to generate SDS/DTT insoluble protein material in treated cells. Cross-linking was observed at concentrations ∼5-fold the IC<sub>50</sub> in cell proliferation assays, suggesting that it was not associated with inhibition of cell proliferation. Cross-linking was observed at both +37 °C and +4 °C, and a mechanism involving oxidation of compounds to reactive quinones that cross-link protein nucleophiles was suggested.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Pinto et al. reported that a benzophenazine photosensitizer, OR141, induced the formation of high molecular weight complexes.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Interestingly, OR141 was shown to induce polyubiquitinated proteins and to inhibit USP14 and UCHL5 activity <i>in vitro</i>. OR141 was speculated to induce disulfide bond formation, leading to formation of high molecular weight complexes.</div><div class="NLM_p last">The findings of cross-link formation by dienone compounds lead to the possibility that (i) specific proteins of importance for cellular homeostasis may be depleted and/or that (ii) cross-linked protein complexes are formed in amounts sufficient to elicit cytotoxicity. The results showing depletion of anamorsin/CIAPIN1 support the first notion (further discussed below).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> We are, however, not aware of evidence supporting the notion that protein complexes formed at pharmacologically relevant concentrations of dienones lead to cytotoxicity.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Induction of Oxidative Stress</h3><div class="NLM_p last">Induction of oxidative stress by dienone compounds has been reported in a number of studies.<a onclick="showRef(event, 'ref23 ref29 ref32 ref36 ref39 ref81 ref98 ref106'); return false;" href="javascript:void(0);" class="ref ref23 ref29 ref32 ref36 ref39 ref81 ref98 ref106">(23,29,32,36,39,81,98,106)</a> Some of these studies use <i>N</i>-acetyl cysteine (NAC) as a tool to demonstrate that oxidative stress is essential for apoptosis induction. This is problematic since NAC will bind directly to the compounds, leading to their inactivation.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Other scavengers have, however, also been used, and the results showed that oxidative stress induction is involved in triggering apoptosis (but not cell death).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Different mechanisms have been put forward to explain the induction of oxidative stress. The enzymatic activity of thioredoxin reductase (TrxR), an enzyme essential for cellular redox-homeostasis, is dependent on the motif Gly-Cys-Sec-Gly in which Sec is selenocysteine and particularly reactive to electrophiles.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Both b-AP15 and EF24 inhibit TrxR,<a onclick="showRef(event, 'ref87 ref106'); return false;" href="javascript:void(0);" class="ref ref87 ref106">(87,106)</a> presumably by binding to the selenocysteine. An alternative mechanism for oxidative stress induction has been proposed involving mitochondria. Stimulation of oxidative stress by b-AP15 was diminshed in Rho<sup>null</sup> cells depleted of mitochondrial DNA,<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> suggesting that the oxidative stress observed in cells exposed to b-AP15 is partly of mitochondrial origin.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Inhibition of Translational Elongation</h3><div class="NLM_p">Bortezomib treatment results in the induction of the unfolded protein response (UPR), including induction of phosphorylation of eIF2α.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Induction in eIF2α phosphorylation will decrease translation and the production of proteasome substrates, constituting a protective response.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> We observed that the induction of various markers such as p21<sup>Cip1</sup> and LYN, proteins known to be proteasome substrates,<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111,112)</a> peak at concentrations of 250–500 nM VLX1570 and then decrease (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). The lower level of induction at higher drug concentrations would be consistent with induction of the UPR, leading to decreased translation. Interestingly, however, the same pattern was observed for Hsp70 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Hsp70 translation is cap-independent due to the presence of an internal ribosome binding site,<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> and translation should therefore not be affected by induction of the UPR. VLX1570 was indeed shown to inhibit translation by another mechanism, at the level of translational elongation, in a recent study.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p last">Inhibition of translation may be relevant to the mechanism of action of VLX1570. Tumor cells are sensitive to obstructions in protein homeostasis, and an inhibitor of translational elongation (omacetaxine mepesuccinate) has been approved for treatment of chronic myeloid leukemia.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> However, it should be noted that translational inhibition is observed at slightly higher concentrations compared to proteasome inhibition.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Inhibition of Intracellular Signaling Systems</h3><div class="NLM_p last">Various investigators have examined the effects of dienones on important cellular signaling molecules such as STAT transcription factors, MAP, AKT, and Src kinases. HO-3867, Tris DBA, and b-AP15 have been described to inhibit STAT3 phosphorylation.<a onclick="showRef(event, 'ref36 ref41 ref66 ref86'); return false;" href="javascript:void(0);" class="ref ref36 ref41 ref66 ref86">(36,41,66,86)</a> Tris DBA and NC2213 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) inhibit Src phosphorylation.<a onclick="showRef(event, 'ref25 ref116'); return false;" href="javascript:void(0);" class="ref ref25 ref116">(25,116)</a> AKT has been demonstrated to be targeted by 2c using mass spectrometry,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and AKT phosphorylation is inhibited by b-AP15 in lymphoma cells,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> by EF24 in colon cancer cells,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> by the compounds RL90 and RL91 in breast cancer cells,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> by E10 in prostate cancer cells,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and by Tris DBA in melanoma cells.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Furthermore, ERK phosphorylation is inhibited by b-AP15<a onclick="showRef(event, 'ref49 ref86'); return false;" href="javascript:void(0);" class="ref ref49 ref86">(49,86)</a> and by DBA/Tris DBA<a onclick="showRef(event, 'ref34 ref66'); return false;" href="javascript:void(0);" class="ref ref34 ref66">(34,66)</a> and E10<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> in different tumor cells. The basal levels of GTP-loaded RAS are decreased by b-AP15.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Whether the effects on these signaling systems are instrumental to the mechanism(s) of action of various compounds or are secondary consequences of severe stress is not well understood.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methionine Aminopeptidase</h3><div class="NLM_p last">Methionine aminopeptidases (MetAPs) remove methionine from the amino terminus of some newly synthesized proteins, essential for co-translational protein maturation processes such as myristoylation.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> MetAP2 is essential for the growth of different types of cancer cells.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> MetAP2 expression decreases in HT29 cancer cells after exposure to NC2213 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Decreased levels of Src phosphorylation were observed in parallel to the decreases in MetAP2; Src is a myristoylated oncoprotein, and a causal relationship was suggested.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Reactivation of Mutant p53</h3><div class="NLM_p last">Much interest has been focused on the possibility of reactivating mutant p53 molecules to active forms.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> It was reported that HO-3867 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) covalently binds to mutant p53, resulting in restoration of a wild-type p53-like response.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> This mechanism would explain the selective cytotoxicity toward cancer cells by this class of compounds. The result is, however, in apparent conflict with findings using b-AP15 where antiproliferative effects and/or apoptosis induction was found to be insensitive to p53 mutational status.<a onclick="showRef(event, 'ref22 ref81'); return false;" href="javascript:void(0);" class="ref ref22 ref81">(22,81)</a> Furthermore, the IC<sub>50</sub> of p53<sup>wt</sup> cell lines in the NCI<sub>60</sub> panel to b-AP15 is 0.18 μM, and the IC<sub>50</sub> of p53<sup>mut</sup> cell lines is 0.15 μM (<i>p</i> = 0.70). The discrepancy could be explained by b-AP15 and HO-3867 having different mechanisms of action (HO-3867 has not been examined for possible inhibition of proteasome function).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Effects on DNA Repair Pathways</h3><div class="NLM_p last">The ataxia telangiectasia mutated (ATM) gene product is activated in cells exposed to 2cPE (a pegylated derivative of 2c).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> ATM is known to be activated by oxidative stress due to disulfide-cross-linked dimerization,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> and the stimulation of ATM signaling may therefore be a consequence of oxidative stress. ATM inhibition was found to increase 2cPE-induced cell death.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> A similar finding has been reported for EF24, showing that ATM-deficient cells are more sensitive to this compound.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> EF24 was also found to inhibit the Fanconi anemia pathway, possibly due to inhibition of IκB kinase complex.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Analyses of Gene Expression Profiles (CMap)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The connectivity map (CMap) is a freely available and quite useful resource for initial characterization of the cellular response to small molecules. The CMap method was originally described in 2006,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and an updated database was presented more recently.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> In the original study by Lamb et al.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> it was demonstrated that compounds sharing molecular targets induce similar molecular signatures (i.e., alterations in gene expression patterns, determined by the microarray method). Conditions were standardized with regard to the concentration of small molecules, time of exposure, and the cell line used (usually the MCF-7 breast cancer cells). The authors were able to show that CMap could be used to elucidate the mechanism of action of a natural product.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">The responses to dienones have been characterized using gene expression profiling (CMap).<a onclick="showRef(event, 'ref21 ref22 ref48 ref120'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref48 ref120">(21,22,48,120)</a> These experiments show high correlation (connectivity) to known inhibitors of the 20S proteasome such as MG-132.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Induction of HSPA6 mRNA transcripts (an inducible form of the Hsp70 family of molecular chaperones) after 6 h of exposure to b-AP15 or P1 was at the level of ∼1000-fold, stronger than that observed using standard 20S proteasome inhibitors<a onclick="showRef(event, 'ref21 ref98'); return false;" href="javascript:void(0);" class="ref ref21 ref98">(21,98)</a> (P1 is identical to EWS-W; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Gene expression analyses have also been performed on cells exposed to 2c-PE and showed induction of expression of chaperones, particularly transcripts encoding Hsp70 proteins.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> The response to the compound MCB-613/CB826 has also been studied.<a onclick="showRef(event, 'ref23 ref57'); return false;" href="javascript:void(0);" class="ref ref23 ref57">(23,57)</a> Gene set enrichment analyses (GSEA)<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> showed an enrichment score of >2 for genes encoding proteins involved in protein folding.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The mechanism underlying the stronger induction of chaperone genes by dienones in comparison to bortezomib is unclear but may at least partly be explained by the limited formation of aggresomes.<a onclick="showRef(event, 'ref81 ref125'); return false;" href="javascript:void(0);" class="ref ref81 ref125">(81,125)</a> The formation of aggresomes represents a mechanism for cells to escape cytotoxic effects of unfolded cellular proteins,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and ineffective formation of these structures may lead to increased proteotoxicity.</div><div class="NLM_p last">Compound F6 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is in the CMap database, and the connectivity score (tau-score) between F6 and loss of function of the proteasome pathway (deletion of proteasome subunits) is +99.55 (<a href="https://clue.io/query" class="extLink">https://clue.io/query</a>). Tau-scores of +90 or higher are considered as strong indicators of related mechanisms of action (<a href="https://clue.io/connectopedia/connectivity_scores" class="extLink">https://clue.io/connectopedia/connectivity_scores</a>). It should be noted, however, that compounds that affect protein homeostasis at other levels also show strong connectivity to loss of function of the proteasome pathway, including 17-DMAG (Hsp90 inhibitor, tau-score of +95.9) and puromycin (protein synthesis inhibitor, tau-score of +97.4). Furthermore, heat shock factor-1 (HSF1), essential for induction of chaperones, is activated by electrophiles<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> and electrophiles will therefore show connectivity to UPS inhibitors. The extent of this latter effect may, however, be limited since the dienone curcumin shows only weak connectivity to loss of function of the proteasome pathway (tau-score of +19.5). We conclude that CMap data are consistent with the notion that dienone compounds are proteasome inhibitors but do not provide positive proof.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Association between Inhibition of Proteasome Function and Cell Death</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is known that a considerable fraction of newly synthesized proteins is not folded correctly.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> High levels of protein synthesis will therefore result in an increased production of proteasome substrates.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> This would explain the therapeutic window of proteasome inhibitors, tumor cells being more active in protein synthesis, particularly the high sensitivity of myeloma cells that synthesize massive amounts of immunoglobulins. We previously reported that enhancing the levels of proteasome substrates by blocking anterograde transport of proteins through the ER increases the cytotoxic effect of b-AP15 (for details, see <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Interestingly, elevation of proteasome substrate levels increases the sensitivity of immortalized hTERT-RPE1 epithelial cells and normal human fibroblasts to b-AP15-induced apoptosis and to cell death (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C)<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> and suggests that the difference in sensitivity of cancer cells and normal cells to b-AP15 is, at least in part, due to differences in the production of proteasome substrates (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Association between polyubiquitin association and cell death. (A) HCT116 colon cancer cells were exposed to 1 μM b-AP15 or 100 nM bortezomib and harvested at the indicated time points. Lysates were subjected to immunoblotting for K48-linked polyubiquitin, HSP-70B′, p21<sup>Cip1</sup>, PARP, or β-actin (loading control). (B) HCT116 cells or hTERT-RPE1 cells (immortalized epithelial cells) were exposed to different concentrations of b-AP15 for 1 h, followed by washing and incubation for 16 h in drug-free medium. Lysates were subjected to immunoblotting for K48-linked polyubiquitin, PARP and β-actin (loading control). Note the stronger accumulation of polyubiquitinated proteins and the induction of PARP cleavage in the colon cancer cells. (C) CpdA is an inhibitor of the Sec61 complex of anterograde protein export into the ER.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Immortalized hTERT-RPE1 epithelial cells were exposed to increasing concentration of b-AP15 in the presence or absence of CpdA (“Sec61 inhib”). Note the increase in polyubiquitin accumulation, PARP cleavage, and cell death in the presence of CpdA (* <i>p</i> < 0.05). Parts A–C are reproduced from Sun et al.,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> which is licensed under <a href="https://creativecommons.org/licenses/by/4.0/" class="ext-link">CC BY 4.0</a>. (D) Graphic illustration of the results. Shown are proteasomes (red, 20S; green, 19S) and polyubiquitinated proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Evidence linking proteasome inhibition to cell death has been presented using cell lines expressing a proteasome-degradable reporter protein (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).<a onclick="showRef(event, 'ref87 ref98'); return false;" href="javascript:void(0);" class="ref ref87 ref98">(87,98)</a> Cells can be followed after initiation of treatment and the fate of individual cells determined. Using concentrations close to IC<sub>50</sub>, it is found that cells where the proteasome reporter accumulates subsequently die (where loss of membrane integrity results in leakage of YFP from the cells), whereas cells where proteasome inhibition is not observed survive and continue to proliferate<a onclick="showRef(event, 'ref87 ref98'); return false;" href="javascript:void(0);" class="ref ref87 ref98">(87,98)</a> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Bortezomib induces an increase in nuclear fluorescence after 2 h, followed by increases in cytoplasmic fluorescence (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). This pattern is consistent with reports of predominant presence of 26S proteasomes in the nucleus.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Exposure to b-AP15 results in the same pattern of initial nuclear fluorescence (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D), first observed after 1 h. The difference in onset can be explained by the more rapid uptake of b-AP15 into cells compared to bortezomib.<a onclick="showRef(event, 'ref87 ref132'); return false;" href="javascript:void(0);" class="ref ref87 ref132">(87,132)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proteasome inhibition induced by b-AP15 is associated with cell death. (A) A reporter protein (Ub<sup>G76V</sup>-YFP) is degraded by the proteasome (PS) in human melanoma cells. Proteasome inhibition (PI) leads to accumulation of the reporter protein in the cells.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> (B) Tracing individual cells expressing Ub<sup>G76V</sup>-YFP following exposure to 250 nM b-AP15. Cells become Ub<sup>G76V</sup>-YFP positive after 1–4 h, showing accumulation of the proteasome reporter. YFP-positive cells subsequently round up and the YFP leaks out from the cells after membrane disintegration. In contrast, cells that remain YFP-negative at 4 h of exposure survive and continue to divide. Results were obtained using an IncuCyte instrument (see refs <a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and <a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a>). (C) Time-lapse recordings of Ub<sup>G76V</sup>-YFP-expressing human melanoma cells after addition of compounds. Upper panel: Human melanoma cells expressing Ub<sup>G76V</sup>-YFP were exposed to 100 nM bortezomib and traced for 10 h. Notice the appearance of YFP fluorescence in cell nuclei at 2 h and later appearance in the cytoplasm (one cell highlighted at 2 h). Middle panel: Cells were exposed to 250 nM b-AP15. Note the similar pattern of initial nuclear and later cytoplasmic fluorescence (one cell highlighted at 1 h), similar to the pattern observed using bortezomib. Also note that cells either become positive and die or remain completely negative and survive. Lower panel, left: control. Vehicle-treated control cells remain YFP-negative and proliferate. Lower panel, right: >90% of the cells exposed to 500 nM b-AP15 become YFP-positive after 6 h, and most of these cells have rounded up at 18 h, some have lost membrane integrity and the YFP content. Original data were published in refs <a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and <a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The accumulation of the Ub<sup>G76V</sup>-YFP reporter in cells could be argued to be due to cross-linking and aggregation of the reporter protein and an inaccessibility of aggregated proteins to proteasomal degradation. We find this scenario unlikely for a number of reasons: (i) the same pattern of initial nuclear accumulation of Ub<sup>G76V</sup>-YFP is observed in b-AP15- and bortezomib-treated cells; (ii) the phenomenon of “all-or-nothing” in terms of Ub<sup>G76V</sup>-YFP positivity; it is difficult to understand how chemical cross-linking of Ub<sup>G76V</sup>-YFP, leading to aggregation, will occur in some cells, whereas no (or undetectable) cross-linking and aggregation will occur in neighboring cells. This “all-or-nothing” phenomenon is identical in cells exposed to b-AP15 and bortezomib and is likely to reflect differences in the thresholds of proteasome degradation capacity and/or generation of proteasome substrates in different cells; (iii) we have not observed aggregation of Ub<sup>G76V</sup>-YFP by immunoblotting in b-AP15-exposed cells using pharmacologically relevant concentrations;<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> (iv) cross-linking of cellular proteins<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> (see above) could be expected to result in general toxicity, not consistent with the tumor cell selectivity of dienones and the relative insensitivity of noncancerous cells to b-AP-15 and other dienones.</div><div class="NLM_p last">The notion that inhibition of the UPS is of importance for cytotoxicity of dienones is supported by experiments involving genetic manipulation: (i) deletion of Rpn13 and deletion of the Pru-domain of Rpn13 lead to a decreased (but not totally lost) sensitivity to RA-190;<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> (ii) overexpression of USP14 results in decreased sensitivity to b-AP15;<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> (iii) knock-out of <i>SRC-3</i>, the protein product of which has been suggested to be upstream of proteasome inhibition, leads to a decreased induction of DDIT3/CHOP and other stress-related markers.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Studies of Binding and Degradation of Electrophile-Adducted Proteins</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Some information is available with regard to the binding of dienones to the cellular proteome and the subsequent fate of adducted proteins. It was recently reported that 44 proteins were covalently adducted by VLX1570, including the anamorsin/CIAPIN1 apoptosis regulator.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Studies have been performed on 4-hydroxy-2-nonenal (HNE), an α,β-unsaturated aldehyde that shows reactivity to proteomic cysteines,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> and the endogenous electrophile 15-deoxy-Δ<sup>12,14</sup>-prostaglandin-J2 (PG-J2, a cross-conjugated α,β-unsaturated dienone). HNE is known to be selective, and only a limited number of nucleophilic residues are carbonylated within each protein.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> The reactivities of different residues appear to be affected by the protein environment.<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(135,136)</a> PG-J2 has been demonstrated to bind ∼350 proteins, the largest group related to metabolic processes involved in protein modification, protein folding, translation, and proteolysis.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p">Thioredoxin reductase (TrxR) is expected to be a common target of cytotoxic electrophiles due to its nucleophilic active site Sec residue, present in an unstructured portion of the enzyme.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> We recently evaluated 141 cytotoxic α,β-unsaturated compounds for their ability to inhibit proteasome function and their ability to inhibit TrxR. Surprisingly, whereas 28 compounds were found to inhibit proteasome function, only 20 could be shown to inhibit TrxR.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> One of the compounds that was found not to inhibit TrxR was the dienone compound CB826/MCB-613. The finding was unexpected both with regard to the presence of the nucleophilic Sec residue in the TrxR enzyme and with regard to the PAINS properties of many of the compounds. Furthermore, the findings did not show a direct relationship between electrophilicity of the compounds and their cytotoxicity.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">The inhibition of proteasome DUB activity and of USP14 was reported to be reversible under <i>in vitro</i> conditions.<a onclick="showRef(event, 'ref22 ref87'); return false;" href="javascript:void(0);" class="ref ref22 ref87">(22,87)</a> In surface plasmon resonance experiments (SPR), VLX1570 rapidly associates and subsequently dissociates from proteasomes.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> We have subsequently found that extended incubation of 19S proteasomes with b-AP15 (20 min at 37 °C) results in reduced recovery of (∼60%) of the DUB activity after dilution.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> We interpret these results to suggest that b-AP15 recognizes proteasome-associated DUBs by noncovalent interactions, increasing the residence time to facilitate subsequent covalent binding.</div><div class="NLM_p last">Is the strong and rapid accumulation of polyubiquitinated proteins in cells exposed to dienones a secondary consequence of adduct formation and aggregation? An early study suggested that HNE-modified proteins were significantly ubiquitinated and showed that proteasome inhibitors suppressed the elimination of such proteins.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> A later study showed that the elimination of HNE-modified proteins in cells was not stabilized by proteasome inhibitors, whereas the lysosome inhibitor chloroquine prevented their loss.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> In a study of HNE-induced degeneration of neurons, Zhang et al. observed an abnormal accumulation of both K48- and K63-linked polyubiquitinated proteins.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> The increases in K48-linked polyubiquitinated proteins were, however, quite modest, approximately 2-fold by 24 h. A particularly interesting study using mass spectrometry was published by Yang et al.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> These authors showed that the alkylation of some cysteine residues by HNE was stable over time, whereas and interestingly the modification of other cysteines decreased rapidly after removal of HNE. These findings suggest the existence of a repair mechanism for HNE adducts in cells but is not consistent with alkylated proteins being removed by mechanisms of global protein degradation. Although the literature is conflicting with regard to mechanisms of degradation of HNE-adducted proteins, we are unaware of any study demonstrating accumulation of K48-linked polyubiquitinated proteins similar to what is observed using b-AP15 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Since both the kinetics and amplitude of the increases in polyubiquitin are similar to those observed using the 20S proteasome inhibitor bortezomib, our interpretation is that they are likely due to a direct inhibitory effect of proteasome function.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Pharmacology and Toxicity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Measurement of HO-3867 uptake in tissue cultured cells showed maximal uptake within 60 min followed by a decline of intracellular levels.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> HO-3867 could still be detected after 72 h in cells exposed for 1 h followed by change of medium.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> We have reported very similar results using b-AP15, demonstrating a rapid uptake from the culture medium and enrichment of the compound in exposed cells.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Intracellular enrichment of drugs is not uncommon and is also observed for the 20S proteasome inhibitor bortezomib.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> The underlying mechanism for the rapid uptake and enrichment of dienone compounds is unclear, but we have observed that cellular uptake was impaired by 30 min of pretreatment of cells with a relatively low concentration of <i>N</i>-ethylmaleimide (10 μM). One interpretation of this result is that the uptake is driven by the availability of intracellular thiol groups. Alternatively, uptake is dependent on a <i>N</i>-ethylmaleimide-sensitive transporter.</div><div class="NLM_p">The higher potency of b-AP15 and VLX1570 in intact cells compared to its potency using <i>in vitro</i> assays for USP14 and UCHL5 has been recently discussed.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Intracellular enrichment explains the findings by different investigators of USP14 activity being inhibited in cells exposed to relevant concentrations (0.1–1 μM) of b-AP15/VLX1570.<a onclick="showRef(event, 'ref22 ref48 ref49 ref50 ref81 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref22 ref48 ref49 ref50 ref81 ref86 ref87">(22,48−50,81,86,87)</a></div><div class="NLM_p">The relevant drug concentrations that are to be used in <i>in vitro</i> studies have been an enigma in cancer drug research since compounds are often reactive and exhibit polypharmacology. Cisplatin can be used to illustrate this problem. Cisplatin is known to cross-link DNA, representing the major mechanism of action.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> The cisplatin molecule will also react with proteins, in particular with thiols, and a number of other targets will become relevant using suprapharmacological concentrations of the drug. Cisplatin-induced acute apoptotic cell death, studied by many groups (PubMed search September 2020, cisplatin + apoptosis + mechanism: ∼4000 hits), may be of limited importance for clinical drug sensitivity since concentrations of >10-fold the IC<sub>50</sub> are required to induce this phenomenon.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div><div class="NLM_p">A number of investigators have demonstrated that dienone compounds display considerable higher cytotoxicity to tumor cells compared to noncancerous cells.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref38 ref42 ref53 ref59 ref60 ref129'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref38 ref42 ref53 ref59 ref60 ref129">(18−26,38,42,53,59,60,129)</a> Some of these studies have presented IC<sub>50</sub> values, and these are summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">Supplementary Table 1</a>. These results, using <i>in vitro</i> cultured cells, are interesting from a mechanistic point of view but are difficult to extrapolate to toxicity in living organisms. It was recently reported that b-AP15/VLX1570 shows similar cytotoxicities to cancer cell lines and HUVECs (human vascular endothelial cells) and, based on this observation, it was suggested that these compounds are generally cytotoxic.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The sensitivity of HUVECs to b-AP15/VLX1570 is consistent with reports from other studies of dienones. In one study the IC<sub>50</sub> of EF24 toward HUVECs was reported to be 2.6 μM, lower in comparison to two different liver cancer cell lines (3.8 and 4.4 μM).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In another study, the IC<sub>50</sub> of EF24 toward HUVECs was reported to be 1.1 μM, compared to 0.2 μM for leukemia cells, 0.3 μM for colon cancer cells, 0.4 μM for prostate cancer cells, and 1.4 μM for melanoma cells.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> MCB-613 showed IC<sub>50</sub> values of 3–6 μM in cancer cell lines, whereas no effect was observed on the proliferation of primary hepatocytes or fibroblasts at these concentrations.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> HUVECs were, however, sensitive to high doses of MCB-613.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> On the basis of the sensitivity of endothelial cells, dienones have been advocated as angiogenesis inhibitors.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Whether studies of the <i>in vitro</i> sensitivity of HUVECs predict the antiangiogenic potential of small molecules or whether HUVEC sensitivity can be used to argue that dienones are generally cytotoxic can be debated.</div><div class="NLM_p last">Multiple reports that demonstrated preclinical antitumor activity of dienones did not report animal toxicity (see above). In the specific case of VLX1570, preclinical use requires oil/detergents for formulation, leading to complications in the evaluation of toxicology due to species differences in the tolerance to such formulations.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> A phase 1 study has been performed using VLX1570 in a formulation based on polyethylene glycol, polyoxyethylated castor oil, and polysorbate 80 (PCT) formulation.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> The study used an accelerated protocol, and pulmonary toxicity was encountered at 1.2 mg/kg.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Pulmonary toxicity has also been observed with bortezomib,<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> and it was found that the PCT formulation enhances this type of adverse event by bortezomib and VLX1570.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> These problems will hopefully be possible to resolve using prodrugs that do not require oil/detergent for administration.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Cell Death Mode Induced by Dienones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60573" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60573" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of different cell death modes have been described,<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> many of which may be induced by anticancer drugs. Describing the cell death mode being elicited by a particular compound is of importance both for understanding mechanisms of action and for understanding potential mechanisms of resistance.</div><div class="NLM_p">The death mode induced by G5 has been studied in some detail.<a onclick="showRef(event, 'ref150 ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref150 ref151 ref152">(150−152)</a> G5-induced apoptosis requires the Bcl-2 family proteins Bax and Bak.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> However, and in distinction to bortezomib, G5 is able to kill apoptosis-resistant cells deficient in Bax and Bak by activating a necrotic response.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> In fact, the kinetics of cell death observed in G5-exposed cultures is indistinguishable using wild-type cells and Bax/Bak defective cells.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> The morphology of cells exposed to G5 is characterized by massive cytoplasmic vacuolization.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Interestingly, a similar phenomenon of vacuolization was reported in cells exposed to MCB-613<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and has also been demonstrated for b-AP15-treated cells.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The death mode induced by MCB-613 was interpreted as paroptosis,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> a nonapoptotic form of cell death characterized by massive cytoplasmic vacuolization due to dilation of the ER and mitochondria,<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> and it is possible that all dienone compounds induce this cell death mode.</div><div class="NLM_p last">b-AP15 induces various stress responses, including ER stress and oxidative stress.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Inhibition of these stress responses impairs apoptosis but does not prevent cell death.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> It was recently demonstrated that VLX1570 induces dimerization of the apoptosis inhibitor anamorsin/CIAPIN1, leading to a depletion of the active monomeric form.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> This finding raises the possibility that inactivation of anamorsin contributes to apoptosis induction by VLX1570. However, the findings that dienones are able to kill apoptosis-resistant cells, possibly by paroptosis, lead to questions with regard to the importance of anamorsin depletion for cell death by VLX1570 and other dienones.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dienones such as b-AP15/VLX1570 have obvious chemical liabilities leading to predictions of engagement of multiple targets and of general toxicity. Dienones have indeed been demonstrated to engage a number of target proteins in cells. These different targets will not be equivalent in terms of the pharmacological response that will be elicited and will not be engaged at the same drug concentrations (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B). Spliceosome, ribosome, and proteasome functions represent major vulnerabilities of tumor cells;<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> evidence reviewed here suggests that effects on the UPS can be linked to the cytotoxicity of dienones. The exact mechanism(s) by which dienones elicit these effects, by inhibition of proteasome-associated DUBs, by effects on Rpn13, and/or by additional components, is (are) not clear at present.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Target affinity does not necessarily correlate to mechanism of action. A major fraction of cellular genes (∼90%) have been found to be nonessential for proliferation of tumor cells <i>in vitro</i>.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Small molecules that bind to the protein products of these genes are therefore unlikely to affect tumor cell proliferation. In contrast, low affinity binding to essential proteins may result in strong inhibition of proliferation. An example is microtubule dynamics, known to be sensitive to low concentrations of small molecules<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> and for which off-target effects may occur for various compounds when used in screens at 5–10 μM. (B) Illustration of responses to VLX1570 reported in different studies.<a onclick="showRef(event, 'ref93 ref114 ref157'); return false;" href="javascript:void(0);" class="ref ref93 ref114 ref157">(93,114,157)</a> HMOX1 is induced at lower concentration of b-AP15/VLX1570 than other markers (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Nrf-2/KEAP is targeted by electrophiles, and the Nrf-2 system is likely to be particularly sensitive to electrophiles.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Increases of polyubiquitinated proteins, Hsp70 chaperones, and proteasome substrates such p21<sup>Cip1</sup> are observed at somewhat higher concentrations of VLX1570; increased levels of Hsp70 are also observed at these concentrations (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Inhibition of translation is observed at increasing concentrations of VLX1570,<a onclick="showRef(event, 'ref114 ref157'); return false;" href="javascript:void(0);" class="ref ref114 ref157">(114,157)</a> leading to a blunted response of Hsp70, HMOX1, p21<sup>Cip1</sup>, and LYN expression (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Depletion of anamorsin/CIAPIN1 was reported to occur at concentrations of 0.5–1 μM <a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> and the formation of higher molecular weight protein complexes at 10 μM <a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> (using HeLa cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Despite the chemical liabilities of the class of compounds reviewed here, a substantial number of studies have shown that these compounds show preferential toxicity to tumor cells and show activity in <i>in vivo</i> tumor models. The ability of dienones to kill apoptosis-resistant cells and the limited development of resistance have stimulated considerable interest in these molecules. These compounds are unsuitable as, and should not be used as, biological probes. They could possibly be developed into anticancer drugs, however, if soluble prodrugs such as 2c-PE will be found to be safe and effective.</div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e1737-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00812" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00812?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00812</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Table 1 listing selective antiproliferative activity to tumor cells, as verified by other laboratories (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf">jm0c00812_si_001.pdf (56.56 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00812" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stig Linder</span> - <span class="hlFld-Affiliation affiliation">Department
of Biomedical and Clinical Sciences (BKV), Linköping University, SE-58183 Linköping, Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Oncology and Pathology, Karolinska Institute, SE-17176 Stockholm, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4952-445X" title="Orcid link">http://orcid.org/0000-0002-4952-445X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2655524f41084a4f48424354664a4f530855430675524f41086a4f48424354664d4f085543"><span class="__cf_email__" data-cfemail="1360677a743d7f7a7d777661537f7a663d6076">[email protected]</span> <span class="__cf_email__" data-cfemail="f8ab8c919fd6b491969c9d8ab89391d68b9d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Bazzaro</span> - <span class="hlFld-Affiliation affiliation">Masonic
Cancer Center and Department of Obstetrics, Gynecology and Women’s
Heath, University of Minnesota, Minneapolis, Minnesota 55455, United States</span></div></li></ul></li><li></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by Department of Defense Ovarian Cancer Research Program Grant OC160377, the Minnesota Ovarian Cancer Alliance, the Randy Shaver Cancer Research Funds and the NIH grant NIGMS R01-GM130800 to Martina Bazzaro.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Martina Bazzaro</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=BIO-d7e1994-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Martina Bazzaro</b> is an Associate Professor at the University of Minnesota. She received her Ph.D. in Pharmaceutical Chemistry from the University of Ferrara, Italy, became a Visiting Fellow at the University of Lausanne, Switzerland, and carried out postdoctoral research at the Karolinska Institute in Sweden and Johns Hopkins Medical School. She has 15 years’ experience in cancer biology, with a focus on metabolic pathways including deubiquitinases and the proteasome. She has published extensively in the area of medicinal chemistry and cancer biology and serves as Editor in Chief of the <i>Journal of Gynecology and Obstetrics</i> and as Topic Editor for <i>Cancers</i>. She is funded by and serves as reviewer for national and international grant agencies including the National Institutes of Health and the Department of Defense.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Stig Linder</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=BIO-d7e2005-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Stig Linder</b> is an Emeritus Professor in Pharmacology at the Department of Biomedical and Clinical Sciences, Linköping, Sweden, and in Cancer Pharmacology at the Department of Oncology and Pathology, Karolinska Institute, Sweden. He received his Ph.D. degree in Cell Biology from the Karolinska Institute and carried out postdoctoral research at Yale University School of Medicine, CT. He is an Adjunct Professor (Docent) in Medical Microbiology at Uppsala University and in Experimental Oncology at the Karolinska Institute. He has published original research papers, reviews, and book chapters in various fields of biology. He has been a scientific advisor for enterprises in the biotechnology area and holds several patents. He is a member of the research board of the Swedish Cancer Society (Cancerfonden).</p></figure></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">ATM</td><td class="NLM_def"><p class="first last">ataxia telangiectasia mutated</p></td></tr><tr><td class="NLM_term">CETSA</td><td class="NLM_def"><p class="first last">cellular thermal shift assay</p></td></tr><tr><td class="NLM_term">CFTR</td><td class="NLM_def"><p class="first last">cystic fibrosis transmembrane conductance regulator</p></td></tr><tr><td class="NLM_term">CIAPIN1</td><td class="NLM_def"><p class="first last">cytokine-induced inhibitor of apoptosis</p></td></tr><tr><td class="NLM_term">CMap</td><td class="NLM_def"><p class="first last">connectivity map</p></td></tr><tr><td class="NLM_term">DBA</td><td class="NLM_def"><p class="first last">dibenzylidene-acetone</p></td></tr><tr><td class="NLM_term">DDIT3/CHOP</td><td class="NLM_def"><p class="first last">DNA damage-inducible transcript 3/C/EBP homologous protein</p></td></tr><tr><td class="NLM_term">DUB</td><td class="NLM_def"><p class="first last">deubiquitinase</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiotreitol</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated</p></td></tr><tr><td class="NLM_term">HMOX1</td><td class="NLM_def"><p class="first last">heme oxygenase 1</p></td></tr><tr><td class="NLM_term">HNE</td><td class="NLM_def"><p class="first last">4-hydroxy-2-nonenal</p></td></tr><tr><td class="NLM_term">HPV</td><td class="NLM_def"><p class="first last">human papilloma virus</p></td></tr><tr><td class="NLM_term">Hsp</td><td class="NLM_def"><p class="first last">heat shock protein</p></td></tr><tr><td class="NLM_term">hTERT</td><td class="NLM_def"><p class="first last">human telomerase reverse transcriptase</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human vascular endothelial cell</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger RNA</p></td></tr><tr><td class="NLM_term">LYN</td><td class="NLM_def"><p class="first last">Src family tyrosine kinase LYN</p></td></tr><tr><td class="NLM_term">MALDI</td><td class="NLM_def"><p class="first last">matrix-assisted laser desorption/ionization</p></td></tr><tr><td class="NLM_term">MAP kinase</td><td class="NLM_def"><p class="first last">mitogen activated protein kinase</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κB</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan-assay interference compounds</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly ADP-ribose polymerase</p></td></tr><tr><td class="NLM_term">PG-J2</td><td class="NLM_def"><p class="first last">prostaglandin-J2</p></td></tr><tr><td class="NLM_term">Rpn</td><td class="NLM_def"><p class="first last">regulatory particle of non-ATPase</p></td></tr><tr><td class="NLM_term">SDS–PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate–polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">Sec61</td><td class="NLM_def"><p class="first last">human secretory translocase</p></td></tr><tr><td class="NLM_term">Src</td><td class="NLM_def"><p class="first last">sarcoma oncogene</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">steroid receptor coactivator</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducers and activators of transcription</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TrxR</td><td class="NLM_def"><p class="first last">thioredoxin reductase</p></td></tr><tr><td class="NLM_term">UPR</td><td class="NLM_def"><p class="first last">unfolded protein response</p></td></tr><tr><td class="NLM_term">USP</td><td class="NLM_def"><p class="first last">ubiquitin specific peptidase</p></td></tr><tr><td class="NLM_term">UCH</td><td class="NLM_def"><p class="first last">ubiquitin C-terminal hydrolase</p></td></tr><tr><td class="NLM_term">UPS</td><td class="NLM_def"><p class="first last">ubiquitin proteasome system</p></td></tr><tr><td class="NLM_term">YFP</td><td class="NLM_def"><p class="first last">yellow fluorescent protein</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 158 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, J.</span></span> <span> </span><span class="NLM_article-title">How were new medicines discovered?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0lgbgH3olSsifw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayr, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojanic, D.</span></span> <span> </span><span class="NLM_article-title">Novel trends in high-throughput screening</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2009.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.coph.2009.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19775937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1WntLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=580-588&author=L.+M.+Mayrauthor=D.+Bojanic&title=Novel+trends+in+high-throughput+screening&doi=10.1016%2Fj.coph.2009.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Novel trends in high-throughput screening</span></div><div class="casAuthors">Mayr, Lorenz M.; Bojanic, Dejan</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">580-588</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) is a well-established process for lead discovery in Pharma and Biotech companies and is now also being used for basic and applied research in academia.  It comprises the screening of large chem. libraries for activity against biol. targets via the use of automation, miniaturized assays and large-scale data anal.  Since its first advent in the early to mid 1990s, the field of HTS has seen not only a continuous change in technol. and processes, but also an adaptation to various needs in lead discovery.  HTS has now evolved into a mature discipline that is a crucial source of chem. starting points for drug discovery.  Whereas in previous years much emphasis has been put on a steady increase in screening capacity (quant. increase') via automation and miniaturization, the past years have seen a much greater emphasis on content and quality (qual. increase').  Today, many experts in the field see HTS at a crossroad with the need to decide on either higher throughput/more experimentation or a greater focus on assays of greater physiol. relevance, both of which may lead to higher productivity in pharmaceutical R&D.  In this paper, we describe the development of HTS over the past decade and point out our own ideas for future directions of HTS in biomedical research.  We predict that the trend toward further miniaturization will slow down with the balanced implementation of 384 well, 1536 well, and 384 low vol. well plates.  Furthermore, we envisage that there will be much more emphasis on rigorous assay and chem. characterization, particularly considering that novel and more difficult target classes will be pursued.  In recent years we have witnessed a clear trend in the drug discovery community toward rigorous hit validation by the use of orthogonal readout technologies, label free and biophys. methodologies.  We also see a trend toward a more flexible use of the various screening approaches in lead discovery, i.e., the use of both full deck compd. screening as well as the use of focused screening and iterative screening approaches.  Moreover, we expect greater usage of target identification strategies downstream of phenotypic screening and the more effective implementation of affinity selection technologies as a result of advances in chem. diversity methodologies.  We predict that, ultimately, each hit finding strategy will be much more project-related, tailor-made, and better integrated into the broader drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3Oo1Orzt87Vg90H21EOLACvtfcHk0lgbgH3olSsifw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1WntLnL&md5=50284fdd9f4d610e81fb442b78b7b69e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2009.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2009.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DMayr%26aufirst%3DL.%2BM.%26aulast%3DBojanic%26aufirst%3DD.%26atitle%3DNovel%2520trends%2520in%2520high-throughput%2520screening%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2009%26volume%3D9%26spage%3D580%26epage%3D588%26doi%3D10.1016%2Fj.coph.2009.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schenone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dancik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span> <span> </span><span class="NLM_article-title">Target identification and mechanism of action in chemical biology and drug discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnchembio.1199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=23508189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=232-240&author=M.+Schenoneauthor=V.+Dancikauthor=B.+K.+Wagnerauthor=P.+A.+Clemons&title=Target+identification+and+mechanism+of+action+in+chemical+biology+and+drug+discovery&doi=10.1038%2Fnchembio.1199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Target identification and mechanism of action in chemical biology and drug discovery</span></div><div class="casAuthors">Schenone, Monica; Dancik, Vlado; Wagner, Bridget K.; Clemons, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">232-240</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Target-identification and mechanism-of-action studies have important roles in small-mol. probe and drug discovery.  Biol. and technol. advances have resulted in the increasing use of cell-based assays to discover new biol. active small mols.  Such studies allow small-mol. action to be tested in a more disease-relevant setting at the outset, but they require follow-up studies to det. the precise protein target or targets responsible for the obsd. phenotype.  Target identification can be approached by direct biochem. methods, genetic interactions or computational inference.  In many cases, however, combinations of approaches may be required to fully characterize on-target and off-target effects and to understand mechanisms of small-mol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMV_Mv_6-O-rVg90H21EOLACvtfcHk0lgbgH3olSsifw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWmsLs%253D&md5=7aa5556d8dfbf259ab7e60fda1d8fdc2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1199%26sid%3Dliteratum%253Aachs%26aulast%3DSchenone%26aufirst%3DM.%26aulast%3DDancik%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26atitle%3DTarget%2520identification%2520and%2520mechanism%2520of%2520action%2520in%2520chemical%2520biology%2520and%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D232%26epage%3D240%26doi%3D10.1038%2Fnchembio.1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blat, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieronymus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span> <span> </span><span class="NLM_article-title">The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">1929</span>– <span class="NLM_lpage">1935</span>, <span class="refDoi"> DOI: 10.1126/science.1132939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1126%2Fscience.1132939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=17008526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2006&pages=1929-1935&author=J.+Lambauthor=E.+D.+Crawfordauthor=D.+Peckauthor=J.+W.+Modellauthor=I.+C.+Blatauthor=M.+J.+Wrobelauthor=J.+Lernerauthor=J.+P.+Brunetauthor=A.+Subramanianauthor=K.+N.+Rossauthor=M.+Reichauthor=H.+Hieronymusauthor=G.+Weiauthor=S.+A.+Armstrongauthor=S.+J.+Haggartyauthor=P.+A.+Clemonsauthor=R.+Weiauthor=S.+A.+Carrauthor=E.+S.+Landerauthor=T.+R.+Golub&title=The+connectivity+map%3A+using+gene-expression+signatures+to+connect+small+molecules%2C+genes%2C+and+disease&doi=10.1126%2Fscience.1132939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease</span></div><div class="casAuthors">Lamb, Justin; Crawford, Emily D.; Peck, David; Modell, Joshua W.; Blat, Irene C.; Wrobel, Matthew J.; Lerner, Jim; Brunet, Jean-Philippe; Subramanian, Aravind; Ross, Kenneth N.; Reich, Michael; Hieronymus, Haley; Wei, Guo; Armstrong, Scott A.; Haggarty, Stephen J.; Clemons, Paul A.; Wei, Ru; Carr, Steven A.; Lander, Eric S.; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">5795</span>),
    <span class="NLM_cas:pages">1929-1935</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a ref. collection of gene-expression profiles from cultured human cells treated with bioactive small mols., together with pattern-matching software to mine these data.  We demonstrate that this "Connectivity Map" resource can be used to find connections among small mols. sharing a mechanism of action, chems. and physiol. processes, and diseases and drugs.  These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtu0M2BUO2w7Vg90H21EOLACvtfcHk0ljoWu9Lxc_oEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN&md5=1fad887ad515ffdd8064e526ff25a4db</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132939%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DE.%2BD.%26aulast%3DPeck%26aufirst%3DD.%26aulast%3DModell%26aufirst%3DJ.%2BW.%26aulast%3DBlat%26aufirst%3DI.%2BC.%26aulast%3DWrobel%26aufirst%3DM.%2BJ.%26aulast%3DLerner%26aufirst%3DJ.%26aulast%3DBrunet%26aufirst%3DJ.%2BP.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DHieronymus%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DArmstrong%26aufirst%3DS.%2BA.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DThe%2520connectivity%2520map%253A%2520using%2520gene-expression%2520signatures%2520to%2520connect%2520small%2520molecules%252C%2520genes%252C%2520and%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D313%26spage%3D1929%26epage%3D1935%26doi%3D10.1126%2Fscience.1132939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almqvist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatushchenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez Molina, D.</span></span> <span> </span><span class="NLM_article-title">The cellular thermal shift assay for evaluating drug target interactions in cells</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1038/nprot.2014.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnprot.2014.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25101824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2100-2122&author=R.+Jafariauthor=H.+Almqvistauthor=H.+Axelssonauthor=M.+Ignatushchenkoauthor=T.+Lundbackauthor=P.+Nordlundauthor=D.+Martinez+Molina&title=The+cellular+thermal+shift+assay+for+evaluating+drug+target+interactions+in+cells&doi=10.1038%2Fnprot.2014.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The cellular thermal shift assay for evaluating drug target interactions in cells</span></div><div class="casAuthors">Jafari, Rozbeh; Almqvist, Helena; Axelsson, Hanna; Ignatushchenko, Marina; Lundbaeck, Thomas; Nordlund, Paer; Molina, Daniel Martinez</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2100-2122</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thermal shift assays are used to study thermal stabilization of proteins upon ligand binding.  Such assays have been used extensively on purified proteins in the drug discovery industry and in academia to detect interactions.  Recently, we published a proof-of-principle study describing the implementation of thermal shift assays in a cellular format, which we call the cellular thermal shift assay (CETSA).  The method allows studies of target engagement of drug candidates in a cellular context, herein exemplified with exptl. data on the human kinases p38α and ERK1/2.  The assay involves treatment of cells with a compd. of interest, heating to denature and ppt. proteins, cell lysis, and the sepn. of cell debris and aggregates from the sol. protein fraction.  Whereas unbound proteins denature and ppt. at elevated temps., ligand-bound proteins remain in soln.  We describe two procedures for detecting the stabilized protein in the sol. fraction of the samples.  One approach involves sample workup and detection using quant. western blotting, whereas the second is performed directly in soln. and relies on the induced proximity of two target-directed antibodies upon binding to sol. protein.  The latter protocol has been optimized to allow an increased throughput, as potential applications require large nos. of samples.  Both approaches can be completed in a day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzarqomAK6eLVg90H21EOLACvtfcHk0ljoWu9Lxc_oEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ&md5=e7852e1a306bca1698a8e8463ae566b1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2014.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2014.138%26sid%3Dliteratum%253Aachs%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DAlmqvist%26aufirst%3DH.%26aulast%3DAxelsson%26aufirst%3DH.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DLundback%26aufirst%3DT.%26aulast%3DNordlund%26aufirst%3DP.%26aulast%3DMartinez%2BMolina%26aufirst%3DD.%26atitle%3DThe%2520cellular%2520thermal%2520shift%2520assay%2520for%2520evaluating%2520drug%2520target%2520interactions%2520in%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2014%26volume%3D9%26spage%3D2100%26epage%3D2122%26doi%3D10.1038%2Fnprot.2014.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernobrovkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutishauser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allardyce, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Expression proteomics study to determine metallodrug targets and optimal drug combinations</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1590</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-01643-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41598-017-01643-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28484215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1crlt1yjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1590&author=R.+F.+S.+Leeauthor=A.+Chernobrovkinauthor=D.+Rutishauserauthor=C.+S.+Allardyceauthor=D.+Hackerauthor=K.+Johnssonauthor=R.+A.+Zubarevauthor=P.+J.+Dyson&title=Expression+proteomics+study+to+determine+metallodrug+targets+and+optimal+drug+combinations&doi=10.1038%2Fs41598-017-01643-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Expression proteomics study to determine metallodrug targets and optimal drug combinations</span></div><div class="casAuthors">Lee Ronald F S; Allardyce Claire S; Johnsson Kai; Dyson Paul J; Chernobrovkin Alexey; Rutishauser Dorothea; Zubarev Roman A; Rutishauser Dorothea; Hacker David</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1590</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The emerging technique termed functional identification of target by expression proteomics (FITExP) has been shown to identify the key protein targets of anti-cancer drugs.  Here, we use this approach to elucidate the proteins involved in the mechanism of action of two ruthenium(II)-based anti-cancer compounds, RAPTA-T and RAPTA-EA in breast cancer cells, revealing significant differences in the proteins upregulated.  RAPTA-T causes upregulation of multiple proteins suggesting a broad mechanism of action involving suppression of both metastasis and tumorigenicity.  RAPTA-EA bearing a GST inhibiting ethacrynic acid moiety, causes upregulation of mainly oxidative stress related proteins.  The approach used in this work could be applied to the prediction of effective drug combinations to test in cancer chemotherapy clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4jjyyuPoPp0ewzGPswiWOfW6udTcc2ebCn83PvYBxS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crlt1yjug%253D%253D&md5=b388f49064ff216825cd199e9269a54c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-01643-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-01643-1%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BF.%2BS.%26aulast%3DChernobrovkin%26aufirst%3DA.%26aulast%3DRutishauser%26aufirst%3DD.%26aulast%3DAllardyce%26aufirst%3DC.%2BS.%26aulast%3DHacker%26aufirst%3DD.%26aulast%3DJohnsson%26aufirst%3DK.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DExpression%2520proteomics%2520study%2520to%2520determine%2520metallodrug%2520targets%2520and%2520optimal%2520drug%2520combinations%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D1590%26doi%3D10.1038%2Fs41598-017-01643-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaetani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beusch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundstrom, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span> <span> </span><span class="NLM_article-title">Proteome integral solubility alteration: a high-throughput proteomics assay for target deconvolution</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4027</span>– <span class="NLM_lpage">4037</span>, <span class="refDoi"> DOI: 10.1021/acs.jproteome.9b00500</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jproteome.9b00500" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVant7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=4027-4037&author=M.+Gaetaniauthor=P.+Sabatierauthor=A.+A.+Saeiauthor=C.+M.+Beuschauthor=Z.+Yangauthor=S.+L.+Lundstromauthor=R.+A.+Zubarev&title=Proteome+integral+solubility+alteration%3A+a+high-throughput+proteomics+assay+for+target+deconvolution&doi=10.1021%2Facs.jproteome.9b00500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution</span></div><div class="casAuthors">Gaetani, Massimiliano; Sabatier, Pierre; Saei, Amir A.; Beusch, Christian M.; Yang, Zhe; Lundstroem, Susanna L.; Zubarev, Roman A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4027-4037</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Various agents, including drugs as well as nonmol. stimuli, induce alterations in the physicochem. properties of proteins in cell lysates, living cells, and organisms.  These alterations can be probed by applying a stability- and soly.-modifying factor, such as elevated temp., to a varying degree.  As a second dimension of variation, drug concn. or agent intensity/concn. can be used.  Compared to std. approaches where curves are fitted to protein soly. data acquired at different temps. and drug concns., Proteome Integral Soly. Alteration (PISA) assay increases the anal. throughput by 1 to 2 orders of magnitude for an unlimited no. of factor variation points in such a scheme.  The consumption of the compd. and biol. material decreases in PISA by the same factor.  We envision widespread use of the PISA approach in chem. biol. and drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYSOgJoUSrA7Vg90H21EOLACvtfcHk0lhgivyvONURfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVant7fE&md5=0a759cc7bc9940d36bca47dadb4177db</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jproteome.9b00500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jproteome.9b00500%26sid%3Dliteratum%253Aachs%26aulast%3DGaetani%26aufirst%3DM.%26aulast%3DSabatier%26aufirst%3DP.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DBeusch%26aufirst%3DC.%2BM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLundstrom%26aufirst%3DS.%2BL.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26atitle%3DProteome%2520integral%2520solubility%2520alteration%253A%2520a%2520high-throughput%2520proteomics%2520assay%2520for%2520target%2520deconvolution%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2019%26volume%3D18%26spage%3D4027%26epage%3D4037%26doi%3D10.1021%2Facs.jproteome.9b00500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
Silva-Diz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzo-Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernat-Peguera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Cerda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, P.</span></span> <span> </span><span class="NLM_article-title">Cancer cell plasticity: impact on tumor progression and therapy response</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2018.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.semcancer.2018.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30130663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2gtLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2018&pages=48-58&author=V.+da%0ASilva-Dizauthor=L.+Lorenzo-Sanzauthor=A.+Bernat-Pegueraauthor=M.+Lopez-Cerdaauthor=P.+Munoz&title=Cancer+cell+plasticity%3A+impact+on+tumor+progression+and+therapy+response&doi=10.1016%2Fj.semcancer.2018.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cell plasticity: Impact on tumor progression and therapy response</span></div><div class="casAuthors">da Silva-Diz, Victoria; Lorenzo-Sanz, Laura; Bernat-Peguera, Adria; Lopez-Cerda, Marta; Munoz, Purificacion</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Most tumors exhibit intra-tumor heterogeneity, which is assocd. with disease progression and an impaired response to therapy.  Cancer cell plasticity has been proposed as being an important mechanism that, along with genetic and epigenetic alterations, promotes cancer cell diversity and contributes to intra-tumor heterogeneity.  Plasticity endows cancer cells with the capacity to shift dynamically between a differentiated state, with limited tumorigenic potential, and an undifferentiated or cancer stem-like cell (CSC) state, which is responsible for long-term tumor growth.  In addn., it confers the ability to transit into distinct CSC states with different competence to invade, disseminate and seed metastasis.  Cancer cell plasticity has been linked to the epithelial-to-mesenchymal transition program and relies not only on cell-autonomous mechanisms, but also on signals provided by the tumor microenvironment and/or induced in response to therapy.  We provide an overview of the dynamic transition for cancer cell states, the mechanisms governing cell plasticity and their impact on tumor progression, metastasis and therapy response.  Understanding the mechanisms involved in cancer cell plasticity will provide insights for establishing new therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8dLPWvlwMx7Vg90H21EOLACvtfcHk0lhgivyvONURfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2gtLjO&md5=ef3f0e7c144804437d6f937756176019</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2018.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2018.08.009%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BSilva-Diz%26aufirst%3DV.%26aulast%3DLorenzo-Sanz%26aufirst%3DL.%26aulast%3DBernat-Peguera%26aufirst%3DA.%26aulast%3DLopez-Cerda%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DP.%26atitle%3DCancer%2520cell%2520plasticity%253A%2520impact%2520on%2520tumor%2520progression%2520and%2520therapy%2520response%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2018%26volume%3D53%26spage%3D48%26epage%3D58%26doi%3D10.1016%2Fj.semcancer.2018.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochanard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehoe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macconaill, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span> <span> </span><span class="NLM_article-title">Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3085</span>– <span class="NLM_lpage">3096</span>, <span class="refDoi"> DOI: 10.1200/JCO.2010.33.2312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1200%2FJCO.2010.33.2312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21383288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCqtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=3085-3096&author=N.+Wagleauthor=C.+Emeryauthor=M.+F.+Bergerauthor=M.+J.+Davisauthor=A.+Sawyerauthor=P.+Pochanardauthor=S.+M.+Kehoeauthor=C.+M.+Johannessenauthor=L.+E.+Macconaillauthor=W.+C.+Hahnauthor=M.+Meyersonauthor=L.+A.+Garraway&title=Dissecting+therapeutic+resistance+to+RAF+inhibition+in+melanoma+by+tumor+genomic+profiling&doi=10.1200%2FJCO.2010.33.2312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling</span></div><div class="casAuthors">Wagle, Nikhil; Emery, Caroline; Berger, Michael F.; Davis, Matthew J.; Sawyer, Allison; Pochanard, Panisa; Kehoe, Sarah M.; Johannessen, Cory M.; MacConaill, Laura E.; Hahn, William C.; Meyerson, Matthew; Garraway, Levi A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3085-3096</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A detailed understanding of the mechanisms by which tumors acquire resistance to targeted anticancer agents should speed the development of treatment strategies with lasting clin. efficacy.  RAF inhibition in BRAF-mutant melanoma exemplifies the promise and challenge of many targeted drugs; although response rates are high, resistance invariably develops.  Here, we articulate overarching principles of resistance to kinase inhibitors, as well as a translational approach to characterize resistance in the clin. setting through tumor mutation profiling.  As a proof of principle, we performed targeted, massively parallel sequencing of 138 cancer genes in a tumor obtained from a patient with melanoma who developed resistance to PLX4032 after an initial dramatic response.  The resulting profile identified an activating mutation at codon 121 in the downstream kinase MEK1 that was absent in the corresponding pretreatment tumor.  The MEK1C121S mutation was shown to increase kinase activity and confer robust resistance to both RAF and MEK inhibition in vitro.  Thus, MEK1C121S or functionally similar mutations are predicted to confer resistance to combined MEK/RAF inhibition.  These results provide an instructive framework for assessing mechanisms of acquired resistance to kinase inhibition and illustrate the use of emerging technologies in a manner that may accelerate personalized cancer medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK-2C4fs22UbVg90H21EOLACvtfcHk0liTnAb3JKXzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCqtLfO&md5=d872acb5ba41d7eccc2717e31d856dd3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.33.2312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.33.2312%26sid%3Dliteratum%253Aachs%26aulast%3DWagle%26aufirst%3DN.%26aulast%3DEmery%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%2BF.%26aulast%3DDavis%26aufirst%3DM.%2BJ.%26aulast%3DSawyer%26aufirst%3DA.%26aulast%3DPochanard%26aufirst%3DP.%26aulast%3DKehoe%26aufirst%3DS.%2BM.%26aulast%3DJohannessen%26aufirst%3DC.%2BM.%26aulast%3DMacconaill%26aufirst%3DL.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26atitle%3DDissecting%2520therapeutic%2520resistance%2520to%2520RAF%2520inhibition%2520in%2520melanoma%2520by%2520tumor%2520genomic%2520profiling%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D3085%26epage%3D3096%26doi%3D10.1200%2FJCO.2010.33.2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Wekken, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltermann, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Berg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, H. J.</span></span> <span> </span><span class="NLM_article-title">Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature</span>. <i>Crit. Rev. Oncol./Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.critrevonc.2016.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.critrevonc.2016.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26852079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC28notlalsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=107-116&author=A.+J.+van%0Ader+Wekkenauthor=A.+Saberauthor=T.+J.+Hiltermannauthor=K.+Kokauthor=A.+van+den+Bergauthor=H.+J.+Groen&title=Resistance+mechanisms+after+tyrosine+kinase+inhibitors+afatinib+and+crizotinib+in+non-small+cell+lung+cancer%2C+a+review+of+the+literature&doi=10.1016%2Fj.critrevonc.2016.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature</span></div><div class="casAuthors">van der Wekken A J; Saber A; van den Berg A; Hiltermann T J N; Groen H J M; Kok K</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Targeted treatment of advanced non-small cell lung cancer patients with afatinib in EGFR mutation or crizotinib in ALK break positive patients results in profound tumor responses but inevitably induces resistance.  In this review we present currently known resistance mechanisms for afatinib and crizotinib two recently approved drugs.  Resistance mechanisms identified for afatinib include c-MET amplification and the V843I EGFR mutation.  Expression of FGFR1, increased IL6R/JAK/STAT signaling, enhanced interference with aerobic glycolysis and autophagy are associated with resistance to afatinib.  Most common resistance mechanisms for ALK break positive cases are gatekeeper mutations in the ALK gene.  Also activation of the EGFR pathway, KRAS mutations, the autophagy pathway and epithelial mesenchymal transition (EMT), have been associated with resistance.  Many of the proposed resistance mechanisms need to be functionally studied to proof a causative relationship with resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMme8zra2hFP_I8Jvzw4xCfW6udTcc2eZjEE4UyI843Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28notlalsA%253D%253D&md5=b59090714fdbad24f00410f756453589</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2016.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2016.01.024%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWekken%26aufirst%3DA.%2BJ.%26aulast%3DSaber%26aufirst%3DA.%26aulast%3DHiltermann%26aufirst%3DT.%2BJ.%26aulast%3DKok%26aufirst%3DK.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DA.%26aulast%3DGroen%26aufirst%3DH.%2BJ.%26atitle%3DResistance%2520mechanisms%2520after%2520tyrosine%2520kinase%2520inhibitors%2520afatinib%2520and%2520crizotinib%2520in%2520non-small%2520cell%2520lung%2520cancer%252C%2520a%2520review%2520of%2520the%2520literature%26jtitle%3DCrit.%2520Rev.%2520Oncol.%252FHematol.%26date%3D2016%26volume%3D100%26spage%3D107%26epage%3D116%26doi%3D10.1016%2Fj.critrevonc.2016.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">Recent advances in alpha, beta-unsaturated carbonyl compounds as mitochondrial toxins</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">111687</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ejmech.2019.111687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31539776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWkt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2019&pages=111687&author=M.+Hossainauthor=U.+Dasauthor=J.+R.+Dimmock&title=Recent+advances+in+alpha%2C+beta-unsaturated+carbonyl+compounds+as+mitochondrial+toxins&doi=10.1016%2Fj.ejmech.2019.111687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in α,β-unsaturated carbonyl compounds as mitochondrial toxins</span></div><div class="casAuthors">Hossain, Mohammad; Das, Umashankar; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111687</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Conjugated α,β-unsatd. ketones are very useful compds. assocd. with diverse medicinal properties.  This review outlines α,β-unsatd. ketones as candidate cytotoxic agents which affect mitochondrial function.  Both naturally occurring compds. and synthetic chems. have been discussed which exert their cytotoxic effects, at least in part, by acting on mitochondria.  Biochem. differences between tumor mitochondria and this organelle in non-malignant cells have been exploited to investigate various compds. that can cause greater toxicity to neoplasms than normal cells.  On a no. of instances, correlations between the structures of various α,β-unsatd. ketones and cytotoxic potencies have been obsd.  The aspiration is that this review will assist drug designers to create compds. which are significantly more toxic to neoplasms than normal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU6m_b1BjhvrVg90H21EOLACvtfcHk0liTnAb3JKXzvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWkt7zF&md5=8ed19f35c4a5c2775a5d67e301a8c623</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111687%26sid%3Dliteratum%253Aachs%26aulast%3DHossain%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3DRecent%2520advances%2520in%2520alpha%252C%2520beta-unsaturated%2520carbonyl%2520compounds%2520as%2520mitochondrial%2520toxins%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D183%26spage%3D111687%26doi%3D10.1016%2Fj.ejmech.2019.111687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonko, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrington, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span> <span> </span><span class="NLM_article-title">3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells</span>. <i>Drug Des. Delivery</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=2076179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlGmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1990&pages=183-194&author=J.+R.+Dimmockauthor=V.+K.+Aroraauthor=S.+L.+Wonkoauthor=N.+W.+Hamonauthor=J.+W.+Quailauthor=Z.+Jiaauthor=R.+C.+Warringtonauthor=W.+D.+Fangauthor=J.+S.+Lee&title=3%2C5-Bis-benzylidene-4-piperidones+and+related+compounds+with+high+activity+towards+P388+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Bisbenzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells</span></div><div class="casAuthors">Dimmock, J. R.; Arora, V. K.; Wonko, S. L.; Hamon, N. W.; Quail, J. W.; Jia, Z.; Warrington, R. C.; Fang, W. D.; Lee, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design and Delivery</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-94</span>CODEN:
                <span class="NLM_cas:coden">DDDEEJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-2884</span>.
    </div><div class="casAbstract">3,5-Bis(benzylidene)-4-piperidones and related compds. were prepd. and found to have between 100 and 9700 times the activity of N,N'-bis(2-chloroethyl)-N-nitrosourea towards P388 leukemia cells.  The shapes of 6 of these mols., as detd. by x-ray crystallog., were compared, but no correlation between the stereochem. of the mols. or their electronic properties and cytotoxicity was apparent.  Mol. modification of the compds. by forming 2 monobenzylidene compds., a related acyclic deriv. and an N-acyl compd. resulted in diminished but retained high cytotoxicity.  Two representative compds. lowered glutathione levels of liver following their i.p. injection into mice.  Two quaternary ammonium compds. bound to the minor groove of DNA, while 4 related nonquaternary ammonium derivs. did not demonstrate this property.  Thus, the modes of action of these highly cytotoxic compds. include alkylation of cellular thiols and DNA binding, but interference with other biochem. processes is also probably involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW9uGqI3er_rVg90H21EOLACvtfcHk0liEuCwQph6otQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlGmtrg%253D&md5=6183f99a475c28a7af119719268e13e3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DWonko%26aufirst%3DS.%2BL.%26aulast%3DHamon%26aufirst%3DN.%2BW.%26aulast%3DQuail%26aufirst%3DJ.%2BW.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DWarrington%26aufirst%3DR.%2BC.%26aulast%3DFang%26aufirst%3DW.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26atitle%3D3%252C5-Bis-benzylidene-4-piperidones%2520and%2520related%2520compounds%2520with%2520high%2520activity%2520towards%2520P388%2520leukemia%2520cells%26jtitle%3DDrug%2520Des.%2520Delivery%26date%3D1990%26volume%3D6%26spage%3D183%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugazhenthi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic evaluation of some 3,5-diarylidene-4-piperidones and various related quaternary ammonium compounds and analogs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1002/jps.2600830811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fjps.2600830811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=7983596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK2cXls12kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1994&pages=1124-1130&author=J.+R.+Dimmockauthor=V.+K.+Aroraauthor=J.+W.+Quailauthor=U.+Pugazhenthiauthor=T.+M.+Allenauthor=G.+Y.+Kaoauthor=E.+De+Clercq&title=Cytotoxic+evaluation+of+some+3%2C5-diarylidene-4-piperidones+and+various+related+quaternary+ammonium+compounds+and+analogs&doi=10.1002%2Fjps.2600830811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Evaluation of Some 3,5-diarylidene-4-piperidones and Various Related Quaternary Ammonium Compounds and Analogs</span></div><div class="casAuthors">Dimmock, J. R.; Arora, V. K.; Quail, J. W.; Pugazhenthi, U.; Allen, T. M.; De Clercq, E.; Kao, G. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1124-30</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A no. of 3,5-diarylidene-4-piperidones (I; R1 = H, NMe2, SMe2, 4-OMe, Me, CO2K, Cl; R2 = H, Cl, R3X = HCl and n = 0 or 1) and some related quaternary ammonium salts (II; R1 = H, NMe2, NEt2, OMe, OH, F; X = I) as well as closely related analogs (III) were prepd. principally as candidate cytotoxic agents in two screens.  The first test system used an av. of 54 human tumor cell lines from eight neoplastic diseases, namely leukemia, melanoma, colon, non-small-cell lung, small-cell lung, central nervous system, ovarian, and renal cancers.  Selective toxicity was demonstrated by some of the compds., esp. toward leukemia.  The second screen used L1210 lymphoid leukemia cells.  In general, the compds. were less cytotoxic than the ref. drug melphalan in both screens.  Linear plots were made between the Hammett (σ), fragment (f), and molar refractivity (MR) consts. of the nuclear substituents in series I and II with the IC50 figures of both the human tumor cell lines and L1210 cells.  Evaluation against the human tumor cell lines revealed that increases in the f values were correlated with elevation of cytotoxicity in both series I and II; MR consts. were also important in series II.  In the L1210 screen, σ and MR consts. were pos. correlated with cytotoxicity.  X-ray crystallog. was undertaken on 3,5-bis[[4'-(methylthio)phenyl]methylene]-1-methyl-4-piperidone methiodide, which had significant cytotoxicity, and 3,5-bis(4-pyridylmethylene)-1-methyl-4-piperidone methiodide (III), which was virtually inactive in both screens.  A no. of structural features were noted, and in particular a smaller interplanar angle made by one of the arylidene groups with the central piperidine ring in the case of II (R1 = SMe, X = I) than either of the 4-pyridylmethylene moieties in III may contribute to the variation in cytotoxicity between these two compds.  Eleven compds. which were examd. for activity against a panel of 12 viruses were shown to display only marginal potencies or to be inactive at the highest concns. utilized.  Two compds. with slight activity both had the hydrophilic carboxylate ion in the aryl rings.  From this study, various conclusions pertaining to future mol. modification with a view to increasing cytotoxic potency were made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Vznv6FGz17Vg90H21EOLACvtfcHk0liEuCwQph6otQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXls12kt7w%253D&md5=a6bd1764f68069e01ba7565408e554cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600830811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600830811%26sid%3Dliteratum%253Aachs%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DQuail%26aufirst%3DJ.%2BW.%26aulast%3DPugazhenthi%26aufirst%3DU.%26aulast%3DAllen%26aufirst%3DT.%2BM.%26aulast%3DKao%26aufirst%3DG.%2BY.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DCytotoxic%2520evaluation%2520of%2520some%25203%252C5-diarylidene-4-piperidones%2520and%2520various%2520related%2520quaternary%2520ammonium%2520compounds%2520and%2520analogs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1994%26volume%3D83%26spage%3D1124%26epage%3D1130%26doi%3D10.1002%2Fjps.2600830811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Subbagh, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Zaid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahran, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badria, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Obaid, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of certain alpha, beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2915</span>– <span class="NLM_lpage">2921</span>, <span class="refDoi"> DOI: 10.1021/jm000038m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000038m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFGrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2915-2921&author=H.+I.+El-Subbaghauthor=S.+M.+Abu-Zaidauthor=M.+A.+Mahranauthor=F.+A.+Badriaauthor=A.+M.+Al-Obaid&title=Synthesis+and+biological+evaluation+of+certain+alpha%2C+beta-unsaturated+ketones+and+their+corresponding+fused+pyridines+as+antiviral+and+cytotoxic+agents&doi=10.1021%2Fjm000038m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of certain α,β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents</span></div><div class="casAuthors">El-Subbagh, Hussein I.; Abu-Zaid, Suhair M.; Mahran, Mona A.; Badria, Farid A.; Al-Obaid, Abdulrahman M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2915-2921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of 3,5-bis(arylidene)-4-piperidones I (R = 4-NO2C6H4, 2-thienyl, 4-MeC6H4, etc.), as chalcone analogs carrying variety of aryl and heteroaryl groups, pyrazolo[4,3-c]pyridines II (R = 4-MeC6H4, 2-thienyl, 4-MeOC6H4, R' = Me, Ph), pyrido[4,3-d]pyrimidines III, and pyrido[3,2-c]pyridines IV, carrying an arylidene moiety, and a series of pyrano[3,2-c]pyridines V, as flavone and coumarin isosteres, were synthesized and screened for their in vitro antiviral and antitumor activities at the National Cancer Institute (NCI).  Compds. I (R = 4-ClC6H4) and hydroxypyridine VI proved to be active against herpes simplex virus-1 (HSV-1), while compd. I (R = 4-pyridyl) showed moderate activity against human immunodeficiency virus-1 (HIV-1).  Compds. I (R = 2-thienyl), II (R = 2-thienyl, R' = Ph), III (R = 4-MeOC6H4), and V (R = 4-MeC6H4, 2-thienyl) exhibited a broad spectrum antitumor activity.  In addn., compds. II (R = 2-thienyl, R' = Ph) and V (R = 4-MeC6H4, 2-thienyl) proved to be of moderate selectivity toward leukemia cell lines.  The pyrano[3,2-c]pyridines heterocyclic system proved to be the most active antitumors among the investigated heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp16BSvLX8pbbVg90H21EOLACvtfcHk0liEuCwQph6otQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFGrtrg%253D&md5=d8292b5de99db9da0055202da20e585e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm000038m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000038m%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Subbagh%26aufirst%3DH.%2BI.%26aulast%3DAbu-Zaid%26aufirst%3DS.%2BM.%26aulast%3DMahran%26aufirst%3DM.%2BA.%26aulast%3DBadria%26aufirst%3DF.%2BA.%26aulast%3DAl-Obaid%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520certain%2520alpha%252C%2520beta-unsaturated%2520ketones%2520and%2520their%2520corresponding%2520fused%2520pyridines%2520as%2520antiviral%2520and%2520cytotoxic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2915%26epage%3D2921%26doi%3D10.1021%2Fjm000038m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferstl, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camalier, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickles, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3871</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2004.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15210154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3871-3883&author=B.+K.+Adamsauthor=E.+M.+Ferstlauthor=M.+C.+Davisauthor=M.+Heroldauthor=S.+Kurtkayaauthor=R.+F.+Camalierauthor=M.+G.+Hollingsheadauthor=G.+Kaurauthor=E.+A.+Sausvilleauthor=F.+R.+Ricklesauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=M.+Shoji&title=Synthesis+and+biological+evaluation+of+novel+curcumin+analogs+as+anti-cancer+and+anti-angiogenesis+agents&doi=10.1016%2Fj.bmc.2004.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span></div><div class="casAuthors">Adams, Brian K.; Ferstl, Eva M.; Davis, Matthew C.; Herold, Marike; Kurtkaya, Serdar; Camalier, Richard F.; Hollingshead, Melinda G.; Kaur, Gurmeet; Sausville, Edward A.; Rickles, Frederick R.; Snyder, James P.; Liotta, Dennis C.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3871-3883</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of novel curcumin analogs were synthesized and screened for anti-cancer and anti-angiogenesis activities at Emory University and at the National Cancer Institute (NCI).  These compds. are sym. α,β-unsatd. and satd. ketones.  The majority of the analogs demonstrated a moderate degree of anti-cancer activity.  Three Compds. exhibited a high degree of cytotoxicity in the NCI in vitro anti-cancer cell line screen.  In addn., this screen revealed that these compds. inhibit tumor cell growth with a higher potency than the commonly used chemotherapeutic drug, cisplatin.  In independent in vitro screens conducted at Emory, 5 compds. exhibited a high degree of cytotoxicity to tumor cells.  Analogs that were effective in the anti-cancer screens were also effective in in vitro anti-angiogenesis assays.  In the assays conducted by the NCI, I was almost as potent as the anti-angiogenic drug TNP-470, which has undergone clin. trials.  Based on the favorable in vitro anti-cancer and anti-angiogenesis results with I, further in vivo tests were conducted.  This compd. effectively reduced the size of human breast tumors grown in female athymic nude mice and showed little toxicity.  This data, coupled with the remarkable in vitro data, suggests that I may potentially be an effective chemotherapeutic agent.  As a follow-up, a 3D quant. structure relation based on I has been developed.  It shows a cross-validated r2(q2)=0.83 and a predictive r2(p2)=0.71.  COMPARE anal. suggests the compd. to be a possible RNA/DNA antimetabolite, but also implies that the compd.'s cytotoxicity may arise from a presently unknown mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmpU3h4OlGrVg90H21EOLACvtfcHk0lixlJVOvFYDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D&md5=94f8cdb257139ec0dcd3a742a90b9252</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DFerstl%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DCamalier%26aufirst%3DR.%2BF.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DRickles%26aufirst%3DF.%2BR.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520curcumin%2520analogs%2520as%2520anti-cancer%2520and%2520anti-angiogenesis%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3871%26epage%3D3883%26doi%3D10.1016%2Fj.bmc.2004.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2001</span>– <span class="NLM_lpage">2020</span>, <span class="refDoi"> DOI: 10.2174/092986709788682218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.2174%2F092986709788682218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19519378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2001-2020&author=U.+Dasauthor=R.+K.+Sharmaauthor=J.+R.+Dimmock&title=1%2C5-diaryl-3-oxo-1%2C4-pentadienes%3A+a+case+for+antineoplastics+with+multiple+targets&doi=10.2174%2F092986709788682218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets</span></div><div class="casAuthors">Das, U.; Sharma, R. K.; Dimmock, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2001-2020</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A no. of org. mols. which contain the 1,5-diaryl-3-oxo-1,4-pentadienyl group, referred to hereafter as the dienone moiety, have antineoplastic properties.  Emphasis is made on the attachment of this structural moiety to several mol. scaffolds, namely piperidines, N-acylpiperidines, cycloalkanes and 3,4-dihydro-1H-naphthalenes.  Many of these compds. are potent cytotoxins having micromolar and nanomolar IC50 values towards a wide range of neoplastic and transformed cells.  On occasions, greater toxicity towards neoplasms than normal cells has been demonstrated.  A no. of these compds. have in vivo anticancer properties and in general excellent tolerability in rodents is demonstrated.  The way in which a no. of physicochem. properties such as redox potentials, torsion angles, at. charges and logP values govern cytotoxic potencies are presented.  The importance of the shapes of different compds. as detd. by mol. modeling in contributing to antineoplastic properties is outlined.  Arguments are presented in favor of designing antineoplastics which have multiple sites of action in contrast to those bioactive mols. which have only one mol. target.  A no. of compds. which possess the dienone group have different modes of action some of which are chronicled in this review, such as inducing apoptosis, affecting respiration in mitochondria, inhibiting macro-mol. biosynthesis and both inhibiting and stimulating certain enzymes.  Other important properties of these compds. are discussed including their anti-angiogenic, MDR-revertant and antioxidant properties.  It is hoped that this eulogy of the importance of the dienone group will encourage researchers to consider incorporating this structural unit into candidate cytotoxins in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox_6M2Qt8hoLVg90H21EOLACvtfcHk0lixlJVOvFYDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs7w%253D&md5=d0179d2c273d43faa40606e50897ec71</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F092986709788682218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788682218%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DU.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3D1%252C5-diaryl-3-oxo-1%252C4-pentadienes%253A%2520a%2520case%2520for%2520antineoplastics%2520with%2520multiple%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2001%26epage%3D2020%26doi%3D10.2174%2F092986709788682218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">CoMFA and CoMSIA studies on 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-bis(benzylidene)cyclohexanone, and 3,5-bis(benzylidene)-4-piperidone series of cytotoxic compounds</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2123</span>, <span class="refDoi"> DOI: 10.1021/ci700210z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700210z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2110-2123&author=M.+R.+Patelauthor=J.+R.+Dimmockauthor=T.+T.+Talele&title=CoMFA+and+CoMSIA+studies+on+1%2C3-bis%28benzylidene%29-3%2C4-dihydro-1H-naphthalen-2-one%2C+2%2C6-bis%28benzylidene%29cyclohexanone%2C+and+3%2C5-bis%28benzylidene%29-4-piperidone+series+of+cytotoxic+compounds&doi=10.1021%2Fci700210z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CoMFA and CoMSIA Studies on 1,3-Bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-Bis(benzylidene)cyclohexanone, and 3,5-Bis(benzylidene)-4-piperidone Series of Cytotoxic Compounds</span></div><div class="casAuthors">Patel, Maulik R.; Dimmock, Jonathan R.; Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2110-2123</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A no. of 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-ones, 2,6-bis(benzylidene)cyclohexanones, and 3,5-bis(benzylidene)-4-piperidones possess significant potencies toward L1210, Molt 4/C8, and CEM cell lines.  The objective of the current 3D QSAR study is to discover some of the structural parameters which govern cytotoxic potencies.  The CoMFA models with steric and electrostatic fields provided satisfactory statistical data [(r2cv = 0.485, r2ncv = 0.834, r2pred = 0.591), (r2cv = 0.532, r2ncv = 0.850, r2pred = 0.729), and (r2cv = 0.561, r2ncv = 0.864, r2pred = 0.666)] in regard to the cytotoxic potencies obsd. toward L1210, Molt 4/C8, and CEM cell lines, resp.  The CoMSIA model with steric, electrostatic, hydrophobic, and H-bond donor fields exhibited r2cv = 0.513, r2ncv = 0.833, and r2pred = 0.562 for cytotoxic activity toward L1210 cells, while the best CoMSIA models were obtained by a combination of steric, electrostatic, and hydrophobic fields which yielded statistically significant data [(r2cv = 0.531, r2ncv = 0.828, r2pred = 0.652) and (r2cv = 0.560, r2ncv = 0.841, r2pred = 0.729)] to explain the cytotoxicity toward Molt 4/C8 and CEM cells, resp.  The information obtained from the CoMFA and CoMSIA 3D contour maps can be used in the design of more potent cytotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKAu-d3vKrrVg90H21EOLACvtfcHk0lixlJVOvFYDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitLbO&md5=f7b5e9e361f7c7fe0a4781b360018990</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fci700210z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700210z%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DCoMFA%2520and%2520CoMSIA%2520studies%2520on%25201%252C3-bis%2528benzylidene%2529-3%252C4-dihydro-1H-naphthalen-2-one%252C%25202%252C6-bis%2528benzylidene%2529cyclohexanone%252C%2520and%25203%252C5-bis%2528benzylidene%2529-4-piperidone%2520series%2520of%2520cytotoxic%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2110%26epage%3D2123%26doi%3D10.1021%2Fci700210z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pati, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ejmech.2008.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18468733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFaq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=54-62&author=H.+N.+Patiauthor=U.+Dasauthor=S.+Dasauthor=B.+Bandyauthor=E.+De+Clercqauthor=J.+Balzariniauthor=M.+Kawaseauthor=H.+Sakagamiauthor=J.+W.+Quailauthor=J.+P.+Stablesauthor=J.+R.+Dimmock&title=The+cytotoxic+properties+and+preferential+toxicity+to+tumour+cells+displayed+by+some+2%2C4-bis%28benzylidene%29-8-methyl-8-azabicyclo%5B3.2.1%5D+octan-3-ones+and+3%2C5-bis%28benzylidene%29-1-methyl-4-piperidones&doi=10.1016%2Fj.ejmech.2008.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones</span></div><div class="casAuthors">Pati, Hari N.; Das, Umashankar; Das, Swagatika; Bandy, Brian; De Clercq, Erik; Balzarini, Jan; Kawase, Masami; Sakagami, Hiroshi; Quail, J. Wilson; Stables, James P.; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-62</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This study demonstrated that replacement of the axial protons on the C2 and C6 atoms of various 1-methyl-3,5-bis(benzylidene)-4-piperidones 3 by a dimethylene bridge leading to series 2 lowered cytotoxic potencies.  Compds. emerged as lead mols. based on their toxicity towards different neoplasms and their selective toxicity for malignant rather than normal cells.  Some possible reasons for the disparity between the IC50 values in the two series of compds. are presented based on mol. modeling, log P values and respiration in rat liver mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7c5xUDnok47Vg90H21EOLACvtfcHk0ljtKFTOfwJI7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFaq&md5=55f43b3a39a300c2268a511cc1b5963c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DPati%26aufirst%3DH.%2BN.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DBandy%26aufirst%3DB.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DQuail%26aufirst%3DJ.%2BW.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520cytotoxic%2520properties%2520and%2520preferential%2520toxicity%2520to%2520tumour%2520cells%2520displayed%2520by%2520some%25202%252C4-bis%2528benzylidene%2529-8-methyl-8-azabicyclo%255B3.2.1%255D%2520octan-3-ones%2520and%25203%252C5-bis%2528benzylidene%2529-1-methyl-4-piperidones%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D54%26epage%3D62%26doi%3D10.1016%2Fj.ejmech.2008.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inci Gul, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2219</span>– <span class="NLM_lpage">2224</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.01.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2010.01.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20189402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2219-2224&author=U.+Dasauthor=A.+Doroudiauthor=H.+Inci+Gulauthor=H.+N.+Patiauthor=M.+Kawaseauthor=H.+Sakagamiauthor=Q.+Chuauthor=J.+P.+Stablesauthor=J.+R.+Dimmock&title=Cytotoxic+2-benzylidene-6-%28nitrobenzylidene%29cyclohexanones+which+display+substantially+greater+toxicity+for+neoplasms+than+non-malignant+cells&doi=10.1016%2Fj.bmc.2010.01.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells</span></div><div class="casAuthors">Das, Umashankar; Doroudi, Alireza; Inci Gul, H.; Pati, Hari N.; Kawase, Masami; Sakagami, Hiroshi; Chu, Qing; Stables, James P.; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2219-2224</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Various 2-benzylidene-6-(nitrobenzylidene)cyclohexanones were prepd. as candidate cytotoxins in which the nitro group was located in the ortho, meta and para positions leading to series 1-3, resp.  The CC50 values towards human HSC-2 and HSC-4 oral squamous cell carcinomas as well as human HL-60 promyelocytic leukemic cells are in the low micromolar range in general.  On the other hand, most of the compds. afforded clear evidence of being far less toxic towards human HGF gingival fibroblasts, HPC pulp cells and HPLF periodontal ligament fibroblasts which are non-malignant cells.  Selectivity index (SI) figures were generated which are the ratios of the av. CC50 values towards normal cells and the CC50 figure towards a malignant cell line.  Huge SI values were obtained for many of the compds.  In particular 1c, 2f, 3c and 3g which have av. SI values of >76, >38, 124 and 341, resp., are clearly lead mols. affording direction for amplification of this area of study.  A lead compd. 1c (I) caused internucleosomal DNA fragmentation and activation of caspase-3 in HL-60 cells but not in HSC-2 carcinomas.  In a short-term toxicity study, doses up to and including 300 mg/kg of the majority of the compds. prepd. in this study did not cause any mortalities to mice.  Some guidelines for development of these tumor-selective cytotoxins are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpREUb3JFBtvLVg90H21EOLACvtfcHk0ljtKFTOfwJI7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbY%253D&md5=12ef80ab337b36ac22a7372b5f9a80f6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.01.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.01.069%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDoroudi%26aufirst%3DA.%26aulast%3DInci%2BGul%26aufirst%3DH.%26aulast%3DPati%26aufirst%3DH.%2BN.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DQ.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3DCytotoxic%25202-benzylidene-6-%2528nitrobenzylidene%2529cyclohexanones%2520which%2520display%2520substantially%2520greater%2520toxicity%2520for%2520neoplasms%2520than%2520non-malignant%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2219%26epage%3D2224%26doi%3D10.1016%2Fj.bmc.2010.01.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santiago-Vazquez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baca, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala-Marin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lema, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baryyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, R. J.</span></span> <span> </span><span class="NLM_article-title">Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/ lymphoma cells</span>. <i>Clin. Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.2174/2212697X03666160830165250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.2174%2F2212697X03666160830165250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27857884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs12lu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=138-146&author=Y.+Santiago-Vazquezauthor=U.+Dasauthor=A.+Varela-Ramirezauthor=S.+T.+Bacaauthor=Y.+Ayala-Marinauthor=C.+Lemaauthor=S.+Dasauthor=A.+Baryyanauthor=J.+R.+Dimmockauthor=R.+J.+Aguilera&title=Tumor-selective+cytotoxicity+of+a+novel+pentadiene+analogue+on+human+leukemia%2F+lymphoma+cells&doi=10.2174%2F2212697X03666160830165250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells</span></div><div class="casAuthors">Santiago-Vazquez, Yahaira; Das, Umashankar; Varela-Ramirez, Armando; Baca, Sarah T.; Ayala-Marin, Yoshira; Lema, Carolina; Das, Swagatika; Baryyan, Alaa; Dimmock, Jonathan R.; Aguilera, Renato J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">138-146</span>CODEN:
                <span class="NLM_cas:coden">CCDLBJ</span>;
        ISSN:<span class="NLM_cas:issn">2212-6988</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: A novel series of structurally divergent 1,5-diaryl-3-oxo- 1,4-pentadiene analogs 1-10 displayed marked cytotoxic potencies towards a no. of human leukemia/lymphoma cells.  Objective: To identify novel selective cytotoxic compds. that induce apoptosis.  Methods: The Differential Nuclear Staining (DNS) screening protocol was utilized to measure the cytotoxicity of all exptl. dienones on several cancerous cells.  Addnl., the selective cytotoxicity index was calcd. by comparing the dienone's cytotoxicity between leukemia/lymphoma cells vs. non-cancerous cells.  Furthermore, to discern whether a selected dienone induced cell death via apoptosis or necrosis on T-lymphocyte leukemia cells, diverse approaches were utilized to detect individual biochem. facets of apoptosis.  Results: The dienones were tested for their anti-neoplastic efficiency on human leukemia/lymphomaderived cell lines.  Special emphasis was applied on dienone 1, on the basis of its sub-micromolar cytotoxicity (CC50=0.43+0.02 M) and high selective cytotoxicity index (11.1) exerted on T-leukemia cells.  In general, dienone 1 showed the most potent cytotoxic properties as compared to other dienones and a related ref. cytotoxin curcumin as well as the EF-24 curcumin analog.  Dienone 1 caused cell death by apoptosis in Jurkat cells as evidenced by inducing phosphatidylserine externalization, mitochondrial depolarization and caspase-3/7.  These effects were mainly attributed to the induction of apoptotic pathways.  Conclusion: The novel dienone 1 was found to exhibit potent anti-leukemia activity by inducing programmed cell death/apoptosis.  Consequently, dienone 1 should be developed further to examine its potential efficacy to combat malignancies in a pre-clin. animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8T1yRbKAeu7Vg90H21EOLACvtfcHk0ljtKFTOfwJI7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs12lu7zM&md5=a665bec45f51fe165280077eb5c8bb3f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F2212697X03666160830165250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2212697X03666160830165250%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago-Vazquez%26aufirst%3DY.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DVarela-Ramirez%26aufirst%3DA.%26aulast%3DBaca%26aufirst%3DS.%2BT.%26aulast%3DAyala-Marin%26aufirst%3DY.%26aulast%3DLema%26aufirst%3DC.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DBaryyan%26aufirst%3DA.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DAguilera%26aufirst%3DR.%2BJ.%26atitle%3DTumor-selective%2520cytotoxicity%2520of%2520a%2520novel%2520pentadiene%2520analogue%2520on%2520human%2520leukemia%252F%2520lymphoma%2520cells%26jtitle%3DClin.%2520Cancer%2520Drugs%26date%3D2016%26volume%3D3%26spage%3D138%26epage%3D146%26doi%3D10.2174%2F2212697X03666160830165250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, R. J.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones</span>. <i>Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1007/s13402-018-0397-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs13402-018-0397-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=623-636&author=L.+Contrerasauthor=R.+I.+Calderonauthor=A.+Varela-Ramirezauthor=H.+Y.+Zhangauthor=Y.+Quanauthor=U.+Dasauthor=J.+R.+Dimmockauthor=R.+Skoutaauthor=R.+J.+Aguilera&title=Induction+of+apoptosis+via+proteasome+inhibition+in+leukemia%2Flymphoma+cells+by+two+potent+piperidones&doi=10.1007%2Fs13402-018-0397-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones</span></div><div class="casAuthors">Contreras, Lisett; Calderon, Ruben I.; Varela-Ramirez, Armando; Zhang, Hong-Yu; Quan, Yuan; Das, Umashankar; Dimmock, Jonathan R.; Skouta, Rachid; Aguilera, Renato J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">623-636</span>CODEN:
                <span class="NLM_cas:coden">COENGH</span>;
        ISSN:<span class="NLM_cas:issn">2211-3436</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Previously, compds. contg. a piperidone structure have been shown to be highly cytotoxic to cancer cells.  Recently, we found that the piperidone compd. P2 exhibits a potent anti-neoplastic activity against human breast cancer-derived cells.  Here, we aimed to evaluate two piperidone compds., P1 and P2, for their potential anti-neoplastic activity against human leukemia/lymphoma-derived cells.  Methods: Cytotoxicity and apoptosis induction were evaluated using MTS, annexin V-FITC/PI and mitochondrial membrane potential polychromatic assays to confirm the mode of action of the piperidone compds.  The effects of compd. P1 and P2 treatment on gene expression were assessed using AmpliSeq anal. and, subsequently, confirmed by RT-qPCR and Western blotting.  Results: We found that the two related piperidone compds. P1 and P2 selectively killed the leukemia/lymphoma cells tested at nanomolar concns. through induction of the intrinsic apoptotic pathway, as demonstrated by mitochondrial depolarization and caspase-3 activation.  AmpliSeq-based transcriptome analyses of the effects of compds. P1 and P2 on HL-60 acute leukemia cells revealed a differential expression of hundreds of genes, 358 of which were found to be affected by both.  Addnl. pathway analyses revealed that a significant no. of the common genes were related to the unfolded protein response, implying a possible role of the two compds. in the induction of proteotoxic stress.  Subsequent analyses of the transcriptome data revealed that P1 and P2 induced similar gene expression alterations as other well-known proteasome inhibitors.  Finally, we found that Noxa, an important mediator of the activity of proteasome inhibitors, was significantly upregulated at both the mRNA and protein levels, indicating a possible role in the cytotoxic mechanism induced by P1 and P2.  Conclusions: Our data indicate that the cytotoxic activity of P1 and P2 on leukemia/lymphoma cells is mediated by proteasome inhibition, leading to activation of pro-apoptotic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiMsM0d2vAErVg90H21EOLACvtfcHk0lgVmq39pMAjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bN&md5=06b98488ecebf2e8b3f96101816dc00e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs13402-018-0397-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13402-018-0397-1%26sid%3Dliteratum%253Aachs%26aulast%3DContreras%26aufirst%3DL.%26aulast%3DCalderon%26aufirst%3DR.%2BI.%26aulast%3DVarela-Ramirez%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DAguilera%26aufirst%3DR.%2BJ.%26atitle%3DInduction%2520of%2520apoptosis%2520via%2520proteasome%2520inhibition%2520in%2520leukemia%252Flymphoma%2520cells%2520by%2520two%2520potent%2520piperidones%26jtitle%3DCell.%2520Oncol.%26date%3D2018%26volume%3D41%26spage%3D623%26epage%3D636%26doi%3D10.1007%2Fs13402-018-0397-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brnjic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknäs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of proteasome deubiquitinating activity as a new cancer therapy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1640</span>, <span class="refDoi"> DOI: 10.1038/nm.2536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnm.2536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22057347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1636-1640&author=P.+D%E2%80%99Arcyauthor=S.+Brnjicauthor=M.+H.+Olofssonauthor=M.+Frykn%C3%A4sauthor=K.+Lindstenauthor=M.+De+Cesareauthor=P.+Peregoauthor=B.+Sadeghiauthor=M.+Hassanauthor=R.+Larssonauthor=S.+Linder&title=Inhibition+of+proteasome+deubiquitinating+activity+as+a+new+cancer+therapy&doi=10.1038%2Fnm.2536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of proteasome deubiquitinating activity as a new cancer therapy</span></div><div class="casAuthors">D'Arcy, Padraig; Brnjic, Slavica; Olofsson, Maria Haegg; Fryknaes, Maarten; Lindsten, Kristina; De Cesare, Michelandrea; Perego, Paola; Sadeghi, Behnam; Hassan, Moustapha; Larsson, Rolf; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1636-1640</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ubiquitin-tagged substrates are degraded by the 26S proteasome, which is a multisubunit complex comprising a proteolytic 20S core particle capped by 19S regulatory particles.  The approval of bortezomib for the treatment of multiple myeloma validated the 20S core particle as an anticancer drug target.  Here we describe the small mol. b-AP15 as a previously unidentified class of proteasome inhibitor that abrogates the deubiquitinating activity of the 19S regulatory particle. b-AP15 inhibited the activity of two 19S regulatory-particle-assocd. deubiquitinases, ubiquitin C-terminal hydrolase 5 (UCHL5) and ubiquitin-specific peptidase 14 (USP14), resulting in accumulation of polyubiquitin. b-AP15 induced tumor cell apoptosis that was insensitive to TP53 status and overexpression of the apoptosis inhibitor BCL2.  We show that treatment with b-AP15 inhibited tumor progression in four different in vivo solid tumor models and inhibited organ infiltration in an acute myeloid leukemia model.  Our results show that the deubiquitinating activity of the 19S regulatory particle is a new anticancer drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaMVlVRc-JnbVg90H21EOLACvtfcHk0lgVmq39pMAjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfI&md5=e06ed2f3368197416e3188873080d359</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm.2536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2536%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DBrnjic%26aufirst%3DS.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DFrykn%25C3%25A4s%26aufirst%3DM.%26aulast%3DLindsten%26aufirst%3DK.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DSadeghi%26aufirst%3DB.%26aulast%3DHassan%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520proteasome%2520deubiquitinating%2520activity%2520as%2520a%2520new%2520cancer%2520therapy%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1636%26epage%3D1640%26doi%3D10.1038%2Fnm.2536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonard, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, B. W.</span></span> <span> </span><span class="NLM_article-title">Characterization of a steroid receptor coactivator small molecule stimulator that overstimulates cancer cells and leads to cell stress and death</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ccell.2015.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26267537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWlsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=240-252&author=L.+Wangauthor=Y.+Yuauthor=D.+C.+Chowauthor=F.+Yanauthor=C.+C.+Hsuauthor=F.+Stossiauthor=M.+A.+Manciniauthor=T.+Palzkillauthor=L.+Liaoauthor=S.+Zhouauthor=J.+Xuauthor=D.+M.+Lonardauthor=B.+W.+O%E2%80%99Malley&title=Characterization+of+a+steroid+receptor+coactivator+small+molecule+stimulator+that+overstimulates+cancer+cells+and+leads+to+cell+stress+and+death&doi=10.1016%2Fj.ccell.2015.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death</span></div><div class="casAuthors">Wang, Lei; Yu, Yang; Chow, Dar-Chone; Yan, Fei; Hsu, Chih-Chao; Stossi, Fabio; Mancini, Michael A.; Palzkill, Timothy; Liao, Lan; Zhou, Suoling; Xu, Jianming; Lonard, David M.; O'Malley, Bert W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-252</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">By integrating growth pathways on which cancer cells rely, steroid receptor coactivators (SRC-1, SRC-2, and SRC-3) represent emerging targets in cancer therapeutics.  High-throughput screening for SRC small mol. inhibitors (SMIs) uncovered MCB-613 as a potent SRC small mol. "stimulator" (SMS).  We demonstrate that MCB-613 can super-stimulate SRCs' transcriptional activity.  Further investigation revealed that MCB-613 increases SRCs' interactions with other coactivators and markedly induces ER stress coupled to the generation of reactive oxygen species (ROS).  Because cancer cells overexpress SRCs and rely on them for growth, we show that we can exploit MCB-613 to selectively induce excessive stress in cancer cells.  This suggests that over-stimulating the SRC oncogenic program can be an effective strategy to kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHoOaA2EilYbVg90H21EOLACvtfcHk0lifoKbip9stDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWlsbvJ&md5=c22fe20a8c958af1d78b94c87772a33b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DChow%26aufirst%3DD.%2BC.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DHsu%26aufirst%3DC.%2BC.%26aulast%3DStossi%26aufirst%3DF.%26aulast%3DMancini%26aufirst%3DM.%2BA.%26aulast%3DPalzkill%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLonard%26aufirst%3DD.%2BM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DB.%2BW.%26atitle%3DCharacterization%2520of%2520a%2520steroid%2520receptor%2520coactivator%2520small%2520molecule%2520stimulator%2520that%2520overstimulates%2520cancer%2520cells%2520and%2520leads%2520to%2520cell%2520stress%2520and%2520death%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D240%26epage%3D252%26doi%3D10.1016%2Fj.ccell.2015.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coughlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iizuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meints, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacNeill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3174</span>– <span class="NLM_lpage">3186</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1078-0432.CCR-13-2658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24727327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1Cms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=3174-3186&author=K.+Coughlinauthor=R.+Anchooriauthor=Y.+Iizukaauthor=J.+Meintsauthor=L.+MacNeillauthor=R.+I.+Vogelauthor=R.+Z.+Orlowskiauthor=M.+K.+Leeauthor=R.+B.+Rodenauthor=M.+Bazzaro&title=Small-molecule+RA-9+inhibits+proteasome-associated+DUBs+and+ovarian+cancer+in+vitro+and+in+vivo+via+exacerbating+unfolded+protein+responses&doi=10.1158%2F1078-0432.CCR-13-2658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses</span></div><div class="casAuthors">Coughlin, Kathleen; Anchoori, Ravi; Iizuka, Yoshie; Meints, Joyce; MacNeill, Lauren; Vogel, Rachel Isaksson; Orlowski, Robert Z.; Lee, Michael K.; Roden, Richard B. S.; Bazzaro, Martina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3174-3186</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Ovarian cancer is the deadliest of the gynecol. malignancies.  Carcinogenic progression is accompanied by upregulation of ubiquitin-dependent protein degrdn. machinery as a mechanism to compensate with elevated endogenous proteotoxic stress.  Recent studies support the notion that deubiquitinating enzymes (DUB) are essential factors in proteolytic degrdn. and that their aberrant activity is linked to cancer progression and chemoresistance.  Thus, DUBs are an attractive therapeutic target for ovarian cancer.  Exptl. Design: The potency and selectivity of RA-9 inhibitor for proteasome-assocd. DUBs was detd. in ovarian cancer cell lines and primary cells.  The anticancer activity of RA-9 and its mechanism of action were evaluated in multiple cancer cell lines in vitro and in vivo in immunodeficient mice bearing an i.p. ES-2 xenograft model of human ovarian cancer.  Results: Here, we report the characterization of RA-9 as a small-mol. inhibitor of proteasome-assocd. DUBs.  Treatment with RA-9 selectively induces onset of apoptosis in ovarian cancer cell lines and primary cultures derived from donors.  Loss of cell viability following RA-9 exposure is assocd. with an unfolded protein response as mechanism to compensate for unsustainable levels of proteotoxic stress.  In vivo treatment with RA-9 retards tumor growth, increases overall survival, and was well tolerated by the host.  Conclusions: Our preclin. studies support further evaluation of RA-9 as an ovarian cancer therapeutic.  Clin Cancer Res; 20(12); 3174-86. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodC4WcEvlxarVg90H21EOLACvtfcHk0lifoKbip9stDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1Cms78%253D&md5=ae089c729fd6b591705be804f9493432</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2658%26sid%3Dliteratum%253Aachs%26aulast%3DCoughlin%26aufirst%3DK.%26aulast%3DAnchoori%26aufirst%3DR.%26aulast%3DIizuka%26aufirst%3DY.%26aulast%3DMeints%26aufirst%3DJ.%26aulast%3DMacNeill%26aufirst%3DL.%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DBazzaro%26aufirst%3DM.%26atitle%3DSmall-molecule%2520RA-9%2520inhibits%2520proteasome-associated%2520DUBs%2520and%2520ovarian%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%2520via%2520exacerbating%2520unfolded%2520protein%2520responses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D3174%26epage%3D3186%26doi%3D10.1158%2F1078-0432.CCR-13-2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Puente, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azab, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luderer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azab, A. K.</span></span> <span> </span><span class="NLM_article-title">Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1677</span>– <span class="NLM_lpage">1686</span>, <span class="refDoi"> DOI: 10.3109/10428194.2015.1099645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3109%2F10428194.2015.1099645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26421357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWhsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1677-1686&author=P.+de%0Ala+Puenteauthor=F.+Azabauthor=B.+Muzauthor=M.+Ludererauthor=J.+Arbiserauthor=A.+K.+Azab&title=Tris+DBA+palladium+overcomes+hypoxia-mediated+drug+resistance+in+multiple+myeloma&doi=10.3109%2F10428194.2015.1099645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma</span></div><div class="casAuthors">de la Puente, Pilar; Azab, Feda; Muz, Barbara; Luderer, Micah; Arbiser, Jack; Azab, Abdel Kareem</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1677-1686</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Despite recent progress in novel and targeted therapies, multiple myeloma (MM) remains a therapeutically challenging incurable disease.  The regulation of important cellular processes and its link to cancer presented Src as an attractive target for MM.  We suggest a novel strategy to improve the treatment of MM and overcome the drug resistance for the current therapeutic agents by specific inhibition of Src in MM cells by Tris (Dibenzylideneacetone) dipalladium (Tris DBA).  Tris DBA reduces proliferation, induces G1 arrest and apoptosis in MM cells.  Tris DBA showed additive effect with proteasome inhibitors reducing proliferation, cell cycle signaling, and increasing apoptosis more than each drug alone.  Tris DBA overcame hypoxia-induced effects such as enhanced chemotaxis or drug resistance to proteasome inhibitors by inhibition of HIF1α expression.  Moreover, we found that Tris DBA is an effective anti-myeloma agent alone or in combination with other targeted drugs and that it reverses hypoxia-induced drug resistance in myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq92liKQtr-7bVg90H21EOLACvtfcHk0lifoKbip9stDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWhsb%252FK&md5=da369822fa6a6d5e4d8400c8928e7828</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3109%2F10428194.2015.1099645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2015.1099645%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DP.%26aulast%3DAzab%26aufirst%3DF.%26aulast%3DMuz%26aufirst%3DB.%26aulast%3DLuderer%26aufirst%3DM.%26aulast%3DArbiser%26aufirst%3DJ.%26aulast%3DAzab%26aufirst%3DA.%2BK.%26atitle%3DTris%2520DBA%2520palladium%2520overcomes%2520hypoxia-mediated%2520drug%2520resistance%2520in%2520multiple%2520myeloma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2016%26volume%3D57%26spage%3D1677%26epage%3D1686%26doi%3D10.3109%2F10428194.2015.1099645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureban, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanujam, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieckgraefe, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houchen, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anant, S.</span></span> <span> </span><span class="NLM_article-title">Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1962</span>– <span class="NLM_lpage">1969</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-6011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-07-6011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18339878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1962-1969&author=D.+Subramaniamauthor=R.+Mayauthor=S.+M.+Surebanauthor=K.+B.+Leeauthor=R.+Georgeauthor=P.+Kuppusamyauthor=R.+P.+Ramanujamauthor=K.+Hidegauthor=B.+K.+Dieckgraefeauthor=C.+W.+Houchenauthor=S.+Anant&title=Diphenyl+difluoroketone%3A+a+curcumin+derivative+with+potent+in+vivo+anticancer+activity&doi=10.1158%2F0008-5472.CAN-07-6011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Diphenyl Difluoroketone: A Curcumin Derivative with Potent In vivo Anticancer Activity</span></div><div class="casAuthors">Subramaniam, Dharmalingam; May, Randal; Sureban, Sripathi M.; Lee, Katherine B.; George, Robert; Kuppusamy, Periannan; Ramanujam, Rama P.; Hideg, Kalman; Dieckgraefe, Brian K.; Houchen, Courtney W.; Anant, Shrikant</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1962-1969</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Diphenyldifluoroketone (EF24), a mol. having structural similarity to curcumin, was reported to inhibit proliferation of a variety of cancer cells in vitro.  However, the efficacy and in vivo mechanism of action of EF24 in gastrointestinal cancer cells have not been investigated.  Here, we assessed the in vivo therapeutic effects of EF24 on colon cancer cells.  Using hexosaminidase assay, we detd. that EF24 inhibits proliferation of HCT-116 and HT-29 colon and AGS gastric adenocarcinoma cells but not of mouse embryo fibroblasts.  Furthermore, the cancer cells showed increased levels of activated caspase-3 and increased Bax to Bcl-2 and Bax to Bcl-xL ratios, suggesting that the cells were undergoing apoptosis.  At the same time, cell cycle anal. showed that there was an increased no. of cells in the G2-M phase.  To det. the effects of EF24 in vivo, HCT-116 colon cancer xenografts were established in nude mice and EF24 was given i.p.  EF24 significantly suppressed the growth of colon cancer tumor xenografts.  Immunostaining for CD31 showed that there was a lower no. of microvessels in the EF24-treated animals coupled with decreased cyclooxygenase-2, interleukin-8, and vascular endothelial growth factor mRNA and protein expression.  Western blot analyses also showed decreased AKT and extracellular signal-regulated kinase activation in the tumors.  Taken together, these data suggest that the novel curcumin-related compd. EF24 is a potent antitumor agent that induces caspase-mediated apoptosis during mitosis and has significant therapeutic potential for gastrointestinal cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl00KZe-_nprVg90H21EOLACvtfcHk0lgQjnJ8j68CjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrs%253D&md5=a57c5a7fb7bd1e8e53858c16cf2b60eb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-6011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-6011%26sid%3Dliteratum%253Aachs%26aulast%3DSubramaniam%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DR.%26aulast%3DSureban%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BB.%26aulast%3DGeorge%26aufirst%3DR.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DRamanujam%26aufirst%3DR.%2BP.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DDieckgraefe%26aufirst%3DB.%2BK.%26aulast%3DHouchen%26aufirst%3DC.%2BW.%26aulast%3DAnant%26aufirst%3DS.%26atitle%3DDiphenyl%2520difluoroketone%253A%2520a%2520curcumin%2520derivative%2520with%2520potent%2520in%2520vivo%2520anticancer%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1962%26epage%3D1969%26doi%3D10.1158%2F0008-5472.CAN-07-6011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Starcevic, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diotte, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukowski, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R. F.</span></span> <span> </span><span class="NLM_article-title">Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD)</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfg154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Ftoxsci%2Fkfg154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=12805649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=74-81&author=S.+L.+Starcevicauthor=N.+M.+Diotteauthor=K.+L.+Zukowskiauthor=M.+J.+Cameronauthor=R.+F.+Novak&title=Oxidative+DNA+damage+and+repair+in+a+cell+lineage+model+of+human+proliferative+breast+disease+%28PBD%29&doi=10.1093%2Ftoxsci%2Fkfg154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD)</span></div><div class="casAuthors">Starcevic, Susan L.; Diotte, Nicole M.; Zukowski, Kim L.; Cameron, Mark J.; Novak, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-81</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Oxidative damage to DNA is thought to play a significant role in mutagenesis, aging, and cancer.  Sensitivity to oxidative DNA damage and DNA repair efficiency were examd. using a series of human breast epithelial cell lines-MCF-10A, MCF-10AT, and MCF-10ATG3B-with progressively elevated Ras protein.  Breast epithelial cells were treated with H2O2, in the absence and presence of the DNA-repair inhibitors hydroxyurea (HU) and cytosine arabinoside (Ara-C).  DNA strand breaks were assessed by the mean olive tail moment (μm) using the alk. single-cell gel electrophoresis (Comet) assay.  In untreated cells, the mean olive tail moment values were 4.3, 8.3, and 7.1 μm in the MCF-10A, MCF-10AT, and MCF-10ATG3B cells, resp.  Five min H2O2 treatment produced concn.-dependent DNA damage, with the MCF-10A cells most susceptible and the tumorigenic MCF-10ATG3B cells the least susceptible.  Treatment with 100 μM H2O2 resulted in ∼17-, 6-, and 4.5-fold increases in mean olive tail moment values in the MCF-10A, MCF-10AT, and MCF-10ATG3B cells, resp., compared to untreated cells.  The HCC1937 tumor cell line responded in a manner comparable to the MCF-10ATG3B cells treated with H2O2, HU/Ara-C pre-treatment resulted in a ∼1.5-fold increase in olive tail moment values in all three cell lines.  Protein levels of antioxidant enzymes, including catalase, copper/zinc superoxide dismutase (Cu/Zn SOD), and manganese SOD (MnSOD) were detd. to examine a potential mechanism for increased resistance to H2O2-mediated DNA damage.  Levels of these enzymes increased progressively, with highest expression in MCF-10ATG3B cells.  Increased cellular resistance also coincided with marked decreases in p53 protein levels.  These results demonstrate that, in this cell lineage, sensitivity to oxidative DNA damage by H2O2 decreases with tumorigenicity (i.e., MCF-10A vs. MCF-10ATG3B), and show that DNA repair, altered Ras, and p53 expression, or compensatory mechanisms involving elevated antioxidant enzymes are involved in mediating these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rXY7EKBc47Vg90H21EOLACvtfcHk0lgQjnJ8j68CjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlKlsL4%253D&md5=b54a1d6587bd2c038cbf5386497a3d0f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfg154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfg154%26sid%3Dliteratum%253Aachs%26aulast%3DStarcevic%26aufirst%3DS.%2BL.%26aulast%3DDiotte%26aufirst%3DN.%2BM.%26aulast%3DZukowski%26aufirst%3DK.%2BL.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DNovak%26aufirst%3DR.%2BF.%26atitle%3DOxidative%2520DNA%2520damage%2520and%2520repair%2520in%2520a%2520cell%2520lineage%2520model%2520of%2520human%2520proliferative%2520breast%2520disease%2520%2528PBD%2529%26jtitle%3DToxicol.%2520Sci.%26date%3D2003%26volume%3D75%26spage%3D74%26epage%3D81%26doi%3D10.1093%2Ftoxsci%2Fkfg154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pornin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perraut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picollet-D’hahan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gidrol, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haguet, V.</span></span> <span> </span><span class="NLM_article-title">Time-lapse contact microscopy of cell cultures based on non-coherent illumination</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">14532</span>, <span class="refDoi"> DOI: 10.1038/srep14532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep14532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26459014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1KksrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=14532&author=M.+Gabrielauthor=D.+Balleauthor=S.+Bigaultauthor=C.+Porninauthor=S.+Getinauthor=F.+Perrautauthor=M.+R.+Blockauthor=F.+Chatelainauthor=N.+Picollet-D%E2%80%99hahanauthor=X.+Gidrolauthor=V.+Haguet&title=Time-lapse+contact+microscopy+of+cell+cultures+based+on+non-coherent+illumination&doi=10.1038%2Fsrep14532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Time-lapse contact microscopy of cell cultures based on non-coherent illumination</span></div><div class="casAuthors">Gabriel, Marion; Balle, Dorothee; Bigault, Stephanie; Pornin, Cyrille; Getin, Stephane; Perraut, Francois; Block, Marc R.; Chatelain, Francois; Picollet-D'hahan, Nathalie; Gidrol, Xavier; Haguet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14532</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Video microscopy offers outstanding capabilities to investigate the dynamics of biol. and pathol. mechanisms in optimal culture conditions.  Contact imaging is one of the simplest imaging architectures to digitally record images of cells due to the absence of any objective between the sample and the image sensor.  However, in the framework of in-line holog., other optical components, e.g., an optical filter or a pinhole, are placed underneath the light source in order to illuminate the cells with a coherent or quasi-coherent incident light.  In this study, we demonstrate that contact imaging with an incident light of both limited temporal and spatial coherences can be achieved with sufficiently high quality for most applications in cell biol., including monitoring of cell sedimentation, rolling, adhesion, spreading, proliferation, motility, death and detachment.  Patterns of cells were recorded at various distances between 0 and 1000 μm from the pixel array of the image sensors.  Cells in suspension, just deposited or at mitosis focalise light into photonic nanojets which can be visualised by contact imaging.  Light refraction by cells significantly varies during the adhesion process, the cell cycle and among the cell population in connection with every modification in the tridimensional morphol. of a cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotWjMF0l8Wz7Vg90H21EOLACvtfcHk0lgQjnJ8j68CjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1KksrrO&md5=fce3f1f3c7f14e8d9bff49a75b8cf94d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep14532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep14532%26sid%3Dliteratum%253Aachs%26aulast%3DGabriel%26aufirst%3DM.%26aulast%3DBalle%26aufirst%3DD.%26aulast%3DBigault%26aufirst%3DS.%26aulast%3DPornin%26aufirst%3DC.%26aulast%3DGetin%26aufirst%3DS.%26aulast%3DPerraut%26aufirst%3DF.%26aulast%3DBlock%26aufirst%3DM.%2BR.%26aulast%3DChatelain%26aufirst%3DF.%26aulast%3DPicollet-D%25E2%2580%2599hahan%26aufirst%3DN.%26aulast%3DGidrol%26aufirst%3DX.%26aulast%3DHaguet%26aufirst%3DV.%26atitle%3DTime-lapse%2520contact%2520microscopy%2520of%2520cell%2520cultures%2520based%2520on%2520non-coherent%2520illumination%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D14532%26doi%3D10.1038%2Fsrep14532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, M.</span></span> <span> </span><span class="NLM_article-title">EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1097/00001813-200503000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1097%2F00001813-200503000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15711178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Omtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=263-275&author=B.+K.+Adamsauthor=J.+Caiauthor=J.+Armstrongauthor=M.+Heroldauthor=Y.+J.+Luauthor=A.+Sunauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=D.+P.+Jonesauthor=M.+Shoji&title=EF24%2C+a+novel+synthetic+curcumin+analog%2C+induces+apoptosis+in+cancer+cells+via+a+redox-dependent+mechanism&doi=10.1097%2F00001813-200503000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism</span></div><div class="casAuthors">Adams, Brian K.; Cai, Jiyang; Armstrong, Jeff; Herold, Marike; Lu, Yang J.; Sun, Aiming; Snyder, James P.; Liotta, Dennis C.; Jones, Dean P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-275</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In this study, we show that the novel synthetic curcumin analog, EF24, induces cell cycle arrest and apoptosis by a redox-dependent mechanism in MDA-MB-231 human breast cancer cells and DU-145 human prostate cancer cells.  Cell cycle anal. demonstrated that EF24 causes a G2/M arrest in both cell lines, and that this cell cycle arrest is followed by the induction of apoptosis as evidenced by caspase-3 activation, phosphatidylserine externalization and an increased no. of cells with a sub-G1 DNA fraction.  In addn., we demonstrate that EF24 induces a depolarization of the mitochondrial membrane potential, suggesting that the compd. may also induce apoptosis by altering mitochondrial function.  EF24, like curcumin, serves as a Michael acceptor reacting with glutathione (GSH) and thioredoxin 1.  Reaction of EF24 with these agents in vivo significantly reduced intracellular GSH as well as oxidized GSH in both the wild-type and Bcl-xL overexpressing HT29 human colon cancer cells.  We therefore propose that the anticancer effect of a novel curcumin analog, EF24, is mediated in part by redox-mediated induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHtoIYtggfLVg90H21EOLACvtfcHk0li8piCygC3aRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Omtr4%253D&md5=c43b0ba0222fe5fde2ad556c7ccfa667</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F00001813-200503000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200503000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%2BJ.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DEF24%252C%2520a%2520novel%2520synthetic%2520curcumin%2520analog%252C%2520induces%2520apoptosis%2520in%2520cancer%2520cells%2520via%2520a%2520redox-dependent%2520mechanism%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2005%26volume%3D16%26spage%3D263%26epage%3D275%26doi%3D10.1097%2F00001813-200503000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e48075</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0048075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0048075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=23118928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslWjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=H.+Liuauthor=Y.+Liangauthor=L.+Wangauthor=L.+Tianauthor=R.+Songauthor=T.+Hanauthor=S.+Panauthor=L.+Liu&title=In+vivo+and+in+vitro+suppression+of+hepatocellular+carcinoma+by+EF24%2C+a+curcumin+analog&doi=10.1371%2Fjournal.pone.0048075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog</span></div><div class="casAuthors">Liu, Haitao; Liang, Yingjian; Wang, Luoluo; Tian, Lantian; Song, Ruipeng; Han, Tianwen; Pan, Shangha; Liu, Lianxin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e48075</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The synthetic compd. 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24) is a potent analog of curcumin that exhibits enhanced biol. activity and bioavailability without increasing toxicity.  EF24 exerts antitumor activity by arresting the cell cycle and inducing apoptosis, suppressing many types of cancer cells in vitro.  The antiproliferative and antiangiogenic properties of EF24 provide theor. support for its development and application to liver cancers.  We investigated the in vitro and in vivo activities of EF24 on liver cancer to better understand its therapeutic effects and mechanisms.  EF24 induced significant apoptosis and G2/M-phase cell cycle arrest in mouse liver cancer cell lines, Hepa1-6 and H22.  The expression levels of G2/M cell cycle regulating factors, cyclin B1 and Cdc2, were significantly decreased, pp53, p53 and p21 were significantly increased in EF24-treated cells.  In addn., EF24 treatment significantly reduced Bcl-2 concomitant with an increase in Bax, enhanced the release of cytochrome c from the mitochondria into the cytosol, resulting in an upregulation of cleaved-caspase-3, which promoted poly (ADP-ribose) polymerase cleavage.  EF24-treated cells also displayed decreases in phosphorylated Akt, phosphorylated extracellular signal-regulated kinase and vascular endothelial growth factor.  Our in vitro protein expression data were confirmed in vivo using a s.c. hepatocellular carcinoma (HCC) tumor model.  This mouse HCC model confirmed that total body wt. was unchanged following EF24 treatment, although tumor wt. was significantly decreased.  Using an orthotopic HCC model, EF24 significantly reduced the liver/body wt. ratio and relative tumor areas compared to the control group.  In situ detection of apoptotic cells and quantification of Ki-67, a biomarker of cell proliferation, all indicated significant tumor suppression with EF24 treatment.  These results suggest that EF24 exhibits anti-tumor activity on liver cancer cells via mitochondria-dependent apoptosis and inducing cell cycle arrest coupled with antiangiogenesis.  The demonstrated activities of EF24 support its further evaluation as a treatment for human liver cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBlIUQ9G64q7Vg90H21EOLACvtfcHk0li8piCygC3aRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslWjsLzP&md5=f0d4de7eb4cce84a7ee481f5a805757e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0048075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0048075%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520suppression%2520of%2520hepatocellular%2520carcinoma%2520by%2520EF24%252C%2520a%2520curcumin%2520analog%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0048075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertazza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barollo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redaelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armanini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzani, R.</span></span> <span> </span><span class="NLM_article-title">Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2202</span>, <span class="refDoi"> DOI: 10.3390/molecules24122202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3390%2Fmolecules24122202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWqsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=2202&author=L.+Bertazzaauthor=S.+Barolloauthor=M.+E.+Mariauthor=I.+Faccioauthor=M.+Zorzanauthor=M.+Redaelliauthor=B.+Rubinauthor=D.+Armaniniauthor=C.+Mianauthor=R.+Pezzani&title=Biological+effects+of+EF24%2C+a+curcumin+derivative%2C+alone+or+combined+with+mitotane+in+adrenocortical+tumor+cell+lines&doi=10.3390%2Fmolecules24122202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines</span></div><div class="casAuthors">Bertazza, Loris; Barollo, Susi; Mari, Maria Elena; Faccio, Irene; Zorzan, Maira; Redaelli, Marco; Rubin, Beatrice; Armanini, Decio; Mian, Caterina; Pezzani, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2202</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Background: Curcumin has numerous properties and is used in many preclin. conditions, including cancer.  It has low bioavailability, while its deriv. EF24 shows enhanced soly.  However, its effects have never been explored in adrenocortical tumor cell models.  The efficacy of EF24 alone or combined with mitotane (ref. drug for adrenocortical cancer) was evaluated in two adrenocortical tumor cell lines, SW13 and H295R.  Method and Results: EF24 reduced cell viability with an IC50 (half maximal inhibitory concn.) of 6.5 ± 2.4 muM and 4.9 ± 2.8 muM for SW13 and H295R cells, resp.  Combination index (EF24 assocd. with mitotane) suggested an additivity effect in both cell lines.  Cell cycle anal. revealed an increase in subG0/G1 phase, while motility assay showed a decrease in migratory cell capacity, and similarly, clonogenic assay indicated that EF24 could reduce colony nos.  Furthermore, Wnt/beta-catenin, NF-KB, MAPK, and PI3k/Akt pathways were modulated by Western blot anal. when treating cells with EF24 alone or combined with mitotane.  In addn., intracellular reactive oxygen species levels increased in both cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx3Q0FFkZzxrVg90H21EOLACvtfcHk0li8piCygC3aRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWqsrrI&md5=3cb5599cb3d3d79afc10df4b8fd0887f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24122202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24122202%26sid%3Dliteratum%253Aachs%26aulast%3DBertazza%26aufirst%3DL.%26aulast%3DBarollo%26aufirst%3DS.%26aulast%3DMari%26aufirst%3DM.%2BE.%26aulast%3DFaccio%26aufirst%3DI.%26aulast%3DZorzan%26aufirst%3DM.%26aulast%3DRedaelli%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DB.%26aulast%3DArmanini%26aufirst%3DD.%26aulast%3DMian%26aufirst%3DC.%26aulast%3DPezzani%26aufirst%3DR.%26atitle%3DBiological%2520effects%2520of%2520EF24%252C%2520a%2520curcumin%2520derivative%252C%2520alone%2520or%2520combined%2520with%2520mitotane%2520in%2520adrenocortical%2520tumor%2520cell%2520lines%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D2202%26doi%3D10.3390%2Fmolecules24122202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinothkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span> <span> </span><span class="NLM_article-title">Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1007/s00280-016-3172-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs00280-016-3172-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27787644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOmsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2016&pages=1151-1161&author=G.+Heauthor=C.+Fengauthor=R.+Vinothkumarauthor=W.+Chenauthor=X.+Daiauthor=X.+Chenauthor=Q.+Yeauthor=C.+Qiuauthor=H.+Zhouauthor=Y.+Wangauthor=G.+Liangauthor=Y.+Xieauthor=W.+Wu&title=Curcumin+analog+EF24+induces+apoptosis+via+ROS-dependent+mitochondrial+dysfunction+in+human+colorectal+cancer+cells&doi=10.1007%2Fs00280-016-3172-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells</span></div><div class="casAuthors">He, Guodong; Feng, Chen; Vinothkumar, Rajamanickam; Chen, Weiqian; Dai, Xuanxuan; Chen, Xi; Ye, Qingqing; Qiu, Chenyu; Zhou, Huiping; Wang, Yi; Liang, Guang; Xie, Yubo; Wu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1151-1161</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Colorectal cancer is the most commonly diagnosed malignancy with high mortality rates worldwide.  Improved therapeutic strategies with minimal adverse side effects are urgently needed.  In this study, the anti-tumor effects of EF24, a novel analog of the natural compd. curcumin, were evaluated in colorectal cancer cells.  Methods: The anti-tumor activity of EF24 on human colon cancer lines (HCT-116, SW-620, and HT-29) was detd. by measures of cell cycle arrest, apoptosis, and mitochondrial function.  The contribution of ROS in the EF24-induced anti-tumor activity was evaluated by measures of H2O2 and pretreatment with an ROS scavenger, NAC.  Results: The findings indicated that EF24 treatment dose-dependently inhibited cell viability and caused cell cycle arrest at G2/M phase in all the tested colon cancer cell lines.  Furthermore, we demonstrated that EF24 treatment induced apoptosis effectively via enhancing intracellular accumulation of ROS in both HCT-116 and SW-620 cells, but with moderate effects in HT-29 cells.  We found that EF24 treatment decreased the mitochondrial membrane potential in the colon cancer cells, leading to the release of mitochondrial cytochrome c.  Also, EF24 induced activation of caspases 9 and 3, causing decreased Bcl-2 protein expression and Bcl-2/Bax ratio.  Pretreatment with NAC, a ROS scavenger, abrogated the EF24-induced cell death, apoptosis, cell cycle arrest, and mitochondrial dysfunction, suggesting an upstream ROS generation which was responsible for the anticancer effects of EF24.  Conclusions: Our findings support an anticancer mechanism by which EF24 enhanced ROS accumulation in colon cancer cells, thereby resulting in mitochondrial membrane collapse and activated intrinsic apoptotic signaling.  Thus, EF24 could be a potential candidate for therapeutic application of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK9GwAffPlibVg90H21EOLACvtfcHk0ljvBGatVsh3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOmsrnL&md5=8d0f7f64c1da9981bc01257911f68293</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00280-016-3172-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-016-3172-x%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DC.%26aulast%3DVinothkumar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26atitle%3DCurcumin%2520analog%2520EF24%2520induces%2520apoptosis%2520via%2520ROS-dependent%2520mitochondrial%2520dysfunction%2520in%2520human%2520colorectal%2520cancer%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2016%26volume%3D78%26spage%3D1151%26epage%3D1161%26doi%3D10.1007%2Fs00280-016-3172-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. X.</span></span> <span> </span><span class="NLM_article-title">EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32167</span>, <span class="refDoi"> DOI: 10.1038/srep32167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep32167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27571770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=32167&author=D.+L.+Yinauthor=Y.+J.+Liangauthor=T.+S.+Zhengauthor=R.+P.+Songauthor=J.+B.+Wangauthor=B.+S.+Sunauthor=S.+H.+Panauthor=L.+D.+Quauthor=J.+R.+Liuauthor=H.+C.+Jiangauthor=L.+X.+Liu&title=EF24+inhibits+tumor+growth+and+metastasis+via+suppressing+NF-kappaB+dependent+pathways+in+human+cholangiocarcinoma&doi=10.1038%2Fsrep32167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma</span></div><div class="casAuthors">Yin, Da-long; Liang, Ying-jian; Zheng, Tong-sen; Song, Rui-peng; Wang, Jia-bei; Sun, Bo-shi; Pan, Shang-ha; Qu, Lian-dong; Liu, Jia-ren; Jiang, Hong-chi; Liu, Lian-xin</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32167</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A synthetic monoketone analog of curcumin, termed 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), has been reported to inhibit the growth of a variety of cancer cells both in vitro and in vivo.  However, whether EF24 has anticancer effects on cholangiocarcinoma (CCA) cells and the mechanisms remain to be investigated.  The aim of our study was to evaluate the mol. mechanisms underlying the anticancer effects of EF24 on CCA tumor growth and metastasis.  Cell proliferation, apoptosis, migration, invasion, tumorigenesis and metastasis were examd.  EF24 exhibited time- and dose-dependent inhibitory effects on HuCCT-1, TFK-1 and HuH28 human CCA cell lines.  EF24 inhibited CCA cell proliferation, migration, and induced G2/M phase arrest.  EF24 induced cell apoptosis along with neg. regulation of NF-κB- X-linked inhibitor of apoptosis protein (XIAP) signaling pathway.  XIAP inhibition by lentivirus mediated RNA interference enhanced EF24-induced apoptosis, while XIAP overexpression reduced it in CCA cells.  In vivo, EF24 significantly suppressed the growth of CCA tumor xenografts and tumor metastasis while displaying low toxicity levels.  Our findings indicate that EF24 is a potent antitumor agent that inhibits tumor growth and metastasis by inhibiting NF-κB dependent signaling pathways.  EF24 may represent a novel approach for CCA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJYM4lWbq_iLVg90H21EOLACvtfcHk0ljvBGatVsh3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCqt73E&md5=eae779c49a019ac77d13bc42583abaa3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fsrep32167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32167%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DD.%2BL.%26aulast%3DLiang%26aufirst%3DY.%2BJ.%26aulast%3DZheng%26aufirst%3DT.%2BS.%26aulast%3DSong%26aufirst%3DR.%2BP.%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DSun%26aufirst%3DB.%2BS.%26aulast%3DPan%26aufirst%3DS.%2BH.%26aulast%3DQu%26aufirst%3DL.%2BD.%26aulast%3DLiu%26aufirst%3DJ.%2BR.%26aulast%3DJiang%26aufirst%3DH.%2BC.%26aulast%3DLiu%26aufirst%3DL.%2BX.%26atitle%3DEF24%2520inhibits%2520tumor%2520growth%2520and%2520metastasis%2520via%2520suppressing%2520NF-kappaB%2520dependent%2520pathways%2520in%2520human%2520cholangiocarcinoma%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D32167%26doi%3D10.1038%2Fsrep32167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span> <span> </span><span class="NLM_article-title">Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4927</span>– <span class="NLM_lpage">4933</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3892%2Fmmr.2017.7189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28791378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=4927-4933&author=C.+Linauthor=C.+Tuauthor=Y.+Maauthor=P.+Yeauthor=X.+Shaoauthor=Z.+Yangauthor=Y.+Fang&title=Curcumin+analog+EF24+induces+apoptosis+and+downregulates+the+mitogen+activated+protein+kinase%2Fextracellular+signal-regulated+signaling+pathway+in+oral+squamous+cell+carcinoma&doi=10.3892%2Fmmr.2017.7189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma</span></div><div class="casAuthors">Lin, Chongxiang; Tu, Chengwei; Ma, Yike; Ye, Pengcheng; Shao, Xia; Yang, Zhaoan; Fang, Yiming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4927-4933</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide.  Diphenyldifluoroketone (EF24) is a curcumin analog that has been demonstrated to improve anticancer activity; however, its therapeutic potential and mechanisms in oral cancer remain unknown.  In the present study, the effect of EF24 on apoptosis induction and its potential underlying mechanism in the CAL-27 human OSCC cell line was investigated.  To achieve this, various concns. of cisplatin or EF24 were administrated to CAL-27 cells for 24 h, and cell viability, apoptotic DNA fragmentation, and cleaved caspase 3 and 9 levels were evaluated.  To investigate the potential underlying mechanism, the levels of mitogen-activated protein kinase kinase 1 (MEK1) and extracellular signal-regulated kinase (ERK), two key proteins in the mitogen-activated protein kinase/ERK signaling pathway, were addnl. examd.  The results indicated that EF24 and cisplatin treatment decreased cell viability.  EF24 treatment increased the levels of activated caspase 3 and 9, and decreased the phosphorylated forms of MEK1 and ERK.  Sequential treatments of EF24 and 12-phorbol-13-myristate acetate, a MAPK/ERK activator, resulted in a significant increase of activated MEK1 and ERK, and reversed cell viability.  These results suggested that EF24 has potent anti-tumor activity in OSCC via deactivation of the MAPK/ERK signaling pathway.  Further analyses using animal models are required to confirm these findings in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8brJwaRGdj7Vg90H21EOLACvtfcHk0ljvBGatVsh3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVOgsA%253D%253D&md5=3899730773178d339c614febe71a2d61</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7189%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DTu%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DY.%26atitle%3DCurcumin%2520analog%2520EF24%2520induces%2520apoptosis%2520and%2520downregulates%2520the%2520mitogen%2520activated%2520protein%2520kinase%252Fextracellular%2520signal-regulated%2520signaling%2520pathway%2520in%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D16%26spage%3D4927%26epage%3D4933%26doi%3D10.3892%2Fmmr.2017.7189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential I-kappaB kinase beta inhibitors for the treatment of pancreatic cancer</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1439</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S133172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.2147%2FDDDT.S133172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28553074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKns7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=1439-1451&author=X.+Xieauthor=J.+Tuauthor=H.+Youauthor=B.+Hu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+EF24+and+EF31+analogs+as+potential+I-kappaB+kinase+beta+inhibitors+for+the+treatment+of+pancreatic+cancer&doi=10.2147%2FDDDT.S133172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer</span></div><div class="casAuthors">Xie, Xuemeng; Tu, Jinfu; You, Heyi; Hu, Bingren</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1439-1451</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Given the important role that inhibitory kappa B (IκB) kinase β (IKKβ) plays in pancreatic cancer (PC) development and progression, inhibitors targeting IKKβ are believed to be increasingly popular as novel anti-PC therapies.  Two synthetic mols., named EF24 and EF31, exhibited favorable potential in terms of inhibition of both IKKβ activity and PC cell proliferation.  Aiming to enhance their cellular efficacy and to analyze their structure-activity relationship, four series of EF24 and EF31 analogs were designed and synthesized.  Through kinase activity and vitality screening of cancer cells, D6 displayed excellent inhibition of both IKKβ activity and PC cell proliferation.  Addnl., multiple biol. evaluations showed that D6 was directly bound to IKKβ and significantly suppressed the activation of the IKKβ/nuclear factor κB pathway induced by tumor necrosis factor-α, as well as effectively inducing cancer cell apoptosis.  Moreover, mol. docking and mol. dynamics simulation anal. indicated that the dominant force between D6 and IKKβ comprised hydrophobic interactions.  In conclusion, D6 may be a promising therapeutic agent for PC treatment and it also provides a structural lead for the design of novel IKKβ inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPYPXdLVZu5bVg90H21EOLACvtfcHk0liSpHpN8ZeJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKns7zI&md5=fc287d3c168064b0e840f29cbafc989e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S133172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S133172%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DX.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520EF24%2520and%2520EF31%2520analogs%2520as%2520potential%2520I-kappaB%2520kinase%2520beta%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pancreatic%2520cancer%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2017%26volume%3D11%26spage%3D1439%26epage%3D1451%26doi%3D10.2147%2FDDDT.S133172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tazi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratasz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1228</span>– <span class="NLM_lpage">1235</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.freeradbiomed.2010.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20156552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1228-1235&author=K.+Selvendiranauthor=S.+Ahmedauthor=A.+Daytonauthor=M.+L.+Kuppusamyauthor=M.+Taziauthor=A.+Brataszauthor=L.+Tongauthor=B.+K.+Riveraauthor=T.+Kalaiauthor=K.+Hidegauthor=P.+Kuppusamy&title=Safe+and+targeted+anticancer+efficacy+of+a+novel+class+of+antioxidant-conjugated+difluorodiarylidenyl+piperidones%3A+differential+cytotoxicity+in+healthy+and+cancer+cells&doi=10.1016%2Fj.freeradbiomed.2010.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: Differential cytotoxicity in healthy and cancer cells</span></div><div class="casAuthors">Selvendiran, Karuppaiyah; Ahmed, Shabnam; Dayton, Alex; Kuppusamy, M. Lakshmi; Tazi, Mia; Bratasz, Anna; Tong, Liyue; Rivera, Brian K.; Kalai, Tamas; Hideg, Kalman; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1228-1235</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of smart anticancer drugs that can selectively kill cancer cells while sparing the surrounding healthy tissues/cells is of paramount importance for safe and effective cancer therapy.  We report a novel class of bifunctional compds. based on diarylidenyl piperidone (DAP) conjugated to an N-hydroxypyrroline (NOH; a nitroxide precursor) group.  We hypothesized that the DAP would have cytotoxic (anticancer) activity, whereas the NOH moiety would function as a tissue-specific modulator (antioxidant) of cytotoxicity.  The study used four DAPs, namely H-4073 and H-4318 without NOH and HO-3867 and HO-4200 with NOH substitution.  The goal of the study was to evaluate the proof-of-concept anticancer-vs.-antioxidant efficacy of the DAPs using a no. of cancerous (breast, colon, head and neck, liver, lung, ovarian, and prostate cancer) and noncancerous (smooth muscle, aortic endothelial, and ovarian surface epithelial) human cell lines.  Cytotoxicity was detd. using an MTT-based cell viability assay.  All four compds. induced significant loss of cell viability in cancer cells, whereas HO-3867 and HO-4200 showed significantly less cytotoxicity in noncancerous cells.  EPR measurements showed a metabolic conversion of the N-hydroxylamine function to nitroxide with significantly higher levels of the metabolite and superoxide radical-scavenging (antioxidant) activity in noncancerous cells compared to cancer cells.  Western blot anal. showed that the DAP-induced growth arrest and apoptosis in cancer cells were mediated by inhibition of STAT3 phosphorylation at the Tyr705 and Ser727 residues and induction of apoptotic markers of cleaved caspase-3 and PARP.  The results suggest that the antioxidant-conjugated DAPs will be useful as safe and effective anticancer agents for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVEfHY_7lK7Vg90H21EOLACvtfcHk0liSpHpN8ZeJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVSiu7k%253D&md5=44ff3167de6a87965c14ad90dfb63dd7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DDayton%26aufirst%3DA.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DTazi%26aufirst%3DM.%26aulast%3DBratasz%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DSafe%2520and%2520targeted%2520anticancer%2520efficacy%2520of%2520a%2520novel%2520class%2520of%2520antioxidant-conjugated%2520difluorodiarylidenyl%2520piperidones%253A%2520differential%2520cytotoxicity%2520in%2520healthy%2520and%2520cancer%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1228%26epage%3D1235%26doi%3D10.1016%2Fj.freeradbiomed.2010.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratasz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigg, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-1207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1535-7163.MCT-09-1207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20442315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsleksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1169-1179&author=K.+Selvendiranauthor=L.+Tongauthor=A.+Brataszauthor=M.+L.+Kuppusamyauthor=S.+Ahmedauthor=Y.+Raviauthor=N.+J.+Triggauthor=B.+K.+Riveraauthor=T.+Kalaiauthor=K.+Hidegauthor=P.+Kuppusamy&title=Anticancer+efficacy+of+a+difluorodiarylidenyl+piperidone+%28HO-3867%29+in+human+ovarian+cancer+cells+and+tumor+xenografts&doi=10.1158%2F1535-7163.MCT-09-1207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts</span></div><div class="casAuthors">Selvendiran, Karuppaiyah; Tong, Liyue; Bratasz, Anna; Kuppusamy, M. Lakshmi; Ahmed, Shabnam; Ravi, Yazhini; Trigg, Nancy J.; Rivera, Brian K.; Kalai, Tamas; Hideg, Kalman; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1169-1179</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to evaluate the anticancer potency and mechanism of a novel difluorodiarylidenyl piperidone (H-4073) and its N-hydroxypyrroline modification (HO-3867) in human ovarian cancer.  Studies were done using established human ovarian cancer cell lines (A2870, A2780cDDP, OV-4, SKOV3, PA-1, and OVCAR3) as well as in a murine xenograft tumor (A2780) model.  Both compds. were comparably and significantly cytotoxic to A2780 cells.  However, HO-3867 showed a preferential toxicity toward ovarian cancer cells while sparing healthy cells.  HO-3867 induced G2-M cell cycle arrest in A2780 cells by modulating cell cycle regulatory mols. p53, p21, p27, cyclin-dependent kinase 2, and cyclin, and promoted apoptosis by caspase-8 and caspase-3 activation.  It also caused an increase in the expression of functional Fas/CD95 and decreases in signal transducers and activators of transcription 3 (STAT3; Tyr705) and JAK1 phosphorylation.  There was a significant redn. in STAT3 downstream target protein levels including Bcl-xL, Bcl-2, survivin, and vascular endothelial growth factor, suggesting that HO-3867 exposure disrupted the JAK/STAT3 signaling pathway.  In addn., HO-3867 significantly inhibited the growth of the ovarian xenografted tumors in a dosage-dependent manner without any apparent toxicity.  Western blot anal. of the xenograft tumor tissues showed that HO-3867 inhibited pSTAT3 (Tyr705 and Ser727) and JAK1 and increased apoptotic markers cleaved caspase-3 and poly ADP ribose polymerase.  HO-3867 exhibited significant cytotoxicity toward ovarian cancer cells by inhibition of the JAK/STAT3 signaling pathway.  The study suggested that HO-3867 may be useful as a safe and effective anticancer agent for ovarian cancer therapy.  Mol Cancer Ther; 9(5); 1169-79.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiaW0a9PKE7Vg90H21EOLACvtfcHk0liSpHpN8ZeJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsleksLw%253D&md5=d902bc64501f5ceaa9901814fe09db65</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1207%26sid%3Dliteratum%253Aachs%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DBratasz%26aufirst%3DA.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DRavi%26aufirst%3DY.%26aulast%3DTrigg%26aufirst%3DN.%2BJ.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DAnticancer%2520efficacy%2520of%2520a%2520difluorodiarylidenyl%2520piperidone%2520%2528HO-3867%2529%2520in%2520human%2520ovarian%2520cancer%2520cells%2520and%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1169%26epage%3D1179%26doi%3D10.1158%2F1535-7163.MCT-09-1207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhiman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelham, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiparoidze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomm, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fersht, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">4262</span>– <span class="NLM_lpage">4276</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA117.000950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.RA117.000950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29382728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlslKgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=4262-4276&author=E.+Madanauthor=T.+M.+Parkerauthor=M.+R.+Bauerauthor=A.+Dhimanauthor=C.+J.+Pelhamauthor=M.+Naganeauthor=M.+L.+Kuppusamyauthor=M.+Holmesauthor=T.+R.+Holmesauthor=K.+Shaikauthor=K.+Sheeauthor=S.+Kiparoidzeauthor=S.+D.+Smithauthor=Y.+A.+Parkauthor=J.+J.+Gommauthor=L.+J.+Jonesauthor=A.+R.+Tomasauthor=A.+C.+Cunhaauthor=K.+Selvendiranauthor=L.+A.+Hansenauthor=A.+R.+Fershtauthor=K.+Hidegauthor=R.+Gognaauthor=P.+Kuppusamy&title=The+curcumin+analog+HO-3867+selectively+kills+cancer+cells+by+converting+mutant+p53+protein+to+transcriptionally+active+wildtype+p53&doi=10.1074%2Fjbc.RA117.000950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53</span></div><div class="casAuthors">Madan, Esha; Parker, Taylor M.; Bauer, Matthias R.; Dhiman, Alisha; Pelham, Christopher J.; Nagane, Masaki; Kuppusamy, M. Lakshmi; Holmes, Matti; Holmes, Thomas R.; Shaik, Kranti; Shee, Kevin; Kiparoidze, Salome; Smith, Sean D.; Park, Yu-Soon A.; Gomm, Jennifer J.; Jones, Louise J.; Tomas, Ana R.; Cunha, Ana C.; Selvendiran, Karuppaiyah; Hansen, Laura A.; Fersht, Alan R.; Hideg, Kalman; Gogna, Rajan; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4262-4276</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">P53 is an important tumor-suppressor protein that is mutated in more than 50% of cancers.  Strategies for restoring normal p53 function are complicated by the oncogenic properties of mutant p53 and have not met with clin. success.  To counteract mutant p53 activity, a variety of drugs with the potential to reconvert mutant p53 to an active wildtype form have been developed.  However, these drugs are assocd. with various neg. effects such as cellular toxicity, nonspecific binding to other proteins, and inability to induce a wildtype p53 response in cancer tissue.  Here, we report on the effects of a curcumin analog, HO-3867, on p53 activity in cancer cells from different origins.  We found that HO-3867 covalently binds to mutant p53, initiates a wildtype p53-like anticancer genetic response, is exclusively cytotoxic toward cancer cells, and exhibits high anticancer efficacy in tumor models.  In conclusion, HO-3867 is a p53 mutant-reactivating drug with high clin. anticancer potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-d4SyFtW-bVg90H21EOLACvtfcHk0lgtjiR0_BBkQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlslKgur0%253D&md5=f54bb106deb69ebd79f3159efd2b04a1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA117.000950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA117.000950%26sid%3Dliteratum%253Aachs%26aulast%3DMadan%26aufirst%3DE.%26aulast%3DParker%26aufirst%3DT.%2BM.%26aulast%3DBauer%26aufirst%3DM.%2BR.%26aulast%3DDhiman%26aufirst%3DA.%26aulast%3DPelham%26aufirst%3DC.%2BJ.%26aulast%3DNagane%26aufirst%3DM.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DHolmes%26aufirst%3DM.%26aulast%3DHolmes%26aufirst%3DT.%2BR.%26aulast%3DShaik%26aufirst%3DK.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DKiparoidze%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DS.%2BD.%26aulast%3DPark%26aufirst%3DY.%2BA.%26aulast%3DGomm%26aufirst%3DJ.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BJ.%26aulast%3DTomas%26aufirst%3DA.%2BR.%26aulast%3DCunha%26aufirst%3DA.%2BC.%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DL.%2BA.%26aulast%3DFersht%26aufirst%3DA.%2BR.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DGogna%26aufirst%3DR.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DThe%2520curcumin%2520analog%2520HO-3867%2520selectively%2520kills%2520cancer%2520cells%2520by%2520converting%2520mutant%2520p53%2520protein%2520to%2520transcriptionally%2520active%2520wildtype%2520p53%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D4262%26epage%3D4276%26doi%3D10.1074%2Fjbc.RA117.000950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1097%2FCAD.0000000000000470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28067673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt12qurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=392-400&author=Y.+Huauthor=C.+Zhaoauthor=H.+Zhengauthor=K.+Luauthor=D.+Shiauthor=Z.+Liuauthor=X.+Daiauthor=Y.+Zhangauthor=X.+Zhangauthor=W.+Huauthor=G.+Liang&title=A+novel+STAT3+inhibitor+HO-3867+induces+cell+apoptosis+by+reactive+oxygen+species-dependent+endoplasmic+reticulum+stress+in+human+pancreatic+cancer+cells&doi=10.1097%2FCAD.0000000000000470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells</span></div><div class="casAuthors">Hu, Yan; Zhao, Chengguang; Zheng, Hailun; Lu, Kongqin; Shi, Dengjian; Liu, Zhiguo; Dai, Xuanxuan; Zhang, Yi; Zhang, Xiuhua; Hu, Wanle; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-400</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Pancreatic cancer is the most commonly diagnosed malignancy among solid tumors and has shown an increasing trend year by year.  Thus, there is an urgent need for the discovery of new anticancer drugs for the treatment of pancreatic cancer.  In recent years, it has been reported that the compd. HO-3867, a novel analog of the natural product curcumin, showed antitumor activity with low toxicity.  However, the underlying mechanism of this compd.'s attack on cancer cells is not very clear.  In the present study, it was found that HO-3867 showed good antitumor activity at the concn. of 2 μmol/l in PANC-1 and BXPC-3 cells.  Importantly, it was also found that HO-3867 treatment significantly induced reactive oxygen species (ROS) prodn. in human pancreatic cancer cell lines, inducing PANC-1 and BXPC-3 cells.  Co-treatment with the ROS scavenger, N-acetyl cysteine, partially abrogated HO-3867-induced cell apoptosis.  The activation of mitogen-activated protein kinase and endoplasmic reticulum stress indicated a downstream event of ROS generation in mediating the anticancer effect of the HO-3867.  In addn., independent of the ROS pathway, direct STAT3 inhibition was obsd. in HO-3867-induced cell apoptosis.  Taken together, the results of this work suggest that both the ROS-dependent ER stress and STAT3 pathways were implicated in the cell apoptosis induced by the novel compd. HO-3867.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgiWVMOmX-rLVg90H21EOLACvtfcHk0lgtjiR0_BBkQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt12qurY%253D&md5=337f936149ffacd1a8aa04d60eb118ea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000470%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DA%2520novel%2520STAT3%2520inhibitor%2520HO-3867%2520induces%2520cell%2520apoptosis%2520by%2520reactive%2520oxygen%2520species-dependent%2520endoplasmic%2520reticulum%2520stress%2520in%2520human%2520pancreatic%2520cancer%2520cells%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2017%26volume%3D28%26spage%3D392%26epage%3D400%26doi%3D10.1097%2FCAD.0000000000000470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmi Kuppusamy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmiec, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Diarylidenylpiperidones, H-4073 and HO-3867, induce G2/M cell-cycle arrest, apoptosis and inhibit STAT3 phosphorylation in human pancreatic cancer cells</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1007/s12013-019-00873-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs12013-019-00873-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31089934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpsVyhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2019&pages=109-119&author=J.+M.+Mastauthor=D.+Tseauthor=K.+Sheeauthor=M.+Lakshmi+Kuppusamyauthor=M.+M.+Kmiecauthor=T.+Kalaiauthor=P.+Kuppusamy&title=Diarylidenylpiperidones%2C+H-4073+and+HO-3867%2C+induce+G2%2FM+cell-cycle+arrest%2C+apoptosis+and+inhibit+STAT3+phosphorylation+in+human+pancreatic+cancer+cells&doi=10.1007%2Fs12013-019-00873-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Diarylidenylpiperidones, H-4073 and HO-3867, induce G2/M cell-cycle arrest, apoptosis and inhibit STAT3 phosphorylation in human pancreatic cancer cells</span></div><div class="casAuthors">Mast, Jesse M.; Tse, Dan; Shee, Kevin; Lakshmi Kuppusamy, M.; Kmiec, Maciej M.; Kalai, Tamas; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-119</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Pancreatic cancer has a 5-yr survival rate below 10% and the treatment options are limited.  Signal transducer and activator of transcription (STAT3) is a constitutively expressed protein in human pancreatic cancers and is assocd. with their poor prognosis.  Targeting of STAT3 signaling using novel therapeutic agents is a potential strategy for pancreatic cancer treatment.  Diarylidenylpiperidone (DAP) compds., such as H-4073 and HO-3867, have been shown to be STAT3 inhibitors in several human ovarian cancers.  Particularly, HO-3867 is an N-hydroxypyrroline deriv. of DAP that has targeted cytotoxicity toward cancer cells without affecting healthy cells.  In the present study, we evaluated the anticancer efficacy of H-4073 and HO-3867 in a human pancreatic cell line (AsPC-1).  We found that both the compds. exhibited potential cytotoxicity to AsPC-1 cells by inducing G2/M cell-cycle arrest, apoptosis, and cell death, by mitochondrial damage and inhibition of STAT3 phosphorylation.  In summary, H-4073 and HO-3867 are cytotoxic to AsPC-1 cells and seem to act through similar mechanisms, including STAT3 inhibition, cell-cycle arrest, and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6tUoAPYNIArVg90H21EOLACvtfcHk0li7ccE8LNSlWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpsVyhurk%253D&md5=3d56aec889cd67d3e9e7942b2d90375f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs12013-019-00873-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-019-00873-6%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DJ.%2BM.%26aulast%3DTse%26aufirst%3DD.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DLakshmi%2BKuppusamy%26aufirst%3DM.%26aulast%3DKmiec%26aufirst%3DM.%2BM.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DDiarylidenylpiperidones%252C%2520H-4073%2520and%2520HO-3867%252C%2520induce%2520G2%252FM%2520cell-cycle%2520arrest%252C%2520apoptosis%2520and%2520inhibit%2520STAT3%2520phosphorylation%2520in%2520human%2520pancreatic%2520cancer%2520cells%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2019%26volume%3D77%26spage%3D109%26epage%3D119%26doi%3D10.1007%2Fs12013-019-00873-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span> <span> </span><span class="NLM_article-title">Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2014.07.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ygyno.2014.07.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25038288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2014&pages=133-141&author=B.+J.+Tierneyauthor=G.+A.+McCannauthor=S.+Naiduauthor=K.+S.+Rathauthor=U.+Sainiauthor=R.+Wannerauthor=P.+Kuppusamyauthor=A.+Suarezauthor=P.+J.+Goodfellowauthor=D.+E.+Cohnauthor=K.+Selvendiran&title=Aberrantly+activated+pSTAT3-Ser727+in+human+endometrial+cancer+is+suppressed+by+HO-3867%2C+a+novel+STAT3+inhibitor&doi=10.1016%2Fj.ygyno.2014.07.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor</span></div><div class="casAuthors">Tierney, Brent J.; McCann, Georgia A.; Naidu, Shan; Rath, Kellie S.; Saini, Uksha; Wanner, Ross; Kuppusamy, Periannan; Suarez, Adrian; Goodfellow, Paul J.; Cohn, David E.; Selvendiran, Karuppaiyah</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-141</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Constitutive activation of STAT3 is a hallmark of various human cancers, however an increased pSTAT3 expression in high grade human endometrial cancer has not been reported.  In the present study, we examine the expression of STAT family of proteins in endometrial cancer cell lines and the efficacy of HO-3867, a novel STAT3 inhibitor designed in our lab.  Expression of STAT family proteins was evaluated via Western blot.  The cell viability, post-treatment with HO-3867, was assessed using MTT, cell-cycle profile and Annexin assay.  In vivo efficacy of HO-3867 was evaluated using xenograft mice.  Expression of activated STATs was inconsistent among the cell lines and 18 human endometrial cancer specimens tested.  While pSTAT3 Tyr705 was not expressed in any of the cell lines, pSTAT3 Ser727 was highly expressed in endometrial cancer cell lines and tumor specimens.  HO-3867 decreased the expression of pSTAT3 Ser727 while total STAT3 remained const.; cell viability decreased by 50-80% and induced G2/M arrest in 55% of Ishikawa cells at the G2/M cell cycle checkpoint.  There was an increase in p53, a decrease in Bcl2 and Bcl-xL, and cleavage of caspase-3, caspase-7 and PARP.  HO-3867 mediated a dosage-dependent inhibition of the growth of xenografted endometrial tumors.  HO-3867 treatment decreases the high levels of pSTAT3 Ser727 in endometrial cancer cells by inducing cell cycle arrest and apoptosis.  This suggests a specific role of serine-phosphorylated STAT3, independent of tyrosine phosphorylation in the oncogenesis of endometrial cancer.  HO-3867 could potentially serve as an adjunctive targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdi_yQm8JiH7Vg90H21EOLACvtfcHk0li7ccE8LNSlWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7nE&md5=9ad29945d9869d129a57cb3e3e6d0490</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2014.07.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2014.07.087%26sid%3Dliteratum%253Aachs%26aulast%3DTierney%26aufirst%3DB.%2BJ.%26aulast%3DMcCann%26aufirst%3DG.%2BA.%26aulast%3DNaidu%26aufirst%3DS.%26aulast%3DRath%26aufirst%3DK.%2BS.%26aulast%3DSaini%26aufirst%3DU.%26aulast%3DWanner%26aufirst%3DR.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DSuarez%26aufirst%3DA.%26aulast%3DGoodfellow%26aufirst%3DP.%2BJ.%26aulast%3DCohn%26aufirst%3DD.%2BE.%26aulast%3DSelvendiran%26aufirst%3DK.%26atitle%3DAberrantly%2520activated%2520pSTAT3-Ser727%2520in%2520human%2520endometrial%2520cancer%2520is%2520suppressed%2520by%2520HO-3867%252C%2520a%2520novel%2520STAT3%2520inhibitor%26jtitle%3DGynecol.%2520Oncol.%26date%3D2014%26volume%3D135%26spage%3D133%26epage%3D141%26doi%3D10.1016%2Fj.ygyno.2014.07.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Design and optimize N-substituted EF24 as effective and low toxicity NF-kappaB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">1368</span>– <span class="NLM_lpage">1377</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1111%2Fcbdd.13514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30873716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnslyhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2019&pages=1368-1377&author=L.+Chenauthor=Q.+Liauthor=Z.+Zhengauthor=J.+Xieauthor=X.+Linauthor=C.+Jiangauthor=H.+Xuauthor=X.+Wuauthor=J.+Wuauthor=H.+Zhang&title=Design+and+optimize+N-substituted+EF24+as+effective+and+low+toxicity+NF-kappaB+inhibitor+for+lung+cancer+therapy+via+apoptosis-to-pyroptosis+switch&doi=10.1111%2Fcbdd.13514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch</span></div><div class="casAuthors">Chen, Liping; Li, Qian; Zheng, Zhiwei; Xie, Jingwen; Lin, Xiaoming; Jiang, Chengxi; Xu, Haineng; Wu, Xiaoping; Wu, Jianzhang; Zhang, Huajie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1368-1377</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">As NF-κB signaling pathway is constitutively activated in lung cancer, targeting NF-κB has a potential for the treatment.  EF24 has been proved to be a NF-κB inhibitor with good antitumor activity, while whose toxicity possibly became one of the obstacles to enter into clin. application.  In order to find high efficiency and low toxicity NF-κB inhibitors, EF24 was modified and 13d(I) was screened out.  It was proved that I possessed an effective combination of inhibiting NF-κB pathway and showing lower cytotoxicity on normal cells as well as less toxicity in acute toxicity expt. compared with the lead compd. of EF24.  In addn., I was found to inhibit cell vitality, arrest cell cycle in G2/M phase, promote cell apoptosis, and suppress the xenograft tumor growth.  Furthermore, I was elucidated to induce pyroptosis developing from apoptosis, which was assocd. with the inhibition of NF-κB.  Taken together, it was suggested that I was a potent antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkc2o9B3a3LVg90H21EOLACvtfcHk0li7ccE8LNSlWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnslyhsLg%253D&md5=2eb7f05e191663aeb8cce5dac3b939e9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13514%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DDesign%2520and%2520optimize%2520N-substituted%2520EF24%2520as%2520effective%2520and%2520low%2520toxicity%2520NF-kappaB%2520inhibitor%2520for%2520lung%2520cancer%2520therapy%2520via%2520apoptosis-to-pyroptosis%2520switch%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2019%26volume%3D94%26spage%3D1368%26epage%3D1377%26doi%3D10.1111%2Fcbdd.13514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, Q.</span></span> <span> </span><span class="NLM_article-title">Bioactivities of EF24, a novel curcumin analog: a review</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">614</span>, <span class="refDoi"> DOI: 10.3389/fonc.2018.00614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3389%2Ffonc.2018.00614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30619754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3cnptVOqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=614&author=Y.+Heauthor=W.+Liauthor=G.+Huauthor=H.+Sunauthor=Q.+Kong&title=Bioactivities+of+EF24%2C+a+novel+curcumin+analog%3A+a+review&doi=10.3389%2Ffonc.2018.00614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivities of EF24, a Novel Curcumin Analog: A Review</span></div><div class="casAuthors">He Yonghan; Kong Qingpeng; Li Wen; Hu Guangrong; Sun Hui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">614</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Curcumin is an attractive agent due to its multiple bioactivities.  However, the low oral bioavailability and efficacy profile hinders its clinical application.  To improve the bioavailability, many analogs of curcumin have been developed, among which EF24 is an excellent representative.  EF24 has enhanced bioavailability over curcumin and shows more potent bioactivity, including anti-cancer, anti-inflammatory, and anti-bacterial.  EF24 inhibits tumor growth by inducing cell cycle arrest and apoptosis, mainly through its inhibitory effect on the nuclear factor kappa B (NF-κB) pathway and by regulating key genes through microRNA (miRNA) or the proteosomal pathway.  Based on the current structure, more potent EF24 analogs have been designed and synthesized.  However, some roles of EF24 remain unclear, such as whether it induces or inhibits reactive oxygen species (ROS) production and whether it stimulates or inhibits the mitogen activated kinase-like protein (MAPK) pathway.  This review summarizes the known biological and pharmacological activities and mechanisms of action of EF24.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDRk0Zhzo17IqdXsLcGTEUfW6udTcc2eZ0ryv8f7X0xLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnptVOqug%253D%253D&md5=773283f7349a055270f392f74fe10b43</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2018.00614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2018.00614%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKong%26aufirst%3DQ.%26atitle%3DBioactivities%2520of%2520EF24%252C%2520a%2520novel%2520curcumin%2520analog%253A%2520a%2520review%26jtitle%3DFront.%2520Oncol.%26date%3D2018%26volume%3D8%26spage%3D614%26doi%3D10.3389%2Ffonc.2018.00614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontanini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solazzo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">9235</span>– <span class="NLM_lpage">9244</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-0702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-06-0702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16982768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1ahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9235-9244&author=E.+Aleoauthor=C.+J.+Hendersonauthor=A.+Fontaniniauthor=B.+Solazzoauthor=C.+Brancolini&title=Identification+of+new+compounds+that+trigger+apoptosome-independent+caspase+activation+and+apoptosis&doi=10.1158%2F0008-5472.CAN-06-0702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of New Compounds That Trigger Apoptosome-Independent Caspase Activation and Apoptosis</span></div><div class="casAuthors">Aleo, Emanuela; Henderson, Clare J.; Fontanini, Alessandra; Solazzo, Barbara; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9235-9244</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Identification of alternative pathways of caspase activation is an important step to develop new antitumor treatments.  The authors report here the result of a screening with a small chem. library, the Developmental Therapeutics Program-National Cancer Institute "challenge set", on cells expressing mutated caspase-9.  The authors have identified two mols. capable of activating an apoptosome-independent apoptotic pathway.  These compds., named F6 and G5, target the ubiquitin-proteasome system by inhibiting the ubiquitin isopeptidases.  The authors have shown that F6 and G5 induce a rather unique apoptotic pathway, which includes a Bcl-2-dependent but apoptosome-independent mitochondrial pathway with up-regulation of the BH3-only protein Noxa, stabilization of the inhibitor of apoptosis antagonist Smac, but also the involvement of the death receptor pathway.  Noxa plays an important role in the induction of mitochondrial fragmentation and caspase activation, whereas the death receptor pathway becomes crit. in the absence of a functional apoptosome.  This study suggests that screening of chem. libraries on cancer cells with defined mutations in apoptotic key elements can lead to the identification of compds. that are useful to characterize alternative pathways of caspase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAnl67US3507Vg90H21EOLACvtfcHk0lhCRh47zlFcuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1ahsr4%253D&md5=c161afb2c15bb0e77f813851de8bb6a1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-0702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-0702%26sid%3Dliteratum%253Aachs%26aulast%3DAleo%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DFontanini%26aufirst%3DA.%26aulast%3DSolazzo%26aufirst%3DB.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520new%2520compounds%2520that%2520trigger%2520apoptosome-independent%2520caspase%2520activation%2520and%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9235%26epage%3D9244%26doi%3D10.1158%2F0008-5472.CAN-06-0702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cersosimo, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgorbissa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelica, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semrau, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1704</span>, <span class="refDoi"> DOI: 10.1021/jm501336h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501336h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2jurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1691-1704&author=U.+Cersosimoauthor=A.+Sgorbissaauthor=C.+Fotiauthor=S.+Drioliauthor=R.+Angelicaauthor=A.+Tomasellaauthor=R.+Piccoauthor=M.+S.+Semrauauthor=P.+Storiciauthor=F.+Benedettiauthor=F.+Bertiauthor=C.+Brancolini&title=Synthesis%2C+characterization%2C+and+optimization+for+in+vivo+delivery+of+a+nonselective+isopeptidase+inhibitor+as+new+antineoplastic+agent&doi=10.1021%2Fjm501336h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Optimization for in Vivo Delivery of a Nonselective Isopeptidase Inhibitor as New Antineoplastic Agent</span></div><div class="casAuthors">Cersosimo, Ulma; Sgorbissa, Andrea; Foti, Carmen; Drioli, Sara; Angelica, Rosario; Tomasella, Andrea; Picco, Raffaella; Semrau, Marta Stefania; Storici, Paola; Benedetti, Fabio; Berti, Federico; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1691-1704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bis-arylidenecycloalkanones structurally related to the nonselective isopeptidase inhibitor G5 were synthesized and tested for cytotoxic activity against glioblastoma cells.  Cytotoxicities correlate well with Hammett σ consts. for substituted arylidene groups, confirming the proposed inhibition mechanism.  A new inhibitor (2c, I) based on the 4-hydroxycyclohexanone scaffold, which favors apoptosis over necrosis, was selected for further development.  2C inhibited representative deubiquitinases with micromolar IC50, and its proapoptotic activity was studied on several cancer cell lines.  Inhibitor 2c was conjugated to PEG via dicarbamate and diester linkers.  While the dicarbamate was inactive, the diester (2cPE) behaves like a prodrug and is converted into the active species 2c by secreted esterase activities.  Finally, 2cPE was also tested in vivo on A549 lung carcinoma xenografts generated in mice.  i.v. Treatment with 2cPE led to a significant redn. in primary tumor growth, without appreciable toxicity to mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpujLPIK9nK8rVg90H21EOLACvtfcHk0lhCRh47zlFcuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2jurY%253D&md5=ec9121164549800a59dd00532ab47fc1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm501336h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501336h%26sid%3Dliteratum%253Aachs%26aulast%3DCersosimo%26aufirst%3DU.%26aulast%3DSgorbissa%26aufirst%3DA.%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DDrioli%26aufirst%3DS.%26aulast%3DAngelica%26aufirst%3DR.%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DPicco%26aufirst%3DR.%26aulast%3DSemrau%26aufirst%3DM.%2BS.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DBerti%26aufirst%3DF.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520optimization%2520for%2520in%2520vivo%2520delivery%2520of%2520a%2520nonselective%2520isopeptidase%2520inhibitor%2520as%2520new%2520antineoplastic%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1691%26epage%3D1704%26doi%3D10.1021%2Fjm501336h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erdal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunk, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoshan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1073/pnas.0408592102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1073%2Fpnas.0408592102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15618392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlentg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=192-197&author=H.+Erdalauthor=M.+Berndtssonauthor=J.+Castroauthor=U.+Brunkauthor=M.+C.+Shoshanauthor=S.+Linder&title=Induction+of+lysosomal+membrane+permeabilization+by+compounds+that+activate+p53-independent+apoptosis&doi=10.1073%2Fpnas.0408592102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis</span></div><div class="casAuthors">Erdal, Hamdiye; Berndtsson, Maria; Castro, Juan; Brunk, Ulf; Shoshan, Maria C.; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-197</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The p53 protein activates cellular death programs through multiple pathways.  Because the high frequency of p53 mutations in human tumors is believed to contribute to resistance to commonly used chemotherapeutic agents, it is important to identify drugs that induce p53-independent cell death and to define the mechanisms of action of such drugs.  Here we screened a drug library (the National Cancer Institute mechanistic set; 879 compds. with diverse mechanisms of actions) and identified 175 compds. that induced caspase cleavage of cytokeratin-18 in cultured HCT116 colon cancer cells at ≤5 μM.  Interestingly, whereas most compds. elicited a stronger apoptotic response in cells with functional p53, significant apoptosis was obsd. also in p53-null cells.  A subset of 15 compds. showing weak or no dependence on p53 for induction of apoptosis was examd. in detail.  Of these compds., 11 were capable of activating caspase-3 in enucleated cells.  Seven such compds. with nonnuclear targets were found to induce lysosomal membrane permeabilization (LMP).  Translocation of the lysosomal proteases cathepsin B and cathepsin D into the cytosol was obsd. after treatment with these drugs, and apoptosis was inhibited by pepstatin A, an inhibitor of cathepsin D. Apoptosis depended on Bax, suggesting that LMP induced a mitochondrial apoptotic pathway.  We conclude that a large no. of potential anticancer drugs induce p53-independent apoptosis and that LMP is a mediator of many such responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGvS-gxfmbbVg90H21EOLACvtfcHk0ljkEq1Aw2iPJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlentg%253D%253D&md5=92af37552c4cc92a7bc2525f042b8ed0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408592102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408592102%26sid%3Dliteratum%253Aachs%26aulast%3DErdal%26aufirst%3DH.%26aulast%3DBerndtsson%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DBrunk%26aufirst%3DU.%26aulast%3DShoshan%26aufirst%3DM.%2BC.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInduction%2520of%2520lysosomal%2520membrane%2520permeabilization%2520by%2520compounds%2520that%2520activate%2520p53-independent%2520apoptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D192%26epage%3D197%26doi%3D10.1073%2Fpnas.0408592102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaujouin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickardson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havelka, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaudet-Coopman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">1463</span>– <span class="NLM_lpage">1469</span>, <span class="refDoi"> DOI: 10.1002/ijc.24004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fijc.24004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19089926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFGgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=1463-1469&author=M.+Berndtssonauthor=M.+Beaujouinauthor=L.+Rickardsonauthor=A.+M.+Havelkaauthor=R.+Larssonauthor=J.+Westmanauthor=E.+Liaudet-Coopmanauthor=S.+Linder&title=Induction+of+the+lysosomal+apoptosis+pathway+by+inhibitors+of+the+ubiquitin-proteasome+system&doi=10.1002%2Fijc.24004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system</span></div><div class="casAuthors">Berndtsson, Maria; Beaujouin, Melanie; Rickardson, Linda; Havelka, Aleksandra Mandic; Larsson, Rolf; Westman, Jacob; Liaudet-Coopman, Emmanuelle; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1463-1469</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The lysosomal apoptosis pathway is a potentially interesting therapeutic target.  Since apoptosis involving the lysosomal pathway has been described to involve cathepsins, we screened a drug library for agents that induce cathepsin-dependent apoptosis.  Using pharmacol. inhibitors and siRNA, we identified 2 structurally related agents (NSC687852 and NSC638646) that induced cathepsin D-dependent caspase-cleavage activity in human breast cancer cells.  Both agents were found to induce the mitochondrial apoptosis pathway.  NSC687852 and NSC638646 were found to inhibit the activity of ubiquitin isopeptidases and to induce the accumulation of high-mol.-mass ubiquitins in cells.  We show that 3 other inhibitors of the proteasome degrdn. pathway induce lysosomal membrane permeabilization (LMP) and that cathepsin-D siRNA inhibits apoptosis induced by these agents.  We conclude that a screen for cathepsin-dependent apoptosis-inducing agents resulted in the identification of ubiquitin isopeptidase inhibitors and that proteasome inhibitors with different mechanisms of action induce LMP and cathepsin D-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroi3IbOKSpdrVg90H21EOLACvtfcHk0ljkEq1Aw2iPJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFGgsLk%253D&md5=53e2ebcdc67e34bfbef59d560ae69c56</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fijc.24004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24004%26sid%3Dliteratum%253Aachs%26aulast%3DBerndtsson%26aufirst%3DM.%26aulast%3DBeaujouin%26aufirst%3DM.%26aulast%3DRickardson%26aufirst%3DL.%26aulast%3DHavelka%26aufirst%3DA.%2BM.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DWestman%26aufirst%3DJ.%26aulast%3DLiaudet-Coopman%26aufirst%3DE.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInduction%2520of%2520the%2520lysosomal%2520apoptosis%2520pathway%2520by%2520inhibitors%2520of%2520the%2520ubiquitin-proteasome%2520system%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2009%26volume%3D124%26spage%3D1463%26epage%3D1469%26doi%3D10.1002%2Fijc.24004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohanty, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1036</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1111%2Fcbdd.12571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25854145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovV2qu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=1036-1048&author=X.+Wangauthor=P.+D%E2%80%99Arcyauthor=T.+R.+Caulfieldauthor=A.+Paulusauthor=K.+Chittaauthor=C.+Mohantyauthor=J.+Gullboauthor=A.+Chanan-Khanauthor=S.+Linder&title=Synthesis+and+evaluation+of+derivatives+of+the+proteasome+deubiquitinase+inhibitor+b-AP15&doi=10.1111%2Fcbdd.12571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b-AP15</span></div><div class="casAuthors">Wang, Xin; D'Arcy, Padraig; Caulfield, Thomas R.; Paulus, Aneel; Chitta, Kasyapa; Mohanty, Chitralekha; Gullbo, Joachim; Chanan-Khan, Asher; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1036-1048</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system (UPS) is increasingly recognized as a therapeutic target for the development of anticancer therapies.  The success of the 20S proteasome core particle (20S CP) inhibitor bortezomib in the clin. management of multiple myeloma has raised the possibility of identifying other UPS components for therapeutic intervention.  We previously identified the small mol. b-AP15 as an inhibitor of 19S proteasome deubiquitinase (DUB) activity.  Building upon our previous data, we performed a structure-activity relation (SAR) study on b-AP15 and identified VLX1570 as an analog with promising properties, including enhanced potency and improved soly. in aq. soln.  In silico modeling was consistent with interaction of VLX1570 with key cysteine residues located at the active sites of the proteasome DUBs USP14 and UCHL5.  VLX1570 was found to inhibit proteasome deubiquitinase activity in vitro in a manner consistent with competitive inhibition.  Furthermore, using active-site-directed probes, VLX1570 also inhibited proteasome DUB activity in exposed cells.  Importantly, VLX1570 did not show inhibitory activity on a panel of recombinant non-proteasome DUBs, on recombinant kinases, or on caspase-3 activity, suggesting that VLX1570 is not an overtly reactive general enzyme inhibitor.  Taken together, our data shows the chem. and biol. properties of VLX1570 as an optimized proteasome DUB inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jJ_S5YMId7Vg90H21EOLACvtfcHk0ljkEq1Aw2iPJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovV2qu70%253D&md5=353bf1b03a5378ba70f0835a143516f1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12571%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DChitta%26aufirst%3DK.%26aulast%3DMohanty%26aufirst%3DC.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DChanan-Khan%26aufirst%3DA.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520derivatives%2520of%2520the%2520proteasome%2520deubiquitinase%2520inhibitor%2520b-AP15%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2015%26volume%3D86%26spage%3D1036%26epage%3D1048%26doi%3D10.1111%2Fcbdd.12571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierrou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillertz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span> <span> </span><span class="NLM_article-title">The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">26979</span>, <span class="refDoi"> DOI: 10.1038/srep26979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep26979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27264969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26979&author=X.+Wangauthor=M.+Mazurkiewiczauthor=E.+K.+Hillertauthor=M.+H.+Olofssonauthor=S.+Pierrouauthor=P.+Hillertzauthor=J.+Gullboauthor=K.+Selvarajuauthor=A.+Paulusauthor=S.+Akhtarauthor=F.+Bosslerauthor=A.+C.+Khanauthor=S.+Linderauthor=P.+D%E2%80%99Arcy&title=The+proteasome+deubiquitinase+inhibitor+VLX1570+shows+selectivity+for+ubiquitin-specific+protease-14+and+induces+apoptosis+of+multiple+myeloma+cells&doi=10.1038%2Fsrep26979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells</span></div><div class="casAuthors">Wang, Xin; Mazurkiewicz, Magdalena; Hillert, Ellin-Kristina; Olofsson, Maria Haegg; Pierrou, Stefan; Hillertz, Per; Gullbo, Joachim; Selvaraju, Karthik; Paulus, Aneel; Akhtar, Sharoon; Bossler, Felicitas; Khan, Asher Chanan; Linder, Stig; D'Arcy, Padraig</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26979</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of deubiquitinase (DUB) activity is a promising strategy for cancer therapy.  VLX1570 is an inhibitor of proteasome DUB activity currently in clin. trials for relapsed multiple myeloma.  Here we show that VLX1570 binds to and inhibits the activity of ubiquitin-specific protease-14 (USP14) in vitro, with comparatively weaker inhibitory activity towards UCHL5 (ubiquitin-C-terminal hydrolase-5).  Exposure of multiple myeloma cells to VLX1570 resulted in thermostabilization of USP14 at therapeutically relevant concns.  Transient knockdown of USP14 or UCHL5 expression by electroporation of siRNA reduced the viability of multiple myeloma cells.  Treatment of multiple myeloma cells with VLX1570 induced the accumulation of proteasome-bound high mol. wt. polyubiquitin conjugates and an apoptotic response.  Sensitivity to VLX1570 was moderately affected by altered drug uptake, but was unaffected by overexpression of BCL2-family proteins or inhibitors of caspase activity.  Finally, treatment with VLX1570 was found to lead to extended survival in xenograft models of multiple myeloma.  Our findings demonstrate promising antiproliferative activity of VLX1570 in multiple myeloma, primarily assocd. with inhibition of USP14 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSyNNG3GPEDLVg90H21EOLACvtfcHk0liun_wsO_mSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2qtLg%253D&md5=9826987b387c59f4fc10fa7c2d126011</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsrep26979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26979%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DPierrou%26aufirst%3DS.%26aulast%3DHillertz%26aufirst%3DP.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DBossler%26aufirst%3DF.%26aulast%3DKhan%26aufirst%3DA.%2BC.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26atitle%3DThe%2520proteasome%2520deubiquitinase%2520inhibitor%2520VLX1570%2520shows%2520selectivity%2520for%2520ubiquitin-specific%2520protease-14%2520and%2520induces%2520apoptosis%2520of%2520multiple%2520myeloma%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26979%26doi%3D10.1038%2Fsrep26979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somwar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambati, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antczak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhinder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Stanchina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis-Filho, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouerfelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djaballah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span> <span> </span><span class="NLM_article-title">Proteasome addiction defined in Ewing’s sarcoma is effectively targeted by a novel class of 19S proteasome inhibitors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4534</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-1040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-16-1040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27256563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4525-4534&author=N.+N.+Shuklaauthor=R.+Somwarauthor=R.+S.+Smithauthor=S.+R.+Ambatiauthor=S.+Munozauthor=M.+S.+Merchantauthor=P.+D%E2%80%99Arcyauthor=X.+Wangauthor=R.+Kobosauthor=C.+Antczakauthor=B.+Bhinderauthor=D.+Shumauthor=C.+Raduauthor=G.+Yangauthor=B.+S.+Taylorauthor=C.+K.+Ngauthor=B.+Weigeltauthor=I.+Khodosauthor=E.+de+Stanchinaauthor=J.+S.+Reis-Filhoauthor=O.+Ouerfelliauthor=S.+Linderauthor=H.+Djaballahauthor=M.+Ladanyi&title=Proteasome+addiction+defined+in+Ewing%E2%80%99s+sarcoma+is+effectively+targeted+by+a+novel+class+of+19S+proteasome+inhibitors&doi=10.1158%2F0008-5472.CAN-16-1040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors</span></div><div class="casAuthors">Shukla, Neerav; Somwar, Romel; Smith, Roger S.; Ambati, Sri; Munoz, Stanley; Merchant, Melinda; D'Arcy, Padraig; Wang, Xin; Kobos, Rachel; Antczak, Christophe; Bhinder, Bhavneet; Shum, David; Radu, Constantin; Yang, Guangbin; Taylor, Barry S.; Ng, Charlotte K. Y.; Weigelt, Britta; Khodos, Inna; de Stanchina, Elisa; Reis-Filho, Jorge S.; Ouerfelli, Ouathek; Linder, Stig; Djaballah, Hakim; Ladanyi, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4525-4534</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ewing sarcoma is a primitive round cell sarcoma with a peak incidence in adolescence that is driven by a chimeric oncogene created from the fusion of the EWSR1 gene with a member of the ETS family of genes.  Patients with metastatic and recurrent disease have dismal outcomes and need better therapeutic options.  We screened a library of 309,989 chem. compds. for growth inhibition of Ewing sarcoma cells to provide the basis for the development of novel therapies and to discover vulnerable pathways that might broaden our understanding of the pathobiol. of this aggressive sarcoma.  This screening campaign identified a class of benzyl-4-piperidone compds. that selectively inhibit the growth of Ewing sarcoma cell lines by inducing apoptosis.  These agents disrupt 19S proteasome function through inhibition of the deubiquitinating enzymes USP14 and UCHL5.  Functional genomic data from a genome-wide shRNA screen in Ewing sarcoma cells also identified the proteasome as a node of vulnerability in Ewing sarcoma cells, providing orthologous confirmation of the chem. screen findings.  Furthermore, shRNA-mediated silencing of USP14 or UCHL5 in Ewing sarcoma cells produced significant growth inhibition.  Finally, treatment of a xenograft mouse model of Ewing sarcoma with VLX1570, a benzyl-4-piperidone compd. deriv. currently in clin. trials for relapsed multiple myeloma, significantly inhibited in vivo tumor growth.  Overall, our results offer a preclin. proof of concept for the use of 19S proteasome inhibitors as a novel therapeutic strategy for Ewing sarcoma.  Cancer Res; 76(15); 4525-34. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_BM2OwVlW2bVg90H21EOLACvtfcHk0liun_wsO_mSxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7bE&md5=098d0f39bb8f35485114efddfed50f62</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-1040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-1040%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DN.%2BN.%26aulast%3DSomwar%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BS.%26aulast%3DAmbati%26aufirst%3DS.%2BR.%26aulast%3DMunoz%26aufirst%3DS.%26aulast%3DMerchant%26aufirst%3DM.%2BS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKobos%26aufirst%3DR.%26aulast%3DAntczak%26aufirst%3DC.%26aulast%3DBhinder%26aufirst%3DB.%26aulast%3DShum%26aufirst%3DD.%26aulast%3DRadu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DB.%2BS.%26aulast%3DNg%26aufirst%3DC.%2BK.%26aulast%3DWeigelt%26aufirst%3DB.%26aulast%3DKhodos%26aufirst%3DI.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DOuerfelli%26aufirst%3DO.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DDjaballah%26aufirst%3DH.%26aulast%3DLadanyi%26aufirst%3DM.%26atitle%3DProteasome%2520addiction%2520defined%2520in%2520Ewing%25E2%2580%2599s%2520sarcoma%2520is%2520effectively%2520targeted%2520by%2520a%2520novel%2520class%2520of%252019S%2520proteasome%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4525%26epage%3D4534%26doi%3D10.1158%2F0008-5472.CAN-16-1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousaf, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenfield, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailawadhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A.</span></span> <span> </span><span class="NLM_article-title">Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e492</span> <span class="refDoi"> DOI: 10.1038/bcj.2016.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fbcj.2016.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27813535" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=A.+Paulusauthor=S.+Akhtarauthor=T.+R.+K+Caulfieldauthor=K.+Samuelauthor=H.+Yousafauthor=Y.+Bashirauthor=S.+M.+Paulusauthor=D.+Tranauthor=R.+Hudecauthor=D.+Cogenauthor=J.+Jiangauthor=B.+Edenfieldauthor=A.+Novakauthor=S.+M.+Ansellauthor=T.+Witzigauthor=P.+Martinauthor=M.+Colemanauthor=V.+Royauthor=S.+Ailawadhiauthor=K.+Chittaauthor=S.+Linderauthor=A.+Chanan-Khan&title=Coinhibition+of+the+deubiquitinating+enzymes%2C+USP14+and+UCHL5%2C+with+VLX1570+is+lethal+to+ibrutinib-+or+bortezomib-resistant+Waldenstrom+macroglobulinemia+tumor+cells&doi=10.1038%2Fbcj.2016.93"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2016.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2016.93%26sid%3Dliteratum%253Aachs%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%2BK%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DYousaf%26aufirst%3DH.%26aulast%3DBashir%26aufirst%3DY.%26aulast%3DPaulus%26aufirst%3DS.%2BM.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DHudec%26aufirst%3DR.%26aulast%3DCogen%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DEdenfield%26aufirst%3DB.%26aulast%3DNovak%26aufirst%3DA.%26aulast%3DAnsell%26aufirst%3DS.%2BM.%26aulast%3DWitzig%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DColeman%26aufirst%3DM.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DAilawadhi%26aufirst%3DS.%26aulast%3DChitta%26aufirst%3DK.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DChanan-Khan%26aufirst%3DA.%26atitle%3DCoinhibition%2520of%2520the%2520deubiquitinating%2520enzymes%252C%2520USP14%2520and%2520UCHL5%252C%2520with%2520VLX1570%2520is%2520lethal%2520to%2520ibrutinib-%2520or%2520bortezomib-resistant%2520Waldenstrom%2520macroglobulinemia%2520tumor%2520cells%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fbcj.2016.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bcp.2018.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30149015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1ektLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=291-301&author=X.+Zhangauthor=P.+Pellegriniauthor=A.+A.+Saeiauthor=E.+K.+Hillertauthor=M.+Mazurkiewiczauthor=M.+H.+Olofssonauthor=R.+A.+Zubarevauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=The+deubiquitinase+inhibitor+b-AP15+induces+strong+proteotoxic+stress+and+mitochondrial+damage&doi=10.1016%2Fj.bcp.2018.08.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage</span></div><div class="casAuthors">Zhang, Xiaonan; Pellegrini, Paola; Saei, Amir Ata; Hillert, Ellin-Kristina; Mazurkiewicz, Magdalena; Olofsson, Maria Haegg; Zubarev, Roman A.; D'Arcy, Padraig; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-301</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human cancers are characterized by intrinsic or acquired resistance to apoptosis and evasion of apoptosis has been proposed to contribute to treatment resistance.  Bis-benzylidine piperidone compds., contg. α,β-unsatd. carbonyl functionalities, have been extensively documented as being effective in killing apoptosis-resistant cells and to display promising antineoplastic activities in a no. of tumor models.  The authors here explored the phenotypic response of colon cancer cells to b-AP15, a bis-benzylidine piperidone previously shown to inhibit the proteasome deubiquitinases (DUBs) USP14 and UCHL5.  Whereas similar overall mRNA and protein expression profiles were induced by b-AP15 and the clin. available proteasome inhibitor bortezomib, b-AP15 induced stronger increases of chaperone expression. b-AP15 also induced a stronger accumulation of polyubiquitinated proteins in exposed cells.  These proteins were found to partially colocalize with organelle structures, including mitochondria.  Mitochondrial oxidative phosphorylation decreased in cells exposed to b-AP15, a phenomenon enhanced under conditions of severe proteotoxic stress caused by inhibition of the VCP/p97 ATPase and inhibition of protein translocation over the ER.  The authors propose that mitochondrial damage caused by the assocn. of misfolded proteins with mitochondrial membranes may contribute to the atypical cell death mode induced by b-AP15 and related compds.  The robust mode of cell death induction by this class of drugs holds promise for treatment of tumor cells characterized by apoptosis resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK3vSAM30u7rVg90H21EOLACvtfcHk0ljy40ubeyIDdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1ektLfE&md5=3225a8626d3dc098b2318ecb9fb03a1e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DThe%2520deubiquitinase%2520inhibitor%2520b-AP15%2520induces%2520strong%2520proteotoxic%2520stress%2520and%2520mitochondrial%2520damage%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D156%26spage%3D291%26epage%3D301%26doi%3D10.1016%2Fj.bcp.2018.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudiam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issaenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson Vogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavioli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. R.</span></span> <span> </span><span class="NLM_article-title">alpha, beta-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1021/jm100589p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100589p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Wgt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=449-456&author=M.+Bazzaroauthor=R.+K.+Anchooriauthor=M.+K.+Mudiamauthor=O.+Issaenkoauthor=S.+Kumarauthor=B.+Karanamauthor=Z.+Linauthor=R.+Isaksson+Vogelauthor=R.+Gavioliauthor=F.+Destroauthor=V.+Ferrettiauthor=R.+B.+Rodenauthor=S.+R.+Khan&title=alpha%2C+beta-Unsaturated+carbonyl+system+of+chalcone-based+derivatives+is+responsible+for+broad+inhibition+of+proteasomal+activity+and+preferential+killing+of+human+papilloma+virus+%28HPV%29+positive+cervical+cancer+cells&doi=10.1021%2Fjm100589p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">α,β-Unsaturated Carbonyl System of Chalcone-Based Derivatives is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells</span></div><div class="casAuthors">Bazzaro, Martina; Anchoori, Ravi K.; Mudiam, Mohana Krishna R.; Issaenko, Olga; Kumar, Srinivas; Karanam, Balasubramanyam; Lin, Zhen-Hua; Isaksson Vogel, Rachel; Gavioli, Riccardo; Destro, Federica; Ferretti, Valeria; Roden, Richard B. S.; Khan, Saeed R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteasome inhibitors have potential for the treatment of cervical cancer.  Here, the synthesis and biol. characterization of a new series of 1,3-diphenylpropen-1-one based derivs. I [R = i-Bu, HO2CCH2CH2, H2N(CH2)4, PhCH2, 4-HOC6H4CH2, X = OH; R = HO2CCH2CH2, X = HO2CCH2CH(CO2H)NH; etc.] lacking the boronic acid moieties of the previously reported chalcone-based proteasome inhibitor 3,5-bis(4-boronic acid benzylidene)-1-methylpiperidin-4-one and bearing a variety of amino acid or dipeptide substitutions on the amino group of the 4-piperidone is reported.  The lead compd. I (R = PhCH2; X = OH) inhibited proteasomal activity and had improved dose-dependent antiproliferative and proapoptotic properties in cervical cancer cells contg. human papillomavirus.  Further, it induced synergistic killing of cervical cancer cell lines when tested in combination with an FDA approved proteasome inhibitor.  Exploration of the potential mechanism of proteasomal inhibition by this compd. using in silico docking studies suggests that the carbonyl group of its oxopiperidine moiety is susceptible to nucleophilic attack by the γ-hydroxythreonine side chain within the catalytic sites of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPSoTKQDRj-7Vg90H21EOLACvtfcHk0ljy40ubeyIDdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Wgt7nK&md5=82cf9608533ff6524d4ca2658e8864ef</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm100589p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100589p%26sid%3Dliteratum%253Aachs%26aulast%3DBazzaro%26aufirst%3DM.%26aulast%3DAnchoori%26aufirst%3DR.%2BK.%26aulast%3DMudiam%26aufirst%3DM.%2BK.%26aulast%3DIssaenko%26aufirst%3DO.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DIsaksson%2BVogel%26aufirst%3DR.%26aulast%3DGavioli%26aufirst%3DR.%26aulast%3DDestro%26aufirst%3DF.%26aulast%3DFerretti%26aufirst%3DV.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26atitle%3Dalpha%252C%2520beta-Unsaturated%2520carbonyl%2520system%2520of%2520chalcone-based%2520derivatives%2520is%2520responsible%2520for%2520broad%2520inhibition%2520of%2520proteasomal%2520activity%2520and%2520preferential%2520killing%2520of%2520human%2520papilloma%2520virus%2520%2528HPV%2529%2520positive%2520cervical%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D449%26epage%3D456%26doi%3D10.1021%2Fjm100589p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sueblinvong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felthauser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iizuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavioli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson
Vogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span> <span> </span><span class="NLM_article-title">Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e23888</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0023888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0023888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21909374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wrtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=R.+K.+Anchooriauthor=S.+R.+Khanauthor=T.+Sueblinvongauthor=A.+Felthauserauthor=Y.+Iizukaauthor=R.+Gavioliauthor=F.+Destroauthor=R.+Isaksson%0AVogelauthor=S.+Pengauthor=R.+B.+Rodenauthor=M.+Bazzaro&title=Stressing+the+ubiquitin-proteasome+system+without+20S+proteolytic+inhibition+selectively+kills+cervical+cancer+cells&doi=10.1371%2Fjournal.pone.0023888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells</span></div><div class="casAuthors">Anchoori, Ravi K.; Khan, Saeed R.; Sueblinvong, Thanasak; Felthauser, Alicia; Iizuka, Yoshie; Gavioli, Riccardo; Destro, Federica; Vogel, Rachel Isaksson; Peng, Shiwen; Roden, Richard B. S.; Bazzaro, Martina</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e23888</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cervical cancer cells exhibit an increased requirement for ubiquitin-dependent protein degrdn. assocd. with an elevated metabolic turnover rate, and for specific signaling pathways, notably HPV E6-targeted degrdn. of p53 and PDZ proteins.  Natural compds. with antioxidant properties including flavonoids and triterpenoids hold promise as anticancer agents by interfering with ubiquitin-dependent protein degrdn.  An increasing body of evidence indicates that their α-β unsatd. carbonyl system is the mol. determinant for inhibition of ubiquitin-mediated protein degrdn. up-stream of the catalytic sites of the 20S proteasome.  Herein we report the identification and characterization of a new class of chalcone-based, potent and cell permeable chem. inhibitors of ubiquitin-dependent protein degrdn., and a lead compd. RAMB1.  RAMB1 inhibits ubiquitin-dependent protein degrdn. without compromising the catalytic activities of the 20S proteasome, a mechanism distinct from that of Bortezomib.  Treatment of cervical cancer cells with RAMB1 triggers unfolded protein responses, including aggresome formation and Hsp90 stabilization, and increases p53 steady state levels.  RAMB1 treatment results in activation of lysosomal-dependent degrdn. pathways as a mechanism to compensate for increasing levels of poly-ubiquitin enriched toxic aggregates.  Importantly, RAMB1 synergistically triggers cell death of cervical cancer cells when combined with the lysosome inhibitor Chloroquine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIDa06rGO6tLVg90H21EOLACvtfcHk0ljy40ubeyIDdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wrtb3O&md5=fb75a4e02b8932fc3d18af40995de1bb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0023888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0023888%26sid%3Dliteratum%253Aachs%26aulast%3DAnchoori%26aufirst%3DR.%2BK.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DSueblinvong%26aufirst%3DT.%26aulast%3DFelthauser%26aufirst%3DA.%26aulast%3DIizuka%26aufirst%3DY.%26aulast%3DGavioli%26aufirst%3DR.%26aulast%3DDestro%26aufirst%3DF.%26aulast%3DIsaksson%2BVogel%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DBazzaro%26aufirst%3DM.%26atitle%3DStressing%2520the%2520ubiquitin-proteasome%2520system%2520without%252020S%2520proteolytic%2520inhibition%2520selectively%2520kills%2520cervical%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0023888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span> <span> </span><span class="NLM_article-title">A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ccr.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24332045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=791-805&author=R.+K.+Anchooriauthor=B.+Karanamauthor=S.+Pengauthor=J.+W.+Wangauthor=R.+Jiangauthor=T.+Tannoauthor=R.+Z.+Orlowskiauthor=W.+Matsuiauthor=M.+Zhaoauthor=M.+A.+Rudekauthor=C.+F.+Hungauthor=X.+Chenauthor=K.+J.+Waltersauthor=R.+B.+Roden&title=A+bis-benzylidine+piperidone+targeting+proteasome+ubiquitin+receptor+RPN13%2FADRM1+as+a+therapy+for+cancer&doi=10.1016%2Fj.ccr.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer</span></div><div class="casAuthors">Anchoori, Ravi K.; Karanam, Balasubramanyam; Peng, Shiwen; Wang, Joshua W.; Jiang, Rosie; Tanno, Toshihiko; Orlowski, Robert Z.; Matsui, William; Zhao, Ming; Rudek, Michelle A.; Hung, Chien-fu; Chen, Xiang; Walters, Kylie J.; Roden, Richard B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">791-805</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The bis-benzylidine piperidone RA190 covalently binds to cysteine 88 of ubiquitin receptor RPN13 in the 19S regulatory particle and inhibits proteasome function, triggering rapid accumulation of polyubiquitinated proteins.  Multiple myeloma (MM) lines, even those resistant to bortezomib, were sensitive to RA190 via endoplasmic reticulum stress-related apoptosis.  RA190 stabilized targets of human papillomavirus (HPV) E6 oncoprotein, and preferentially killed HPV-transformed cells.  After oral or i.p. dosing of mice, RA190 distributed to plasma and major organs except the brain and inhibited proteasome function in skin and muscle.  RA190 administration profoundly reduced growth of MM and ovarian cancer xenografts, and oral RA190 treatment retarded HPV16+ syngeneic mouse tumor growth, without affecting spontaneous HPV-specific CD8+ T cell responses, suggesting its therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo94H2sTfVVuLVg90H21EOLACvtfcHk0lgAMJLZrCLfjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyls7bJ&md5=4a9037278dc1e913d5247711ad6f6d30</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DAnchoori%26aufirst%3DR.%2BK.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DTanno%26aufirst%3DT.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DMatsui%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DRudek%26aufirst%3DM.%2BA.%26aulast%3DHung%26aufirst%3DC.%2BF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWalters%26aufirst%3DK.%2BJ.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26atitle%3DA%2520bis-benzylidine%2520piperidone%2520targeting%2520proteasome%2520ubiquitin%2520receptor%2520RPN13%252FADRM1%2520as%2520a%2520therapy%2520for%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26spage%3D791%26epage%3D805%26doi%3D10.1016%2Fj.ccr.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gargallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canete, A.</span></span> <span> </span><span class="NLM_article-title">Precision medicine in Ewing sarcoma: a translational point of view</span>. <i>Clin. Transl. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1440</span>– <span class="NLM_lpage">1454</span>, <span class="refDoi"> DOI: 10.1007/s12094-020-02298-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs12094-020-02298-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=32026343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB38%252FovFCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2020&pages=1440-1454&author=P.+Gargalloauthor=A.+Juanauthor=Y.+Yanezauthor=S.+Dolzauthor=V.+Seguraauthor=V.+Castelauthor=A.+Canete&title=Precision+medicine+in+Ewing+sarcoma%3A+a+translational+point+of+view&doi=10.1007%2Fs12094-020-02298-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Precision medicine in Ewing sarcoma: a translational point of view</span></div><div class="casAuthors">Gargallo P; Yanez Y; Dolz S; Segura V; Castel V; Canete A; Juan A; Yanez Y; Segura V; Castel V; Canete A; Dolz S</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1440-1454</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ewing sarcoma is a rare tumor that arises in bones of children and teenagers but, in 15% of the patients it is presented as a primary soft tissue tumor.  Balanced reciprocal chimeric translocation t(11;22)(q24;q12), which encodes an oncogenic protein fusion (EWSR1/FLI1), is the most generalized and characteristic molecular event.  Using conventional treatments, (chemotherapy, surgery and radiotherapy) long-term overall survival rate is 30% for patients with disseminated disease and 65-75% for patients with localized tumors.  Urgent new effective drug development is a challenge.  This review summarizes the preclinical and clinical investigational knowledge about prognostic and targetable biomarkers in Ewing sarcoma, finally suggesting a workflow for precision medicine committees.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRF18T6RnQ3EgyMywPm6HgQfW6udTcc2earpspMuds0q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38%252FovFCgsw%253D%253D&md5=d830055eccda1473fda8271348312ab3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs12094-020-02298-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-020-02298-7%26sid%3Dliteratum%253Aachs%26aulast%3DGargallo%26aufirst%3DP.%26aulast%3DJuan%26aufirst%3DA.%26aulast%3DYanez%26aufirst%3DY.%26aulast%3DDolz%26aufirst%3DS.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DCastel%26aufirst%3DV.%26aulast%3DCanete%26aufirst%3DA.%26atitle%3DPrecision%2520medicine%2520in%2520Ewing%2520sarcoma%253A%2520a%2520translational%2520point%2520of%2520view%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2020%26volume%3D22%26spage%3D1440%26epage%3D1454%26doi%3D10.1007%2Fs12094-020-02298-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mofers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomonsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkina, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunnerhagen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">9841</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-46168-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41598-019-46168-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31285509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MzltlGlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=9841&author=K.+Selvarajuauthor=A.+Mofersauthor=P.+Pellegriniauthor=J.+Salomonssonauthor=A.+Ahlnerauthor=V.+Moradauthor=E.+K.+Hillertauthor=B.+Espinosaauthor=E.+S.+J.+Arnerauthor=L.+Jensenauthor=J.+Malmstromauthor=M.+V.+Turkinaauthor=P.+D%E2%80%99Arcyauthor=M.+A.+Waltersauthor=M.+Sunnerhagenauthor=S.+Linder&title=Cytotoxic+unsaturated+electrophilic+compounds+commonly+target+the+ubiquitin+proteasome+system&doi=10.1038%2Fs41598-019-46168-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system</span></div><div class="casAuthors">Selvaraju Karthik; Mofers Arjan; Pellegrini Paola; Jensen Lasse; D'Arcy Padraig; Linder Stig; Salomonsson Johannes; Ahlner Alexandra; Morad Vivian; Sunnerhagen Maria; Hillert Ellin-Kristina; Linder Stig; Espinosa Belen; Arner Elias S J; Malmstrom Jonas; Turkina Maria V; Walters Michael A</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9841</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A large number of natural products have been advocated as anticancer agents.  Many of these compounds contain functional groups characterized by chemical reactivity.  It is not clear whether distinct mechanisms of action can be attributed to such compounds.  We used a chemical library screening approach to demonstrate that a substantial fraction (~20%) of cytotoxic synthetic compounds containing Michael acceptor groups inhibit proteasome substrate processing and induce a cellular response characteristic of proteasome inhibition.  Biochemical and structural analyses showed binding to and inhibition of proteasome-associated cysteine deubiquitinases, in particular ubiquitin specific peptidase 14 (USP14).  The results suggested that compounds bind to a crevice close to the USP14 active site with modest affinity, followed by covalent binding.  A subset of compounds was identified where cell death induction was closely associated with proteasome inhibition and that showed significant antineoplastic activity in a zebrafish embryo model.  These findings suggest that proteasome inhibition is a relatively common mode of action by cytotoxic compounds containing Michael acceptor groups and help to explain previous reports on the antineoplastic effects of natural products containing such functional groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAYYvdYFXCx_69nzq6467DfW6udTcc2earpspMuds0q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzltlGlsA%253D%253D&md5=1d237387b71b0f0407c6e9d33019ebb4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-46168-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-46168-x%26sid%3Dliteratum%253Aachs%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DMofers%26aufirst%3DA.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DSalomonsson%26aufirst%3DJ.%26aulast%3DAhlner%26aufirst%3DA.%26aulast%3DMorad%26aufirst%3DV.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DEspinosa%26aufirst%3DB.%26aulast%3DArner%26aufirst%3DE.%2BS.%2BJ.%26aulast%3DJensen%26aufirst%3DL.%26aulast%3DMalmstrom%26aufirst%3DJ.%26aulast%3DTurkina%26aufirst%3DM.%2BV.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DSunnerhagen%26aufirst%3DM.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DCytotoxic%2520unsaturated%2520electrophilic%2520compounds%2520commonly%2520target%2520the%2520ubiquitin%2520proteasome%2520system%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D9841%26doi%3D10.1038%2Fs41598-019-46168-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somers-Edgar, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taurin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandramouli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengren, R. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1007/s10637-009-9339-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs10637-009-9339-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19816657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVOitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=87-97&author=T.+J.+Somers-Edgarauthor=S.+Taurinauthor=L.+Larsenauthor=A.+Chandramouliauthor=M.+A.+Nelsonauthor=R.+J.+Rosengren&title=Mechanisms+for+the+activity+of+heterocyclic+cyclohexanone+curcumin+derivatives+in+estrogen+receptor+negative+human+breast+cancer+cell+lines&doi=10.1007%2Fs10637-009-9339-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines</span></div><div class="casAuthors">Somers-Edgar, Tiffany J.; Taurin, Sebastien; Larsen, Lesley; Chandramouli, Anupama; Nelson, Mark A.; Rosengren, Rhonda J.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Estrogen receptor (ER)-neg. breast cancer is an aggressive form that currently requires more drug treatment options.  Thus, we have further modified cyclohexanone derivs. of curcumin and examd. them for cytotoxicity towards ER-neg. human breast cancer cells.  Two of the analogs screened elicited increased cytotoxic potency compared to curcumin and other previously studied derivs.  Specifically, 2,6-bis(pyridin-3-ylmethylene)-cyclohexanone (RL90) and 2,6-bis(pyridin-4-ylmethylene)-cyclohexanone (RL91) elicited EC50 values of 1.54 and 1.10 μM, resp., in MDA-MB-231 cells and EC50 values of 0.51 and 0.23 in SKBr3 cells.  All other new compds. examd. were less potent than curcumin, which elicited EC50 values of 7.6 and 2.4 μM in MDA-MB-231 and SKBr3 cells, resp.  Mechanistic analyses demonstrated that RL90 and RL91 significantly induced G2/M-phase cell cycle arrest and apoptosis.  RL90 and RL91 also modulated the expression of key cell signaling proteins, specifically, in SKBr3 cells, protein levels of Her-2, Akt, and NFκB were decreased in a time-dependent manner, while activity of stress kinases JNK1/2 and P38 MAPK were increased.  Signaling events in MDA-MB-231 cells were differently implicated, as EGFR protein levels were decreased and activity of GSK-3β transiently decreased, while β-catenin protein level and activity of P38 MAPK, Akt, and JNK1/2 were transiently increased.  In conclusion replacement of the Ph group of cyclohexanone derived curcumin derivs. with heterocyclic rings forms a class of second-generation analogs that are more potent than both curcumin and other derivs.  These new derivs. provide a platform for the further development of drugs for the treatment of ER-neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd34rjHvw_irVg90H21EOLACvtfcHk0lgMaORwDuH8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVOitw%253D%253D&md5=850addac7fe7d91cfd72e3bc8f797fd3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs10637-009-9339-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-009-9339-0%26sid%3Dliteratum%253Aachs%26aulast%3DSomers-Edgar%26aufirst%3DT.%2BJ.%26aulast%3DTaurin%26aufirst%3DS.%26aulast%3DLarsen%26aufirst%3DL.%26aulast%3DChandramouli%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DM.%2BA.%26aulast%3DRosengren%26aufirst%3DR.%2BJ.%26atitle%3DMechanisms%2520for%2520the%2520activity%2520of%2520heterocyclic%2520cyclohexanone%2520curcumin%2520derivatives%2520in%2520estrogen%2520receptor%2520negative%2520human%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2011%26volume%3D29%26spage%3D87%26epage%3D97%26doi%3D10.1007%2Fs10637-009-9339-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robles-Escajeda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, R. J.</span></span> <span> </span><span class="NLM_article-title">A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells</span>. <i>Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1007/s13402-016-0272-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs13402-016-0272-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjslyjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=265-277&author=E.+Robles-Escajedaauthor=U.+Dasauthor=N.+M.+Ortegaauthor=K.+Parraauthor=G.+Franciaauthor=J.+R.+Dimmockauthor=A.+Varela-Ramirezauthor=R.+J.+Aguilera&title=A+novel+curcumin-like+dienone+induces+apoptosis+in+triple-negative+breast+cancer+cells&doi=10.1007%2Fs13402-016-0272-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells</span></div><div class="casAuthors">Robles-Escajeda, Elisa; Das, Umashankar; Ortega, Nora M.; Parra, Karla; Francia, Giulio; Dimmock, Jonathan R.; Varela-Ramirez, Armando; Aguilera, Renato J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-277</span>CODEN:
                <span class="NLM_cas:coden">COENGH</span>;
        ISSN:<span class="NLM_cas:issn">2211-3436</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: According to the World Health Organization (WHO), breast cancer is the most common cancer affecting women worldwide.  In the USA ∼12.3 % of all women are expected to be diagnosed with various types of breast cancer, exhibiting varying degrees of therapeutic response rates.  Therefore, the identification of novel anti-breast cancer drugs is of paramount importance.  Methods: The 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore was incorporated into a no. of cytotoxins.  Three of the resulting dienones, 2a, 2b and 2c, were tested for their anti-neoplastic potencies in a variety of human breast cancer-derived cell lines, including the triple neg. MDA-MB-231 cell line and its metastatic variant, using a live-cell bio-imaging method.  Special emphasis was put on dienone 2c, since its anti-cancer activity and its mode of inflicting cell death have so far not been reported.  Results: We found that all three dienones exhibited potent cytotoxicities towards the breast cancer-derived cell lines tested, whereas significantly lower toxicities were obsd. towards the non-cancerous human breast cell line MCF-10A.  The dienones 2b and 2c exhibited the greatest selective cytotoxicity at submicromolar concn. levels.  We found that these two dienones induced phosphatidylserine externalization in MDA-MB-231 cells in a concn.-dependent manner, suggesting that their cytotoxic effect might be mediated by apoptosis.  This possibility was confirmed by our observation that the dienone 2c can induce mitochondrial depolarization, caspase-3 activation, cell cycle disruption and DNA fragmentation in MDA-MB-231 cells.  Conclusion: Our findings indicate that dienone 2c uses the mitochondrial/intrinsic pathway to inflict apoptosis in triple neg. MDA-MB-231 breast cancer-derived cells.  This observation warrants further assessment of dienone 2c as a potential anti-breast cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCZfQ7V3XJ4bVg90H21EOLACvtfcHk0lgMaORwDuH8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjslyjtbc%253D&md5=cc7efec607ff2ac02aa9f70e018a83d9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs13402-016-0272-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13402-016-0272-x%26sid%3Dliteratum%253Aachs%26aulast%3DRobles-Escajeda%26aufirst%3DE.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DOrtega%26aufirst%3DN.%2BM.%26aulast%3DParra%26aufirst%3DK.%26aulast%3DFrancia%26aufirst%3DG.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DVarela-Ramirez%26aufirst%3DA.%26aulast%3DAguilera%26aufirst%3DR.%2BJ.%26atitle%3DA%2520novel%2520curcumin-like%2520dienone%2520induces%2520apoptosis%2520in%2520triple-negative%2520breast%2520cancer%2520cells%26jtitle%3DCell.%2520Oncol.%26date%3D2016%26volume%3D39%26spage%3D265%26epage%3D277%26doi%3D10.1007%2Fs13402-016-0272-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balog, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5414</span>– <span class="NLM_lpage">5421</span>, <span class="refDoi"> DOI: 10.1021/jm200353f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200353f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5414-5421&author=T.+Kalaiauthor=M.+L.+Kuppusamyauthor=M.+Balogauthor=K.+Selvendiranauthor=B.+K.+Riveraauthor=P.+Kuppusamyauthor=K.+Hideg&title=Synthesis+of+N-substituted+3%2C5-bis%28arylidene%29-4-piperidones+with+high+antitumor+and+antioxidant+activity&doi=10.1021%2Fjm200353f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of N-Substituted 3,5-Bis(arylidene)-4-piperidones with High Antitumor and Antioxidant Activity</span></div><div class="casAuthors">Kalai, Tamas; Kuppusamy, M. Lakshmi; Balog, Maria; Selvendiran, Karuppaiyah; Rivera, Brian K.; Kuppusamy, Periannan; Hideg, Kalman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5414-5421</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-bis(arylidene)-4-piperidone (DAP) compds. are considered as synthetic analogs of curcumin for anticancer properties.  The structure-activity relationship studies by synthesizing a no. of DAPs N-alkylated or acylated with nitroxides or their amine precursors as potent antioxidant moieties were performed.  Both substituents on arylidene rings and on piperidone nitrogen (five- or six-membered, 2- or 3-substituted or 3,4-disubstituted isoindoline nitroxides) were varied.  The anticancer efficacy of the new DAP compds., e.g., I, was tested by measuring their cytotoxicity to cancer cell lines A2780 and MCF-7 and to the H9c2 cell line.  The results showed that all DAP compds. induced a significant loss of cell viability in the human cancer cell lines tested; however, only pyrroline appended nitroxides, e.g., II, showed limited toxicity toward noncancerous cell lines.  Computer docking simulations support the biol. activity tested.  These results suggest that antioxidant-conjugated DAPs will be useful as a safe and effective anticancer agent for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjs1aaGsdcIrVg90H21EOLACvtfcHk0lgMaORwDuH8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCnsLs%253D&md5=6bb71a2cb8298490167d916b835c785a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm200353f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200353f%26sid%3Dliteratum%253Aachs%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DBalog%26aufirst%3DM.%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DHideg%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520N-substituted%25203%252C5-bis%2528arylidene%2529-4-piperidones%2520with%2520high%2520antitumor%2520and%2520antioxidant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5414%26epage%3D5421%26doi%3D10.1021%2Fjm200353f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybalkina, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anikina, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukhov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klochkov, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischenko, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neganova, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrustalev, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemenkova, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brel, V. K.</span></span> <span> </span><span class="NLM_article-title">1,5-diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1007/s00044-016-1726-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs00044-016-1726-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslyis7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=140-152&author=M.+V.+Makarovauthor=E.+Y.+Rybalkinaauthor=L.+V.+Anikinaauthor=S.+A.+Pukhovauthor=S.+G.+Klochkovauthor=D.+V.+Mischenkoauthor=M.+E.+Neganovaauthor=V.+N.+Khrustalevauthor=Z.+S.+Klemenkovaauthor=V.+K.+Brel&title=1%2C5-diaryl-3-oxo-1%2C4-pentadienes+based+on+%284-oxopiperidin-1-yl%29%28aryl%29methyl+phosphonate+scaffold%3A+synthesis+and+antitumor+properties&doi=10.1007%2Fs00044-016-1726-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-Diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties</span></div><div class="casAuthors">Makarov, Mikhail V.; Rybalkina, Ekaterina Yu.; Anikina, Lada V.; Pukhov, Sergey A.; Klochkov, Sergey G.; Mischenko, Denis V.; Neganova, Margarita E.; Khrustalev, Victor N.; Klemenkova, Zinaida S.; Brel, Valery K.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Novel 3,5-bis(arylidene)-4-piperidones modified with diethyl[(aryl)methyl]phosphonate moiety attached to the piperidone N atom were synthesized by crotonic condensation of arom. aldehydes with diethyl[(4-oxopiperidin-1-yl)(aryl)methyl]phosphonates in the presence of LiClO4/Et3N system or MeCN soln. of B trifluoride etherate.  The synthesized phosphonate derivs. of 3,5-bis(arylidene)-4-piperidone series displayed inhibitory properties toward RD, PC3, HCT116, and MCF7 human cancer cell lines with IC50 values at 2.5-8.5 μM, as assessed by an in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVYNJlqwyA2LVg90H21EOLACvtfcHk0ljnX_qTM2lP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslyis7bN&md5=f58380069d4dee1756c7ba5d81f15dd5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00044-016-1726-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-016-1726-4%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DM.%2BV.%26aulast%3DRybalkina%26aufirst%3DE.%2BY.%26aulast%3DAnikina%26aufirst%3DL.%2BV.%26aulast%3DPukhov%26aufirst%3DS.%2BA.%26aulast%3DKlochkov%26aufirst%3DS.%2BG.%26aulast%3DMischenko%26aufirst%3DD.%2BV.%26aulast%3DNeganova%26aufirst%3DM.%2BE.%26aulast%3DKhrustalev%26aufirst%3DV.%2BN.%26aulast%3DKlemenkova%26aufirst%3DZ.%2BS.%26aulast%3DBrel%26aufirst%3DV.%2BK.%26atitle%3D1%252C5-diaryl-3-oxo-1%252C4-pentadienes%2520based%2520on%2520%25284-oxopiperidin-1-yl%2529%2528aryl%2529methyl%2520phosphonate%2520scaffold%253A%2520synthesis%2520and%2520antitumor%2520properties%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2017%26volume%3D26%26spage%3D140%26epage%3D152%26doi%3D10.1007%2Fs00044-016-1726-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antitumor activity evaluation of some new N-aroyl-alpha, beta-unsaturated piperidones with fluorescence</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.3109/14756366.2015.1043296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3109%2F14756366.2015.1043296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26382011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVCjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=495-502&author=J.+Sunauthor=S.+Wangauthor=H.+Liauthor=W.+Jiangauthor=G.+Houauthor=F.+Zhaoauthor=W.+Cong&title=Synthesis%2C+antitumor+activity+evaluation+of+some+new+N-aroyl-alpha%2C+beta-unsaturated+piperidones+with+fluorescence&doi=10.3109%2F14756366.2015.1043296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence</span></div><div class="casAuthors">Sun, Jufeng; Wang, Suwen; Li, Hongjuan; Jiang, Wenguo; Hou, Guige; Zhao, Feng; Cong, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Novel N-aroyl-α,β-unsatd. piperidones (featuring 2-bromo-4,5-dimethoxybenzylidene, 4-dimethylaminobenzylidene and 4-trifluoromethylbenzylidene groups, resp.), were synthesized as candidate cytotoxins.  Most of the compds. displayed potent cytotoxicity against the human neoplastic cell lines SK-BR-3, PG-BE1, NCI-H460, MIA PaCa-2 and SW1990 in vitro, and approx. 64% of the IC50 values were lower than 5 μM.  Among those tested, compd. of series and of series proved to be the most active.  Importantly, I displayed marked inhibitory effects on tumor growth in vivo and had no apparent toxicity to mice; this was evaluated by a nude mouse PG-BE1 xenograft model.  In addn., the fluorescent properties of these compds. were investigated.  The interesting fluorescence exhibited by these compds. could be useful for their visualization in tumor cells, permitting further studies on these α,β-unsatd. piperidones as candidates for novel fluorescent antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGH6MP6HZU37Vg90H21EOLACvtfcHk0ljnX_qTM2lP2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVCjur8%253D&md5=6cb29cc16285811131c1fd0873c8fb8d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1043296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1043296%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DHou%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DCong%26aufirst%3DW.%26atitle%3DSynthesis%252C%2520antitumor%2520activity%2520evaluation%2520of%2520some%2520new%2520N-aroyl-alpha%252C%2520beta-unsaturated%2520piperidones%2520with%2520fluorescence%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D495%26epage%3D502%26doi%3D10.3109%2F14756366.2015.1043296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conney, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of curcumin-related compounds for anticancer activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ejmech.2012.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22551677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=235-245&author=X.+Weiauthor=Z.+Y.+Duauthor=X.+Zhengauthor=X.+X.+Cuiauthor=A.+H.+Conneyauthor=K.+Zhang&title=Synthesis+and+evaluation+of+curcumin-related+compounds+for+anticancer+activity&doi=10.1016%2Fj.ejmech.2012.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of curcumin-related compounds for anticancer activity</span></div><div class="casAuthors">Wei, Xingchuan; Du, Zhi-Yun; Zheng, Xi; Cui, Xiao-Xing; Conney, Allan H.; Zhang, Kun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235-245</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sixty-one curcumin-related compds. were synthesized and evaluated for their anticancer activity toward cultured prostate cancer PC-3 cells, pancreas cancer Panc-1 cells and colon cancer HT-29 cells.  Inhibitory effects of these compds. on the growth of PC-3, Panc-1 and HT-29 cells were detd. by the MTT assay.  Compds. E10 (I), F10, FN1 and FN2 exhibited exceptionally potent inhibitory effects on the growth of cultured PC-3, Panc-1 and HT-29 cells.  The IC50 for these compds. was lower than 1 μM in all three cell lines.  E10 was 72-, 46- and 117-fold more active than curcumin for inhibiting the growth of PC-3, Panc-1 and HT-29 cells, resp.  F10 was 69-, 34- and 72-fold more active than curcumin for inhibiting the growth of PC-3, Panc-1 and HT-29 cells, resp.  FN1 and FN2 had about the same inhibitory effect as E10 and F10 toward Panc-1 cells but were less active than E10 and F10 toward PC-3 and HT-29 cells.  The active compds. were potent stimulators of apoptosis.  The present study indicates that E10, F10, FN1 and FN2 may have useful anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpT8gDD2Bjb7Vg90H21EOLACvtfcHk0lhtaK-0wNdLHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVygsbg%253D&md5=c486de1c34912bfb582dbb0187c09b97</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DZ.%2BY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DX.%2BX.%26aulast%3DConney%26aufirst%3DA.%2BH.%26aulast%3DZhang%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520curcumin-related%2520compounds%2520for%2520anticancer%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D53%26spage%3D235%26epage%3D245%26doi%3D10.1016%2Fj.ejmech.2012.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youssef, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and bioevaluation of novel maleamic amino acid ester conjugates of 3,5-bisarylmethylene-4-piperidones as cytostatic agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6364</span>– <span class="NLM_lpage">6367</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmcl.2009.09.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19819135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWls77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6364-6367&author=D.+Youssefauthor=E.+Potterauthor=M.+Jhaauthor=E.+De+Clercqauthor=J.+Balzariniauthor=J.+P.+Stablesauthor=A.+Jha&title=Design%2C+synthesis+and+bioevaluation+of+novel+maleamic+amino+acid+ester+conjugates+of+3%2C5-bisarylmethylene-4-piperidones+as+cytostatic+agents&doi=10.1016%2Fj.bmcl.2009.09.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and bioevaluation of novel maleamic amino acid ester conjugates of 3,5-bisarylmethylene-4-piperidones as cytostatic agents</span></div><div class="casAuthors">Youssef, Dani; Potter, Elizabeth; Jha, Mamta; De Clercq, Erik; Balzarini, Jan; Stables, James P.; Jha, Amitabh</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6364-6367</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of maleamic amino acid ester conjugates of 3,5-bisarylmethylene-4-piperidones were prepd. to investigate the efficacy of micronutrient conjugation in enhancing cytotoxic potency by improving selectivity and delivery.  These compds., prepd. as anticancer agents, were expected to demonstrate enhanced selectivity towards malignant cells through the inhibition of topoisomerase IIα via protein thiolation.  The cytostatic effects of these compds. were evaluated against three cell lines, namely murine L1210 leukemia cells, human Molt 4/C8 and CEM T-lymphocyte cells.  All compds. were found to have greater potency than the ref. drug melphalan.  Several compds. were found to potently inhibit topoisomerase IIα and displayed cytostatic activity in the nanomolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJOSWaLnUE7Vg90H21EOLACvtfcHk0lhtaK-0wNdLHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWls77N&md5=5d328f1be7701e1802111ceb830acfa9</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.069%26sid%3Dliteratum%253Aachs%26aulast%3DYoussef%26aufirst%3DD.%26aulast%3DPotter%26aufirst%3DE.%26aulast%3DJha%26aufirst%3DM.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DJha%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520bioevaluation%2520of%2520novel%2520maleamic%2520amino%2520acid%2520ester%2520conjugates%2520of%25203%252C5-bisarylmethylene-4-piperidones%2520as%2520cytostatic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6364%26epage%3D6367%26doi%3D10.1016%2Fj.bmcl.2009.09.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbardella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedford, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4928</span>– <span class="NLM_lpage">4932</span>, <span class="refDoi"> DOI: 10.1021/jm200453n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200453n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4928-4932&author=D.+Chengauthor=S.+Valenteauthor=S.+Castellanoauthor=G.+Sbardellaauthor=R.+Di+Santoauthor=R.+Costiauthor=M.+T.+Bedfordauthor=A.+Mai&title=Novel+3%2C5-bis%28bromohydroxybenzylidene%29piperidin-4-ones+as+coactivator-associated+arginine+methyltransferase+1+inhibitors%3A+enzyme+selectivity+and+cellular+activity&doi=10.1021%2Fjm200453n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity</span></div><div class="casAuthors">Cheng, Donghang; Valente, Sergio; Castellano, Sabrina; Sbardella, Gianluca; Di Santo, Roberto; Costi, Roberta; Bedford, Mark T.; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4928-4932</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coactivator-assocd. arginine methyltransferase 1 (CARM1) represents a valuable target for hormone-dependent tumors such as prostate and breast cancers.  Here we report the enzyme and cellular characterization of the 1-benzyl-3,5-bis(3-bromo-4-hydroxybenzylidene)piperidin-4-one (7g) and its analogs 8a-l.  Among them, 7g, 8e, and 8l displayed high and selective CARM1 inhibition, with lower or no activity against a panel of different PRMTs or HKMTs.  In human LNCaP cells, 7g showed a significant dose-dependent redn. of the PSA promoter activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXv4DaWjduarVg90H21EOLACvtfcHk0liNNwC6CJj9yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSjtrw%253D&md5=c9fba6d328440a5e41046ff0c47f661c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm200453n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200453n%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DCastellano%26aufirst%3DS.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DBedford%26aufirst%3DM.%2BT.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DNovel%25203%252C5-bis%2528bromohydroxybenzylidene%2529piperidin-4-ones%2520as%2520coactivator-associated%2520arginine%2520methyltransferase%25201%2520inhibitors%253A%2520enzyme%2520selectivity%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4928%26epage%3D4932%26doi%3D10.1021%2Fjm200453n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhandarkar, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindarajan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fried, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span> <span> </span><span class="NLM_article-title">Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5743</span>– <span class="NLM_lpage">5748</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1078-0432.CCR-08-0405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18794083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaitrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5743-5748&author=S.+S.+Bhandarkarauthor=J.+Brombergauthor=C.+Carrilloauthor=P.+Selvakumarauthor=R.+K.+Sharmaauthor=B.+N.+Perryauthor=B.+Govindarajanauthor=L.+Friedauthor=A.+Sohnauthor=K.+Reddyauthor=J.+L.+Arbiser&title=Tris+%28dibenzylideneacetone%29+dipalladium%2C+a+N-myristoyltransferase-1+inhibitor%2C+is+effective+against+melanoma+growth+in+vitro+and+in+vivo&doi=10.1158%2F1078-0432.CCR-08-0405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Tris (Dibenzylideneacetone) Dipalladium, a N-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth In vitro and In vivo</span></div><div class="casAuthors">Bhandarkar, Sulochana S.; Bromberg, Jacqueline; Carrillo, Carol; Selvakumar, Ponniah; Sharma, Rajendra K.; Perry, Betsy N.; Govindarajan, Baskaran; Fried, Levi; Sohn, Allie; Reddy, Kalpana; Arbiser, Jack L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5743-5748</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Melanoma is a solid tumor that is notoriously resistant to chemotherapy, and its incidence is rapidly increasing.  Recently, several signaling pathways have been shown to contribute to melanoma tumorigenesis, including constitutive activation of mitogen-activated protein kinase, Akt, and Stat-3.  The activation of multiple pathways may account in part for the difficulty in treatment of melanoma.  In a recent screen of compds., we found that an organopalladium compd., Tris (dibenzylideneacetone) dipalladium (Tris DBA), showed significant antiproliferative activity against melanoma cells.  Studies were carried out to det. the mechanism of action of Tris DBA.  Exptl. Design: Tris DBA was tested on efficacy on proliferation of human and murine melanoma cells.  To find the mechanism of action of Tris DBA, we did Western blot and gene array analyses.  The ability of Tris DBA to block tumor growth in vivo was assessed.  Results: Tris DBA has activity against B16 murine and A375 human melanoma in vivo.  Tris DBA inhibits several signaling pathways including activation of mitogen-activated protein kinase, Akt, Stat-3, and S6 kinase activation, suggesting an upstream target.  Tris DBA was found to be a potent inhibitor of N-myristoyltransferase-1, which is required for optimal activity of membrane-based signaling mols.  Tris DBA showed potent antitumor activity in vivo against melanoma.  Conclusion: Tris DBA is thus a novel inhibitor of N-myristoyltransferase-1 with significant antitumor activity and is well tolerated in vivo.  Further preclin. evaluation of Tris DBA and related complexes is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS813NmxzPEbVg90H21EOLACvtfcHk0liNNwC6CJj9yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaitrrE&md5=e393b44045d4877d597ec63fff05a21a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0405%26sid%3Dliteratum%253Aachs%26aulast%3DBhandarkar%26aufirst%3DS.%2BS.%26aulast%3DBromberg%26aufirst%3DJ.%26aulast%3DCarrillo%26aufirst%3DC.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DPerry%26aufirst%3DB.%2BN.%26aulast%3DGovindarajan%26aufirst%3DB.%26aulast%3DFried%26aufirst%3DL.%26aulast%3DSohn%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26atitle%3DTris%2520%2528dibenzylideneacetone%2529%2520dipalladium%252C%2520a%2520N-myristoyltransferase-1%2520inhibitor%252C%2520is%2520effective%2520against%2520melanoma%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5743%26epage%3D5748%26doi%3D10.1158%2F1078-0432.CCR-08-0405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odelberg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span> <span> </span><span class="NLM_article-title">Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4424</span>– <span class="NLM_lpage">4436</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.27040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.27040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31320995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MzovVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4424-4436&author=E.+Musiauthor=G.+K.+Schwartzauthor=J.+H.+Yooauthor=S.+J.+Odelbergauthor=D.+Y.+Liauthor=M.+Y.+Bonnerauthor=P.+Selvakumarauthor=S.+Raoauthor=L.+C.+Gilbertauthor=J.+Elseyauthor=J.+L.+Arbiser&title=Tris+DBA+palladium+is+an+orally+available+inhibitor+of+GNAQ+mutant+uveal+melanoma+in+vivo&doi=10.18632%2Foncotarget.27040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo</span></div><div class="casAuthors">Musi Elgilda; Schwartz Gary K; Schwartz Gary K; Yoo Jae Hyuk; Odelberg Shannon J; Li Dean Y; Odelberg Shannon J; Odelberg Shannon J; Li Dean Y; Li Dean Y; Li Dean Y; Bonner Michael Y; Rao Shikha; Gilbert Linda C; Elsey Justin; Arbiser Jack L; Selvakumar Ponniah; Gilbert Linda C; Arbiser Jack L</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4424-4436</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Uveal melanoma is a rare but often lethal malignancy and is the leading cause of death due to an ophthalmic condition.  Uveal melanoma is often diagnosed at a late stage and has a strong propensity to hepatic metastasis.  Recently, the most common driver mutations in uveal melanoma have been identified, predominantly in the G-proteins GNAQ.  This pattern differs from that of cutaneous melanoma in which Braf and Nras predominate.  There are no current clinically used agents that target GNAQ mutations, unlike the use of Braf inhibitors in cutaneous melanoma.  We tested the novel agent Tris DBA palladium and found that it was markedly more effective against GNAQ mutant melanomas than wild type uveal melanomas.  Given that ARF6 has recently been discovered as a node in GNAQ mutations, we evaluated the efficacy of Tris DBA palladium on ARF6 signaling and found that it was effective in inhibiting ARF6 activation.  Finally, Tris DBA palladium was orally effective against GNAQ mutant melanoma in vivo.  Tris DBA Palladium deserves further evaluation as a systemic agent for uveal melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQumEb1lWXUxmhHGZei4OW9fW6udTcc2eYJB67oUT6tYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzovVKkug%253D%253D&md5=da8a4ea78d23de5e14c7b72f73975300</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.27040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.27040%26sid%3Dliteratum%253Aachs%26aulast%3DMusi%26aufirst%3DE.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DYoo%26aufirst%3DJ.%2BH.%26aulast%3DOdelberg%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DD.%2BY.%26aulast%3DBonner%26aufirst%3DM.%2BY.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DL.%2BC.%26aulast%3DElsey%26aufirst%3DJ.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26atitle%3DTris%2520DBA%2520palladium%2520is%2520an%2520orally%2520available%2520inhibitor%2520of%2520GNAQ%2520mutant%2520uveal%2520melanoma%2520in%2520vivo%26jtitle%3DOncotarget%26date%3D2019%26volume%3D10%26spage%3D4424%26epage%3D4436%26doi%3D10.18632%2Foncotarget.27040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostapoff, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toombs, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curatolo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsay, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span> <span> </span><span class="NLM_article-title">Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">51569</span>– <span class="NLM_lpage">51580</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.10514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27438140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2s3is1aqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=51569-51580&author=B.+Diazauthor=K.+T.+Ostapoffauthor=J.+E.+Toombsauthor=J.+Loauthor=M.+Y.+Bonnerauthor=A.+Curatoloauthor=V.+Adsayauthor=R.+A.+Brekkenauthor=J.+L.+Arbiser&title=Tris+DBA+palladium+is+highly+effective+against+growth+and+metastasis+of+pancreatic+cancer+in+an+orthotopic+model&doi=10.18632%2Foncotarget.10514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model</span></div><div class="casAuthors">Diaz Begona; Diaz Begona; Ostapoff Katherine T; Toombs Jason E; Brekken Rolf A; Ostapoff Katherine T; Toombs Jason E; Brekken Rolf A; Lo Jason; Bonner Michael Y; Arbiser Jack L; Lo Jason; Bonner Michael Y; Arbiser Jack L; Lo Jason; Bonner Michael Y; Arbiser Jack L; Curatolo Adam; Curatolo Adam; Adsay Volkan</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">51569-51580</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic carcinoma ranks among the most lethal of human cancers.  Besides late detection, other factors contribute to its lethality, including a high degree of chemoresistance, invasion, and distant metastases.  Currently, the mainstay of therapy involves resection of local disease in a minority of patients (Whipple procedure) and systemic gemcitabine.  While systemic chemotherapy has some benefit, even with optimal treatment, the five year survival after diagnosis is dismal.  Thus, treatment of pancreatic carcinoma remains a tremendous unmet need.The organometallic compound tris DBA palladium is a potent inhibitor of N-myristoyltransferase 1 (NMT1), an enzyme that catalyzes the transfer of myristate to protein substrates.  This compound is highly effective in vivo against murine models of melanoma with both mutant and wild type b-RAF genotypes.  Based upon the signaling similarities between melanoma and pancreatic carcinoma, we evaluated the efficacy of tris DBA palladium in vitro and in vivo against pancreatic carcinoma.  We found that tris DBA palladium decreased proliferation and colony formation of pancreatic cancer cells in vitro.  In an orthotopic mouse model, tris DBA palladium was highly active in inhibiting growth, ascites production, and distant metastases in vivo.  Furthermore, tris DBA palladium impaired chemotaxis and inhibited cilia formation in Pan02 cells in a NMT1-dependent manner.  We propose that NMT1 is a novel regulator of cilia formation and tris DBA palladium a novel inhibitor of cilia formation and metastasis in pancreatic cancer.  Thus, further evaluation of tris DBA palladium for the treatment of pancreatic cancer is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7qJwwlmPjyK__Jf7-eMvJfW6udTcc2eZ9mbYxtEoxZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3is1aqsg%253D%253D&md5=fef3d3bd0e00d1335c78427a22da4dbd</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10514%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DB.%26aulast%3DOstapoff%26aufirst%3DK.%2BT.%26aulast%3DToombs%26aufirst%3DJ.%2BE.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DBonner%26aufirst%3DM.%2BY.%26aulast%3DCuratolo%26aufirst%3DA.%26aulast%3DAdsay%26aufirst%3DV.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26atitle%3DTris%2520DBA%2520palladium%2520is%2520highly%2520effective%2520against%2520growth%2520and%2520metastasis%2520of%2520pancreatic%2520cancer%2520in%2520an%2520orthotopic%2520model%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D51569%26epage%3D51580%26doi%3D10.18632%2Foncotarget.10514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of specificity protein 1 by dibenzylideneacetone, a curcumin analogue, induces apoptosis in mucoepidermoid carcinomas and tumor xenografts through Bim and truncated Bid</span>. <i>Oral Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.oraloncology.2013.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.oraloncology.2013.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24309154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=189-195&author=H.+E.+Leeauthor=E.+S.+Choiauthor=J.+Y.+Jungauthor=M.+J.+Youauthor=L.+H.+Kimauthor=S.+D.+Cho&title=Inhibition+of+specificity+protein+1+by+dibenzylideneacetone%2C+a+curcumin+analogue%2C+induces+apoptosis+in+mucoepidermoid+carcinomas+and+tumor+xenografts+through+Bim+and+truncated+Bid&doi=10.1016%2Fj.oraloncology.2013.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of specificity protein 1 by dibenzylideneacetone, a curcumin analogue, induces apoptosis in mucoepidermoid carcinomas and tumor xenografts through Bim and truncated Bid</span></div><div class="casAuthors">Lee, Heang-Eun; Choi, Eun-Sun; Jung, Ji-Youn; You, Myung-Jo; Kim, Lee-Han; Cho, Sung-Dae</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-195</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dibenzylideneacetone (DBA), a curcumin analog that has anti-cancer activity in a variety of tumor cells.  In this study, we investigated the apoptotic effects of DBA and its mol. mechanism in human mucoepidermoid carcinoma (MEC) cell lines and tumor xenografts.  The apoptotic effects and related mol. mechanisms of DBA on MEC cell lines were evaluated using cell viability assay, DAPI staining, Western blot anal., reverse transcriptase-polymerase chain reaction (RT-PCR) and Dual-luciferase Reporter Assay.  The anti-tumor activity using in vivo were detd. by Nude mouse xenograft assay and histopathol. examn.  DBA decreased cell viability and induced apoptosis in MEC cells.  These events were accompanied by inhibition of specificity protein 1 (Sp1).  DBA did not induce major changes in Sp1 mRNA and promoter activity.  Furthermore, inhibition of protein synthesis by cycloheximide demonstrated that DBA decreased Sp1 protein stability, but DBA did not attenuate phosphorylation of eIF4E.  DBA also increased Bim and truncated Bid (t-Bid) via Sp1.  Finally, DBA exhibited significant anti-tumor activity in athymic nude mice xenografts bearing MC-3 cells by regulating Sp1, Bim and t-Bid without any systemic toxicity.  These results elucidate a crucial apoptotic mechanism of DBA and suggest that DBA may be a potent anticancer drug candidate for MEC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaTBRJEKNNn7Vg90H21EOLACvtfcHk0ljLiQd-muin6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2ntr0%253D&md5=59518d169d80b36a598833d623877654</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2013.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2013.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DChoi%26aufirst%3DE.%2BS.%26aulast%3DJung%26aufirst%3DJ.%2BY.%26aulast%3DYou%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DL.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BD.%26atitle%3DInhibition%2520of%2520specificity%2520protein%25201%2520by%2520dibenzylideneacetone%252C%2520a%2520curcumin%2520analogue%252C%2520induces%2520apoptosis%2520in%2520mucoepidermoid%2520carcinomas%2520and%2520tumor%2520xenografts%2520through%2520Bim%2520and%2520truncated%2520Bid%26jtitle%3DOral%2520Oncol.%26date%3D2014%26volume%3D50%26spage%3D189%26epage%3D195%26doi%3D10.1016%2Fj.oraloncology.2013.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quincoces
Suarez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rando, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Carvalho, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maria, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiao-Flores, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcucci, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, C.</span></span> <span> </span><span class="NLM_article-title">New antitumoral agents I: in vitro anticancer activity and in vivo acute toxicity of synthetic 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one and derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6275</span>– <span class="NLM_lpage">6281</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2010.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20696583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC3cjnslSguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6275-6281&author=J.+A.+Quincoces%0ASuarezauthor=D.+G.+Randoauthor=R.+P.+Santosauthor=C.+P.+Goncalvesauthor=E.+Ferreiraauthor=J.+E.+de+Carvalhoauthor=L.+Kohnauthor=D.+A.+Mariaauthor=F.+Faiao-Floresauthor=D.+Michalikauthor=M.+C.+Marcucciauthor=C.+Vogel&title=New+antitumoral+agents+I%3A+in+vitro+anticancer+activity+and+in+vivo+acute+toxicity+of+synthetic+1%2C5-bis%284-hydroxy-3-methoxyphenyl%29-1%2C4-pentadien-3-one+and+derivatives&doi=10.1016%2Fj.bmc.2010.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">New antitumoral agents I: In vitro anticancer activity and in vivo acute toxicity of synthetic 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one and derivatives</span></div><div class="casAuthors">Quincoces Suarez Jose Agustin; Rando Daniela Goncales; Santos Reginaldo Pereira; Goncalves Carolina Passarelli; Ferreira Elizabeth; de Carvalho Joao Ernesto; Kohn Luciana; Maria Durvanei Augusto; Faiao-Flores Fernanda; Michalik Dirk; Marcucci Maria Cristina; Vogel Christian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6275-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This paper describes a new method for the preparation of 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one 1 and its derivatives 2-5.  This set of synthetic compounds exhibited high antitumoral activities regarding in vitro screening against several human tumor cell lines as lung carcinoma NCI-460, melanoma UACC-62, breast MCF-7, colon HT-29, renal 786-O, ovarian OVCAR-03 and ovarian expressing the resistance phenotype for adriamycin NCI-ADR/RES, prostate PC-3, and leukemia K-562.  Compounds were also tested against murine tumor cell line B16F10 melanoma and lymphocytic leukemia L1210 as well as to their effect toward normal macrophages.  Specific activity against colon cancer cells HT-29 was observed for all tested compounds and suggests further studies with models of colon cancer.  Compounds 1, 2, and 4 showed significant cytotoxic activity with IC(50) values 2.3 microM for all human cancer cell lines.  Intraperitoneal acute administration of compound 1 and 2 showed very low toxicity rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrRg8-SzzmV36oPH0mYWL1fW6udTcc2eZ9mbYxtEoxZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjnslSguw%253D%253D&md5=f642669c075a2eed33fe4557478e3f28</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DQuincoces%2BSuarez%26aufirst%3DJ.%2BA.%26aulast%3DRando%26aufirst%3DD.%2BG.%26aulast%3DSantos%26aufirst%3DR.%2BP.%26aulast%3DGoncalves%26aufirst%3DC.%2BP.%26aulast%3DFerreira%26aufirst%3DE.%26aulast%3Dde%2BCarvalho%26aufirst%3DJ.%2BE.%26aulast%3DKohn%26aufirst%3DL.%26aulast%3DMaria%26aufirst%3DD.%2BA.%26aulast%3DFaiao-Flores%26aufirst%3DF.%26aulast%3DMichalik%26aufirst%3DD.%26aulast%3DMarcucci%26aufirst%3DM.%2BC.%26aulast%3DVogel%26aufirst%3DC.%26atitle%3DNew%2520antitumoral%2520agents%2520I%253A%2520in%2520vitro%2520anticancer%2520activity%2520and%2520in%2520vivo%2520acute%2520toxicity%2520of%2520synthetic%25201%252C5-bis%25284-hydroxy-3-methoxyphenyl%2529-1%252C4-pentadien-3-one%2520and%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6275%26epage%3D6281%26doi%3D10.1016%2Fj.bmc.2010.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release in LPS-stimulated RAW 264.7 macrophages</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2388</span>– <span class="NLM_lpage">2393</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20338767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVejsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2388-2393&author=C.+Zhaoauthor=J.+Yangauthor=Y.+Wangauthor=D.+Liangauthor=X.+Yangauthor=X.+Liauthor=J.+Wuauthor=X.+Wuauthor=S.+Yangauthor=X.+Liauthor=G.+Liang&title=Synthesis+of+mono-carbonyl+analogues+of+curcumin+and+their+effects+on+inhibition+of+cytokine+release+in+LPS-stimulated+RAW+264.7+macrophages&doi=10.1016%2Fj.bmc.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release in LPS-stimulated RAW 264.7 macrophages</span></div><div class="casAuthors">Zhao, Chengguang; Yang, Ju; Wang, Yi; Liang, Donglou; Yang, Xuyi; Li, Xiaoxia; Wu, Jianzhang; Wu, Xiaoping; Yang, Shulin; Li, Xiaokun; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2393</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Curcumin has been reported to possess multifunctional bioactivities, esp. the ability to inhibit proinflammatory induction.  We previously demonstrated that the mono-carbonyl analogs of curcumin possessed improved pharmacokinetic profiles both in vitro and in vivo.  In this study, we synthesized and examd. a series of 5-carbon linker-contg. mono-carbonyl analogs of curcumin with potent inhibitory activities against TNF-α and IL-6 release in LPS-stimulated RAW 264.7 macrophages.  Discussion and conclusions are given regarding structure-activity relationships (SAR).  The two most potent analogs among the tested compds., B75 (I) and C12, exhibited anti-inflammatory abilities in a dose-dependent manner in macrophages.  This raises the possibility that mono-carbonyl analogs of curcumin might serve as potential agents for the treatment of various inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojJR6qc-UbgbVg90H21EOLACvtfcHk0lhKRLvNOaBiMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVejsL4%253D&md5=f5e8b1c3e63ba5b6c3d6881b60775b65</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520mono-carbonyl%2520analogues%2520of%2520curcumin%2520and%2520their%2520effects%2520on%2520inhibition%2520of%2520cytokine%2520release%2520in%2520LPS-stimulated%2520RAW%2520264.7%2520macrophages%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2388%26epage%3D2393%26doi%3D10.1016%2Fj.bmc.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e24377</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0024377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0024377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21931698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Chsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=Y.+Wangauthor=C.+Yuauthor=Y.+Panauthor=J.+Liauthor=Y.+Zhangauthor=F.+Yeauthor=S.+Yangauthor=H.+Zhangauthor=X.+Liauthor=G.+Liang&title=A+novel+compound+C12+inhibits+inflammatory+cytokine+production+and+protects+from+inflammatory+injury+in+vivo&doi=10.1371%2Fjournal.pone.0024377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo</span></div><div class="casAuthors">Wang, Yi; Yu, Congcong; Pan, Yong; Li, Jianling; Zhang, Yali; Ye, Faqing; Yang, Shulin; Zhang, Hui; Li, Xiaokun; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e24377</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inflammation is a hallmark of many diseases.  Although steroids and cyclooxygenase inhibitors are main anti-inflammatory therapeutical agents, they may cause serious side effects.  Therefore, developing non-steroid anti-inflammatory agents is urgently needed.  A novel hydrosol. compd., C12 (2,6-bis(4-(3-(dimethylamino)-propoxy)benzylidene)cyclohexanone), was designed and synthesized as an anti-inflammatory agent in our previous study.  In the present study, we investigated whether C12 can affect inflammatory processes in vitro and in vivo.  In mouse primary peritoneal macrophages, C12 potently inhibited the prodn. of the proinflammatory gene expression including TNF-α, IL-1β, IL-6, iNOS, COX-2 and PGE synthase.  The activity of C12 was partly dependent on inhibition of ERK/JNK (but p38) phosphorylation and NF-κB activation.  In vivo, C12 suppressed proinflammatory cytokine prodn. in plasma and liver, attenuated lung histopathol., and significantly reduced mortality in endotoxemic mice.  In addn., the pre-treatment with C12 reduced the inflammatory pain in the acetic acid and formalin models and reduced the carrageenan-induced paw edema and acetic acid-increased vascular permeability.  Taken together, C12 has multiple anti-inflammatory effects.  These findings, coupled with the low toxicity and hydrosoly. of C12, suggests that this agent may be useful in the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWiApK5tea2rVg90H21EOLACvtfcHk0lhKRLvNOaBiMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Chsb3O&md5=95f809e6ce08c48f7037cefd93739b15</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0024377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0024377%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DA%2520novel%2520compound%2520C12%2520inhibits%2520inflammatory%2520cytokine%2520production%2520and%2520protects%2520from%2520inflammatory%2520injury%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0024377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, V.</span></span> <span> </span><span class="NLM_article-title">EF24 suppresses maturation and inflammatory response in dendritic cells</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxr121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Fintimm%2Fdxr121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22378503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVOjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=455-464&author=P.+Vilekarauthor=S.+Awasthiauthor=A.+Natarajanauthor=S.+Anantauthor=V.+Awasthi&title=EF24+suppresses+maturation+and+inflammatory+response+in+dendritic+cells&doi=10.1093%2Fintimm%2Fdxr121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">EF24 suppresses maturation and inflammatory response in dendritic cells</span></div><div class="casAuthors">Vilekar, Prachi; Awasthi, Shanjana; Natarajan, Aravindan; Anant, Shrikant; Awasthi, Vibhudutta</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">455-464</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Synthetic curcuminoid EF24 was studied for its effect on the maturation and inflammatory response in murine bone marrow derived immortalized JAWS II dendritic cells (DCs).  EF24 reduced the expression of LPS-induced MHC class II, CD80 and CD86 mols.  It also abrogated the appearance of dendrites, a typical characteristic of mature DCs.  These effects were accompanied by the inhibition of LPS-induced activation of transcription factor nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB).  Simultaneous redn. of pro-inflammatory cytokines [tumor necrosis factor (TNF)-α, IL-6] both at the mRNA and secreted levels was also obsd.  To investigate the dependency of LPS effects on MyD88 adaptor protein, we transfected JAWS II DCs with dominant neg. MyD88 plasmid construct (MyD88-DN).  EF24 reduced NF-κB activity and TNF-α secretion in a MyD88-dependent manner.  These results suggest that EF24 modulates DCs by suppressing their maturation and reducing the secretion of inflammatory cytokines.  Further, it appears that EF24 acts at or upstream of MyD88 in the LPS-TLR4/MyD88/NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOODrr-Fy32LVg90H21EOLACvtfcHk0lhKRLvNOaBiMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVOjs7o%253D&md5=ad3fb49bc2333d3004432abe80d71546</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxr121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxr121%26sid%3Dliteratum%253Aachs%26aulast%3DVilekar%26aufirst%3DP.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DNatarajan%26aufirst%3DA.%26aulast%3DAnant%26aufirst%3DS.%26aulast%3DAwasthi%26aufirst%3DV.%26atitle%3DEF24%2520suppresses%2520maturation%2520and%2520inflammatory%2520response%2520in%2520dendritic%2520cells%26jtitle%3DInt.%2520Immunol.%26date%3D2012%26volume%3D24%26spage%3D455%26epage%3D464%26doi%3D10.1093%2Fintimm%2Fdxr121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, V.</span></span> <span> </span><span class="NLM_article-title">Diphenyldifluoroketone EF24 suppresses pro-inflammatory interleukin-1 receptor 1 and toll-like receptor 4 in lipopolysaccharide-stimulated dendritic cells</span>. <i>J. Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.1186/s12950-015-0096-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2Fs12950-015-0096-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFKitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=55&author=P.+Vilekarauthor=G.+Raoauthor=S.+Awasthiauthor=V.+Awasthi&title=Diphenyldifluoroketone+EF24+suppresses+pro-inflammatory+interleukin-1+receptor+1+and+toll-like+receptor+4+in+lipopolysaccharide-stimulated+dendritic+cells&doi=10.1186%2Fs12950-015-0096-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Diphenyldifluoroketone EF24 suppresses pro-inflammatory interleukin-1 receptor 1 and toll-like receptor 4 in lipopolysaccharidestimulated dendritic cells</span></div><div class="casAuthors">Vilekar, Prachi; Rao, Geeta; Awasthi, Shanjana; Awasthi, Vibhudutta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inflammation (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55/1-55/11</span>CODEN:
                <span class="NLM_cas:coden">JILUAY</span>;
        ISSN:<span class="NLM_cas:issn">1476-9255</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Unresolved and prolonged inflammation is a pathol. basis of many disorders such as cancer and multiple organ failure in shock.  Interleukin-1 receptor (IL-1R) superfamily consists of IL-1R1 and pathogen pattern recognition receptor toll-like receptor-4 (TLR4) which, upon ligand binding, initiate pro-inflammatory signaling.  The study objective was to investigate the effect of a diphenyldifluoroketone EF24 on the expression of IL-1R1 and TLR4 in lipopolysaccharide (LPS)-stimulated dendritic cells (DCs).  Methods: Immortalized murine bone marrow-derived JAWS II dendritic cells (DC) were challenged with LPS (100 ng/mL) for 4 h.  The LPS-stimulated DCs were treated with 10 μM of EF24 for 1 h.  The expression levels of IL-1R1 and TLR4 were monitored by RT-PCR, immunoblotting, and confocal microscopy.  The effect of EF24 on the viability and cell cycle of DCs was examd. by lactate dehydrogenase assay and flow cytometry, resp.  Results: EF24 treatment suppressed the LPS-induced TLR4 and IL-1R1 expression in DCs.  However, the expression levels of IL-1RA and IL-1R2 were not influenced by either LPS or EF24 treatments.  These effects of EF24 were assocd. with a decrease in LPS-induced expression of phospho-NF-κB p65, indicative of its role in the transcriptional control of IL-1R superfamily members.  We did not find any significant effect of EF24 on the proliferation or cell cycle of DCs.  Conclusions: The results suggest that EF24 influences IL-1R superfamily signaling pathway in ways that could have salutary effects in inflammation.  The pluripotent anti-inflammatory actions of EF24 warrant further investigation of EF24 in inflammatory conditions of systemic nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC3TgDcl_eR7Vg90H21EOLACvtfcHk0li5CEHAmq0Gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFKitrY%253D&md5=5d3b6f2e98c7e098e579b8765aab8d3f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2Fs12950-015-0096-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12950-015-0096-x%26sid%3Dliteratum%253Aachs%26aulast%3DVilekar%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DG.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DAwasthi%26aufirst%3DV.%26atitle%3DDiphenyldifluoroketone%2520EF24%2520suppresses%2520pro-inflammatory%2520interleukin-1%2520receptor%25201%2520and%2520toll-like%2520receptor%25204%2520in%2520lipopolysaccharide-stimulated%2520dendritic%2520cells%26jtitle%3DJ.%2520Inflammation%26date%3D2015%26volume%3D12%26spage%3D55%26doi%3D10.1186%2Fs12950-015-0096-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamarulzaman, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahab, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, M. Z.</span></span> <span> </span><span class="NLM_article-title">3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2017.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.apsb.2017.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28752033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1cfhvFOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=479-484&author=H.+Osmanauthor=N.+H.+Idrisauthor=E.+E.+Kamarulzamanauthor=H.+A.+Wahabauthor=M.+Z.+Hassan&title=3%2C5-Bis%28arylidene%29-4-piperidones+as+potential+dengue+protease+inhibitors&doi=10.1016%2Fj.apsb.2017.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors</span></div><div class="casAuthors">Osman Hasnah; Idris Nor Hashima; Hassan Mohd Zaheen; Kamarulzaman Ezatul Ezleen; Wahab Habibah A</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">479-484</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Dengue is a severe mosquito-borne viral infection causing half a million deaths annually.  Dengue virus NS2B/NS3 protease is a validated target for anti-dengue drug design.  A series of hitherto unreported 3,5-bis(arylidene)-4-piperidones analogues 4a-4j were synthesized and screened in silico against DENV2 NS2B/NS3 protease to elucidate their binding mechanism and orientation around the active sites.  Results were validated through an in vitro DENV2 NS2B/NS3 protease assay using a fluorogenic Boc-Gly-Arg-Arg-AMC substrate.  Nitro derivatives of 3,5-bis(arylidene)-4-piperidones (4e and 4j) emerged as promising lead molecules for novel protease inhibitors with an IC50 of 15.22 and 16.23 μmol/L, respectively, compared to the standard, panduratin A, having IC50 of 57.28 μmol/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBDiKJz4VBhtNTrvPZP1IpfW6udTcc2eZEwVkVzB0H_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfhvFOgtw%253D%253D&md5=c642b052a855ab3ea775e2fc0944ce73</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2017.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2017.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DOsman%26aufirst%3DH.%26aulast%3DIdris%26aufirst%3DN.%2BH.%26aulast%3DKamarulzaman%26aufirst%3DE.%2BE.%26aulast%3DWahab%26aufirst%3DH.%2BA.%26aulast%3DHassan%26aufirst%3DM.%2BZ.%26atitle%3D3%252C5-Bis%2528arylidene%2529-4-piperidones%2520as%2520potential%2520dengue%2520protease%2520inhibitors%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2017%26volume%3D7%26spage%3D479%26epage%3D484%26doi%3D10.1016%2Fj.apsb.2017.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aher, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanare, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawathekar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushik, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, V. S.</span></span> <span> </span><span class="NLM_article-title">Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3036</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmcl.2011.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21493068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3034-3036&author=R.+B.+Aherauthor=G.+Wanareauthor=N.+Kawathekarauthor=R.+R.+Kumarauthor=N.+K.+Kaushikauthor=D.+Sahalauthor=V.+S.+Chauhan&title=Dibenzylideneacetone+analogues+as+novel+Plasmodium+falciparum+inhibitors&doi=10.1016%2Fj.bmcl.2011.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors</span></div><div class="casAuthors">Aher, Rahul Balasaheb; Wanare, Gajanan; Kawathekar, Neha; Kumar, Ravi Ranjan; Kaushik, Naveen Kumar; Sahal, Dinkar; Chauhan, Virander Singh</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3034-3036</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of dibenzylideneacetones and some of their pyrazolines were synthesized and evaluated in vitro for blood stage antiplasmodial properties in Plasmodium falciparum culture using SYBR-green-I fluorescence assay.  The compd. I was found to be the most active with IC50 of 1.97 μM against chloroquine-sensitive strain (3D7) and 1.69 μM against chloroquine-resistant field isolate (RKL9).  The MTT based cytotoxicity assay on HeLa cell line has confirmed that I is selective in its action against malaria parasite (with a therapeutic index of 166).  Our results revealed that these compds. exhibited promising antiplasmodial activities which can be further explored as potential leads for the development of cheaper, safe, effective and potent drugs against chloroquine-resistant malarial parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2XOYPTrGFNrVg90H21EOLACvtfcHk0li5CEHAmq0Gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCmurc%253D&md5=64a042dd847a7b8ea4a983004373078e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DAher%26aufirst%3DR.%2BB.%26aulast%3DWanare%26aufirst%3DG.%26aulast%3DKawathekar%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DR.%2BR.%26aulast%3DKaushik%26aufirst%3DN.%2BK.%26aulast%3DSahal%26aufirst%3DD.%26aulast%3DChauhan%26aufirst%3DV.%2BS.%26atitle%3DDibenzylideneacetone%2520analogues%2520as%2520novel%2520Plasmodium%2520falciparum%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3034%26epage%3D3036%26doi%3D10.1016%2Fj.bmcl.2011.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delahunty, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz-Wolf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahlfs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helena Prieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span> <span> </span><span class="NLM_article-title">Characterization of the 26S proteasome network in Plasmodium falciparum</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">17818</span>, <span class="refDoi"> DOI: 10.1038/srep17818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep17818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26639022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKit77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17818&author=L.+Wangauthor=C.+Delahuntyauthor=K.+Fritz-Wolfauthor=S.+Rahlfsauthor=J.+Helena+Prietoauthor=J.+R.+Yatesauthor=K.+Becker&title=Characterization+of+the+26S+proteasome+network+in+Plasmodium+falciparum&doi=10.1038%2Fsrep17818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the 26S proteasome network in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Lihui; Delahunty, Claire; Fritz-Wolf, Karin; Rahlfs, Stefan; Helena Prieto, Judith; Yates, John R.; Becker, Katja</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17818</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In eukaryotic cells, the ubiquitin-proteasome system as a key regulator of protein quality control is an excellent drug target.  The authors analyzed the 26S proteasome complex in the malaria parasite Plasmodium falciparum, which still threatens almost half of the world's population.  First, they established an affinity purifn. protocol allowing for the isolation of functional 26S proteasome complexes from the parasite.  Subunit compn. of the proteasome and component stoichiometry were studied and physiol. interacting partners were identified via in situ protein crosslinking.  Intrinsic ubiquitin receptors of the plasmodial proteasome were detd., and their roles in proteasomal substrate recognition were analyzed.  Notably, PfUSP14 was characterized as a proteasome-assocd. deubiquitinase resulting in the concept that targeting proteasomal deubiquitinating activity in P. falciparum may represent a promising antimalarial strategy.  The data provide insights into a profound network orchestrated by the plasmodial proteasome and identified novel drug target candidates in the ubiquitin-proteasome system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow51eGPR1PZ7Vg90H21EOLACvtfcHk0lgyu6YBkMT2yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKit77N&md5=00d1c9908395d76ab0d3da89530829ea</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fsrep17818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17818%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDelahunty%26aufirst%3DC.%26aulast%3DFritz-Wolf%26aufirst%3DK.%26aulast%3DRahlfs%26aufirst%3DS.%26aulast%3DHelena%2BPrieto%26aufirst%3DJ.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DBecker%26aufirst%3DK.%26atitle%3DCharacterization%2520of%2520the%252026S%2520proteasome%2520network%2520in%2520Plasmodium%2520falciparum%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17818%26doi%3D10.1038%2Fsrep17818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, L. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapadia, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of Leishmaniasis: in-vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani</span>. <i>Parasitol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1016/j.parint.2018.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.parint.2018.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29913255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2jtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2018&pages=627-636&author=I.+S.+Chauhanauthor=G.+S.+Raoauthor=J.+Shankarauthor=L.+K.+S.+Chauhanauthor=G.+J.+Kapadiaauthor=N.+Singh&title=Chemoprevention+of+Leishmaniasis%3A+in-vitro+antiparasitic+activity+of+dibenzalacetone%2C+a+synthetic+curcumin+analog+leads+to+apoptotic+cell+death+in+Leishmania+donovani&doi=10.1016%2Fj.parint.2018.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of Leishmaniasis: In-vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani</span></div><div class="casAuthors">Chauhan, Indira Singh; Rao, G. Subba; Shankar, Jai; Chauhan, Lalit Kumar Singh; Kapadia, Govind J.; Singh, Neeloo</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">627-636</span>CODEN:
                <span class="NLM_cas:coden">PAINFD</span>;
        ISSN:<span class="NLM_cas:issn">1383-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Curcumin is the major phenolic compd. found in turmeric, a dry powder of rhizomes and roots of the plant, Curcuma longa L., which is widely used as spice and food colorant around the world, and in herbal medicinal practice in Asian countries.  The present study reports the leishmanicidal activity of trans-dibenzalacetone (DBA), a synthetic monoketone analog of curcumin, against Leishmania donovani parasites.  We for the first time report the antiproliferative effect of a curcumin analog (DBA) on the intracellular amastigotes of L. donovani, the clin. more relevant stage of the parasite than its promastigotes stage.  The leishmanicidal effect of DBA was further confirmed by scanning and transmission electron microscopies.  Cell growth was arrested in G0/G1 phase with increased concn. of cytosolic calcium and dissipation of mitochondrial membrane potential.  Further, the unique trypanothione/trypanothione reductase (TR) system of Leishmania cells was significantly inhibited by DBA.  This economically synthesizable simple monoketone analog of curcumin has the potential for field use against visceral leishmaniasis which is currently widespread in tropical and subtropical developing countries of the world.  In conclusion, we have identified an analog of curcumin for potential applications against leishmaniasis, based on its strong antiparasitic activity and low toxicity.  This curcumin analog compares favorably, at least in vitro, with the existing medication miltefosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGVUI5Dns5bVg90H21EOLACvtfcHk0lgyu6YBkMT2yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2jtr3F&md5=a35eb7027671c587f81f081400303c4d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.parint.2018.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parint.2018.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DI.%2BS.%26aulast%3DRao%26aufirst%3DG.%2BS.%26aulast%3DShankar%26aufirst%3DJ.%26aulast%3DChauhan%26aufirst%3DL.%2BK.%2BS.%26aulast%3DKapadia%26aufirst%3DG.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DChemoprevention%2520of%2520Leishmaniasis%253A%2520in-vitro%2520antiparasitic%2520activity%2520of%2520dibenzalacetone%252C%2520a%2520synthetic%2520curcumin%2520analog%2520leads%2520to%2520apoptotic%2520cell%2520death%2520in%2520Leishmania%2520donovani%26jtitle%3DParasitol.%2520Int.%26date%3D2018%26volume%3D67%26spage%3D627%26epage%3D636%26doi%3D10.1016%2Fj.parint.2018.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span> <span> </span><span class="NLM_article-title">Chemistry: Chemical con artists foil drug discovery</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1038/513481a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2F513481a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25254460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=481-483&author=J.+Baellauthor=M.+A.+Walters&title=Chemistry%3A+Chemical+con+artists+foil+drug+discovery&doi=10.1038%2F513481a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry: Chemical con artists foil drug discovery</span></div><div class="casAuthors">Baell, Jonathan; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7519</span>),
    <span class="NLM_cas:pages">481-483</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Naivety about promiscuous, assay-duping mols. is polluting the literature and wasting resources, warn Jonathan Baell and Michael A. Walters.  Academic drug discoverers must be more vigilant.  Mols. that show the strongest activity in screening might not be the best starting points for drugs.  PAINS hits should almost always be ignored.  Even trained medicinal chemists have to be careful until they become experienced in screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFYQ0B4VVoLVg90H21EOLACvtfcHk0lgyu6YBkMT2yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M&md5=f5788d81d006460c688e4b78e6200503</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2F513481a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F513481a%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DChemistry%253A%2520Chemical%2520con%2520artists%2520foil%2520drug%2520discovery%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D481%26epage%3D483%26doi%3D10.1038%2F513481a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span> <span> </span><span class="NLM_article-title">Badapple: promiscuity patterns from noisy evidence</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">29</span>, <span class="refDoi"> DOI: 10.1186/s13321-016-0137-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2Fs13321-016-0137-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=29&author=J.+J.+Yangauthor=O.+Ursuauthor=C.+A.+Lipinskiauthor=L.+A.+Sklarauthor=T.+I.+Opreaauthor=C.+G.+Bologa&title=Badapple%3A+promiscuity+patterns+from+noisy+evidence&doi=10.1186%2Fs13321-016-0137-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1186%2Fs13321-016-0137-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-016-0137-3%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%2BJ.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DSklar%26aufirst%3DL.%2BA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26atitle%3DBadapple%253A%2520promiscuity%2520patterns%2520from%2520noisy%2520evidence%26jtitle%3DJ.%2520Cheminf.%26date%3D2016%26volume%3D8%26spage%3D29%26doi%3D10.1186%2Fs13321-016-0137-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallavialle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Jouira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domdom, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohanna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartare-Deckert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckert, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the proteasome-associated deubiquitinating enzyme USP14 impairs melanoma cell survival and overcomes resistance to MAPK-targeting therapies</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">1429</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1535-7163.MCT-17-0919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29703842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1alurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1416-1429&author=R.+Didierauthor=A.+Mallavialleauthor=R.+Ben+Jouiraauthor=M.+A.+Domdomauthor=M.+Tichetauthor=P.+Aubergerauthor=F.+Lucianoauthor=M.+Ohannaauthor=S.+Tartare-Deckertauthor=M.+Deckert&title=Targeting+the+proteasome-associated+deubiquitinating+enzyme+USP14+impairs+melanoma+cell+survival+and+overcomes+resistance+to+MAPK-targeting+therapies&doi=10.1158%2F1535-7163.MCT-17-0919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies</span></div><div class="casAuthors">Didier, Robin; Mallavialle, Aude; Ben Jouira, Rania; Domdom, Marie Angela; Tichet, Melanie; Auberger, Patrick; Luciano, Freedeeeric; Ohanna, Mickael; Tartare-Deckert, Sophie; Deckert, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1416-1429</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Advanced cutaneous melanoma is one of the most challenging cancers to treat because of its high plasticity, metastatic potential, and resistance to treatment.  New targeted therapies and immunotherapies have shown remarkable clin. efficacy.  However, such treatments are limited to a subset of patients and relapses often occur, warranting validation of novel targeted therapies.  Posttranslational modification of proteins by ubiquitin coordinates essential cellular functions, including ubiquitin-proteasome system (UPS) function and protein homeostasis.  Deubiquitinating enzymes (DUB) have been assocd. to multiple diseases, including cancer.  However, their exact involvement in melanoma development and therapeutic resistance remains poorly understood.  Using a DUB trap assay to label cellular active DUBs, we have obsd. an increased activity of the proteasome-assocd. DUB, USP14 (Ubiquitin-specific peptidase 14) in melanoma cells compared with melanocytes.  Our survey of public gene expression databases indicates that high expression of USP14 correlates with melanoma progression and with a poorer survival rate in metastatic melanoma patients.  Knockdown or pharmacol. inhibition of USP14 dramatically impairs viability of melanoma cells irresp. of the mutational status of BRAF, NRAS, or TP53 and their transcriptional cell state, and overcomes resistance to MAPK-targeting therapies both in vitro and in human melanoma xenografted mice.  At the mol. level, we find that inhibition of USP14 rapidly triggers accumulation of poly-ubiquitinated proteins and chaperones, mitochondrial dysfunction, ER stress, and a ROS prodn. leading to a caspase-independent cell death.  Our results provide a rationale for targeting the proteasome-assocd. DUB USP14 to treat and combat melanomas.  Mol Cancer Ther; 17(7); 1416-29. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeAleNrhGtbVg90H21EOLACvtfcHk0liRORVVHv5yag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1alurzO&md5=0895514d6c4458a743025a6c8ecc7fb4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0919%26sid%3Dliteratum%253Aachs%26aulast%3DDidier%26aufirst%3DR.%26aulast%3DMallavialle%26aufirst%3DA.%26aulast%3DBen%2BJouira%26aufirst%3DR.%26aulast%3DDomdom%26aufirst%3DM.%2BA.%26aulast%3DTichet%26aufirst%3DM.%26aulast%3DAuberger%26aufirst%3DP.%26aulast%3DLuciano%26aufirst%3DF.%26aulast%3DOhanna%26aufirst%3DM.%26aulast%3DTartare-Deckert%26aufirst%3DS.%26aulast%3DDeckert%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520proteasome-associated%2520deubiquitinating%2520enzyme%2520USP14%2520impairs%2520melanoma%2520cell%2520survival%2520and%2520overcomes%2520resistance%2520to%2520MAPK-targeting%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1416%26epage%3D1429%26doi%3D10.1158%2F1535-7163.MCT-17-0919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlossman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">New treatments for multiple myeloma</span>. <i>Oncology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1781</span>– <span class="NLM_lpage">1792</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16506632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD287hvFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1781-1792&author=P.+G.+Richardsonauthor=R.+Schlossmanauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=New+treatments+for+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">New treatments for multiple myeloma</span></div><div class="casAuthors">Richardson Paul G; Schlossman Robert; Hideshima Teru; Anderson Kenneth C</div><div class="citationInfo"><span class="NLM_cas:title">Oncology (Williston Park, N.Y.)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1781-92; discussion 1792, 1795-7</span>
        ISSN:<span class="NLM_cas:issn">0890-9091</span>.
    </div><div class="casAbstract">In 2004, multiple myeloma was diagnosed in more than 15,000 people in the United States and will account for approximately 20% of deaths due to hematologic malignancies.  Although traditional therapies such as melphalan (Alkeran)/prednisone, combination chemotherapy with VAD (vincristine, doxorubicin [Adriamycin], and dexamethasone), and high-dose chemotherapy with stem cell transplantation have shown some success, median survival remains between 3 to 5 years.  Treatment options for patients with multiple myeloma have increased in recent years, with the promise of improvement in survival.  New agents, such as the proteasome inhibitor bortezomib (Velcade), the antiangiogenic and immunomodulator thalidomide (Thalomid) and its analogs, such as lenalidomide (Revlimid), together with other small molecules, including arsenic trioxide (Trisenox), and other targeted therapies, have been studied alone and in combination with other antineoplastic therapies, either as induction therapy prior to stem cell transplantation or in patients with relapsed disease.  Bortezomib recently was approved in the United States for the treatment of multiple myeloma in patients who have received at least one prior therapy.  The use of bortezomib-based regimens as front-line therapy as well as the use of other agents in multiple myeloma remain under investigation, and approvals for both thalidomide and lenalidomide are hoped for soon, with the overall prospect of patient outcome continuing to be increasingly positive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1SXjtuLu517JzI8owOhpDfW6udTcc2eYq0HsPtmrRxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287hvFyjsw%253D%253D&md5=0027cb5d53be579a6504f180246f812e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DSchlossman%26aufirst%3DR.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DNew%2520treatments%2520for%2520multiple%2520myeloma%26jtitle%3DOncology%26date%3D2005%26volume%3D19%26spage%3D1781%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgarra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgorbissa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casarsa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfioletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">184</span>, <span class="refDoi"> DOI: 10.1038/s41419-017-0259-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41419-017-0259-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29416018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1MvovVyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=184&author=S.+Ciottiauthor=R.+Sgarraauthor=A.+Sgorbissaauthor=C.+Penzoauthor=A.+Tomasellaauthor=F.+Casarsaauthor=F.+Benedettiauthor=F.+Bertiauthor=G.+Manfiolettiauthor=C.+Brancolini&title=The+binding+landscape+of+a+partially-selective+isopeptidase+inhibitor+with+potent+pro-death+activity%2C+based+on+the+bis%28arylidene%29cyclohexanone+scaffold&doi=10.1038%2Fs41419-017-0259-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold</span></div><div class="casAuthors">Ciotti Sonia; Sgorbissa Andrea; Tomasella Andrea; Brancolini Claudio; Sgarra Riccardo; Penzo Carlotta; Manfioletti Guidalberto; Casarsa Federico; Benedetti Fabio; Berti Federico</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diaryldienone derivatives with accessible β-carbons show strong anti-neoplastic properties, related to their ability to make covalent adducts with free thiols by Michael addition, and low toxicity in vivo.  Accumulation of poly-ubiquitylated proteins, activation of the unfolded protein response (UPR) and induction of cell death are universal hallmarks of their activities.  These compounds have been characterized as inhibitors of isopeptidases, a family of cysteine-proteases, which de-conjugate ubiquitin and ubiquitin-like proteins from their targets.  However, it is unclear whether they can also react with additional proteins.  In this work, we utilized the biotin-conjugated diaryldienone-derivative named 2c, as a bait to purify novel cellular targets of these small molecules.  Proteomic analyses have unveiled that, in addition to isopeptidases, these inhibitors can form stable covalent adducts with different intracellular proteins, thus potentially impacting on multiple functions of the cells, from cytoskeletal organization to metabolism.  These widespread activities can explain the ability of diaryldienone derivatives to efficiently trigger different cell death pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWIOh1FM9PF6cY7HFp97qMfW6udTcc2eYq0HsPtmrRxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvovVyltw%253D%253D&md5=63b26866895372f4d9b4557d712765e7</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fs41419-017-0259-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-017-0259-1%26sid%3Dliteratum%253Aachs%26aulast%3DCiotti%26aufirst%3DS.%26aulast%3DSgarra%26aufirst%3DR.%26aulast%3DSgorbissa%26aufirst%3DA.%26aulast%3DPenzo%26aufirst%3DC.%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DCasarsa%26aufirst%3DF.%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DBerti%26aufirst%3DF.%26aulast%3DManfioletti%26aufirst%3DG.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DThe%2520binding%2520landscape%2520of%2520a%2520partially-selective%2520isopeptidase%2520inhibitor%2520with%2520potent%2520pro-death%2520activity%252C%2520based%2520on%2520the%2520bis%2528arylidene%2529cyclohexanone%2520scaffold%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D184%26doi%3D10.1038%2Fs41419-017-0259-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koulich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, G. N.</span></span> <span> </span><span class="NLM_article-title">Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1072</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-10-1040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1091%2Fmbc.e07-10-1040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18162577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1072-1082&author=E.+Koulichauthor=X.+Liauthor=G.+N.+DeMartino&title=Relative+structural+and+functional+roles+of+multiple+deubiquitylating+proteins+associated+with+mammalian+26S+proteasome&doi=10.1091%2Fmbc.e07-10-1040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome</span></div><div class="casAuthors">Koulich, Elena; Li, Xiaohua; DeMartino, George N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1072-1082</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The authors detd. the compn. and relative roles of deubiquitinating enzymes (DUBs) assocd. with the 26S proteasome in mammalian cells.  Three DUBS were assocd. with the 26S proteasome: 2 from constituent subunits, Rpn11/S13 and Uch37, and 1 from a reversibly assocd. protein, Usp14.  RNA interference (RNAi) of Rpn11/S13 inhibited cell growth, decreased cellular proteasome activity via disrupted 26S proteasome assembly, and inhibited cellular protein degrdn.  In contrast, RNAi of Uch37 or Usp14 had no detectable effect on cell growth, proteasome structure of proteolytic capacity, but accelerated cellular protein degrdn.  RNAi of both Uch37 and Usp14 also had no effect on proteasome structure or proteolytic capacity, but inhibited cellular protein degrdn.  Thus, proper proteasomal processing of ubiquitinated substrates requires Rpn11 plus either Uch37 or Usp14.  Although the latter proteins featured redundant deubiquitination functions, they also appeared to exert noncatalytic effects on proteasome activity that were similar to but independent of one another.  These results reveal unexpected functional relations among multiple DUBs and suggest a model for mammalian 26S proteasome function whereby their concerted action governs proteasome function by linking deubiquitination to substrate hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZ5aaxxXNl7Vg90H21EOLACvtfcHk0lj0bi2xmLEU1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsL0%253D&md5=4152d3af3c28f2c24ac9f3f484ff2879</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-10-1040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-10-1040%26sid%3Dliteratum%253Aachs%26aulast%3DKoulich%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDeMartino%26aufirst%3DG.%2BN.%26atitle%3DRelative%2520structural%2520and%2520functional%2520roles%2520of%2520multiple%2520deubiquitylating%2520proteins%2520associated%2520with%2520mammalian%252026S%2520proteasome%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1072%26epage%3D1082%26doi%3D10.1091%2Fmbc.e07-10-1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">706</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-05-500033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1182%2Fblood-2013-05-500033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24319254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVGqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2014&pages=706-716&author=Z.+Tianauthor=P.+D%E2%80%99Arcyauthor=X.+Wangauthor=A.+Rayauthor=Y.+T.+Taiauthor=Y.+Huauthor=R.+D.+Carrascoauthor=P.+Richardsonauthor=S.+Linderauthor=D.+Chauhanauthor=K.+C.+Anderson&title=A+novel+small+molecule+inhibitor+of+deubiquitylating+enzyme+USP14+and+UCHL5+induces+apoptosis+in+multiple+myeloma+and+overcomes+bortezomib+resistance&doi=10.1182%2Fblood-2013-05-500033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance</span></div><div class="casAuthors">Tian, Ze; D'Arcy, Padraig; Wang, Xin; Ray, Arghya; Tai, Yu-Tzu; Hu, Yiguo; Carrasco, Ruben D.; Richardson, Paul; Linder, Stig; Chauhan, Dharminder; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">706-716</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Proteasome inhibitors have demonstrated that targeting protein degrdn. is effective therapy in multiple myeloma (MM).  Here we show that deubiquitylating enzymes (DUBs) USP14 and UCHL5 are more highly expressed in MM cells than in normal plasma cells.  USP14 and UCHL5 short interfering RNA knockdown decreases MM cell viability.  A novel 19S regulatory particle inhibitor b-AP15 selectively blocks deubiquitylating activity of USP14 and UCHL5 without inhibiting proteasome activity.  B-AP15 decreases viability in MM cell lines and patient MM cells, inhibits proliferation of MM cells even in the presence of bone marrow stroma cells, and overcomes bortezomib resistance.  Anti-MM activity of b-AP15 is assocd. with growth arrest via downregulation of CDC25C, CDC2, and cyclin B1 as well as induction of caspase-dependent apoptosis and activation of unfolded protein response.  In vivo studies using distinct human MM xenograft models show that b-AP15 is well tolerated, inhibits tumor growth, and prolongs survival.  Combining b-AP15 with suberoylanilide hydroxamic acid, lenalidomide, or dexamethasone induces synergistic anti-MM activity.  Our preclin. data showing efficacy of b-AP15 in MM disease models validates targeting DUBs in the ubiquitin proteasomal cascade to overcome proteasome inhibitor resistance and provides the framework for clin. evaluation of USP14/UCHL5 inhibitors to improve patient outcome in MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aTcAtVqIcbVg90H21EOLACvtfcHk0lj0bi2xmLEU1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVGqtLc%253D&md5=abf0d4ca5dadf6f7bf0cd1de3798702f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-05-500033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-05-500033%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DTai%26aufirst%3DY.%2BT.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCarrasco%26aufirst%3DR.%2BD.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DA%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520deubiquitylating%2520enzyme%2520USP14%2520and%2520UCHL5%2520induces%2520apoptosis%2520in%2520multiple%2520myeloma%2520and%2520overcomes%2520bortezomib%2520resistance%26jtitle%3DBlood%26date%3D2014%26volume%3D123%26spage%3D706%26epage%3D716%26doi%3D10.1182%2Fblood-2013-05-500033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">453</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1446-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2Fs13046-019-1446-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31694672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MjlvFCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=453&author=L.+Jiangauthor=Y.+Sunauthor=J.+Wangauthor=Q.+Heauthor=X.+Chenauthor=X.+Lanauthor=J.+Chenauthor=Q.+P.+Douauthor=X.+Shiauthor=J.+Liu&title=Proteasomal+cysteine+deubiquitinase+inhibitor+b-AP15+suppresses+migration+and+induces+apoptosis+in+diffuse+large+B+cell+lymphoma&doi=10.1186%2Fs13046-019-1446-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma</span></div><div class="casAuthors">Jiang Liling; Sun Yuening; Wang Jinxiang; He Qingyan; Chen Xinmei; Lan Xiaoying; Chen Jinghong; Dou Q Ping; Shi Xianping; Liu Jinbao; Dou Q Ping; Shi Xianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">453</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP.  About half of DLBCL patients are either refractory to, or will relapse, after the treatment.  Therefore, identifying novel drug targets and effective therapeutic agents is urgently needed for improving DLBCL patient survival. b-AP15, a selective small molecule inhibitor of proteasomal USP14 and UCHL5 deubiquitinases (DUBs), has shown selectivity and efficacy in several other types of cancer cells.  This is the first study to report the effect of b-AP15 in DLBCL.  METHODS:  Cell lines of two DLBCL subtypes, Germinal Center B Cell/ GCB (SU-DHL-4, OCI-LY-1, OCI-LY-19) and Activated B Cell/ABC (SU-DHL-2), were used in the current study.  Cell viability was measured by MTS assay, proliferation by trypan blue exclusion staining assay, cellular apoptosis by Annexin V-FITC/PI staining and mitochondrial outer membrane permeability assays, the activities of 20S proteasome peptidases by cleavage of specific fluorogenic substrates, and cell migration was detected by transwell assay in these GCB- and ABC-DLBCL cell lines.  Mouse xenograft models of SU-DHL-4 and SU-DHL-2 cells were used to determine in vivo effects of b-AP15 in DLBCL tumors.  RESULTS:  b-AP15 inhibited proteasome DUB activities and activated cell death pathway, as evident by caspase activation and mitochondria apoptosis in GCB- and ABC- DLBCL cell lines. b-AP15 treatment suppressed migration of GCB- and ABC-DLBCL cells via inhibiting Wnt/β-catenin and TGFβ/Smad pathways.  Additionally, b-AP15 significantly inhibited the growth of GCB- and ABC DLBCL in xenograft models.  CONCLUSIONS:  These results indicate that b-AP15 inhibits cell migration and induces apoptosis in GCB- and ABC-DLBCL cells, and suggest that inhibition of 19S proteasomal DUB should be a novel strategy for DLBCL treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBjiWNDyT7QrxanA7vODO6fW6udTcc2eb0Q1N1Ub77krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjlvFCksA%253D%253D&md5=8c018a8c1d5f7d07108a5c3b6ebf80cd</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1446-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1446-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DProteasomal%2520cysteine%2520deubiquitinase%2520inhibitor%2520b-AP15%2520suppresses%2520migration%2520and%2520induces%2520apoptosis%2520in%2520diffuse%2520large%2520B%2520cell%2520lymphoma%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D453%26doi%3D10.1186%2Fs13046-019-1446-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brjnic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1124/mol.113.091322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1124%2Fmol.113.091322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24714215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGmsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=932-945&author=X.+Wangauthor=W.+Staffordauthor=M.+Mazurkiewiczauthor=M.+Fryknasauthor=S.+Brjnicauthor=X.+Zhangauthor=J.+Gullboauthor=R.+Larssonauthor=E.+S.+Arnerauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=The+19S+Deubiquitinase+inhibitor+b-AP15+is+enriched+in+cells+and+elicits+rapid+commitment+to+cell+death&doi=10.1124%2Fmol.113.091322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The 19S deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death</span></div><div class="casAuthors">Wang, Xin; Stafford, William; Mazurkiewicz, Magdalena; Fryknaes, Maarten; Brjnic, Slavica; Zhang, Xiaonan; Gullbo, Joachim; Larsson, Rolf; Arner, Elias S. J.; D'Arcy, Padraig; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">932-945, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">B-AP15 [(3E,5E)-3,5-bis[(4-nitrophenyl)methylidene]-1-(prop-2-enoyl)piperidin-4-one] is a small mol. inhibitor of the ubiquitin specific peptidase (USP) 14/ubiquitin carboxyl-terminal hydrolase (UCH) L5 deubiquitinases of the 19S proteasome that shows antitumor activity in a no. of tumor models, including multiple myeloma.  B-AP15 contains an α-, β-unsatd. carbonyl unit that is likely to react with intracellular nucleophiles such as cysteine thiolates by Michael addn.  We found that binding of b-AP15 to USP14 is partially reversible, and that inhibition of proteasome function is reversible in cells.  Despite reversible binding, tumor cells are rapidly committed to apoptosis/cell death after exposure to b-AP15.  We show that b-AP15 is rapidly taken up from the medium and enriched in cells.  Enrichment provides an explanation of the stronger potency of the compd. in cellular assays compared with in vitro biochem. assays.  Cellular uptake was impaired by 30-min pretreatment of cells with low concns. of N-ethylmaleimide (10 μM), suggesting that enrichment was thiol dependent.  We report that in addn. to inhibition of deubiquitinases, b-AP15 inhibits the selenoprotein thioredoxin reductase (TrxR).  Whereas proteasome inhibition was closely assocd. with cell death induction, inhibition of TrxR was not.  TrxR inhibition is, however, likely to contribute to triggering of oxidative stress obsd. with b-AP15.  Furthermore, we present structure-activity, in vivo pharmacokinetic, and hepatocyte metab. data for b-AP15.  We conclude that the strong enrichment of b-AP15 in cells and a rapid commitment to apoptosis/cell death are factors that likely contribute to the strong antitumor activity of this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp889oZOoWzgbVg90H21EOLACvtfcHk0lg1CF7mksltCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGmsLjJ&md5=3aaf8d1e0dd9695da48f93e68a821c9d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.091322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.091322%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DStafford%26aufirst%3DW.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DFryknas%26aufirst%3DM.%26aulast%3DBrjnic%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DArner%26aufirst%3DE.%2BS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DThe%252019S%2520Deubiquitinase%2520inhibitor%2520b-AP15%2520is%2520enriched%2520in%2520cells%2520and%2520elicits%2520rapid%2520commitment%2520to%2520cell%2520death%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D932%26epage%3D945%26doi%3D10.1124%2Fmol.113.091322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borodovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H. L.</span></span> <span> </span><span class="NLM_article-title">A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5187</span>– <span class="NLM_lpage">5196</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.18.5187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Femboj%2F20.18.5187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=11566882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1Ghs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5187-5196&author=A.+Borodovskyauthor=B.+M.+Kesslerauthor=R.+Casagrandeauthor=H.+S.+Overkleeftauthor=K.+D.+Wilkinsonauthor=H.+L.+Ploegh&title=A+novel+active+site-directed+probe+specific+for+deubiquitylating+enzymes+reveals+proteasome+association+of+USP14&doi=10.1093%2Femboj%2F20.18.5187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14</span></div><div class="casAuthors">Borodovsky, Anna; Kessler, Benedikt M.; Casagrande, Rocco; Overkleeft, Herman S.; Wilkinson, Keith D.; Ploegh, Hidde L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5187-5196</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A C-terminally modified ubiquitin (Ub) deriv., ubiquitin vinyl sulfone (UbVS), was synthesized as an active site-directed probe that irreversibly modifies a subset of Ub C-terminal hydrolases (UCHs) and Ub-specific processing proteases (UBPs).  Specificity of UbVS for deubiquitylating enzymes (DUBs) is demonstrated not only by inhibition of [125I]UbVS labeling with N-ethylmaleimide and Ub aldehyde, but also by genetic anal.  [125I]UbVS modifies six of the 17 known and putative yeast deubiquitylating enzymes (Yuh1p, Ubp1p, Ubp2p, Ubp6p, Ubp12p and Ubp15p), as revealed by anal. of corresponding mutant strains.  In mammalian cells, greater nos. of polypeptides are labeled, most of which are likely to be DUBs.  Using [125I]UbVS as a probe, we report the assocn. of an addnl. DUB with the mammalian 26S proteasome.  In addn. to the 37 kDa enzyme reported to be part of the 19S cap, we identified USP14, a mammalian homolog of yeast Ubp6p, as being bound to the proteasome.  Remarkably, labeling of 26S-assocd. USP14 with [125I]UbVS is increased when proteasome function is impaired, suggesting functional coupling between the activities of USP14 and the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY6kbqcL1FOLVg90H21EOLACvtfcHk0lg1CF7mksltCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1Ghs74%253D&md5=1090c312d50142b754aac504a7f5cd06</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.18.5187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.18.5187%26sid%3Dliteratum%253Aachs%26aulast%3DBorodovsky%26aufirst%3DA.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DCasagrande%26aufirst%3DR.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26atitle%3DA%2520novel%2520active%2520site-directed%2520probe%2520specific%2520for%2520deubiquitylating%2520enzymes%2520reveals%2520proteasome%2520association%2520of%2520USP14%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D5187%26epage%3D5196%26doi%3D10.1093%2Femboj%2F20.18.5187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, J. W.</span></span> <span> </span><span class="NLM_article-title">Thermal stability and activation of bovine lens multicatalytic proteinase complex (proteasome)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1006/abbi.1993.1573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1006%2Fabbi.1993.1573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=8239652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVShsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1993&pages=146-152&author=B.+J.+Wagnerauthor=J.+W.+Margolis&title=Thermal+stability+and+activation+of+bovine+lens+multicatalytic+proteinase+complex+%28proteasome%29&doi=10.1006%2Fabbi.1993.1573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Thermal stability and activation of bovine lens multicatalytic proteinase complex (proteasome)</span></div><div class="casAuthors">Wagner, B. J.; Margolis, Joyce W.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-52</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The multicatalytic proteinase complex (MPC; proteasome) can be isolated in a latent form which then can be activated for protein hydrolysis by physiol. and nonphysiol. treatments, including high temp.  In this study, the temp. dependency profile for the hydrolysis of carbobenzoxy (Cbz)-Gly-Gly-Leu-p-nitroanilide (pNA) and Cbz-Val-Gly-Arg-pNA by bovine lens MPC are found to be those expected for a thermostable enzyme, with single optima above 50°C.  In contrast, hydrolyses of Cbz-Leu-Leu-Glu-naphthylamide and α2-crystallin, a lens structural protein, show two temp. transitions, indicating that hydrolysis of these substrates can be activated by elevated temp.  Temp. dependency profiles of peptidase activity in Tris-HCl compared to Hepes buffer suggest that Tris decreases the thermal stability of MPC.  After 10 min preincubation in Tris-HCl at 53°C, lens MPC activities are reduced by 50-60% and loss of the major MPC band can be seen on nondenaturing gels.  The presence of α2-crystallin during preincubation partially prevents the loss of activity.  Although α-crystallin has been reported to function as a mol. chaperone, similar protection by other MPC substrates suggests that α2-crystallin stabilized the MPC as a substrate.  These findings indicate both activation and inactivation of the enzyme at elevated temps.  It is proposed therefore that high temp. activates the MPC but to a more labile form which can be partially stabilized by protein substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnZ6h99-6wbVg90H21EOLACvtfcHk0lg1CF7mksltCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVShsrc%253D&md5=1f2b1da9abffb4de6cec89dc0c66f5fa</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1993.1573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1993.1573%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DB.%2BJ.%26aulast%3DMargolis%26aufirst%3DJ.%2BW.%26atitle%3DThermal%2520stability%2520and%2520activation%2520of%2520bovine%2520lens%2520multicatalytic%2520proteinase%2520complex%2520%2528proteasome%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1993%26volume%3D307%26spage%3D146%26epage%3D152%26doi%3D10.1006%2Fabbi.1993.1573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowicka, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randles, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasov, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasova, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamazaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, K. J.</span></span> <span> </span><span class="NLM_article-title">Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15540</span>, <span class="refDoi"> DOI: 10.1038/ncomms15540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fncomms15540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28598414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmslSiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15540&author=X.+Luauthor=U.+Nowickaauthor=V.+Sridharanauthor=F.+Liuauthor=L.+Randlesauthor=D.+Hymelauthor=M.+Dybaauthor=S.+G.+Tarasovauthor=N.+I.+Tarasovaauthor=X.+Z.+Zhaoauthor=J.+Hamazakiauthor=S.+Murataauthor=T.+R.+Burkeauthor=K.+J.+Walters&title=Structure+of+the+Rpn13-Rpn2+complex+provides+insights+for+Rpn13+and+Uch37+as+anticancer+targets&doi=10.1038%2Fncomms15540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets</span></div><div class="casAuthors">Lu Xiuxiu; Nowicka Urszula; Sridharan Vinidhra; Liu Fen; Randles Leah; Walters Kylie J; Hymel David; Zhao Xue Zhi; Burke Terrence R Jr; Dyba Marzena; Dyba Marzena; Tarasov Sergey G; Tarasova Nadya I; Hamazaki Jun; Murata Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15540</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Proteasome-ubiquitin receptor hRpn13/Adrm1 binds and activates deubiquitinating enzyme Uch37/UCHL5 and is targeted by bis-benzylidine piperidone RA190, which restricts cancer growth in mice xenografts.  Here, we solve the structure of hRpn13 with a segment of hRpn2 that serves as its proteasome docking site; a proline-rich C-terminal hRpn2 extension stretches across a narrow canyon of the ubiquitin-binding hRpn13 Pru domain blocking an RA190-binding surface.  Biophysical analyses in combination with cell-based assays indicate that hRpn13 binds preferentially to hRpn2 and proteasomes over RA190. hRpn13 also exists outside of proteasomes where it may be RA190 sensitive.  RA190 does not affect hRpn13 interaction with Uch37, but rather directly binds and inactivates Uch37. hRpn13 deletion from HCT116 cells abrogates RA190-induced accumulation of substrates at proteasomes.  We propose that RA190 targets hRpn13 and Uch37 through parallel mechanisms and at proteasomes, RA190-inactivated Uch37 cannot disassemble hRpn13-bound ubiquitin chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeCgKMDdtGrfh3YQQtAhNufW6udTcc2ebx3lAEkPWfmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmslSiuw%253D%253D&md5=767c1f12875d0f4a147720707bb7ad7a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fncomms15540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15540%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DNowicka%26aufirst%3DU.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRandles%26aufirst%3DL.%26aulast%3DHymel%26aufirst%3DD.%26aulast%3DDyba%26aufirst%3DM.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DTarasova%26aufirst%3DN.%2BI.%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DHamazaki%26aufirst%3DJ.%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DWalters%26aufirst%3DK.%2BJ.%26atitle%3DStructure%2520of%2520the%2520Rpn13-Rpn2%2520complex%2520provides%2520insights%2520for%2520Rpn13%2520and%2520Uch37%2520as%2520anticancer%2520targets%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15540%26doi%3D10.1038%2Fncomms15540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coughlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iizuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marastoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span> <span> </span><span class="NLM_article-title">Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">4159</span>– <span class="NLM_lpage">4170</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.2904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25784654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2Mnls1Sksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=4159-4170&author=R.+I.+Vogelauthor=K.+Coughlinauthor=A.+Scottiauthor=Y.+Iizukaauthor=R.+Anchooriauthor=R.+B.+Rodenauthor=M.+Marastoniauthor=M.+Bazzaro&title=Simultaneous+inhibition+of+deubiquitinating+enzymes+%28DUBs%29+and+autophagy+synergistically+kills+breast+cancer+cells&doi=10.18632%2Foncotarget.2904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells</span></div><div class="casAuthors">Vogel Rachel Isaksson; Bazzaro Martina; Coughlin Kathleen; Iizuka Yoshie; Bazzaro Martina; Scotti Alessandra; Marastoni Mauro; Anchoori Ravi; Roden Richard B S; Anchoori Ravi; Roden Richard B S; Roden Richard B S</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4159-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the leading causes of cancer death among women in the United States.  Patients expressing the estrogen and progesterone receptor (ER and PR) and human epidermal growth factor 2 (HER-2) tumor markers have favorable prognosis and efficacious therapeutic options.  In contrast, tumors that are negative for these markers (triple-negative) have a disproportionate share of morbidity and mortality due to lack of a validated molecular target.  Deubiquitinating enzymes (DUBs) are a critical component of ubiquitin-proteasome-system degradation and have been shown to be differentially expressed and activated in a number of cancers, including breast, with their aberrant activity linked to cancer prognosis and clinical outcome.  We evaluated the effect of the DUB inhibitors b-AP15 and RA-9 alone and in combination with early- and late-stage lysosomal inhibitors on cell viability in a panel of triple negative breast cancer (TNBC) cell lines.  Our results indicate small-molecule DUB inhibitors have a profound effect on TNBC viability and lead to activation of autophagy as a cellular mechanism to compensate for ubiquitin-proteasome-system stress.  Treatment with sub-optimal doses of DUB and lysosome inhibitors synergistically kills TNBC cells.  This supports the evaluation of DUB inhibition, in combination with lysosomal inhibition, as a therapeutic approach for the treatment of TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvDoMDseirLGhHGZei4OW9fW6udTcc2ebx3lAEkPWfmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mnls1Sksg%253D%253D&md5=4cae506139805133d1a3776a41149aa6</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2904%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DCoughlin%26aufirst%3DK.%26aulast%3DScotti%26aufirst%3DA.%26aulast%3DIizuka%26aufirst%3DY.%26aulast%3DAnchoori%26aufirst%3DR.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DMarastoni%26aufirst%3DM.%26aulast%3DBazzaro%26aufirst%3DM.%26atitle%3DSimultaneous%2520inhibition%2520of%2520deubiquitinating%2520enzymes%2520%2528DUBs%2529%2520and%2520autophagy%2520synergistically%2520kills%2520breast%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D4159%26epage%3D4170%26doi%3D10.18632%2Foncotarget.2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodrasov, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, T. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1043</span>, <span class="refDoi"> DOI: 10.1110/ps.083450408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1110%2Fps.083450408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18424514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1035-1043&author=B.+Nicholsonauthor=C.+A.+Leachauthor=S.+J.+Goldenbergauthor=D.+M.+Francisauthor=M.+P.+Kodrasovauthor=X.+Tianauthor=J.+Shanksauthor=D.+E.+Sternerauthor=A.+Bernalauthor=M.+R.+Matternauthor=K.+D.+Wilkinsonauthor=T.+R.+Butt&title=Characterization+of+ubiquitin+and+ubiquitin-like-protein+isopeptidase+activities&doi=10.1110%2Fps.083450408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities</span></div><div class="casAuthors">Nicholson, Benjamin; Leach, Craig A.; Goldenberg, Seth J.; Francis, Dana M.; Kodrasov, Matthew P.; Tian, Xufan; Shanks, John; Sterner, David E.; Bernal, Alejandro; Mattern, Michael R.; Wilkinson, Keith D.; Butt, Tauseef R.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1035-1043</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Conjugation or deconjugation of ubiquitin (Ub) or ubiquitin-like proteins (UBLs) to or from cellular proteins is a multifaceted and universal means of regulating cellular physiol., controlling the lifetime, localization, and activity of many crit. proteins.  Deconjugation of Ub or UBL from proteins is performed by a class of proteases called isopeptidases.  Herein is described a readily quantifiable novel isopeptidase assay platform consisting of Ub or UBL fused to the reporter enzyme phospholipase A2 (PLA2).  Isopeptidase activity releases PLA2, which cleaves its substrate, generating a signal that is linear with deubiquitylase (DUB) concn. and is able to discriminate DUB, deSUMOylase, deNEDDylase, and deISGylase activities.  The power and sensitivity of the UBL-PLA2 assay are demonstrated by its ability to differentiate the contrasting deISGylase and DUB activities of two coronavirus proteases: severe acute respiratory syndrome papain-like protease (SARS-CoV PLpro) and NL63 CoV papain-like protease 2 (PLP2).  Furthermore, direct comparisons with the current Ub-7-amino-4-methylcoumarin (Ub-AMC) assay demonstrated that the Ub-PLA2 assay is an effective tool for characterizing modulators of isopeptidase activity.  This observation was expanded by profiling the inhibitory activity of the nonselective isopeptidase inhibitor NSC 632839 against DUBs and deSUMOylases.  Taken together, these studies illustrate the utility of the reporter-based approach to measuring isopeptidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8B_bxI25uwbVg90H21EOLACvtfcHk0lgXA4LDEVSvLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFKhtLo%253D&md5=eae8fac2cc0e3c82aa7a75c982c635cd</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1110%2Fps.083450408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.083450408%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DB.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26aulast%3DGoldenberg%26aufirst%3DS.%2BJ.%26aulast%3DFrancis%26aufirst%3DD.%2BM.%26aulast%3DKodrasov%26aufirst%3DM.%2BP.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DShanks%26aufirst%3DJ.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DBernal%26aufirst%3DA.%26aulast%3DMattern%26aufirst%3DM.%2BR.%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26aulast%3DButt%26aufirst%3DT.%2BR.%26atitle%3DCharacterization%2520of%2520ubiquitin%2520and%2520ubiquitin-like-protein%2520isopeptidase%2520activities%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D1035%26epage%3D1043%26doi%3D10.1110%2Fps.083450408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelissen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Saez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riant, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Re-evaluating the mechanism of action of alpha, beta-unsaturated carbonyl DUB inhibitors b-AP15 and VLX1570: a paradigmatic example of unspecific protein cross-linking with Michael acceptor motif-containing drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3756</span>– <span class="NLM_lpage">3762</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3756-3762&author=J.+A.+Wardauthor=A.+Pinto-Fernandezauthor=L.+Cornelissenauthor=S.+Bonhamauthor=L.+Diaz-Saezauthor=O.+Riantauthor=K.+V.+M.+Huberauthor=B.+M.+Kesslerauthor=O.+Feronauthor=E.+W.+Tate&title=Re-evaluating+the+mechanism+of+action+of+alpha%2C+beta-unsaturated+carbonyl+DUB+inhibitors+b-AP15+and+VLX1570%3A+a+paradigmatic+example+of+unspecific+protein+cross-linking+with+Michael+acceptor+motif-containing+drugs&doi=10.1021%2Facs.jmedchem.0c00144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs</span></div><div class="casAuthors">Ward, Jennifer A.; Pinto-Fernandez, Adan; Cornelissen, Loic; Bonham, Sarah; Diaz-Saez, Laura; Riant, Olivier; Huber, Kilian V. M.; Kessler, Benedikt M.; Feron, Olivier; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3756-3762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) are a growing target class across multiple disease states, with several inhibitors now reported. b-AP15 and VLX1570 are two structurally related USP14/UCH-37 inhibitors.  Through a proteomic approach, we demonstrate that these compds. target a diverse range of proteins, resulting in the formation of higher mol. wt. (MW) complexes.  Activity-based proteome profiling identified CIAPIN1 as a submicromolar covalent target of VLX1570, and further anal. demonstrated that high MW complex formation leads to aggregation of CIAPIN1 in intact cells.  Our results suggest that in addn. to DUB inhibition, these compds. induce nonspecific protein aggregation, providing mol. explanation for general cellular toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUJKosQOrcbVg90H21EOLACvtfcHk0ljLZFP3dj7JdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOlt70%253D&md5=05300126a6e9b191ea41d1834837916f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00144%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DJ.%2BA.%26aulast%3DPinto-Fernandez%26aufirst%3DA.%26aulast%3DCornelissen%26aufirst%3DL.%26aulast%3DBonham%26aufirst%3DS.%26aulast%3DDiaz-Saez%26aufirst%3DL.%26aulast%3DRiant%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DFeron%26aufirst%3DO.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DRe-evaluating%2520the%2520mechanism%2520of%2520action%2520of%2520alpha%252C%2520beta-unsaturated%2520carbonyl%2520DUB%2520inhibitors%2520b-AP15%2520and%2520VLX1570%253A%2520a%2520paradigmatic%2520example%2520of%2520unspecific%2520protein%2520cross-linking%2520with%2520Michael%2520acceptor%2520motif-containing%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3756%26epage%3D3762%26doi%3D10.1021%2Facs.jmedchem.0c00144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizemore, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharia, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubonja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawes, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivich, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsherniak, A.</span></span> <span> </span><span class="NLM_article-title">Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1038/ng.3984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fng.3984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29083409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=1779-1784&author=R.+M.+Meyersauthor=J.+G.+Bryanauthor=J.+M.+McFarlandauthor=B.+A.+Weirauthor=A.+E.+Sizemoreauthor=H.+Xuauthor=N.+V.+Dhariaauthor=P.+G.+Montgomeryauthor=G.+S.+Cowleyauthor=S.+Pantelauthor=A.+Goodaleauthor=Y.+Leeauthor=L.+D.+Aliauthor=G.+Jiangauthor=R.+Lubonjaauthor=W.+F.+Harringtonauthor=M.+Stricklandauthor=T.+Wuauthor=D.+C.+Hawesauthor=V.+A.+Zhivichauthor=M.+R.+Wyattauthor=Z.+Kalaniauthor=J.+J.+Changauthor=M.+Okamotoauthor=K.+Stegmaierauthor=T.+R.+Golubauthor=J.+S.+Boehmauthor=F.+Vazquezauthor=D.+E.+Rootauthor=W.+C.+Hahnauthor=A.+Tsherniak&title=Computational+correction+of+copy+number+effect+improves+specificity+of+CRISPR-Cas9+essentiality+screens+in+cancer+cells&doi=10.1038%2Fng.3984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells</span></div><div class="casAuthors">Meyers, Robin M.; Bryan, Jordan G.; McFarland, James M.; Weir, Barbara A.; Sizemore, Ann E.; Xu, Han; Dharia, Neekesh V.; Montgomery, Phillip G.; Cowley, Glenn S.; Pantel, Sasha; Goodale, Amy; Ali, Levi D.; Jiang, Guozhi; Lubonja, Rakela; Harrington, William F.; Strickland, Matthew; Wu, Ting; Hawes, Derek C.; Zhivich, Victor A.; Wyatt, Meghan R.; Kalani, Zohra; Chang, Jaime J.; Okamoto, Michael; Stegmaier, Kimberly; Golub, Todd R.; Boehm, Jesse S.; Vazquez, Francisca; Root, David E.; Hahn, William C.; Tsherniak, Aviad</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1779-1784</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The CRISPR-Cas9 system has revolutionized gene editing both at single genes and in multiplexed loss-of-function screens, thus enabling precise genome-scale identification of genes essential for proliferation and survival of cancer cells.  However, previous studies have reported that a gene-independent antiproliferative effect of Cas9-mediated DNA cleavage confounds such measurement of genetic dependency, thereby leading to false-pos. results in copy no.-amplified regions.  We developed CERES, a computational method to est. gene-dependency levels from CRISPR-Cas9 essentiality screens while accounting for the copy no.-specific effect.  In our efforts to define a cancer dependency map, we performed genome-scale CRISPR-Cas9 essentiality screens across 342 cancer cell lines and applied CERES to this data set.  We found that CERES decreased false-pos. results and estd. sgRNA activity for both this data set and previously published screens performed with different sgRNA libraries.  We further demonstrate the utility of this collection of screens, after CERES correction, for identifying cancer-type-specific vulnerabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8iODR9NtDbVg90H21EOLACvtfcHk0ljLZFP3dj7JdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehtrjI&md5=539e8fb16958480ce2d430a7f8e6cddf</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fng.3984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3984%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DR.%2BM.%26aulast%3DBryan%26aufirst%3DJ.%2BG.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DSizemore%26aufirst%3DA.%2BE.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DMontgomery%26aufirst%3DP.%2BG.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DPantel%26aufirst%3DS.%26aulast%3DGoodale%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DAli%26aufirst%3DL.%2BD.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DLubonja%26aufirst%3DR.%26aulast%3DHarrington%26aufirst%3DW.%2BF.%26aulast%3DStrickland%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DHawes%26aufirst%3DD.%2BC.%26aulast%3DZhivich%26aufirst%3DV.%2BA.%26aulast%3DWyatt%26aufirst%3DM.%2BR.%26aulast%3DKalani%26aufirst%3DZ.%26aulast%3DChang%26aufirst%3DJ.%2BJ.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DVazquez%26aufirst%3DF.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DTsherniak%26aufirst%3DA.%26atitle%3DComputational%2520correction%2520of%2520copy%2520number%2520effect%2520improves%2520specificity%2520of%2520CRISPR-Cas9%2520essentiality%2520screens%2520in%2520cancer%2520cells%26jtitle%3DNat.%2520Genet.%26date%3D2017%26volume%3D49%26spage%3D1779%26epage%3D1784%26doi%3D10.1038%2Fng.3984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span> <span> </span><span class="NLM_article-title">A role for mitochondrial translation in promotion of viability in K-Ras mutant cells</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2017.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.celrep.2017.06.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28700943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKhtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=427-438&author=T.+D.+Martinauthor=D.+R.+Cookauthor=M.+Y.+Choiauthor=M.+Z.+Liauthor=K.+M.+Haigisauthor=S.+J.+Elledge&title=A+role+for+mitochondrial+translation+in+promotion+of+viability+in+K-Ras+mutant+cells&doi=10.1016%2Fj.celrep.2017.06.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells</span></div><div class="casAuthors">Martin, Timothy D.; Cook, Danielle R.; Choi, Mei Yuk; Li, Mamie Z.; Haigis, Kevin M.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-438</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activating mutations in the KRAS oncogene are highly prevalent in tumors, esp. those of the colon, lung, and pancreas.  To better understand the genetic dependencies that K-Ras mutant cells rely upon for their growth, we employed whole-genome CRISPR loss-of-function screens in two isogenic pairs of cell lines.  Since loss of essential genes is uniformly toxic in CRISPR-based screens, we also developed a small hairpin RNA (shRNA) library targeting essential genes.  These approaches uncovered a large set of proteins whose loss results in the selective redn. of K-Ras mutant cell growth.  Pathway anal. revealed that many of these genes function in the mitochondria.  For validation, we generated isogenic pairs of cell lines using CRISPR-based genome engineering, which confirmed the dependency of K-Ras mutant cells on these mitochondrial pathways.  Finally, we found that mitochondrial inhibitors reduce the growth of K-Ras mutant tumors in vivo, aiding in the advancement of strategies to target K-Ras-driven malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Fr6oDktcerVg90H21EOLACvtfcHk0lgdQjIydPfo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKhtrzN&md5=cac8a6a7e0b3b44dff54734c2d293eb9</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2017.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2017.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DT.%2BD.%26aulast%3DCook%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DM.%2BY.%26aulast%3DLi%26aufirst%3DM.%2BZ.%26aulast%3DHaigis%26aufirst%3DK.%2BM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DA%2520role%2520for%2520mitochondrial%2520translation%2520in%2520promotion%2520of%2520viability%2520in%2520K-Ras%2520mutant%2520cells%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D20%26spage%3D427%26epage%3D438%26doi%3D10.1016%2Fj.celrep.2017.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkepang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, V.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin receptor RPN13 mediates the inhibitory interaction of diphenyldihaloketones CLEFMA and EF24 with the 26S proteasome</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">392</span>, <span class="refDoi"> DOI: 10.3389/fchem.2018.00392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3389%2Ffchem.2018.00392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30280096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaitrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=392&author=G.+Raoauthor=G.+Nkepangauthor=J.+Xuauthor=H.+Yariauthor=H.+Housonauthor=C.+Tengauthor=V.+Awasthi&title=Ubiquitin+receptor+RPN13+mediates+the+inhibitory+interaction+of+diphenyldihaloketones+CLEFMA+and+EF24+with+the+26S+proteasome&doi=10.3389%2Ffchem.2018.00392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin receptor RPN13 mediates the inhibitory interaction of diphenyldihaloketones CLEFMA and EF24 with the 26S proteasome</span></div><div class="casAuthors">Rao, Geeta; Nkepang, Gregory; Xu, Jian; Yari, Hooman; Houson, Hailey; Teng, Chengwen; Awasthi, Vibhudutta</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392/1-392/13</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The proteasome is a validated target in drug discovery for diseases assocd. with unusual proteasomal activity.  Here we report that two diphenyldihaloketones, CLEFMA and EF24, inhibit the peptidase activity of the 26S proteasome.  The objective of this study was to investigate interaction of these compds. with the proteasome and identify a putative target within the protein components of the 26S proteasome.  We employed std. fluorogenic peptide-based proteasome activity assay for trypsinlike, chymotrypsin-like, and caspase-like activities of human purified 26S proteasome in cell-free conditions.  GFPu-1 and HUVEC cells were used as proteasome reporter cells.  Direct binding studies used purified 19S, 20S, 26S, and recombinant RPN13-Pru for interaction with biotinylated analogs of CLEFMA and EF24.  The reaction mixts. were subjected to horizontal gel electrophoresis, streptavidin-blotting, pull-down assays, and immunoblotting.  The identity of the interacting protein was detd. by 2D gel electrophoresis and LC-MS/MS.  Drug affinity responsive target stability technique was utilized to examine if CLEFMA binding confers protection to RPN13 against thermolysincatalyzed proteolysis.  We found that trypsin-and chymotrypsin-like activities of the 26S proteasome were reduced significantly by both compds.  The compds. also reduced the proteolytic activity in GFPu-1 and HUVEC cells, resulting in accumulation of ubiquitinated proteins without affecting the autophagy process.  From direct binding assays a 43 kDa protein in the 26S proteasome was found to be the interacting partner.  This protein was identified by tandem mass spectroscopy as regulatory particle subunit 13 (RPN13), a ubiquitin receptor in the 19S regulatory particle.  Furthermore, binding of CLEFMA to RPN13 did not protect latter from thermolysin-mediated proteolysis.  Together, this study showed diphenyldihaloketones as potential proteasome inhibitors for treatment of diseases with perturbed proteasome function.  The results also unraveled RPN13 as a unique target of CLEFMA and EF24.  As a result, these compds. inhibit both trypsin-like and chymotrypsin-like proteasome activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1KhmCHlo637Vg90H21EOLACvtfcHk0lgdQjIydPfo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaitrzN&md5=3638c6bdd16d4b7dff38fe5cbb27740a</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2018.00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2018.00392%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DG.%26aulast%3DNkepang%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYari%26aufirst%3DH.%26aulast%3DHouson%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DC.%26aulast%3DAwasthi%26aufirst%3DV.%26atitle%3DUbiquitin%2520receptor%2520RPN13%2520mediates%2520the%2520inhibitory%2520interaction%2520of%2520diphenyldihaloketones%2520CLEFMA%2520and%2520EF24%2520with%2520the%252026S%2520proteasome%26jtitle%3DFront.%2520Chem.%26date%3D2018%26volume%3D6%26spage%3D392%26doi%3D10.3389%2Ffchem.2018.00392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Amponsa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tandon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, K. J.</span></span> <span> </span><span class="NLM_article-title">Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquitinated proteins and RA190 cytotoxicity</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>, <span class="NLM_elocation-id">e00122</span> <span class="refDoi"> DOI: 10.1128/MCB.00122-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1128%2FMCB.00122-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=32631902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFyks7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&author=V.+Osei-Amponsaauthor=V.+Sridharanauthor=M.+Tandonauthor=C.+N.+Evansauthor=K.+Klarmannauthor=K.+T.+Chengauthor=J.+Lackauthor=R.+Chariauthor=K.+J.+Walters&title=Impact+of+losing+hRpn13+Pru+or+UCHL5+on+proteasome+clearance+of+ubiquitinated+proteins+and+RA190+cytotoxicity&doi=10.1128%2FMCB.00122-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquitinated proteins and RA190 cytotoxicity</span></div><div class="casAuthors">Osei-Amponsa, Vasty; Sridharan, Vinidhra; Tandon, Mayank; Evans, Christine N.; Klarmann, Kimberly; Cheng, Kwong Tai; Lack, Justin; Chari, Raj; Walters, Kylie J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">e00122-20</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HRpn13/ADRM1 links substrate recruitment with deubiquitination at the proteasome through its proteasome- and ubiquitin-binding Pru domain and DEUBAD domain, which binds and activates deubiquitinating enzyme (DUB) UCHL5/Uch37.  Here, we edit the HCT116 colorectal cancer cell line to delete part of the hRpn13 Pru, producing cells that express truncated hRpn13 (trRpn13), which is competent for UCHL5 binding but defective for proteasome interaction. trRpn13 cells demonstrate reduced levels of proteasome-bound ubiquitinated proteins, indicating that the loss of hRpn13 function at proteasomes cannot be fully compensated for by the two other dedicated substrate receptors (hRpn1 and hRpn10).  Previous studies indicated that the loss of full-length hRpn13 causes a corresponding redn. of UCHL5.  We find UCHL5 levels unaltered in trRpn13 cells, but hRpn11 is elevated in ΔhRpn13 and trRpn13 cells, perhaps from cell stress.  Despite the ∼90 DUBs in human cells, including two others in addn. to UCHL5 at the proteasome, we found deletion of UCHL5 from HCT116 cells to cause increased levels of ubiquitinated proteins in whole-cell ext. and at proteasomes, suggesting that UCHL5 activity cannot be fully assumed by other DUBs.  We also report anticancer mol. RA190, which binds covalently to hRpn13 and UCHL5, to require hRpn13 Pru and not UCHL5 for cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSMEdwHoTb9bVg90H21EOLACvtfcHk0lgdQjIydPfo0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFyks7zJ&md5=03295ca7bf229dd637c0822c3a1d9189</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1128%2FMCB.00122-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00122-20%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Amponsa%26aufirst%3DV.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DTandon%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DC.%2BN.%26aulast%3DKlarmann%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DK.%2BT.%26aulast%3DLack%26aufirst%3DJ.%26aulast%3DChari%26aufirst%3DR.%26aulast%3DWalters%26aufirst%3DK.%2BJ.%26atitle%3DImpact%2520of%2520losing%2520hRpn13%2520Pru%2520or%2520UCHL5%2520on%2520proteasome%2520clearance%2520of%2520ubiquitinated%2520proteins%2520and%2520RA190%2520cytotoxicity%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2020%26volume%3D40%26doi%3D10.1128%2FMCB.00122-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brnjic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2271</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1089/ars.2013.5322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1089%2Fars.2013.5322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24011031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKltrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=2271-2285&author=S.+Brnjicauthor=M.+Mazurkiewiczauthor=M.+Fryknasauthor=C.+Sunauthor=X.+Zhangauthor=R.+Larssonauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=Induction+of+tumor+cell+apoptosis+by+a+proteasome+deubiquitinase+inhibitor+is+associated+with+oxidative+stress&doi=10.1089%2Fars.2013.5322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Tumor Cell Apoptosis by a Proteasome Deubiquitinase Inhibitor Is Associated with Oxidative Stress</span></div><div class="casAuthors">Brnjic, Slavica; Mazurkiewicz, Magdalena; Fryknaes, Marten; Sun, Chao; Zhang, Xiaonan; Larsson, Rolf; D'Arcy, Padraig; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2271-2285</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: b-AP15 is a recently described inhibitor of the USP14/UCHL5 deubiquitinases (DUBs) of the 19S proteasome.  Exposure to b-AP15 results in blocking of proteasome function and accumulation of polyubiquitinated protein substrates in cells.  This novel mechanism of proteasome inhibition may potentially be exploited for cancer therapy, in particular for treatment of malignancies resistant to currently used proteasome inhibitors.  The aim of the present study was to characterize the cellular response to b-AP15-mediated proteasome DUB inhibition.  Results: We report that b-AP15 elicits a similar, but yet distinct, cellular response as the clin. used proteasome inhibitor bortezomib. b-AP15 induces a rapid apoptotic response, assocd. with enhanced induction of oxidative stress and rapid activation of Jun-N-terminal kinase 1/2 (JNK)/activating protein-1 signaling.  Scavenging of reactive oxygen species and pharmacol. inhibition of JNK reduced b-AP15-induced apoptosis.  We further report that endoplasmic reticulum (ER) stress is induced by b-AP15 and is involved in apoptosis induction.  In contrast to bortezomib, ER stress is assocd. with induction of α-subunit of eukaryotic initiation factor 2 phosphorylation.  Innovation: The findings establish that different modes of proteasome inhibition result in distinct cellular responses, a finding of potential therapeutic importance.  Conclusion: Our data show that enhanced oxidative stress and ER stress are major determinants of the strong apoptotic response elicited by the 19S DUB inhibitor b-AP15.  Antioxid. Redox Signal. 21, 2271-2285.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGossfQ3ZNXfWrVg90H21EOLACvtfcHk0liXWdouFX7-4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKltrzJ&md5=b66cecc85c4f3b1981ff84d7078bcf5f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1089%2Fars.2013.5322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2013.5322%26sid%3Dliteratum%253Aachs%26aulast%3DBrnjic%26aufirst%3DS.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DFryknas%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInduction%2520of%2520tumor%2520cell%2520apoptosis%2520by%2520a%2520proteasome%2520deubiquitinase%2520inhibitor%2520is%2520associated%2520with%2520oxidative%2520stress%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D21%26spage%3D2271%26epage%3D2285%26doi%3D10.1089%2Fars.2013.5322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of bisbenzylidenedioxotetrahydrothiopranones as activators of endoplasmic reticulum (ER) stress signaling pathways and apoptotic cell death in acute promyelocytic leukemic cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5904</span>– <span class="NLM_lpage">5918</span>, <span class="refDoi"> DOI: 10.1021/jm401352a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401352a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5904-5918&author=K.+L.+Tanauthor=A.+Aliauthor=Y.+Duauthor=H.+Fuauthor=H.+X.+Jinauthor=T.+M.+Chinauthor=M.+Khanauthor=M.+L.+Go&title=Synthesis+and+evaluation+of+bisbenzylidenedioxotetrahydrothiopranones+as+activators+of+endoplasmic+reticulum+%28ER%29+stress+signaling+pathways+and+apoptotic+cell+death+in+acute+promyelocytic+leukemic+cells&doi=10.1021%2Fjm401352a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Bisbenzylidenedioxotetrahydrothiopranones as Activators of Endoplasmic Reticulum (ER) Stress Signaling Pathways and Apoptotic Cell Death in Acute Promyelocytic Leukemic Cells</span></div><div class="casAuthors">Tan, Kheng-Lin; Ali, Azhar; Du, Yuhong; Fu, Hainan; Jin, Hai-Xiao; Chin, Tan-Min; Khan, Matiullah; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5904-5918</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Curcumin is known to trigger ER-stress induced cell death of acute promyelocytic leukemic (APL) cells by intercepting the degrdn. of nuclear co-repressor (N-CoR) protein which has a key role in the pathogenesis of APL.  Replacing the heptadienedione moiety of curcumin with a monocarbonyl cross-conjugated dienone embedded in a tetrahydrothiopyranone dioxide ring resulted in thiopyranone dioxides that were more resilient to hydrolysis and had greater growth inhibitory activities than curcumin on APL cells.  Several members intercepted the degrdn. of misfolded N-CoR and triggered the signaling cascade in the unfolded protein response (UPR) which led to apoptotic cell death.  Microarray anal. showed that genes involved in protein processing pathways that were germane to the activation of the UPR were preferentially up-regulated in treated APL cells, supporting the notion that the UPR was a consequential mechanistic pathway affected by thiopyranone dioxides.  The Michael acceptor reactivity of the scaffold may have a role in exacerbating ER stress in APL cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL70rFGCpFeLVg90H21EOLACvtfcHk0liXWdouFX7-4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentLbP&md5=2dc7244e25775db0258697e3f347b732</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm401352a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401352a%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DK.%2BL.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%2BX.%26aulast%3DChin%26aufirst%3DT.%2BM.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bisbenzylidenedioxotetrahydrothiopranones%2520as%2520activators%2520of%2520endoplasmic%2520reticulum%2520%2528ER%2529%2520stress%2520signaling%2520pathways%2520and%2520apoptotic%2520cell%2520death%2520in%2520acute%2520promyelocytic%2520leukemic%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5904%26epage%3D5918%26doi%3D10.1021%2Fjm401352a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafiei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">3,5-Bis(3-dimethylaminomethyl-4-hydroxybenzylidene)-4-piperidone and related compounds induce glutathione oxidation and mitochondria-mediated cell death in HCT-116 colon cancer cells</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3669</span>– <span class="NLM_lpage">3673</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmcl.2017.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28716495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3669-3673&author=E.+Addalaauthor=H.+Rafieiauthor=S.+Dasauthor=B.+Bandyauthor=U.+Dasauthor=S.+S.+Karkiauthor=J.+R.+Dimmock&title=3%2C5-Bis%283-dimethylaminomethyl-4-hydroxybenzylidene%29-4-piperidone+and+related+compounds+induce+glutathione+oxidation+and+mitochondria-mediated+cell+death+in+HCT-116+colon+cancer+cells&doi=10.1016%2Fj.bmcl.2017.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Bis(3-dimethylaminomethyl-4-hydroxybenzylidene)-4-piperidone and related compounds induce glutathione oxidation and mitochondria-mediated cell death in HCT-116 colon cancer cells</span></div><div class="casAuthors">Addala, Eshwari; Rafiei, Hossein; Das, Swagatika; Bandy, Brian; Das, Umashankar; Karki, Subhas S.; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3669-3673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study aims at investigating the cytotoxicity and some of the modes of action of 3,5-bis(3-dimethylamino-4-hydroxybenzylidene)-4-piperidone trihydrochloride 3 and two related compds. 2 (which lacks the dimethylaminomethyl groups) and 4 (which has an addnl. dimethylaminoethyl substituent in both aryl rings) in order to ascertain the contribution of dimethylaminoethyl substituent to bioactivity.  The bioactivities of 2-4 were compared with curcumin 5.  Both 2 and 3 displayed submicromolar GI50 values towards HCT-116 cells and were significantly more potent than 4, 5 and 5-fluorouracil (5-FU).  All of the compds. displayed greater toxicity towards HCT-116 cells than human CRL-1790 non-malignant colon cells.  In HCT-116 cells, the compds. 2, 3 and 5 increased the ratio of oxidised to reduced glutathione and destabilized the mitochondrial membrane potential.  Both 2 and 5 produced an increase in mitochondrial superoxide and a burst in intracellular reactive oxygen species in HCT 116 cells.  In addn., 2 and 4 stimulated respiration in rat liver mitochondria while 2 and 5 induced mitochondrial swelling.  The results suggest that 2 and 5 cause oxidn. or crosslinking of the thiols which control the mitochondrial permeability transition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpurPa-Lnc4gLVg90H21EOLACvtfcHk0liXWdouFX7-4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrvP&md5=ae2e7638f6e54ac66dbfbf63db89b7c9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DAddala%26aufirst%3DE.%26aulast%3DRafiei%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DBandy%26aufirst%3DB.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DKarki%26aufirst%3DS.%2BS.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3D3%252C5-Bis%25283-dimethylaminomethyl-4-hydroxybenzylidene%2529-4-piperidone%2520and%2520related%2520compounds%2520induce%2520glutathione%2520oxidation%2520and%2520mitochondria-mediated%2520cell%2520death%2520in%2520HCT-116%2520colon%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3669%26epage%3D3673%26doi%3D10.1016%2Fj.bmcl.2017.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehman, M. F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustaqeem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleem, M.</span></span> <span> </span><span class="NLM_article-title">Exploration of noncovalent interactions, chemical reactivity, and nonlinear optical properties of piperidone derivatives: a concise theoretical approach</span>. <i>ACS omega</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13236</span>– <span class="NLM_lpage">13249</span>, <span class="refDoi"> DOI: 10.1021/acsomega.0c01273</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.0c01273" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVSgtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=13236-13249&author=M.+Khalidauthor=A.+Aliauthor=M.+F.+U.+Rehmanauthor=M.+Mustaqeemauthor=S.+Aliauthor=M.+U.+Khanauthor=S.+Asimauthor=N.+Ahmadauthor=M.+Saleem&title=Exploration+of+noncovalent+interactions%2C+chemical+reactivity%2C+and+nonlinear+optical+properties+of+piperidone+derivatives%3A+a+concise+theoretical+approach&doi=10.1021%2Facsomega.0c01273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Noncovalent Interactions, Chemical Reactivity, and Nonlinear Optical Properties of Piperidone Derivatives: A Concise Theoretical Approach</span></div><div class="casAuthors">Khalid, Muhammad; Ali, Akbar; Rehman, Muhammad Fayyaz Ur; Mustaqeem, Muhammad; Ali, Shehbaz; Khan, Muhammad Usman; Asim, Sumreen; Ahmad, Naseeb; Saleem, Muhammad</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13236-13249</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The org. compds. with a π-bond system lead to elec. charge delocalization which enables them to reveal fascinating nonlinear optical properties.  Mono-carbonyl curcuminoids also have an appealing skeleton from the conjugation view point.  Interesting chem. structures of the 3,5-bis(arylidene)-N-benzenesulfonyl-4-piperidone derivs. motivated us to perform d. functional theory (DFT)-based studies.  Therefore, computations using the B3LYP/6-311G(d,p) functional of DFT were executed to explore geometric parameters, HOMO-LUMO energies, and natural bond orbital (NBO) analyses.  Moreover, three different functionals such as HF, B3LYP, and M06 with the 6-311G(d,p) basis set were used to investigate the av. polarizability 〈α〉 and first hyperpolarizability (βtot)-based properties of all compds.  A good concurrence among calcd. and exptl. parameters was obtained through root mean square error calcns.  The mol. stability of piperidone derivs. was examd. using the Hirshfeld surface and NBO analyses.  Natural population anal. was also performed to obtain insights about at. charges.  Calcd. HOMO-LUMO energies showed that charge transfer interactions take place within the mols.  Moreover, global reactivity parameters including electronegativity, chem. hardness, softness, ionization potential, and electrophilicity were calcd. using the HOMO and LUMO energies.  The av. polarizability 〈α〉 and first hyperpolarizability (βtot) values of all compds. were obsd. to be larger in magnitude at the aforesaid functional than the std. compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeiTHPtk4V_7Vg90H21EOLACvtfcHk0lgP2t6vNG2ajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVSgtL7O&md5=97b4e9b58233a0e6b6cb7d1031b3873a</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Facsomega.0c01273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.0c01273%26sid%3Dliteratum%253Aachs%26aulast%3DKhalid%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DRehman%26aufirst%3DM.%2BF.%2BU.%26aulast%3DMustaqeem%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DM.%2BU.%26aulast%3DAsim%26aufirst%3DS.%26aulast%3DAhmad%26aufirst%3DN.%26aulast%3DSaleem%26aufirst%3DM.%26atitle%3DExploration%2520of%2520noncovalent%2520interactions%252C%2520chemical%2520reactivity%252C%2520and%2520nonlinear%2520optical%2520properties%2520of%2520piperidone%2520derivatives%253A%2520a%2520concise%2520theoretical%2520approach%26jtitle%3DACS%2520omega%26date%3D2020%26volume%3D5%26spage%3D13236%26epage%3D13249%26doi%3D10.1021%2Facsomega.0c01273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narlawar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span> <span> </span><span class="NLM_article-title">Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">30754</span>– <span class="NLM_lpage">30765</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.056010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.M109.056010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19740743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlequ7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=30754-30765&author=K.+Bernardauthor=W.+Wangauthor=R.+Narlawarauthor=B.+Schmidtauthor=K.+L.+Kirk&title=Curcumin+cross-links+cystic+fibrosis+transmembrane+conductance+regulator+%28CFTR%29+polypeptides+and+potentiates+CFTR+channel+activity+by+distinct+mechanisms&doi=10.1074%2Fjbc.M109.056010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin Cross-links Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Polypeptides and Potentiates CFTR Channel Activity by Distinct Mechanisms</span></div><div class="casAuthors">Bernard, Karen; Wang, Wei; Narlawar, Rajeshwar; Schmidt, Boris; Kirk, Kevin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">30754-30765</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cystic fibrosis (CF) is caused by loss-of-function mutations in the CFTR chloride channel.  Wild type and mutant CFTR channels can be activated by curcumin, a well tolerated dietary compd. with some appeal as a prospective CF therapeutic.  However, we show here that curcumin has the unexpected effect of crosslinking CFTR polypeptides into SDS-resistant oligomers.  This effect occurred for CFTR channels in microsomes as well as in intact cells and at the same concns. that are effective for promoting CFTR channel activity (5-50 μM).  Both mature CFTR polypeptides at the cell surface and immature CFTR protein in the endoplasmic reticulum were cross-linked by curcumin, although the latter pool was more susceptible to this modification.  Curcumin cross-linked two CF mutant channels (ΔF508 and G551D) as well as a variety of deletion constructs that lack the major cytoplasmic domains.  In vitro crosslinking could be prevented by high concns. of oxidant scavengers (i.e. reduced glutathione and sodium azide) indicating a possible oxidn. reaction with the CFTR polypeptide.  Importantly, cyclic derivs. of curcumin that lack the reactive β diketone moiety had no crosslinking activity.  One of these cyclic derivs. stimulated the activities of wild type CFTR channels, Δ1198-CFTR channels, and G551D-CFTR channels in excised membrane patches.  Like the parent compd., the cyclic deriv. irreversibly activated CFTR channels in excised patches during prolonged exposure (>5 min).  Our results raise a note of caution about secondary biochem. effects of reactive compds. like curcumin in the treatment of CF.  Cyclic curcumin derivs. may have better therapeutic potential in this regard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dPRDUXYDpbVg90H21EOLACvtfcHk0lgP2t6vNG2ajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlequ7vN&md5=fcf4df6b19c9a5ef163c801856dfceb3</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.056010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.056010%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DCurcumin%2520cross-links%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%2520%2528CFTR%2529%2520polypeptides%2520and%2520potentiates%2520CFTR%2520channel%2520activity%2520by%2520distinct%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D30754%26epage%3D30765%26doi%3D10.1074%2Fjbc.M109.056010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuspa, S. H.</span></span> <span> </span><span class="NLM_article-title">The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4950</span>– <span class="NLM_lpage">4956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=7585535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK2MXptFKhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=4950-4956&author=C.+Stanwellauthor=T.+R.+Burkeauthor=S.+H.+Yuspa&title=The+erbstatin+analogue+methyl+2%2C5-dihydroxycinnamate+cross-links+proteins+and+is+cytotoxic+to+normal+and+neoplastic+epithelial+cells+by+a+mechanism+independent+of+tyrosine+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The erbstatin analog methyl 2,5-dihydroxycinnamate crosslinks proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition</span></div><div class="casAuthors">Stanwell, Caroline; Burke, Terrence R., Jr.; Yuspa, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4950-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Differentiation therapy is an attractive option for the treatment of superficial, localized neoplastic lesions of the skin.  Topical application of agents that induce differentiation could selectively inhibit tumor cell growth, inducing a program of cell death with the prodn. of crosslinked protein envelopes as the terminal event of this process at the skin surface, effectively eliminating the neoplastic phenotype.  The nonspecific kinase inhibitor staurosporine induces cornified envelope assembly in neoplastic keratinocytes and causes tumor regression (A. A. Dlugosz and S. H. Yuspa, Cancer Res., 51: 4677-4684, 1991).  In pursuit of less toxic agents, specific tyrosine kinase inhibitors were tested for the ability to induce differentiation in keratinocyte-derived cells.  Of a range of inhibitors tested, only Me 2,5-dihydroxycinnamate (MC) was able to induce crosslinked protein and consequent cell death in mouse and human primary normal keratinocytes, 308 neoplastic mouse keratinocytes, HPV-18-infected immortalized human keratinocytes, and human lines SQCC-Y1 (squamous carcinoma) and A431 (epidermoid carcinoma).  MC increased crosslinked protein in a dose-dependent manner (0.05-1 mM).  To confirm differentiation, MC-treated mouse primary normal keratinocytes were tested for activation of the endogenous crosslinking enzyme transglutaminase, but no assocn. was found between transglutaminase activity and MC-induced protein crosslinking.  MC also induced protein crosslinking in the fibroblast cell line NIH3T3 and in B16 melanoma cells, in which cornified envelope assembly is not part of the differentiation process.  This crosslinking occurred at 4°, suggesting a nonphysiol. process.  Western blot anal. of an in vitro assay with purified EGF receptor showed that MC was able to crosslink the receptor.  As in NIH3T3 cells, DTT inhibited crosslinking, suggesting that oxidn. of MC or an acceptor group may be required for this effect.  Thus, MC does not induce differentiation by a physiol. mechanism in epithelial cells but causes chem. protein crosslinking into cornified envelope-like structures at high concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2GZcAqbBSeLVg90H21EOLACvtfcHk0lgP2t6vNG2ajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptFKhsrs%253D&md5=7a82b2377da1147615d2cd51f9a75bf2</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanwell%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DYuspa%26aufirst%3DS.%2BH.%26atitle%3DThe%2520erbstatin%2520analogue%2520methyl%25202%252C5-dihydroxycinnamate%2520cross-links%2520proteins%2520and%2520is%2520cytotoxic%2520to%2520normal%2520and%2520neoplastic%2520epithelial%2520cells%2520by%2520a%2520mechanism%2520independent%2520of%2520tyrosine%2520kinase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D4950%26epage%3D4956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuspa, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Cell protein cross-linking by erbstatin and related compounds</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(96)00250-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2F0006-2952%2896%2900250-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=8687502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1Ogurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=475-480&author=C.+Stanwellauthor=B.+Yeauthor=S.+H.+Yuspaauthor=T.+R.+Burke&title=Cell+protein+cross-linking+by+erbstatin+and+related+compounds&doi=10.1016%2F0006-2952%2896%2900250-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Cell protein crosslinking by erbstatin and related compounds</span></div><div class="casAuthors">Stanwell, Caroline; Ye, Bin; Yuspa, Stuart H.; Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-480</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The protein-tyrosine kinase inhibitor and stable erbstatin analog Me 2,5-dihydroxycinnamate (4) cross-links cell proteins by a non-physiol. chem. mechanism (Stanwell et al., Cancer Res 55: 4950-4956, 1995).  To det. the structural requirements for this effect, erbstatin and fifteen related compds., including caffeic acid phenylethyl ester were synthesized and examd. for their ability to induce crosslinking of cellular protein at concns. ranging from low micromolar up to 1000 μM.  Tests were conducted in NIH3T3 fibroblasts as well as mouse keratinocytes.  Potent crosslinking of cellular protein was obsd. for a no. of analogs, including erbstatin, at concns. as low as 10-50 μM.  The inactivity of methoxy and fluoro as compared with their corresponding dihydroxylated counterparts indicated that free arom. hydroxyls were essential for crosslinking.  Addnl., compds. contg. Ph rings with 1,4-dihydroxy substituents were more potent than those having 1,2-dihydroxylated patterns.  As with the prototype compd. 4, crosslinking was induced at both 37° and 4°, suggesting a chem. rather than physiol. mechanism.  Consistent with the data, a mechanism of action is proposed which involves initial oxidn. to reactive quinone intermediates that subsequently cross-link protein nucleophiles via multiple 1,4-Michael-type addns.  Similar alkylation of protein by protein-tyrosine kinase inhibitors, such as herbimycin A, has been invoked.  While the latter benzoquinoid ansamycin antibiotics contain preformed quinone moieties, results of the present study suggest that other hydroxylated kinase inhibitors can potentially participate in similar phenomena.  A large no. of potential therapeutics, including HIV integrase inhibitors, possess polyhydroxylated nuclei.  The non-specific nature of the protein crosslinking reaction demonstrated for these erbstatin analogs, and the fact that crosslinking can occur at micromolar concns., may limit the therapeutic usefulness of such compds. to specific applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqalvwfi9wR37Vg90H21EOLACvtfcHk0lh8sCw71darbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1Ogurc%253D&md5=870f60adfebc883cffbab6f911019b64</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2896%2900250-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252896%252900250-X%26sid%3Dliteratum%253Aachs%26aulast%3DStanwell%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DYuspa%26aufirst%3DS.%2BH.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DCell%2520protein%2520cross-linking%2520by%2520erbstatin%2520and%2520related%2520compounds%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D52%26spage%3D475%26epage%3D480%26doi%3D10.1016%2F0006-2952%2896%2900250-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mace, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bony, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boidot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draoui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobysheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martherus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deraedt, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schicke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvaux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriegsheim, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quetin-Leclercq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riant, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, O.</span></span> <span> </span><span class="NLM_article-title">A new ER-specific photosensitizer unravels O-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">3976</span>– <span class="NLM_lpage">3985</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fonc.2015.474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26686091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGnsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=3976-3985&author=A.+Pintoauthor=Y.+Maceauthor=F.+Drouetauthor=E.+Bonyauthor=R.+Boidotauthor=N.+Draouiauthor=I.+Lobyshevaauthor=C.+Corbetauthor=F.+Poletauthor=R.+Martherusauthor=Q.+Deraedtauthor=J.+Rodriguezauthor=C.+Lamyauthor=O.+Schickeauthor=D.+Delvauxauthor=C.+Louisauthor=R.+Kissauthor=A.+V.+Kriegsheimauthor=C.+Dessyauthor=B.+Eliasauthor=J.+Quetin-Leclercqauthor=O.+Riantauthor=O.+Feron&title=A+new+ER-specific+photosensitizer+unravels+O-driven+protein+oxidation+and+inhibition+of+deubiquitinases+as+a+generic+mechanism+for+cancer+PDT&doi=10.1038%2Fonc.2015.474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT</span></div><div class="casAuthors">Pinto, A.; Mace, Y.; Drouet, F.; Bony, E.; Boidot, R.; Draoui, N.; Lobysheva, I.; Corbet, C.; Polet, F.; Martherus, R.; Deraedt, Q.; Rodriguez, J.; Lamy, C.; Schicke, O.; Delvaux, D.; Louis, C.; Kiss, R.; Kriegsheim, A. V.; Dessy, C.; Elias, B.; Quetin-Leclercq, J.; Riant, O.; Feron, O.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3976-3985</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Photosensitizers (PS) are ideally devoid of any activity in the absence of photoactivation, and rely on mol. oxygen for the formation of singlet oxygen (1O2) to produce cellular damage.  Off-targets and tumor hypoxia therefore represent obstacles for the use of PS for cancer photodynamic therapy.  Herein, we describe the characterization of OR141, a benzophenazine compd. identified through a phenotypic screening for its capacity to be strictly activated by light and to kill a large variety of tumor cells under both normoxia and hypoxia.  This new class of PS unraveled an unsuspected common mechanism of action for PS that involves the combined inhibition of the mammalian target of rapamycin (mTOR) signaling pathway and proteasomal deubiquitinases (DUBs) USP14 and UCH37.  Oxidn. of mTOR and other endoplasmic reticulum (ER)-assocd. proteins drives the early formation of high mol. wt. (MW) complexes of multimeric proteins, the concomitant blockade of DUBs preventing their degrdn. and pptg. cell death.  Furthermore, we validated the antitumor effects of OR141 in vivo and documented its highly selective accumulation in the ER, further increasing the ER stress resulting from 1O2 generation upon light activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNwQORDD1qDrVg90H21EOLACvtfcHk0lh8sCw71darbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGnsr7O&md5=fbb8efe6d7a70c798cd48e7629b09456</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.474%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DMace%26aufirst%3DY.%26aulast%3DDrouet%26aufirst%3DF.%26aulast%3DBony%26aufirst%3DE.%26aulast%3DBoidot%26aufirst%3DR.%26aulast%3DDraoui%26aufirst%3DN.%26aulast%3DLobysheva%26aufirst%3DI.%26aulast%3DCorbet%26aufirst%3DC.%26aulast%3DPolet%26aufirst%3DF.%26aulast%3DMartherus%26aufirst%3DR.%26aulast%3DDeraedt%26aufirst%3DQ.%26aulast%3DRodriguez%26aufirst%3DJ.%26aulast%3DLamy%26aufirst%3DC.%26aulast%3DSchicke%26aufirst%3DO.%26aulast%3DDelvaux%26aufirst%3DD.%26aulast%3DLouis%26aufirst%3DC.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKriegsheim%26aufirst%3DA.%2BV.%26aulast%3DDessy%26aufirst%3DC.%26aulast%3DElias%26aufirst%3DB.%26aulast%3DQuetin-Leclercq%26aufirst%3DJ.%26aulast%3DRiant%26aufirst%3DO.%26aulast%3DFeron%26aufirst%3DO.%26atitle%3DA%2520new%2520ER-specific%2520photosensitizer%2520unravels%2520O-driven%2520protein%2520oxidation%2520and%2520inhibition%2520of%2520deubiquitinases%2520as%2520a%2520generic%2520mechanism%2520for%2520cancer%2520PDT%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D3976%26epage%3D3985%26doi%3D10.1038%2Fonc.2015.474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">18050</span>– <span class="NLM_lpage">18064</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.7633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26919110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC28jks1Krug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=18050-18064&author=P.+Zouauthor=Y.+Xiaauthor=W.+Chenauthor=X.+Chenauthor=S.+Yingauthor=Z.+Fengauthor=T.+Chenauthor=Q.+Yeauthor=Z.+Wangauthor=C.+Qiuauthor=S.+Yangauthor=G.+Liang&title=EF24+induces+ROS-mediated+apoptosis+via+targeting+thioredoxin+reductase+1+in+gastric+cancer+cells&doi=10.18632%2Foncotarget.7633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells</span></div><div class="casAuthors">Zou Peng; Yang Shulin; Zou Peng; Chen Weiqian; Chen Xi; Ying Shilong; Feng Zhiguo; Chen Tongke; Ye Qingqing; Wang Zhe; Qiu Chenyu; Liang Guang; Xia Yiqun</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">18050-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gastric cancer (GC) is one of the leading causes of cancer mortality in the world, and finding novel agents for the treatment of advanced gastric cancer is of urgent need.  Diphenyl difluoroketone (EF24), a molecule having structural similarity to curcumin, exhibits potent anti-tumor activities by arresting cell cycle and inducing apoptosis.  Although EF24 demonstrates potent anticancer efficacy in numerous types of human cancer cells, the cellular targets of EF24 have not been fully dei(logical not)ned.  We report here that EF24 may interact with the thioredoxin reductase 1 (TrxR1), an important selenocysteine (Sec)-containing antioxidant enzyme, to induce reactive oxygen species (ROS)-mediated apoptosis in human gastric cancer cells.  By inhibiting TrxR1 activity and increasing intracellular ROS levels, EF24 induces a lethal endoplasmic reticulum stress in human gastric cancer cells.  Importantly, knockdown of TrxR1 sensitizes cells to EF24 treatment.  In vivo, EF24 treatment markedly reduces the TrxR1 activity and tumor cell burden, and displays synergistic lethality with 5-FU against gastric cancer cells.  Targeting TrxR1 with EF24 thus discloses a previously unrecognized mechanism underlying the biological activity of EF24, and reveals that TrxR1 is a good target for gastric cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB4hk6rM5szxBrI9DTGjC0fW6udTcc2eZ6bj-Blr0Ed7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jks1Krug%253D%253D&md5=98d603d2001ba782c1d2b695c17d51f9</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7633%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DP.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYing%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DEF24%2520induces%2520ROS-mediated%2520apoptosis%2520via%2520targeting%2520thioredoxin%2520reductase%25201%2520in%2520gastric%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D18050%26epage%3D18064%26doi%3D10.18632%2Foncotarget.7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skoupa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzickova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlejnek, P.</span></span> <span> </span><span class="NLM_article-title">Apoptosis induced by the curcumin analogue EF-24 is neither mediated by oxidative stress-related mechanisms nor affected by expression of main drug transporters ABCB1 and ABCG2 in human leukemia cells</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2289</span>, <span class="refDoi"> DOI: 10.3390/ijms18112289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3390%2Fijms18112289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOgurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2289&author=N.+Skoupaauthor=P.+Dolezelauthor=E.+Ruzickovaauthor=P.+Mlejnek&title=Apoptosis+induced+by+the+curcumin+analogue+EF-24+is+neither+mediated+by+oxidative+stress-related+mechanisms+nor+affected+by+expression+of+main+drug+transporters+ABCB1+and+ABCG2+in+human+leukemia+cells&doi=10.3390%2Fijms18112289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis induced by the curcumin analogue EF-24 is neither mediated by oxidative stress-related mechanisms nor affected by expression of main drug transporters ABCB1 and ABCG2 in human leukemia cells</span></div><div class="casAuthors">Skoupa, Nikola; Dolezel, Petr; Ruzickova, Eliska; Mlejnek, Petr</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2289/1-2289/18</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The synthetic curcumin analog, 3,5-bis[(2-fluorophenyl)methylene]-4-piperidinone (EF-24), suppresses NF-κB activity and exhibits antiproliferative effects against a variety of cancer cells in vitro.  Recently, it was reported that EF-24-induced apoptosis was mediated by a redox-dependent mechanism.  Here, we studied the effects of N-acetylcysteine (NAC) on EF-24-induced cell death.  We also addressed the question of whether the main drug transporters, ABCB1 and ABCG2, affect the cytotoxic of EF-24.  We obsd. that EF-24 induced cell death with apoptotic hallmarks in human leukemia K562 cells.  Importantly, the loss of cell viability was preceded by prodn. of reactive oxygen species (ROS), and by a decrease of reduced glutathione (GSH).  However, neither ROS prodn. nor the decrease in GSH predominantly contributed to the EF-24-induced cell death.  We found that EF-24 formed an adduct with GSH, which is likely the mechanism contributing to the decrease of GSH.  Although NAC abrogated ROS prodn., decreased GSH and prevented cell death, its protective effect was mainly due to a rapid conversion of intra- and extra-cellular EF-24 into the EF-24-NAC adduct without cytotoxic effects.  Furthermore, we found that neither overexpression of ABCB1 nor ABCG2 reduced the antiproliferative effects of EF-24.  In conclusion, a redox-dependent-mediated mechanism only marginally contributes to the EF-24-induced apoptosis in K562 cells.  The main mechanism of NAC protection against EF-24-induced apoptosis is conversion of cytotoxic EF-24 into the noncytotoxic EF-24-NAC adduct.  Neither ABCB1 nor ABCG2 mediated resistance to EF-24.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-qKzLF0ko57Vg90H21EOLACvtfcHk0lh6QRIyeIALkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOgurbF&md5=1917a4a73abca627fbcaa6b395d87474</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3390%2Fijms18112289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18112289%26sid%3Dliteratum%253Aachs%26aulast%3DSkoupa%26aufirst%3DN.%26aulast%3DDolezel%26aufirst%3DP.%26aulast%3DRuzickova%26aufirst%3DE.%26aulast%3DMlejnek%26aufirst%3DP.%26atitle%3DApoptosis%2520induced%2520by%2520the%2520curcumin%2520analogue%2520EF-24%2520is%2520neither%2520mediated%2520by%2520oxidative%2520stress-related%2520mechanisms%2520nor%2520affected%2520by%2520expression%2520of%2520main%2520drug%2520transporters%2520ABCB1%2520and%2520ABCG2%2520in%2520human%2520leukemia%2520cells%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D2289%26doi%3D10.3390%2Fijms18112289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rundlof, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S.</span></span> <span> </span><span class="NLM_article-title">Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1089/152308604771978336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1089%2F152308604771978336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=14980055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FptVGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=41-52&author=A.+K.+Rundlofauthor=E.+S.+Arner&title=Regulation+of+the+mammalian+selenoprotein+thioredoxin+reductase+1+in+relation+to+cellular+phenotype%2C+growth%2C+and+signaling+events&doi=10.1089%2F152308604771978336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events</span></div><div class="casAuthors">Rundlof Anna-Klara; Arner Elias S J</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-52</span>
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are generated as toxic by-products of aerobic metabolism, but are also essential biomolecules in cell signaling.  The thioredoxin (Trx) system is a major enzymatic system modulating ROS levels and is important for redox regulation of cellular function.  It consists of Trx and thioredoxin reductase (TrxR), which reduces Trx using NADPH.  Most, if not all, of the functions of Trx depend on the activity of TrxR.  Mammalian TrxR enzymes are selenoproteins with broad substrate specificities, and alteration of cytosolic TrxR1 expression and activity is likely to be an important determinant for the control of cellular redox regulation.  TrxR1 activity in cells seems to be modulated by an intricate interplay, involving a housekeeping type promoter in combination with alternative splice variants and transcriptional start sites, posttranscriptional regulation through AU-rich elements, inactivation by electrophilic agents and by itself modulating the effects of several key signaling molecules.  TrxR1 activity is also intimately linked with several aspects of selenium metabolism, and hence selenoprotein function in general.  Here, we summarize the current knowledge of these different levels of TrxR1 regulation in diverse cell types and in response to growth and signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGPTOqFKV0pyCEBeYuoi7AfW6udTcc2eaBq17VZd5tcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FptVGnsw%253D%253D&md5=56df701d5a86ad1c74df9423afd2ee86</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1089%2F152308604771978336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F152308604771978336%26sid%3Dliteratum%253Aachs%26aulast%3DRundlof%26aufirst%3DA.%2BK.%26aulast%3DArner%26aufirst%3DE.%2BS.%26atitle%3DRegulation%2520of%2520the%2520mammalian%2520selenoprotein%2520thioredoxin%2520reductase%25201%2520in%2520relation%2520to%2520cellular%2520phenotype%252C%2520growth%252C%2520and%2520signaling%2520events%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2004%26volume%3D6%26spage%3D41%26epage%3D52%26doi%3D10.1089%2F152308604771978336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress induced by the deubiquitinase Inhibitor b-AP15 is associated with mitochondrial impairment</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">1659468</span>, <span class="refDoi"> DOI: 10.1155/2019/1659468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1155%2F2019%2F1659468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31281566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MzkvFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=1659468&author=X.+Zhangauthor=B.+Espinosaauthor=A.+A.+Saeiauthor=P.+D%E2%80%99Arcyauthor=R.+A.+Zubarevauthor=S.+Linder&title=Oxidative+stress+induced+by+the+deubiquitinase+Inhibitor+b-AP15+is+associated+with+mitochondrial+impairment&doi=10.1155%2F2019%2F1659468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment</span></div><div class="casAuthors">Zhang Xiaonan; Linder Stig; Espinosa Belen; Saei Amir Ata; Zubarev Roman A; D'Arcy Padraig; Linder Stig</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1659468</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibitors of the 20S proteasome such as bortezomib are cytotoxic to tumor cells and have been proven to be valuable for the clinical management of multiple myeloma.  The therapeutic efficacy of bortezomib is, however, hampered by the emergence of acquired resistance.  Available data suggest that blocking proteasome activity at the level of proteasome-associated deubiquitinases (DUBs) provides a mechanism to overcome resistance to bortezomib and also to other cancer therapies.  The small molecule b-AP15 is an inhibitor of proteasome-associated DUB activity that induces both proteotoxic stress and increases in the levels of reactive oxygen species (ROS) in tumor cells.  Antioxidants have been shown to decrease apoptosis induction by b-AP15 and we here addressed the question of the mechanism of redox perturbation by this compound.  We show that oxidative stress induction by b-AP15 is abrogated in cells deprived of mitochondrial DNA (ρ(0) cells).  We also show associations between the level of proteotoxic stress, the degree of mitochondrial dysfunction, and the extent of induction of hemeoxygenase-1 (HO-1), a target of the redox-regulated Nrf-2 transcription factor.  Decreased expression of COX5b (cytochrome c oxidase subunit 5b) and TOMM34 (translocase of outer mitochondrial membrane 34) was observed in b-AP15-treated cells.  These findings suggest a mitochondrial origin of the increased levels of ROS observed in cells exposed to the DUB inhibitor b-AP15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2QtG6nKnyx8ULxIEhxUjPfW6udTcc2eaBq17VZd5tcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzkvFKlsg%253D%253D&md5=9ea850d717dca2979aada651565b8da3</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1155%2F2019%2F1659468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F1659468%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DEspinosa%26aufirst%3DB.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DOxidative%2520stress%2520induced%2520by%2520the%2520deubiquitinase%2520Inhibitor%2520b-AP15%2520is%2520associated%2520with%2520mitochondrial%2520impairment%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2019%26volume%3D2019%26spage%3D1659468%26doi%3D10.1155%2F2019%2F1659468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConkey, D. J.</span></span> <span> </span><span class="NLM_article-title">The integrated stress response and proteotoxicity in cancer therapy</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>482</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.11.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bbrc.2016.11.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28212730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislOls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2017&pages=450-453&author=D.+J.+McConkey&title=The+integrated+stress+response+and+proteotoxicity+in+cancer+therapy&doi=10.1016%2Fj.bbrc.2016.11.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The integrated stress response and proteotoxicity in cancer therapy</span></div><div class="casAuthors">McConkey, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-453</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A variety of different forms of cellular stress can cause protein misfolding and aggregation and proteotoxicity.  The cytoprotective response to proteotoxicity is termed the integrated stress response and involves 4 distinct serine/threonine protein kinases that converge on the translation initiation factor eIF2α, resulting in phosphorylation at S51, cell cycle arrest, and a general inhibition of global protein synthesis.  Phosphorylation of eIF2α also promotes translation of ATF4 and the expression of ATF4 target genes that ameliorate proteotoxic stress but can also promote apoptosis.  This mini review provides a general overview of these mechanisms and discusses how the inter-tumor heterogeneity that involves them affects sensitivity and resistance to proteasome inhibitors, a new class of cancer therapeutics that promotes tumor cell killing via proteotoxic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY5ozOt66h4LVg90H21EOLACvtfcHk0lhPcmTEtVIC4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislOls7c%253D&md5=a431bf879aee79b0a557c91fcd301990</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.11.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.11.047%26sid%3Dliteratum%253Aachs%26aulast%3DMcConkey%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520integrated%2520stress%2520response%2520and%2520proteotoxicity%2520in%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D482%26spage%3D450%26epage%3D453%26doi%3D10.1016%2Fj.bbrc.2016.11.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheaff, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitherman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clurman, B. E.</span></span> <span> </span><span class="NLM_article-title">Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80435-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2FS1097-2765%2800%2980435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10882081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslyhtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=403-410&author=R.+J.+Sheaffauthor=J.+D.+Singerauthor=J.+Swangerauthor=M.+Smithermanauthor=J.+M.+Robertsauthor=B.+E.+Clurman&title=Proteasomal+turnover+of+p21Cip1+does+not+require+p21Cip1+ubiquitination&doi=10.1016%2FS1097-2765%2800%2980435-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination</span></div><div class="casAuthors">Sheaff, Robert J.; Singer, Jeffrey D.; Swanger, Jherek; Smitherman, Matthew; Roberts, James M.; Clurman, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-410</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Cdk inhibitor p21Cip1 is an unstable protein.  Pharmacol. inhibition of the proteasome increases the half-life of p21 from less than 30 min to more than 2 h and results in the accumulation of p21-ubiquitin conjugates.  To det. whether ubiquitination was required for proteasomal degrdn. of p21, we constructed mutant versions of p21 that were not ubiquitinated in vivo.  Remarkably, these mutants remained unstable and increased in abundance upon proteasome inhibition, indicating that direct ubiquitination of p21 is not necessary for its turnover by the proteasome.  The frequently obsd. correlation between protein ubiquitination and proteasomal degrdn. is insufficient to conclude that ubiquitination is a prerequisite for degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-UG8R_ulhbVg90H21EOLACvtfcHk0lhPcmTEtVIC4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslyhtb0%253D&md5=7febf859b6a71afe9488bbbcb12be8e2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980435-9%26sid%3Dliteratum%253Aachs%26aulast%3DSheaff%26aufirst%3DR.%2BJ.%26aulast%3DSinger%26aufirst%3DJ.%2BD.%26aulast%3DSwanger%26aufirst%3DJ.%26aulast%3DSmitherman%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DClurman%26aufirst%3DB.%2BE.%26atitle%3DProteasomal%2520turnover%2520of%2520p21Cip1%2520does%2520not%2520require%2520p21Cip1%2520ubiquitination%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D5%26spage%3D403%26epage%3D410%26doi%3D10.1016%2FS1097-2765%2800%2980435-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldeeb, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahlman, R. P.</span></span> <span> </span><span class="NLM_article-title">The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2714</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.1931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24798867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2cjgtVyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2714-2722&author=M.+A.+Eldeebauthor=R.+P.+Fahlman&title=The+anti-apoptotic+form+of+tyrosine+kinase+Lyn+that+is+generated+by+proteolysis+is+degraded+by+the+N-end+rule+pathway&doi=10.18632%2Foncotarget.1931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathway</span></div><div class="casAuthors">Eldeeb Mohamed A; Fahlman Richard P</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2714-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activation of apoptotic pathways results in the caspase cleavage of the Lyn tyrosine kinase to generate the N-terminal truncated LynΔN.  This LynΔN fragment has been demonstrated to exert negative feedback on imatinib induced apoptosis in chronic myelogenous leukemia (CML) K562 cells.  Our investigations focus on LynΔN stability and how reduced stability reduces imatinib resistance.  As the proteolytical generated LynΔN has a leucine as an N-terminal amino acid, we hypothesized that LynΔN would be degraded by the N-end rule pathway.  We demonstrated that LynΔN is unstable and that its stability is dependent on the identity of its N-terminus.  Additionally we established that LynΔN degradation could be inhibited by inhibiting either the proteasome or knocking down the UBR1 and UBR2 ubiquitin E3 ligases.  Importantly, we also demonstrate that LynΔN degradation by the N-end rule counters the imatinib resistance of K562 cells provided by LynΔN expression.  Together our data suggest a possible mechanism for the N-end rule pathway having a link to imatinib resistance in CML.  With LynΔN being an N-end rule substrate, it provides the first example that this pathway can also provide a pro-apoptotic function as previous reports have currently only demonstrated anti-apoptotic roles for the N-end rule pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuCHvDMYE2QxKDYG3bNImrfW6udTcc2eb-0RConYyd4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjgtVyksw%253D%253D&md5=f6b2fcb56e0cf4d9637a2b47daca1701</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1931%26sid%3Dliteratum%253Aachs%26aulast%3DEldeeb%26aufirst%3DM.%2BA.%26aulast%3DFahlman%26aufirst%3DR.%2BP.%26atitle%3DThe%2520anti-apoptotic%2520form%2520of%2520tyrosine%2520kinase%2520Lyn%2520that%2520is%2520generated%2520by%2520proteolysis%2520is%2520degraded%2520by%2520the%2520N-end%2520rule%2520pathway%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D2714%26epage%3D2722%26doi%3D10.18632%2Foncotarget.1931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Pianzola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierra, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Pomar, R.</span></span> <span> </span><span class="NLM_article-title">Internal ribosome entry site drives cap-independent translation of reaper and heat shock protein 70 mRNAs in Drosophila embryos</span>. <i>RNA</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1797</span>, <span class="refDoi"> DOI: 10.1261/rna.7154104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1261%2Frna.7154104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15496524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1783-1797&author=G.+Hernandezauthor=P.+Vazquez-Pianzolaauthor=J.+M.+Sierraauthor=R.+Rivera-Pomar&title=Internal+ribosome+entry+site+drives+cap-independent+translation+of+reaper+and+heat+shock+protein+70+mRNAs+in+Drosophila+embryos&doi=10.1261%2Frna.7154104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Internal ribosome entry site drives cap-independent translation of reaper and heat shock protein 70 mRNAs in Drosophila embryos</span></div><div class="casAuthors">Hernandez, Greco; Vazquez-Pianzola, Paula; Sierra, Jose M.; Rivera-Pomar, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">RNA</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1783-1797</span>CODEN:
                <span class="NLM_cas:coden">RNARFU</span>;
        ISSN:<span class="NLM_cas:issn">1355-8382</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Translation is a sensitive regulatory step during cellular stress and the apoptosis response.  Under such conditions, cap-dependent translation is reduced and internal ribosome entry site (IRES)-dependent translation plays a major role.  However, many aspects of how mRNAs are translated under stress remain to be elucidated.  Here we report that reaper mRNA, a pro-apoptotic gene from Drosophila melanogaster, is translated in a cap-independent manner.  In Drosophila mutant embryos devoid of the eukaryotic initiation factor 4E (eIF4E), reaper transcription is induced and apoptosis proceeds.  In vitro translation expts. using wild-type and eIF4E mutant embryonic exts. show that reporter mRNA bearing reaper 5' untranslated region (UTR) is effectively translated in a cap-independent manner.  The 5'UTR of reaper exhibits a high degree of similarity with that of Drosophila heat shock protein 70 mRNA, and both display IRES activity.  Studies of mRNA assocn. to polysomes in embryos indicate that both reaper and heat shock protein 70 mRNAs are recruited to polysomes under apoptosis or thermal stress.  Our data suggest that heat shock protein 70 and reaper, two antagonizing factors in apoptosis, use a similar mechanism for protein synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD460bVM8BDbVg90H21EOLACvtfcHk0lhPcmTEtVIC4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOksb4%253D&md5=2e03fa37ee026975f001d15eac90bf81</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1261%2Frna.7154104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1261%252Frna.7154104%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DG.%26aulast%3DVazquez-Pianzola%26aufirst%3DP.%26aulast%3DSierra%26aufirst%3DJ.%2BM.%26aulast%3DRivera-Pomar%26aufirst%3DR.%26atitle%3DInternal%2520ribosome%2520entry%2520site%2520drives%2520cap-independent%2520translation%2520of%2520reaper%2520and%2520heat%2520shock%2520protein%252070%2520mRNAs%2520in%2520Drosophila%2520embryos%26jtitle%3DRNA%26date%3D2004%26volume%3D10%26spage%3D1783%26epage%3D1797%26doi%3D10.1261%2Frna.7154104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faustini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mofers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ternerot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span> <span> </span><span class="NLM_article-title">Induction of ER stress in acute lymphoblastic leukemia cells by the deubiquitinase inhibitor VLX1570</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4757</span>, <span class="refDoi"> DOI: 10.3390/ijms21134757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3390%2Fijms21134757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvF2gsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=4757&author=P.+Pellegriniauthor=K.+Selvarajuauthor=E.+Faustiniauthor=A.+Mofersauthor=X.+Zhangauthor=J.+Ternerotauthor=A.+Schubertauthor=S.+Linderauthor=P.+D%E2%80%99Arcy&title=Induction+of+ER+stress+in+acute+lymphoblastic+leukemia+cells+by+the+deubiquitinase+inhibitor+VLX1570&doi=10.3390%2Fijms21134757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of ER stress in acute lymphoblastic leukemia cells by the deubiquitinase inhibitor VLX1570</span></div><div class="casAuthors">Pellegrini, Paola; Selvaraju, Karthik; Faustini, Elena; Mofers, Arjan; Zhang, Xiaonan; Ternerot, Jens; Schubert, Alice; Linder, Stig; D'Arcy, Padraig</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4757</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The proteasome is a validated target of cancer therapeutics.  Defects in the UPR response has been reported to result in altered sensitivity of tumor cells to proteasome inhibitors.  Here, we characterized the effects of the deubiquitinase (DUB) inhibitor VLX1570 on protein homeostasis, both at the level of the UPR and on protein translation, in acute lymphoblastic leukemia (ALL).  Similar to the 20S inhibitor bortezomib, VLX1570 induced accumulation of polyubiquitinated proteins and increased expression of the chaperone Grp78/Bip in ALL cells.  Both compds. induced cleavage of PARP (Poly (ADP-ribose) polymerase) in ALL cells, consistent with induction of apoptosis.  However, and in contrast to bortezomib, VLX1570 treatment resulted in limited induction of the proapoptotic CHOP protein.  Translational inhibition was obsd. by both bortezomib and VLX1570.  We report that in distinction to bortezomib, suppression of translation by VXL1570 occurred at the level of elongation.  Increased levels of Hsc70/Hsp70 proteins were obsd. on polysomes following exposure to VLX1570, possibly suggesting defects in nascent protein folding.  Our findings demonstrate apoptosis induction in ALL cells that appears to be uncoupled from CHOP induction, and show that VLX1570 suppresses protein translation by a mechanism distinct from that of bortezomib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVZghJ89hltLVg90H21EOLACvtfcHk0liKR8TR63K5FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvF2gsLrM&md5=d4fdc0c9159cc67138e679ec5971e358</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.3390%2Fijms21134757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21134757%26sid%3Dliteratum%253Aachs%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DFaustini%26aufirst%3DE.%26aulast%3DMofers%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTernerot%26aufirst%3DJ.%26aulast%3DSchubert%26aufirst%3DA.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26atitle%3DInduction%2520of%2520ER%2520stress%2520in%2520acute%2520lymphoblastic%2520leukemia%2520cells%2520by%2520the%2520deubiquitinase%2520inhibitor%2520VLX1570%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D4757%26doi%3D10.3390%2Fijms21134757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baccarani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masszi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digumarti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benichou, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akard, L.</span></span> <span> </span><span class="NLM_article-title">Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.3109/10428194.2014.889826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3109%2F10428194.2014.889826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24650054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Cnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=120-127&author=H.+J.+Khouryauthor=J.+Cortesauthor=M.+Baccaraniauthor=M.+Wetzlerauthor=T.+Massziauthor=R.+Digumartiauthor=A.+Craigauthor=A.+C.+Benichouauthor=L.+Akard&title=Omacetaxine+mepesuccinate+in+patients+with+advanced+chronic+myeloid+leukemia+with+resistance+or+intolerance+to+tyrosine+kinase+inhibitors&doi=10.3109%2F10428194.2014.889826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors</span></div><div class="casAuthors">Khoury, H. Jean; Cortes, Jorge; Baccarani, Michele; Wetzler, Meir; Masszi, Tamas; Digumarti, Raghunadharao; Craig, Adam; Benichou, Annie-Claude; Akard, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-127</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Omacetaxine mepesuccinate promotes apoptosis by inhibiting the prodn. of short-lived oncoproteins.  The efficacy and safety of omacetaxine in patients with advanced chronic myeloid leukemia (CML) previously treated with tyrosine kinase inhibitors were assessed in two phase II trials (CML-202 and CML-203).  Fifty-one patients in accelerated phase (AP-CML) and 44 in myeloid blast phase (BP-CML) received s.c. omacetaxine 1.25 mg/m2 twice daily days 1-14 every 28 days until hematol. response/improvement or any cytogenetic response, then days 1-7 every 28 days until disease progression.  The primary endpoint was maintenance or attainment of a major hematol. response (MHR).  Cytogenetic responses were also evaluated.  MHR was 37% in patients with AP-CML and 9% with BP-CML (22% and 5% in those with a history of T315I).  Most grade 3/4 adverse events were related to myelosuppression, and were generally manageable.  Omacetaxine demonstrates activity and an acceptable safety profile in pretreated patients with advanced CML, irresp. of mutational status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDKeSVnLwULbVg90H21EOLACvtfcHk0liKR8TR63K5FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Cnu78%253D&md5=1eb6327e31fec17474705e16e3a166ec</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.3109%2F10428194.2014.889826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2014.889826%26sid%3Dliteratum%253Aachs%26aulast%3DKhoury%26aufirst%3DH.%2BJ.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DBaccarani%26aufirst%3DM.%26aulast%3DWetzler%26aufirst%3DM.%26aulast%3DMasszi%26aufirst%3DT.%26aulast%3DDigumarti%26aufirst%3DR.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DBenichou%26aufirst%3DA.%2BC.%26aulast%3DAkard%26aufirst%3DL.%26atitle%3DOmacetaxine%2520mepesuccinate%2520in%2520patients%2520with%2520advanced%2520chronic%2520myeloid%2520leukemia%2520with%2520resistance%2520or%2520intolerance%2520to%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2015%26volume%3D56%26spage%3D120%26epage%3D127%26doi%3D10.3109%2F10428194.2014.889826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikuttyamma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span> <span> </span><span class="NLM_article-title">NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">65</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-8-65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2F1476-4598-8-65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19703310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD1MnhtVWmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=65&author=P.+Selvakumarauthor=A.+Lakshmikuttyammaauthor=U.+Dasauthor=H.+N.+Patiauthor=J.+R.+Dimmockauthor=R.+K.+Sharma&title=NC2213%3A+a+novel+methionine+aminopeptidase+2+inhibitor+in+human+colon+cancer+HT29+cells&doi=10.1186%2F1476-4598-8-65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells</span></div><div class="casAuthors">Selvakumar Ponniah; Lakshmikuttyamma Ashakumary; Das Umashankar; Pati Hari N; Dimmock Jonathan R; Sharma Rajendra K</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Methionine aminopeptidase 2 (MetAP2) is a bifunctional protein that plays a critical role in the regulation of post-translational processing and protein synthesis.  MetAP2 is overexpressed in human colon cancer.  In this report we screened various MetAP2 inhibitors and treated HT29 cells with various concentrations of compounds.  We evaluated the expression of MetAP2 and pp60c-src expressions in HT29 cells.  In addition we also carried out the cell proliferation and cell cycle analysis in the MetAP2 inhibitor-treated HT29 cells.  The cell cycle analysis of HT29 treated with 1.0 microM of NC2213 showed an arrest in the G2 phase followed by an induction in the percentage of cells undergoing apoptosis in the sub-G1 phase.  Western blot analysis revealed that the MetAP2 expression was dose-dependently decreased when the HT29 cells were treated with the 3,5-bis(benzylidene)-4-piperidone derivative (NC2213).  In addition, phosphorylation of Src, a myristoylated oncoprotein was significantly decreased by 1.0 microM of NC2213 as revealed by Western blot analysis.  Furthermore, NC2213 also inhibits the expression of pp60c-src in HT29 cells.  Interestingly, this compound also inhibits the phosphorylation at Tyr416 of pp60c-src while increasing the phosphorylation at Tyr527 of pp60c-src.  NC2213 inhibits the growth of HT29 cells by inducing apoptosis and might be useful for the treatment of human colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3GexXt5buJoUSrryheKE6fW6udTcc2eYtNCC-K5KkT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnhtVWmsg%253D%253D&md5=a394a79edc860725073dce736e94c2e2</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-8-65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-8-65%26sid%3Dliteratum%253Aachs%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DLakshmikuttyamma%26aufirst%3DA.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DPati%26aufirst%3DH.%2BN.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26atitle%3DNC2213%253A%2520a%2520novel%2520methionine%2520aminopeptidase%25202%2520inhibitor%2520in%2520human%2520colon%2520cancer%2520HT29%2520cells%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26spage%3D65%26doi%3D10.1186%2F1476-4598-8-65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giglione, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fieulaine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinnel, T.</span></span> <span> </span><span class="NLM_article-title">N-terminal protein modifications: Bringing back into play the ribosome</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2014.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.biochi.2014.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25450248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2015&pages=134-146&author=C.+Giglioneauthor=S.+Fieulaineauthor=T.+Meinnel&title=N-terminal+protein+modifications%3A+Bringing+back+into+play+the+ribosome&doi=10.1016%2Fj.biochi.2014.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">N-terminal protein modifications: Bringing back into play the ribosome</span></div><div class="casAuthors">Giglione, Carmela; Fieulaine, Sonia; Meinnel, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  N-terminal protein modifications correspond to the first modifications which in principle any protein may undergo, before translation is completed by the ribosome.  This class of essential modifications can have different nature or function and be catalyzed by a variety of dedicated enzymes.  Here, we review the current state of the major N-terminal co-translational modifications, with a particular emphasis to their catalysts, which belong to metalloprotease and acyltransferase clans.  The earliest of these modifications corresponds to the N-terminal methionine excision, an ubiquitous and essential process leading to the removal of the first methionine.  N-alpha acetylation occurs also in all Kingdoms although its extent appears to be significantly increased in higher eukaryotes.  Finally, N-myristoylation is a crucial pathway existing only in eukaryotes.  Recent studies dealing on how some of these co-translational modifiers might work in close vicinity of the ribosome is starting to provide new information on when these modifications exactly take place on the elongating nascent chain and the interplay with other ribosome biogenesis factors taking in charge the nascent chains.  Here a comprehensive overview of the recent advances in the field of N-terminal protein modifications is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7hWM170y6XbVg90H21EOLACvtfcHk0liC6WQ2-WDGWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgs7bL&md5=f872bd9f355dc93f16963f633996fc74</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2014.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2014.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DGiglione%26aufirst%3DC.%26aulast%3DFieulaine%26aufirst%3DS.%26aulast%3DMeinnel%26aufirst%3DT.%26atitle%3DN-terminal%2520protein%2520modifications%253A%2520Bringing%2520back%2520into%2520play%2520the%2520ribosome%26jtitle%3DBiochimie%26date%3D2015%26volume%3D114%26spage%3D134%26epage%3D146%26doi%3D10.1016%2Fj.biochi.2014.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghazizadeh, M.</span></span> <span> </span><span class="NLM_article-title">Methionine aminopeptidase 2 as a potential therapeutic target for human Non-Small-Cell Lung Cancers</span>. <i>Adv. clin exp med</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.17219/acem/60715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.17219%2Facem%2F60715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26935506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC28jmt1ymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=117-128&author=H.+Shimizuauthor=S.+Yamagishiauthor=H.+Chibaauthor=M.+Ghazizadeh&title=Methionine+aminopeptidase+2+as+a+potential+therapeutic+target+for+human+Non-Small-Cell+Lung+Cancers&doi=10.17219%2Facem%2F60715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers</span></div><div class="casAuthors">Shimizu Hajime; Yamagishi Shigeki; Chiba Hideki; Ghazizadeh Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Advances in clinical and experimental medicine : official organ Wroclaw Medical University</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-28</span>
        ISSN:<span class="NLM_cas:issn">1899-5276</span>.
    </div><div class="casAbstract">BACKGROUND:  Methionine aminopeptidase 2 (MetAP2) is a bi-functional protein that plays a critical role in the regulation of post-translational processing and protein synthesis.  OBJECTIVES:  We studied whether MetAP2 is activated and expressed in human non-small-cell lung cancer (NSCLC) tissues and whether inactivation of MetAP2 activity, with its specific inhibitor fumagillin, potentially inhibits proliferation of NSCLC cells.  MATERIAL AND METHODS:  The expression and function of MetAP2 were evaluated in NSCLC tissues, primary cell cultures and cell lines using immunohistochemistry, RT-PCR, Western blot, aminopeptidase activity assay and flow cytometry.  MetAP2 expression was also studied in relation to clinicopathological factors.  RESULTS:  MetAP2 expression in NSCLS, including adenocarcinoma (ADC) and squamous cell carcinoma (SCC), showed a moderate to strong positive reaction while normal appearing bronchial epithelium showed weak staining and normal alveolar epithelial cells were widely negative.  A high MetAP2 mRNA and protein expression was found in NSCLC tissues.  The aminopeptidase activity in NSCLC was 2-fold higher than that in normal lung tissues.  In a series of 41 ADC patients, MetAP2 expression was significantly correlated with patient's outcome or survival time.  Inhibition of MetAP2 by fumagillin in SCC cell lines revealed a significant increase in caspase-3 activity as compared to the control (p = 0.001).  CONCLUSIONS:  Our results indicate that MetAP2 is involved in NSCLC and is an important regulator of proliferative and apoptotic targets.  Thus inhibition of MetAP2, such as by fumagillin, may be a potential therapeutic modality for prevention of tumor cell growth, development and progression in NSCLC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZdBShAtFS45Pq5LRczm8ffW6udTcc2eb-v9vc9HU_rLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jmt1ymsw%253D%253D&md5=9e1837c67441b54ad779aa5a53d75d3f</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.17219%2Facem%2F60715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.17219%252Facem%252F60715%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DYamagishi%26aufirst%3DS.%26aulast%3DChiba%26aufirst%3DH.%26aulast%3DGhazizadeh%26aufirst%3DM.%26atitle%3DMethionine%2520aminopeptidase%25202%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520human%2520Non-Small-Cell%2520Lung%2520Cancers%26jtitle%3DAdv.%2520clin%2520exp%2520med%26date%3D2016%26volume%3D25%26spage%3D117%26epage%3D128%26doi%3D10.17219%2Facem%2F60715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheok, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, D. P.</span></span> <span> </span><span class="NLM_article-title">Reactivation of p53: from peptides to small molecules</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2010.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.tips.2010.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21145600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=53-62&author=C.+J.+Brownauthor=C.+F.+Cheokauthor=C.+S.+Vermaauthor=D.+P.+Lane&title=Reactivation+of+p53%3A+from+peptides+to+small+molecules&doi=10.1016%2Fj.tips.2010.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of p53: from peptides to small molecules</span></div><div class="casAuthors">Brown, Christopher J.; Cheok, Chit F.; Verma, Chandra S.; Lane, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Approx. 27 million people are living with a tumor in which the tumor suppressing activity of p53 has been inactivated.  In half of these tumors, p53 itself is not mutated but the pathway is partially abrogated.  Mechanisms include the overexpression of neg. regulators of p53, such as MDM2 and MDM4, and deletion or epigenetic inactivation of the pos. regulators of p53 such as ARF.  In the other half of tumors, in which p53 is inactivated, p53 is mutated and ∼95% of these mutations lie in the core DNA-binding domain, which reflects the key role of p53 as a transcriptional activator.  Reactivation of the tumor suppressive properties of p53 is a key therapeutic goal, and the use of peptides in p53 research has led directly to the development of two alternative small mol. approaches: stabilization of mutant p53 to rescue its DNA-binding activity and inhibition of MDM2 or MDM4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEwC8b8rPel7Vg90H21EOLACvtfcHk0liC6WQ2-WDGWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFyqug%253D%253D&md5=7db8e66bc56b36244aa359d22451f43d</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DC.%2BJ.%26aulast%3DCheok%26aufirst%3DC.%2BF.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3DReactivation%2520of%2520p53%253A%2520from%2520peptides%2520to%2520small%2520molecules%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D53%26epage%3D62%26doi%3D10.1016%2Fj.tips.2010.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgorbissa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trimarco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frezzato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">45429</span>– <span class="NLM_lpage">45443</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.9742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.9742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27259251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FmtlCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=45429-45443&author=A.+Tomasellaauthor=R.+Piccoauthor=S.+Ciottiauthor=A.+Sgorbissaauthor=E.+Bianchiauthor=R.+Manfrediniauthor=F.+Benedettiauthor=V.+Trimarcoauthor=F.+Frezzatoauthor=L.+Trentinauthor=G.+Semenzatoauthor=D.+Deliaauthor=C.+Brancolini&title=The+isopeptidase+inhibitor+2cPE+triggers+proteotoxic+stress+and+ATM+activation+in+chronic+lymphocytic+leukemia+cells&doi=10.18632%2Foncotarget.9742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells</span></div><div class="casAuthors">Tomasella Andrea; Picco Raffaella; Ciotti Sonia; Sgorbissa Andrea; Brancolini Claudio; Bianchi Elisa; Manfredini Rossella; Brancolini Claudio; Benedetti Fabio; Trimarco Valentina; Frezzato Federica; Trentin Livio; Semenzato Gianpietro; Delia Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">45429-45443</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Relapse after treatment is a common and unresolved problem for patients suffering of the B-cell chronic lymphocytic leukemia (B-CLL).  Here we investigated the ability of the isopeptidase inhibitor 2cPE to trigger apoptosis in leukemia cells in comparison with bortezomib, another inhibitor of the ubiquitin-proteasome system (UPS).  Both inhibitors trigger apoptosis in CLL B cells and gene expression profiles studies denoted how a substantial part of genes up-regulated by these compounds are elements of adaptive responses, aimed to sustain cell survival. 2cPE treatment elicits the up-regulation of chaperones, proteasomal subunits and elements of the anti-oxidant response.  Selective inhibition of these responses augments apoptosis in response to 2cPE treatment.  We have also observed that the product of the ataxia telangiectasia mutated gene (ATM) is activated in 2cPE treated cells.  Stimulation of ATM signaling is possibly dependent on the alteration of the redox homeostasis.  Importantly ATM inhibition, mutations or down-modulation increase cell death in response to 2cPE.  Overall this work suggests that 2cPE could offer new opportunities for the treatment of B-CLL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXcM3Hnwm7KB0LsK7uFuY7fW6udTcc2eYkeEyyVmU3eLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FmtlCisQ%253D%253D&md5=e5e8637e4f46ea547f2671bc7e99f1bf</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.9742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.9742%26sid%3Dliteratum%253Aachs%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DPicco%26aufirst%3DR.%26aulast%3DCiotti%26aufirst%3DS.%26aulast%3DSgorbissa%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DManfredini%26aufirst%3DR.%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DTrimarco%26aufirst%3DV.%26aulast%3DFrezzato%26aufirst%3DF.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DSemenzato%26aufirst%3DG.%26aulast%3DDelia%26aufirst%3DD.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DThe%2520isopeptidase%2520inhibitor%25202cPE%2520triggers%2520proteotoxic%2520stress%2520and%2520ATM%2520activation%2520in%2520chronic%2520lymphocytic%2520leukemia%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D45429%26epage%3D45443%26doi%3D10.18632%2Foncotarget.9742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavin, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Person, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, T. T.</span></span> <span> </span><span class="NLM_article-title">ATM activation by oxidative stress</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1126/science.1192912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1126%2Fscience.1192912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20966255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSjsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=517-521&author=Z.+Guoauthor=S.+Kozlovauthor=M.+F.+Lavinauthor=M.+D.+Personauthor=T.+T.+Paull&title=ATM+activation+by+oxidative+stress&doi=10.1126%2Fscience.1192912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">ATM activation by oxidative stress</span></div><div class="casAuthors">Guo, Zhi; Kozlov, Sergei; Lavin, Martin F.; Person, Maria D.; Paull, Tanya T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6003</span>),
    <span class="NLM_cas:pages">517-521</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  The ataxia-telangiectasia mutated (ATM) protein kinase is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex and orchestrates signaling cascades that initiate the DNA damage response.  Cells lacking ATM are also hypersensitive to insults other than DSBs, particularly oxidative stress.  We show that oxidn. of ATM directly induces ATM activation in the absence of DNA DSBs and the MRN complex.  The oxidized form of ATM is a disulfide-crosslinked dimer, and mutation of a crit. cysteine residue involved in disulfide bond formation specifically blocked activation through the oxidn. pathway.  Identification of this pathway explains observations of ATM activation under conditions of oxidative stress and shows that ATM is an important sensor of reactive oxygen species in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQRoS4m9lFAbVg90H21EOLACvtfcHk0li94vvJNXnI8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSjsbrO&md5=e491c99d5f4f09e270d8df52af316102</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1126%2Fscience.1192912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1192912%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DKozlov%26aufirst%3DS.%26aulast%3DLavin%26aufirst%3DM.%2BF.%26aulast%3DPerson%26aufirst%3DM.%2BD.%26aulast%3DPaull%26aufirst%3DT.%2BT.%26atitle%3DATM%2520activation%2520by%2520oxidative%2520stress%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D517%26epage%3D521%26doi%3D10.1126%2Fscience.1192912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddingh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarroll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoatlin, M. E.</span></span> <span> </span><span class="NLM_article-title">Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">133</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-8-133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2F1476-4598-8-133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20043851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FjtFWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=133&author=I.+Landaisauthor=S.+Hiddinghauthor=M.+McCarrollauthor=C.+Yangauthor=A.+Sunauthor=M.+S.+Turkerauthor=J.+P.+Snyderauthor=M.+E.+Hoatlin&title=Monoketone+analogs+of+curcumin%2C+a+new+class+of+Fanconi+anemia+pathway+inhibitors&doi=10.1186%2F1476-4598-8-133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors</span></div><div class="casAuthors">Landais Igor; Hiddingh Sanne; McCarroll Matthew; Yang Chao; Sun Aiming; Turker Mitchell S; Snyder James P; Hoatlin Maureen E</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Fanconi anemia (FA) pathway is a multigene DNA damage response network implicated in the repair of DNA lesions that arise during replication or after exogenous DNA damage.  The FA pathway displays synthetic lethal relationship with certain DNA repair genes such as ATM (Ataxia Telangectasia Mutated) that are frequently mutated in tumors.  Thus, inhibition of FANCD2 monoubiquitylation (FANCD2-Ub), a key step in the FA pathway, might target tumor cells defective in ATM through synthetic lethal interaction.  Curcumin was previously identified as a weak inhibitor of FANCD2-Ub.  The aim of this study is to identify derivatives of curcumin with better activity and specificity.  RESULTS:  Using a replication-free assay in Xenopus extracts, we screened monoketone analogs of curcumin for inhibition of FANCD2-Ub and identified analog EF24 as a strong inhibitor.  Mechanistic studies suggest that EF24 targets the FA pathway through inhibition of the NF-kB pathway kinase IKK.  In HeLa cells, nanomolar concentrations of EF24 inhibited hydroxyurea (HU)-induced FANCD2-Ub and foci in a cell-cycle independent manner.  Survival assays revealed that EF24 specifically sensitizes FA-competent cells to the DNA crosslinking agent mitomycin C (MMC).  In addition, in contrast with curcumin, ATM-deficient cells are twofold more sensitive to EF24 than matched wild-type cells, consistent with a synthetic lethal effect between FA pathway inhibition and ATM deficiency.  An independent screen identified 4H-TTD, a compound structurally related to EF24 that displays similar activity in egg extracts and in cells.  CONCLUSIONS:  These results suggest that monoketone analogs of curcumin are potent inhibitors of the FA pathway and constitute a promising new class of targeted anticancer compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNk4F0MtY8P669lAbTj9rGfW6udTcc2eYkeEyyVmU3eLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FjtFWgtQ%253D%253D&md5=5c1d2ac76d4b6b5707b608ec4e215afb</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-8-133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-8-133%26sid%3Dliteratum%253Aachs%26aulast%3DLandais%26aufirst%3DI.%26aulast%3DHiddingh%26aufirst%3DS.%26aulast%3DMcCarroll%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DTurker%26aufirst%3DM.%2BS.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DHoatlin%26aufirst%3DM.%2BE.%26atitle%3DMonoketone%2520analogs%2520of%2520curcumin%252C%2520a%2520new%2520class%2520of%2520Fanconi%2520anemia%2520pathway%2520inhibitors%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26spage%3D133%26doi%3D10.1186%2F1476-4598-8-133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsello, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natoli, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubelli, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asiedu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahr, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberzon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzechowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enache, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrcic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosains, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardlie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenside, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read-Button, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span> <span> </span><span class="NLM_article-title">A next generation connectivity map: L1000 platform and the first 1,000,000 profiles</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1452</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.10.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.cell.2017.10.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29195078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2017&pages=1437-1452&author=A.+Subramanianauthor=R.+Narayanauthor=S.+M.+Corselloauthor=D.+D.+Peckauthor=T.+E.+Natoliauthor=X.+Luauthor=J.+Gouldauthor=J.+F.+Davisauthor=A.+A.+Tubelliauthor=J.+K.+Asieduauthor=D.+L.+Lahrauthor=J.+E.+Hirschmanauthor=Z.+Liuauthor=M.+Donahueauthor=B.+Julianauthor=M.+Khanauthor=D.+Waddenauthor=I.+C.+Smithauthor=D.+Lamauthor=A.+Liberzonauthor=C.+Toderauthor=M.+Bagulauthor=M.+Orzechowskiauthor=O.+M.+Enacheauthor=F.+Piccioniauthor=S.+A.+Johnsonauthor=N.+J.+Lyonsauthor=A.+H.+Bergerauthor=A.+F.+Shamjiauthor=A.+N.+Brooksauthor=A.+Vrcicauthor=C.+Flynnauthor=J.+Rosainsauthor=D.+Y.+Takedaauthor=R.+Huauthor=D.+Davisonauthor=J.+Lambauthor=K.+Ardlieauthor=L.+Hogstromauthor=P.+Greensideauthor=N.+S.+Grayauthor=P.+A.+Clemonsauthor=S.+Silverauthor=X.+Wuauthor=W.+N.+Zhaoauthor=W.+Read-Buttonauthor=X.+Wuauthor=S.+J.+Haggartyauthor=L.+V.+Roncoauthor=J.+S.+Boehmauthor=S.+L.+Schreiberauthor=J.+G.+Doenchauthor=J.+A.+Bittkerauthor=D.+E.+Rootauthor=B.+Wongauthor=T.+R.+Golub&title=A+next+generation+connectivity+map%3A+L1000+platform+and+the+first+1%2C000%2C000+profiles&doi=10.1016%2Fj.cell.2017.10.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A next generation connectivity map: L1000 platform and the first 1,000,000 profiles</span></div><div class="casAuthors">Subramanian, Aravind; Narayan, Rajiv; Corsello, Steven M.; Peck, David D.; Natoli, Ted E.; Lu, Xiaodong; Gould, Joshua; Davis, John F.; Tubelli, Andrew A.; Asiedu, Jacob K.; Lahr, David L.; Hirschman, Jodi E.; Liu, Zihan; Donahue, Melanie; Julian, Bina; Khan, Mariya; Wadden, David; Smith, Ian C.; Lam, Daniel; Liberzon, Arthur; Toder, Courtney; Bagul, Mukta; Orzechowski, Marek; Enache, Oana M.; Piccioni, Federica; Johnson, Sarah A.; Lyons, Nicholas J.; Berger, Alice H.; Shamji, Alykhan F.; Brooks, Angela N.; Vrcic, Anita; Flynn, Corey; Rosains, Jacqueline; Takeda, David Y.; Hu, Roger; Davison, Desiree; Lamb, Justin; Ardlie, Kristin; Hogstrom, Larson; Greenside, Peyton; Gray, Nathanael S.; Clemons, Paul A.; Silver, Serena; Wu, Xiaoyun; Zhao, Wen-Ning; Read-Button, Willis; Wu, Xiaohua; Haggarty, Stephen J.; Ronco, Lucienne V.; Boehm, Jesse S.; Schreiber, Stuart L.; Doench, John G.; Bittker, Joshua A.; Root, David E.; Wong, Bang; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1437-1452.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures.  Here, we report more than a 1000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000.  We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts.  We further show that the expanded CMap can be used to discover mechanism of action of small mols., functionally annotate genetic variants of disease genes, and inform clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIWrWy5IxY-rVg90H21EOLACvtfcHk0lgNgEqCN_htVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsbrE&md5=d2b13f2b80fe94021ac03f6a8c859a4a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.10.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.10.049%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DNarayan%26aufirst%3DR.%26aulast%3DCorsello%26aufirst%3DS.%2BM.%26aulast%3DPeck%26aufirst%3DD.%2BD.%26aulast%3DNatoli%26aufirst%3DT.%2BE.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DGould%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DJ.%2BF.%26aulast%3DTubelli%26aufirst%3DA.%2BA.%26aulast%3DAsiedu%26aufirst%3DJ.%2BK.%26aulast%3DLahr%26aufirst%3DD.%2BL.%26aulast%3DHirschman%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDonahue%26aufirst%3DM.%26aulast%3DJulian%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DWadden%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DI.%2BC.%26aulast%3DLam%26aufirst%3DD.%26aulast%3DLiberzon%26aufirst%3DA.%26aulast%3DToder%26aufirst%3DC.%26aulast%3DBagul%26aufirst%3DM.%26aulast%3DOrzechowski%26aufirst%3DM.%26aulast%3DEnache%26aufirst%3DO.%2BM.%26aulast%3DPiccioni%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DLyons%26aufirst%3DN.%2BJ.%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DBrooks%26aufirst%3DA.%2BN.%26aulast%3DVrcic%26aufirst%3DA.%26aulast%3DFlynn%26aufirst%3DC.%26aulast%3DRosains%26aufirst%3DJ.%26aulast%3DTakeda%26aufirst%3DD.%2BY.%26aulast%3DHu%26aufirst%3DR.%26aulast%3DDavison%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DArdlie%26aufirst%3DK.%26aulast%3DHogstrom%26aufirst%3DL.%26aulast%3DGreenside%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DSilver%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DW.%2BN.%26aulast%3DRead-Button%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DRonco%26aufirst%3DL.%2BV.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DDoench%26aufirst%3DJ.%2BG.%26aulast%3DBittker%26aufirst%3DJ.%2BA.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DA%2520next%2520generation%2520connectivity%2520map%253A%2520L1000%2520platform%2520and%2520the%2520first%25201%252C000%252C000%2520profiles%26jtitle%3DCell%26date%3D2017%26volume%3D171%26spage%3D1437%26epage%3D1452%26doi%3D10.1016%2Fj.cell.2017.10.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mootha, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span> <span> </span><span class="NLM_article-title">Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15550</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506580102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1073%2Fpnas.0506580102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16199517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=15545-15550&author=A.+Subramanianauthor=P.+Tamayoauthor=V.+K.+Moothaauthor=S.+Mukherjeeauthor=B.+L.+Ebertauthor=M.+A.+Gilletteauthor=A.+Paulovichauthor=S.+L.+Pomeroyauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=J.+P.+Mesirov&title=Gene+set+enrichment+analysis%3A+a+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles&doi=10.1073%2Fpnas.0506580102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span></div><div class="casAuthors">Subramanian, Aravind; Tamayo, Pablo; Mootha, Vamsi K.; Mukherjee, Sayan; Ebert, Benjamin L.; Gillette, Michael A.; Paulovich, Amanda; Pomeroy, Scott L.; Golub, Todd R.; Lander, Eric S.; Mesirov, Jill P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15545-15550</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although genomewide RNA expression anal. has become a routine tool in biomedical research, extg. biol. insight from such information remains a major challenge.  Here, we describe a powerful anal. method called Gene Set Enrichment Anal. (GSEA) for interpreting gene expression data.  The method derives its power by focusing on gene sets, i.e., groups of genes that share common biol. function, chromosomal location, or regulation.  We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer.  Notably, where single-gene anal. finds little similarity between two independent studies of patients survival in lung cancer, GSEA reveals many biol. pathways in common.  The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biol. defined gene sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH2_E6gWd0yrVg90H21EOLACvtfcHk0lgNgEqCN_htVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO&md5=ca2eb221010f20379199e6442c65fc2e</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506580102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506580102%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGillette%26aufirst%3DM.%2BA.%26aulast%3DPaulovich%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26atitle%3DGene%2520set%2520enrichment%2520analysis%253A%2520a%2520knowledge-based%2520approach%2520for%2520interpreting%2520genome-wide%2520expression%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D15545%26epage%3D15550%26doi%3D10.1073%2Fpnas.0506580102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brnjic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mofers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>448</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2019.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.canlet.2019.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30768956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2019&pages=70-83&author=E.+K.+Hillertauthor=S.+Brnjicauthor=X.+Zhangauthor=M.+Mazurkiewiczauthor=A.+A.+Saeiauthor=A.+Mofersauthor=K.+Selvarajuauthor=R.+Zubarevauthor=S.+Linderauthor=P.+D%E2%80%99Arcy&title=Proteasome+inhibitor+b-AP15+induces+enhanced+proteotoxicity+by+inhibiting+cytoprotective+aggresome+formation&doi=10.1016%2Fj.canlet.2019.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation</span></div><div class="casAuthors">Hillert, Ellin-Kristina; Brnjic, Slavica; Zhang, Xiaonan; Mazurkiewicz, Magdalena; Saei, Amir Ata; Mofers, Arjan; Selvaraju, Karthik; Zubarev, Roman; Linder, Stig; D'Arcy, Padraig</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Proteasome inhibitors have been shown to induce cell death in cancer cells by triggering an acute proteotoxic stress response characterized by accumulation of poly-ubiquitinated proteins, ER stress and the prodn. of reactive oxygen species.  The aggresome pathway has been described as an escape mechanism from proteotoxicity by sequestering toxic cellular aggregates.  Here we show that b-AP15, a small-mol. inhibitor of proteasomal deubiquitinase activity, induces poly-ubiquitin accumulation in absence of aggresome formation. b-AP15 was found to affect organelle transport in treated cells, raising the possibility that microtubule-transport of toxic protein aggregates is inhibited, leading to enhanced cytotoxicity.  In contrast to the antiproliferative effects of the clin. used proteasome inhibitor bortezomib, the effects of b-AP15 are not further enhanced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).  Our results suggest an inhibitory effect of b-AP15 on the transport of misfolded proteins, resulting in a lack of aggresome formation, and a strong proteotoxic stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAsKIith5aTrVg90H21EOLACvtfcHk0ljguVndE4c7dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbg%253D&md5=29b6a15a8926a57b43f3ad0980a22a27</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2019.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2019.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DBrnjic%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DMofers%26aufirst%3DA.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DZubarev%26aufirst%3DR.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26atitle%3DProteasome%2520inhibitor%2520b-AP15%2520induces%2520enhanced%2520proteotoxicity%2520by%2520inhibiting%2520cytoprotective%2520aggresome%2520formation%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D448%26spage%3D70%26epage%3D83%26doi%3D10.1016%2Fj.canlet.2019.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simms-Waldrip, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K. M.</span></span> <span> </span><span class="NLM_article-title">Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2557</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-07-5989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18413721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Git7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2557-2560&author=A.+Rodriguez-Gonzalezauthor=T.+Linauthor=A.+K.+Ikedaauthor=T.+Simms-Waldripauthor=C.+Fuauthor=K.+M.+Sakamoto&title=Role+of+the+aggresome+pathway+in+cancer%3A+targeting+histone+deacetylase+6-dependent+protein+degradation&doi=10.1158%2F0008-5472.CAN-07-5989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6-Dependent Protein Degradation</span></div><div class="casAuthors">Rodriguez-Gonzalez, Agustin; Lin, Tara; Ikeda, Alan K.; Simms-Waldrip, Tiffany; Fu, Cecilia; Sakamoto, Kathleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2557-2560</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Misfolded or aggregated proteins have two fates: they are either refolded with the help of chaperones or degraded by the proteasome.  Cells also have an alternative pathway that involves intracellular "storage bins" for misfolded intracellular proteins known as aggresomes.  Aggresomes recruit motor proteins that transport misfolded or aggregated proteins to chaperones and proteasomes for subsequent destruction.  There is emerging evidence that inhibiting the aggresome pathway leads to accumulation of misfolded proteins and apoptosis in tumor cells through autophagy.  We discuss the role of aggresomes in cancer and the potential to target this pathway for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO2L35Ht3RbVg90H21EOLACvtfcHk0ljguVndE4c7dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Git7o%253D&md5=1e811e9d6cbc801be733fbb74e5fa2f3</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5989%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Gonzalez%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DA.%2BK.%26aulast%3DSimms-Waldrip%26aufirst%3DT.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26atitle%3DRole%2520of%2520the%2520aggresome%2520pathway%2520in%2520cancer%253A%2520targeting%2520histone%2520deacetylase%25206-dependent%2520protein%2520degradation%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2557%26epage%3D2560%26doi%3D10.1158%2F0008-5472.CAN-07-5989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cajone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescente, M.</span></span> <span> </span><span class="NLM_article-title">In vitro activation of heat shock transcription factor by 4-hydroxynonenal</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/0009-2797(92)90071-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2F0009-2797%2892%2990071-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1394624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK3sXit12i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1992&pages=97-112&author=F.+Cajoneauthor=M.+Crescente&title=In+vitro+activation+of+heat+shock+transcription+factor+by+4-hydroxynonenal&doi=10.1016%2F0009-2797%2892%2990071-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activation of heat shock transcription factor by 4-hydroxynonenal</span></div><div class="casAuthors">Cajone, Francesco; Crescente, Melchiorre</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-112</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    </div><div class="casAbstract">The in vitro activation of heat shock factor (HSF) by treating at 0° a HeLa cell-free system with the aldehyde 4-hydroxynonenal (HNE), a highly cytotoxic product of lipid peroxidn. was investigated.  The in vitro activation of HSF by HNE occurred only if some components of the cell-free system were not sedimented at 100,000 × g.  The reason for this is unclear but the release of active HSF from nuclei of unshocked cells and the involvement of Ca2+ contained in the mitochondria and ER have been excluded.  Although HNE is known to be a sulfhydryl blocking agent, the results obtained with N-ethylmaleimide suggest that different mechanisms might be involved in the in vitro activation of HSF by HNE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUevonBZf3gbVg90H21EOLACvtfcHk0ljguVndE4c7dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12i&md5=9d38c1e5d92b7149cc5b7a7e2792f7a7</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2F0009-2797%2892%2990071-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-2797%252892%252990071-R%26sid%3Dliteratum%253Aachs%26aulast%3DCajone%26aufirst%3DF.%26aulast%3DCrescente%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520activation%2520of%2520heat%2520shock%2520transcription%2520factor%2520by%25204-hydroxynonenal%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D1992%26volume%3D84%26spage%3D97%26epage%3D112%26doi%3D10.1016%2F0009-2797%2892%2990071-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anton, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norbury, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yewdell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennink, J. R.</span></span> <span> </span><span class="NLM_article-title">Rapid degradation of a large fraction of newly synthesized proteins by proteasomes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>404</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1038/35008096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2F35008096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10783891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=404&publication_year=2000&pages=770-774&author=U.+Schubertauthor=L.+C.+Antonauthor=J.+Gibbsauthor=C.+C.+Norburyauthor=J.+W.+Yewdellauthor=J.+R.+Bennink&title=Rapid+degradation+of+a+large+fraction+of+newly+synthesized+proteins+by+proteasomes&doi=10.1038%2F35008096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid degradation of a large fraction of newly synthesized proteins by proteasomes</span></div><div class="casAuthors">Schubert, Ulrich; Anton, Luis C.; Gibbs, James; Norbury, Christopher C.; Yewdell, Jonathan W.; Bennink, Jack R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">404</span>
        (<span class="NLM_cas:issue">6779</span>),
    <span class="NLM_cas:pages">770-774</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MHC class I mols. function to present peptides eight to ten residues long to the immune system.  These peptides originate primarily from a cytosolic pool of proteins through the actions of proteasomes, and are transported into the endoplasmic reticulum, where they assemble with nascent class I mols.  Most peptides are generated from proteins that are apparently metabolically stable.  To explain this, we previously proposed that peptides arise from proteasomal degrdn. of defective ribosomal products (DRiPs).  DRiPs are polypeptides that never attain native structure owing to errors in translation or post-translational processes necessary for proper protein folding.  Here we show, first, that DRiPs constitute upwards of 30% of newly synthesized proteins as detd. in a variety of cell types; second, that at least some DRiPs represent ubiquitinated proteins; and last, that ubiquitinated DRiPs are formed from human immunodeficiency virus Gag polyprotein, a long-lived viral protein that serves as a source of antigenic peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIZmF6WIlRkbVg90H21EOLACvtfcHk0liFkvxRbMkPaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVamtbs%253D&md5=939730948ac7e6819a540336b06b1ee6</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2F35008096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35008096%26sid%3Dliteratum%253Aachs%26aulast%3DSchubert%26aufirst%3DU.%26aulast%3DAnton%26aufirst%3DL.%2BC.%26aulast%3DGibbs%26aufirst%3DJ.%26aulast%3DNorbury%26aufirst%3DC.%2BC.%26aulast%3DYewdell%26aufirst%3DJ.%2BW.%26aulast%3DBennink%26aufirst%3DJ.%2BR.%26atitle%3DRapid%2520degradation%2520of%2520a%2520large%2520fraction%2520of%2520newly%2520synthesized%2520proteins%2520by%2520proteasomes%26jtitle%3DNature%26date%3D2000%26volume%3D404%26spage%3D770%26epage%3D774%26doi%3D10.1038%2F35008096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puumalainen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hult, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">High, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanton, E.</span></span> <span> </span><span class="NLM_article-title">Elevation of proteasomal substrate levels sensitizes cells to apoptosis induced by inhibition of proteasomal deubiquitinases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e108839</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0108839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0108839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25286379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjs7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=C.+Sunauthor=P.+Robotiauthor=M.+R.+Puumalainenauthor=M.+Fryknasauthor=X.+Wangauthor=P.+D%E2%80%99Arcyauthor=M.+Hultauthor=S.+Highauthor=S.+Linderauthor=E.+Swanton&title=Elevation+of+proteasomal+substrate+levels+sensitizes+cells+to+apoptosis+induced+by+inhibition+of+proteasomal+deubiquitinases&doi=10.1371%2Fjournal.pone.0108839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Elevation of proteasomal substrate levels sensitizes cells to apoptosis induced by inhibition of proteasomal deubiquitinases</span></div><div class="casAuthors">Sun, Chao; Roboti, Peristera; Puumalainen, Marjo-Riitta; Fryknaes, Maarten; Wang, Xin; D'Arcy, Padraig; Hult, Malin; High, Stephen; Linder, Stig; Swanton, Eileithyia</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e108839/1-e108839/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inhibitors of the catalytic activity of the 20S proteasome are cytotoxic to tumor cells and are currently in clin. use for treatment of multiple myeloma, while the deubiquitinase activity assocd. with the 19S regulatory subunit of the proteasome is also a valid target for anti-cancer drugs.  The mechanisms underlying the therapeutic efficacy of these drugs and their selective toxicity towards cancer cells are not known.  Here, we show that increasing the cellular levels of proteasome substrates using an inhibitor of Sec61-mediated protein translocation significantly increases the extent of apoptosis that is induced by inhibition of proteasomal deubiquitinase activity in both cancer derived and non-transformed cell lines.  Our results suggest that increased generation of misfolded proteasome substrates may contribute to the mechanism(s) underlying the increased sensitivity of tumor cells to inhibitors of the ubiquitin-proteasome system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv3i0iiIVLWbVg90H21EOLACvtfcHk0liFkvxRbMkPaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjs7jK&md5=998aad975eb148f0a4a0e73362d80ae3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108839%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%26aulast%3DRoboti%26aufirst%3DP.%26aulast%3DPuumalainen%26aufirst%3DM.%2BR.%26aulast%3DFryknas%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DHult%26aufirst%3DM.%26aulast%3DHigh%26aufirst%3DS.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DSwanton%26aufirst%3DE.%26atitle%3DElevation%2520of%2520proteasomal%2520substrate%2520levels%2520sensitizes%2520cells%2520to%2520apoptosis%2520induced%2520by%2520inhibition%2520of%2520proteasomal%2520deubiquitinases%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0108839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harant, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberhauser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquardt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dascher-Nadel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindley, I. J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>436</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1038/nature03670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnature03670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16015337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVeku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=290-293&author=J.+Besemerauthor=H.+Harantauthor=S.+Wangauthor=B.+Oberhauserauthor=K.+Marquardtauthor=C.+A.+Fosterauthor=E.+P.+Schreinerauthor=J.+E.+de+Vriesauthor=C.+Dascher-Nadelauthor=I.+J.+Lindley&title=Selective+inhibition+of+cotranslational+translocation+of+vascular+cell+adhesion+molecule+1&doi=10.1038%2Fnature03670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1</span></div><div class="casAuthors">Besemer, Juergen; Harant, Hanna; Wang, Shirley; Oberhauser, Berndt; Marquardt, Katharina; Foster, Carolyn A.; Schreiner, Erwin P.; de Vries, Jan E.; Dascher-Nadel, Christiane; Lindley, Ivan J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7048</span>),
    <span class="NLM_cas:pages">290-293</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increased expression of vascular cell adhesion mol. 1 (VCAM1) is assocd. with a variety of chronic inflammatory conditions, making its expression and function a target for therapeutic intervention.  The authors have recently identified CAM741, a deriv. of a fungus-derived cyclopeptolide that acts as a selective inhibitor of VCAM1 synthesis in endothelial cells.  Here the authors show that the compd. represses the biosynthesis of VCAM1 in cells by blocking the process of cotranslational translocation, which is dependent on the signal peptide of VCAM1.  CAM741 does not inhibit targeting of the VCAM1 nascent chains to the translocon channel but prevents translocation to the luminal side of the endoplasmic reticulum (ER), through a process that involves the translocon component Sec61β.  Consequently, the VCAM1 precursor protein is synthesized towards the cytosolic compartment of the cells, where it is degraded.  Our results indicate that the inhibition of cotranslational translocation with low-mol.-mass compds., using specificity conferred by signal peptides, can modulate the biosynthesis of certain secreted and/or membrane proteins.  In addn., they highlight cotranslational translocation at the ER membrane as a potential target for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe18k16JGYwrVg90H21EOLACvtfcHk0liFkvxRbMkPaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVeku7c%253D&md5=6f0bf182517369a03787dcae708e35a9</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Fnature03670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03670%26sid%3Dliteratum%253Aachs%26aulast%3DBesemer%26aufirst%3DJ.%26aulast%3DHarant%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DOberhauser%26aufirst%3DB.%26aulast%3DMarquardt%26aufirst%3DK.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DSchreiner%26aufirst%3DE.%2BP.%26aulast%3Dde%2BVries%26aufirst%3DJ.%2BE.%26aulast%3DDascher-Nadel%26aufirst%3DC.%26aulast%3DLindley%26aufirst%3DI.%2BJ.%26atitle%3DSelective%2520inhibition%2520of%2520cotranslational%2520translocation%2520of%2520vascular%2520cell%2520adhesion%2520molecule%25201%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D290%26epage%3D293%26doi%3D10.1038%2Fnature03670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, R. G.</span></span> <span> </span><span class="NLM_article-title">Protein quality control degradation in the nucleus</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">725</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-062917-012730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1146%2Fannurev-biochem-062917-012730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29925261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=725-749&author=C.+Enamauthor=Y.+Geffenauthor=T.+Ravidauthor=R.+G.+Gardner&title=Protein+quality+control+degradation+in+the+nucleus&doi=10.1146%2Fannurev-biochem-062917-012730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Quality Control Degradation in the Nucleus</span></div><div class="casAuthors">Enam, Charisma; Geffen, Yifat; Ravid, Tommer; Gardner, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">725-749</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Nuclear proteins participate in diverse cellular processes, many of which are essential for cell survival and viability.  To maintain optimal nuclear physiol., the cell employs the ubiquitin-proteasome system to eliminate damaged and misfolded proteins in the nucleus that could otherwise harm the cell.  In this review, we highlight the current knowledge about the major ubiquitin-protein ligases involved in protein quality control degrdn. (PQCD) in the nucleus and how they orchestrate their functions to eliminate misfolded proteins in different nuclear subcompartments.  Many human disorders are causally linked to protein misfolding in the nucleus, hence we discuss major concepts that still need to be clarified to better understand the basis of the nuclear misfolded proteins' toxic effects.  Addnl., we touch upon potential strategies for manipulating nuclear PQCD pathways to ameliorate diseases assocd. with protein misfolding and aggregation in the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGrwGXTr8ZLVg90H21EOLACvtfcHk0lh1XomwyhJhPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrI&md5=5a4bce377874dbbbd1072b04f08e41da</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-062917-012730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-062917-012730%26sid%3Dliteratum%253Aachs%26aulast%3DEnam%26aufirst%3DC.%26aulast%3DGeffen%26aufirst%3DY.%26aulast%3DRavid%26aufirst%3DT.%26aulast%3DGardner%26aufirst%3DR.%2BG.%26atitle%3DProtein%2520quality%2520control%2520degradation%2520in%2520the%2520nucleus%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26spage%3D725%26epage%3D749%26doi%3D10.1146%2Fannurev-biochem-062917-012730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seckinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hose, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haefeli, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burhenne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J.</span></span> <span> </span><span class="NLM_article-title">Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1007/s00280-014-2643-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs00280-014-2643-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25477008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2gtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=281-291&author=J.+Clemensauthor=A.+Seckingerauthor=D.+Hoseauthor=D.+Theileauthor=M.+Longoauthor=W.+E.+Haefeliauthor=J.+Burhenneauthor=J.+Weiss&title=Cellular+uptake+kinetics+of+bortezomib+in+relation+to+efficacy+in+myeloma+cells+and+the+influence+of+drug+transporters&doi=10.1007%2Fs00280-014-2643-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters</span></div><div class="casAuthors">Clemens, Jannick; Seckinger, Anja; Hose, Dirk; Theile, Dirk; Longo, Magdalena; Haefeli, Walter Emil; Burhenne, Juergen; Weiss, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-291</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Despite overall successful application to multiple myeloma patients, clin. efficacy of the proteasome inhibitor bortezomib is typically challenged by primary and secondary resistance of unknown origin.  So far, the potential impact of intracellular concns. on drug efficacy of bortezomib and the influence of drug transporters are unknown.  Methods: We detd. cellular bortezomib kinetics in nine myeloma cell lines using ultrahigh-performance liq. chromatog. coupled to tandem mass spectrometry.  The potential influence of drug transporters on the uptake kinetics obsd. in these cell lines was investigated by testing substrate characteristics of bortezomib for several transporters in over-expressing model cells.  Addnl., transporter mRNA expression was quantified in myeloma cell lines by real-time polymerase chain reaction (RT-PCR).  Results: All myeloma cells revealed an extensive intracellular bortezomib accumulation (47.5-183 ng/mL) exceeding extracellular concns. (0.04-0.17 ng/mL) by more than factor 1,000.  Only org. anion-transporting polypeptide 1B1 facilitated the uptake in over-expressing cells, however, to a negligible extent (factor 1.36).  Bortezomib efflux via P-glycoprotein was confirmed by demonstrating reduced sensitivity (IC50 11.6 vs. 2.8 ng/mL) and intracellular concns. (-56.1 %) in over-expressing cells compared to controls.  RT-PCR revealed a varying but overall weak transporter expression in the studied myeloma cells without any correlation to intracellular concns.  Although principally valid as demonstrated in the P-glycoprotein over-expressing cell model, there was no significant correlation between intracellular concns. and bortezomib efficacy in myeloma cell lines.  Conclusion: Differences in intracellular concns. in myeloma cell lines neither result from variable transporter expression nor represent the main factor detg. bortezomib efficacy in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Hx5lUe6yULVg90H21EOLACvtfcHk0lh1XomwyhJhPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2gtL3N&md5=d7af0098f6411bd69213589f0fe1ef50</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1007%2Fs00280-014-2643-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-014-2643-1%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DSeckinger%26aufirst%3DA.%26aulast%3DHose%26aufirst%3DD.%26aulast%3DTheile%26aufirst%3DD.%26aulast%3DLongo%26aufirst%3DM.%26aulast%3DHaefeli%26aufirst%3DW.%2BE.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DJ.%26atitle%3DCellular%2520uptake%2520kinetics%2520of%2520bortezomib%2520in%2520relation%2520to%2520efficacy%2520in%2520myeloma%2520cells%2520and%2520the%2520influence%2520of%2520drug%2520transporters%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2015%26volume%3D75%26spage%3D281%26epage%3D291%26doi%3D10.1007%2Fs00280-014-2643-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menendez-Benito, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoef, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masucci, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantuma, N. P.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum stress compromises the ubiquitin-proteasome system</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2787</span>– <span class="NLM_lpage">2799</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddi312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Fhmg%2Fddi312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16103128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWnt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=2787-2799&author=V.+Menendez-Benitoauthor=L.+G.+Verhoefauthor=M.+G.+Masucciauthor=N.+P.+Dantuma&title=Endoplasmic+reticulum+stress+compromises+the+ubiquitin-proteasome+system&doi=10.1093%2Fhmg%2Fddi312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum stress compromises the ubiquitin-proteasome system</span></div><div class="casAuthors">Menendez-Benito, Victoria; Verhoef, Lisette G. G. C.; Masucci, Maria G.; Dantuma, Nico P.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2787-2799</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The presence of endoplasmic reticulum (ER) stress and impaired ubiquitin-proteasome system (UPS) activity has been independently implicated in the pathophysiol. of conformational diseases.  Here, we reveal a link between ER stress and the functionality of the UPS.  Treatment of cells with different ER stressors delayed the degrdn. of an ER reporter substrate and caused a subtle but consistent accumulation of three independent nuclear/cytosolic UPS reporter substrates.  A similar signature increase was obsd. upon induction of ER stress in transgenic mice expressing a reporter substrate.  Cells undergoing ER stress failed to clear efficiently UBB+1, an aberrant ubiquitin found in conformational diseases, which in turn caused general impairment of the UPS.  We conclude that ER stress has a general inhibitory effect on the UPS.  The compromised UPS during ER stress may explain the long-term gradual accumulation of misfolded proteins as well as the selective vulnerability of particular cell populations in conformational diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr82G8RTTmfY7Vg90H21EOLACvtfcHk0lh1XomwyhJhPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWnt7jO&md5=dabc18061d0fb7bdd246708ffdbc1532</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi312%26sid%3Dliteratum%253Aachs%26aulast%3DMenendez-Benito%26aufirst%3DV.%26aulast%3DVerhoef%26aufirst%3DL.%2BG.%26aulast%3DMasucci%26aufirst%3DM.%2BG.%26aulast%3DDantuma%26aufirst%3DN.%2BP.%26atitle%3DEndoplasmic%2520reticulum%2520stress%2520compromises%2520the%2520ubiquitin-proteasome%2520system%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2005%26volume%3D14%26spage%3D2787%26epage%3D2799%26doi%3D10.1093%2Fhmg%2Fddi312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span> <span> </span><span class="NLM_article-title">Quantitative chemoproteomics for site-specific analysis of protein alkylation by 4-hydroxy-2-nonenal in cells</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2535</span>– <span class="NLM_lpage">2541</span>, <span class="refDoi"> DOI: 10.1021/ac504685y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac504685y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit12msLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=2535-2541&author=J.+Yangauthor=K.+A.+Tallmanauthor=N.+A.+Porterauthor=D.+C.+Liebler&title=Quantitative+chemoproteomics+for+site-specific+analysis+of+protein+alkylation+by+4-hydroxy-2-nonenal+in+cells&doi=10.1021%2Fac504685y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Chemoproteomics for Site-Specific Analysis of Protein Alkylation by 4-Hydroxy-2-Nonenal in Cells</span></div><div class="casAuthors">Yang, Jing; Tallman, Keri A.; Porter, Ned A.; Liebler, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2535-2541</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein alkylation by 4-hydroxy-2-nonenal (HNE), an endogenous lipid derived electrophile, contributes to stress signaling and cellular toxicity.  Although previous work has identified protein targets for HNE alkylation, the sequence specificity of alkylation and dynamics in a cellular context remain largely unexplored.  The authors developed a new quant. chemoproteomic platform, which uses isotopically tagged, photocleavable azido-biotin reagents to selectively capture and quantify the cellular targets labeled by the alkynyl analog of HNE (aHNE).  The authors' analyses site-specifically identified and quantified 398 aHNE protein alkylation events (386 cysteine sites and 12 histidine sites) in intact cells.  This data set expands by at least an order of magnitude the no. of such modification sites previously reported.  Although adducts formed by Michael addn. are thought to be largely irreversible, most aHNE modifications are lost rapidly in situ.  Moreover, aHNE adduct turnover occurs only in intact cells and loss rates are site-selective.  This quant. chemoproteomics platform provides a versatile general approach to map bioorthogonal-chem. engineered post-translational modifications and their cellular dynamics in a site-specific and unbiased manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKhDp3eK6t4bVg90H21EOLACvtfcHk0lh1XomwyhJhPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit12msLY%253D&md5=da2595e75c2f67c0ad0ef233c53cf284</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fac504685y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac504685y%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTallman%26aufirst%3DK.%2BA.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26atitle%3DQuantitative%2520chemoproteomics%2520for%2520site-specific%2520analysis%2520of%2520protein%2520alkylation%2520by%25204-hydroxy-2-nonenal%2520in%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2015%26volume%3D87%26spage%3D2535%26epage%3D2541%26doi%3D10.1021%2Fac504685y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regazzoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altomare, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldini, G.</span></span> <span> </span><span class="NLM_article-title">Enzymatic and non-enzymatic detoxification of 4-hydroxynonenal: methodological aspects and biological consequences</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2017.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.freeradbiomed.2017.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28161307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1Wkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2017&pages=328-344&author=M.+Molauthor=L.+Regazzoniauthor=A.+Altomareauthor=G.+Deganiauthor=M.+Cariniauthor=G.+Vistoliauthor=G.+Aldini&title=Enzymatic+and+non-enzymatic+detoxification+of+4-hydroxynonenal%3A+methodological+aspects+and+biological+consequences&doi=10.1016%2Fj.freeradbiomed.2017.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic and non-enzymatic detoxification of 4-hydroxynonenal: Methodological aspects and biological consequences</span></div><div class="casAuthors">Mol, Marco; Regazzoni, Luca; Altomare, Alessandra; Degani, Genny; Carini, Marina; Vistoli, Giulio; Aldini, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">328-344</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  4-Hydroxynonenal (HNE), an electrophilic end-product deriving from lipid peroxidn., undergoes a heterogeneous set of biotransformations including enzymic and non-enzymic reactions.  The former mostly involve red-ox reactions on the HNE oxygenated functions (phase I metab.) and GSH conjugations (phase II) while the latter are due to the HNE capacity to spontaneously condense with nucleophilic sites within endogenous mols. such as proteins, nucleic acids and phospholipids.  The overall metabolic fate of HNE has recently attracted great interest not only because it clearly dets. the HNE disposal, but esp. because the generated metabolites and adducts are not inactive mols. (as initially believed) but show biol. activities even more pronounced than those of the parent compd. as exemplified by potent pro-inflammatory stimulus induced by GSH conjugates.  Similarly, several studies revealed that the non-enzymic reactions, initially considered as damaging processes randomly involving all endogenous nucleophilic reactants, are in fact quite selective in terms of both reactivity of the nucleophilic sites and stability of the generated adducts.  Even though many formed adducts retain the expected toxic consequences, some adducts exhibit well-defined beneficial roles as documented by the protective effects of sublethal concns. of HNE against toxic concns. of HNE.  Clearly, future investigations are required to gain a more detailed understanding of the metabolic fate of HNE as well as to identify novel targets involved in the biol. activity of the HNE metabolites.  These studies are and will be permitted by the continuous progress in the anal. for the identification and quantitation of novel HNE metabolites as well as for proteomic analyses able to offer a comprehensive picture of the HNE-induced adducted targets.  On these grounds, the present review will focus on the major enzymic and non-enzymic HNE biotransformations discussing both the mol. mechanisms involved and the biol. effects elicited.  The review will also describe the most important anal. enhancements that have permitted the here discussed advancements in the authors' understanding of the HNE metabolic fate and which will permit in a near future an even better knowledge of this enigmatic mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKk4UUjc_R7rVg90H21EOLACvtfcHk0liyegPqMMfVQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1Wkurs%253D&md5=048cab6f29c0710fdfcfea3c20d2d446</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2017.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2017.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DMol%26aufirst%3DM.%26aulast%3DRegazzoni%26aufirst%3DL.%26aulast%3DAltomare%26aufirst%3DA.%26aulast%3DDegani%26aufirst%3DG.%26aulast%3DCarini%26aufirst%3DM.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DAldini%26aufirst%3DG.%26atitle%3DEnzymatic%2520and%2520non-enzymatic%2520detoxification%2520of%25204-hydroxynonenal%253A%2520methodological%2520aspects%2520and%2520biological%2520consequences%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2017%26volume%3D111%26spage%3D328%26epage%3D344%26doi%3D10.1016%2Fj.freeradbiomed.2017.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maisonneuve, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoueiry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lignon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talla, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukan, S.</span></span> <span> </span><span class="NLM_article-title">Rules governing selective protein carbonylation</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e7269</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0007269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0007269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19802390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD1Mnmsl2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=E.+Maisonneuveauthor=A.+Ducretauthor=P.+Khoueiryauthor=S.+Lignonauthor=S.+Longhiauthor=E.+Tallaauthor=S.+Dukan&title=Rules+governing+selective+protein+carbonylation&doi=10.1371%2Fjournal.pone.0007269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Rules governing selective protein carbonylation</span></div><div class="casAuthors">Maisonneuve Etienne; Ducret Adrien; Khoueiry Pierre; Lignon Sabrina; Longhi Sonia; Talla Emmanuel; Dukan Sam</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e7269</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Carbonyl derivatives are mainly formed by direct metal-catalysed oxidation (MCO) attacks on the amino-acid side chains of proline, arginine, lysine and threonine residues.  For reasons unknown, only some proteins are prone to carbonylation.  METHODOLOGY/PRINCIPAL FINDINGS:  we used mass spectrometry analysis to identify carbonylated sites in: BSA that had undergone in vitro MCO, and 23 carbonylated proteins in Escherichia coli.  The presence of a carbonylated site rendered the neighbouring carbonylatable site more prone to carbonylation.  Most carbonylated sites were present within hot spots of carbonylation.  These observations led us to suggest rules for identifying sites more prone to carbonylation.  We used these rules to design an in silico model (available at http://www.lcb.cnrs-mrs.fr/CSPD/), allowing an effective and accurate prediction of sites and of proteins more prone to carbonylation in the E. coli proteome.  CONCLUSIONS/SIGNIFICANCE:  We observed that proteins evolve to either selectively maintain or lose predicted hot spots of carbonylation depending on their biological function.  As our predictive model also allows efficient detection of carbonylated proteins in Bacillus subtilis, we believe that our model may be extended to direct MCO attacks in all organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj4ywhhj4VNGZyxfu64m4ffW6udTcc2eYNBcEcmo0yirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mnmsl2nsQ%253D%253D&md5=17d8e3d6e60f8a109b31f7aba0dc3bd4</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007269%26sid%3Dliteratum%253Aachs%26aulast%3DMaisonneuve%26aufirst%3DE.%26aulast%3DDucret%26aufirst%3DA.%26aulast%3DKhoueiry%26aufirst%3DP.%26aulast%3DLignon%26aufirst%3DS.%26aulast%3DLonghi%26aufirst%3DS.%26aulast%3DTalla%26aufirst%3DE.%26aulast%3DDukan%26aufirst%3DS.%26atitle%3DRules%2520governing%2520selective%2520protein%2520carbonylation%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0007269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, D. J.</span></span> <span> </span><span class="NLM_article-title">Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2135</span>– <span class="NLM_lpage">2139</span>, <span class="refDoi"> DOI: 10.1002/pmic.201200289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fpmic.201200289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=23606334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlGgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2135-2139&author=S.+Marconeauthor=D.+J.+Fitzgerald&title=Proteomic+identification+of+the+candidate+target+proteins+of+15-deoxy-delta12%2C14-prostaglandin+J2&doi=10.1002%2Fpmic.201200289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2S</span></div><div class="casAuthors">Marcone, Simone; Fitzgerald, Desmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2135-2139</span>CODEN:
                <span class="NLM_cas:coden">PROTC7</span>;
        ISSN:<span class="NLM_cas:issn">1615-9853</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">15-Deoxy-delta12, 14-prostaglandin J2 (15d-PGJ2) is an endogenous anti-inflammatory lipid derived from PGD2.  One potential mechanism for its activity is the covalent modification of cellular proteins, via a reactive α,β-unsatd. carbonyl group in its cyclopentenone ring, which in turn alters protein function.  In order to identify the candidate target proteins covalently modified by 15d-PGJ2 in human aortic endothelial cell (EC), EC was treated with biotinylated-15d-PGJ2, the modified proteins extd. by Neutravidin affinity-purifn. and the proteins identified by LTQ Orbitrap mass spectrometer.  Classification of the 358 identified proteins was performed using PANTHER classification system (www.pantherdb.org), showing that the proteins mapped to metabolic process, cellular process, and transport activity.  This protein data set highlights the potential for 15d-PGJ2 to covalently modify cellular proteins and provides a source of data that will aid further studies on the mechanism of action of this endogenous regulator of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJlCCjyM7kY7Vg90H21EOLACvtfcHk0liyegPqMMfVQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlGgs7o%253D&md5=aefebb28d27b1e7166c95d85243be831</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2Fpmic.201200289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.201200289%26sid%3Dliteratum%253Aachs%26aulast%3DMarcone%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DD.%2BJ.%26atitle%3DProteomic%2520identification%2520of%2520the%2520candidate%2520target%2520proteins%2520of%252015-deoxy-delta12%252C14-prostaglandin%2520J2%26jtitle%3DProteomics%26date%3D2013%26volume%3D13%26spage%3D2135%26epage%3D2139%26doi%3D10.1002%2Fpmic.201200289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">25284</span>– <span class="NLM_lpage">25290</span>, <span class="refDoi"> DOI: 10.1074/jbc.M414645200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.M414645200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15879598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFyqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25284-25290&author=J.+Fangauthor=J.+Luauthor=A.+Holmgren&title=Thioredoxin+reductase+is+irreversibly+modified+by+curcumin%3A+a+novel+molecular+mechanism+for+its+anticancer+activity&doi=10.1074%2Fjbc.M414645200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin Reductase Is Irreversibly Modified by Curcumin: a novel molecular mechanism for its anticancer activity</span></div><div class="casAuthors">Fang, Jianguo; Lu, Jun; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">25284-25290</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The thioredoxin reductase (TrxR) isoenzymes, TrxR1 in cytosol or nucleus and TrxR2 in mitochondria, are essential mammalian selenocysteine (Sec)-contg. flavoenzymes with a -Gly-Cys-Sec-Gly active site.  TrxRs are the only enzymes catalyzing the NADPH-dependent redn. of the active site disulfide in thioredoxins (Trxs), which play essential roles in substrate redns., defense against oxidative stress, and redox regulation by thiol redox control.  TrxRs have been found to be overexpressed by a no. of human tumors.  Curcumin, which is consumed daily by millions of people, is a polyphenol derived from the plant Curcuma longa.  This phytochem. has well known anticancer and antiangiogenic properties.  In this study we report that rat TrxR1 activity in Trx-dependent disulfide redn. was inhibited by curcumin.  The IC50 value for the enzyme was 3.6 μM after incubation at room temp. for 2 h in vitro.  The inhibition occurred with enzyme only in the presence of NADPH and persisted after removal of curcumin.  By using mass spectrometry and blotting anal., we proved that this irreversible inhibition by curcumin was caused by alkylation of both residues in the catalytically active site (Cys496/Sec497) of the enzyme.  However, the curcumin-modified enzyme showed a strongly induced NADPH oxidase activity to produce reactive oxygen species.  Inhibition of TrxR by curcumin added to cultured HeLa cells was also obsd. with an IC50 of around 15 μM.  Modification of TrxR by curcumin provides a possible mechanistic explanation for its cancer preventive activity, shifting the enzyme from an antioxidant to a prooxidant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWrKagjmS1sLVg90H21EOLACvtfcHk0ligj4fQX2hLdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFyqtbw%253D&md5=373d0ddf866fdab1c60f811c75a200d7</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M414645200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M414645200%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520reductase%2520is%2520irreversibly%2520modified%2520by%2520curcumin%253A%2520a%2520novel%2520molecular%2520mechanism%2520for%2520its%2520anticancer%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25284%26epage%3D25290%26doi%3D10.1074%2Fjbc.M414645200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangpoengtrakul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">23787</span>– <span class="NLM_lpage">23793</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.34.23787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.274.34.23787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10446139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=23787-23793&author=K.+Okadaauthor=C.+Wangpoengtrakulauthor=T.+Osawaauthor=S.+Toyokuniauthor=K.+Tanakaauthor=K.+Uchida&title=4-Hydroxy-2-nonenal-mediated+impairment+of+intracellular+proteolysis+during+oxidative+stress.+Identification+of+proteasomes+as+target+molecules&doi=10.1074%2Fjbc.274.34.23787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules</span></div><div class="casAuthors">Okada, Kunihiko; Wangpoengtrakul, Chantima; Osawa, Toshihiko; Toyokuni, Shinya; Tanaka, Keiji; Uchida, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">23787-23793</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Oxidative stress is assocd. with important pathophysiol. events in a variety of diseases.  It has been postulated that free radicals and lipid peroxidn. products generated during the process may be responsible for these effects because of their ability to damage cellular components such as membranes, proteins, and DNA.  In the present study, we provide evidence that oxidative stress causes a transient impairment of intracellular proteolysis via covalent binding of 4-hydroxy-2-nonenal (HNE), a major end product of lipid peroxidn., to proteasomes.  A single i.p. treatment with the renal carcinogen, ferric nitrilotriacetate, caused oxidative stress, as monitored by accumulation of lipid peroxidn. products and 8-hydroxy-2'-deoxyguanosine, in the kidney of mice.  In addn., transient accumulation of HNE-modified proteins in the kidney was also found by competitive ELISA and immunohistochem. analyses.  This and the observation that the HNE-modified proteins were significantly ubiquitinated suggested a crucial role of proteasomes in the metab. of HNE-modified proteins.  In vitro incubation of the kidney homogenates with HNE indeed resulted in a transient accumulation of HNE-modified proteins, whereas the proteasome inhibitor significantly suppressed the time-dependent elimination of HNE-modified proteins.  We found that, among three proteolytic activities (trypsin, chymotrypsin, and peptidylglutamyl peptide hydrolase activities) of proteasomes, both trypsin and peptidylglutamyl peptide hydrolase activities in the kidney were transiently diminished in accordance with the accumulation of HNE-modified proteins during oxidative stress.  The loss of proteasome activities was partially ascribed to the direct attachment of HNE to the protein, based on the detection of HNE-proteasome conjugates by an immunopptn. technique.  These results suggest that HNE may contribute to the enhanced accumulation of oxidatively modified proteins via an impairment of ubiquitin/proteasome-dependent intracellular proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopxKQt5H6rxLVg90H21EOLACvtfcHk0ligj4fQX2hLdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOnsLg%253D&md5=8d0e2faf6a7e649a82b3e211195dd0db</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.34.23787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.34.23787%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DWangpoengtrakul%26aufirst%3DC.%26aulast%3DOsawa%26aufirst%3DT.%26aulast%3DToyokuni%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DUchida%26aufirst%3DK.%26atitle%3D4-Hydroxy-2-nonenal-mediated%2520impairment%2520of%2520intracellular%2520proteolysis%2520during%2520oxidative%2520stress.%2520Identification%2520of%2520proteasomes%2520as%2520target%2520molecules%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D23787%26epage%3D23793%26doi%3D10.1074%2Fjbc.274.34.23787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szweda, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, F.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1426</span>, <span class="refDoi"> DOI: 10.1096/fj.04-1743fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1096%2Ffj.04-1743fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15247152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlKlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1424-1426&author=C.+Marquesauthor=P.+Pereiraauthor=A.+Taylorauthor=J.+N.+Liangauthor=V.+N.+Reddyauthor=L.+I.+Szwedaauthor=F.+Shang&title=Ubiquitin-dependent+lysosomal+degradation+of+the+HNE-modified+proteins+in+lens+epithelial+cells&doi=10.1096%2Ffj.04-1743fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells</span></div><div class="casAuthors">Marques, Carla; Pereira, Paulo; Taylor, Allen; Liang, Jack N.; Reddy, Venkat N.; Szweda, Luke I.; Shang, Fu</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1424-1426, 10.1096/fj.04-1743fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">4-Hydroxynonenal (HNE), a highly reactive lipid peroxidn. product, may adversely modify proteins.  Accumulation of HNE-modified proteins may be responsible for pathol. lesions assocd. with oxidative stress.  The objective of this work was to det. how HNE-modified proteins are removed from cells.  The data showed that αB-crystallin modified by HNE was ubiquitinated at a faster rate than that of native αB-crystallin in a cell-free system.  However, its susceptibility to proteasome-dependent degrdn. in the cell-free system did not increase.  When delivered into cultured lens epithelial cells, HNE-modified αB-crystallin was degraded at a faster rate than that of unmodified αB-crystallin.  Inhibition of the lysosomal activity stabilized HNE-modified αB-crystallin, but inhibition of the proteasome activity alone had little effect.  To det. if other HNE-modified proteins are also degraded in a ubiquitin-dependent lysosomal pathway, lens epithelial cells were treated with HNE and the removal of HNE-modified proteins in the cells was monitored.  The levels of HNE-modified proteins in the cell decreased rapidly upon removal of HNE from the medium.  Depletion of ATP or the presence of MG132, a proteasome/lysosome inhibitor, resulted in stabilization of HNE-modified proteins.  However, proteasome-specific inhibitors, lactacystin-β-lactone and epoxomicin, could not stabilize HNE-modified proteins in the cells.  In contrast, chloroquine, a lysosome inhibitor, stabilized HNE-modified proteins.  The enrichment of HNE-modified proteins in the fraction of ubiquitin conjugates suggests that HNE-modified proteins are preferentially ubiquitinated.  Taken together, these findings show that HNE-modified proteins are degraded via a novel ubiquitin and lysosomal-dependent but proteasome-independent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnpjgJoSdy7Vg90H21EOLACvtfcHk0ligj4fQX2hLdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlKlu7w%253D&md5=11ec46c217186f08a18bc8b612cd82fd</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-1743fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-1743fje%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DC.%26aulast%3DPereira%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DJ.%2BN.%26aulast%3DReddy%26aufirst%3DV.%2BN.%26aulast%3DSzweda%26aufirst%3DL.%2BI.%26aulast%3DShang%26aufirst%3DF.%26atitle%3DUbiquitin-dependent%2520lysosomal%2520degradation%2520of%2520the%2520HNE-modified%2520proteins%2520in%2520lens%2520epithelial%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1424%26epage%3D1426%26doi%3D10.1096%2Ffj.04-1743fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span> <span> </span><span class="NLM_article-title">Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1111/jnc.13957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1111%2Fjnc.13957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28095639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislWnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=941-954&author=S.+Zhangauthor=E.+Eitanauthor=M.+P.+Mattson&title=Early+involvement+of+lysosome+dysfunction+in+the+degeneration+of+cerebral+cortical+neurons+caused+by+the+lipid+peroxidation+product+4-hydroxynonenal&doi=10.1111%2Fjnc.13957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal</span></div><div class="casAuthors">Zhang, Shi; Eitan, Erez; Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-954</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Free radical-mediated oxidative damage to proteins, lipids, and DNA occurs in neurons during acute brain injuries and in neurodegenerative disorders.  Membrane lipid peroxidn. contributes to neuronal dysfunction and death, in part by disrupting neuronal ion homeostasis and cellular bioenergetics.  Emerging findings suggest that 4-hydroxynonenal (HNE), an aldehyde produced during lipid peroxidn., impairs the function of various proteins involved in neuronal homeostasis.  Here we tested the hypothesis that HNE impairs the cellular system that removes damaged proteins and organelles, the autophagy-lysosome pathway in rat primary cortical neurons.  We found that HNE, at a concn. that causes apoptosis over a 48-72 h period, increases protein levels of LC3 II and p62 and within 1 and 4 h of exposure, resp.; LC3 II and p62 immunoreactive puncta were obsd. in the cytoplasm of HNE-treated neurons at 6 h.  The extent of up-regulation of p62 and LC3 II in response to HNE was not affected by co-treatment with the lysosome inhibitor bafilomycin A1, suggesting that the effects of HNE on autophagy were secondary to lysosome inhibition.  Indeed, we found that neurons exposed to HNE exhibit elevated pH levels, and decreased protein substrate hydrolysis and cathepsin B activity.  Neurons exposed to HNE also exhibited the accumulation of K63-linked polyubiquitinated proteins, which are substrates targeted for lysosomal degrdn.  Moreover, we found that the levels of LAMP2a and constitutively active heat-shock protein 70, and nos. of LAMP2a-pos. lysosomes, are decreased in neurons exposed to HNE.  Our findings demonstrate that the lipid peroxidn. product HNE causes early impairment of lysosomes which may contribute to the accumulation of damaged and dysfunctional proteins and organelles and consequent neuronal death.  Because impaired lysosome function is increasingly recognized as an early event in the neuronal death that occurs in neurodegenerative disorders, our findings suggest a role for HNE in such lysosomal dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq6NywODZ6XrVg90H21EOLACvtfcHk0lgnmzTr1gLbtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislWnsb4%253D&md5=8344befc0d840a6bc38a0fe9dea9ecc2</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13957%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DEitan%26aufirst%3DE.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DEarly%2520involvement%2520of%2520lysosome%2520dysfunction%2520in%2520the%2520degeneration%2520of%2520cerebral%2520cortical%2520neurons%2520caused%2520by%2520the%2520lipid%2520peroxidation%2520product%25204-hydroxynonenal%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D140%26spage%3D941%26epage%3D954%26doi%3D10.1111%2Fjnc.13957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meduru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.4161/cbt.10.10.13250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.4161%2Fcbt.10.10.13250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20798598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1egsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1027-1032&author=A.+Daytonauthor=K.+Selvendiranauthor=M.+L.+Kuppusamyauthor=B.+K.+Riveraauthor=S.+Meduruauthor=T.+Kalaiauthor=K.+Hidegauthor=P.+Kuppusamy&title=Cellular+uptake%2C+retention+and+bioabsorption+of+HO-3867%2C+a+fluorinated+curcumin+analog+with+potential+antitumor+properties&doi=10.4161%2Fcbt.10.10.13250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties</span></div><div class="casAuthors">Dayton, Alex; Selvendiran, Karuppaiyah; Kuppusamy, M. Lakshmi; Rivera, Brian K.; Meduru, Sarath; Kalai, Tamas; Hideg, Kalman; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1027-1032</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Curcumin, a naturally-occurring compd. found in the rhizome of Curcuma longa plant, is known for its antitumor activities.  However, its clin. efficacy is limited due to poor bioabsorption.  A new class of synthetic analogs of curcumin, namely diarylidenylpiperidone (DAP), has been developed with substantially higher anticancer activity than curcumin.  However, its cellular uptake and bioabsorption have riot been evaluated.  In this study we have detd. the absorption of a representative DAP compd., HO-3867, using optical and ESR spectrometry.  The cellular uptake of HO-3867 was measured in a variety of cancer cell lines.  HO-3867 was taken in cells within 15 min of exposure and its uptake was more than 100-fold higher than curcumin.  HO-3867 was also retained in cells in an active form for 72 h and possibly longer.  HO-3867 was substantially cytotoxic to all the cancer cells tested.  However, there was no direct correlation between cellular uptake and cytotoxicity suggesting that the cytotoxic mechanisms could be cell-type specific.  When administered to rats by i.p. injection, significantly high levels of HO-3867 were found in the liver, kidney, stomach and blood after 3 h.  Also, significant accumulation of HO-3867 was found in murine tumor xenografts with a dose-dependent inhibition of tumor growth.  The results suggest that the curcumin analog has substantially higher bioabsorption when compared to curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHVmuXcv8U7Vg90H21EOLACvtfcHk0lgnmzTr1gLbtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1egsr0%253D&md5=10edc00c082ff97ba8e0d28d116155e8</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.4161%2Fcbt.10.10.13250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.10.10.13250%26sid%3Dliteratum%253Aachs%26aulast%3DDayton%26aufirst%3DA.%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DMeduru%26aufirst%3DS.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DCellular%2520uptake%252C%2520retention%2520and%2520bioabsorption%2520of%2520HO-3867%252C%2520a%2520fluorinated%2520curcumin%2520analog%2520with%2520potential%2520antitumor%2520properties%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D1027%26epage%3D1032%26doi%3D10.4161%2Fcbt.10.10.13250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Cellular processing of platinum anticancer drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nrd1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnrd1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15789122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=307-320&author=D.+Wangauthor=S.+J.+Lippard&title=Cellular+processing+of+platinum+anticancer+drugs&doi=10.1038%2Fnrd1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular processing of platinum anticancer drugs</span></div><div class="casAuthors">Wang, Dong; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-320</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy.  Platinum-DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs.  This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signaling of DNA damage, cell-cycle checkpoints and arrest, DNA repair and cell death.  Such knowledge of the cellular processing of cisplatin adducts with DNA provides valuable clues for the rational design of more efficient platinum-based drugs as well as the development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHJfZNaqwy67Vg90H21EOLACvtfcHk0lhVmUHtfN7XUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D&md5=e44a8e87683ba5cfe3e165f9f4229fee</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fnrd1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1691%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DCellular%2520processing%2520of%2520platinum%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D307%26epage%3D320%26doi%3D10.1038%2Fnrd1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havelka, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoshan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1002/ijc.22132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fijc.22132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=17044026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD28nltVyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=175-180&author=M.+Berndtssonauthor=M.+Haggauthor=T.+Panaretakisauthor=A.+M.+Havelkaauthor=M.+C.+Shoshanauthor=S.+Linder&title=Acute+apoptosis+by+cisplatin+requires+induction+of+reactive+oxygen+species+but+is+not+associated+with+damage+to+nuclear+DNA&doi=10.1002%2Fijc.22132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA</span></div><div class="casAuthors">Berndtsson Maria; Hagg Maria; Panaretakis Theocharis; Havelka Aleksandra Mandic; Shoshan Maria C; Linder Stig</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-80</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Cisplatin is a broad-spectrum anticancer drug that is also widely used in experimental studies on DNA damage-induced apoptosis.  Induction of apoptosis within 24-48 hr requires cisplatin concentrations that are at least one order of magnitude higher than the IC(50).  Here, we show that such high, apoptosis-inducing cisplatin concentrations induce cellular superoxide formation and that apoptosis is inhibited by superoxide scavengers.  The same concentration limit and the requirement for superoxide are also true for induction of caspase activation in enucleated cells (cytoplasts), showing that cisplatin-induced apoptosis occurs independently of nuclear DNA damage.  In contrast, lower cisplatin concentrations, which do not induce acute apoptosis, are sufficient for induction of DNA damage signaling.  We propose that the antiproliferative effects of cisplatin at IC(50) doses involve premature senescence and secondary, nonstress-induced apoptosis.  The higher doses currently used in in vitro studies lead to acute, stress-induced apoptosis that involves induction of superoxide but is largely DNA damage-independent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5_jtJBSbIKPSAs_PE1QvifW6udTcc2eacxHWXvbcpkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nltVyktw%253D%253D&md5=a7861d675ec983eddfd53d85a031beec</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1002%2Fijc.22132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22132%26sid%3Dliteratum%253Aachs%26aulast%3DBerndtsson%26aufirst%3DM.%26aulast%3DHagg%26aufirst%3DM.%26aulast%3DPanaretakis%26aufirst%3DT.%26aulast%3DHavelka%26aufirst%3DA.%2BM.%26aulast%3DShoshan%26aufirst%3DM.%2BC.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DAcute%2520apoptosis%2520by%2520cisplatin%2520requires%2520induction%2520of%2520reactive%2520oxygen%2520species%2520but%2520is%2520not%2520associated%2520with%2520damage%2520to%2520nuclear%2520DNA%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D175%26epage%3D180%26doi%3D10.1002%2Fijc.22132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. B.,  IV</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, J. P.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00832-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2FS0960-894X%2802%2900832-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=12467629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Cqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=115-117&author=T.+P.+Robinsonauthor=T.+Ehlersauthor=R.+B.+Hubbardauthor=X.+Baiauthor=J.+L.+Arbiserauthor=D.+J.+Goldsmithauthor=J.+P.+Bowen&title=Design%2C+synthesis%2C+and+biological+evaluation+of+angiogenesis+inhibitors%3A+aromatic+enone+and+dienone+analogues+of+curcumin&doi=10.1016%2FS0960-894X%2802%2900832-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin</span></div><div class="casAuthors">Robinson, Thomas Philip; Ehlers, Tedman; Hubbard, Richard B.; Bai, Xianhe; Arbiser, Jack L.; Goldsmith, David J.; Bowen, J. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-117</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The quest to find new antitumor compds. is an ongoing research endeavor in many labs. around the world.  The use of small-mol. angiogenesis inhibitors promises to be a potentially effective method for cancer treatment and possible prevention.  Many antiangiogenic compds. are in various stages of lab. evaluations and clin. trials.  Curcumin is a natural product that has exhibited potent antiangiogenic properties.  Based on a simple pharmacophore model, using std. drug design concepts, arom. enone and arom. dienone analogs of curcumin were prepd. and/or obtained com.  These compds. were screened for antiangiogenic properties via an in vitro SVR assay and were found to inhibit cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7aewmjUsjirVg90H21EOLACvtfcHk0lhVmUHtfN7XUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Cqu7o%253D&md5=2a05b0fc5afd81d5f4142231c0e2d08d</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900832-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900832-6%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DT.%2BP.%26aulast%3DEhlers%26aufirst%3DT.%26aulast%3DHubbard%26aufirst%3DR.%2BB.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26aulast%3DGoldsmith%26aufirst%3DD.%2BJ.%26aulast%3DBowen%26aufirst%3DJ.%2BP.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520angiogenesis%2520inhibitors%253A%2520aromatic%2520enone%2520and%2520dienone%2520analogues%2520of%2520curcumin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D115%26epage%3D117%26doi%3D10.1016%2FS0960-894X%2802%2900832-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thackaberry, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopytek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherratt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trouba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, B.</span></span> <span> </span><span class="NLM_article-title">Comprehensive investigation of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-beta-cyclodextrin for use in general toxicology studies</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfq207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Ftoxsci%2Fkfq207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20643750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyltb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2010&pages=485-492&author=E.+A.+Thackaberryauthor=S.+Kopytekauthor=P.+Sherrattauthor=K.+Troubaauthor=B.+McIntyre&title=Comprehensive+investigation+of+hydroxypropyl+methylcellulose%2C+propylene+glycol%2C+polysorbate+80%2C+and+hydroxypropyl-beta-cyclodextrin+for+use+in+general+toxicology+studies&doi=10.1093%2Ftoxsci%2Fkfq207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive Investigation of Hydroxypropyl Methylcellulose, Propylene Glycol, Polysorbate 80, and Hydroxypropyl-Beta-Cyclodextrin for use in General Toxicology Studies</span></div><div class="casAuthors">Thackaberry, Evan A.; Kopytek, Stephen; Sherratt, Phillip; Trouba, Kevin; McIntyre, Barry</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">485-492</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">This study was conducted to assess the safety and tolerability of the alternative formulation vehicles polysorbate 80 (PS80), propylene glycol (PG), and hydroxypropyl-beta-cyclodextrin (HPβCD) in general toxicol. studies in the mouse, rat, dog, and monkey.  Twenty (20) mg/kg of hydroxypropyl methylcellulose (MC, control), 10 mg/kg PS80, 1000 mg/kg PG, 500 mg/kg HPβCD, or 1000 mg/kg HPβCD were administered by oral gavage to mice, rats, dogs, and cynomolgus monkeys for approx. 90 days.  The effects of these formulations on clin. observations, body wt. and food consumption parameters, clin. pathol., and histopathol. were evaluated across all species.  The suitability of formulations contg. up to 20 mg/kg MC, 10 mg/kg PS80, and 1000 mg/kg PG for use in preclin. safety studies was confirmed by a lack of effects on all parameters examd.  However, formulations contg. HPβCD produced elevated transaminase (aspartate and alanine aminotransferase) levels in rats and mice and fecal changes (loose and soft stool) in large animals.  Although the etiol. and toxicol. significance of the transaminase elevations in rats and mice is uncertain, this finding could represent a significant liability for a preclin. formulation because of the crit. importance of these biomarkers in the risk assessment of novel therapeutic agents.  Based on these data, PS80 and PG are considered to be practical alternatives to MC in preclin. toxicol. studies.  However, formulations contg. HPβCD should be used with caution because of the elevations in rodent transaminase levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQeX-9u3aWf7Vg90H21EOLACvtfcHk0lhCCIkCrjf4nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyltb7F&md5=afd1e4fa16a34edefb0ac0ff79da673f</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq207%26sid%3Dliteratum%253Aachs%26aulast%3DThackaberry%26aufirst%3DE.%2BA.%26aulast%3DKopytek%26aufirst%3DS.%26aulast%3DSherratt%26aufirst%3DP.%26aulast%3DTrouba%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DB.%26atitle%3DComprehensive%2520investigation%2520of%2520hydroxypropyl%2520methylcellulose%252C%2520propylene%2520glycol%252C%2520polysorbate%252080%252C%2520and%2520hydroxypropyl-beta-cyclodextrin%2520for%2520use%2520in%2520general%2520toxicology%2520studies%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D117%26spage%3D485%26epage%3D492%26doi%3D10.1093%2Ftoxsci%2Fkfq207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowinsky, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdeja, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paba-Prada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venugopal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porkka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loskog, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landgren, O.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1453</span>, <span class="refDoi"> DOI: 10.1007/s10637-020-00915-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs10637-020-00915-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=32125598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslykurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=1448-1453&author=E.+K.+Rowinskyauthor=A.+Panerauthor=J.+G.+Berdejaauthor=C.+Paba-Pradaauthor=P.+Venugopalauthor=K.+Porkkaauthor=J.+Gullboauthor=S.+Linderauthor=A.+Loskogauthor=P.+G.+Richardsonauthor=O.+Landgren&title=Phase+1+study+of+the+protein+deubiquitinase+inhibitor+VLX1570+in+patients+with+relapsed+and%2For+refractory+multiple+myeloma&doi=10.1007%2Fs10637-020-00915-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma</span></div><div class="casAuthors">Rowinsky, Eric K.; Paner, Agne; Berdeja, Jesus G.; Paba-Prada, Claudia; Venugopal, Parameswaran; Porkka, Kimmo; Gullbo, Joachim; Linder, Stig; Loskog, Angelica; Richardson, Paul G.; Landgren, Ola</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1448-1453</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Summary: This phase 1 study sought to characterize the safety, tolerability, and pharmacokinetic behavior of VLX1570, a small mol. inhibitor of the deubiquitinases (DUBs) that remove sterically bulky ubiquitin chains from proteins during processing in the19S regulatory subunit of the proteasome, in patients with relapsed and refractory multiple myeloma (MM).  Fourteen patients were treated with escalating doses of VLX1570 ranging from 0.05 to 1.2 mg/kg as a brief i.v. (IV) infusion on Days 1, 2, 8, 9, 15, and 16 of a 28-day cycle.  Due to its poor aq. soly., VLX1570 was formulated in polyethylene glycol, polyoxyethylated castor oil, and polysorbate 80 and administered as a brief i.v. (IV) infusion via a central venous catheter.  Anti-myeloma effects were noted at doses at or above 0.6 mg/kg, however, two patients treated at the 1.2 mg/kg dose level experienced severe, abrupt, and progressive respiratory insufficiency, which was assocd. with diffuse pulmonary infiltrates on imaging studies, similar to those rarely noted with bortezomib and other inhibitors of the 20S proteasome, culminating in death.  Although the contribution of VLX1570's formulation to the pulmonary toxicity could not be ruled out, the severity and precipitous nature of the toxicity and the steep relationship between dose and toxicity, the study was discontinued.  Despite the severe pulmonary toxicity noted with VLX1570, efforts directed at identifying DUB inhibitors with greater therapeutic indexes appear warranted based on the unique mechanism of action, robustness of preclin. antitumor activity, and activity of the DUB inhibitors in MM resistant to PIs targeting the 20S proteasome subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6mUOQ3zhPrVg90H21EOLACvtfcHk0lhCCIkCrjf4nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslykurs%253D&md5=ecde1e0e66c08aa1d3602cc89a7b05c7</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1007%2Fs10637-020-00915-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-020-00915-4%26sid%3Dliteratum%253Aachs%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26aulast%3DPaner%26aufirst%3DA.%26aulast%3DBerdeja%26aufirst%3DJ.%2BG.%26aulast%3DPaba-Prada%26aufirst%3DC.%26aulast%3DVenugopal%26aufirst%3DP.%26aulast%3DPorkka%26aufirst%3DK.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DLoskog%26aufirst%3DA.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DLandgren%26aufirst%3DO.%26atitle%3DPhase%25201%2520study%2520of%2520the%2520protein%2520deubiquitinase%2520inhibitor%2520VLX1570%2520in%2520patients%2520with%2520relapsed%2520and%252For%2520refractory%2520multiple%2520myeloma%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2020%26volume%3D38%26spage%3D1448%26epage%3D1453%26doi%3D10.1007%2Fs10637-020-00915-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uprety, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belur, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakal, A.</span></span> <span> </span><span class="NLM_article-title">Bortezomib-Induced Pulmonary Toxicity: A case report and review of literature</span>. <i>Case Rep. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">2913124</span>, <span class="refDoi"> DOI: 10.1155/2018/2913124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1155%2F2018%2F2913124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30595697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3cnms1yiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=2913124&author=P.+Kharelauthor=D.+Upretyauthor=A.+B.+Chandraauthor=Y.+Huauthor=A.+A.+Belurauthor=A.+Dhakal&title=Bortezomib-Induced+Pulmonary+Toxicity%3A+A+case+report+and+review+of+literature&doi=10.1155%2F2018%2F2913124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature</span></div><div class="casAuthors">Kharel Prakash; Uprety Deekchha; Chandra Abhinav B; Hu Yirui; Belur Anuradha Avinash; Dhakal Ajay</div><div class="citationInfo"><span class="NLM_cas:title">Case reports in medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2913124</span>
        ISSN:<span class="NLM_cas:issn">1687-9627</span>.
    </div><div class="casAbstract">Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma.  Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports.  The objective of this study is to report a case of bortezomib-induced lung injury, review current literature, and perform exploratory analysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsDA0LaTEnU7YtC3U5jeOifW6udTcc2eY9ighnZA9W_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnms1yiug%253D%253D&md5=5b4a198b273c85d181c6dd830a987bed</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1155%2F2018%2F2913124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F2913124%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DP.%26aulast%3DUprety%26aufirst%3DD.%26aulast%3DChandra%26aufirst%3DA.%2BB.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBelur%26aufirst%3DA.%2BA.%26aulast%3DDhakal%26aufirst%3DA.%26atitle%3DBortezomib-Induced%2520Pulmonary%2520Toxicity%253A%2520A%2520case%2520report%2520and%2520review%2520of%2520literature%26jtitle%3DCase%2520Rep.%2520Med.%26date%3D2018%26volume%3D2018%26spage%3D2913124%26doi%3D10.1155%2F2018%2F2913124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alnemri, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amelio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annicchiarico-Petruzzelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehrecke, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlev, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernassola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagosklonny, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona-Gutierrez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cubillos-Ruiz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Angiolella, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Laurenzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Daniele, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynlacht, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimia, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Saez, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golstein, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajnoczky, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengartner, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaattela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juin, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemasters, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockshin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malorni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marine, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Pinedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervaiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacentini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prehn, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puthalakath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, C. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistigu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait, S. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgin, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vousden, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakeri, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/s41418-017-0012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41418-017-0012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29362479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=486-541&author=L.+Galluzziauthor=I.+Vitaleauthor=S.+A.+Aaronsonauthor=J.+M.+Abramsauthor=D.+Adamauthor=P.+Agostinisauthor=E.+S.+Alnemriauthor=L.+Altucciauthor=I.+Amelioauthor=D.+W.+Andrewsauthor=M.+Annicchiarico-Petruzzelliauthor=A.+V.+Antonovauthor=E.+Aramaauthor=E.+H.+Baehreckeauthor=N.+A.+Barlevauthor=N.+G.+Bazanauthor=F.+Bernassolaauthor=M.+J.+M.+Bertrandauthor=K.+Bianchiauthor=M.+V.+Blagosklonnyauthor=K.+Blomgrenauthor=C.+Bornerauthor=P.+Boyaauthor=C.+Brennerauthor=M.+Campanellaauthor=E.+Candiauthor=D.+Carmona-Gutierrezauthor=F.+Cecconiauthor=F.+K.-M.+Chanauthor=N.+S.+Chandelauthor=E.+H.+Chengauthor=J.+E.+Chipukauthor=J.+A.+Cidlowskiauthor=A.+Ciechanoverauthor=G.+M.+Cohenauthor=M.+Conradauthor=J.+R.+Cubillos-Ruizauthor=P.+E.+Czabotarauthor=V.+D%E2%80%99Angiolellaauthor=T.+M.+Dawsonauthor=V.+L.+Dawsonauthor=V.+De+Laurenziauthor=R.+De+Mariaauthor=K.-M.+Debatinauthor=R.+J.+DeBerardinisauthor=M.+Deshmukhauthor=N.+Di+Danieleauthor=F.+Di+Virgilioauthor=V.+M.+Dixitauthor=S.+J.+Dixonauthor=C.+S.+Duckettauthor=B.+D.+Dynlachtauthor=W.+S.+El-Deiryauthor=J.+W.+Elrodauthor=G.+M.+Fimiaauthor=S.+Fuldaauthor=A.+J.+Garcia-Saezauthor=A.+D.+Gargauthor=C.+Garridoauthor=E.+Gavathiotisauthor=P.+Golsteinauthor=E.+Gottliebauthor=D.+R.+Greenauthor=L.+A.+Greeneauthor=H.+Gronemeyerauthor=A.+Grossauthor=G.+Hajnoczkyauthor=J.+M.+Hardwickauthor=I.+S.+Harrisauthor=M.+O.+Hengartnerauthor=C.+Hetzauthor=H.+Ichijoauthor=M.+Jaattelaauthor=B.+Josephauthor=P.+J.+Jostauthor=P.+P.+Juinauthor=W.+J.+Kaiserauthor=M.+Karinauthor=T.+Kaufmannauthor=O.+Keppauthor=A.+Kimchiauthor=R.+N.+Kitsisauthor=D.+J.+Klionskyauthor=R.+A.+Knightauthor=S.+Kumarauthor=S.+W.+Leeauthor=J.+J.+Lemastersauthor=B.+Levineauthor=A.+Linkermannauthor=S.+A.+Liptonauthor=R.+A.+Lockshinauthor=C.+Lopez-Otinauthor=S.+W.+Loweauthor=T.+Lueddeauthor=E.+Lugliauthor=M.+MacFarlaneauthor=F.+Madeoauthor=M.+Malewiczauthor=W.+Malorniauthor=G.+Manicauthor=J.-C.+Marineauthor=S.+J.+Martinauthor=J.-C.+Martinouauthor=J.+P.+Medemaauthor=P.+Mehlenauthor=P.+Meierauthor=S.+Melinoauthor=E.+A.+Miaoauthor=J.+D.+Molkentinauthor=U.+M.+Mollauthor=C.+Munoz-Pinedoauthor=S.+Nagataauthor=G.+Nunezauthor=A.+Oberstauthor=M.+Orenauthor=M.+Overholtzerauthor=M.+Paganoauthor=T.+Panaretakisauthor=M.+Pasparakisauthor=J.+M.+Penningerauthor=D.+M.+Pereiraauthor=S.+Pervaizauthor=M.+E.+Peterauthor=M.+Piacentiniauthor=P.+Pintonauthor=J.+H.+M.+Prehnauthor=H.+Puthalakathauthor=G.+A.+Rabinovichauthor=M.+Rehmauthor=R.+Rizzutoauthor=C.+M.+P.+Rodriguesauthor=D.+C.+Rubinszteinauthor=T.+Rudelauthor=K.+M.+Ryanauthor=E.+Sayanauthor=L.+Scorranoauthor=F.+Shaoauthor=Y.+Shiauthor=J.+Silkeauthor=H.-U.+Simonauthor=A.+Sistiguauthor=B.+R.+Stockwellauthor=A.+Strasserauthor=G.+Szabadkaiauthor=S.+W.+G.+Taitauthor=D.+Tangauthor=N.+Tavernarakisauthor=A.+Thorburnauthor=Y.+Tsujimotoauthor=B.+Turkauthor=T.+Vanden+Bergheauthor=P.+Vandenabeeleauthor=M.+G.+Vander+Heidenauthor=A.+Villungerauthor=H.+W.+Virginauthor=K.+H.+Vousdenauthor=D.+Vucicauthor=E.+F.+Wagnerauthor=H.+Walczakauthor=D.+Wallachauthor=Y.+Wangauthor=J.+A.+Wellsauthor=W.+Woodauthor=J.+Yuanauthor=Z.+Zakeriauthor=B.+Zhivotovskyauthor=L.+Zitvogelauthor=G.+Melinoauthor=G.+Kroemer&title=Molecular+mechanisms+of+cell+death%3A+recommendations+of+the+Nomenclature+Committee+on+Cell+Death+2018&doi=10.1038%2Fs41418-017-0012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span></div><div class="casAuthors">Galluzzi Lorenzo; Galluzzi Lorenzo; Cubillos-Ruiz Juan R; Galluzzi Lorenzo; Kepp Oliver; Kroemer Guido; Vitale Ilio; Campanella Michelangelo; Cecconi Francesco; Manic Gwenola; Piacentini Mauro; Vitale Ilio; Campanella Michelangelo; Manic Gwenola; Aaronson Stuart A; Chipuk Jerry E; Abrams John M; Adam Dieter; Agostinis Patrizia; Garg Abhishek D; Alnemri Emad S; Altucci Lucia; Amelio Ivano; Antonov Alexey V; Knight Richard A; MacFarlane Marion; Malewicz Michal; Melino Gerry; Andrews David W; Andrews David W; Andrews David W; Annicchiarico-Petruzzelli Margherita; Candi Eleonora; Arama Eli; Kimchi Adi; Baehrecke Eric H; Barlev Nickolai A; Bazan Nicolas G; Bernassola Francesca; Candi Eleonora; Melino Gerry; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bianchi Katiuscia; Blagosklonny Mikhail V; Blomgren Klas; Kroemer Guido; Blomgren Klas; Borner Christoph; Borner Christoph; Boya Patricia; Brenner Catherine; Brenner Catherine; Campanella Michelangelo; Campanella Michelangelo; Carmona-Gutierrez Didac; Madeo Frank; Cecconi Francesco; Cecconi Francesco; Chan Francis K-M; Chandel Navdeep S; Cheng Emily H; Cidlowski John A; Ciechanover Aaron; Gottlieb Eyal; Cohen Gerald M; Conrad Marcus; Cubillos-Ruiz Juan R; Czabotar Peter E; Strasser Andreas; Czabotar Peter E; Silke John; D'Angiolella Vincenzo; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Ted M; Dawson Valina L; Dawson Valina L; De Laurenzi Vincenzo; De Maria Ruggero; Sistigu Antonella; Debatin Klaus-Michael; DeBerardinis Ralph J; Deshmukh Mohanish; Di Daniele Nicola; Di Virgilio Francesco; Pinton Paolo; Dixit Vishva M; Dixon Scott J; Duckett Colin S; Dynlacht Brian D; Dynlacht Brian D; Pagano Michele; El-Deiry Wafik S; El-Deiry Wafik S; Elrod John W; Fimia Gian Maria; Piacentini Mauro; Fimia Gian Maria; Fulda Simone; Fulda Simone; Fulda Simone; Garcia-Saez Ana J; Garrido Carmen; Garrido Carmen; Garrido Carmen; Gavathiotis Evripidis; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Golstein Pierre; Gottlieb Eyal; Ryan Kevin M; Tait Stephen W G; Green Douglas R; Greene Lloyd A; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gross Atan; Hajnoczky Gyorgy; Hardwick J Marie; Harris Isaac S; Yuan Junying; Hengartner Michael O; Hetz Claudio; Hetz Claudio; Hetz Claudio; Ichijo Hidenori; Jaattela Marja; Joseph Bertrand; Zhivotovsky Boris; Jost Philipp J; Juin Philippe P; Juin Philippe P; Juin Philippe P; Juin Philippe P; Kaiser William J; Karin Michael; Karin Michael; Karin Michael; Karin Michael; Kaufmann Thomas; Simon Hans-Uwe; Kepp Oliver; Zitvogel Laurence; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kitsis Richard N; Kitsis Richard N; Klionsky Daniel J; Klionsky Daniel J; Kumar Sharad; Lee Sam W; Lemasters John J; Lemasters John J; Levine Beth; Levine Beth; Levine Beth; Linkermann Andreas; Lipton Stuart A; Lipton Stuart A; Lipton Stuart A; Lockshin Richard A; Lockshin Richard A; Lopez-Otin Carlos; Lowe Scott W; Lowe Scott W; Luedde Tom; Lugli Enrico; Lugli Enrico; Madeo Frank; Malorni Walter; Marine Jean-Christophe; Marine Jean-Christophe; Martin Seamus J; Martinou Jean-Claude; Medema Jan Paul; Medema Jan Paul; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Meier Pascal; Melino Sonia; Miao Edward A; Miao Edward A; Miao Edward A; Molkentin Jeffery D; Moll Ute M; Munoz-Pinedo Cristina; Nagata Shigekazu; Nunez Gabriel; Nunez Gabriel; Oberst Andrew; Oberst Andrew; Oren Moshe; Overholtzer Michael; Pagano Michele; Pagano Michele; Panaretakis Theocharis; Panaretakis Theocharis; Pasparakis Manolis; Pasparakis Manolis; Penninger Josef M; Pereira David M; Pervaiz Shazib; Pervaiz Shazib; Pervaiz Shazib; Peter Marcus E; Peter Marcus E; Pinton Paolo; Pinton Paolo; Prehn Jochen H M; Puthalakath Hamsa; Rabinovich Gabriel A; Rabinovich Gabriel A; Rehm Markus; Rehm Markus; Rizzuto Rosario; Szabadkai Gyorgy; Rodrigues Cecilia M P; Rubinsztein David C; Rudel Thomas; Sayan Emre; Scorrano Luca; Scorrano Luca; Shao Feng; Shi Yufang; Shi Yufang; Shi Yufang; Silke John; Sistigu Antonella; Stockwell Brent R; Stockwell Brent R; Szabadkai Gyorgy; Szabadkai Gyorgy; Vousden Karen H; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tavernarakis Nektarios; Thorburn Andrew; Tsujimoto Yoshihide; Turk Boris; Turk Boris; Vander Heiden Matthew G; Vander Heiden Matthew G; Vander Heiden Matthew G; Villunger Andreas; Virgin Herbert W; Vucic Domagoj; Wagner Erwin F; Walczak Henning; Wallach David; Wang Ying; Wells James A; Wood Will; Yuan Junying; Zakeri Zahra; Zhivotovsky Boris; Zitvogel Laurence; Zitvogel Laurence; Zitvogel Laurence; Kroemer Guido</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">486-541</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives.  Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process.  As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes.  The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVakKpC8MvO-R_TJajKxJDfW6udTcc2ebp3KoBI9wPB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D&md5=4f2b2e5757ae4448c16f7114cd494a7c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fs41418-017-0012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-017-0012-4%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BM.%26aulast%3DAdam%26aufirst%3DD.%26aulast%3DAgostinis%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DAmelio%26aufirst%3DI.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DAnnicchiarico-Petruzzelli%26aufirst%3DM.%26aulast%3DAntonov%26aufirst%3DA.%2BV.%26aulast%3DArama%26aufirst%3DE.%26aulast%3DBaehrecke%26aufirst%3DE.%2BH.%26aulast%3DBarlev%26aufirst%3DN.%2BA.%26aulast%3DBazan%26aufirst%3DN.%2BG.%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%2BM.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26aulast%3DBlomgren%26aufirst%3DK.%26aulast%3DBorner%26aufirst%3DC.%26aulast%3DBoya%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DCampanella%26aufirst%3DM.%26aulast%3DCandi%26aufirst%3DE.%26aulast%3DCarmona-Gutierrez%26aufirst%3DD.%26aulast%3DCecconi%26aufirst%3DF.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DCubillos-Ruiz%26aufirst%3DJ.%2BR.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DD%25E2%2580%2599Angiolella%26aufirst%3DV.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDe%2BLaurenzi%26aufirst%3DV.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26aulast%3DDebatin%26aufirst%3DK.-M.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DM.%26aulast%3DDi%2BDaniele%26aufirst%3DN.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26aulast%3DDynlacht%26aufirst%3DB.%2BD.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26aulast%3DElrod%26aufirst%3DJ.%2BW.%26aulast%3DFimia%26aufirst%3DG.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DGarcia-Saez%26aufirst%3DA.%2BJ.%26aulast%3DGarg%26aufirst%3DA.%2BD.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DGolstein%26aufirst%3DP.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DHajnoczky%26aufirst%3DG.%26aulast%3DHardwick%26aufirst%3DJ.%2BM.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DHengartner%26aufirst%3DM.%2BO.%26aulast%3DHetz%26aufirst%3DC.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJaattela%26aufirst%3DM.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DJost%26aufirst%3DP.%2BJ.%26aulast%3DJuin%26aufirst%3DP.%2BP.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DT.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKimchi%26aufirst%3DA.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26aulast%3DKnight%26aufirst%3DR.%2BA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DLemasters%26aufirst%3DJ.%2BJ.%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26aulast%3DLockshin%26aufirst%3DR.%2BA.%26aulast%3DLopez-Otin%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DLuedde%26aufirst%3DT.%26aulast%3DLugli%26aufirst%3DE.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DMalewicz%26aufirst%3DM.%26aulast%3DMalorni%26aufirst%3DW.%26aulast%3DManic%26aufirst%3DG.%26aulast%3DMarine%26aufirst%3DJ.-C.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DMartinou%26aufirst%3DJ.-C.%26aulast%3DMedema%26aufirst%3DJ.%2BP.%26aulast%3DMehlen%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DP.%26aulast%3DMelino%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DE.%2BA.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26aulast%3DMoll%26aufirst%3DU.%2BM.%26aulast%3DMunoz-Pinedo%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DOren%26aufirst%3DM.%26aulast%3DOverholtzer%26aufirst%3DM.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DPanaretakis%26aufirst%3DT.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DPereira%26aufirst%3DD.%2BM.%26aulast%3DPervaiz%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26aulast%3DPiacentini%26aufirst%3DM.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DPrehn%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DRabinovich%26aufirst%3DG.%2BA.%26aulast%3DRehm%26aufirst%3DM.%26aulast%3DRizzuto%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DC.%2BM.%2BP.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DRudel%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DK.%2BM.%26aulast%3DSayan%26aufirst%3DE.%26aulast%3DScorrano%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DH.-U.%26aulast%3DSistigu%26aufirst%3DA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DSzabadkai%26aufirst%3DG.%26aulast%3DTait%26aufirst%3DS.%2BW.%2BG.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DTavernarakis%26aufirst%3DN.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DY.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DVirgin%26aufirst%3DH.%2BW.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DE.%2BF.%26aulast%3DWalczak%26aufirst%3DH.%26aulast%3DWallach%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DWood%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZakeri%26aufirst%3DZ.%26aulast%3DZhivotovsky%26aufirst%3DB.%26aulast%3DZitvogel%26aufirst%3DL.%26aulast%3DMelino%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520cell%2520death%253A%2520recommendations%2520of%2520the%2520Nomenclature%2520Committee%2520on%2520Cell%2520Death%25202018%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2018%26volume%3D25%26spage%3D486%26epage%3D541%26doi%3D10.1038%2Fs41418-017-0012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the ubiquitin-proteasome system are not all alike: identification of a new necrotic pathway</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.4161/auto.5.4.8169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.4161%2Fauto.5.4.8169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19270488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVyrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=543-545&author=C.+Fotiauthor=F.+Demarchiauthor=C.+Brancolini&title=Inhibitors+of+the+ubiquitin-proteasome+system+are+not+all+alike%3A+identification+of+a+new+necrotic+pathway&doi=10.4161%2Fauto.5.4.8169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the ubiquitin-proteasome system are not all alike: identification of a new necrotic pathway</span></div><div class="casAuthors">Foti, Carmela; Demarchi, Francesca; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-545</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">An addendum to the author's earlier paper (J Biol Chem 2009; 284:8369-81).  In response to stress, cells can not only activate survival pathways, but also death pathways, when the stresses are ungovernable.  The case of proteasome impairment is emblematic in this respect.  Autophagy is induced, as a prosurvival response, which antagonizes apoptosis.  As an addnl. option, cells can activate necrosis.  We have found that certain inhibitors of the ubiquitin-proteasome system can activate a rather peculiar type of necrotic death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNa3SJqhYDbVg90H21EOLACvtfcHk0lgJnBEfY6lL5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVyrsbo%253D&md5=88e9d073c6e2c5224c95b1230b91e372</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.4161%2Fauto.5.4.8169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.5.4.8169%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DDemarchi%26aufirst%3DF.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520ubiquitin-proteasome%2520system%2520are%2520not%2520all%2520alike%253A%2520identification%2520of%2520a%2520new%2520necrotic%2520pathway%26jtitle%3DAutophagy%26date%3D2009%26volume%3D5%26spage%3D543%26epage%3D545%26doi%3D10.4161%2Fauto.5.4.8169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzutto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncaglia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustincich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3140</span>– <span class="NLM_lpage">3150</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1535-7163.MCT-09-0431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19887551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3140-3150&author=C.+Fotiauthor=C.+Floreanauthor=A.+Pezzuttoauthor=P.+Roncagliaauthor=A.+Tomasellaauthor=S.+Gustincichauthor=C.+Brancolini&title=Characterization+of+caspase-dependent+and+caspase-independent+deaths+in+glioblastoma+cells+treated+with+inhibitors+of+the+ubiquitin-proteasome+system&doi=10.1158%2F1535-7163.MCT-09-0431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system</span></div><div class="casAuthors">Foti, Carmela; Florean, Cristina; Pezzutto, Antonio; Roncaglia, Paola; Tomasella, Andrea; Gustincich, Stefano; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3140-3150</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The regulation of the necrotic death and its relevance in anticancer therapy are largely unknown.  Here, we have investigated the proapoptotic and pronecrotic activities of two ubiquitin-proteasome system inhibitors: bortezomib and G5.  The present study points out that the glioblastoma cell lines U87MG and T98G are useful models to study the susceptibility to apoptosis and necrosis in response to ubiquitin-proteasome system inhibitors.  U87MG cells show resistance to apoptosis induced by bortezomib and G5, but they are more susceptible to necrosis induced by G5.  Conversely, T98G cells are more susceptible to apoptosis induced by both inhibitors but show some resistance to G5-induced necrosis.  No overt differences in the induction of Noxa and Mcl-1 or in the expression levels of other components of the apoptotic machinery were obsd. between U87MG and T98G cells.  Instead, by comparing the transcriptional profiles of the two cell lines, we have found that the resistance to G5-induced necrosis could arise from differences in glutathione synthesis/utilization and in the microenvironment.  In particular, collagen IV, which is highly expressed in T98G cells, and fibronectin, whose adhesive function is counteracted by tenascin-C in U87MG cells, can restrain the necrotic response to G5.  Collectively, our results provide an initial characterization of the mol. signals governing cell death by necrosis in glioblastoma cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom1sxLYUap7LVg90H21EOLACvtfcHk0li1gYsOOz9FHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zM&md5=089096f305ec8b5694415dd11152929f</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0431%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DPezzutto%26aufirst%3DA.%26aulast%3DRoncaglia%26aufirst%3DP.%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DGustincich%26aufirst%3DS.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DCharacterization%2520of%2520caspase-dependent%2520and%2520caspase-independent%2520deaths%2520in%2520glioblastoma%2520cells%2520treated%2520with%2520inhibitors%2520of%2520the%2520ubiquitin-proteasome%2520system%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D3140%26epage%3D3150%26doi%3D10.1158%2F1535-7163.MCT-09-0431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crivellato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maestro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">The isopeptidase inhibitor G5 triggers a caspase-independent necrotic death in cells resistant to apoptosis: a comparative study with the proteasome inhibitor bortezomib</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">8369</span>– <span class="NLM_lpage">8381</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806113200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.M806113200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19139105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8369-8381&author=A.+Fontaniniauthor=C.+Fotiauthor=H.+Potuauthor=E.+Crivellatoauthor=R.+Maestroauthor=P.+Bernardiauthor=F.+Demarchiauthor=C.+Brancolini&title=The+isopeptidase+inhibitor+G5+triggers+a+caspase-independent+necrotic+death+in+cells+resistant+to+apoptosis%3A+a+comparative+study+with+the+proteasome+inhibitor+bortezomib&doi=10.1074%2Fjbc.M806113200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: a comparative study with the proteasome inhibitor bortezomib</span></div><div class="casAuthors">Fontanini, Alessandra; Foti, Carmela; Potu, Harish; Crivellato, Enrico; Maestro, Roberta; Bernardi, Paolo; Demarchi, Francesca; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">8369-8381</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inhibitors of the ubiquitin-proteasome system (UPSIs) promote apoptosis of cancer cells and show encouraging anti-tumor activities in vivo.  In this study, we evaluated the death activities of two different UPSIs: bortezomib and the isopeptidase inhibitor G5.  To unveil whether these compds. elicit different types of death, we compared their effect both on apoptosis-proficient wild type mouse embryo fibroblasts and on cells defective for apoptosis (double-deficient Bax/Bak mouse embryo fibroblasts) (double knockout; DKO).  We have discovered that (i) both inhibitors induce apoptosis in a Bax and Bak-dependent manner, (ii) both inhibitors elicit autophagy in WT and DKO cells, and (iii) only G5 can kill apoptosis-resistant DKO cells by activating a necrotic response.  The induction of necrosis was confirmed by different exptl. approaches, including time lapse anal., HMGB1 release, and electron microscopy studies.  Neither treatment with antinecrotic agents, such as antioxidants, poly(ADP-ribose) polymerase and JNK inhibitors, necrostatin, and the intracellular Ca2+ chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester, nor overexpression of Bcl-2 and Bcl-xL prevented necrosis induced by G5.  This necrotic death is characterized by the absence of protein oxidn. and by the rapid cyclosporin A-independent dissipation of the mitochondrial membrane potential.  Notably, a peculiar feature of the G5-induced necrosis is an early and dramatic reorganization of the actin cytoskeleton, coupled to an alteration of cell adhesion.  The importance of cell adhesion impairment in the G5-induced necrotic death of DKO cells was confirmed by the antagonist effect of the extracellular matrix-adhesive components, collagen and fibronectin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlFWDM_c67bVg90H21EOLACvtfcHk0li1gYsOOz9FHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSisLs%253D&md5=dc56d684f7b32c0ab2a51938ecd7e82c</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806113200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806113200%26sid%3Dliteratum%253Aachs%26aulast%3DFontanini%26aufirst%3DA.%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DPotu%26aufirst%3DH.%26aulast%3DCrivellato%26aufirst%3DE.%26aulast%3DMaestro%26aufirst%3DR.%26aulast%3DBernardi%26aufirst%3DP.%26aulast%3DDemarchi%26aufirst%3DF.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DThe%2520isopeptidase%2520inhibitor%2520G5%2520triggers%2520a%2520caspase-independent%2520necrotic%2520death%2520in%2520cells%2520resistant%2520to%2520apoptosis%253A%2520a%2520comparative%2520study%2520with%2520the%2520proteasome%2520inhibitor%2520bortezomib%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8369%26epage%3D8381%26doi%3D10.1074%2Fjbc.M806113200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Belle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredesen, D. E.</span></span> <span> </span><span class="NLM_article-title">An alternative, nonapoptotic form of programmed cell death</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">14376</span>– <span class="NLM_lpage">14381</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.26.14376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1073%2Fpnas.97.26.14376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=11121041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=14376-14381&author=S.+Sperandioauthor=I.+de+Belleauthor=D.+E.+Bredesen&title=An+alternative%2C+nonapoptotic+form+of+programmed+cell+death&doi=10.1073%2Fpnas.97.26.14376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">An alternative, nonapoptotic form of programmed cell death</span></div><div class="casAuthors">Sperandio, Sabina; De Belle, Ian; Bredesen, Dale E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">14376-14381</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The term apoptosis often has been used interchangeably with the term programmed cell death.  Here we describe a form of programmed cell death that is distinct from apoptosis by the criteria of morphol., biochem., and response to apoptosis inhibitors.  Morphol., this alternative form of programmed cell death appears during development and in some cases of neuro-degeneration.  Despite its lack of response to caspase inhibitors and Bcl-xL, we show that this form of cell death is driven by an alternative caspase-9 activity that is Apaf-1-independent.  Characterization of this alternative form of programmed cell death should lead to new insight into cell death programs and their roles in development and degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4H2cvUAMyLVg90H21EOLACvtfcHk0li1gYsOOz9FHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVCktw%253D%253D&md5=6f69e53b6ba4cfd765a3560fe22f9232</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.26.14376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.26.14376%26sid%3Dliteratum%253Aachs%26aulast%3DSperandio%26aufirst%3DS.%26aulast%3Dde%2BBelle%26aufirst%3DI.%26aulast%3DBredesen%26aufirst%3DD.%2BE.%26atitle%3DAn%2520alternative%252C%2520nonapoptotic%2520form%2520of%2520programmed%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D14376%26epage%3D14381%26doi%3D10.1073%2Fpnas.97.26.14376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nijhawan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zack, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamothe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsherniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besche, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbluh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shehata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">Cancer vulnerabilities unveiled by genomic loss</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.cell.2012.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22901813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Sktb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=842-854&author=D.+Nijhawanauthor=T.+I.+Zackauthor=Y.+Renauthor=M.+R.+Stricklandauthor=R.+Lamotheauthor=S.+E.+Schumacherauthor=A.+Tsherniakauthor=H.+C.+Bescheauthor=J.+Rosenbluhauthor=S.+Shehataauthor=G.+S.+Cowleyauthor=B.+A.+Weirauthor=A.+L.+Goldbergauthor=J.+P.+Mesirovauthor=D.+E.+Rootauthor=S.+N.+Bhatiaauthor=R.+Beroukhimauthor=W.+C.+Hahn&title=Cancer+vulnerabilities+unveiled+by+genomic+loss&doi=10.1016%2Fj.cell.2012.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Vulnerabilities Unveiled by Genomic Loss</span></div><div class="casAuthors">Nijhawan, Deepak; Zack, Travis I.; Ren, Yin; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Tsherniak, Aviad; Besche, Henrike C.; Rosenbluh, Joseph; Shehata, Shyemaa; Cowley, Glenn S.; Weir, Barbara A.; Goldberg, Alfred L.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">842-854</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Due to genome instability, most cancers exhibit loss of regions contg. tumor suppressor genes and collateral loss of other genes.  To identify cancer-specific vulnerabilities that are the result of copy no. losses, we performed integrated analyses of genome-wide copy no. and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy no. loss of that gene.  These CYCLOPS (copy no. alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components.  One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome.  Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression.  Cells harboring partial PSMC2 copy no. loss lack this complex and die after PSMC2 suppression.  These observations define a distinct class of cancer-specific liabilities resulting from genome instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohXVIvmqAsLVg90H21EOLACvtfcHk0li8B6Fe-QvyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Sktb7I&md5=0349098aaa4a6626abbabf0eddea1f5c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DNijhawan%26aufirst%3DD.%26aulast%3DZack%26aufirst%3DT.%2BI.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DStrickland%26aufirst%3DM.%2BR.%26aulast%3DLamothe%26aufirst%3DR.%26aulast%3DSchumacher%26aufirst%3DS.%2BE.%26aulast%3DTsherniak%26aufirst%3DA.%26aulast%3DBesche%26aufirst%3DH.%2BC.%26aulast%3DRosenbluh%26aufirst%3DJ.%26aulast%3DShehata%26aufirst%3DS.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DCancer%2520vulnerabilities%2520unveiled%2520by%2520genomic%2520loss%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D842%26epage%3D854%26doi%3D10.1016%2Fj.cell.2012.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birsoy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupczak, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of essential genes in the human genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1101</span>, <span class="refDoi"> DOI: 10.1126/science.aac7041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1126%2Fscience.aac7041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26472758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFamtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=1096-1101&author=T.+Wangauthor=K.+Birsoyauthor=N.+W.+Hughesauthor=K.+M.+Krupczakauthor=Y.+Postauthor=J.+J.+Weiauthor=E.+S.+Landerauthor=D.+M.+Sabatini&title=Identification+and+characterization+of+essential+genes+in+the+human+genome&doi=10.1126%2Fscience.aac7041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of essential genes in the human genome</span></div><div class="casAuthors">Wang, Tim; Birsoy, Kivanc; Hughes, Nicholas W.; Krupczak, Kevin M.; Post, Yorick; Wei, Jenny J.; Lander, Eric S.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6264</span>),
    <span class="NLM_cas:pages">1096-1101</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Large-scale genetic anal. of lethal phenotypes has elucidated the mol. underpinnings of many biol. processes.  Using the bacterial clustered regularly interspaced short palindromic repeats (CRISPR) system, we constructed a genome-wide single-guide RNA library to screen for genes required for proliferation and survival in a human cancer cell line.  Our screen revealed the set of cell-essential genes, which was validated with an orthogonal gene-trap-based screen and comparison with yeast gene knockouts.  This set is enriched for genes that encode components of fundamental pathways, are expressed at high levels, and contain few inactivating polymorphisms in the human population.  We also uncovered a large group of uncharacterized genes involved in RNA processing, a no. of whose products localize to the nucleolus.  Last, screens in addnl. cell lines showed a high degree of overlap in gene essentiality but also revealed differences specific to each cell line and cancer type that reflect the developmental origin, oncogenic drivers, paralogous gene expression pattern, and chromosomal structure of each line.  These results demonstrate the power of CRISPR-based screens and suggest a general strategy for identifying liabilities in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonjG02K7R4iLVg90H21EOLACvtfcHk0li8B6Fe-QvyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFamtL3F&md5=61273ba03938104748f0458f662a3c34</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac7041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac7041%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBirsoy%26aufirst%3DK.%26aulast%3DHughes%26aufirst%3DN.%2BW.%26aulast%3DKrupczak%26aufirst%3DK.%2BM.%26aulast%3DPost%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DJ.%2BJ.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520essential%2520genes%2520in%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3D1096%26epage%3D1101%26doi%3D10.1126%2Fscience.aac7041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ode, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Identification of simple compounds with microtubule-binding activity that inhibit cancer cell growth with high potency</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1021/ml200195s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200195s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlylt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=35-38&author=W.+S.+Yangauthor=K.+Shimadaauthor=D.+Delvaauthor=M.+Patelauthor=E.+Odeauthor=R.+Skoutaauthor=B.+R.+Stockwell&title=Identification+of+simple+compounds+with+microtubule-binding+activity+that+inhibit+cancer+cell+growth+with+high+potency&doi=10.1021%2Fml200195s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency</span></div><div class="casAuthors">Yang, Wan Seok; Shimada, Kenichi; Delva, Darnelle; Patel, Milesh; Ode, Egberamwen; Skouta, Rachid; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-38</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We analyzed more than 1 million small mols. with the goal of finding simple synthetic compds. that potently inhibit cancer cell growth.  We identified three such compds. with unknown mechanisms of action.  Subsequent studies revealed that all three of these small mols. target microtubules.  These three scaffolds can serve as templates for developing new microtubule-targeted agents, overcoming the limits of existing microtubule-inhibiting drugs derived from complex natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcL7aucy03LVg90H21EOLACvtfcHk0li8B6Fe-QvyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlylt7fM&md5=14be45185e15c7ffe594492e756c1f25</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fml200195s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200195s%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DDelva%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DOde%26aufirst%3DE.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DIdentification%2520of%2520simple%2520compounds%2520with%2520microtubule-binding%2520activity%2520that%2520inhibit%2520cancer%2520cell%2520growth%2520with%2520high%2520potency%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D35%26epage%3D38%26doi%3D10.1021%2Fml200195s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">21115</span>– <span class="NLM_lpage">21127</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.15501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28423502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1cvpt1ajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=21115-21127&author=M.+Mazurkiewiczauthor=E.+K.+Hillertauthor=X.+Wangauthor=P.+Pellegriniauthor=M.+H.+Olofssonauthor=K.+Selvarajuauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=Acute+lymphoblastic+leukemia+cells+are+sensitive+to+disturbances+in+protein+homeostasis+induced+by+proteasome+deubiquitinase+inhibition&doi=10.18632%2Foncotarget.15501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition</span></div><div class="casAuthors">Mazurkiewicz Magdalena; Hillert Ellin-Kristina; Olofsson Maria Hagg; Linder Stig; Wang Xin; Pellegrini Paola; Selvaraju Karthik; D'Arcy Padraig; Linder Stig</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">21115-21127</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The non-genotoxic nature of proteasome inhibition makes it an attractive therapeutic option for the treatment of pediatric malignancies.  We recently described the small molecule VLX1570 as an inhibitor of proteasome deubiquitinase (DUB) activity that induces proteotoxic stress and apoptosis in cancer cells.  Here we show that acute lymphoblastic leukemia (ALL) cells are highly sensitive to treatment with VLX1570, resulting in the accumulation of polyubiquitinated proteasome substrates and loss of cell viability.  VLX1570 treatment increased the levels of a number of proteins, including the chaperone HSP70B', the oxidative stress marker heme oxygenase-1 (HO-1) and the cell cycle regulator p21Cip1.  Unexpectedly, polybiquitin accumulation was found to be uncoupled from ER stress in ALL cells.  Thus, increased phosphorylation of eIF2α occurred only at supra-pharmacological VLX1570 concentrations and did not correlate with polybiquitin accumulation.  Total cellular protein synthesis was found to decrease in the absence of eIF2α phosphorylation.  Furthermore, ISRIB (Integrated Stress Response inhibitor) did not overcome the inhibition of protein synthesis.  We finally show that VLX1570 can be combined with L-asparaginase for additive or synergistic antiproliferative effects on ALL cells.  We conclude that ALL cells are highly sensitive to the proteasome DUB inhibitor VLX1570 suggesting a novel therapeutic option for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0Sy6WJkt3Igqdek-gHSrIfW6udTcc2eZmsQwMklvZ4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvpt1ajsg%253D%253D&md5=c120ebf5961057717aed171c6a09f61b</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15501%26sid%3Dliteratum%253Aachs%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DAcute%2520lymphoblastic%2520leukemia%2520cells%2520are%2520sensitive%2520to%2520disturbances%2520in%2520protein%2520homeostasis%2520induced%2520by%2520proteasome%2520deubiquitinase%2520inhibition%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D21115%26epage%3D21127%26doi%3D10.18632%2Foncotarget.15501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7130</span>– <span class="NLM_lpage">7139</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.16.7130-7139.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1128%2FMCB.24.16.7130-7139.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15282312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=7130-7139&author=A.+Kobayashiauthor=M.+I.+Kangauthor=H.+Okawaauthor=M.+Ohtsujiauthor=Y.+Zenkeauthor=T.+Chibaauthor=K.+Igarashiauthor=M.+Yamamoto&title=Oxidative+stress+sensor+Keap1+functions+as+an+adaptor+for+Cul3-based+E3+ligase+to+regulate+proteasomal+degradation+of+Nrf2&doi=10.1128%2FMCB.24.16.7130-7139.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2</span></div><div class="casAuthors">Kobayashi, Akira; Kang, Moon-Il; Okawa, Hiromi; Ohtsuji, Makiko; Zenke, Yukari; Chiba, Tomoki; Igarashi, Kazuhiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7130-7139</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is a major regulator of genes encoding phase 2 detoxifying enzymes and antioxidant stress proteins in response to electrophilic agents and oxidative stress.  In the absence of such stimuli, Nrf2 is inactive owing to its cytoplasmic retention by Keap1 and rapid degrdn. through the proteasome system.  We examd. the contribution of Keap1 to the rapid turnover of Nrf2 (half-life of less than 20 min) and found that a direct assocn. between Keap1 and Nrf2 is required for Nrf2 degrdn.  In a series of domain function analyses of Keap1, we found that both the BTB and intervening-region (IVR) domains are crucial for Nrf2 degrdn., implying that these two domains act to recruit ubiquitin-proteasome factors.  Indeed, Cullin 3 (Cul3), a subunit of the E3 ligase complex, was found to interact specifically with Keap1 in vivo.  Keap1 assocs. with the N-terminal region of Cul3 through the IVR domain and promotes the ubiquitination of Nrf2 in cooperation with the Cul3-Roc1 complex.  These results thus provide solid evidence that Keap1 functions as an adaptor of Cul3-based E3 ligase.  To our knowledge, Nrf2 and Keap1 are the first reported mammalian substrate and adaptor, resp., of the Cul3-based E3 ligase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrut4YvhAuZKrVg90H21EOLACvtfcHk0ljv07T8XWFS5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D&md5=3d6e356865cd6f33c800bf9124d7c8da</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.16.7130-7139.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.16.7130-7139.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DM.%2BI.%26aulast%3DOkawa%26aufirst%3DH.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DZenke%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DOxidative%2520stress%2520sensor%2520Keap1%2520functions%2520as%2520an%2520adaptor%2520for%2520Cul3-based%2520E3%2520ligase%2520to%2520regulate%2520proteasomal%2520degradation%2520of%2520Nrf2%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D7130%26epage%3D7139%26doi%3D10.1128%2FMCB.24.16.7130-7139.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nami  Kurozumi</span>, <span class="hlFld-ContribAuthor ">Takayuki  Tsujioka</span>, <span class="hlFld-ContribAuthor ">Mamoru  Ouchida</span>, <span class="hlFld-ContribAuthor ">Kanae  Sakakibara</span>, <span class="hlFld-ContribAuthor ">Takako  Nakahara</span>, <span class="hlFld-ContribAuthor ">Shin‐ichiro  Suemori</span>, <span class="hlFld-ContribAuthor ">Masaki  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Akira  Kitanaka</span>, <span class="hlFld-ContribAuthor ">Misako  Shibakura</span>, <span class="hlFld-ContribAuthor ">Kaoru  Tohyama</span>. </span><span class="cited-content_cbyCitation_article-title">VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2021,</strong> <em>301 </em><a href="https://doi.org/10.1111/cas.14982" title="DOI URL">https://doi.org/10.1111/cas.14982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14982%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DVLX1570%252Binduces%252Bapoptosis%252Bthrough%252Bthe%252Bgeneration%252Bof%252BROS%252Band%252Binduction%252Bof%252BER%252Bstress%252Bon%252Bleukemia%252Bcell%252Blines%26aulast%3DKurozumi%26aufirst%3DNami%26date%3D2021%26date%3D2021%26volume%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of some of the compounds discussed in the text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Tumor cell selectivity of dienone compounds. The log<sub>10</sub> IC<sub>50</sub> values are shown on the <i>y</i>-axis in the upper graph and selectivity indices on the <i>y</i>-axis in the lower graph. Shown are the mean ± SD values where possible to calculate (i.e., where data from three or more cell lines were reported). The figure is based on the data in presented <a href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf" class="ext-link">Supplementary Table 1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. b-AP15 and structurally related compound induce accumulation of polyubiquitinated proteins on proteasomes. Lysates from cells exposed to different compounds were fractionated by glycerol gradient centrifugation, and fractions were collected and processed for immunoblotting. Compounds CID1381237, CID2247230, and CID2175947 were identified in a cell-based screen for compounds stimulate accumulation of Ub<sup>G76V</sup>-YFP in exposed cells.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> CID 2175947 (CB826 in ref <a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a>) is also known as MCB-613 and has been described to stimulate steroid receptor coactivator activity and to be preferentially cytotoxic to cancer cell lines.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> CID1381237 is also known as A9<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and C8.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Data reproduced from ref <a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a>, which licensed under <a href="https://creativecommons.org/licenses/by/4.0/" class="ext-link">CC BY 4.0</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentration-dependent responses to VLX1570. (A) Induction of polyubiquitinated proteins in RS4;11 ALL cells. Note strong increases of polyubiquitin and induction of Hsp70 at 250 nM VLX1570. (B) Increases in p21<sup>Cip1</sup>, LYN, and HMOX1. RS4;11 cells were exposed to VLX1570, and different markers were analyzed in the same extracts using a PCR-based multiplex method (OLINK, Uppsala, Sweden). Note the increases of HMOX1 at 50–100 nM VLX1570 and the decreases of all markers at high concentrations. Figure from ref <a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a>, which licensed under <a href="https://creativecommons.org/licenses/by/3.0/" class="ext-link">CC BY 3.0</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Association between polyubiquitin association and cell death. (A) HCT116 colon cancer cells were exposed to 1 μM b-AP15 or 100 nM bortezomib and harvested at the indicated time points. Lysates were subjected to immunoblotting for K48-linked polyubiquitin, HSP-70B′, p21<sup>Cip1</sup>, PARP, or β-actin (loading control). (B) HCT116 cells or hTERT-RPE1 cells (immortalized epithelial cells) were exposed to different concentrations of b-AP15 for 1 h, followed by washing and incubation for 16 h in drug-free medium. Lysates were subjected to immunoblotting for K48-linked polyubiquitin, PARP and β-actin (loading control). Note the stronger accumulation of polyubiquitinated proteins and the induction of PARP cleavage in the colon cancer cells. (C) CpdA is an inhibitor of the Sec61 complex of anterograde protein export into the ER.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Immortalized hTERT-RPE1 epithelial cells were exposed to increasing concentration of b-AP15 in the presence or absence of CpdA (“Sec61 inhib”). Note the increase in polyubiquitin accumulation, PARP cleavage, and cell death in the presence of CpdA (* <i>p</i> < 0.05). Parts A–C are reproduced from Sun et al.,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> which is licensed under <a href="https://creativecommons.org/licenses/by/4.0/" class="ext-link">CC BY 4.0</a>. (D) Graphic illustration of the results. Shown are proteasomes (red, 20S; green, 19S) and polyubiquitinated proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proteasome inhibition induced by b-AP15 is associated with cell death. (A) A reporter protein (Ub<sup>G76V</sup>-YFP) is degraded by the proteasome (PS) in human melanoma cells. Proteasome inhibition (PI) leads to accumulation of the reporter protein in the cells.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> (B) Tracing individual cells expressing Ub<sup>G76V</sup>-YFP following exposure to 250 nM b-AP15. Cells become Ub<sup>G76V</sup>-YFP positive after 1–4 h, showing accumulation of the proteasome reporter. YFP-positive cells subsequently round up and the YFP leaks out from the cells after membrane disintegration. In contrast, cells that remain YFP-negative at 4 h of exposure survive and continue to divide. Results were obtained using an IncuCyte instrument (see refs <a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and <a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a>). (C) Time-lapse recordings of Ub<sup>G76V</sup>-YFP-expressing human melanoma cells after addition of compounds. Upper panel: Human melanoma cells expressing Ub<sup>G76V</sup>-YFP were exposed to 100 nM bortezomib and traced for 10 h. Notice the appearance of YFP fluorescence in cell nuclei at 2 h and later appearance in the cytoplasm (one cell highlighted at 2 h). Middle panel: Cells were exposed to 250 nM b-AP15. Note the similar pattern of initial nuclear and later cytoplasmic fluorescence (one cell highlighted at 1 h), similar to the pattern observed using bortezomib. Also note that cells either become positive and die or remain completely negative and survive. Lower panel, left: control. Vehicle-treated control cells remain YFP-negative and proliferate. Lower panel, right: >90% of the cells exposed to 500 nM b-AP15 become YFP-positive after 6 h, and most of these cells have rounded up at 18 h, some have lost membrane integrity and the YFP content. Original data were published in refs <a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and <a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/medium/jm0c00812_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Target affinity does not necessarily correlate to mechanism of action. A major fraction of cellular genes (∼90%) have been found to be nonessential for proliferation of tumor cells <i>in vitro</i>.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Small molecules that bind to the protein products of these genes are therefore unlikely to affect tumor cell proliferation. In contrast, low affinity binding to essential proteins may result in strong inhibition of proliferation. An example is microtubule dynamics, known to be sensitive to low concentrations of small molecules<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> and for which off-target effects may occur for various compounds when used in screens at 5–10 μM. (B) Illustration of responses to VLX1570 reported in different studies.<a onclick="showRef(event, 'ref93 ref114 ref157'); return false;" href="javascript:void(0);" class="ref ref93 ref114 ref157">(93,114,157)</a> HMOX1 is induced at lower concentration of b-AP15/VLX1570 than other markers (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Nrf-2/KEAP is targeted by electrophiles, and the Nrf-2 system is likely to be particularly sensitive to electrophiles.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Increases of polyubiquitinated proteins, Hsp70 chaperones, and proteasome substrates such p21<sup>Cip1</sup> are observed at somewhat higher concentrations of VLX1570; increased levels of Hsp70 are also observed at these concentrations (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Inhibition of translation is observed at increasing concentrations of VLX1570,<a onclick="showRef(event, 'ref114 ref157'); return false;" href="javascript:void(0);" class="ref ref114 ref157">(114,157)</a> leading to a blunted response of Hsp70, HMOX1, p21<sup>Cip1</sup>, and LYN expression (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Depletion of anamorsin/CIAPIN1 was reported to occur at concentrations of 0.5–1 μM <a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> and the formation of higher molecular weight protein complexes at 10 μM <a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> (using HeLa cells).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c00812/20201218/images/large/jm0c00812_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00812&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 158 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, J.</span></span> <span> </span><span class="NLM_article-title">How were new medicines discovered?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0ljBBJc9X9NvRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayr, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojanic, D.</span></span> <span> </span><span class="NLM_article-title">Novel trends in high-throughput screening</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2009.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.coph.2009.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19775937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1WntLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=580-588&author=L.+M.+Mayrauthor=D.+Bojanic&title=Novel+trends+in+high-throughput+screening&doi=10.1016%2Fj.coph.2009.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Novel trends in high-throughput screening</span></div><div class="casAuthors">Mayr, Lorenz M.; Bojanic, Dejan</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">580-588</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) is a well-established process for lead discovery in Pharma and Biotech companies and is now also being used for basic and applied research in academia.  It comprises the screening of large chem. libraries for activity against biol. targets via the use of automation, miniaturized assays and large-scale data anal.  Since its first advent in the early to mid 1990s, the field of HTS has seen not only a continuous change in technol. and processes, but also an adaptation to various needs in lead discovery.  HTS has now evolved into a mature discipline that is a crucial source of chem. starting points for drug discovery.  Whereas in previous years much emphasis has been put on a steady increase in screening capacity (quant. increase') via automation and miniaturization, the past years have seen a much greater emphasis on content and quality (qual. increase').  Today, many experts in the field see HTS at a crossroad with the need to decide on either higher throughput/more experimentation or a greater focus on assays of greater physiol. relevance, both of which may lead to higher productivity in pharmaceutical R&D.  In this paper, we describe the development of HTS over the past decade and point out our own ideas for future directions of HTS in biomedical research.  We predict that the trend toward further miniaturization will slow down with the balanced implementation of 384 well, 1536 well, and 384 low vol. well plates.  Furthermore, we envisage that there will be much more emphasis on rigorous assay and chem. characterization, particularly considering that novel and more difficult target classes will be pursued.  In recent years we have witnessed a clear trend in the drug discovery community toward rigorous hit validation by the use of orthogonal readout technologies, label free and biophys. methodologies.  We also see a trend toward a more flexible use of the various screening approaches in lead discovery, i.e., the use of both full deck compd. screening as well as the use of focused screening and iterative screening approaches.  Moreover, we expect greater usage of target identification strategies downstream of phenotypic screening and the more effective implementation of affinity selection technologies as a result of advances in chem. diversity methodologies.  We predict that, ultimately, each hit finding strategy will be much more project-related, tailor-made, and better integrated into the broader drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3Oo1Orzt87Vg90H21EOLACvtfcHk0ljBBJc9X9NvRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1WntLnL&md5=50284fdd9f4d610e81fb442b78b7b69e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2009.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2009.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DMayr%26aufirst%3DL.%2BM.%26aulast%3DBojanic%26aufirst%3DD.%26atitle%3DNovel%2520trends%2520in%2520high-throughput%2520screening%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2009%26volume%3D9%26spage%3D580%26epage%3D588%26doi%3D10.1016%2Fj.coph.2009.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schenone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dancik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span> <span> </span><span class="NLM_article-title">Target identification and mechanism of action in chemical biology and drug discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnchembio.1199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=23508189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=232-240&author=M.+Schenoneauthor=V.+Dancikauthor=B.+K.+Wagnerauthor=P.+A.+Clemons&title=Target+identification+and+mechanism+of+action+in+chemical+biology+and+drug+discovery&doi=10.1038%2Fnchembio.1199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Target identification and mechanism of action in chemical biology and drug discovery</span></div><div class="casAuthors">Schenone, Monica; Dancik, Vlado; Wagner, Bridget K.; Clemons, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">232-240</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Target-identification and mechanism-of-action studies have important roles in small-mol. probe and drug discovery.  Biol. and technol. advances have resulted in the increasing use of cell-based assays to discover new biol. active small mols.  Such studies allow small-mol. action to be tested in a more disease-relevant setting at the outset, but they require follow-up studies to det. the precise protein target or targets responsible for the obsd. phenotype.  Target identification can be approached by direct biochem. methods, genetic interactions or computational inference.  In many cases, however, combinations of approaches may be required to fully characterize on-target and off-target effects and to understand mechanisms of small-mol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMV_Mv_6-O-rVg90H21EOLACvtfcHk0ljBBJc9X9NvRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWmsLs%253D&md5=7aa5556d8dfbf259ab7e60fda1d8fdc2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1199%26sid%3Dliteratum%253Aachs%26aulast%3DSchenone%26aufirst%3DM.%26aulast%3DDancik%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DB.%2BK.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26atitle%3DTarget%2520identification%2520and%2520mechanism%2520of%2520action%2520in%2520chemical%2520biology%2520and%2520drug%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D232%26epage%3D240%26doi%3D10.1038%2Fnchembio.1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blat, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieronymus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span> <span> </span><span class="NLM_article-title">The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">1929</span>– <span class="NLM_lpage">1935</span>, <span class="refDoi"> DOI: 10.1126/science.1132939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1126%2Fscience.1132939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=17008526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2006&pages=1929-1935&author=J.+Lambauthor=E.+D.+Crawfordauthor=D.+Peckauthor=J.+W.+Modellauthor=I.+C.+Blatauthor=M.+J.+Wrobelauthor=J.+Lernerauthor=J.+P.+Brunetauthor=A.+Subramanianauthor=K.+N.+Rossauthor=M.+Reichauthor=H.+Hieronymusauthor=G.+Weiauthor=S.+A.+Armstrongauthor=S.+J.+Haggartyauthor=P.+A.+Clemonsauthor=R.+Weiauthor=S.+A.+Carrauthor=E.+S.+Landerauthor=T.+R.+Golub&title=The+connectivity+map%3A+using+gene-expression+signatures+to+connect+small+molecules%2C+genes%2C+and+disease&doi=10.1126%2Fscience.1132939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease</span></div><div class="casAuthors">Lamb, Justin; Crawford, Emily D.; Peck, David; Modell, Joshua W.; Blat, Irene C.; Wrobel, Matthew J.; Lerner, Jim; Brunet, Jean-Philippe; Subramanian, Aravind; Ross, Kenneth N.; Reich, Michael; Hieronymus, Haley; Wei, Guo; Armstrong, Scott A.; Haggarty, Stephen J.; Clemons, Paul A.; Wei, Ru; Carr, Steven A.; Lander, Eric S.; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">5795</span>),
    <span class="NLM_cas:pages">1929-1935</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a ref. collection of gene-expression profiles from cultured human cells treated with bioactive small mols., together with pattern-matching software to mine these data.  We demonstrate that this "Connectivity Map" resource can be used to find connections among small mols. sharing a mechanism of action, chems. and physiol. processes, and diseases and drugs.  These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtu0M2BUO2w7Vg90H21EOLACvtfcHk0lgQPSC7BV21vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN&md5=1fad887ad515ffdd8064e526ff25a4db</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132939%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DE.%2BD.%26aulast%3DPeck%26aufirst%3DD.%26aulast%3DModell%26aufirst%3DJ.%2BW.%26aulast%3DBlat%26aufirst%3DI.%2BC.%26aulast%3DWrobel%26aufirst%3DM.%2BJ.%26aulast%3DLerner%26aufirst%3DJ.%26aulast%3DBrunet%26aufirst%3DJ.%2BP.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DHieronymus%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DArmstrong%26aufirst%3DS.%2BA.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DThe%2520connectivity%2520map%253A%2520using%2520gene-expression%2520signatures%2520to%2520connect%2520small%2520molecules%252C%2520genes%252C%2520and%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D313%26spage%3D1929%26epage%3D1935%26doi%3D10.1126%2Fscience.1132939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almqvist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatushchenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez Molina, D.</span></span> <span> </span><span class="NLM_article-title">The cellular thermal shift assay for evaluating drug target interactions in cells</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2100</span>– <span class="NLM_lpage">2122</span>, <span class="refDoi"> DOI: 10.1038/nprot.2014.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnprot.2014.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25101824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2100-2122&author=R.+Jafariauthor=H.+Almqvistauthor=H.+Axelssonauthor=M.+Ignatushchenkoauthor=T.+Lundbackauthor=P.+Nordlundauthor=D.+Martinez+Molina&title=The+cellular+thermal+shift+assay+for+evaluating+drug+target+interactions+in+cells&doi=10.1038%2Fnprot.2014.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The cellular thermal shift assay for evaluating drug target interactions in cells</span></div><div class="casAuthors">Jafari, Rozbeh; Almqvist, Helena; Axelsson, Hanna; Ignatushchenko, Marina; Lundbaeck, Thomas; Nordlund, Paer; Molina, Daniel Martinez</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2100-2122</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thermal shift assays are used to study thermal stabilization of proteins upon ligand binding.  Such assays have been used extensively on purified proteins in the drug discovery industry and in academia to detect interactions.  Recently, we published a proof-of-principle study describing the implementation of thermal shift assays in a cellular format, which we call the cellular thermal shift assay (CETSA).  The method allows studies of target engagement of drug candidates in a cellular context, herein exemplified with exptl. data on the human kinases p38α and ERK1/2.  The assay involves treatment of cells with a compd. of interest, heating to denature and ppt. proteins, cell lysis, and the sepn. of cell debris and aggregates from the sol. protein fraction.  Whereas unbound proteins denature and ppt. at elevated temps., ligand-bound proteins remain in soln.  We describe two procedures for detecting the stabilized protein in the sol. fraction of the samples.  One approach involves sample workup and detection using quant. western blotting, whereas the second is performed directly in soln. and relies on the induced proximity of two target-directed antibodies upon binding to sol. protein.  The latter protocol has been optimized to allow an increased throughput, as potential applications require large nos. of samples.  Both approaches can be completed in a day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzarqomAK6eLVg90H21EOLACvtfcHk0lgQPSC7BV21vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12msrfJ&md5=e7852e1a306bca1698a8e8463ae566b1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2014.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2014.138%26sid%3Dliteratum%253Aachs%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DAlmqvist%26aufirst%3DH.%26aulast%3DAxelsson%26aufirst%3DH.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DLundback%26aufirst%3DT.%26aulast%3DNordlund%26aufirst%3DP.%26aulast%3DMartinez%2BMolina%26aufirst%3DD.%26atitle%3DThe%2520cellular%2520thermal%2520shift%2520assay%2520for%2520evaluating%2520drug%2520target%2520interactions%2520in%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2014%26volume%3D9%26spage%3D2100%26epage%3D2122%26doi%3D10.1038%2Fnprot.2014.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernobrovkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutishauser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allardyce, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Expression proteomics study to determine metallodrug targets and optimal drug combinations</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1590</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-01643-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41598-017-01643-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28484215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1crlt1yjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1590&author=R.+F.+S.+Leeauthor=A.+Chernobrovkinauthor=D.+Rutishauserauthor=C.+S.+Allardyceauthor=D.+Hackerauthor=K.+Johnssonauthor=R.+A.+Zubarevauthor=P.+J.+Dyson&title=Expression+proteomics+study+to+determine+metallodrug+targets+and+optimal+drug+combinations&doi=10.1038%2Fs41598-017-01643-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Expression proteomics study to determine metallodrug targets and optimal drug combinations</span></div><div class="casAuthors">Lee Ronald F S; Allardyce Claire S; Johnsson Kai; Dyson Paul J; Chernobrovkin Alexey; Rutishauser Dorothea; Zubarev Roman A; Rutishauser Dorothea; Hacker David</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1590</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The emerging technique termed functional identification of target by expression proteomics (FITExP) has been shown to identify the key protein targets of anti-cancer drugs.  Here, we use this approach to elucidate the proteins involved in the mechanism of action of two ruthenium(II)-based anti-cancer compounds, RAPTA-T and RAPTA-EA in breast cancer cells, revealing significant differences in the proteins upregulated.  RAPTA-T causes upregulation of multiple proteins suggesting a broad mechanism of action involving suppression of both metastasis and tumorigenicity.  RAPTA-EA bearing a GST inhibiting ethacrynic acid moiety, causes upregulation of mainly oxidative stress related proteins.  The approach used in this work could be applied to the prediction of effective drug combinations to test in cancer chemotherapy clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4jjyyuPoPp0ewzGPswiWOfW6udTcc2eZyZRCtDvXFiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crlt1yjug%253D%253D&md5=b388f49064ff216825cd199e9269a54c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-01643-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-01643-1%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BF.%2BS.%26aulast%3DChernobrovkin%26aufirst%3DA.%26aulast%3DRutishauser%26aufirst%3DD.%26aulast%3DAllardyce%26aufirst%3DC.%2BS.%26aulast%3DHacker%26aufirst%3DD.%26aulast%3DJohnsson%26aufirst%3DK.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DExpression%2520proteomics%2520study%2520to%2520determine%2520metallodrug%2520targets%2520and%2520optimal%2520drug%2520combinations%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D1590%26doi%3D10.1038%2Fs41598-017-01643-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaetani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beusch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundstrom, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span> <span> </span><span class="NLM_article-title">Proteome integral solubility alteration: a high-throughput proteomics assay for target deconvolution</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4027</span>– <span class="NLM_lpage">4037</span>, <span class="refDoi"> DOI: 10.1021/acs.jproteome.9b00500</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jproteome.9b00500" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVant7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=4027-4037&author=M.+Gaetaniauthor=P.+Sabatierauthor=A.+A.+Saeiauthor=C.+M.+Beuschauthor=Z.+Yangauthor=S.+L.+Lundstromauthor=R.+A.+Zubarev&title=Proteome+integral+solubility+alteration%3A+a+high-throughput+proteomics+assay+for+target+deconvolution&doi=10.1021%2Facs.jproteome.9b00500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution</span></div><div class="casAuthors">Gaetani, Massimiliano; Sabatier, Pierre; Saei, Amir A.; Beusch, Christian M.; Yang, Zhe; Lundstroem, Susanna L.; Zubarev, Roman A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4027-4037</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Various agents, including drugs as well as nonmol. stimuli, induce alterations in the physicochem. properties of proteins in cell lysates, living cells, and organisms.  These alterations can be probed by applying a stability- and soly.-modifying factor, such as elevated temp., to a varying degree.  As a second dimension of variation, drug concn. or agent intensity/concn. can be used.  Compared to std. approaches where curves are fitted to protein soly. data acquired at different temps. and drug concns., Proteome Integral Soly. Alteration (PISA) assay increases the anal. throughput by 1 to 2 orders of magnitude for an unlimited no. of factor variation points in such a scheme.  The consumption of the compd. and biol. material decreases in PISA by the same factor.  We envision widespread use of the PISA approach in chem. biol. and drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYSOgJoUSrA7Vg90H21EOLACvtfcHk0liqbMi1RKEQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVant7fE&md5=0a759cc7bc9940d36bca47dadb4177db</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jproteome.9b00500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jproteome.9b00500%26sid%3Dliteratum%253Aachs%26aulast%3DGaetani%26aufirst%3DM.%26aulast%3DSabatier%26aufirst%3DP.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DBeusch%26aufirst%3DC.%2BM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLundstrom%26aufirst%3DS.%2BL.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26atitle%3DProteome%2520integral%2520solubility%2520alteration%253A%2520a%2520high-throughput%2520proteomics%2520assay%2520for%2520target%2520deconvolution%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2019%26volume%3D18%26spage%3D4027%26epage%3D4037%26doi%3D10.1021%2Facs.jproteome.9b00500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
Silva-Diz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzo-Sanz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernat-Peguera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Cerda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, P.</span></span> <span> </span><span class="NLM_article-title">Cancer cell plasticity: impact on tumor progression and therapy response</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2018.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.semcancer.2018.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30130663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2gtLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2018&pages=48-58&author=V.+da%0ASilva-Dizauthor=L.+Lorenzo-Sanzauthor=A.+Bernat-Pegueraauthor=M.+Lopez-Cerdaauthor=P.+Munoz&title=Cancer+cell+plasticity%3A+impact+on+tumor+progression+and+therapy+response&doi=10.1016%2Fj.semcancer.2018.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cell plasticity: Impact on tumor progression and therapy response</span></div><div class="casAuthors">da Silva-Diz, Victoria; Lorenzo-Sanz, Laura; Bernat-Peguera, Adria; Lopez-Cerda, Marta; Munoz, Purificacion</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Most tumors exhibit intra-tumor heterogeneity, which is assocd. with disease progression and an impaired response to therapy.  Cancer cell plasticity has been proposed as being an important mechanism that, along with genetic and epigenetic alterations, promotes cancer cell diversity and contributes to intra-tumor heterogeneity.  Plasticity endows cancer cells with the capacity to shift dynamically between a differentiated state, with limited tumorigenic potential, and an undifferentiated or cancer stem-like cell (CSC) state, which is responsible for long-term tumor growth.  In addn., it confers the ability to transit into distinct CSC states with different competence to invade, disseminate and seed metastasis.  Cancer cell plasticity has been linked to the epithelial-to-mesenchymal transition program and relies not only on cell-autonomous mechanisms, but also on signals provided by the tumor microenvironment and/or induced in response to therapy.  We provide an overview of the dynamic transition for cancer cell states, the mechanisms governing cell plasticity and their impact on tumor progression, metastasis and therapy response.  Understanding the mechanisms involved in cancer cell plasticity will provide insights for establishing new therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8dLPWvlwMx7Vg90H21EOLACvtfcHk0liqbMi1RKEQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2gtLjO&md5=ef3f0e7c144804437d6f937756176019</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2018.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2018.08.009%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BSilva-Diz%26aufirst%3DV.%26aulast%3DLorenzo-Sanz%26aufirst%3DL.%26aulast%3DBernat-Peguera%26aufirst%3DA.%26aulast%3DLopez-Cerda%26aufirst%3DM.%26aulast%3DMunoz%26aufirst%3DP.%26atitle%3DCancer%2520cell%2520plasticity%253A%2520impact%2520on%2520tumor%2520progression%2520and%2520therapy%2520response%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2018%26volume%3D53%26spage%3D48%26epage%3D58%26doi%3D10.1016%2Fj.semcancer.2018.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochanard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehoe, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannessen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macconaill, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garraway, L. A.</span></span> <span> </span><span class="NLM_article-title">Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3085</span>– <span class="NLM_lpage">3096</span>, <span class="refDoi"> DOI: 10.1200/JCO.2010.33.2312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1200%2FJCO.2010.33.2312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21383288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCqtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=3085-3096&author=N.+Wagleauthor=C.+Emeryauthor=M.+F.+Bergerauthor=M.+J.+Davisauthor=A.+Sawyerauthor=P.+Pochanardauthor=S.+M.+Kehoeauthor=C.+M.+Johannessenauthor=L.+E.+Macconaillauthor=W.+C.+Hahnauthor=M.+Meyersonauthor=L.+A.+Garraway&title=Dissecting+therapeutic+resistance+to+RAF+inhibition+in+melanoma+by+tumor+genomic+profiling&doi=10.1200%2FJCO.2010.33.2312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling</span></div><div class="casAuthors">Wagle, Nikhil; Emery, Caroline; Berger, Michael F.; Davis, Matthew J.; Sawyer, Allison; Pochanard, Panisa; Kehoe, Sarah M.; Johannessen, Cory M.; MacConaill, Laura E.; Hahn, William C.; Meyerson, Matthew; Garraway, Levi A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3085-3096</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A detailed understanding of the mechanisms by which tumors acquire resistance to targeted anticancer agents should speed the development of treatment strategies with lasting clin. efficacy.  RAF inhibition in BRAF-mutant melanoma exemplifies the promise and challenge of many targeted drugs; although response rates are high, resistance invariably develops.  Here, we articulate overarching principles of resistance to kinase inhibitors, as well as a translational approach to characterize resistance in the clin. setting through tumor mutation profiling.  As a proof of principle, we performed targeted, massively parallel sequencing of 138 cancer genes in a tumor obtained from a patient with melanoma who developed resistance to PLX4032 after an initial dramatic response.  The resulting profile identified an activating mutation at codon 121 in the downstream kinase MEK1 that was absent in the corresponding pretreatment tumor.  The MEK1C121S mutation was shown to increase kinase activity and confer robust resistance to both RAF and MEK inhibition in vitro.  Thus, MEK1C121S or functionally similar mutations are predicted to confer resistance to combined MEK/RAF inhibition.  These results provide an instructive framework for assessing mechanisms of acquired resistance to kinase inhibition and illustrate the use of emerging technologies in a manner that may accelerate personalized cancer medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK-2C4fs22UbVg90H21EOLACvtfcHk0liqbMi1RKEQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCqtLfO&md5=d872acb5ba41d7eccc2717e31d856dd3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.33.2312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.33.2312%26sid%3Dliteratum%253Aachs%26aulast%3DWagle%26aufirst%3DN.%26aulast%3DEmery%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%2BF.%26aulast%3DDavis%26aufirst%3DM.%2BJ.%26aulast%3DSawyer%26aufirst%3DA.%26aulast%3DPochanard%26aufirst%3DP.%26aulast%3DKehoe%26aufirst%3DS.%2BM.%26aulast%3DJohannessen%26aufirst%3DC.%2BM.%26aulast%3DMacconaill%26aufirst%3DL.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26atitle%3DDissecting%2520therapeutic%2520resistance%2520to%2520RAF%2520inhibition%2520in%2520melanoma%2520by%2520tumor%2520genomic%2520profiling%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D3085%26epage%3D3096%26doi%3D10.1200%2FJCO.2010.33.2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Wekken, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiltermann, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Berg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groen, H. J.</span></span> <span> </span><span class="NLM_article-title">Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature</span>. <i>Crit. Rev. Oncol./Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.critrevonc.2016.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.critrevonc.2016.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26852079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC28notlalsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=107-116&author=A.+J.+van%0Ader+Wekkenauthor=A.+Saberauthor=T.+J.+Hiltermannauthor=K.+Kokauthor=A.+van+den+Bergauthor=H.+J.+Groen&title=Resistance+mechanisms+after+tyrosine+kinase+inhibitors+afatinib+and+crizotinib+in+non-small+cell+lung+cancer%2C+a+review+of+the+literature&doi=10.1016%2Fj.critrevonc.2016.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature</span></div><div class="casAuthors">van der Wekken A J; Saber A; van den Berg A; Hiltermann T J N; Groen H J M; Kok K</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Targeted treatment of advanced non-small cell lung cancer patients with afatinib in EGFR mutation or crizotinib in ALK break positive patients results in profound tumor responses but inevitably induces resistance.  In this review we present currently known resistance mechanisms for afatinib and crizotinib two recently approved drugs.  Resistance mechanisms identified for afatinib include c-MET amplification and the V843I EGFR mutation.  Expression of FGFR1, increased IL6R/JAK/STAT signaling, enhanced interference with aerobic glycolysis and autophagy are associated with resistance to afatinib.  Most common resistance mechanisms for ALK break positive cases are gatekeeper mutations in the ALK gene.  Also activation of the EGFR pathway, KRAS mutations, the autophagy pathway and epithelial mesenchymal transition (EMT), have been associated with resistance.  Many of the proposed resistance mechanisms need to be functionally studied to proof a causative relationship with resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMme8zra2hFP_I8Jvzw4xCfW6udTcc2eaMyvxCeUR3wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28notlalsA%253D%253D&md5=b59090714fdbad24f00410f756453589</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2016.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2016.01.024%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWekken%26aufirst%3DA.%2BJ.%26aulast%3DSaber%26aufirst%3DA.%26aulast%3DHiltermann%26aufirst%3DT.%2BJ.%26aulast%3DKok%26aufirst%3DK.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DA.%26aulast%3DGroen%26aufirst%3DH.%2BJ.%26atitle%3DResistance%2520mechanisms%2520after%2520tyrosine%2520kinase%2520inhibitors%2520afatinib%2520and%2520crizotinib%2520in%2520non-small%2520cell%2520lung%2520cancer%252C%2520a%2520review%2520of%2520the%2520literature%26jtitle%3DCrit.%2520Rev.%2520Oncol.%252FHematol.%26date%3D2016%26volume%3D100%26spage%3D107%26epage%3D116%26doi%3D10.1016%2Fj.critrevonc.2016.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">Recent advances in alpha, beta-unsaturated carbonyl compounds as mitochondrial toxins</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">111687</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ejmech.2019.111687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31539776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWkt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2019&pages=111687&author=M.+Hossainauthor=U.+Dasauthor=J.+R.+Dimmock&title=Recent+advances+in+alpha%2C+beta-unsaturated+carbonyl+compounds+as+mitochondrial+toxins&doi=10.1016%2Fj.ejmech.2019.111687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in α,β-unsaturated carbonyl compounds as mitochondrial toxins</span></div><div class="casAuthors">Hossain, Mohammad; Das, Umashankar; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111687</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Conjugated α,β-unsatd. ketones are very useful compds. assocd. with diverse medicinal properties.  This review outlines α,β-unsatd. ketones as candidate cytotoxic agents which affect mitochondrial function.  Both naturally occurring compds. and synthetic chems. have been discussed which exert their cytotoxic effects, at least in part, by acting on mitochondria.  Biochem. differences between tumor mitochondria and this organelle in non-malignant cells have been exploited to investigate various compds. that can cause greater toxicity to neoplasms than normal cells.  On a no. of instances, correlations between the structures of various α,β-unsatd. ketones and cytotoxic potencies have been obsd.  The aspiration is that this review will assist drug designers to create compds. which are significantly more toxic to neoplasms than normal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU6m_b1BjhvrVg90H21EOLACvtfcHk0lgKUC-n8YxAwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWkt7zF&md5=8ed19f35c4a5c2775a5d67e301a8c623</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111687%26sid%3Dliteratum%253Aachs%26aulast%3DHossain%26aufirst%3DM.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3DRecent%2520advances%2520in%2520alpha%252C%2520beta-unsaturated%2520carbonyl%2520compounds%2520as%2520mitochondrial%2520toxins%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D183%26spage%3D111687%26doi%3D10.1016%2Fj.ejmech.2019.111687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wonko, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrington, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span> <span> </span><span class="NLM_article-title">3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells</span>. <i>Drug Des. Delivery</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=2076179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK3MXhtlGmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1990&pages=183-194&author=J.+R.+Dimmockauthor=V.+K.+Aroraauthor=S.+L.+Wonkoauthor=N.+W.+Hamonauthor=J.+W.+Quailauthor=Z.+Jiaauthor=R.+C.+Warringtonauthor=W.+D.+Fangauthor=J.+S.+Lee&title=3%2C5-Bis-benzylidene-4-piperidones+and+related+compounds+with+high+activity+towards+P388+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Bisbenzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells</span></div><div class="casAuthors">Dimmock, J. R.; Arora, V. K.; Wonko, S. L.; Hamon, N. W.; Quail, J. W.; Jia, Z.; Warrington, R. C.; Fang, W. D.; Lee, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design and Delivery</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-94</span>CODEN:
                <span class="NLM_cas:coden">DDDEEJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-2884</span>.
    </div><div class="casAbstract">3,5-Bis(benzylidene)-4-piperidones and related compds. were prepd. and found to have between 100 and 9700 times the activity of N,N'-bis(2-chloroethyl)-N-nitrosourea towards P388 leukemia cells.  The shapes of 6 of these mols., as detd. by x-ray crystallog., were compared, but no correlation between the stereochem. of the mols. or their electronic properties and cytotoxicity was apparent.  Mol. modification of the compds. by forming 2 monobenzylidene compds., a related acyclic deriv. and an N-acyl compd. resulted in diminished but retained high cytotoxicity.  Two representative compds. lowered glutathione levels of liver following their i.p. injection into mice.  Two quaternary ammonium compds. bound to the minor groove of DNA, while 4 related nonquaternary ammonium derivs. did not demonstrate this property.  Thus, the modes of action of these highly cytotoxic compds. include alkylation of cellular thiols and DNA binding, but interference with other biochem. processes is also probably involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW9uGqI3er_rVg90H21EOLACvtfcHk0lgKUC-n8YxAwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtlGmtrg%253D&md5=6183f99a475c28a7af119719268e13e3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DWonko%26aufirst%3DS.%2BL.%26aulast%3DHamon%26aufirst%3DN.%2BW.%26aulast%3DQuail%26aufirst%3DJ.%2BW.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DWarrington%26aufirst%3DR.%2BC.%26aulast%3DFang%26aufirst%3DW.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26atitle%3D3%252C5-Bis-benzylidene-4-piperidones%2520and%2520related%2520compounds%2520with%2520high%2520activity%2520towards%2520P388%2520leukemia%2520cells%26jtitle%3DDrug%2520Des.%2520Delivery%26date%3D1990%26volume%3D6%26spage%3D183%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugazhenthi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic evaluation of some 3,5-diarylidene-4-piperidones and various related quaternary ammonium compounds and analogs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1002/jps.2600830811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fjps.2600830811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=7983596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK2cXls12kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1994&pages=1124-1130&author=J.+R.+Dimmockauthor=V.+K.+Aroraauthor=J.+W.+Quailauthor=U.+Pugazhenthiauthor=T.+M.+Allenauthor=G.+Y.+Kaoauthor=E.+De+Clercq&title=Cytotoxic+evaluation+of+some+3%2C5-diarylidene-4-piperidones+and+various+related+quaternary+ammonium+compounds+and+analogs&doi=10.1002%2Fjps.2600830811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Evaluation of Some 3,5-diarylidene-4-piperidones and Various Related Quaternary Ammonium Compounds and Analogs</span></div><div class="casAuthors">Dimmock, J. R.; Arora, V. K.; Quail, J. W.; Pugazhenthi, U.; Allen, T. M.; De Clercq, E.; Kao, G. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1124-30</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A no. of 3,5-diarylidene-4-piperidones (I; R1 = H, NMe2, SMe2, 4-OMe, Me, CO2K, Cl; R2 = H, Cl, R3X = HCl and n = 0 or 1) and some related quaternary ammonium salts (II; R1 = H, NMe2, NEt2, OMe, OH, F; X = I) as well as closely related analogs (III) were prepd. principally as candidate cytotoxic agents in two screens.  The first test system used an av. of 54 human tumor cell lines from eight neoplastic diseases, namely leukemia, melanoma, colon, non-small-cell lung, small-cell lung, central nervous system, ovarian, and renal cancers.  Selective toxicity was demonstrated by some of the compds., esp. toward leukemia.  The second screen used L1210 lymphoid leukemia cells.  In general, the compds. were less cytotoxic than the ref. drug melphalan in both screens.  Linear plots were made between the Hammett (σ), fragment (f), and molar refractivity (MR) consts. of the nuclear substituents in series I and II with the IC50 figures of both the human tumor cell lines and L1210 cells.  Evaluation against the human tumor cell lines revealed that increases in the f values were correlated with elevation of cytotoxicity in both series I and II; MR consts. were also important in series II.  In the L1210 screen, σ and MR consts. were pos. correlated with cytotoxicity.  X-ray crystallog. was undertaken on 3,5-bis[[4'-(methylthio)phenyl]methylene]-1-methyl-4-piperidone methiodide, which had significant cytotoxicity, and 3,5-bis(4-pyridylmethylene)-1-methyl-4-piperidone methiodide (III), which was virtually inactive in both screens.  A no. of structural features were noted, and in particular a smaller interplanar angle made by one of the arylidene groups with the central piperidine ring in the case of II (R1 = SMe, X = I) than either of the 4-pyridylmethylene moieties in III may contribute to the variation in cytotoxicity between these two compds.  Eleven compds. which were examd. for activity against a panel of 12 viruses were shown to display only marginal potencies or to be inactive at the highest concns. utilized.  Two compds. with slight activity both had the hydrophilic carboxylate ion in the aryl rings.  From this study, various conclusions pertaining to future mol. modification with a view to increasing cytotoxic potency were made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2Vznv6FGz17Vg90H21EOLACvtfcHk0lhP7cBoTKauBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXls12kt7w%253D&md5=a6bd1764f68069e01ba7565408e554cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600830811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600830811%26sid%3Dliteratum%253Aachs%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DArora%26aufirst%3DV.%2BK.%26aulast%3DQuail%26aufirst%3DJ.%2BW.%26aulast%3DPugazhenthi%26aufirst%3DU.%26aulast%3DAllen%26aufirst%3DT.%2BM.%26aulast%3DKao%26aufirst%3DG.%2BY.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DCytotoxic%2520evaluation%2520of%2520some%25203%252C5-diarylidene-4-piperidones%2520and%2520various%2520related%2520quaternary%2520ammonium%2520compounds%2520and%2520analogs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1994%26volume%3D83%26spage%3D1124%26epage%3D1130%26doi%3D10.1002%2Fjps.2600830811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Subbagh, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Zaid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahran, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badria, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Obaid, A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of certain alpha, beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2915</span>– <span class="NLM_lpage">2921</span>, <span class="refDoi"> DOI: 10.1021/jm000038m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000038m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFGrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2915-2921&author=H.+I.+El-Subbaghauthor=S.+M.+Abu-Zaidauthor=M.+A.+Mahranauthor=F.+A.+Badriaauthor=A.+M.+Al-Obaid&title=Synthesis+and+biological+evaluation+of+certain+alpha%2C+beta-unsaturated+ketones+and+their+corresponding+fused+pyridines+as+antiviral+and+cytotoxic+agents&doi=10.1021%2Fjm000038m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of certain α,β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents</span></div><div class="casAuthors">El-Subbagh, Hussein I.; Abu-Zaid, Suhair M.; Mahran, Mona A.; Badria, Farid A.; Al-Obaid, Abdulrahman M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2915-2921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of 3,5-bis(arylidene)-4-piperidones I (R = 4-NO2C6H4, 2-thienyl, 4-MeC6H4, etc.), as chalcone analogs carrying variety of aryl and heteroaryl groups, pyrazolo[4,3-c]pyridines II (R = 4-MeC6H4, 2-thienyl, 4-MeOC6H4, R' = Me, Ph), pyrido[4,3-d]pyrimidines III, and pyrido[3,2-c]pyridines IV, carrying an arylidene moiety, and a series of pyrano[3,2-c]pyridines V, as flavone and coumarin isosteres, were synthesized and screened for their in vitro antiviral and antitumor activities at the National Cancer Institute (NCI).  Compds. I (R = 4-ClC6H4) and hydroxypyridine VI proved to be active against herpes simplex virus-1 (HSV-1), while compd. I (R = 4-pyridyl) showed moderate activity against human immunodeficiency virus-1 (HIV-1).  Compds. I (R = 2-thienyl), II (R = 2-thienyl, R' = Ph), III (R = 4-MeOC6H4), and V (R = 4-MeC6H4, 2-thienyl) exhibited a broad spectrum antitumor activity.  In addn., compds. II (R = 2-thienyl, R' = Ph) and V (R = 4-MeC6H4, 2-thienyl) proved to be of moderate selectivity toward leukemia cell lines.  The pyrano[3,2-c]pyridines heterocyclic system proved to be the most active antitumors among the investigated heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp16BSvLX8pbbVg90H21EOLACvtfcHk0lhP7cBoTKauBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFGrtrg%253D&md5=d8292b5de99db9da0055202da20e585e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm000038m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000038m%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Subbagh%26aufirst%3DH.%2BI.%26aulast%3DAbu-Zaid%26aufirst%3DS.%2BM.%26aulast%3DMahran%26aufirst%3DM.%2BA.%26aulast%3DBadria%26aufirst%3DF.%2BA.%26aulast%3DAl-Obaid%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520certain%2520alpha%252C%2520beta-unsaturated%2520ketones%2520and%2520their%2520corresponding%2520fused%2520pyridines%2520as%2520antiviral%2520and%2520cytotoxic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2915%26epage%3D2921%26doi%3D10.1021%2Fjm000038m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferstl, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camalier, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickles, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3871</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2004.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15210154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3871-3883&author=B.+K.+Adamsauthor=E.+M.+Ferstlauthor=M.+C.+Davisauthor=M.+Heroldauthor=S.+Kurtkayaauthor=R.+F.+Camalierauthor=M.+G.+Hollingsheadauthor=G.+Kaurauthor=E.+A.+Sausvilleauthor=F.+R.+Ricklesauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=M.+Shoji&title=Synthesis+and+biological+evaluation+of+novel+curcumin+analogs+as+anti-cancer+and+anti-angiogenesis+agents&doi=10.1016%2Fj.bmc.2004.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents</span></div><div class="casAuthors">Adams, Brian K.; Ferstl, Eva M.; Davis, Matthew C.; Herold, Marike; Kurtkaya, Serdar; Camalier, Richard F.; Hollingshead, Melinda G.; Kaur, Gurmeet; Sausville, Edward A.; Rickles, Frederick R.; Snyder, James P.; Liotta, Dennis C.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3871-3883</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of novel curcumin analogs were synthesized and screened for anti-cancer and anti-angiogenesis activities at Emory University and at the National Cancer Institute (NCI).  These compds. are sym. α,β-unsatd. and satd. ketones.  The majority of the analogs demonstrated a moderate degree of anti-cancer activity.  Three Compds. exhibited a high degree of cytotoxicity in the NCI in vitro anti-cancer cell line screen.  In addn., this screen revealed that these compds. inhibit tumor cell growth with a higher potency than the commonly used chemotherapeutic drug, cisplatin.  In independent in vitro screens conducted at Emory, 5 compds. exhibited a high degree of cytotoxicity to tumor cells.  Analogs that were effective in the anti-cancer screens were also effective in in vitro anti-angiogenesis assays.  In the assays conducted by the NCI, I was almost as potent as the anti-angiogenic drug TNP-470, which has undergone clin. trials.  Based on the favorable in vitro anti-cancer and anti-angiogenesis results with I, further in vivo tests were conducted.  This compd. effectively reduced the size of human breast tumors grown in female athymic nude mice and showed little toxicity.  This data, coupled with the remarkable in vitro data, suggests that I may potentially be an effective chemotherapeutic agent.  As a follow-up, a 3D quant. structure relation based on I has been developed.  It shows a cross-validated r2(q2)=0.83 and a predictive r2(p2)=0.71.  COMPARE anal. suggests the compd. to be a possible RNA/DNA antimetabolite, but also implies that the compd.'s cytotoxicity may arise from a presently unknown mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmpU3h4OlGrVg90H21EOLACvtfcHk0lhP7cBoTKauBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVKisr8%253D&md5=94f8cdb257139ec0dcd3a742a90b9252</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DFerstl%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DM.%2BC.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DCamalier%26aufirst%3DR.%2BF.%26aulast%3DHollingshead%26aufirst%3DM.%2BG.%26aulast%3DKaur%26aufirst%3DG.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DRickles%26aufirst%3DF.%2BR.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520curcumin%2520analogs%2520as%2520anti-cancer%2520and%2520anti-angiogenesis%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3871%26epage%3D3883%26doi%3D10.1016%2Fj.bmc.2004.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2001</span>– <span class="NLM_lpage">2020</span>, <span class="refDoi"> DOI: 10.2174/092986709788682218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.2174%2F092986709788682218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19519378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2001-2020&author=U.+Dasauthor=R.+K.+Sharmaauthor=J.+R.+Dimmock&title=1%2C5-diaryl-3-oxo-1%2C4-pentadienes%3A+a+case+for+antineoplastics+with+multiple+targets&doi=10.2174%2F092986709788682218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets</span></div><div class="casAuthors">Das, U.; Sharma, R. K.; Dimmock, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2001-2020</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A no. of org. mols. which contain the 1,5-diaryl-3-oxo-1,4-pentadienyl group, referred to hereafter as the dienone moiety, have antineoplastic properties.  Emphasis is made on the attachment of this structural moiety to several mol. scaffolds, namely piperidines, N-acylpiperidines, cycloalkanes and 3,4-dihydro-1H-naphthalenes.  Many of these compds. are potent cytotoxins having micromolar and nanomolar IC50 values towards a wide range of neoplastic and transformed cells.  On occasions, greater toxicity towards neoplasms than normal cells has been demonstrated.  A no. of these compds. have in vivo anticancer properties and in general excellent tolerability in rodents is demonstrated.  The way in which a no. of physicochem. properties such as redox potentials, torsion angles, at. charges and logP values govern cytotoxic potencies are presented.  The importance of the shapes of different compds. as detd. by mol. modeling in contributing to antineoplastic properties is outlined.  Arguments are presented in favor of designing antineoplastics which have multiple sites of action in contrast to those bioactive mols. which have only one mol. target.  A no. of compds. which possess the dienone group have different modes of action some of which are chronicled in this review, such as inducing apoptosis, affecting respiration in mitochondria, inhibiting macro-mol. biosynthesis and both inhibiting and stimulating certain enzymes.  Other important properties of these compds. are discussed including their anti-angiogenic, MDR-revertant and antioxidant properties.  It is hoped that this eulogy of the importance of the dienone group will encourage researchers to consider incorporating this structural unit into candidate cytotoxins in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox_6M2Qt8hoLVg90H21EOLACvtfcHk0lgyIYhjlX2Iag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs7w%253D&md5=d0179d2c273d43faa40606e50897ec71</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F092986709788682218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788682218%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DU.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3D1%252C5-diaryl-3-oxo-1%252C4-pentadienes%253A%2520a%2520case%2520for%2520antineoplastics%2520with%2520multiple%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2001%26epage%3D2020%26doi%3D10.2174%2F092986709788682218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">CoMFA and CoMSIA studies on 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-bis(benzylidene)cyclohexanone, and 3,5-bis(benzylidene)-4-piperidone series of cytotoxic compounds</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2123</span>, <span class="refDoi"> DOI: 10.1021/ci700210z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700210z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2110-2123&author=M.+R.+Patelauthor=J.+R.+Dimmockauthor=T.+T.+Talele&title=CoMFA+and+CoMSIA+studies+on+1%2C3-bis%28benzylidene%29-3%2C4-dihydro-1H-naphthalen-2-one%2C+2%2C6-bis%28benzylidene%29cyclohexanone%2C+and+3%2C5-bis%28benzylidene%29-4-piperidone+series+of+cytotoxic+compounds&doi=10.1021%2Fci700210z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CoMFA and CoMSIA Studies on 1,3-Bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-Bis(benzylidene)cyclohexanone, and 3,5-Bis(benzylidene)-4-piperidone Series of Cytotoxic Compounds</span></div><div class="casAuthors">Patel, Maulik R.; Dimmock, Jonathan R.; Talele, Tanaji T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2110-2123</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A no. of 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-ones, 2,6-bis(benzylidene)cyclohexanones, and 3,5-bis(benzylidene)-4-piperidones possess significant potencies toward L1210, Molt 4/C8, and CEM cell lines.  The objective of the current 3D QSAR study is to discover some of the structural parameters which govern cytotoxic potencies.  The CoMFA models with steric and electrostatic fields provided satisfactory statistical data [(r2cv = 0.485, r2ncv = 0.834, r2pred = 0.591), (r2cv = 0.532, r2ncv = 0.850, r2pred = 0.729), and (r2cv = 0.561, r2ncv = 0.864, r2pred = 0.666)] in regard to the cytotoxic potencies obsd. toward L1210, Molt 4/C8, and CEM cell lines, resp.  The CoMSIA model with steric, electrostatic, hydrophobic, and H-bond donor fields exhibited r2cv = 0.513, r2ncv = 0.833, and r2pred = 0.562 for cytotoxic activity toward L1210 cells, while the best CoMSIA models were obtained by a combination of steric, electrostatic, and hydrophobic fields which yielded statistically significant data [(r2cv = 0.531, r2ncv = 0.828, r2pred = 0.652) and (r2cv = 0.560, r2ncv = 0.841, r2pred = 0.729)] to explain the cytotoxicity toward Molt 4/C8 and CEM cells, resp.  The information obtained from the CoMFA and CoMSIA 3D contour maps can be used in the design of more potent cytotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyKAu-d3vKrrVg90H21EOLACvtfcHk0lgyIYhjlX2Iag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitLbO&md5=f7b5e9e361f7c7fe0a4781b360018990</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fci700210z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700210z%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DCoMFA%2520and%2520CoMSIA%2520studies%2520on%25201%252C3-bis%2528benzylidene%2529-3%252C4-dihydro-1H-naphthalen-2-one%252C%25202%252C6-bis%2528benzylidene%2529cyclohexanone%252C%2520and%25203%252C5-bis%2528benzylidene%2529-4-piperidone%2520series%2520of%2520cytotoxic%2520compounds%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2110%26epage%3D2123%26doi%3D10.1021%2Fci700210z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pati, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ejmech.2008.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18468733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFaq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=54-62&author=H.+N.+Patiauthor=U.+Dasauthor=S.+Dasauthor=B.+Bandyauthor=E.+De+Clercqauthor=J.+Balzariniauthor=M.+Kawaseauthor=H.+Sakagamiauthor=J.+W.+Quailauthor=J.+P.+Stablesauthor=J.+R.+Dimmock&title=The+cytotoxic+properties+and+preferential+toxicity+to+tumour+cells+displayed+by+some+2%2C4-bis%28benzylidene%29-8-methyl-8-azabicyclo%5B3.2.1%5D+octan-3-ones+and+3%2C5-bis%28benzylidene%29-1-methyl-4-piperidones&doi=10.1016%2Fj.ejmech.2008.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones</span></div><div class="casAuthors">Pati, Hari N.; Das, Umashankar; Das, Swagatika; Bandy, Brian; De Clercq, Erik; Balzarini, Jan; Kawase, Masami; Sakagami, Hiroshi; Quail, J. Wilson; Stables, James P.; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-62</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This study demonstrated that replacement of the axial protons on the C2 and C6 atoms of various 1-methyl-3,5-bis(benzylidene)-4-piperidones 3 by a dimethylene bridge leading to series 2 lowered cytotoxic potencies.  Compds. emerged as lead mols. based on their toxicity towards different neoplasms and their selective toxicity for malignant rather than normal cells.  Some possible reasons for the disparity between the IC50 values in the two series of compds. are presented based on mol. modeling, log P values and respiration in rat liver mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7c5xUDnok47Vg90H21EOLACvtfcHk0lgyIYhjlX2Iag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFaq&md5=55f43b3a39a300c2268a511cc1b5963c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DPati%26aufirst%3DH.%2BN.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DBandy%26aufirst%3DB.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DQuail%26aufirst%3DJ.%2BW.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520cytotoxic%2520properties%2520and%2520preferential%2520toxicity%2520to%2520tumour%2520cells%2520displayed%2520by%2520some%25202%252C4-bis%2528benzylidene%2529-8-methyl-8-azabicyclo%255B3.2.1%255D%2520octan-3-ones%2520and%25203%252C5-bis%2528benzylidene%2529-1-methyl-4-piperidones%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D54%26epage%3D62%26doi%3D10.1016%2Fj.ejmech.2008.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inci Gul, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2219</span>– <span class="NLM_lpage">2224</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.01.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2010.01.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20189402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2219-2224&author=U.+Dasauthor=A.+Doroudiauthor=H.+Inci+Gulauthor=H.+N.+Patiauthor=M.+Kawaseauthor=H.+Sakagamiauthor=Q.+Chuauthor=J.+P.+Stablesauthor=J.+R.+Dimmock&title=Cytotoxic+2-benzylidene-6-%28nitrobenzylidene%29cyclohexanones+which+display+substantially+greater+toxicity+for+neoplasms+than+non-malignant+cells&doi=10.1016%2Fj.bmc.2010.01.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells</span></div><div class="casAuthors">Das, Umashankar; Doroudi, Alireza; Inci Gul, H.; Pati, Hari N.; Kawase, Masami; Sakagami, Hiroshi; Chu, Qing; Stables, James P.; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2219-2224</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Various 2-benzylidene-6-(nitrobenzylidene)cyclohexanones were prepd. as candidate cytotoxins in which the nitro group was located in the ortho, meta and para positions leading to series 1-3, resp.  The CC50 values towards human HSC-2 and HSC-4 oral squamous cell carcinomas as well as human HL-60 promyelocytic leukemic cells are in the low micromolar range in general.  On the other hand, most of the compds. afforded clear evidence of being far less toxic towards human HGF gingival fibroblasts, HPC pulp cells and HPLF periodontal ligament fibroblasts which are non-malignant cells.  Selectivity index (SI) figures were generated which are the ratios of the av. CC50 values towards normal cells and the CC50 figure towards a malignant cell line.  Huge SI values were obtained for many of the compds.  In particular 1c, 2f, 3c and 3g which have av. SI values of >76, >38, 124 and 341, resp., are clearly lead mols. affording direction for amplification of this area of study.  A lead compd. 1c (I) caused internucleosomal DNA fragmentation and activation of caspase-3 in HL-60 cells but not in HSC-2 carcinomas.  In a short-term toxicity study, doses up to and including 300 mg/kg of the majority of the compds. prepd. in this study did not cause any mortalities to mice.  Some guidelines for development of these tumor-selective cytotoxins are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpREUb3JFBtvLVg90H21EOLACvtfcHk0lix74N9Z4TWvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbY%253D&md5=12ef80ab337b36ac22a7372b5f9a80f6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.01.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.01.069%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDoroudi%26aufirst%3DA.%26aulast%3DInci%2BGul%26aufirst%3DH.%26aulast%3DPati%26aufirst%3DH.%2BN.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DQ.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3DCytotoxic%25202-benzylidene-6-%2528nitrobenzylidene%2529cyclohexanones%2520which%2520display%2520substantially%2520greater%2520toxicity%2520for%2520neoplasms%2520than%2520non-malignant%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2219%26epage%3D2224%26doi%3D10.1016%2Fj.bmc.2010.01.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santiago-Vazquez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baca, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala-Marin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lema, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baryyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, R. J.</span></span> <span> </span><span class="NLM_article-title">Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/ lymphoma cells</span>. <i>Clin. Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.2174/2212697X03666160830165250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.2174%2F2212697X03666160830165250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27857884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs12lu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=138-146&author=Y.+Santiago-Vazquezauthor=U.+Dasauthor=A.+Varela-Ramirezauthor=S.+T.+Bacaauthor=Y.+Ayala-Marinauthor=C.+Lemaauthor=S.+Dasauthor=A.+Baryyanauthor=J.+R.+Dimmockauthor=R.+J.+Aguilera&title=Tumor-selective+cytotoxicity+of+a+novel+pentadiene+analogue+on+human+leukemia%2F+lymphoma+cells&doi=10.2174%2F2212697X03666160830165250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells</span></div><div class="casAuthors">Santiago-Vazquez, Yahaira; Das, Umashankar; Varela-Ramirez, Armando; Baca, Sarah T.; Ayala-Marin, Yoshira; Lema, Carolina; Das, Swagatika; Baryyan, Alaa; Dimmock, Jonathan R.; Aguilera, Renato J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">138-146</span>CODEN:
                <span class="NLM_cas:coden">CCDLBJ</span>;
        ISSN:<span class="NLM_cas:issn">2212-6988</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: A novel series of structurally divergent 1,5-diaryl-3-oxo- 1,4-pentadiene analogs 1-10 displayed marked cytotoxic potencies towards a no. of human leukemia/lymphoma cells.  Objective: To identify novel selective cytotoxic compds. that induce apoptosis.  Methods: The Differential Nuclear Staining (DNS) screening protocol was utilized to measure the cytotoxicity of all exptl. dienones on several cancerous cells.  Addnl., the selective cytotoxicity index was calcd. by comparing the dienone's cytotoxicity between leukemia/lymphoma cells vs. non-cancerous cells.  Furthermore, to discern whether a selected dienone induced cell death via apoptosis or necrosis on T-lymphocyte leukemia cells, diverse approaches were utilized to detect individual biochem. facets of apoptosis.  Results: The dienones were tested for their anti-neoplastic efficiency on human leukemia/lymphomaderived cell lines.  Special emphasis was applied on dienone 1, on the basis of its sub-micromolar cytotoxicity (CC50=0.43+0.02 M) and high selective cytotoxicity index (11.1) exerted on T-leukemia cells.  In general, dienone 1 showed the most potent cytotoxic properties as compared to other dienones and a related ref. cytotoxin curcumin as well as the EF-24 curcumin analog.  Dienone 1 caused cell death by apoptosis in Jurkat cells as evidenced by inducing phosphatidylserine externalization, mitochondrial depolarization and caspase-3/7.  These effects were mainly attributed to the induction of apoptotic pathways.  Conclusion: The novel dienone 1 was found to exhibit potent anti-leukemia activity by inducing programmed cell death/apoptosis.  Consequently, dienone 1 should be developed further to examine its potential efficacy to combat malignancies in a pre-clin. animal model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8T1yRbKAeu7Vg90H21EOLACvtfcHk0lix74N9Z4TWvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs12lu7zM&md5=a665bec45f51fe165280077eb5c8bb3f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F2212697X03666160830165250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2212697X03666160830165250%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago-Vazquez%26aufirst%3DY.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DVarela-Ramirez%26aufirst%3DA.%26aulast%3DBaca%26aufirst%3DS.%2BT.%26aulast%3DAyala-Marin%26aufirst%3DY.%26aulast%3DLema%26aufirst%3DC.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DBaryyan%26aufirst%3DA.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DAguilera%26aufirst%3DR.%2BJ.%26atitle%3DTumor-selective%2520cytotoxicity%2520of%2520a%2520novel%2520pentadiene%2520analogue%2520on%2520human%2520leukemia%252F%2520lymphoma%2520cells%26jtitle%3DClin.%2520Cancer%2520Drugs%26date%3D2016%26volume%3D3%26spage%3D138%26epage%3D146%26doi%3D10.2174%2F2212697X03666160830165250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, R. J.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones</span>. <i>Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1007/s13402-018-0397-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs13402-018-0397-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=623-636&author=L.+Contrerasauthor=R.+I.+Calderonauthor=A.+Varela-Ramirezauthor=H.+Y.+Zhangauthor=Y.+Quanauthor=U.+Dasauthor=J.+R.+Dimmockauthor=R.+Skoutaauthor=R.+J.+Aguilera&title=Induction+of+apoptosis+via+proteasome+inhibition+in+leukemia%2Flymphoma+cells+by+two+potent+piperidones&doi=10.1007%2Fs13402-018-0397-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones</span></div><div class="casAuthors">Contreras, Lisett; Calderon, Ruben I.; Varela-Ramirez, Armando; Zhang, Hong-Yu; Quan, Yuan; Das, Umashankar; Dimmock, Jonathan R.; Skouta, Rachid; Aguilera, Renato J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">623-636</span>CODEN:
                <span class="NLM_cas:coden">COENGH</span>;
        ISSN:<span class="NLM_cas:issn">2211-3436</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Previously, compds. contg. a piperidone structure have been shown to be highly cytotoxic to cancer cells.  Recently, we found that the piperidone compd. P2 exhibits a potent anti-neoplastic activity against human breast cancer-derived cells.  Here, we aimed to evaluate two piperidone compds., P1 and P2, for their potential anti-neoplastic activity against human leukemia/lymphoma-derived cells.  Methods: Cytotoxicity and apoptosis induction were evaluated using MTS, annexin V-FITC/PI and mitochondrial membrane potential polychromatic assays to confirm the mode of action of the piperidone compds.  The effects of compd. P1 and P2 treatment on gene expression were assessed using AmpliSeq anal. and, subsequently, confirmed by RT-qPCR and Western blotting.  Results: We found that the two related piperidone compds. P1 and P2 selectively killed the leukemia/lymphoma cells tested at nanomolar concns. through induction of the intrinsic apoptotic pathway, as demonstrated by mitochondrial depolarization and caspase-3 activation.  AmpliSeq-based transcriptome analyses of the effects of compds. P1 and P2 on HL-60 acute leukemia cells revealed a differential expression of hundreds of genes, 358 of which were found to be affected by both.  Addnl. pathway analyses revealed that a significant no. of the common genes were related to the unfolded protein response, implying a possible role of the two compds. in the induction of proteotoxic stress.  Subsequent analyses of the transcriptome data revealed that P1 and P2 induced similar gene expression alterations as other well-known proteasome inhibitors.  Finally, we found that Noxa, an important mediator of the activity of proteasome inhibitors, was significantly upregulated at both the mRNA and protein levels, indicating a possible role in the cytotoxic mechanism induced by P1 and P2.  Conclusions: Our data indicate that the cytotoxic activity of P1 and P2 on leukemia/lymphoma cells is mediated by proteasome inhibition, leading to activation of pro-apoptotic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiMsM0d2vAErVg90H21EOLACvtfcHk0lix74N9Z4TWvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVKiu7bN&md5=06b98488ecebf2e8b3f96101816dc00e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs13402-018-0397-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13402-018-0397-1%26sid%3Dliteratum%253Aachs%26aulast%3DContreras%26aufirst%3DL.%26aulast%3DCalderon%26aufirst%3DR.%2BI.%26aulast%3DVarela-Ramirez%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DAguilera%26aufirst%3DR.%2BJ.%26atitle%3DInduction%2520of%2520apoptosis%2520via%2520proteasome%2520inhibition%2520in%2520leukemia%252Flymphoma%2520cells%2520by%2520two%2520potent%2520piperidones%26jtitle%3DCell.%2520Oncol.%26date%3D2018%26volume%3D41%26spage%3D623%26epage%3D636%26doi%3D10.1007%2Fs13402-018-0397-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brnjic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknäs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cesare, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perego, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of proteasome deubiquitinating activity as a new cancer therapy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1640</span>, <span class="refDoi"> DOI: 10.1038/nm.2536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnm.2536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22057347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1636-1640&author=P.+D%E2%80%99Arcyauthor=S.+Brnjicauthor=M.+H.+Olofssonauthor=M.+Frykn%C3%A4sauthor=K.+Lindstenauthor=M.+De+Cesareauthor=P.+Peregoauthor=B.+Sadeghiauthor=M.+Hassanauthor=R.+Larssonauthor=S.+Linder&title=Inhibition+of+proteasome+deubiquitinating+activity+as+a+new+cancer+therapy&doi=10.1038%2Fnm.2536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of proteasome deubiquitinating activity as a new cancer therapy</span></div><div class="casAuthors">D'Arcy, Padraig; Brnjic, Slavica; Olofsson, Maria Haegg; Fryknaes, Maarten; Lindsten, Kristina; De Cesare, Michelandrea; Perego, Paola; Sadeghi, Behnam; Hassan, Moustapha; Larsson, Rolf; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1636-1640</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ubiquitin-tagged substrates are degraded by the 26S proteasome, which is a multisubunit complex comprising a proteolytic 20S core particle capped by 19S regulatory particles.  The approval of bortezomib for the treatment of multiple myeloma validated the 20S core particle as an anticancer drug target.  Here we describe the small mol. b-AP15 as a previously unidentified class of proteasome inhibitor that abrogates the deubiquitinating activity of the 19S regulatory particle. b-AP15 inhibited the activity of two 19S regulatory-particle-assocd. deubiquitinases, ubiquitin C-terminal hydrolase 5 (UCHL5) and ubiquitin-specific peptidase 14 (USP14), resulting in accumulation of polyubiquitin. b-AP15 induced tumor cell apoptosis that was insensitive to TP53 status and overexpression of the apoptosis inhibitor BCL2.  We show that treatment with b-AP15 inhibited tumor progression in four different in vivo solid tumor models and inhibited organ infiltration in an acute myeloid leukemia model.  Our results show that the deubiquitinating activity of the 19S regulatory particle is a new anticancer drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaMVlVRc-JnbVg90H21EOLACvtfcHk0lhHQh8PlCG5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtLfI&md5=e06ed2f3368197416e3188873080d359</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm.2536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2536%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DBrnjic%26aufirst%3DS.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DFrykn%25C3%25A4s%26aufirst%3DM.%26aulast%3DLindsten%26aufirst%3DK.%26aulast%3DDe%2BCesare%26aufirst%3DM.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DSadeghi%26aufirst%3DB.%26aulast%3DHassan%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520proteasome%2520deubiquitinating%2520activity%2520as%2520a%2520new%2520cancer%2520therapy%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1636%26epage%3D1640%26doi%3D10.1038%2Fnm.2536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palzkill, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lonard, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, B. W.</span></span> <span> </span><span class="NLM_article-title">Characterization of a steroid receptor coactivator small molecule stimulator that overstimulates cancer cells and leads to cell stress and death</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ccell.2015.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26267537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWlsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=240-252&author=L.+Wangauthor=Y.+Yuauthor=D.+C.+Chowauthor=F.+Yanauthor=C.+C.+Hsuauthor=F.+Stossiauthor=M.+A.+Manciniauthor=T.+Palzkillauthor=L.+Liaoauthor=S.+Zhouauthor=J.+Xuauthor=D.+M.+Lonardauthor=B.+W.+O%E2%80%99Malley&title=Characterization+of+a+steroid+receptor+coactivator+small+molecule+stimulator+that+overstimulates+cancer+cells+and+leads+to+cell+stress+and+death&doi=10.1016%2Fj.ccell.2015.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death</span></div><div class="casAuthors">Wang, Lei; Yu, Yang; Chow, Dar-Chone; Yan, Fei; Hsu, Chih-Chao; Stossi, Fabio; Mancini, Michael A.; Palzkill, Timothy; Liao, Lan; Zhou, Suoling; Xu, Jianming; Lonard, David M.; O'Malley, Bert W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">240-252</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">By integrating growth pathways on which cancer cells rely, steroid receptor coactivators (SRC-1, SRC-2, and SRC-3) represent emerging targets in cancer therapeutics.  High-throughput screening for SRC small mol. inhibitors (SMIs) uncovered MCB-613 as a potent SRC small mol. "stimulator" (SMS).  We demonstrate that MCB-613 can super-stimulate SRCs' transcriptional activity.  Further investigation revealed that MCB-613 increases SRCs' interactions with other coactivators and markedly induces ER stress coupled to the generation of reactive oxygen species (ROS).  Because cancer cells overexpress SRCs and rely on them for growth, we show that we can exploit MCB-613 to selectively induce excessive stress in cancer cells.  This suggests that over-stimulating the SRC oncogenic program can be an effective strategy to kill cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHoOaA2EilYbVg90H21EOLACvtfcHk0lhHQh8PlCG5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWlsbvJ&md5=c22fe20a8c958af1d78b94c87772a33b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DChow%26aufirst%3DD.%2BC.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DHsu%26aufirst%3DC.%2BC.%26aulast%3DStossi%26aufirst%3DF.%26aulast%3DMancini%26aufirst%3DM.%2BA.%26aulast%3DPalzkill%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLonard%26aufirst%3DD.%2BM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DB.%2BW.%26atitle%3DCharacterization%2520of%2520a%2520steroid%2520receptor%2520coactivator%2520small%2520molecule%2520stimulator%2520that%2520overstimulates%2520cancer%2520cells%2520and%2520leads%2520to%2520cell%2520stress%2520and%2520death%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D28%26spage%3D240%26epage%3D252%26doi%3D10.1016%2Fj.ccell.2015.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coughlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iizuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meints, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacNeill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3174</span>– <span class="NLM_lpage">3186</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1078-0432.CCR-13-2658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24727327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1Cms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=3174-3186&author=K.+Coughlinauthor=R.+Anchooriauthor=Y.+Iizukaauthor=J.+Meintsauthor=L.+MacNeillauthor=R.+I.+Vogelauthor=R.+Z.+Orlowskiauthor=M.+K.+Leeauthor=R.+B.+Rodenauthor=M.+Bazzaro&title=Small-molecule+RA-9+inhibits+proteasome-associated+DUBs+and+ovarian+cancer+in+vitro+and+in+vivo+via+exacerbating+unfolded+protein+responses&doi=10.1158%2F1078-0432.CCR-13-2658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses</span></div><div class="casAuthors">Coughlin, Kathleen; Anchoori, Ravi; Iizuka, Yoshie; Meints, Joyce; MacNeill, Lauren; Vogel, Rachel Isaksson; Orlowski, Robert Z.; Lee, Michael K.; Roden, Richard B. S.; Bazzaro, Martina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3174-3186</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Ovarian cancer is the deadliest of the gynecol. malignancies.  Carcinogenic progression is accompanied by upregulation of ubiquitin-dependent protein degrdn. machinery as a mechanism to compensate with elevated endogenous proteotoxic stress.  Recent studies support the notion that deubiquitinating enzymes (DUB) are essential factors in proteolytic degrdn. and that their aberrant activity is linked to cancer progression and chemoresistance.  Thus, DUBs are an attractive therapeutic target for ovarian cancer.  Exptl. Design: The potency and selectivity of RA-9 inhibitor for proteasome-assocd. DUBs was detd. in ovarian cancer cell lines and primary cells.  The anticancer activity of RA-9 and its mechanism of action were evaluated in multiple cancer cell lines in vitro and in vivo in immunodeficient mice bearing an i.p. ES-2 xenograft model of human ovarian cancer.  Results: Here, we report the characterization of RA-9 as a small-mol. inhibitor of proteasome-assocd. DUBs.  Treatment with RA-9 selectively induces onset of apoptosis in ovarian cancer cell lines and primary cultures derived from donors.  Loss of cell viability following RA-9 exposure is assocd. with an unfolded protein response as mechanism to compensate for unsustainable levels of proteotoxic stress.  In vivo treatment with RA-9 retards tumor growth, increases overall survival, and was well tolerated by the host.  Conclusions: Our preclin. studies support further evaluation of RA-9 as an ovarian cancer therapeutic.  Clin Cancer Res; 20(12); 3174-86. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodC4WcEvlxarVg90H21EOLACvtfcHk0lhHQh8PlCG5vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1Cms78%253D&md5=ae089c729fd6b591705be804f9493432</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2658%26sid%3Dliteratum%253Aachs%26aulast%3DCoughlin%26aufirst%3DK.%26aulast%3DAnchoori%26aufirst%3DR.%26aulast%3DIizuka%26aufirst%3DY.%26aulast%3DMeints%26aufirst%3DJ.%26aulast%3DMacNeill%26aufirst%3DL.%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DBazzaro%26aufirst%3DM.%26atitle%3DSmall-molecule%2520RA-9%2520inhibits%2520proteasome-associated%2520DUBs%2520and%2520ovarian%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%2520via%2520exacerbating%2520unfolded%2520protein%2520responses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D3174%26epage%3D3186%26doi%3D10.1158%2F1078-0432.CCR-13-2658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Puente, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azab, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luderer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azab, A. K.</span></span> <span> </span><span class="NLM_article-title">Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1677</span>– <span class="NLM_lpage">1686</span>, <span class="refDoi"> DOI: 10.3109/10428194.2015.1099645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3109%2F10428194.2015.1099645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26421357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWhsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1677-1686&author=P.+de%0Ala+Puenteauthor=F.+Azabauthor=B.+Muzauthor=M.+Ludererauthor=J.+Arbiserauthor=A.+K.+Azab&title=Tris+DBA+palladium+overcomes+hypoxia-mediated+drug+resistance+in+multiple+myeloma&doi=10.3109%2F10428194.2015.1099645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma</span></div><div class="casAuthors">de la Puente, Pilar; Azab, Feda; Muz, Barbara; Luderer, Micah; Arbiser, Jack; Azab, Abdel Kareem</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1677-1686</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Despite recent progress in novel and targeted therapies, multiple myeloma (MM) remains a therapeutically challenging incurable disease.  The regulation of important cellular processes and its link to cancer presented Src as an attractive target for MM.  We suggest a novel strategy to improve the treatment of MM and overcome the drug resistance for the current therapeutic agents by specific inhibition of Src in MM cells by Tris (Dibenzylideneacetone) dipalladium (Tris DBA).  Tris DBA reduces proliferation, induces G1 arrest and apoptosis in MM cells.  Tris DBA showed additive effect with proteasome inhibitors reducing proliferation, cell cycle signaling, and increasing apoptosis more than each drug alone.  Tris DBA overcame hypoxia-induced effects such as enhanced chemotaxis or drug resistance to proteasome inhibitors by inhibition of HIF1α expression.  Moreover, we found that Tris DBA is an effective anti-myeloma agent alone or in combination with other targeted drugs and that it reverses hypoxia-induced drug resistance in myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq92liKQtr-7bVg90H21EOLACvtfcHk0ljo9V4DoIwg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWhsb%252FK&md5=da369822fa6a6d5e4d8400c8928e7828</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3109%2F10428194.2015.1099645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2015.1099645%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BPuente%26aufirst%3DP.%26aulast%3DAzab%26aufirst%3DF.%26aulast%3DMuz%26aufirst%3DB.%26aulast%3DLuderer%26aufirst%3DM.%26aulast%3DArbiser%26aufirst%3DJ.%26aulast%3DAzab%26aufirst%3DA.%2BK.%26atitle%3DTris%2520DBA%2520palladium%2520overcomes%2520hypoxia-mediated%2520drug%2520resistance%2520in%2520multiple%2520myeloma%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2016%26volume%3D57%26spage%3D1677%26epage%3D1686%26doi%3D10.3109%2F10428194.2015.1099645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureban, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanujam, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieckgraefe, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houchen, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anant, S.</span></span> <span> </span><span class="NLM_article-title">Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1962</span>– <span class="NLM_lpage">1969</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-6011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-07-6011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18339878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1962-1969&author=D.+Subramaniamauthor=R.+Mayauthor=S.+M.+Surebanauthor=K.+B.+Leeauthor=R.+Georgeauthor=P.+Kuppusamyauthor=R.+P.+Ramanujamauthor=K.+Hidegauthor=B.+K.+Dieckgraefeauthor=C.+W.+Houchenauthor=S.+Anant&title=Diphenyl+difluoroketone%3A+a+curcumin+derivative+with+potent+in+vivo+anticancer+activity&doi=10.1158%2F0008-5472.CAN-07-6011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Diphenyl Difluoroketone: A Curcumin Derivative with Potent In vivo Anticancer Activity</span></div><div class="casAuthors">Subramaniam, Dharmalingam; May, Randal; Sureban, Sripathi M.; Lee, Katherine B.; George, Robert; Kuppusamy, Periannan; Ramanujam, Rama P.; Hideg, Kalman; Dieckgraefe, Brian K.; Houchen, Courtney W.; Anant, Shrikant</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1962-1969</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Diphenyldifluoroketone (EF24), a mol. having structural similarity to curcumin, was reported to inhibit proliferation of a variety of cancer cells in vitro.  However, the efficacy and in vivo mechanism of action of EF24 in gastrointestinal cancer cells have not been investigated.  Here, we assessed the in vivo therapeutic effects of EF24 on colon cancer cells.  Using hexosaminidase assay, we detd. that EF24 inhibits proliferation of HCT-116 and HT-29 colon and AGS gastric adenocarcinoma cells but not of mouse embryo fibroblasts.  Furthermore, the cancer cells showed increased levels of activated caspase-3 and increased Bax to Bcl-2 and Bax to Bcl-xL ratios, suggesting that the cells were undergoing apoptosis.  At the same time, cell cycle anal. showed that there was an increased no. of cells in the G2-M phase.  To det. the effects of EF24 in vivo, HCT-116 colon cancer xenografts were established in nude mice and EF24 was given i.p.  EF24 significantly suppressed the growth of colon cancer tumor xenografts.  Immunostaining for CD31 showed that there was a lower no. of microvessels in the EF24-treated animals coupled with decreased cyclooxygenase-2, interleukin-8, and vascular endothelial growth factor mRNA and protein expression.  Western blot analyses also showed decreased AKT and extracellular signal-regulated kinase activation in the tumors.  Taken together, these data suggest that the novel curcumin-related compd. EF24 is a potent antitumor agent that induces caspase-mediated apoptosis during mitosis and has significant therapeutic potential for gastrointestinal cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl00KZe-_nprVg90H21EOLACvtfcHk0ljo9V4DoIwg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFOhtrs%253D&md5=a57c5a7fb7bd1e8e53858c16cf2b60eb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-6011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-6011%26sid%3Dliteratum%253Aachs%26aulast%3DSubramaniam%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DR.%26aulast%3DSureban%26aufirst%3DS.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BB.%26aulast%3DGeorge%26aufirst%3DR.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DRamanujam%26aufirst%3DR.%2BP.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DDieckgraefe%26aufirst%3DB.%2BK.%26aulast%3DHouchen%26aufirst%3DC.%2BW.%26aulast%3DAnant%26aufirst%3DS.%26atitle%3DDiphenyl%2520difluoroketone%253A%2520a%2520curcumin%2520derivative%2520with%2520potent%2520in%2520vivo%2520anticancer%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D1962%26epage%3D1969%26doi%3D10.1158%2F0008-5472.CAN-07-6011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Starcevic, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diotte, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukowski, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R. F.</span></span> <span> </span><span class="NLM_article-title">Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD)</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfg154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Ftoxsci%2Fkfg154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=12805649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2003&pages=74-81&author=S.+L.+Starcevicauthor=N.+M.+Diotteauthor=K.+L.+Zukowskiauthor=M.+J.+Cameronauthor=R.+F.+Novak&title=Oxidative+DNA+damage+and+repair+in+a+cell+lineage+model+of+human+proliferative+breast+disease+%28PBD%29&doi=10.1093%2Ftoxsci%2Fkfg154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD)</span></div><div class="casAuthors">Starcevic, Susan L.; Diotte, Nicole M.; Zukowski, Kim L.; Cameron, Mark J.; Novak, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-81</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Oxidative damage to DNA is thought to play a significant role in mutagenesis, aging, and cancer.  Sensitivity to oxidative DNA damage and DNA repair efficiency were examd. using a series of human breast epithelial cell lines-MCF-10A, MCF-10AT, and MCF-10ATG3B-with progressively elevated Ras protein.  Breast epithelial cells were treated with H2O2, in the absence and presence of the DNA-repair inhibitors hydroxyurea (HU) and cytosine arabinoside (Ara-C).  DNA strand breaks were assessed by the mean olive tail moment (μm) using the alk. single-cell gel electrophoresis (Comet) assay.  In untreated cells, the mean olive tail moment values were 4.3, 8.3, and 7.1 μm in the MCF-10A, MCF-10AT, and MCF-10ATG3B cells, resp.  Five min H2O2 treatment produced concn.-dependent DNA damage, with the MCF-10A cells most susceptible and the tumorigenic MCF-10ATG3B cells the least susceptible.  Treatment with 100 μM H2O2 resulted in ∼17-, 6-, and 4.5-fold increases in mean olive tail moment values in the MCF-10A, MCF-10AT, and MCF-10ATG3B cells, resp., compared to untreated cells.  The HCC1937 tumor cell line responded in a manner comparable to the MCF-10ATG3B cells treated with H2O2, HU/Ara-C pre-treatment resulted in a ∼1.5-fold increase in olive tail moment values in all three cell lines.  Protein levels of antioxidant enzymes, including catalase, copper/zinc superoxide dismutase (Cu/Zn SOD), and manganese SOD (MnSOD) were detd. to examine a potential mechanism for increased resistance to H2O2-mediated DNA damage.  Levels of these enzymes increased progressively, with highest expression in MCF-10ATG3B cells.  Increased cellular resistance also coincided with marked decreases in p53 protein levels.  These results demonstrate that, in this cell lineage, sensitivity to oxidative DNA damage by H2O2 decreases with tumorigenicity (i.e., MCF-10A vs. MCF-10ATG3B), and show that DNA repair, altered Ras, and p53 expression, or compensatory mechanisms involving elevated antioxidant enzymes are involved in mediating these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rXY7EKBc47Vg90H21EOLACvtfcHk0ljo9V4DoIwg0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlKlsL4%253D&md5=b54a1d6587bd2c038cbf5386497a3d0f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfg154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfg154%26sid%3Dliteratum%253Aachs%26aulast%3DStarcevic%26aufirst%3DS.%2BL.%26aulast%3DDiotte%26aufirst%3DN.%2BM.%26aulast%3DZukowski%26aufirst%3DK.%2BL.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DNovak%26aufirst%3DR.%2BF.%26atitle%3DOxidative%2520DNA%2520damage%2520and%2520repair%2520in%2520a%2520cell%2520lineage%2520model%2520of%2520human%2520proliferative%2520breast%2520disease%2520%2528PBD%2529%26jtitle%3DToxicol.%2520Sci.%26date%3D2003%26volume%3D75%26spage%3D74%26epage%3D81%26doi%3D10.1093%2Ftoxsci%2Fkfg154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigault, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pornin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perraut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picollet-D’hahan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gidrol, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haguet, V.</span></span> <span> </span><span class="NLM_article-title">Time-lapse contact microscopy of cell cultures based on non-coherent illumination</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">14532</span>, <span class="refDoi"> DOI: 10.1038/srep14532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep14532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26459014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1KksrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=14532&author=M.+Gabrielauthor=D.+Balleauthor=S.+Bigaultauthor=C.+Porninauthor=S.+Getinauthor=F.+Perrautauthor=M.+R.+Blockauthor=F.+Chatelainauthor=N.+Picollet-D%E2%80%99hahanauthor=X.+Gidrolauthor=V.+Haguet&title=Time-lapse+contact+microscopy+of+cell+cultures+based+on+non-coherent+illumination&doi=10.1038%2Fsrep14532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Time-lapse contact microscopy of cell cultures based on non-coherent illumination</span></div><div class="casAuthors">Gabriel, Marion; Balle, Dorothee; Bigault, Stephanie; Pornin, Cyrille; Getin, Stephane; Perraut, Francois; Block, Marc R.; Chatelain, Francois; Picollet-D'hahan, Nathalie; Gidrol, Xavier; Haguet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14532</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Video microscopy offers outstanding capabilities to investigate the dynamics of biol. and pathol. mechanisms in optimal culture conditions.  Contact imaging is one of the simplest imaging architectures to digitally record images of cells due to the absence of any objective between the sample and the image sensor.  However, in the framework of in-line holog., other optical components, e.g., an optical filter or a pinhole, are placed underneath the light source in order to illuminate the cells with a coherent or quasi-coherent incident light.  In this study, we demonstrate that contact imaging with an incident light of both limited temporal and spatial coherences can be achieved with sufficiently high quality for most applications in cell biol., including monitoring of cell sedimentation, rolling, adhesion, spreading, proliferation, motility, death and detachment.  Patterns of cells were recorded at various distances between 0 and 1000 μm from the pixel array of the image sensors.  Cells in suspension, just deposited or at mitosis focalise light into photonic nanojets which can be visualised by contact imaging.  Light refraction by cells significantly varies during the adhesion process, the cell cycle and among the cell population in connection with every modification in the tridimensional morphol. of a cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotWjMF0l8Wz7Vg90H21EOLACvtfcHk0liBrq9_izWvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1KksrrO&md5=fce3f1f3c7f14e8d9bff49a75b8cf94d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsrep14532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep14532%26sid%3Dliteratum%253Aachs%26aulast%3DGabriel%26aufirst%3DM.%26aulast%3DBalle%26aufirst%3DD.%26aulast%3DBigault%26aufirst%3DS.%26aulast%3DPornin%26aufirst%3DC.%26aulast%3DGetin%26aufirst%3DS.%26aulast%3DPerraut%26aufirst%3DF.%26aulast%3DBlock%26aufirst%3DM.%2BR.%26aulast%3DChatelain%26aufirst%3DF.%26aulast%3DPicollet-D%25E2%2580%2599hahan%26aufirst%3DN.%26aulast%3DGidrol%26aufirst%3DX.%26aulast%3DHaguet%26aufirst%3DV.%26atitle%3DTime-lapse%2520contact%2520microscopy%2520of%2520cell%2520cultures%2520based%2520on%2520non-coherent%2520illumination%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D14532%26doi%3D10.1038%2Fsrep14532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, M.</span></span> <span> </span><span class="NLM_article-title">EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1097/00001813-200503000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1097%2F00001813-200503000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15711178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Omtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=263-275&author=B.+K.+Adamsauthor=J.+Caiauthor=J.+Armstrongauthor=M.+Heroldauthor=Y.+J.+Luauthor=A.+Sunauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=D.+P.+Jonesauthor=M.+Shoji&title=EF24%2C+a+novel+synthetic+curcumin+analog%2C+induces+apoptosis+in+cancer+cells+via+a+redox-dependent+mechanism&doi=10.1097%2F00001813-200503000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism</span></div><div class="casAuthors">Adams, Brian K.; Cai, Jiyang; Armstrong, Jeff; Herold, Marike; Lu, Yang J.; Sun, Aiming; Snyder, James P.; Liotta, Dennis C.; Jones, Dean P.; Shoji, Mamoru</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-275</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">In this study, we show that the novel synthetic curcumin analog, EF24, induces cell cycle arrest and apoptosis by a redox-dependent mechanism in MDA-MB-231 human breast cancer cells and DU-145 human prostate cancer cells.  Cell cycle anal. demonstrated that EF24 causes a G2/M arrest in both cell lines, and that this cell cycle arrest is followed by the induction of apoptosis as evidenced by caspase-3 activation, phosphatidylserine externalization and an increased no. of cells with a sub-G1 DNA fraction.  In addn., we demonstrate that EF24 induces a depolarization of the mitochondrial membrane potential, suggesting that the compd. may also induce apoptosis by altering mitochondrial function.  EF24, like curcumin, serves as a Michael acceptor reacting with glutathione (GSH) and thioredoxin 1.  Reaction of EF24 with these agents in vivo significantly reduced intracellular GSH as well as oxidized GSH in both the wild-type and Bcl-xL overexpressing HT29 human colon cancer cells.  We therefore propose that the anticancer effect of a novel curcumin analog, EF24, is mediated in part by redox-mediated induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHtoIYtggfLVg90H21EOLACvtfcHk0liBrq9_izWvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Omtr4%253D&md5=c43b0ba0222fe5fde2ad556c7ccfa667</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F00001813-200503000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200503000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DB.%2BK.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DArmstrong%26aufirst%3DJ.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%2BJ.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BP.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DEF24%252C%2520a%2520novel%2520synthetic%2520curcumin%2520analog%252C%2520induces%2520apoptosis%2520in%2520cancer%2520cells%2520via%2520a%2520redox-dependent%2520mechanism%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2005%26volume%3D16%26spage%3D263%26epage%3D275%26doi%3D10.1097%2F00001813-200503000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span> <span> </span><span class="NLM_article-title">In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e48075</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0048075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0048075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=23118928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslWjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=H.+Liuauthor=Y.+Liangauthor=L.+Wangauthor=L.+Tianauthor=R.+Songauthor=T.+Hanauthor=S.+Panauthor=L.+Liu&title=In+vivo+and+in+vitro+suppression+of+hepatocellular+carcinoma+by+EF24%2C+a+curcumin+analog&doi=10.1371%2Fjournal.pone.0048075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog</span></div><div class="casAuthors">Liu, Haitao; Liang, Yingjian; Wang, Luoluo; Tian, Lantian; Song, Ruipeng; Han, Tianwen; Pan, Shangha; Liu, Lianxin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e48075</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The synthetic compd. 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24) is a potent analog of curcumin that exhibits enhanced biol. activity and bioavailability without increasing toxicity.  EF24 exerts antitumor activity by arresting the cell cycle and inducing apoptosis, suppressing many types of cancer cells in vitro.  The antiproliferative and antiangiogenic properties of EF24 provide theor. support for its development and application to liver cancers.  We investigated the in vitro and in vivo activities of EF24 on liver cancer to better understand its therapeutic effects and mechanisms.  EF24 induced significant apoptosis and G2/M-phase cell cycle arrest in mouse liver cancer cell lines, Hepa1-6 and H22.  The expression levels of G2/M cell cycle regulating factors, cyclin B1 and Cdc2, were significantly decreased, pp53, p53 and p21 were significantly increased in EF24-treated cells.  In addn., EF24 treatment significantly reduced Bcl-2 concomitant with an increase in Bax, enhanced the release of cytochrome c from the mitochondria into the cytosol, resulting in an upregulation of cleaved-caspase-3, which promoted poly (ADP-ribose) polymerase cleavage.  EF24-treated cells also displayed decreases in phosphorylated Akt, phosphorylated extracellular signal-regulated kinase and vascular endothelial growth factor.  Our in vitro protein expression data were confirmed in vivo using a s.c. hepatocellular carcinoma (HCC) tumor model.  This mouse HCC model confirmed that total body wt. was unchanged following EF24 treatment, although tumor wt. was significantly decreased.  Using an orthotopic HCC model, EF24 significantly reduced the liver/body wt. ratio and relative tumor areas compared to the control group.  In situ detection of apoptotic cells and quantification of Ki-67, a biomarker of cell proliferation, all indicated significant tumor suppression with EF24 treatment.  These results suggest that EF24 exhibits anti-tumor activity on liver cancer cells via mitochondria-dependent apoptosis and inducing cell cycle arrest coupled with antiangiogenesis.  The demonstrated activities of EF24 support its further evaluation as a treatment for human liver cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBlIUQ9G64q7Vg90H21EOLACvtfcHk0liBrq9_izWvIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslWjsLzP&md5=f0d4de7eb4cce84a7ee481f5a805757e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0048075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0048075%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520suppression%2520of%2520hepatocellular%2520carcinoma%2520by%2520EF24%252C%2520a%2520curcumin%2520analog%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0048075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertazza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barollo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faccio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redaelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armanini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzani, R.</span></span> <span> </span><span class="NLM_article-title">Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2202</span>, <span class="refDoi"> DOI: 10.3390/molecules24122202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3390%2Fmolecules24122202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWqsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=2202&author=L.+Bertazzaauthor=S.+Barolloauthor=M.+E.+Mariauthor=I.+Faccioauthor=M.+Zorzanauthor=M.+Redaelliauthor=B.+Rubinauthor=D.+Armaniniauthor=C.+Mianauthor=R.+Pezzani&title=Biological+effects+of+EF24%2C+a+curcumin+derivative%2C+alone+or+combined+with+mitotane+in+adrenocortical+tumor+cell+lines&doi=10.3390%2Fmolecules24122202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines</span></div><div class="casAuthors">Bertazza, Loris; Barollo, Susi; Mari, Maria Elena; Faccio, Irene; Zorzan, Maira; Redaelli, Marco; Rubin, Beatrice; Armanini, Decio; Mian, Caterina; Pezzani, Raffaele</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2202</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Background: Curcumin has numerous properties and is used in many preclin. conditions, including cancer.  It has low bioavailability, while its deriv. EF24 shows enhanced soly.  However, its effects have never been explored in adrenocortical tumor cell models.  The efficacy of EF24 alone or combined with mitotane (ref. drug for adrenocortical cancer) was evaluated in two adrenocortical tumor cell lines, SW13 and H295R.  Method and Results: EF24 reduced cell viability with an IC50 (half maximal inhibitory concn.) of 6.5 ± 2.4 muM and 4.9 ± 2.8 muM for SW13 and H295R cells, resp.  Combination index (EF24 assocd. with mitotane) suggested an additivity effect in both cell lines.  Cell cycle anal. revealed an increase in subG0/G1 phase, while motility assay showed a decrease in migratory cell capacity, and similarly, clonogenic assay indicated that EF24 could reduce colony nos.  Furthermore, Wnt/beta-catenin, NF-KB, MAPK, and PI3k/Akt pathways were modulated by Western blot anal. when treating cells with EF24 alone or combined with mitotane.  In addn., intracellular reactive oxygen species levels increased in both cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx3Q0FFkZzxrVg90H21EOLACvtfcHk0lik3BfWdEYJ0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWqsrrI&md5=3cb5599cb3d3d79afc10df4b8fd0887f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24122202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24122202%26sid%3Dliteratum%253Aachs%26aulast%3DBertazza%26aufirst%3DL.%26aulast%3DBarollo%26aufirst%3DS.%26aulast%3DMari%26aufirst%3DM.%2BE.%26aulast%3DFaccio%26aufirst%3DI.%26aulast%3DZorzan%26aufirst%3DM.%26aulast%3DRedaelli%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DB.%26aulast%3DArmanini%26aufirst%3DD.%26aulast%3DMian%26aufirst%3DC.%26aulast%3DPezzani%26aufirst%3DR.%26atitle%3DBiological%2520effects%2520of%2520EF24%252C%2520a%2520curcumin%2520derivative%252C%2520alone%2520or%2520combined%2520with%2520mitotane%2520in%2520adrenocortical%2520tumor%2520cell%2520lines%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D2202%26doi%3D10.3390%2Fmolecules24122202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinothkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span> <span> </span><span class="NLM_article-title">Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1007/s00280-016-3172-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs00280-016-3172-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27787644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOmsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2016&pages=1151-1161&author=G.+Heauthor=C.+Fengauthor=R.+Vinothkumarauthor=W.+Chenauthor=X.+Daiauthor=X.+Chenauthor=Q.+Yeauthor=C.+Qiuauthor=H.+Zhouauthor=Y.+Wangauthor=G.+Liangauthor=Y.+Xieauthor=W.+Wu&title=Curcumin+analog+EF24+induces+apoptosis+via+ROS-dependent+mitochondrial+dysfunction+in+human+colorectal+cancer+cells&doi=10.1007%2Fs00280-016-3172-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells</span></div><div class="casAuthors">He, Guodong; Feng, Chen; Vinothkumar, Rajamanickam; Chen, Weiqian; Dai, Xuanxuan; Chen, Xi; Ye, Qingqing; Qiu, Chenyu; Zhou, Huiping; Wang, Yi; Liang, Guang; Xie, Yubo; Wu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1151-1161</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Colorectal cancer is the most commonly diagnosed malignancy with high mortality rates worldwide.  Improved therapeutic strategies with minimal adverse side effects are urgently needed.  In this study, the anti-tumor effects of EF24, a novel analog of the natural compd. curcumin, were evaluated in colorectal cancer cells.  Methods: The anti-tumor activity of EF24 on human colon cancer lines (HCT-116, SW-620, and HT-29) was detd. by measures of cell cycle arrest, apoptosis, and mitochondrial function.  The contribution of ROS in the EF24-induced anti-tumor activity was evaluated by measures of H2O2 and pretreatment with an ROS scavenger, NAC.  Results: The findings indicated that EF24 treatment dose-dependently inhibited cell viability and caused cell cycle arrest at G2/M phase in all the tested colon cancer cell lines.  Furthermore, we demonstrated that EF24 treatment induced apoptosis effectively via enhancing intracellular accumulation of ROS in both HCT-116 and SW-620 cells, but with moderate effects in HT-29 cells.  We found that EF24 treatment decreased the mitochondrial membrane potential in the colon cancer cells, leading to the release of mitochondrial cytochrome c.  Also, EF24 induced activation of caspases 9 and 3, causing decreased Bcl-2 protein expression and Bcl-2/Bax ratio.  Pretreatment with NAC, a ROS scavenger, abrogated the EF24-induced cell death, apoptosis, cell cycle arrest, and mitochondrial dysfunction, suggesting an upstream ROS generation which was responsible for the anticancer effects of EF24.  Conclusions: Our findings support an anticancer mechanism by which EF24 enhanced ROS accumulation in colon cancer cells, thereby resulting in mitochondrial membrane collapse and activated intrinsic apoptotic signaling.  Thus, EF24 could be a potential candidate for therapeutic application of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK9GwAffPlibVg90H21EOLACvtfcHk0lik3BfWdEYJ0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOmsrnL&md5=8d0f7f64c1da9981bc01257911f68293</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00280-016-3172-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-016-3172-x%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DC.%26aulast%3DVinothkumar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26atitle%3DCurcumin%2520analog%2520EF24%2520induces%2520apoptosis%2520via%2520ROS-dependent%2520mitochondrial%2520dysfunction%2520in%2520human%2520colorectal%2520cancer%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2016%26volume%3D78%26spage%3D1151%26epage%3D1161%26doi%3D10.1007%2Fs00280-016-3172-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. X.</span></span> <span> </span><span class="NLM_article-title">EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32167</span>, <span class="refDoi"> DOI: 10.1038/srep32167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep32167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27571770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=32167&author=D.+L.+Yinauthor=Y.+J.+Liangauthor=T.+S.+Zhengauthor=R.+P.+Songauthor=J.+B.+Wangauthor=B.+S.+Sunauthor=S.+H.+Panauthor=L.+D.+Quauthor=J.+R.+Liuauthor=H.+C.+Jiangauthor=L.+X.+Liu&title=EF24+inhibits+tumor+growth+and+metastasis+via+suppressing+NF-kappaB+dependent+pathways+in+human+cholangiocarcinoma&doi=10.1038%2Fsrep32167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma</span></div><div class="casAuthors">Yin, Da-long; Liang, Ying-jian; Zheng, Tong-sen; Song, Rui-peng; Wang, Jia-bei; Sun, Bo-shi; Pan, Shang-ha; Qu, Lian-dong; Liu, Jia-ren; Jiang, Hong-chi; Liu, Lian-xin</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32167</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A synthetic monoketone analog of curcumin, termed 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), has been reported to inhibit the growth of a variety of cancer cells both in vitro and in vivo.  However, whether EF24 has anticancer effects on cholangiocarcinoma (CCA) cells and the mechanisms remain to be investigated.  The aim of our study was to evaluate the mol. mechanisms underlying the anticancer effects of EF24 on CCA tumor growth and metastasis.  Cell proliferation, apoptosis, migration, invasion, tumorigenesis and metastasis were examd.  EF24 exhibited time- and dose-dependent inhibitory effects on HuCCT-1, TFK-1 and HuH28 human CCA cell lines.  EF24 inhibited CCA cell proliferation, migration, and induced G2/M phase arrest.  EF24 induced cell apoptosis along with neg. regulation of NF-κB- X-linked inhibitor of apoptosis protein (XIAP) signaling pathway.  XIAP inhibition by lentivirus mediated RNA interference enhanced EF24-induced apoptosis, while XIAP overexpression reduced it in CCA cells.  In vivo, EF24 significantly suppressed the growth of CCA tumor xenografts and tumor metastasis while displaying low toxicity levels.  Our findings indicate that EF24 is a potent antitumor agent that inhibits tumor growth and metastasis by inhibiting NF-κB dependent signaling pathways.  EF24 may represent a novel approach for CCA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJYM4lWbq_iLVg90H21EOLACvtfcHk0lik3BfWdEYJ0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCqt73E&md5=eae779c49a019ac77d13bc42583abaa3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fsrep32167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32167%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DD.%2BL.%26aulast%3DLiang%26aufirst%3DY.%2BJ.%26aulast%3DZheng%26aufirst%3DT.%2BS.%26aulast%3DSong%26aufirst%3DR.%2BP.%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DSun%26aufirst%3DB.%2BS.%26aulast%3DPan%26aufirst%3DS.%2BH.%26aulast%3DQu%26aufirst%3DL.%2BD.%26aulast%3DLiu%26aufirst%3DJ.%2BR.%26aulast%3DJiang%26aufirst%3DH.%2BC.%26aulast%3DLiu%26aufirst%3DL.%2BX.%26atitle%3DEF24%2520inhibits%2520tumor%2520growth%2520and%2520metastasis%2520via%2520suppressing%2520NF-kappaB%2520dependent%2520pathways%2520in%2520human%2520cholangiocarcinoma%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D32167%26doi%3D10.1038%2Fsrep32167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span> <span> </span><span class="NLM_article-title">Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4927</span>– <span class="NLM_lpage">4933</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3892%2Fmmr.2017.7189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28791378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=4927-4933&author=C.+Linauthor=C.+Tuauthor=Y.+Maauthor=P.+Yeauthor=X.+Shaoauthor=Z.+Yangauthor=Y.+Fang&title=Curcumin+analog+EF24+induces+apoptosis+and+downregulates+the+mitogen+activated+protein+kinase%2Fextracellular+signal-regulated+signaling+pathway+in+oral+squamous+cell+carcinoma&doi=10.3892%2Fmmr.2017.7189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous cell carcinoma</span></div><div class="casAuthors">Lin, Chongxiang; Tu, Chengwei; Ma, Yike; Ye, Pengcheng; Shao, Xia; Yang, Zhaoan; Fang, Yiming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4927-4933</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide.  Diphenyldifluoroketone (EF24) is a curcumin analog that has been demonstrated to improve anticancer activity; however, its therapeutic potential and mechanisms in oral cancer remain unknown.  In the present study, the effect of EF24 on apoptosis induction and its potential underlying mechanism in the CAL-27 human OSCC cell line was investigated.  To achieve this, various concns. of cisplatin or EF24 were administrated to CAL-27 cells for 24 h, and cell viability, apoptotic DNA fragmentation, and cleaved caspase 3 and 9 levels were evaluated.  To investigate the potential underlying mechanism, the levels of mitogen-activated protein kinase kinase 1 (MEK1) and extracellular signal-regulated kinase (ERK), two key proteins in the mitogen-activated protein kinase/ERK signaling pathway, were addnl. examd.  The results indicated that EF24 and cisplatin treatment decreased cell viability.  EF24 treatment increased the levels of activated caspase 3 and 9, and decreased the phosphorylated forms of MEK1 and ERK.  Sequential treatments of EF24 and 12-phorbol-13-myristate acetate, a MAPK/ERK activator, resulted in a significant increase of activated MEK1 and ERK, and reversed cell viability.  These results suggested that EF24 has potent anti-tumor activity in OSCC via deactivation of the MAPK/ERK signaling pathway.  Further analyses using animal models are required to confirm these findings in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8brJwaRGdj7Vg90H21EOLACvtfcHk0lhPl_V9Ue3pmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVOgsA%253D%253D&md5=3899730773178d339c614febe71a2d61</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7189%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DTu%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DY.%26atitle%3DCurcumin%2520analog%2520EF24%2520induces%2520apoptosis%2520and%2520downregulates%2520the%2520mitogen%2520activated%2520protein%2520kinase%252Fextracellular%2520signal-regulated%2520signaling%2520pathway%2520in%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D16%26spage%3D4927%26epage%3D4933%26doi%3D10.3892%2Fmmr.2017.7189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential I-kappaB kinase beta inhibitors for the treatment of pancreatic cancer</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1439</span>– <span class="NLM_lpage">1451</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S133172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.2147%2FDDDT.S133172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28553074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKns7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=1439-1451&author=X.+Xieauthor=J.+Tuauthor=H.+Youauthor=B.+Hu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+EF24+and+EF31+analogs+as+potential+I-kappaB+kinase+beta+inhibitors+for+the+treatment+of+pancreatic+cancer&doi=10.2147%2FDDDT.S133172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer</span></div><div class="casAuthors">Xie, Xuemeng; Tu, Jinfu; You, Heyi; Hu, Bingren</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1439-1451</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Given the important role that inhibitory kappa B (IκB) kinase β (IKKβ) plays in pancreatic cancer (PC) development and progression, inhibitors targeting IKKβ are believed to be increasingly popular as novel anti-PC therapies.  Two synthetic mols., named EF24 and EF31, exhibited favorable potential in terms of inhibition of both IKKβ activity and PC cell proliferation.  Aiming to enhance their cellular efficacy and to analyze their structure-activity relationship, four series of EF24 and EF31 analogs were designed and synthesized.  Through kinase activity and vitality screening of cancer cells, D6 displayed excellent inhibition of both IKKβ activity and PC cell proliferation.  Addnl., multiple biol. evaluations showed that D6 was directly bound to IKKβ and significantly suppressed the activation of the IKKβ/nuclear factor κB pathway induced by tumor necrosis factor-α, as well as effectively inducing cancer cell apoptosis.  Moreover, mol. docking and mol. dynamics simulation anal. indicated that the dominant force between D6 and IKKβ comprised hydrophobic interactions.  In conclusion, D6 may be a promising therapeutic agent for PC treatment and it also provides a structural lead for the design of novel IKKβ inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPYPXdLVZu5bVg90H21EOLACvtfcHk0lhPl_V9Ue3pmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKns7zI&md5=fc287d3c168064b0e840f29cbafc989e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S133172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S133172%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DX.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520EF24%2520and%2520EF31%2520analogs%2520as%2520potential%2520I-kappaB%2520kinase%2520beta%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pancreatic%2520cancer%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2017%26volume%3D11%26spage%3D1439%26epage%3D1451%26doi%3D10.2147%2FDDDT.S133172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tazi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratasz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1228</span>– <span class="NLM_lpage">1235</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.freeradbiomed.2010.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20156552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1228-1235&author=K.+Selvendiranauthor=S.+Ahmedauthor=A.+Daytonauthor=M.+L.+Kuppusamyauthor=M.+Taziauthor=A.+Brataszauthor=L.+Tongauthor=B.+K.+Riveraauthor=T.+Kalaiauthor=K.+Hidegauthor=P.+Kuppusamy&title=Safe+and+targeted+anticancer+efficacy+of+a+novel+class+of+antioxidant-conjugated+difluorodiarylidenyl+piperidones%3A+differential+cytotoxicity+in+healthy+and+cancer+cells&doi=10.1016%2Fj.freeradbiomed.2010.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: Differential cytotoxicity in healthy and cancer cells</span></div><div class="casAuthors">Selvendiran, Karuppaiyah; Ahmed, Shabnam; Dayton, Alex; Kuppusamy, M. Lakshmi; Tazi, Mia; Bratasz, Anna; Tong, Liyue; Rivera, Brian K.; Kalai, Tamas; Hideg, Kalman; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1228-1235</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of smart anticancer drugs that can selectively kill cancer cells while sparing the surrounding healthy tissues/cells is of paramount importance for safe and effective cancer therapy.  We report a novel class of bifunctional compds. based on diarylidenyl piperidone (DAP) conjugated to an N-hydroxypyrroline (NOH; a nitroxide precursor) group.  We hypothesized that the DAP would have cytotoxic (anticancer) activity, whereas the NOH moiety would function as a tissue-specific modulator (antioxidant) of cytotoxicity.  The study used four DAPs, namely H-4073 and H-4318 without NOH and HO-3867 and HO-4200 with NOH substitution.  The goal of the study was to evaluate the proof-of-concept anticancer-vs.-antioxidant efficacy of the DAPs using a no. of cancerous (breast, colon, head and neck, liver, lung, ovarian, and prostate cancer) and noncancerous (smooth muscle, aortic endothelial, and ovarian surface epithelial) human cell lines.  Cytotoxicity was detd. using an MTT-based cell viability assay.  All four compds. induced significant loss of cell viability in cancer cells, whereas HO-3867 and HO-4200 showed significantly less cytotoxicity in noncancerous cells.  EPR measurements showed a metabolic conversion of the N-hydroxylamine function to nitroxide with significantly higher levels of the metabolite and superoxide radical-scavenging (antioxidant) activity in noncancerous cells compared to cancer cells.  Western blot anal. showed that the DAP-induced growth arrest and apoptosis in cancer cells were mediated by inhibition of STAT3 phosphorylation at the Tyr705 and Ser727 residues and induction of apoptotic markers of cleaved caspase-3 and PARP.  The results suggest that the antioxidant-conjugated DAPs will be useful as safe and effective anticancer agents for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVEfHY_7lK7Vg90H21EOLACvtfcHk0lhPl_V9Ue3pmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVSiu7k%253D&md5=44ff3167de6a87965c14ad90dfb63dd7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DDayton%26aufirst%3DA.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DTazi%26aufirst%3DM.%26aulast%3DBratasz%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DSafe%2520and%2520targeted%2520anticancer%2520efficacy%2520of%2520a%2520novel%2520class%2520of%2520antioxidant-conjugated%2520difluorodiarylidenyl%2520piperidones%253A%2520differential%2520cytotoxicity%2520in%2520healthy%2520and%2520cancer%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1228%26epage%3D1235%26doi%3D10.1016%2Fj.freeradbiomed.2010.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratasz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigg, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1169</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-1207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1535-7163.MCT-09-1207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20442315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsleksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1169-1179&author=K.+Selvendiranauthor=L.+Tongauthor=A.+Brataszauthor=M.+L.+Kuppusamyauthor=S.+Ahmedauthor=Y.+Raviauthor=N.+J.+Triggauthor=B.+K.+Riveraauthor=T.+Kalaiauthor=K.+Hidegauthor=P.+Kuppusamy&title=Anticancer+efficacy+of+a+difluorodiarylidenyl+piperidone+%28HO-3867%29+in+human+ovarian+cancer+cells+and+tumor+xenografts&doi=10.1158%2F1535-7163.MCT-09-1207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts</span></div><div class="casAuthors">Selvendiran, Karuppaiyah; Tong, Liyue; Bratasz, Anna; Kuppusamy, M. Lakshmi; Ahmed, Shabnam; Ravi, Yazhini; Trigg, Nancy J.; Rivera, Brian K.; Kalai, Tamas; Hideg, Kalman; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1169-1179</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of this study was to evaluate the anticancer potency and mechanism of a novel difluorodiarylidenyl piperidone (H-4073) and its N-hydroxypyrroline modification (HO-3867) in human ovarian cancer.  Studies were done using established human ovarian cancer cell lines (A2870, A2780cDDP, OV-4, SKOV3, PA-1, and OVCAR3) as well as in a murine xenograft tumor (A2780) model.  Both compds. were comparably and significantly cytotoxic to A2780 cells.  However, HO-3867 showed a preferential toxicity toward ovarian cancer cells while sparing healthy cells.  HO-3867 induced G2-M cell cycle arrest in A2780 cells by modulating cell cycle regulatory mols. p53, p21, p27, cyclin-dependent kinase 2, and cyclin, and promoted apoptosis by caspase-8 and caspase-3 activation.  It also caused an increase in the expression of functional Fas/CD95 and decreases in signal transducers and activators of transcription 3 (STAT3; Tyr705) and JAK1 phosphorylation.  There was a significant redn. in STAT3 downstream target protein levels including Bcl-xL, Bcl-2, survivin, and vascular endothelial growth factor, suggesting that HO-3867 exposure disrupted the JAK/STAT3 signaling pathway.  In addn., HO-3867 significantly inhibited the growth of the ovarian xenografted tumors in a dosage-dependent manner without any apparent toxicity.  Western blot anal. of the xenograft tumor tissues showed that HO-3867 inhibited pSTAT3 (Tyr705 and Ser727) and JAK1 and increased apoptotic markers cleaved caspase-3 and poly ADP ribose polymerase.  HO-3867 exhibited significant cytotoxicity toward ovarian cancer cells by inhibition of the JAK/STAT3 signaling pathway.  The study suggested that HO-3867 may be useful as a safe and effective anticancer agent for ovarian cancer therapy.  Mol Cancer Ther; 9(5); 1169-79.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiaW0a9PKE7Vg90H21EOLACvtfcHk0liyM-Asf6-DIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsleksLw%253D&md5=d902bc64501f5ceaa9901814fe09db65</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1207%26sid%3Dliteratum%253Aachs%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DBratasz%26aufirst%3DA.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DRavi%26aufirst%3DY.%26aulast%3DTrigg%26aufirst%3DN.%2BJ.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DAnticancer%2520efficacy%2520of%2520a%2520difluorodiarylidenyl%2520piperidone%2520%2528HO-3867%2529%2520in%2520human%2520ovarian%2520cancer%2520cells%2520and%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1169%26epage%3D1179%26doi%3D10.1158%2F1535-7163.MCT-09-1207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhiman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelham, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiparoidze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomm, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunha, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fersht, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">4262</span>– <span class="NLM_lpage">4276</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA117.000950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.RA117.000950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29382728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlslKgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=4262-4276&author=E.+Madanauthor=T.+M.+Parkerauthor=M.+R.+Bauerauthor=A.+Dhimanauthor=C.+J.+Pelhamauthor=M.+Naganeauthor=M.+L.+Kuppusamyauthor=M.+Holmesauthor=T.+R.+Holmesauthor=K.+Shaikauthor=K.+Sheeauthor=S.+Kiparoidzeauthor=S.+D.+Smithauthor=Y.+A.+Parkauthor=J.+J.+Gommauthor=L.+J.+Jonesauthor=A.+R.+Tomasauthor=A.+C.+Cunhaauthor=K.+Selvendiranauthor=L.+A.+Hansenauthor=A.+R.+Fershtauthor=K.+Hidegauthor=R.+Gognaauthor=P.+Kuppusamy&title=The+curcumin+analog+HO-3867+selectively+kills+cancer+cells+by+converting+mutant+p53+protein+to+transcriptionally+active+wildtype+p53&doi=10.1074%2Fjbc.RA117.000950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53</span></div><div class="casAuthors">Madan, Esha; Parker, Taylor M.; Bauer, Matthias R.; Dhiman, Alisha; Pelham, Christopher J.; Nagane, Masaki; Kuppusamy, M. Lakshmi; Holmes, Matti; Holmes, Thomas R.; Shaik, Kranti; Shee, Kevin; Kiparoidze, Salome; Smith, Sean D.; Park, Yu-Soon A.; Gomm, Jennifer J.; Jones, Louise J.; Tomas, Ana R.; Cunha, Ana C.; Selvendiran, Karuppaiyah; Hansen, Laura A.; Fersht, Alan R.; Hideg, Kalman; Gogna, Rajan; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4262-4276</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">P53 is an important tumor-suppressor protein that is mutated in more than 50% of cancers.  Strategies for restoring normal p53 function are complicated by the oncogenic properties of mutant p53 and have not met with clin. success.  To counteract mutant p53 activity, a variety of drugs with the potential to reconvert mutant p53 to an active wildtype form have been developed.  However, these drugs are assocd. with various neg. effects such as cellular toxicity, nonspecific binding to other proteins, and inability to induce a wildtype p53 response in cancer tissue.  Here, we report on the effects of a curcumin analog, HO-3867, on p53 activity in cancer cells from different origins.  We found that HO-3867 covalently binds to mutant p53, initiates a wildtype p53-like anticancer genetic response, is exclusively cytotoxic toward cancer cells, and exhibits high anticancer efficacy in tumor models.  In conclusion, HO-3867 is a p53 mutant-reactivating drug with high clin. anticancer potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-d4SyFtW-bVg90H21EOLACvtfcHk0liyM-Asf6-DIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlslKgur0%253D&md5=f54bb106deb69ebd79f3159efd2b04a1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA117.000950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA117.000950%26sid%3Dliteratum%253Aachs%26aulast%3DMadan%26aufirst%3DE.%26aulast%3DParker%26aufirst%3DT.%2BM.%26aulast%3DBauer%26aufirst%3DM.%2BR.%26aulast%3DDhiman%26aufirst%3DA.%26aulast%3DPelham%26aufirst%3DC.%2BJ.%26aulast%3DNagane%26aufirst%3DM.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DHolmes%26aufirst%3DM.%26aulast%3DHolmes%26aufirst%3DT.%2BR.%26aulast%3DShaik%26aufirst%3DK.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DKiparoidze%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DS.%2BD.%26aulast%3DPark%26aufirst%3DY.%2BA.%26aulast%3DGomm%26aufirst%3DJ.%2BJ.%26aulast%3DJones%26aufirst%3DL.%2BJ.%26aulast%3DTomas%26aufirst%3DA.%2BR.%26aulast%3DCunha%26aufirst%3DA.%2BC.%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DL.%2BA.%26aulast%3DFersht%26aufirst%3DA.%2BR.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DGogna%26aufirst%3DR.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DThe%2520curcumin%2520analog%2520HO-3867%2520selectively%2520kills%2520cancer%2520cells%2520by%2520converting%2520mutant%2520p53%2520protein%2520to%2520transcriptionally%2520active%2520wildtype%2520p53%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D4262%26epage%3D4276%26doi%3D10.1074%2Fjbc.RA117.000950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1097%2FCAD.0000000000000470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28067673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt12qurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=392-400&author=Y.+Huauthor=C.+Zhaoauthor=H.+Zhengauthor=K.+Luauthor=D.+Shiauthor=Z.+Liuauthor=X.+Daiauthor=Y.+Zhangauthor=X.+Zhangauthor=W.+Huauthor=G.+Liang&title=A+novel+STAT3+inhibitor+HO-3867+induces+cell+apoptosis+by+reactive+oxygen+species-dependent+endoplasmic+reticulum+stress+in+human+pancreatic+cancer+cells&doi=10.1097%2FCAD.0000000000000470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells</span></div><div class="casAuthors">Hu, Yan; Zhao, Chengguang; Zheng, Hailun; Lu, Kongqin; Shi, Dengjian; Liu, Zhiguo; Dai, Xuanxuan; Zhang, Yi; Zhang, Xiuhua; Hu, Wanle; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">392-400</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Pancreatic cancer is the most commonly diagnosed malignancy among solid tumors and has shown an increasing trend year by year.  Thus, there is an urgent need for the discovery of new anticancer drugs for the treatment of pancreatic cancer.  In recent years, it has been reported that the compd. HO-3867, a novel analog of the natural product curcumin, showed antitumor activity with low toxicity.  However, the underlying mechanism of this compd.'s attack on cancer cells is not very clear.  In the present study, it was found that HO-3867 showed good antitumor activity at the concn. of 2 μmol/l in PANC-1 and BXPC-3 cells.  Importantly, it was also found that HO-3867 treatment significantly induced reactive oxygen species (ROS) prodn. in human pancreatic cancer cell lines, inducing PANC-1 and BXPC-3 cells.  Co-treatment with the ROS scavenger, N-acetyl cysteine, partially abrogated HO-3867-induced cell apoptosis.  The activation of mitogen-activated protein kinase and endoplasmic reticulum stress indicated a downstream event of ROS generation in mediating the anticancer effect of the HO-3867.  In addn., independent of the ROS pathway, direct STAT3 inhibition was obsd. in HO-3867-induced cell apoptosis.  Taken together, the results of this work suggest that both the ROS-dependent ER stress and STAT3 pathways were implicated in the cell apoptosis induced by the novel compd. HO-3867.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgiWVMOmX-rLVg90H21EOLACvtfcHk0lh5rN-KbJR-kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt12qurY%253D&md5=337f936149ffacd1a8aa04d60eb118ea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000470%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DA%2520novel%2520STAT3%2520inhibitor%2520HO-3867%2520induces%2520cell%2520apoptosis%2520by%2520reactive%2520oxygen%2520species-dependent%2520endoplasmic%2520reticulum%2520stress%2520in%2520human%2520pancreatic%2520cancer%2520cells%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2017%26volume%3D28%26spage%3D392%26epage%3D400%26doi%3D10.1097%2FCAD.0000000000000470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mast, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmi Kuppusamy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kmiec, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Diarylidenylpiperidones, H-4073 and HO-3867, induce G2/M cell-cycle arrest, apoptosis and inhibit STAT3 phosphorylation in human pancreatic cancer cells</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1007/s12013-019-00873-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs12013-019-00873-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31089934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpsVyhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2019&pages=109-119&author=J.+M.+Mastauthor=D.+Tseauthor=K.+Sheeauthor=M.+Lakshmi+Kuppusamyauthor=M.+M.+Kmiecauthor=T.+Kalaiauthor=P.+Kuppusamy&title=Diarylidenylpiperidones%2C+H-4073+and+HO-3867%2C+induce+G2%2FM+cell-cycle+arrest%2C+apoptosis+and+inhibit+STAT3+phosphorylation+in+human+pancreatic+cancer+cells&doi=10.1007%2Fs12013-019-00873-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Diarylidenylpiperidones, H-4073 and HO-3867, induce G2/M cell-cycle arrest, apoptosis and inhibit STAT3 phosphorylation in human pancreatic cancer cells</span></div><div class="casAuthors">Mast, Jesse M.; Tse, Dan; Shee, Kevin; Lakshmi Kuppusamy, M.; Kmiec, Maciej M.; Kalai, Tamas; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-119</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Pancreatic cancer has a 5-yr survival rate below 10% and the treatment options are limited.  Signal transducer and activator of transcription (STAT3) is a constitutively expressed protein in human pancreatic cancers and is assocd. with their poor prognosis.  Targeting of STAT3 signaling using novel therapeutic agents is a potential strategy for pancreatic cancer treatment.  Diarylidenylpiperidone (DAP) compds., such as H-4073 and HO-3867, have been shown to be STAT3 inhibitors in several human ovarian cancers.  Particularly, HO-3867 is an N-hydroxypyrroline deriv. of DAP that has targeted cytotoxicity toward cancer cells without affecting healthy cells.  In the present study, we evaluated the anticancer efficacy of H-4073 and HO-3867 in a human pancreatic cell line (AsPC-1).  We found that both the compds. exhibited potential cytotoxicity to AsPC-1 cells by inducing G2/M cell-cycle arrest, apoptosis, and cell death, by mitochondrial damage and inhibition of STAT3 phosphorylation.  In summary, H-4073 and HO-3867 are cytotoxic to AsPC-1 cells and seem to act through similar mechanisms, including STAT3 inhibition, cell-cycle arrest, and apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6tUoAPYNIArVg90H21EOLACvtfcHk0lh5rN-KbJR-kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpsVyhurk%253D&md5=3d56aec889cd67d3e9e7942b2d90375f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fs12013-019-00873-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-019-00873-6%26sid%3Dliteratum%253Aachs%26aulast%3DMast%26aufirst%3DJ.%2BM.%26aulast%3DTse%26aufirst%3DD.%26aulast%3DShee%26aufirst%3DK.%26aulast%3DLakshmi%2BKuppusamy%26aufirst%3DM.%26aulast%3DKmiec%26aufirst%3DM.%2BM.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DDiarylidenylpiperidones%252C%2520H-4073%2520and%2520HO-3867%252C%2520induce%2520G2%252FM%2520cell-cycle%2520arrest%252C%2520apoptosis%2520and%2520inhibit%2520STAT3%2520phosphorylation%2520in%2520human%2520pancreatic%2520cancer%2520cells%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2019%26volume%3D77%26spage%3D109%26epage%3D119%26doi%3D10.1007%2Fs12013-019-00873-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tierney, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span> <span> </span><span class="NLM_article-title">Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2014.07.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ygyno.2014.07.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25038288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2014&pages=133-141&author=B.+J.+Tierneyauthor=G.+A.+McCannauthor=S.+Naiduauthor=K.+S.+Rathauthor=U.+Sainiauthor=R.+Wannerauthor=P.+Kuppusamyauthor=A.+Suarezauthor=P.+J.+Goodfellowauthor=D.+E.+Cohnauthor=K.+Selvendiran&title=Aberrantly+activated+pSTAT3-Ser727+in+human+endometrial+cancer+is+suppressed+by+HO-3867%2C+a+novel+STAT3+inhibitor&doi=10.1016%2Fj.ygyno.2014.07.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor</span></div><div class="casAuthors">Tierney, Brent J.; McCann, Georgia A.; Naidu, Shan; Rath, Kellie S.; Saini, Uksha; Wanner, Ross; Kuppusamy, Periannan; Suarez, Adrian; Goodfellow, Paul J.; Cohn, David E.; Selvendiran, Karuppaiyah</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-141</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Constitutive activation of STAT3 is a hallmark of various human cancers, however an increased pSTAT3 expression in high grade human endometrial cancer has not been reported.  In the present study, we examine the expression of STAT family of proteins in endometrial cancer cell lines and the efficacy of HO-3867, a novel STAT3 inhibitor designed in our lab.  Expression of STAT family proteins was evaluated via Western blot.  The cell viability, post-treatment with HO-3867, was assessed using MTT, cell-cycle profile and Annexin assay.  In vivo efficacy of HO-3867 was evaluated using xenograft mice.  Expression of activated STATs was inconsistent among the cell lines and 18 human endometrial cancer specimens tested.  While pSTAT3 Tyr705 was not expressed in any of the cell lines, pSTAT3 Ser727 was highly expressed in endometrial cancer cell lines and tumor specimens.  HO-3867 decreased the expression of pSTAT3 Ser727 while total STAT3 remained const.; cell viability decreased by 50-80% and induced G2/M arrest in 55% of Ishikawa cells at the G2/M cell cycle checkpoint.  There was an increase in p53, a decrease in Bcl2 and Bcl-xL, and cleavage of caspase-3, caspase-7 and PARP.  HO-3867 mediated a dosage-dependent inhibition of the growth of xenografted endometrial tumors.  HO-3867 treatment decreases the high levels of pSTAT3 Ser727 in endometrial cancer cells by inducing cell cycle arrest and apoptosis.  This suggests a specific role of serine-phosphorylated STAT3, independent of tyrosine phosphorylation in the oncogenesis of endometrial cancer.  HO-3867 could potentially serve as an adjunctive targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdi_yQm8JiH7Vg90H21EOLACvtfcHk0lh5rN-KbJR-kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSqs7nE&md5=9ad29945d9869d129a57cb3e3e6d0490</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2014.07.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2014.07.087%26sid%3Dliteratum%253Aachs%26aulast%3DTierney%26aufirst%3DB.%2BJ.%26aulast%3DMcCann%26aufirst%3DG.%2BA.%26aulast%3DNaidu%26aufirst%3DS.%26aulast%3DRath%26aufirst%3DK.%2BS.%26aulast%3DSaini%26aufirst%3DU.%26aulast%3DWanner%26aufirst%3DR.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DSuarez%26aufirst%3DA.%26aulast%3DGoodfellow%26aufirst%3DP.%2BJ.%26aulast%3DCohn%26aufirst%3DD.%2BE.%26aulast%3DSelvendiran%26aufirst%3DK.%26atitle%3DAberrantly%2520activated%2520pSTAT3-Ser727%2520in%2520human%2520endometrial%2520cancer%2520is%2520suppressed%2520by%2520HO-3867%252C%2520a%2520novel%2520STAT3%2520inhibitor%26jtitle%3DGynecol.%2520Oncol.%26date%3D2014%26volume%3D135%26spage%3D133%26epage%3D141%26doi%3D10.1016%2Fj.ygyno.2014.07.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Design and optimize N-substituted EF24 as effective and low toxicity NF-kappaB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">1368</span>– <span class="NLM_lpage">1377</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1111%2Fcbdd.13514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30873716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnslyhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2019&pages=1368-1377&author=L.+Chenauthor=Q.+Liauthor=Z.+Zhengauthor=J.+Xieauthor=X.+Linauthor=C.+Jiangauthor=H.+Xuauthor=X.+Wuauthor=J.+Wuauthor=H.+Zhang&title=Design+and+optimize+N-substituted+EF24+as+effective+and+low+toxicity+NF-kappaB+inhibitor+for+lung+cancer+therapy+via+apoptosis-to-pyroptosis+switch&doi=10.1111%2Fcbdd.13514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch</span></div><div class="casAuthors">Chen, Liping; Li, Qian; Zheng, Zhiwei; Xie, Jingwen; Lin, Xiaoming; Jiang, Chengxi; Xu, Haineng; Wu, Xiaoping; Wu, Jianzhang; Zhang, Huajie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1368-1377</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">As NF-κB signaling pathway is constitutively activated in lung cancer, targeting NF-κB has a potential for the treatment.  EF24 has been proved to be a NF-κB inhibitor with good antitumor activity, while whose toxicity possibly became one of the obstacles to enter into clin. application.  In order to find high efficiency and low toxicity NF-κB inhibitors, EF24 was modified and 13d(I) was screened out.  It was proved that I possessed an effective combination of inhibiting NF-κB pathway and showing lower cytotoxicity on normal cells as well as less toxicity in acute toxicity expt. compared with the lead compd. of EF24.  In addn., I was found to inhibit cell vitality, arrest cell cycle in G2/M phase, promote cell apoptosis, and suppress the xenograft tumor growth.  Furthermore, I was elucidated to induce pyroptosis developing from apoptosis, which was assocd. with the inhibition of NF-κB.  Taken together, it was suggested that I was a potent antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkc2o9B3a3LVg90H21EOLACvtfcHk0lj-pSqcLy7ZmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnslyhsLg%253D&md5=2eb7f05e191663aeb8cce5dac3b939e9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13514%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DDesign%2520and%2520optimize%2520N-substituted%2520EF24%2520as%2520effective%2520and%2520low%2520toxicity%2520NF-kappaB%2520inhibitor%2520for%2520lung%2520cancer%2520therapy%2520via%2520apoptosis-to-pyroptosis%2520switch%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2019%26volume%3D94%26spage%3D1368%26epage%3D1377%26doi%3D10.1111%2Fcbdd.13514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, Q.</span></span> <span> </span><span class="NLM_article-title">Bioactivities of EF24, a novel curcumin analog: a review</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">614</span>, <span class="refDoi"> DOI: 10.3389/fonc.2018.00614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3389%2Ffonc.2018.00614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30619754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3cnptVOqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=614&author=Y.+Heauthor=W.+Liauthor=G.+Huauthor=H.+Sunauthor=Q.+Kong&title=Bioactivities+of+EF24%2C+a+novel+curcumin+analog%3A+a+review&doi=10.3389%2Ffonc.2018.00614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivities of EF24, a Novel Curcumin Analog: A Review</span></div><div class="casAuthors">He Yonghan; Kong Qingpeng; Li Wen; Hu Guangrong; Sun Hui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">614</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Curcumin is an attractive agent due to its multiple bioactivities.  However, the low oral bioavailability and efficacy profile hinders its clinical application.  To improve the bioavailability, many analogs of curcumin have been developed, among which EF24 is an excellent representative.  EF24 has enhanced bioavailability over curcumin and shows more potent bioactivity, including anti-cancer, anti-inflammatory, and anti-bacterial.  EF24 inhibits tumor growth by inducing cell cycle arrest and apoptosis, mainly through its inhibitory effect on the nuclear factor kappa B (NF-κB) pathway and by regulating key genes through microRNA (miRNA) or the proteosomal pathway.  Based on the current structure, more potent EF24 analogs have been designed and synthesized.  However, some roles of EF24 remain unclear, such as whether it induces or inhibits reactive oxygen species (ROS) production and whether it stimulates or inhibits the mitogen activated kinase-like protein (MAPK) pathway.  This review summarizes the known biological and pharmacological activities and mechanisms of action of EF24.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDRk0Zhzo17IqdXsLcGTEUfW6udTcc2eZ6fIHCgkq3DLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnptVOqug%253D%253D&md5=773283f7349a055270f392f74fe10b43</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2018.00614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2018.00614%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKong%26aufirst%3DQ.%26atitle%3DBioactivities%2520of%2520EF24%252C%2520a%2520novel%2520curcumin%2520analog%253A%2520a%2520review%26jtitle%3DFront.%2520Oncol.%26date%3D2018%26volume%3D8%26spage%3D614%26doi%3D10.3389%2Ffonc.2018.00614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontanini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solazzo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">9235</span>– <span class="NLM_lpage">9244</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-0702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-06-0702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16982768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1ahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9235-9244&author=E.+Aleoauthor=C.+J.+Hendersonauthor=A.+Fontaniniauthor=B.+Solazzoauthor=C.+Brancolini&title=Identification+of+new+compounds+that+trigger+apoptosome-independent+caspase+activation+and+apoptosis&doi=10.1158%2F0008-5472.CAN-06-0702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of New Compounds That Trigger Apoptosome-Independent Caspase Activation and Apoptosis</span></div><div class="casAuthors">Aleo, Emanuela; Henderson, Clare J.; Fontanini, Alessandra; Solazzo, Barbara; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9235-9244</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Identification of alternative pathways of caspase activation is an important step to develop new antitumor treatments.  The authors report here the result of a screening with a small chem. library, the Developmental Therapeutics Program-National Cancer Institute "challenge set", on cells expressing mutated caspase-9.  The authors have identified two mols. capable of activating an apoptosome-independent apoptotic pathway.  These compds., named F6 and G5, target the ubiquitin-proteasome system by inhibiting the ubiquitin isopeptidases.  The authors have shown that F6 and G5 induce a rather unique apoptotic pathway, which includes a Bcl-2-dependent but apoptosome-independent mitochondrial pathway with up-regulation of the BH3-only protein Noxa, stabilization of the inhibitor of apoptosis antagonist Smac, but also the involvement of the death receptor pathway.  Noxa plays an important role in the induction of mitochondrial fragmentation and caspase activation, whereas the death receptor pathway becomes crit. in the absence of a functional apoptosome.  This study suggests that screening of chem. libraries on cancer cells with defined mutations in apoptotic key elements can lead to the identification of compds. that are useful to characterize alternative pathways of caspase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAnl67US3507Vg90H21EOLACvtfcHk0lj-pSqcLy7ZmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1ahsr4%253D&md5=c161afb2c15bb0e77f813851de8bb6a1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-0702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-0702%26sid%3Dliteratum%253Aachs%26aulast%3DAleo%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DC.%2BJ.%26aulast%3DFontanini%26aufirst%3DA.%26aulast%3DSolazzo%26aufirst%3DB.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520new%2520compounds%2520that%2520trigger%2520apoptosome-independent%2520caspase%2520activation%2520and%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9235%26epage%3D9244%26doi%3D10.1158%2F0008-5472.CAN-06-0702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cersosimo, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgorbissa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelica, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semrau, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1704</span>, <span class="refDoi"> DOI: 10.1021/jm501336h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501336h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvV2jurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1691-1704&author=U.+Cersosimoauthor=A.+Sgorbissaauthor=C.+Fotiauthor=S.+Drioliauthor=R.+Angelicaauthor=A.+Tomasellaauthor=R.+Piccoauthor=M.+S.+Semrauauthor=P.+Storiciauthor=F.+Benedettiauthor=F.+Bertiauthor=C.+Brancolini&title=Synthesis%2C+characterization%2C+and+optimization+for+in+vivo+delivery+of+a+nonselective+isopeptidase+inhibitor+as+new+antineoplastic+agent&doi=10.1021%2Fjm501336h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Optimization for in Vivo Delivery of a Nonselective Isopeptidase Inhibitor as New Antineoplastic Agent</span></div><div class="casAuthors">Cersosimo, Ulma; Sgorbissa, Andrea; Foti, Carmen; Drioli, Sara; Angelica, Rosario; Tomasella, Andrea; Picco, Raffaella; Semrau, Marta Stefania; Storici, Paola; Benedetti, Fabio; Berti, Federico; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1691-1704</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bis-arylidenecycloalkanones structurally related to the nonselective isopeptidase inhibitor G5 were synthesized and tested for cytotoxic activity against glioblastoma cells.  Cytotoxicities correlate well with Hammett σ consts. for substituted arylidene groups, confirming the proposed inhibition mechanism.  A new inhibitor (2c, I) based on the 4-hydroxycyclohexanone scaffold, which favors apoptosis over necrosis, was selected for further development.  2C inhibited representative deubiquitinases with micromolar IC50, and its proapoptotic activity was studied on several cancer cell lines.  Inhibitor 2c was conjugated to PEG via dicarbamate and diester linkers.  While the dicarbamate was inactive, the diester (2cPE) behaves like a prodrug and is converted into the active species 2c by secreted esterase activities.  Finally, 2cPE was also tested in vivo on A549 lung carcinoma xenografts generated in mice.  i.v. Treatment with 2cPE led to a significant redn. in primary tumor growth, without appreciable toxicity to mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpujLPIK9nK8rVg90H21EOLACvtfcHk0lie_3zPGmMOlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvV2jurY%253D&md5=ec9121164549800a59dd00532ab47fc1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm501336h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501336h%26sid%3Dliteratum%253Aachs%26aulast%3DCersosimo%26aufirst%3DU.%26aulast%3DSgorbissa%26aufirst%3DA.%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DDrioli%26aufirst%3DS.%26aulast%3DAngelica%26aufirst%3DR.%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DPicco%26aufirst%3DR.%26aulast%3DSemrau%26aufirst%3DM.%2BS.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DBerti%26aufirst%3DF.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520optimization%2520for%2520in%2520vivo%2520delivery%2520of%2520a%2520nonselective%2520isopeptidase%2520inhibitor%2520as%2520new%2520antineoplastic%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1691%26epage%3D1704%26doi%3D10.1021%2Fjm501336h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erdal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunk, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoshan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1073/pnas.0408592102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1073%2Fpnas.0408592102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15618392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlentg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=192-197&author=H.+Erdalauthor=M.+Berndtssonauthor=J.+Castroauthor=U.+Brunkauthor=M.+C.+Shoshanauthor=S.+Linder&title=Induction+of+lysosomal+membrane+permeabilization+by+compounds+that+activate+p53-independent+apoptosis&doi=10.1073%2Fpnas.0408592102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis</span></div><div class="casAuthors">Erdal, Hamdiye; Berndtsson, Maria; Castro, Juan; Brunk, Ulf; Shoshan, Maria C.; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-197</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The p53 protein activates cellular death programs through multiple pathways.  Because the high frequency of p53 mutations in human tumors is believed to contribute to resistance to commonly used chemotherapeutic agents, it is important to identify drugs that induce p53-independent cell death and to define the mechanisms of action of such drugs.  Here we screened a drug library (the National Cancer Institute mechanistic set; 879 compds. with diverse mechanisms of actions) and identified 175 compds. that induced caspase cleavage of cytokeratin-18 in cultured HCT116 colon cancer cells at ≤5 μM.  Interestingly, whereas most compds. elicited a stronger apoptotic response in cells with functional p53, significant apoptosis was obsd. also in p53-null cells.  A subset of 15 compds. showing weak or no dependence on p53 for induction of apoptosis was examd. in detail.  Of these compds., 11 were capable of activating caspase-3 in enucleated cells.  Seven such compds. with nonnuclear targets were found to induce lysosomal membrane permeabilization (LMP).  Translocation of the lysosomal proteases cathepsin B and cathepsin D into the cytosol was obsd. after treatment with these drugs, and apoptosis was inhibited by pepstatin A, an inhibitor of cathepsin D. Apoptosis depended on Bax, suggesting that LMP induced a mitochondrial apoptotic pathway.  We conclude that a large no. of potential anticancer drugs induce p53-independent apoptosis and that LMP is a mediator of many such responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGvS-gxfmbbVg90H21EOLACvtfcHk0lie_3zPGmMOlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlentg%253D%253D&md5=92af37552c4cc92a7bc2525f042b8ed0</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0408592102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0408592102%26sid%3Dliteratum%253Aachs%26aulast%3DErdal%26aufirst%3DH.%26aulast%3DBerndtsson%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DBrunk%26aufirst%3DU.%26aulast%3DShoshan%26aufirst%3DM.%2BC.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInduction%2520of%2520lysosomal%2520membrane%2520permeabilization%2520by%2520compounds%2520that%2520activate%2520p53-independent%2520apoptosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D192%26epage%3D197%26doi%3D10.1073%2Fpnas.0408592102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaujouin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickardson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havelka, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaudet-Coopman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">1463</span>– <span class="NLM_lpage">1469</span>, <span class="refDoi"> DOI: 10.1002/ijc.24004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fijc.24004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19089926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFGgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=1463-1469&author=M.+Berndtssonauthor=M.+Beaujouinauthor=L.+Rickardsonauthor=A.+M.+Havelkaauthor=R.+Larssonauthor=J.+Westmanauthor=E.+Liaudet-Coopmanauthor=S.+Linder&title=Induction+of+the+lysosomal+apoptosis+pathway+by+inhibitors+of+the+ubiquitin-proteasome+system&doi=10.1002%2Fijc.24004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin-proteasome system</span></div><div class="casAuthors">Berndtsson, Maria; Beaujouin, Melanie; Rickardson, Linda; Havelka, Aleksandra Mandic; Larsson, Rolf; Westman, Jacob; Liaudet-Coopman, Emmanuelle; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1463-1469</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The lysosomal apoptosis pathway is a potentially interesting therapeutic target.  Since apoptosis involving the lysosomal pathway has been described to involve cathepsins, we screened a drug library for agents that induce cathepsin-dependent apoptosis.  Using pharmacol. inhibitors and siRNA, we identified 2 structurally related agents (NSC687852 and NSC638646) that induced cathepsin D-dependent caspase-cleavage activity in human breast cancer cells.  Both agents were found to induce the mitochondrial apoptosis pathway.  NSC687852 and NSC638646 were found to inhibit the activity of ubiquitin isopeptidases and to induce the accumulation of high-mol.-mass ubiquitins in cells.  We show that 3 other inhibitors of the proteasome degrdn. pathway induce lysosomal membrane permeabilization (LMP) and that cathepsin-D siRNA inhibits apoptosis induced by these agents.  We conclude that a screen for cathepsin-dependent apoptosis-inducing agents resulted in the identification of ubiquitin isopeptidase inhibitors and that proteasome inhibitors with different mechanisms of action induce LMP and cathepsin D-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroi3IbOKSpdrVg90H21EOLACvtfcHk0lie_3zPGmMOlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFGgsLk%253D&md5=53e2ebcdc67e34bfbef59d560ae69c56</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fijc.24004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24004%26sid%3Dliteratum%253Aachs%26aulast%3DBerndtsson%26aufirst%3DM.%26aulast%3DBeaujouin%26aufirst%3DM.%26aulast%3DRickardson%26aufirst%3DL.%26aulast%3DHavelka%26aufirst%3DA.%2BM.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DWestman%26aufirst%3DJ.%26aulast%3DLiaudet-Coopman%26aufirst%3DE.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInduction%2520of%2520the%2520lysosomal%2520apoptosis%2520pathway%2520by%2520inhibitors%2520of%2520the%2520ubiquitin-proteasome%2520system%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2009%26volume%3D124%26spage%3D1463%26epage%3D1469%26doi%3D10.1002%2Fijc.24004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohanty, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1036</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1111%2Fcbdd.12571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25854145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovV2qu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=1036-1048&author=X.+Wangauthor=P.+D%E2%80%99Arcyauthor=T.+R.+Caulfieldauthor=A.+Paulusauthor=K.+Chittaauthor=C.+Mohantyauthor=J.+Gullboauthor=A.+Chanan-Khanauthor=S.+Linder&title=Synthesis+and+evaluation+of+derivatives+of+the+proteasome+deubiquitinase+inhibitor+b-AP15&doi=10.1111%2Fcbdd.12571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b-AP15</span></div><div class="casAuthors">Wang, Xin; D'Arcy, Padraig; Caulfield, Thomas R.; Paulus, Aneel; Chitta, Kasyapa; Mohanty, Chitralekha; Gullbo, Joachim; Chanan-Khan, Asher; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1036-1048</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The ubiquitin-proteasome system (UPS) is increasingly recognized as a therapeutic target for the development of anticancer therapies.  The success of the 20S proteasome core particle (20S CP) inhibitor bortezomib in the clin. management of multiple myeloma has raised the possibility of identifying other UPS components for therapeutic intervention.  We previously identified the small mol. b-AP15 as an inhibitor of 19S proteasome deubiquitinase (DUB) activity.  Building upon our previous data, we performed a structure-activity relation (SAR) study on b-AP15 and identified VLX1570 as an analog with promising properties, including enhanced potency and improved soly. in aq. soln.  In silico modeling was consistent with interaction of VLX1570 with key cysteine residues located at the active sites of the proteasome DUBs USP14 and UCHL5.  VLX1570 was found to inhibit proteasome deubiquitinase activity in vitro in a manner consistent with competitive inhibition.  Furthermore, using active-site-directed probes, VLX1570 also inhibited proteasome DUB activity in exposed cells.  Importantly, VLX1570 did not show inhibitory activity on a panel of recombinant non-proteasome DUBs, on recombinant kinases, or on caspase-3 activity, suggesting that VLX1570 is not an overtly reactive general enzyme inhibitor.  Taken together, our data shows the chem. and biol. properties of VLX1570 as an optimized proteasome DUB inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jJ_S5YMId7Vg90H21EOLACvtfcHk0liQcYosX8a9Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovV2qu70%253D&md5=353bf1b03a5378ba70f0835a143516f1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12571%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DChitta%26aufirst%3DK.%26aulast%3DMohanty%26aufirst%3DC.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DChanan-Khan%26aufirst%3DA.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520derivatives%2520of%2520the%2520proteasome%2520deubiquitinase%2520inhibitor%2520b-AP15%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2015%26volume%3D86%26spage%3D1036%26epage%3D1048%26doi%3D10.1111%2Fcbdd.12571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierrou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillertz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span> <span> </span><span class="NLM_article-title">The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">26979</span>, <span class="refDoi"> DOI: 10.1038/srep26979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep26979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27264969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=26979&author=X.+Wangauthor=M.+Mazurkiewiczauthor=E.+K.+Hillertauthor=M.+H.+Olofssonauthor=S.+Pierrouauthor=P.+Hillertzauthor=J.+Gullboauthor=K.+Selvarajuauthor=A.+Paulusauthor=S.+Akhtarauthor=F.+Bosslerauthor=A.+C.+Khanauthor=S.+Linderauthor=P.+D%E2%80%99Arcy&title=The+proteasome+deubiquitinase+inhibitor+VLX1570+shows+selectivity+for+ubiquitin-specific+protease-14+and+induces+apoptosis+of+multiple+myeloma+cells&doi=10.1038%2Fsrep26979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells</span></div><div class="casAuthors">Wang, Xin; Mazurkiewicz, Magdalena; Hillert, Ellin-Kristina; Olofsson, Maria Haegg; Pierrou, Stefan; Hillertz, Per; Gullbo, Joachim; Selvaraju, Karthik; Paulus, Aneel; Akhtar, Sharoon; Bossler, Felicitas; Khan, Asher Chanan; Linder, Stig; D'Arcy, Padraig</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26979</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of deubiquitinase (DUB) activity is a promising strategy for cancer therapy.  VLX1570 is an inhibitor of proteasome DUB activity currently in clin. trials for relapsed multiple myeloma.  Here we show that VLX1570 binds to and inhibits the activity of ubiquitin-specific protease-14 (USP14) in vitro, with comparatively weaker inhibitory activity towards UCHL5 (ubiquitin-C-terminal hydrolase-5).  Exposure of multiple myeloma cells to VLX1570 resulted in thermostabilization of USP14 at therapeutically relevant concns.  Transient knockdown of USP14 or UCHL5 expression by electroporation of siRNA reduced the viability of multiple myeloma cells.  Treatment of multiple myeloma cells with VLX1570 induced the accumulation of proteasome-bound high mol. wt. polyubiquitin conjugates and an apoptotic response.  Sensitivity to VLX1570 was moderately affected by altered drug uptake, but was unaffected by overexpression of BCL2-family proteins or inhibitors of caspase activity.  Finally, treatment with VLX1570 was found to lead to extended survival in xenograft models of multiple myeloma.  Our findings demonstrate promising antiproliferative activity of VLX1570 in multiple myeloma, primarily assocd. with inhibition of USP14 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSyNNG3GPEDLVg90H21EOLACvtfcHk0liQcYosX8a9Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2qtLg%253D&md5=9826987b387c59f4fc10fa7c2d126011</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsrep26979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep26979%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DPierrou%26aufirst%3DS.%26aulast%3DHillertz%26aufirst%3DP.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DBossler%26aufirst%3DF.%26aulast%3DKhan%26aufirst%3DA.%2BC.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26atitle%3DThe%2520proteasome%2520deubiquitinase%2520inhibitor%2520VLX1570%2520shows%2520selectivity%2520for%2520ubiquitin-specific%2520protease-14%2520and%2520induces%2520apoptosis%2520of%2520multiple%2520myeloma%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D26979%26doi%3D10.1038%2Fsrep26979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somwar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambati, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antczak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhinder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Stanchina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis-Filho, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouerfelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djaballah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladanyi, M.</span></span> <span> </span><span class="NLM_article-title">Proteasome addiction defined in Ewing’s sarcoma is effectively targeted by a novel class of 19S proteasome inhibitors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4534</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-1040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-16-1040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27256563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4525-4534&author=N.+N.+Shuklaauthor=R.+Somwarauthor=R.+S.+Smithauthor=S.+R.+Ambatiauthor=S.+Munozauthor=M.+S.+Merchantauthor=P.+D%E2%80%99Arcyauthor=X.+Wangauthor=R.+Kobosauthor=C.+Antczakauthor=B.+Bhinderauthor=D.+Shumauthor=C.+Raduauthor=G.+Yangauthor=B.+S.+Taylorauthor=C.+K.+Ngauthor=B.+Weigeltauthor=I.+Khodosauthor=E.+de+Stanchinaauthor=J.+S.+Reis-Filhoauthor=O.+Ouerfelliauthor=S.+Linderauthor=H.+Djaballahauthor=M.+Ladanyi&title=Proteasome+addiction+defined+in+Ewing%E2%80%99s+sarcoma+is+effectively+targeted+by+a+novel+class+of+19S+proteasome+inhibitors&doi=10.1158%2F0008-5472.CAN-16-1040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors</span></div><div class="casAuthors">Shukla, Neerav; Somwar, Romel; Smith, Roger S.; Ambati, Sri; Munoz, Stanley; Merchant, Melinda; D'Arcy, Padraig; Wang, Xin; Kobos, Rachel; Antczak, Christophe; Bhinder, Bhavneet; Shum, David; Radu, Constantin; Yang, Guangbin; Taylor, Barry S.; Ng, Charlotte K. Y.; Weigelt, Britta; Khodos, Inna; de Stanchina, Elisa; Reis-Filho, Jorge S.; Ouerfelli, Ouathek; Linder, Stig; Djaballah, Hakim; Ladanyi, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4525-4534</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ewing sarcoma is a primitive round cell sarcoma with a peak incidence in adolescence that is driven by a chimeric oncogene created from the fusion of the EWSR1 gene with a member of the ETS family of genes.  Patients with metastatic and recurrent disease have dismal outcomes and need better therapeutic options.  We screened a library of 309,989 chem. compds. for growth inhibition of Ewing sarcoma cells to provide the basis for the development of novel therapies and to discover vulnerable pathways that might broaden our understanding of the pathobiol. of this aggressive sarcoma.  This screening campaign identified a class of benzyl-4-piperidone compds. that selectively inhibit the growth of Ewing sarcoma cell lines by inducing apoptosis.  These agents disrupt 19S proteasome function through inhibition of the deubiquitinating enzymes USP14 and UCHL5.  Functional genomic data from a genome-wide shRNA screen in Ewing sarcoma cells also identified the proteasome as a node of vulnerability in Ewing sarcoma cells, providing orthologous confirmation of the chem. screen findings.  Furthermore, shRNA-mediated silencing of USP14 or UCHL5 in Ewing sarcoma cells produced significant growth inhibition.  Finally, treatment of a xenograft mouse model of Ewing sarcoma with VLX1570, a benzyl-4-piperidone compd. deriv. currently in clin. trials for relapsed multiple myeloma, significantly inhibited in vivo tumor growth.  Overall, our results offer a preclin. proof of concept for the use of 19S proteasome inhibitors as a novel therapeutic strategy for Ewing sarcoma.  Cancer Res; 76(15); 4525-34. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_BM2OwVlW2bVg90H21EOLACvtfcHk0liQcYosX8a9Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7bE&md5=098d0f39bb8f35485114efddfed50f62</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-1040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-1040%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DN.%2BN.%26aulast%3DSomwar%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BS.%26aulast%3DAmbati%26aufirst%3DS.%2BR.%26aulast%3DMunoz%26aufirst%3DS.%26aulast%3DMerchant%26aufirst%3DM.%2BS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKobos%26aufirst%3DR.%26aulast%3DAntczak%26aufirst%3DC.%26aulast%3DBhinder%26aufirst%3DB.%26aulast%3DShum%26aufirst%3DD.%26aulast%3DRadu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DB.%2BS.%26aulast%3DNg%26aufirst%3DC.%2BK.%26aulast%3DWeigelt%26aufirst%3DB.%26aulast%3DKhodos%26aufirst%3DI.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DOuerfelli%26aufirst%3DO.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DDjaballah%26aufirst%3DH.%26aulast%3DLadanyi%26aufirst%3DM.%26atitle%3DProteasome%2520addiction%2520defined%2520in%2520Ewing%25E2%2580%2599s%2520sarcoma%2520is%2520effectively%2520targeted%2520by%2520a%2520novel%2520class%2520of%252019S%2520proteasome%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4525%26epage%3D4534%26doi%3D10.1158%2F0008-5472.CAN-16-1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R. K</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousaf, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenfield, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ailawadhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanan-Khan, A.</span></span> <span> </span><span class="NLM_article-title">Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells</span>. <i>Blood Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e492</span> <span class="refDoi"> DOI: 10.1038/bcj.2016.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fbcj.2016.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27813535" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=A.+Paulusauthor=S.+Akhtarauthor=T.+R.+K+Caulfieldauthor=K.+Samuelauthor=H.+Yousafauthor=Y.+Bashirauthor=S.+M.+Paulusauthor=D.+Tranauthor=R.+Hudecauthor=D.+Cogenauthor=J.+Jiangauthor=B.+Edenfieldauthor=A.+Novakauthor=S.+M.+Ansellauthor=T.+Witzigauthor=P.+Martinauthor=M.+Colemanauthor=V.+Royauthor=S.+Ailawadhiauthor=K.+Chittaauthor=S.+Linderauthor=A.+Chanan-Khan&title=Coinhibition+of+the+deubiquitinating+enzymes%2C+USP14+and+UCHL5%2C+with+VLX1570+is+lethal+to+ibrutinib-+or+bortezomib-resistant+Waldenstrom+macroglobulinemia+tumor+cells&doi=10.1038%2Fbcj.2016.93"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2016.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2016.93%26sid%3Dliteratum%253Aachs%26aulast%3DPaulus%26aufirst%3DA.%26aulast%3DAkhtar%26aufirst%3DS.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%2BK%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DYousaf%26aufirst%3DH.%26aulast%3DBashir%26aufirst%3DY.%26aulast%3DPaulus%26aufirst%3DS.%2BM.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DHudec%26aufirst%3DR.%26aulast%3DCogen%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DEdenfield%26aufirst%3DB.%26aulast%3DNovak%26aufirst%3DA.%26aulast%3DAnsell%26aufirst%3DS.%2BM.%26aulast%3DWitzig%26aufirst%3DT.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DColeman%26aufirst%3DM.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DAilawadhi%26aufirst%3DS.%26aulast%3DChitta%26aufirst%3DK.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DChanan-Khan%26aufirst%3DA.%26atitle%3DCoinhibition%2520of%2520the%2520deubiquitinating%2520enzymes%252C%2520USP14%2520and%2520UCHL5%252C%2520with%2520VLX1570%2520is%2520lethal%2520to%2520ibrutinib-%2520or%2520bortezomib-resistant%2520Waldenstrom%2520macroglobulinemia%2520tumor%2520cells%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fbcj.2016.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bcp.2018.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30149015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1ektLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=291-301&author=X.+Zhangauthor=P.+Pellegriniauthor=A.+A.+Saeiauthor=E.+K.+Hillertauthor=M.+Mazurkiewiczauthor=M.+H.+Olofssonauthor=R.+A.+Zubarevauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=The+deubiquitinase+inhibitor+b-AP15+induces+strong+proteotoxic+stress+and+mitochondrial+damage&doi=10.1016%2Fj.bcp.2018.08.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage</span></div><div class="casAuthors">Zhang, Xiaonan; Pellegrini, Paola; Saei, Amir Ata; Hillert, Ellin-Kristina; Mazurkiewicz, Magdalena; Olofsson, Maria Haegg; Zubarev, Roman A.; D'Arcy, Padraig; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-301</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human cancers are characterized by intrinsic or acquired resistance to apoptosis and evasion of apoptosis has been proposed to contribute to treatment resistance.  Bis-benzylidine piperidone compds., contg. α,β-unsatd. carbonyl functionalities, have been extensively documented as being effective in killing apoptosis-resistant cells and to display promising antineoplastic activities in a no. of tumor models.  The authors here explored the phenotypic response of colon cancer cells to b-AP15, a bis-benzylidine piperidone previously shown to inhibit the proteasome deubiquitinases (DUBs) USP14 and UCHL5.  Whereas similar overall mRNA and protein expression profiles were induced by b-AP15 and the clin. available proteasome inhibitor bortezomib, b-AP15 induced stronger increases of chaperone expression. b-AP15 also induced a stronger accumulation of polyubiquitinated proteins in exposed cells.  These proteins were found to partially colocalize with organelle structures, including mitochondria.  Mitochondrial oxidative phosphorylation decreased in cells exposed to b-AP15, a phenomenon enhanced under conditions of severe proteotoxic stress caused by inhibition of the VCP/p97 ATPase and inhibition of protein translocation over the ER.  The authors propose that mitochondrial damage caused by the assocn. of misfolded proteins with mitochondrial membranes may contribute to the atypical cell death mode induced by b-AP15 and related compds.  The robust mode of cell death induction by this class of drugs holds promise for treatment of tumor cells characterized by apoptosis resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK3vSAM30u7rVg90H21EOLACvtfcHk0lhCGeoljthMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1ektLfE&md5=3225a8626d3dc098b2318ecb9fb03a1e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DThe%2520deubiquitinase%2520inhibitor%2520b-AP15%2520induces%2520strong%2520proteotoxic%2520stress%2520and%2520mitochondrial%2520damage%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D156%26spage%3D291%26epage%3D301%26doi%3D10.1016%2Fj.bcp.2018.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudiam, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Issaenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson Vogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavioli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. R.</span></span> <span> </span><span class="NLM_article-title">alpha, beta-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1021/jm100589p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100589p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Wgt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=449-456&author=M.+Bazzaroauthor=R.+K.+Anchooriauthor=M.+K.+Mudiamauthor=O.+Issaenkoauthor=S.+Kumarauthor=B.+Karanamauthor=Z.+Linauthor=R.+Isaksson+Vogelauthor=R.+Gavioliauthor=F.+Destroauthor=V.+Ferrettiauthor=R.+B.+Rodenauthor=S.+R.+Khan&title=alpha%2C+beta-Unsaturated+carbonyl+system+of+chalcone-based+derivatives+is+responsible+for+broad+inhibition+of+proteasomal+activity+and+preferential+killing+of+human+papilloma+virus+%28HPV%29+positive+cervical+cancer+cells&doi=10.1021%2Fjm100589p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">α,β-Unsaturated Carbonyl System of Chalcone-Based Derivatives is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells</span></div><div class="casAuthors">Bazzaro, Martina; Anchoori, Ravi K.; Mudiam, Mohana Krishna R.; Issaenko, Olga; Kumar, Srinivas; Karanam, Balasubramanyam; Lin, Zhen-Hua; Isaksson Vogel, Rachel; Gavioli, Riccardo; Destro, Federica; Ferretti, Valeria; Roden, Richard B. S.; Khan, Saeed R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">449-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteasome inhibitors have potential for the treatment of cervical cancer.  Here, the synthesis and biol. characterization of a new series of 1,3-diphenylpropen-1-one based derivs. I [R = i-Bu, HO2CCH2CH2, H2N(CH2)4, PhCH2, 4-HOC6H4CH2, X = OH; R = HO2CCH2CH2, X = HO2CCH2CH(CO2H)NH; etc.] lacking the boronic acid moieties of the previously reported chalcone-based proteasome inhibitor 3,5-bis(4-boronic acid benzylidene)-1-methylpiperidin-4-one and bearing a variety of amino acid or dipeptide substitutions on the amino group of the 4-piperidone is reported.  The lead compd. I (R = PhCH2; X = OH) inhibited proteasomal activity and had improved dose-dependent antiproliferative and proapoptotic properties in cervical cancer cells contg. human papillomavirus.  Further, it induced synergistic killing of cervical cancer cell lines when tested in combination with an FDA approved proteasome inhibitor.  Exploration of the potential mechanism of proteasomal inhibition by this compd. using in silico docking studies suggests that the carbonyl group of its oxopiperidine moiety is susceptible to nucleophilic attack by the γ-hydroxythreonine side chain within the catalytic sites of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPSoTKQDRj-7Vg90H21EOLACvtfcHk0lhCGeoljthMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Wgt7nK&md5=82cf9608533ff6524d4ca2658e8864ef</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm100589p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100589p%26sid%3Dliteratum%253Aachs%26aulast%3DBazzaro%26aufirst%3DM.%26aulast%3DAnchoori%26aufirst%3DR.%2BK.%26aulast%3DMudiam%26aufirst%3DM.%2BK.%26aulast%3DIssaenko%26aufirst%3DO.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DIsaksson%2BVogel%26aufirst%3DR.%26aulast%3DGavioli%26aufirst%3DR.%26aulast%3DDestro%26aufirst%3DF.%26aulast%3DFerretti%26aufirst%3DV.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26atitle%3Dalpha%252C%2520beta-Unsaturated%2520carbonyl%2520system%2520of%2520chalcone-based%2520derivatives%2520is%2520responsible%2520for%2520broad%2520inhibition%2520of%2520proteasomal%2520activity%2520and%2520preferential%2520killing%2520of%2520human%2520papilloma%2520virus%2520%2528HPV%2529%2520positive%2520cervical%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D449%26epage%3D456%26doi%3D10.1021%2Fjm100589p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sueblinvong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felthauser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iizuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavioli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaksson
Vogel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span> <span> </span><span class="NLM_article-title">Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e23888</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0023888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0023888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21909374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wrtb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=R.+K.+Anchooriauthor=S.+R.+Khanauthor=T.+Sueblinvongauthor=A.+Felthauserauthor=Y.+Iizukaauthor=R.+Gavioliauthor=F.+Destroauthor=R.+Isaksson%0AVogelauthor=S.+Pengauthor=R.+B.+Rodenauthor=M.+Bazzaro&title=Stressing+the+ubiquitin-proteasome+system+without+20S+proteolytic+inhibition+selectively+kills+cervical+cancer+cells&doi=10.1371%2Fjournal.pone.0023888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells</span></div><div class="casAuthors">Anchoori, Ravi K.; Khan, Saeed R.; Sueblinvong, Thanasak; Felthauser, Alicia; Iizuka, Yoshie; Gavioli, Riccardo; Destro, Federica; Vogel, Rachel Isaksson; Peng, Shiwen; Roden, Richard B. S.; Bazzaro, Martina</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e23888</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cervical cancer cells exhibit an increased requirement for ubiquitin-dependent protein degrdn. assocd. with an elevated metabolic turnover rate, and for specific signaling pathways, notably HPV E6-targeted degrdn. of p53 and PDZ proteins.  Natural compds. with antioxidant properties including flavonoids and triterpenoids hold promise as anticancer agents by interfering with ubiquitin-dependent protein degrdn.  An increasing body of evidence indicates that their α-β unsatd. carbonyl system is the mol. determinant for inhibition of ubiquitin-mediated protein degrdn. up-stream of the catalytic sites of the 20S proteasome.  Herein we report the identification and characterization of a new class of chalcone-based, potent and cell permeable chem. inhibitors of ubiquitin-dependent protein degrdn., and a lead compd. RAMB1.  RAMB1 inhibits ubiquitin-dependent protein degrdn. without compromising the catalytic activities of the 20S proteasome, a mechanism distinct from that of Bortezomib.  Treatment of cervical cancer cells with RAMB1 triggers unfolded protein responses, including aggresome formation and Hsp90 stabilization, and increases p53 steady state levels.  RAMB1 treatment results in activation of lysosomal-dependent degrdn. pathways as a mechanism to compensate for increasing levels of poly-ubiquitin enriched toxic aggregates.  Importantly, RAMB1 synergistically triggers cell death of cervical cancer cells when combined with the lysosome inhibitor Chloroquine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIDa06rGO6tLVg90H21EOLACvtfcHk0lhw6hF3d3iiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wrtb3O&md5=fb75a4e02b8932fc3d18af40995de1bb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0023888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0023888%26sid%3Dliteratum%253Aachs%26aulast%3DAnchoori%26aufirst%3DR.%2BK.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DSueblinvong%26aufirst%3DT.%26aulast%3DFelthauser%26aufirst%3DA.%26aulast%3DIizuka%26aufirst%3DY.%26aulast%3DGavioli%26aufirst%3DR.%26aulast%3DDestro%26aufirst%3DF.%26aulast%3DIsaksson%2BVogel%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DBazzaro%26aufirst%3DM.%26atitle%3DStressing%2520the%2520ubiquitin-proteasome%2520system%2520without%252020S%2520proteolytic%2520inhibition%2520selectively%2520kills%2520cervical%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0023888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span> <span> </span><span class="NLM_article-title">A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ccr.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24332045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=791-805&author=R.+K.+Anchooriauthor=B.+Karanamauthor=S.+Pengauthor=J.+W.+Wangauthor=R.+Jiangauthor=T.+Tannoauthor=R.+Z.+Orlowskiauthor=W.+Matsuiauthor=M.+Zhaoauthor=M.+A.+Rudekauthor=C.+F.+Hungauthor=X.+Chenauthor=K.+J.+Waltersauthor=R.+B.+Roden&title=A+bis-benzylidine+piperidone+targeting+proteasome+ubiquitin+receptor+RPN13%2FADRM1+as+a+therapy+for+cancer&doi=10.1016%2Fj.ccr.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer</span></div><div class="casAuthors">Anchoori, Ravi K.; Karanam, Balasubramanyam; Peng, Shiwen; Wang, Joshua W.; Jiang, Rosie; Tanno, Toshihiko; Orlowski, Robert Z.; Matsui, William; Zhao, Ming; Rudek, Michelle A.; Hung, Chien-fu; Chen, Xiang; Walters, Kylie J.; Roden, Richard B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">791-805</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The bis-benzylidine piperidone RA190 covalently binds to cysteine 88 of ubiquitin receptor RPN13 in the 19S regulatory particle and inhibits proteasome function, triggering rapid accumulation of polyubiquitinated proteins.  Multiple myeloma (MM) lines, even those resistant to bortezomib, were sensitive to RA190 via endoplasmic reticulum stress-related apoptosis.  RA190 stabilized targets of human papillomavirus (HPV) E6 oncoprotein, and preferentially killed HPV-transformed cells.  After oral or i.p. dosing of mice, RA190 distributed to plasma and major organs except the brain and inhibited proteasome function in skin and muscle.  RA190 administration profoundly reduced growth of MM and ovarian cancer xenografts, and oral RA190 treatment retarded HPV16+ syngeneic mouse tumor growth, without affecting spontaneous HPV-specific CD8+ T cell responses, suggesting its therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo94H2sTfVVuLVg90H21EOLACvtfcHk0lhw6hF3d3iiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyls7bJ&md5=4a9037278dc1e913d5247711ad6f6d30</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DAnchoori%26aufirst%3DR.%2BK.%26aulast%3DKaranam%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BW.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DTanno%26aufirst%3DT.%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DMatsui%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DRudek%26aufirst%3DM.%2BA.%26aulast%3DHung%26aufirst%3DC.%2BF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWalters%26aufirst%3DK.%2BJ.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26atitle%3DA%2520bis-benzylidine%2520piperidone%2520targeting%2520proteasome%2520ubiquitin%2520receptor%2520RPN13%252FADRM1%2520as%2520a%2520therapy%2520for%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26spage%3D791%26epage%3D805%26doi%3D10.1016%2Fj.ccr.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gargallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanez, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canete, A.</span></span> <span> </span><span class="NLM_article-title">Precision medicine in Ewing sarcoma: a translational point of view</span>. <i>Clin. Transl. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1440</span>– <span class="NLM_lpage">1454</span>, <span class="refDoi"> DOI: 10.1007/s12094-020-02298-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs12094-020-02298-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=32026343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB38%252FovFCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2020&pages=1440-1454&author=P.+Gargalloauthor=A.+Juanauthor=Y.+Yanezauthor=S.+Dolzauthor=V.+Seguraauthor=V.+Castelauthor=A.+Canete&title=Precision+medicine+in+Ewing+sarcoma%3A+a+translational+point+of+view&doi=10.1007%2Fs12094-020-02298-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Precision medicine in Ewing sarcoma: a translational point of view</span></div><div class="casAuthors">Gargallo P; Yanez Y; Dolz S; Segura V; Castel V; Canete A; Juan A; Yanez Y; Segura V; Castel V; Canete A; Dolz S</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1440-1454</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ewing sarcoma is a rare tumor that arises in bones of children and teenagers but, in 15% of the patients it is presented as a primary soft tissue tumor.  Balanced reciprocal chimeric translocation t(11;22)(q24;q12), which encodes an oncogenic protein fusion (EWSR1/FLI1), is the most generalized and characteristic molecular event.  Using conventional treatments, (chemotherapy, surgery and radiotherapy) long-term overall survival rate is 30% for patients with disseminated disease and 65-75% for patients with localized tumors.  Urgent new effective drug development is a challenge.  This review summarizes the preclinical and clinical investigational knowledge about prognostic and targetable biomarkers in Ewing sarcoma, finally suggesting a workflow for precision medicine committees.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRF18T6RnQ3EgyMywPm6HgQfW6udTcc2eb82LpR4fnMsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38%252FovFCgsw%253D%253D&md5=d830055eccda1473fda8271348312ab3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2Fs12094-020-02298-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-020-02298-7%26sid%3Dliteratum%253Aachs%26aulast%3DGargallo%26aufirst%3DP.%26aulast%3DJuan%26aufirst%3DA.%26aulast%3DYanez%26aufirst%3DY.%26aulast%3DDolz%26aufirst%3DS.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DCastel%26aufirst%3DV.%26aulast%3DCanete%26aufirst%3DA.%26atitle%3DPrecision%2520medicine%2520in%2520Ewing%2520sarcoma%253A%2520a%2520translational%2520point%2520of%2520view%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2020%26volume%3D22%26spage%3D1440%26epage%3D1454%26doi%3D10.1007%2Fs12094-020-02298-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mofers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomonsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morad, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkina, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunnerhagen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">9841</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-46168-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41598-019-46168-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31285509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MzltlGlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=9841&author=K.+Selvarajuauthor=A.+Mofersauthor=P.+Pellegriniauthor=J.+Salomonssonauthor=A.+Ahlnerauthor=V.+Moradauthor=E.+K.+Hillertauthor=B.+Espinosaauthor=E.+S.+J.+Arnerauthor=L.+Jensenauthor=J.+Malmstromauthor=M.+V.+Turkinaauthor=P.+D%E2%80%99Arcyauthor=M.+A.+Waltersauthor=M.+Sunnerhagenauthor=S.+Linder&title=Cytotoxic+unsaturated+electrophilic+compounds+commonly+target+the+ubiquitin+proteasome+system&doi=10.1038%2Fs41598-019-46168-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system</span></div><div class="casAuthors">Selvaraju Karthik; Mofers Arjan; Pellegrini Paola; Jensen Lasse; D'Arcy Padraig; Linder Stig; Salomonsson Johannes; Ahlner Alexandra; Morad Vivian; Sunnerhagen Maria; Hillert Ellin-Kristina; Linder Stig; Espinosa Belen; Arner Elias S J; Malmstrom Jonas; Turkina Maria V; Walters Michael A</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9841</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A large number of natural products have been advocated as anticancer agents.  Many of these compounds contain functional groups characterized by chemical reactivity.  It is not clear whether distinct mechanisms of action can be attributed to such compounds.  We used a chemical library screening approach to demonstrate that a substantial fraction (~20%) of cytotoxic synthetic compounds containing Michael acceptor groups inhibit proteasome substrate processing and induce a cellular response characteristic of proteasome inhibition.  Biochemical and structural analyses showed binding to and inhibition of proteasome-associated cysteine deubiquitinases, in particular ubiquitin specific peptidase 14 (USP14).  The results suggested that compounds bind to a crevice close to the USP14 active site with modest affinity, followed by covalent binding.  A subset of compounds was identified where cell death induction was closely associated with proteasome inhibition and that showed significant antineoplastic activity in a zebrafish embryo model.  These findings suggest that proteasome inhibition is a relatively common mode of action by cytotoxic compounds containing Michael acceptor groups and help to explain previous reports on the antineoplastic effects of natural products containing such functional groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAYYvdYFXCx_69nzq6467DfW6udTcc2eaG21w1zFnBxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzltlGlsA%253D%253D&md5=1d237387b71b0f0407c6e9d33019ebb4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-46168-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-46168-x%26sid%3Dliteratum%253Aachs%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DMofers%26aufirst%3DA.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DSalomonsson%26aufirst%3DJ.%26aulast%3DAhlner%26aufirst%3DA.%26aulast%3DMorad%26aufirst%3DV.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DEspinosa%26aufirst%3DB.%26aulast%3DArner%26aufirst%3DE.%2BS.%2BJ.%26aulast%3DJensen%26aufirst%3DL.%26aulast%3DMalmstrom%26aufirst%3DJ.%26aulast%3DTurkina%26aufirst%3DM.%2BV.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DSunnerhagen%26aufirst%3DM.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DCytotoxic%2520unsaturated%2520electrophilic%2520compounds%2520commonly%2520target%2520the%2520ubiquitin%2520proteasome%2520system%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D9841%26doi%3D10.1038%2Fs41598-019-46168-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somers-Edgar, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taurin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandramouli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosengren, R. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1007/s10637-009-9339-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs10637-009-9339-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19816657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVOitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=87-97&author=T.+J.+Somers-Edgarauthor=S.+Taurinauthor=L.+Larsenauthor=A.+Chandramouliauthor=M.+A.+Nelsonauthor=R.+J.+Rosengren&title=Mechanisms+for+the+activity+of+heterocyclic+cyclohexanone+curcumin+derivatives+in+estrogen+receptor+negative+human+breast+cancer+cell+lines&doi=10.1007%2Fs10637-009-9339-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines</span></div><div class="casAuthors">Somers-Edgar, Tiffany J.; Taurin, Sebastien; Larsen, Lesley; Chandramouli, Anupama; Nelson, Mark A.; Rosengren, Rhonda J.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-97</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Estrogen receptor (ER)-neg. breast cancer is an aggressive form that currently requires more drug treatment options.  Thus, we have further modified cyclohexanone derivs. of curcumin and examd. them for cytotoxicity towards ER-neg. human breast cancer cells.  Two of the analogs screened elicited increased cytotoxic potency compared to curcumin and other previously studied derivs.  Specifically, 2,6-bis(pyridin-3-ylmethylene)-cyclohexanone (RL90) and 2,6-bis(pyridin-4-ylmethylene)-cyclohexanone (RL91) elicited EC50 values of 1.54 and 1.10 μM, resp., in MDA-MB-231 cells and EC50 values of 0.51 and 0.23 in SKBr3 cells.  All other new compds. examd. were less potent than curcumin, which elicited EC50 values of 7.6 and 2.4 μM in MDA-MB-231 and SKBr3 cells, resp.  Mechanistic analyses demonstrated that RL90 and RL91 significantly induced G2/M-phase cell cycle arrest and apoptosis.  RL90 and RL91 also modulated the expression of key cell signaling proteins, specifically, in SKBr3 cells, protein levels of Her-2, Akt, and NFκB were decreased in a time-dependent manner, while activity of stress kinases JNK1/2 and P38 MAPK were increased.  Signaling events in MDA-MB-231 cells were differently implicated, as EGFR protein levels were decreased and activity of GSK-3β transiently decreased, while β-catenin protein level and activity of P38 MAPK, Akt, and JNK1/2 were transiently increased.  In conclusion replacement of the Ph group of cyclohexanone derived curcumin derivs. with heterocyclic rings forms a class of second-generation analogs that are more potent than both curcumin and other derivs.  These new derivs. provide a platform for the further development of drugs for the treatment of ER-neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd34rjHvw_irVg90H21EOLACvtfcHk0lgoW9dP5g6MgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVOitw%253D%253D&md5=850addac7fe7d91cfd72e3bc8f797fd3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1007%2Fs10637-009-9339-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-009-9339-0%26sid%3Dliteratum%253Aachs%26aulast%3DSomers-Edgar%26aufirst%3DT.%2BJ.%26aulast%3DTaurin%26aufirst%3DS.%26aulast%3DLarsen%26aufirst%3DL.%26aulast%3DChandramouli%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DM.%2BA.%26aulast%3DRosengren%26aufirst%3DR.%2BJ.%26atitle%3DMechanisms%2520for%2520the%2520activity%2520of%2520heterocyclic%2520cyclohexanone%2520curcumin%2520derivatives%2520in%2520estrogen%2520receptor%2520negative%2520human%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2011%26volume%3D29%26spage%3D87%26epage%3D97%26doi%3D10.1007%2Fs10637-009-9339-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robles-Escajeda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela-Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilera, R. J.</span></span> <span> </span><span class="NLM_article-title">A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells</span>. <i>Cell. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1007/s13402-016-0272-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs13402-016-0272-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjslyjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=265-277&author=E.+Robles-Escajedaauthor=U.+Dasauthor=N.+M.+Ortegaauthor=K.+Parraauthor=G.+Franciaauthor=J.+R.+Dimmockauthor=A.+Varela-Ramirezauthor=R.+J.+Aguilera&title=A+novel+curcumin-like+dienone+induces+apoptosis+in+triple-negative+breast+cancer+cells&doi=10.1007%2Fs13402-016-0272-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells</span></div><div class="casAuthors">Robles-Escajeda, Elisa; Das, Umashankar; Ortega, Nora M.; Parra, Karla; Francia, Giulio; Dimmock, Jonathan R.; Varela-Ramirez, Armando; Aguilera, Renato J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-277</span>CODEN:
                <span class="NLM_cas:coden">COENGH</span>;
        ISSN:<span class="NLM_cas:issn">2211-3436</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: According to the World Health Organization (WHO), breast cancer is the most common cancer affecting women worldwide.  In the USA ∼12.3 % of all women are expected to be diagnosed with various types of breast cancer, exhibiting varying degrees of therapeutic response rates.  Therefore, the identification of novel anti-breast cancer drugs is of paramount importance.  Methods: The 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore was incorporated into a no. of cytotoxins.  Three of the resulting dienones, 2a, 2b and 2c, were tested for their anti-neoplastic potencies in a variety of human breast cancer-derived cell lines, including the triple neg. MDA-MB-231 cell line and its metastatic variant, using a live-cell bio-imaging method.  Special emphasis was put on dienone 2c, since its anti-cancer activity and its mode of inflicting cell death have so far not been reported.  Results: We found that all three dienones exhibited potent cytotoxicities towards the breast cancer-derived cell lines tested, whereas significantly lower toxicities were obsd. towards the non-cancerous human breast cell line MCF-10A.  The dienones 2b and 2c exhibited the greatest selective cytotoxicity at submicromolar concn. levels.  We found that these two dienones induced phosphatidylserine externalization in MDA-MB-231 cells in a concn.-dependent manner, suggesting that their cytotoxic effect might be mediated by apoptosis.  This possibility was confirmed by our observation that the dienone 2c can induce mitochondrial depolarization, caspase-3 activation, cell cycle disruption and DNA fragmentation in MDA-MB-231 cells.  Conclusion: Our findings indicate that dienone 2c uses the mitochondrial/intrinsic pathway to inflict apoptosis in triple neg. MDA-MB-231 breast cancer-derived cells.  This observation warrants further assessment of dienone 2c as a potential anti-breast cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCZfQ7V3XJ4bVg90H21EOLACvtfcHk0lgoW9dP5g6MgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjslyjtbc%253D&md5=cc7efec607ff2ac02aa9f70e018a83d9</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs13402-016-0272-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13402-016-0272-x%26sid%3Dliteratum%253Aachs%26aulast%3DRobles-Escajeda%26aufirst%3DE.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DOrtega%26aufirst%3DN.%2BM.%26aulast%3DParra%26aufirst%3DK.%26aulast%3DFrancia%26aufirst%3DG.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DVarela-Ramirez%26aufirst%3DA.%26aulast%3DAguilera%26aufirst%3DR.%2BJ.%26atitle%3DA%2520novel%2520curcumin-like%2520dienone%2520induces%2520apoptosis%2520in%2520triple-negative%2520breast%2520cancer%2520cells%26jtitle%3DCell.%2520Oncol.%26date%3D2016%26volume%3D39%26spage%3D265%26epage%3D277%26doi%3D10.1007%2Fs13402-016-0272-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balog, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5414</span>– <span class="NLM_lpage">5421</span>, <span class="refDoi"> DOI: 10.1021/jm200353f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200353f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5414-5421&author=T.+Kalaiauthor=M.+L.+Kuppusamyauthor=M.+Balogauthor=K.+Selvendiranauthor=B.+K.+Riveraauthor=P.+Kuppusamyauthor=K.+Hideg&title=Synthesis+of+N-substituted+3%2C5-bis%28arylidene%29-4-piperidones+with+high+antitumor+and+antioxidant+activity&doi=10.1021%2Fjm200353f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of N-Substituted 3,5-Bis(arylidene)-4-piperidones with High Antitumor and Antioxidant Activity</span></div><div class="casAuthors">Kalai, Tamas; Kuppusamy, M. Lakshmi; Balog, Maria; Selvendiran, Karuppaiyah; Rivera, Brian K.; Kuppusamy, Periannan; Hideg, Kalman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5414-5421</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 3,5-bis(arylidene)-4-piperidone (DAP) compds. are considered as synthetic analogs of curcumin for anticancer properties.  The structure-activity relationship studies by synthesizing a no. of DAPs N-alkylated or acylated with nitroxides or their amine precursors as potent antioxidant moieties were performed.  Both substituents on arylidene rings and on piperidone nitrogen (five- or six-membered, 2- or 3-substituted or 3,4-disubstituted isoindoline nitroxides) were varied.  The anticancer efficacy of the new DAP compds., e.g., I, was tested by measuring their cytotoxicity to cancer cell lines A2780 and MCF-7 and to the H9c2 cell line.  The results showed that all DAP compds. induced a significant loss of cell viability in the human cancer cell lines tested; however, only pyrroline appended nitroxides, e.g., II, showed limited toxicity toward noncancerous cell lines.  Computer docking simulations support the biol. activity tested.  These results suggest that antioxidant-conjugated DAPs will be useful as a safe and effective anticancer agent for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjs1aaGsdcIrVg90H21EOLACvtfcHk0ljGrHDf1r3iYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCnsLs%253D&md5=6bb71a2cb8298490167d916b835c785a</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm200353f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200353f%26sid%3Dliteratum%253Aachs%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DBalog%26aufirst%3DM.%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DHideg%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520N-substituted%25203%252C5-bis%2528arylidene%2529-4-piperidones%2520with%2520high%2520antitumor%2520and%2520antioxidant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5414%26epage%3D5421%26doi%3D10.1021%2Fjm200353f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybalkina, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anikina, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukhov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klochkov, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischenko, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neganova, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrustalev, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemenkova, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brel, V. K.</span></span> <span> </span><span class="NLM_article-title">1,5-diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1007/s00044-016-1726-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs00044-016-1726-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslyis7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=140-152&author=M.+V.+Makarovauthor=E.+Y.+Rybalkinaauthor=L.+V.+Anikinaauthor=S.+A.+Pukhovauthor=S.+G.+Klochkovauthor=D.+V.+Mischenkoauthor=M.+E.+Neganovaauthor=V.+N.+Khrustalevauthor=Z.+S.+Klemenkovaauthor=V.+K.+Brel&title=1%2C5-diaryl-3-oxo-1%2C4-pentadienes+based+on+%284-oxopiperidin-1-yl%29%28aryl%29methyl+phosphonate+scaffold%3A+synthesis+and+antitumor+properties&doi=10.1007%2Fs00044-016-1726-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-Diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties</span></div><div class="casAuthors">Makarov, Mikhail V.; Rybalkina, Ekaterina Yu.; Anikina, Lada V.; Pukhov, Sergey A.; Klochkov, Sergey G.; Mischenko, Denis V.; Neganova, Margarita E.; Khrustalev, Victor N.; Klemenkova, Zinaida S.; Brel, Valery K.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Novel 3,5-bis(arylidene)-4-piperidones modified with diethyl[(aryl)methyl]phosphonate moiety attached to the piperidone N atom were synthesized by crotonic condensation of arom. aldehydes with diethyl[(4-oxopiperidin-1-yl)(aryl)methyl]phosphonates in the presence of LiClO4/Et3N system or MeCN soln. of B trifluoride etherate.  The synthesized phosphonate derivs. of 3,5-bis(arylidene)-4-piperidone series displayed inhibitory properties toward RD, PC3, HCT116, and MCF7 human cancer cell lines with IC50 values at 2.5-8.5 μM, as assessed by an in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVYNJlqwyA2LVg90H21EOLACvtfcHk0ljGrHDf1r3iYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslyis7bN&md5=f58380069d4dee1756c7ba5d81f15dd5</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00044-016-1726-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-016-1726-4%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DM.%2BV.%26aulast%3DRybalkina%26aufirst%3DE.%2BY.%26aulast%3DAnikina%26aufirst%3DL.%2BV.%26aulast%3DPukhov%26aufirst%3DS.%2BA.%26aulast%3DKlochkov%26aufirst%3DS.%2BG.%26aulast%3DMischenko%26aufirst%3DD.%2BV.%26aulast%3DNeganova%26aufirst%3DM.%2BE.%26aulast%3DKhrustalev%26aufirst%3DV.%2BN.%26aulast%3DKlemenkova%26aufirst%3DZ.%2BS.%26aulast%3DBrel%26aufirst%3DV.%2BK.%26atitle%3D1%252C5-diaryl-3-oxo-1%252C4-pentadienes%2520based%2520on%2520%25284-oxopiperidin-1-yl%2529%2528aryl%2529methyl%2520phosphonate%2520scaffold%253A%2520synthesis%2520and%2520antitumor%2520properties%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2017%26volume%3D26%26spage%3D140%26epage%3D152%26doi%3D10.1007%2Fs00044-016-1726-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antitumor activity evaluation of some new N-aroyl-alpha, beta-unsaturated piperidones with fluorescence</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.3109/14756366.2015.1043296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3109%2F14756366.2015.1043296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26382011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVCjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=495-502&author=J.+Sunauthor=S.+Wangauthor=H.+Liauthor=W.+Jiangauthor=G.+Houauthor=F.+Zhaoauthor=W.+Cong&title=Synthesis%2C+antitumor+activity+evaluation+of+some+new+N-aroyl-alpha%2C+beta-unsaturated+piperidones+with+fluorescence&doi=10.3109%2F14756366.2015.1043296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence</span></div><div class="casAuthors">Sun, Jufeng; Wang, Suwen; Li, Hongjuan; Jiang, Wenguo; Hou, Guige; Zhao, Feng; Cong, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Novel N-aroyl-α,β-unsatd. piperidones (featuring 2-bromo-4,5-dimethoxybenzylidene, 4-dimethylaminobenzylidene and 4-trifluoromethylbenzylidene groups, resp.), were synthesized as candidate cytotoxins.  Most of the compds. displayed potent cytotoxicity against the human neoplastic cell lines SK-BR-3, PG-BE1, NCI-H460, MIA PaCa-2 and SW1990 in vitro, and approx. 64% of the IC50 values were lower than 5 μM.  Among those tested, compd. of series and of series proved to be the most active.  Importantly, I displayed marked inhibitory effects on tumor growth in vivo and had no apparent toxicity to mice; this was evaluated by a nude mouse PG-BE1 xenograft model.  In addn., the fluorescent properties of these compds. were investigated.  The interesting fluorescence exhibited by these compds. could be useful for their visualization in tumor cells, permitting further studies on these α,β-unsatd. piperidones as candidates for novel fluorescent antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGH6MP6HZU37Vg90H21EOLACvtfcHk0ljGrHDf1r3iYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVCjur8%253D&md5=6cb29cc16285811131c1fd0873c8fb8d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1043296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1043296%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DHou%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DCong%26aufirst%3DW.%26atitle%3DSynthesis%252C%2520antitumor%2520activity%2520evaluation%2520of%2520some%2520new%2520N-aroyl-alpha%252C%2520beta-unsaturated%2520piperidones%2520with%2520fluorescence%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D495%26epage%3D502%26doi%3D10.3109%2F14756366.2015.1043296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conney, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of curcumin-related compounds for anticancer activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.ejmech.2012.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22551677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=235-245&author=X.+Weiauthor=Z.+Y.+Duauthor=X.+Zhengauthor=X.+X.+Cuiauthor=A.+H.+Conneyauthor=K.+Zhang&title=Synthesis+and+evaluation+of+curcumin-related+compounds+for+anticancer+activity&doi=10.1016%2Fj.ejmech.2012.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of curcumin-related compounds for anticancer activity</span></div><div class="casAuthors">Wei, Xingchuan; Du, Zhi-Yun; Zheng, Xi; Cui, Xiao-Xing; Conney, Allan H.; Zhang, Kun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">235-245</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sixty-one curcumin-related compds. were synthesized and evaluated for their anticancer activity toward cultured prostate cancer PC-3 cells, pancreas cancer Panc-1 cells and colon cancer HT-29 cells.  Inhibitory effects of these compds. on the growth of PC-3, Panc-1 and HT-29 cells were detd. by the MTT assay.  Compds. E10 (I), F10, FN1 and FN2 exhibited exceptionally potent inhibitory effects on the growth of cultured PC-3, Panc-1 and HT-29 cells.  The IC50 for these compds. was lower than 1 μM in all three cell lines.  E10 was 72-, 46- and 117-fold more active than curcumin for inhibiting the growth of PC-3, Panc-1 and HT-29 cells, resp.  F10 was 69-, 34- and 72-fold more active than curcumin for inhibiting the growth of PC-3, Panc-1 and HT-29 cells, resp.  FN1 and FN2 had about the same inhibitory effect as E10 and F10 toward Panc-1 cells but were less active than E10 and F10 toward PC-3 and HT-29 cells.  The active compds. were potent stimulators of apoptosis.  The present study indicates that E10, F10, FN1 and FN2 may have useful anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpT8gDD2Bjb7Vg90H21EOLACvtfcHk0ljgpSvbRlXKcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVygsbg%253D&md5=c486de1c34912bfb582dbb0187c09b97</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DZ.%2BY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DX.%2BX.%26aulast%3DConney%26aufirst%3DA.%2BH.%26aulast%3DZhang%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520curcumin-related%2520compounds%2520for%2520anticancer%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D53%26spage%3D235%26epage%3D245%26doi%3D10.1016%2Fj.ejmech.2012.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youssef, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stables, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and bioevaluation of novel maleamic amino acid ester conjugates of 3,5-bisarylmethylene-4-piperidones as cytostatic agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6364</span>– <span class="NLM_lpage">6367</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.09.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmcl.2009.09.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19819135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWls77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6364-6367&author=D.+Youssefauthor=E.+Potterauthor=M.+Jhaauthor=E.+De+Clercqauthor=J.+Balzariniauthor=J.+P.+Stablesauthor=A.+Jha&title=Design%2C+synthesis+and+bioevaluation+of+novel+maleamic+amino+acid+ester+conjugates+of+3%2C5-bisarylmethylene-4-piperidones+as+cytostatic+agents&doi=10.1016%2Fj.bmcl.2009.09.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and bioevaluation of novel maleamic amino acid ester conjugates of 3,5-bisarylmethylene-4-piperidones as cytostatic agents</span></div><div class="casAuthors">Youssef, Dani; Potter, Elizabeth; Jha, Mamta; De Clercq, Erik; Balzarini, Jan; Stables, James P.; Jha, Amitabh</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6364-6367</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of maleamic amino acid ester conjugates of 3,5-bisarylmethylene-4-piperidones were prepd. to investigate the efficacy of micronutrient conjugation in enhancing cytotoxic potency by improving selectivity and delivery.  These compds., prepd. as anticancer agents, were expected to demonstrate enhanced selectivity towards malignant cells through the inhibition of topoisomerase IIα via protein thiolation.  The cytostatic effects of these compds. were evaluated against three cell lines, namely murine L1210 leukemia cells, human Molt 4/C8 and CEM T-lymphocyte cells.  All compds. were found to have greater potency than the ref. drug melphalan.  Several compds. were found to potently inhibit topoisomerase IIα and displayed cytostatic activity in the nanomolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJOSWaLnUE7Vg90H21EOLACvtfcHk0ljgpSvbRlXKcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWls77N&md5=5d328f1be7701e1802111ceb830acfa9</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.09.069%26sid%3Dliteratum%253Aachs%26aulast%3DYoussef%26aufirst%3DD.%26aulast%3DPotter%26aufirst%3DE.%26aulast%3DJha%26aufirst%3DM.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DJha%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520bioevaluation%2520of%2520novel%2520maleamic%2520amino%2520acid%2520ester%2520conjugates%2520of%25203%252C5-bisarylmethylene-4-piperidones%2520as%2520cytostatic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6364%26epage%3D6367%26doi%3D10.1016%2Fj.bmcl.2009.09.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbardella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedford, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4928</span>– <span class="NLM_lpage">4932</span>, <span class="refDoi"> DOI: 10.1021/jm200453n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200453n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4928-4932&author=D.+Chengauthor=S.+Valenteauthor=S.+Castellanoauthor=G.+Sbardellaauthor=R.+Di+Santoauthor=R.+Costiauthor=M.+T.+Bedfordauthor=A.+Mai&title=Novel+3%2C5-bis%28bromohydroxybenzylidene%29piperidin-4-ones+as+coactivator-associated+arginine+methyltransferase+1+inhibitors%3A+enzyme+selectivity+and+cellular+activity&doi=10.1021%2Fjm200453n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity</span></div><div class="casAuthors">Cheng, Donghang; Valente, Sergio; Castellano, Sabrina; Sbardella, Gianluca; Di Santo, Roberto; Costi, Roberta; Bedford, Mark T.; Mai, Antonello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4928-4932</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coactivator-assocd. arginine methyltransferase 1 (CARM1) represents a valuable target for hormone-dependent tumors such as prostate and breast cancers.  Here we report the enzyme and cellular characterization of the 1-benzyl-3,5-bis(3-bromo-4-hydroxybenzylidene)piperidin-4-one (7g) and its analogs 8a-l.  Among them, 7g, 8e, and 8l displayed high and selective CARM1 inhibition, with lower or no activity against a panel of different PRMTs or HKMTs.  In human LNCaP cells, 7g showed a significant dose-dependent redn. of the PSA promoter activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXv4DaWjduarVg90H21EOLACvtfcHk0ljgpSvbRlXKcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSjtrw%253D&md5=c9fba6d328440a5e41046ff0c47f661c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm200453n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200453n%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DValente%26aufirst%3DS.%26aulast%3DCastellano%26aufirst%3DS.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DBedford%26aufirst%3DM.%2BT.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DNovel%25203%252C5-bis%2528bromohydroxybenzylidene%2529piperidin-4-ones%2520as%2520coactivator-associated%2520arginine%2520methyltransferase%25201%2520inhibitors%253A%2520enzyme%2520selectivity%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4928%26epage%3D4932%26doi%3D10.1021%2Fjm200453n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhandarkar, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindarajan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fried, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span> <span> </span><span class="NLM_article-title">Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5743</span>– <span class="NLM_lpage">5748</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1078-0432.CCR-08-0405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18794083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaitrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5743-5748&author=S.+S.+Bhandarkarauthor=J.+Brombergauthor=C.+Carrilloauthor=P.+Selvakumarauthor=R.+K.+Sharmaauthor=B.+N.+Perryauthor=B.+Govindarajanauthor=L.+Friedauthor=A.+Sohnauthor=K.+Reddyauthor=J.+L.+Arbiser&title=Tris+%28dibenzylideneacetone%29+dipalladium%2C+a+N-myristoyltransferase-1+inhibitor%2C+is+effective+against+melanoma+growth+in+vitro+and+in+vivo&doi=10.1158%2F1078-0432.CCR-08-0405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Tris (Dibenzylideneacetone) Dipalladium, a N-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth In vitro and In vivo</span></div><div class="casAuthors">Bhandarkar, Sulochana S.; Bromberg, Jacqueline; Carrillo, Carol; Selvakumar, Ponniah; Sharma, Rajendra K.; Perry, Betsy N.; Govindarajan, Baskaran; Fried, Levi; Sohn, Allie; Reddy, Kalpana; Arbiser, Jack L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5743-5748</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Melanoma is a solid tumor that is notoriously resistant to chemotherapy, and its incidence is rapidly increasing.  Recently, several signaling pathways have been shown to contribute to melanoma tumorigenesis, including constitutive activation of mitogen-activated protein kinase, Akt, and Stat-3.  The activation of multiple pathways may account in part for the difficulty in treatment of melanoma.  In a recent screen of compds., we found that an organopalladium compd., Tris (dibenzylideneacetone) dipalladium (Tris DBA), showed significant antiproliferative activity against melanoma cells.  Studies were carried out to det. the mechanism of action of Tris DBA.  Exptl. Design: Tris DBA was tested on efficacy on proliferation of human and murine melanoma cells.  To find the mechanism of action of Tris DBA, we did Western blot and gene array analyses.  The ability of Tris DBA to block tumor growth in vivo was assessed.  Results: Tris DBA has activity against B16 murine and A375 human melanoma in vivo.  Tris DBA inhibits several signaling pathways including activation of mitogen-activated protein kinase, Akt, Stat-3, and S6 kinase activation, suggesting an upstream target.  Tris DBA was found to be a potent inhibitor of N-myristoyltransferase-1, which is required for optimal activity of membrane-based signaling mols.  Tris DBA showed potent antitumor activity in vivo against melanoma.  Conclusion: Tris DBA is thus a novel inhibitor of N-myristoyltransferase-1 with significant antitumor activity and is well tolerated in vivo.  Further preclin. evaluation of Tris DBA and related complexes is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS813NmxzPEbVg90H21EOLACvtfcHk0li97k0e0Lqhmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaitrrE&md5=e393b44045d4877d597ec63fff05a21a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0405%26sid%3Dliteratum%253Aachs%26aulast%3DBhandarkar%26aufirst%3DS.%2BS.%26aulast%3DBromberg%26aufirst%3DJ.%26aulast%3DCarrillo%26aufirst%3DC.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DPerry%26aufirst%3DB.%2BN.%26aulast%3DGovindarajan%26aufirst%3DB.%26aulast%3DFried%26aufirst%3DL.%26aulast%3DSohn%26aufirst%3DA.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26atitle%3DTris%2520%2528dibenzylideneacetone%2529%2520dipalladium%252C%2520a%2520N-myristoyltransferase-1%2520inhibitor%252C%2520is%2520effective%2520against%2520melanoma%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5743%26epage%3D5748%26doi%3D10.1158%2F1078-0432.CCR-08-0405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odelberg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span> <span> </span><span class="NLM_article-title">Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4424</span>– <span class="NLM_lpage">4436</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.27040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.27040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31320995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MzovVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4424-4436&author=E.+Musiauthor=G.+K.+Schwartzauthor=J.+H.+Yooauthor=S.+J.+Odelbergauthor=D.+Y.+Liauthor=M.+Y.+Bonnerauthor=P.+Selvakumarauthor=S.+Raoauthor=L.+C.+Gilbertauthor=J.+Elseyauthor=J.+L.+Arbiser&title=Tris+DBA+palladium+is+an+orally+available+inhibitor+of+GNAQ+mutant+uveal+melanoma+in+vivo&doi=10.18632%2Foncotarget.27040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo</span></div><div class="casAuthors">Musi Elgilda; Schwartz Gary K; Schwartz Gary K; Yoo Jae Hyuk; Odelberg Shannon J; Li Dean Y; Odelberg Shannon J; Odelberg Shannon J; Li Dean Y; Li Dean Y; Li Dean Y; Bonner Michael Y; Rao Shikha; Gilbert Linda C; Elsey Justin; Arbiser Jack L; Selvakumar Ponniah; Gilbert Linda C; Arbiser Jack L</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">4424-4436</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Uveal melanoma is a rare but often lethal malignancy and is the leading cause of death due to an ophthalmic condition.  Uveal melanoma is often diagnosed at a late stage and has a strong propensity to hepatic metastasis.  Recently, the most common driver mutations in uveal melanoma have been identified, predominantly in the G-proteins GNAQ.  This pattern differs from that of cutaneous melanoma in which Braf and Nras predominate.  There are no current clinically used agents that target GNAQ mutations, unlike the use of Braf inhibitors in cutaneous melanoma.  We tested the novel agent Tris DBA palladium and found that it was markedly more effective against GNAQ mutant melanomas than wild type uveal melanomas.  Given that ARF6 has recently been discovered as a node in GNAQ mutations, we evaluated the efficacy of Tris DBA palladium on ARF6 signaling and found that it was effective in inhibiting ARF6 activation.  Finally, Tris DBA palladium was orally effective against GNAQ mutant melanoma in vivo.  Tris DBA Palladium deserves further evaluation as a systemic agent for uveal melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQumEb1lWXUxmhHGZei4OW9fW6udTcc2eacf1g2C7niALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzovVKkug%253D%253D&md5=da8a4ea78d23de5e14c7b72f73975300</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.27040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.27040%26sid%3Dliteratum%253Aachs%26aulast%3DMusi%26aufirst%3DE.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DYoo%26aufirst%3DJ.%2BH.%26aulast%3DOdelberg%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DD.%2BY.%26aulast%3DBonner%26aufirst%3DM.%2BY.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DL.%2BC.%26aulast%3DElsey%26aufirst%3DJ.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26atitle%3DTris%2520DBA%2520palladium%2520is%2520an%2520orally%2520available%2520inhibitor%2520of%2520GNAQ%2520mutant%2520uveal%2520melanoma%2520in%2520vivo%26jtitle%3DOncotarget%26date%3D2019%26volume%3D10%26spage%3D4424%26epage%3D4436%26doi%3D10.18632%2Foncotarget.27040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostapoff, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toombs, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curatolo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adsay, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span> <span> </span><span class="NLM_article-title">Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">51569</span>– <span class="NLM_lpage">51580</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.10514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.10514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27438140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2s3is1aqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=51569-51580&author=B.+Diazauthor=K.+T.+Ostapoffauthor=J.+E.+Toombsauthor=J.+Loauthor=M.+Y.+Bonnerauthor=A.+Curatoloauthor=V.+Adsayauthor=R.+A.+Brekkenauthor=J.+L.+Arbiser&title=Tris+DBA+palladium+is+highly+effective+against+growth+and+metastasis+of+pancreatic+cancer+in+an+orthotopic+model&doi=10.18632%2Foncotarget.10514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model</span></div><div class="casAuthors">Diaz Begona; Diaz Begona; Ostapoff Katherine T; Toombs Jason E; Brekken Rolf A; Ostapoff Katherine T; Toombs Jason E; Brekken Rolf A; Lo Jason; Bonner Michael Y; Arbiser Jack L; Lo Jason; Bonner Michael Y; Arbiser Jack L; Lo Jason; Bonner Michael Y; Arbiser Jack L; Curatolo Adam; Curatolo Adam; Adsay Volkan</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">51569-51580</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic carcinoma ranks among the most lethal of human cancers.  Besides late detection, other factors contribute to its lethality, including a high degree of chemoresistance, invasion, and distant metastases.  Currently, the mainstay of therapy involves resection of local disease in a minority of patients (Whipple procedure) and systemic gemcitabine.  While systemic chemotherapy has some benefit, even with optimal treatment, the five year survival after diagnosis is dismal.  Thus, treatment of pancreatic carcinoma remains a tremendous unmet need.The organometallic compound tris DBA palladium is a potent inhibitor of N-myristoyltransferase 1 (NMT1), an enzyme that catalyzes the transfer of myristate to protein substrates.  This compound is highly effective in vivo against murine models of melanoma with both mutant and wild type b-RAF genotypes.  Based upon the signaling similarities between melanoma and pancreatic carcinoma, we evaluated the efficacy of tris DBA palladium in vitro and in vivo against pancreatic carcinoma.  We found that tris DBA palladium decreased proliferation and colony formation of pancreatic cancer cells in vitro.  In an orthotopic mouse model, tris DBA palladium was highly active in inhibiting growth, ascites production, and distant metastases in vivo.  Furthermore, tris DBA palladium impaired chemotaxis and inhibited cilia formation in Pan02 cells in a NMT1-dependent manner.  We propose that NMT1 is a novel regulator of cilia formation and tris DBA palladium a novel inhibitor of cilia formation and metastasis in pancreatic cancer.  Thus, further evaluation of tris DBA palladium for the treatment of pancreatic cancer is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ7qJwwlmPjyK__Jf7-eMvJfW6udTcc2eacf1g2C7niALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3is1aqsg%253D%253D&md5=fef3d3bd0e00d1335c78427a22da4dbd</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.10514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.10514%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DB.%26aulast%3DOstapoff%26aufirst%3DK.%2BT.%26aulast%3DToombs%26aufirst%3DJ.%2BE.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DBonner%26aufirst%3DM.%2BY.%26aulast%3DCuratolo%26aufirst%3DA.%26aulast%3DAdsay%26aufirst%3DV.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26atitle%3DTris%2520DBA%2520palladium%2520is%2520highly%2520effective%2520against%2520growth%2520and%2520metastasis%2520of%2520pancreatic%2520cancer%2520in%2520an%2520orthotopic%2520model%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D51569%26epage%3D51580%26doi%3D10.18632%2Foncotarget.10514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of specificity protein 1 by dibenzylideneacetone, a curcumin analogue, induces apoptosis in mucoepidermoid carcinomas and tumor xenografts through Bim and truncated Bid</span>. <i>Oral Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.oraloncology.2013.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.oraloncology.2013.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24309154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2ntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=189-195&author=H.+E.+Leeauthor=E.+S.+Choiauthor=J.+Y.+Jungauthor=M.+J.+Youauthor=L.+H.+Kimauthor=S.+D.+Cho&title=Inhibition+of+specificity+protein+1+by+dibenzylideneacetone%2C+a+curcumin+analogue%2C+induces+apoptosis+in+mucoepidermoid+carcinomas+and+tumor+xenografts+through+Bim+and+truncated+Bid&doi=10.1016%2Fj.oraloncology.2013.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of specificity protein 1 by dibenzylideneacetone, a curcumin analogue, induces apoptosis in mucoepidermoid carcinomas and tumor xenografts through Bim and truncated Bid</span></div><div class="casAuthors">Lee, Heang-Eun; Choi, Eun-Sun; Jung, Ji-Youn; You, Myung-Jo; Kim, Lee-Han; Cho, Sung-Dae</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-195</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Dibenzylideneacetone (DBA), a curcumin analog that has anti-cancer activity in a variety of tumor cells.  In this study, we investigated the apoptotic effects of DBA and its mol. mechanism in human mucoepidermoid carcinoma (MEC) cell lines and tumor xenografts.  The apoptotic effects and related mol. mechanisms of DBA on MEC cell lines were evaluated using cell viability assay, DAPI staining, Western blot anal., reverse transcriptase-polymerase chain reaction (RT-PCR) and Dual-luciferase Reporter Assay.  The anti-tumor activity using in vivo were detd. by Nude mouse xenograft assay and histopathol. examn.  DBA decreased cell viability and induced apoptosis in MEC cells.  These events were accompanied by inhibition of specificity protein 1 (Sp1).  DBA did not induce major changes in Sp1 mRNA and promoter activity.  Furthermore, inhibition of protein synthesis by cycloheximide demonstrated that DBA decreased Sp1 protein stability, but DBA did not attenuate phosphorylation of eIF4E.  DBA also increased Bim and truncated Bid (t-Bid) via Sp1.  Finally, DBA exhibited significant anti-tumor activity in athymic nude mice xenografts bearing MC-3 cells by regulating Sp1, Bim and t-Bid without any systemic toxicity.  These results elucidate a crucial apoptotic mechanism of DBA and suggest that DBA may be a potent anticancer drug candidate for MEC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaTBRJEKNNn7Vg90H21EOLACvtfcHk0lgk_5UTcCkyqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2ntr0%253D&md5=59518d169d80b36a598833d623877654</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2013.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2013.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DChoi%26aufirst%3DE.%2BS.%26aulast%3DJung%26aufirst%3DJ.%2BY.%26aulast%3DYou%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DL.%2BH.%26aulast%3DCho%26aufirst%3DS.%2BD.%26atitle%3DInhibition%2520of%2520specificity%2520protein%25201%2520by%2520dibenzylideneacetone%252C%2520a%2520curcumin%2520analogue%252C%2520induces%2520apoptosis%2520in%2520mucoepidermoid%2520carcinomas%2520and%2520tumor%2520xenografts%2520through%2520Bim%2520and%2520truncated%2520Bid%26jtitle%3DOral%2520Oncol.%26date%3D2014%26volume%3D50%26spage%3D189%26epage%3D195%26doi%3D10.1016%2Fj.oraloncology.2013.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quincoces
Suarez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rando, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Carvalho, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maria, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiao-Flores, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcucci, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, C.</span></span> <span> </span><span class="NLM_article-title">New antitumoral agents I: in vitro anticancer activity and in vivo acute toxicity of synthetic 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one and derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6275</span>– <span class="NLM_lpage">6281</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2010.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20696583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC3cjnslSguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6275-6281&author=J.+A.+Quincoces%0ASuarezauthor=D.+G.+Randoauthor=R.+P.+Santosauthor=C.+P.+Goncalvesauthor=E.+Ferreiraauthor=J.+E.+de+Carvalhoauthor=L.+Kohnauthor=D.+A.+Mariaauthor=F.+Faiao-Floresauthor=D.+Michalikauthor=M.+C.+Marcucciauthor=C.+Vogel&title=New+antitumoral+agents+I%3A+in+vitro+anticancer+activity+and+in+vivo+acute+toxicity+of+synthetic+1%2C5-bis%284-hydroxy-3-methoxyphenyl%29-1%2C4-pentadien-3-one+and+derivatives&doi=10.1016%2Fj.bmc.2010.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">New antitumoral agents I: In vitro anticancer activity and in vivo acute toxicity of synthetic 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one and derivatives</span></div><div class="casAuthors">Quincoces Suarez Jose Agustin; Rando Daniela Goncales; Santos Reginaldo Pereira; Goncalves Carolina Passarelli; Ferreira Elizabeth; de Carvalho Joao Ernesto; Kohn Luciana; Maria Durvanei Augusto; Faiao-Flores Fernanda; Michalik Dirk; Marcucci Maria Cristina; Vogel Christian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6275-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This paper describes a new method for the preparation of 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one 1 and its derivatives 2-5.  This set of synthetic compounds exhibited high antitumoral activities regarding in vitro screening against several human tumor cell lines as lung carcinoma NCI-460, melanoma UACC-62, breast MCF-7, colon HT-29, renal 786-O, ovarian OVCAR-03 and ovarian expressing the resistance phenotype for adriamycin NCI-ADR/RES, prostate PC-3, and leukemia K-562.  Compounds were also tested against murine tumor cell line B16F10 melanoma and lymphocytic leukemia L1210 as well as to their effect toward normal macrophages.  Specific activity against colon cancer cells HT-29 was observed for all tested compounds and suggests further studies with models of colon cancer.  Compounds 1, 2, and 4 showed significant cytotoxic activity with IC(50) values 2.3 microM for all human cancer cell lines.  Intraperitoneal acute administration of compound 1 and 2 showed very low toxicity rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrRg8-SzzmV36oPH0mYWL1fW6udTcc2eZTaulMYTBK7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjnslSguw%253D%253D&md5=f642669c075a2eed33fe4557478e3f28</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DQuincoces%2BSuarez%26aufirst%3DJ.%2BA.%26aulast%3DRando%26aufirst%3DD.%2BG.%26aulast%3DSantos%26aufirst%3DR.%2BP.%26aulast%3DGoncalves%26aufirst%3DC.%2BP.%26aulast%3DFerreira%26aufirst%3DE.%26aulast%3Dde%2BCarvalho%26aufirst%3DJ.%2BE.%26aulast%3DKohn%26aufirst%3DL.%26aulast%3DMaria%26aufirst%3DD.%2BA.%26aulast%3DFaiao-Flores%26aufirst%3DF.%26aulast%3DMichalik%26aufirst%3DD.%26aulast%3DMarcucci%26aufirst%3DM.%2BC.%26aulast%3DVogel%26aufirst%3DC.%26atitle%3DNew%2520antitumoral%2520agents%2520I%253A%2520in%2520vitro%2520anticancer%2520activity%2520and%2520in%2520vivo%2520acute%2520toxicity%2520of%2520synthetic%25201%252C5-bis%25284-hydroxy-3-methoxyphenyl%2529-1%252C4-pentadien-3-one%2520and%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6275%26epage%3D6281%26doi%3D10.1016%2Fj.bmc.2010.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release in LPS-stimulated RAW 264.7 macrophages</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2388</span>– <span class="NLM_lpage">2393</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmc.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20338767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVejsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2388-2393&author=C.+Zhaoauthor=J.+Yangauthor=Y.+Wangauthor=D.+Liangauthor=X.+Yangauthor=X.+Liauthor=J.+Wuauthor=X.+Wuauthor=S.+Yangauthor=X.+Liauthor=G.+Liang&title=Synthesis+of+mono-carbonyl+analogues+of+curcumin+and+their+effects+on+inhibition+of+cytokine+release+in+LPS-stimulated+RAW+264.7+macrophages&doi=10.1016%2Fj.bmc.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release in LPS-stimulated RAW 264.7 macrophages</span></div><div class="casAuthors">Zhao, Chengguang; Yang, Ju; Wang, Yi; Liang, Donglou; Yang, Xuyi; Li, Xiaoxia; Wu, Jianzhang; Wu, Xiaoping; Yang, Shulin; Li, Xiaokun; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2393</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Curcumin has been reported to possess multifunctional bioactivities, esp. the ability to inhibit proinflammatory induction.  We previously demonstrated that the mono-carbonyl analogs of curcumin possessed improved pharmacokinetic profiles both in vitro and in vivo.  In this study, we synthesized and examd. a series of 5-carbon linker-contg. mono-carbonyl analogs of curcumin with potent inhibitory activities against TNF-α and IL-6 release in LPS-stimulated RAW 264.7 macrophages.  Discussion and conclusions are given regarding structure-activity relationships (SAR).  The two most potent analogs among the tested compds., B75 (I) and C12, exhibited anti-inflammatory abilities in a dose-dependent manner in macrophages.  This raises the possibility that mono-carbonyl analogs of curcumin might serve as potential agents for the treatment of various inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojJR6qc-UbgbVg90H21EOLACvtfcHk0lgkVs7Jkxt7ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVejsL4%253D&md5=f5e8b1c3e63ba5b6c3d6881b60775b65</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520mono-carbonyl%2520analogues%2520of%2520curcumin%2520and%2520their%2520effects%2520on%2520inhibition%2520of%2520cytokine%2520release%2520in%2520LPS-stimulated%2520RAW%2520264.7%2520macrophages%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2388%26epage%3D2393%26doi%3D10.1016%2Fj.bmc.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e24377</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0024377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0024377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21931698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Chsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=Y.+Wangauthor=C.+Yuauthor=Y.+Panauthor=J.+Liauthor=Y.+Zhangauthor=F.+Yeauthor=S.+Yangauthor=H.+Zhangauthor=X.+Liauthor=G.+Liang&title=A+novel+compound+C12+inhibits+inflammatory+cytokine+production+and+protects+from+inflammatory+injury+in+vivo&doi=10.1371%2Fjournal.pone.0024377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo</span></div><div class="casAuthors">Wang, Yi; Yu, Congcong; Pan, Yong; Li, Jianling; Zhang, Yali; Ye, Faqing; Yang, Shulin; Zhang, Hui; Li, Xiaokun; Liang, Guang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e24377</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inflammation is a hallmark of many diseases.  Although steroids and cyclooxygenase inhibitors are main anti-inflammatory therapeutical agents, they may cause serious side effects.  Therefore, developing non-steroid anti-inflammatory agents is urgently needed.  A novel hydrosol. compd., C12 (2,6-bis(4-(3-(dimethylamino)-propoxy)benzylidene)cyclohexanone), was designed and synthesized as an anti-inflammatory agent in our previous study.  In the present study, we investigated whether C12 can affect inflammatory processes in vitro and in vivo.  In mouse primary peritoneal macrophages, C12 potently inhibited the prodn. of the proinflammatory gene expression including TNF-α, IL-1β, IL-6, iNOS, COX-2 and PGE synthase.  The activity of C12 was partly dependent on inhibition of ERK/JNK (but p38) phosphorylation and NF-κB activation.  In vivo, C12 suppressed proinflammatory cytokine prodn. in plasma and liver, attenuated lung histopathol., and significantly reduced mortality in endotoxemic mice.  In addn., the pre-treatment with C12 reduced the inflammatory pain in the acetic acid and formalin models and reduced the carrageenan-induced paw edema and acetic acid-increased vascular permeability.  Taken together, C12 has multiple anti-inflammatory effects.  These findings, coupled with the low toxicity and hydrosoly. of C12, suggests that this agent may be useful in the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWiApK5tea2rVg90H21EOLACvtfcHk0lgkVs7Jkxt7ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Chsb3O&md5=95f809e6ce08c48f7037cefd93739b15</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0024377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0024377%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DA%2520novel%2520compound%2520C12%2520inhibits%2520inflammatory%2520cytokine%2520production%2520and%2520protects%2520from%2520inflammatory%2520injury%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0024377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, V.</span></span> <span> </span><span class="NLM_article-title">EF24 suppresses maturation and inflammatory response in dendritic cells</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxr121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Fintimm%2Fdxr121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22378503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVOjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=455-464&author=P.+Vilekarauthor=S.+Awasthiauthor=A.+Natarajanauthor=S.+Anantauthor=V.+Awasthi&title=EF24+suppresses+maturation+and+inflammatory+response+in+dendritic+cells&doi=10.1093%2Fintimm%2Fdxr121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">EF24 suppresses maturation and inflammatory response in dendritic cells</span></div><div class="casAuthors">Vilekar, Prachi; Awasthi, Shanjana; Natarajan, Aravindan; Anant, Shrikant; Awasthi, Vibhudutta</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">455-464</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Synthetic curcuminoid EF24 was studied for its effect on the maturation and inflammatory response in murine bone marrow derived immortalized JAWS II dendritic cells (DCs).  EF24 reduced the expression of LPS-induced MHC class II, CD80 and CD86 mols.  It also abrogated the appearance of dendrites, a typical characteristic of mature DCs.  These effects were accompanied by the inhibition of LPS-induced activation of transcription factor nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB).  Simultaneous redn. of pro-inflammatory cytokines [tumor necrosis factor (TNF)-α, IL-6] both at the mRNA and secreted levels was also obsd.  To investigate the dependency of LPS effects on MyD88 adaptor protein, we transfected JAWS II DCs with dominant neg. MyD88 plasmid construct (MyD88-DN).  EF24 reduced NF-κB activity and TNF-α secretion in a MyD88-dependent manner.  These results suggest that EF24 modulates DCs by suppressing their maturation and reducing the secretion of inflammatory cytokines.  Further, it appears that EF24 acts at or upstream of MyD88 in the LPS-TLR4/MyD88/NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOODrr-Fy32LVg90H21EOLACvtfcHk0lgkVs7Jkxt7ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVOjs7o%253D&md5=ad3fb49bc2333d3004432abe80d71546</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxr121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxr121%26sid%3Dliteratum%253Aachs%26aulast%3DVilekar%26aufirst%3DP.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DNatarajan%26aufirst%3DA.%26aulast%3DAnant%26aufirst%3DS.%26aulast%3DAwasthi%26aufirst%3DV.%26atitle%3DEF24%2520suppresses%2520maturation%2520and%2520inflammatory%2520response%2520in%2520dendritic%2520cells%26jtitle%3DInt.%2520Immunol.%26date%3D2012%26volume%3D24%26spage%3D455%26epage%3D464%26doi%3D10.1093%2Fintimm%2Fdxr121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, V.</span></span> <span> </span><span class="NLM_article-title">Diphenyldifluoroketone EF24 suppresses pro-inflammatory interleukin-1 receptor 1 and toll-like receptor 4 in lipopolysaccharide-stimulated dendritic cells</span>. <i>J. Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">55</span>, <span class="refDoi"> DOI: 10.1186/s12950-015-0096-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2Fs12950-015-0096-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtFKitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=55&author=P.+Vilekarauthor=G.+Raoauthor=S.+Awasthiauthor=V.+Awasthi&title=Diphenyldifluoroketone+EF24+suppresses+pro-inflammatory+interleukin-1+receptor+1+and+toll-like+receptor+4+in+lipopolysaccharide-stimulated+dendritic+cells&doi=10.1186%2Fs12950-015-0096-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Diphenyldifluoroketone EF24 suppresses pro-inflammatory interleukin-1 receptor 1 and toll-like receptor 4 in lipopolysaccharidestimulated dendritic cells</span></div><div class="casAuthors">Vilekar, Prachi; Rao, Geeta; Awasthi, Shanjana; Awasthi, Vibhudutta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inflammation (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55/1-55/11</span>CODEN:
                <span class="NLM_cas:coden">JILUAY</span>;
        ISSN:<span class="NLM_cas:issn">1476-9255</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Unresolved and prolonged inflammation is a pathol. basis of many disorders such as cancer and multiple organ failure in shock.  Interleukin-1 receptor (IL-1R) superfamily consists of IL-1R1 and pathogen pattern recognition receptor toll-like receptor-4 (TLR4) which, upon ligand binding, initiate pro-inflammatory signaling.  The study objective was to investigate the effect of a diphenyldifluoroketone EF24 on the expression of IL-1R1 and TLR4 in lipopolysaccharide (LPS)-stimulated dendritic cells (DCs).  Methods: Immortalized murine bone marrow-derived JAWS II dendritic cells (DC) were challenged with LPS (100 ng/mL) for 4 h.  The LPS-stimulated DCs were treated with 10 μM of EF24 for 1 h.  The expression levels of IL-1R1 and TLR4 were monitored by RT-PCR, immunoblotting, and confocal microscopy.  The effect of EF24 on the viability and cell cycle of DCs was examd. by lactate dehydrogenase assay and flow cytometry, resp.  Results: EF24 treatment suppressed the LPS-induced TLR4 and IL-1R1 expression in DCs.  However, the expression levels of IL-1RA and IL-1R2 were not influenced by either LPS or EF24 treatments.  These effects of EF24 were assocd. with a decrease in LPS-induced expression of phospho-NF-κB p65, indicative of its role in the transcriptional control of IL-1R superfamily members.  We did not find any significant effect of EF24 on the proliferation or cell cycle of DCs.  Conclusions: The results suggest that EF24 influences IL-1R superfamily signaling pathway in ways that could have salutary effects in inflammation.  The pluripotent anti-inflammatory actions of EF24 warrant further investigation of EF24 in inflammatory conditions of systemic nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC3TgDcl_eR7Vg90H21EOLACvtfcHk0lgkVs7Jkxt7ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtFKitrY%253D&md5=5d3b6f2e98c7e098e579b8765aab8d3f</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2Fs12950-015-0096-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12950-015-0096-x%26sid%3Dliteratum%253Aachs%26aulast%3DVilekar%26aufirst%3DP.%26aulast%3DRao%26aufirst%3DG.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DAwasthi%26aufirst%3DV.%26atitle%3DDiphenyldifluoroketone%2520EF24%2520suppresses%2520pro-inflammatory%2520interleukin-1%2520receptor%25201%2520and%2520toll-like%2520receptor%25204%2520in%2520lipopolysaccharide-stimulated%2520dendritic%2520cells%26jtitle%3DJ.%2520Inflammation%26date%3D2015%26volume%3D12%26spage%3D55%26doi%3D10.1186%2Fs12950-015-0096-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idris, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamarulzaman, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahab, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassan, M. Z.</span></span> <span> </span><span class="NLM_article-title">3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">484</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2017.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.apsb.2017.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28752033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1cfhvFOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=479-484&author=H.+Osmanauthor=N.+H.+Idrisauthor=E.+E.+Kamarulzamanauthor=H.+A.+Wahabauthor=M.+Z.+Hassan&title=3%2C5-Bis%28arylidene%29-4-piperidones+as+potential+dengue+protease+inhibitors&doi=10.1016%2Fj.apsb.2017.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors</span></div><div class="casAuthors">Osman Hasnah; Idris Nor Hashima; Hassan Mohd Zaheen; Kamarulzaman Ezatul Ezleen; Wahab Habibah A</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">479-484</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Dengue is a severe mosquito-borne viral infection causing half a million deaths annually.  Dengue virus NS2B/NS3 protease is a validated target for anti-dengue drug design.  A series of hitherto unreported 3,5-bis(arylidene)-4-piperidones analogues 4a-4j were synthesized and screened in silico against DENV2 NS2B/NS3 protease to elucidate their binding mechanism and orientation around the active sites.  Results were validated through an in vitro DENV2 NS2B/NS3 protease assay using a fluorogenic Boc-Gly-Arg-Arg-AMC substrate.  Nitro derivatives of 3,5-bis(arylidene)-4-piperidones (4e and 4j) emerged as promising lead molecules for novel protease inhibitors with an IC50 of 15.22 and 16.23 μmol/L, respectively, compared to the standard, panduratin A, having IC50 of 57.28 μmol/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBDiKJz4VBhtNTrvPZP1IpfW6udTcc2eaN9NG55ne1Krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfhvFOgtw%253D%253D&md5=c642b052a855ab3ea775e2fc0944ce73</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2017.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2017.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DOsman%26aufirst%3DH.%26aulast%3DIdris%26aufirst%3DN.%2BH.%26aulast%3DKamarulzaman%26aufirst%3DE.%2BE.%26aulast%3DWahab%26aufirst%3DH.%2BA.%26aulast%3DHassan%26aufirst%3DM.%2BZ.%26atitle%3D3%252C5-Bis%2528arylidene%2529-4-piperidones%2520as%2520potential%2520dengue%2520protease%2520inhibitors%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2017%26volume%3D7%26spage%3D479%26epage%3D484%26doi%3D10.1016%2Fj.apsb.2017.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aher, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanare, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawathekar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushik, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, V. S.</span></span> <span> </span><span class="NLM_article-title">Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3034</span>– <span class="NLM_lpage">3036</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmcl.2011.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21493068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3034-3036&author=R.+B.+Aherauthor=G.+Wanareauthor=N.+Kawathekarauthor=R.+R.+Kumarauthor=N.+K.+Kaushikauthor=D.+Sahalauthor=V.+S.+Chauhan&title=Dibenzylideneacetone+analogues+as+novel+Plasmodium+falciparum+inhibitors&doi=10.1016%2Fj.bmcl.2011.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors</span></div><div class="casAuthors">Aher, Rahul Balasaheb; Wanare, Gajanan; Kawathekar, Neha; Kumar, Ravi Ranjan; Kaushik, Naveen Kumar; Sahal, Dinkar; Chauhan, Virander Singh</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3034-3036</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of dibenzylideneacetones and some of their pyrazolines were synthesized and evaluated in vitro for blood stage antiplasmodial properties in Plasmodium falciparum culture using SYBR-green-I fluorescence assay.  The compd. I was found to be the most active with IC50 of 1.97 μM against chloroquine-sensitive strain (3D7) and 1.69 μM against chloroquine-resistant field isolate (RKL9).  The MTT based cytotoxicity assay on HeLa cell line has confirmed that I is selective in its action against malaria parasite (with a therapeutic index of 166).  Our results revealed that these compds. exhibited promising antiplasmodial activities which can be further explored as potential leads for the development of cheaper, safe, effective and potent drugs against chloroquine-resistant malarial parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2XOYPTrGFNrVg90H21EOLACvtfcHk0lgEWi5GdDs9Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVCmurc%253D&md5=64a042dd847a7b8ea4a983004373078e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DAher%26aufirst%3DR.%2BB.%26aulast%3DWanare%26aufirst%3DG.%26aulast%3DKawathekar%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DR.%2BR.%26aulast%3DKaushik%26aufirst%3DN.%2BK.%26aulast%3DSahal%26aufirst%3DD.%26aulast%3DChauhan%26aufirst%3DV.%2BS.%26atitle%3DDibenzylideneacetone%2520analogues%2520as%2520novel%2520Plasmodium%2520falciparum%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3034%26epage%3D3036%26doi%3D10.1016%2Fj.bmcl.2011.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delahunty, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz-Wolf, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahlfs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helena Prieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span> <span> </span><span class="NLM_article-title">Characterization of the 26S proteasome network in Plasmodium falciparum</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">17818</span>, <span class="refDoi"> DOI: 10.1038/srep17818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fsrep17818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26639022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKit77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17818&author=L.+Wangauthor=C.+Delahuntyauthor=K.+Fritz-Wolfauthor=S.+Rahlfsauthor=J.+Helena+Prietoauthor=J.+R.+Yatesauthor=K.+Becker&title=Characterization+of+the+26S+proteasome+network+in+Plasmodium+falciparum&doi=10.1038%2Fsrep17818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the 26S proteasome network in Plasmodium falciparum</span></div><div class="casAuthors">Wang, Lihui; Delahunty, Claire; Fritz-Wolf, Karin; Rahlfs, Stefan; Helena Prieto, Judith; Yates, John R.; Becker, Katja</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17818</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In eukaryotic cells, the ubiquitin-proteasome system as a key regulator of protein quality control is an excellent drug target.  The authors analyzed the 26S proteasome complex in the malaria parasite Plasmodium falciparum, which still threatens almost half of the world's population.  First, they established an affinity purifn. protocol allowing for the isolation of functional 26S proteasome complexes from the parasite.  Subunit compn. of the proteasome and component stoichiometry were studied and physiol. interacting partners were identified via in situ protein crosslinking.  Intrinsic ubiquitin receptors of the plasmodial proteasome were detd., and their roles in proteasomal substrate recognition were analyzed.  Notably, PfUSP14 was characterized as a proteasome-assocd. deubiquitinase resulting in the concept that targeting proteasomal deubiquitinating activity in P. falciparum may represent a promising antimalarial strategy.  The data provide insights into a profound network orchestrated by the plasmodial proteasome and identified novel drug target candidates in the ubiquitin-proteasome system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow51eGPR1PZ7Vg90H21EOLACvtfcHk0lgEWi5GdDs9Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKit77N&md5=00d1c9908395d76ab0d3da89530829ea</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fsrep17818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17818%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDelahunty%26aufirst%3DC.%26aulast%3DFritz-Wolf%26aufirst%3DK.%26aulast%3DRahlfs%26aufirst%3DS.%26aulast%3DHelena%2BPrieto%26aufirst%3DJ.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DBecker%26aufirst%3DK.%26atitle%3DCharacterization%2520of%2520the%252026S%2520proteasome%2520network%2520in%2520Plasmodium%2520falciparum%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17818%26doi%3D10.1038%2Fsrep17818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, L. K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapadia, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of Leishmaniasis: in-vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani</span>. <i>Parasitol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1016/j.parint.2018.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.parint.2018.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29913255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2jtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2018&pages=627-636&author=I.+S.+Chauhanauthor=G.+S.+Raoauthor=J.+Shankarauthor=L.+K.+S.+Chauhanauthor=G.+J.+Kapadiaauthor=N.+Singh&title=Chemoprevention+of+Leishmaniasis%3A+in-vitro+antiparasitic+activity+of+dibenzalacetone%2C+a+synthetic+curcumin+analog+leads+to+apoptotic+cell+death+in+Leishmania+donovani&doi=10.1016%2Fj.parint.2018.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of Leishmaniasis: In-vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani</span></div><div class="casAuthors">Chauhan, Indira Singh; Rao, G. Subba; Shankar, Jai; Chauhan, Lalit Kumar Singh; Kapadia, Govind J.; Singh, Neeloo</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology International</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">627-636</span>CODEN:
                <span class="NLM_cas:coden">PAINFD</span>;
        ISSN:<span class="NLM_cas:issn">1383-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Curcumin is the major phenolic compd. found in turmeric, a dry powder of rhizomes and roots of the plant, Curcuma longa L., which is widely used as spice and food colorant around the world, and in herbal medicinal practice in Asian countries.  The present study reports the leishmanicidal activity of trans-dibenzalacetone (DBA), a synthetic monoketone analog of curcumin, against Leishmania donovani parasites.  We for the first time report the antiproliferative effect of a curcumin analog (DBA) on the intracellular amastigotes of L. donovani, the clin. more relevant stage of the parasite than its promastigotes stage.  The leishmanicidal effect of DBA was further confirmed by scanning and transmission electron microscopies.  Cell growth was arrested in G0/G1 phase with increased concn. of cytosolic calcium and dissipation of mitochondrial membrane potential.  Further, the unique trypanothione/trypanothione reductase (TR) system of Leishmania cells was significantly inhibited by DBA.  This economically synthesizable simple monoketone analog of curcumin has the potential for field use against visceral leishmaniasis which is currently widespread in tropical and subtropical developing countries of the world.  In conclusion, we have identified an analog of curcumin for potential applications against leishmaniasis, based on its strong antiparasitic activity and low toxicity.  This curcumin analog compares favorably, at least in vitro, with the existing medication miltefosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiGVUI5Dns5bVg90H21EOLACvtfcHk0ljU7OK7evdOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2jtr3F&md5=a35eb7027671c587f81f081400303c4d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.parint.2018.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parint.2018.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DI.%2BS.%26aulast%3DRao%26aufirst%3DG.%2BS.%26aulast%3DShankar%26aufirst%3DJ.%26aulast%3DChauhan%26aufirst%3DL.%2BK.%2BS.%26aulast%3DKapadia%26aufirst%3DG.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DChemoprevention%2520of%2520Leishmaniasis%253A%2520in-vitro%2520antiparasitic%2520activity%2520of%2520dibenzalacetone%252C%2520a%2520synthetic%2520curcumin%2520analog%2520leads%2520to%2520apoptotic%2520cell%2520death%2520in%2520Leishmania%2520donovani%26jtitle%3DParasitol.%2520Int.%26date%3D2018%26volume%3D67%26spage%3D627%26epage%3D636%26doi%3D10.1016%2Fj.parint.2018.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span> <span> </span><span class="NLM_article-title">Chemistry: Chemical con artists foil drug discovery</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1038/513481a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2F513481a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25254460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=481-483&author=J.+Baellauthor=M.+A.+Walters&title=Chemistry%3A+Chemical+con+artists+foil+drug+discovery&doi=10.1038%2F513481a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry: Chemical con artists foil drug discovery</span></div><div class="casAuthors">Baell, Jonathan; Walters, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7519</span>),
    <span class="NLM_cas:pages">481-483</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Naivety about promiscuous, assay-duping mols. is polluting the literature and wasting resources, warn Jonathan Baell and Michael A. Walters.  Academic drug discoverers must be more vigilant.  Mols. that show the strongest activity in screening might not be the best starting points for drugs.  PAINS hits should almost always be ignored.  Even trained medicinal chemists have to be careful until they become experienced in screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJFYQ0B4VVoLVg90H21EOLACvtfcHk0ljU7OK7evdOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsL7M&md5=f5788d81d006460c688e4b78e6200503</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2F513481a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F513481a%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26atitle%3DChemistry%253A%2520Chemical%2520con%2520artists%2520foil%2520drug%2520discovery%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D481%26epage%3D483%26doi%3D10.1038%2F513481a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span> <span> </span><span class="NLM_article-title">Badapple: promiscuity patterns from noisy evidence</span>. <i>J. Cheminf.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">29</span>, <span class="refDoi"> DOI: 10.1186/s13321-016-0137-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2Fs13321-016-0137-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=29&author=J.+J.+Yangauthor=O.+Ursuauthor=C.+A.+Lipinskiauthor=L.+A.+Sklarauthor=T.+I.+Opreaauthor=C.+G.+Bologa&title=Badapple%3A+promiscuity+patterns+from+noisy+evidence&doi=10.1186%2Fs13321-016-0137-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1186%2Fs13321-016-0137-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13321-016-0137-3%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%2BJ.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DSklar%26aufirst%3DL.%2BA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26atitle%3DBadapple%253A%2520promiscuity%2520patterns%2520from%2520noisy%2520evidence%26jtitle%3DJ.%2520Cheminf.%26date%3D2016%26volume%3D8%26spage%3D29%26doi%3D10.1186%2Fs13321-016-0137-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallavialle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Jouira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domdom, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohanna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartare-Deckert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckert, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the proteasome-associated deubiquitinating enzyme USP14 impairs melanoma cell survival and overcomes resistance to MAPK-targeting therapies</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">1429</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1535-7163.MCT-17-0919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29703842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1alurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1416-1429&author=R.+Didierauthor=A.+Mallavialleauthor=R.+Ben+Jouiraauthor=M.+A.+Domdomauthor=M.+Tichetauthor=P.+Aubergerauthor=F.+Lucianoauthor=M.+Ohannaauthor=S.+Tartare-Deckertauthor=M.+Deckert&title=Targeting+the+proteasome-associated+deubiquitinating+enzyme+USP14+impairs+melanoma+cell+survival+and+overcomes+resistance+to+MAPK-targeting+therapies&doi=10.1158%2F1535-7163.MCT-17-0919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies</span></div><div class="casAuthors">Didier, Robin; Mallavialle, Aude; Ben Jouira, Rania; Domdom, Marie Angela; Tichet, Melanie; Auberger, Patrick; Luciano, Freedeeeric; Ohanna, Mickael; Tartare-Deckert, Sophie; Deckert, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1416-1429</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Advanced cutaneous melanoma is one of the most challenging cancers to treat because of its high plasticity, metastatic potential, and resistance to treatment.  New targeted therapies and immunotherapies have shown remarkable clin. efficacy.  However, such treatments are limited to a subset of patients and relapses often occur, warranting validation of novel targeted therapies.  Posttranslational modification of proteins by ubiquitin coordinates essential cellular functions, including ubiquitin-proteasome system (UPS) function and protein homeostasis.  Deubiquitinating enzymes (DUB) have been assocd. to multiple diseases, including cancer.  However, their exact involvement in melanoma development and therapeutic resistance remains poorly understood.  Using a DUB trap assay to label cellular active DUBs, we have obsd. an increased activity of the proteasome-assocd. DUB, USP14 (Ubiquitin-specific peptidase 14) in melanoma cells compared with melanocytes.  Our survey of public gene expression databases indicates that high expression of USP14 correlates with melanoma progression and with a poorer survival rate in metastatic melanoma patients.  Knockdown or pharmacol. inhibition of USP14 dramatically impairs viability of melanoma cells irresp. of the mutational status of BRAF, NRAS, or TP53 and their transcriptional cell state, and overcomes resistance to MAPK-targeting therapies both in vitro and in human melanoma xenografted mice.  At the mol. level, we find that inhibition of USP14 rapidly triggers accumulation of poly-ubiquitinated proteins and chaperones, mitochondrial dysfunction, ER stress, and a ROS prodn. leading to a caspase-independent cell death.  Our results provide a rationale for targeting the proteasome-assocd. DUB USP14 to treat and combat melanomas.  Mol Cancer Ther; 17(7); 1416-29. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeAleNrhGtbVg90H21EOLACvtfcHk0ljU7OK7evdOug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1alurzO&md5=0895514d6c4458a743025a6c8ecc7fb4</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0919%26sid%3Dliteratum%253Aachs%26aulast%3DDidier%26aufirst%3DR.%26aulast%3DMallavialle%26aufirst%3DA.%26aulast%3DBen%2BJouira%26aufirst%3DR.%26aulast%3DDomdom%26aufirst%3DM.%2BA.%26aulast%3DTichet%26aufirst%3DM.%26aulast%3DAuberger%26aufirst%3DP.%26aulast%3DLuciano%26aufirst%3DF.%26aulast%3DOhanna%26aufirst%3DM.%26aulast%3DTartare-Deckert%26aufirst%3DS.%26aulast%3DDeckert%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520proteasome-associated%2520deubiquitinating%2520enzyme%2520USP14%2520impairs%2520melanoma%2520cell%2520survival%2520and%2520overcomes%2520resistance%2520to%2520MAPK-targeting%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1416%26epage%3D1429%26doi%3D10.1158%2F1535-7163.MCT-17-0919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlossman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">New treatments for multiple myeloma</span>. <i>Oncology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1781</span>– <span class="NLM_lpage">1792</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16506632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD287hvFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1781-1792&author=P.+G.+Richardsonauthor=R.+Schlossmanauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=New+treatments+for+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">New treatments for multiple myeloma</span></div><div class="casAuthors">Richardson Paul G; Schlossman Robert; Hideshima Teru; Anderson Kenneth C</div><div class="citationInfo"><span class="NLM_cas:title">Oncology (Williston Park, N.Y.)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1781-92; discussion 1792, 1795-7</span>
        ISSN:<span class="NLM_cas:issn">0890-9091</span>.
    </div><div class="casAbstract">In 2004, multiple myeloma was diagnosed in more than 15,000 people in the United States and will account for approximately 20% of deaths due to hematologic malignancies.  Although traditional therapies such as melphalan (Alkeran)/prednisone, combination chemotherapy with VAD (vincristine, doxorubicin [Adriamycin], and dexamethasone), and high-dose chemotherapy with stem cell transplantation have shown some success, median survival remains between 3 to 5 years.  Treatment options for patients with multiple myeloma have increased in recent years, with the promise of improvement in survival.  New agents, such as the proteasome inhibitor bortezomib (Velcade), the antiangiogenic and immunomodulator thalidomide (Thalomid) and its analogs, such as lenalidomide (Revlimid), together with other small molecules, including arsenic trioxide (Trisenox), and other targeted therapies, have been studied alone and in combination with other antineoplastic therapies, either as induction therapy prior to stem cell transplantation or in patients with relapsed disease.  Bortezomib recently was approved in the United States for the treatment of multiple myeloma in patients who have received at least one prior therapy.  The use of bortezomib-based regimens as front-line therapy as well as the use of other agents in multiple myeloma remain under investigation, and approvals for both thalidomide and lenalidomide are hoped for soon, with the overall prospect of patient outcome continuing to be increasingly positive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1SXjtuLu517JzI8owOhpDfW6udTcc2eaLNzFvAja8pLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287hvFyjsw%253D%253D&md5=0027cb5d53be579a6504f180246f812e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DSchlossman%26aufirst%3DR.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DNew%2520treatments%2520for%2520multiple%2520myeloma%26jtitle%3DOncology%26date%3D2005%26volume%3D19%26spage%3D1781%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgarra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgorbissa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casarsa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfioletti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">184</span>, <span class="refDoi"> DOI: 10.1038/s41419-017-0259-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41419-017-0259-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29416018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1MvovVyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=184&author=S.+Ciottiauthor=R.+Sgarraauthor=A.+Sgorbissaauthor=C.+Penzoauthor=A.+Tomasellaauthor=F.+Casarsaauthor=F.+Benedettiauthor=F.+Bertiauthor=G.+Manfiolettiauthor=C.+Brancolini&title=The+binding+landscape+of+a+partially-selective+isopeptidase+inhibitor+with+potent+pro-death+activity%2C+based+on+the+bis%28arylidene%29cyclohexanone+scaffold&doi=10.1038%2Fs41419-017-0259-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold</span></div><div class="casAuthors">Ciotti Sonia; Sgorbissa Andrea; Tomasella Andrea; Brancolini Claudio; Sgarra Riccardo; Penzo Carlotta; Manfioletti Guidalberto; Casarsa Federico; Benedetti Fabio; Berti Federico</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diaryldienone derivatives with accessible β-carbons show strong anti-neoplastic properties, related to their ability to make covalent adducts with free thiols by Michael addition, and low toxicity in vivo.  Accumulation of poly-ubiquitylated proteins, activation of the unfolded protein response (UPR) and induction of cell death are universal hallmarks of their activities.  These compounds have been characterized as inhibitors of isopeptidases, a family of cysteine-proteases, which de-conjugate ubiquitin and ubiquitin-like proteins from their targets.  However, it is unclear whether they can also react with additional proteins.  In this work, we utilized the biotin-conjugated diaryldienone-derivative named 2c, as a bait to purify novel cellular targets of these small molecules.  Proteomic analyses have unveiled that, in addition to isopeptidases, these inhibitors can form stable covalent adducts with different intracellular proteins, thus potentially impacting on multiple functions of the cells, from cytoskeletal organization to metabolism.  These widespread activities can explain the ability of diaryldienone derivatives to efficiently trigger different cell death pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWIOh1FM9PF6cY7HFp97qMfW6udTcc2eaLNzFvAja8pLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvovVyltw%253D%253D&md5=63b26866895372f4d9b4557d712765e7</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fs41419-017-0259-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-017-0259-1%26sid%3Dliteratum%253Aachs%26aulast%3DCiotti%26aufirst%3DS.%26aulast%3DSgarra%26aufirst%3DR.%26aulast%3DSgorbissa%26aufirst%3DA.%26aulast%3DPenzo%26aufirst%3DC.%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DCasarsa%26aufirst%3DF.%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DBerti%26aufirst%3DF.%26aulast%3DManfioletti%26aufirst%3DG.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DThe%2520binding%2520landscape%2520of%2520a%2520partially-selective%2520isopeptidase%2520inhibitor%2520with%2520potent%2520pro-death%2520activity%252C%2520based%2520on%2520the%2520bis%2528arylidene%2529cyclohexanone%2520scaffold%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D184%26doi%3D10.1038%2Fs41419-017-0259-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koulich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, G. N.</span></span> <span> </span><span class="NLM_article-title">Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1072</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1091/mbc.e07-10-1040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1091%2Fmbc.e07-10-1040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18162577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslemsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1072-1082&author=E.+Koulichauthor=X.+Liauthor=G.+N.+DeMartino&title=Relative+structural+and+functional+roles+of+multiple+deubiquitylating+proteins+associated+with+mammalian+26S+proteasome&doi=10.1091%2Fmbc.e07-10-1040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome</span></div><div class="casAuthors">Koulich, Elena; Li, Xiaohua; DeMartino, George N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1072-1082</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The authors detd. the compn. and relative roles of deubiquitinating enzymes (DUBs) assocd. with the 26S proteasome in mammalian cells.  Three DUBS were assocd. with the 26S proteasome: 2 from constituent subunits, Rpn11/S13 and Uch37, and 1 from a reversibly assocd. protein, Usp14.  RNA interference (RNAi) of Rpn11/S13 inhibited cell growth, decreased cellular proteasome activity via disrupted 26S proteasome assembly, and inhibited cellular protein degrdn.  In contrast, RNAi of Uch37 or Usp14 had no detectable effect on cell growth, proteasome structure of proteolytic capacity, but accelerated cellular protein degrdn.  RNAi of both Uch37 and Usp14 also had no effect on proteasome structure or proteolytic capacity, but inhibited cellular protein degrdn.  Thus, proper proteasomal processing of ubiquitinated substrates requires Rpn11 plus either Uch37 or Usp14.  Although the latter proteins featured redundant deubiquitination functions, they also appeared to exert noncatalytic effects on proteasome activity that were similar to but independent of one another.  These results reveal unexpected functional relations among multiple DUBs and suggest a model for mammalian 26S proteasome function whereby their concerted action governs proteasome function by linking deubiquitination to substrate hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZ5aaxxXNl7Vg90H21EOLACvtfcHk0lgXi_J1dlhnAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslemsL0%253D&md5=4152d3af3c28f2c24ac9f3f484ff2879</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e07-10-1040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e07-10-1040%26sid%3Dliteratum%253Aachs%26aulast%3DKoulich%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDeMartino%26aufirst%3DG.%2BN.%26atitle%3DRelative%2520structural%2520and%2520functional%2520roles%2520of%2520multiple%2520deubiquitylating%2520proteins%2520associated%2520with%2520mammalian%252026S%2520proteasome%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2008%26volume%3D19%26spage%3D1072%26epage%3D1082%26doi%3D10.1091%2Fmbc.e07-10-1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">706</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-05-500033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1182%2Fblood-2013-05-500033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24319254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVGqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2014&pages=706-716&author=Z.+Tianauthor=P.+D%E2%80%99Arcyauthor=X.+Wangauthor=A.+Rayauthor=Y.+T.+Taiauthor=Y.+Huauthor=R.+D.+Carrascoauthor=P.+Richardsonauthor=S.+Linderauthor=D.+Chauhanauthor=K.+C.+Anderson&title=A+novel+small+molecule+inhibitor+of+deubiquitylating+enzyme+USP14+and+UCHL5+induces+apoptosis+in+multiple+myeloma+and+overcomes+bortezomib+resistance&doi=10.1182%2Fblood-2013-05-500033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance</span></div><div class="casAuthors">Tian, Ze; D'Arcy, Padraig; Wang, Xin; Ray, Arghya; Tai, Yu-Tzu; Hu, Yiguo; Carrasco, Ruben D.; Richardson, Paul; Linder, Stig; Chauhan, Dharminder; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">706-716</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Proteasome inhibitors have demonstrated that targeting protein degrdn. is effective therapy in multiple myeloma (MM).  Here we show that deubiquitylating enzymes (DUBs) USP14 and UCHL5 are more highly expressed in MM cells than in normal plasma cells.  USP14 and UCHL5 short interfering RNA knockdown decreases MM cell viability.  A novel 19S regulatory particle inhibitor b-AP15 selectively blocks deubiquitylating activity of USP14 and UCHL5 without inhibiting proteasome activity.  B-AP15 decreases viability in MM cell lines and patient MM cells, inhibits proliferation of MM cells even in the presence of bone marrow stroma cells, and overcomes bortezomib resistance.  Anti-MM activity of b-AP15 is assocd. with growth arrest via downregulation of CDC25C, CDC2, and cyclin B1 as well as induction of caspase-dependent apoptosis and activation of unfolded protein response.  In vivo studies using distinct human MM xenograft models show that b-AP15 is well tolerated, inhibits tumor growth, and prolongs survival.  Combining b-AP15 with suberoylanilide hydroxamic acid, lenalidomide, or dexamethasone induces synergistic anti-MM activity.  Our preclin. data showing efficacy of b-AP15 in MM disease models validates targeting DUBs in the ubiquitin proteasomal cascade to overcome proteasome inhibitor resistance and provides the framework for clin. evaluation of USP14/UCHL5 inhibitors to improve patient outcome in MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8aTcAtVqIcbVg90H21EOLACvtfcHk0lgjGqixO7vbJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVGqtLc%253D&md5=abf0d4ca5dadf6f7bf0cd1de3798702f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-05-500033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-05-500033%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DTai%26aufirst%3DY.%2BT.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCarrasco%26aufirst%3DR.%2BD.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DA%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520deubiquitylating%2520enzyme%2520USP14%2520and%2520UCHL5%2520induces%2520apoptosis%2520in%2520multiple%2520myeloma%2520and%2520overcomes%2520bortezomib%2520resistance%26jtitle%3DBlood%26date%3D2014%26volume%3D123%26spage%3D706%26epage%3D716%26doi%3D10.1182%2Fblood-2013-05-500033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">453</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1446-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2Fs13046-019-1446-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31694672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MjlvFCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=453&author=L.+Jiangauthor=Y.+Sunauthor=J.+Wangauthor=Q.+Heauthor=X.+Chenauthor=X.+Lanauthor=J.+Chenauthor=Q.+P.+Douauthor=X.+Shiauthor=J.+Liu&title=Proteasomal+cysteine+deubiquitinase+inhibitor+b-AP15+suppresses+migration+and+induces+apoptosis+in+diffuse+large+B+cell+lymphoma&doi=10.1186%2Fs13046-019-1446-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma</span></div><div class="casAuthors">Jiang Liling; Sun Yuening; Wang Jinxiang; He Qingyan; Chen Xinmei; Lan Xiaoying; Chen Jinghong; Dou Q Ping; Shi Xianping; Liu Jinbao; Dou Q Ping; Shi Xianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of experimental & clinical cancer research : CR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">453</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP.  About half of DLBCL patients are either refractory to, or will relapse, after the treatment.  Therefore, identifying novel drug targets and effective therapeutic agents is urgently needed for improving DLBCL patient survival. b-AP15, a selective small molecule inhibitor of proteasomal USP14 and UCHL5 deubiquitinases (DUBs), has shown selectivity and efficacy in several other types of cancer cells.  This is the first study to report the effect of b-AP15 in DLBCL.  METHODS:  Cell lines of two DLBCL subtypes, Germinal Center B Cell/ GCB (SU-DHL-4, OCI-LY-1, OCI-LY-19) and Activated B Cell/ABC (SU-DHL-2), were used in the current study.  Cell viability was measured by MTS assay, proliferation by trypan blue exclusion staining assay, cellular apoptosis by Annexin V-FITC/PI staining and mitochondrial outer membrane permeability assays, the activities of 20S proteasome peptidases by cleavage of specific fluorogenic substrates, and cell migration was detected by transwell assay in these GCB- and ABC-DLBCL cell lines.  Mouse xenograft models of SU-DHL-4 and SU-DHL-2 cells were used to determine in vivo effects of b-AP15 in DLBCL tumors.  RESULTS:  b-AP15 inhibited proteasome DUB activities and activated cell death pathway, as evident by caspase activation and mitochondria apoptosis in GCB- and ABC- DLBCL cell lines. b-AP15 treatment suppressed migration of GCB- and ABC-DLBCL cells via inhibiting Wnt/β-catenin and TGFβ/Smad pathways.  Additionally, b-AP15 significantly inhibited the growth of GCB- and ABC DLBCL in xenograft models.  CONCLUSIONS:  These results indicate that b-AP15 inhibits cell migration and induces apoptosis in GCB- and ABC-DLBCL cells, and suggest that inhibition of 19S proteasomal DUB should be a novel strategy for DLBCL treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBjiWNDyT7QrxanA7vODO6fW6udTcc2eavFJmZXLXQ-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjlvFCksA%253D%253D&md5=8c018a8c1d5f7d07108a5c3b6ebf80cd</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1446-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1446-y%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DProteasomal%2520cysteine%2520deubiquitinase%2520inhibitor%2520b-AP15%2520suppresses%2520migration%2520and%2520induces%2520apoptosis%2520in%2520diffuse%2520large%2520B%2520cell%2520lymphoma%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26spage%3D453%26doi%3D10.1186%2Fs13046-019-1446-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brjnic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1124/mol.113.091322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1124%2Fmol.113.091322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24714215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGmsLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=932-945&author=X.+Wangauthor=W.+Staffordauthor=M.+Mazurkiewiczauthor=M.+Fryknasauthor=S.+Brjnicauthor=X.+Zhangauthor=J.+Gullboauthor=R.+Larssonauthor=E.+S.+Arnerauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=The+19S+Deubiquitinase+inhibitor+b-AP15+is+enriched+in+cells+and+elicits+rapid+commitment+to+cell+death&doi=10.1124%2Fmol.113.091322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The 19S deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death</span></div><div class="casAuthors">Wang, Xin; Stafford, William; Mazurkiewicz, Magdalena; Fryknaes, Maarten; Brjnic, Slavica; Zhang, Xiaonan; Gullbo, Joachim; Larsson, Rolf; Arner, Elias S. J.; D'Arcy, Padraig; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">932-945, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">B-AP15 [(3E,5E)-3,5-bis[(4-nitrophenyl)methylidene]-1-(prop-2-enoyl)piperidin-4-one] is a small mol. inhibitor of the ubiquitin specific peptidase (USP) 14/ubiquitin carboxyl-terminal hydrolase (UCH) L5 deubiquitinases of the 19S proteasome that shows antitumor activity in a no. of tumor models, including multiple myeloma.  B-AP15 contains an α-, β-unsatd. carbonyl unit that is likely to react with intracellular nucleophiles such as cysteine thiolates by Michael addn.  We found that binding of b-AP15 to USP14 is partially reversible, and that inhibition of proteasome function is reversible in cells.  Despite reversible binding, tumor cells are rapidly committed to apoptosis/cell death after exposure to b-AP15.  We show that b-AP15 is rapidly taken up from the medium and enriched in cells.  Enrichment provides an explanation of the stronger potency of the compd. in cellular assays compared with in vitro biochem. assays.  Cellular uptake was impaired by 30-min pretreatment of cells with low concns. of N-ethylmaleimide (10 μM), suggesting that enrichment was thiol dependent.  We report that in addn. to inhibition of deubiquitinases, b-AP15 inhibits the selenoprotein thioredoxin reductase (TrxR).  Whereas proteasome inhibition was closely assocd. with cell death induction, inhibition of TrxR was not.  TrxR inhibition is, however, likely to contribute to triggering of oxidative stress obsd. with b-AP15.  Furthermore, we present structure-activity, in vivo pharmacokinetic, and hepatocyte metab. data for b-AP15.  We conclude that the strong enrichment of b-AP15 in cells and a rapid commitment to apoptosis/cell death are factors that likely contribute to the strong antitumor activity of this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp889oZOoWzgbVg90H21EOLACvtfcHk0lgjGqixO7vbJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGmsLjJ&md5=3aaf8d1e0dd9695da48f93e68a821c9d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.091322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.091322%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DStafford%26aufirst%3DW.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DFryknas%26aufirst%3DM.%26aulast%3DBrjnic%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DArner%26aufirst%3DE.%2BS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DThe%252019S%2520Deubiquitinase%2520inhibitor%2520b-AP15%2520is%2520enriched%2520in%2520cells%2520and%2520elicits%2520rapid%2520commitment%2520to%2520cell%2520death%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D932%26epage%3D945%26doi%3D10.1124%2Fmol.113.091322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borodovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casagrande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H. L.</span></span> <span> </span><span class="NLM_article-title">A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5187</span>– <span class="NLM_lpage">5196</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.18.5187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Femboj%2F20.18.5187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=11566882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1Ghs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5187-5196&author=A.+Borodovskyauthor=B.+M.+Kesslerauthor=R.+Casagrandeauthor=H.+S.+Overkleeftauthor=K.+D.+Wilkinsonauthor=H.+L.+Ploegh&title=A+novel+active+site-directed+probe+specific+for+deubiquitylating+enzymes+reveals+proteasome+association+of+USP14&doi=10.1093%2Femboj%2F20.18.5187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14</span></div><div class="casAuthors">Borodovsky, Anna; Kessler, Benedikt M.; Casagrande, Rocco; Overkleeft, Herman S.; Wilkinson, Keith D.; Ploegh, Hidde L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5187-5196</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A C-terminally modified ubiquitin (Ub) deriv., ubiquitin vinyl sulfone (UbVS), was synthesized as an active site-directed probe that irreversibly modifies a subset of Ub C-terminal hydrolases (UCHs) and Ub-specific processing proteases (UBPs).  Specificity of UbVS for deubiquitylating enzymes (DUBs) is demonstrated not only by inhibition of [125I]UbVS labeling with N-ethylmaleimide and Ub aldehyde, but also by genetic anal.  [125I]UbVS modifies six of the 17 known and putative yeast deubiquitylating enzymes (Yuh1p, Ubp1p, Ubp2p, Ubp6p, Ubp12p and Ubp15p), as revealed by anal. of corresponding mutant strains.  In mammalian cells, greater nos. of polypeptides are labeled, most of which are likely to be DUBs.  Using [125I]UbVS as a probe, we report the assocn. of an addnl. DUB with the mammalian 26S proteasome.  In addn. to the 37 kDa enzyme reported to be part of the 19S cap, we identified USP14, a mammalian homolog of yeast Ubp6p, as being bound to the proteasome.  Remarkably, labeling of 26S-assocd. USP14 with [125I]UbVS is increased when proteasome function is impaired, suggesting functional coupling between the activities of USP14 and the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY6kbqcL1FOLVg90H21EOLACvtfcHk0litIa0FteIuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1Ghs74%253D&md5=1090c312d50142b754aac504a7f5cd06</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.18.5187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.18.5187%26sid%3Dliteratum%253Aachs%26aulast%3DBorodovsky%26aufirst%3DA.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DCasagrande%26aufirst%3DR.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26atitle%3DA%2520novel%2520active%2520site-directed%2520probe%2520specific%2520for%2520deubiquitylating%2520enzymes%2520reveals%2520proteasome%2520association%2520of%2520USP14%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D5187%26epage%3D5196%26doi%3D10.1093%2Femboj%2F20.18.5187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, J. W.</span></span> <span> </span><span class="NLM_article-title">Thermal stability and activation of bovine lens multicatalytic proteinase complex (proteasome)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1006/abbi.1993.1573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1006%2Fabbi.1993.1573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=8239652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVShsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1993&pages=146-152&author=B.+J.+Wagnerauthor=J.+W.+Margolis&title=Thermal+stability+and+activation+of+bovine+lens+multicatalytic+proteinase+complex+%28proteasome%29&doi=10.1006%2Fabbi.1993.1573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Thermal stability and activation of bovine lens multicatalytic proteinase complex (proteasome)</span></div><div class="casAuthors">Wagner, B. J.; Margolis, Joyce W.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-52</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The multicatalytic proteinase complex (MPC; proteasome) can be isolated in a latent form which then can be activated for protein hydrolysis by physiol. and nonphysiol. treatments, including high temp.  In this study, the temp. dependency profile for the hydrolysis of carbobenzoxy (Cbz)-Gly-Gly-Leu-p-nitroanilide (pNA) and Cbz-Val-Gly-Arg-pNA by bovine lens MPC are found to be those expected for a thermostable enzyme, with single optima above 50°C.  In contrast, hydrolyses of Cbz-Leu-Leu-Glu-naphthylamide and α2-crystallin, a lens structural protein, show two temp. transitions, indicating that hydrolysis of these substrates can be activated by elevated temp.  Temp. dependency profiles of peptidase activity in Tris-HCl compared to Hepes buffer suggest that Tris decreases the thermal stability of MPC.  After 10 min preincubation in Tris-HCl at 53°C, lens MPC activities are reduced by 50-60% and loss of the major MPC band can be seen on nondenaturing gels.  The presence of α2-crystallin during preincubation partially prevents the loss of activity.  Although α-crystallin has been reported to function as a mol. chaperone, similar protection by other MPC substrates suggests that α2-crystallin stabilized the MPC as a substrate.  These findings indicate both activation and inactivation of the enzyme at elevated temps.  It is proposed therefore that high temp. activates the MPC but to a more labile form which can be partially stabilized by protein substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnZ6h99-6wbVg90H21EOLACvtfcHk0litIa0FteIuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVShsrc%253D&md5=1f2b1da9abffb4de6cec89dc0c66f5fa</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1993.1573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1993.1573%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DB.%2BJ.%26aulast%3DMargolis%26aufirst%3DJ.%2BW.%26atitle%3DThermal%2520stability%2520and%2520activation%2520of%2520bovine%2520lens%2520multicatalytic%2520proteinase%2520complex%2520%2528proteasome%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1993%26volume%3D307%26spage%3D146%26epage%3D152%26doi%3D10.1006%2Fabbi.1993.1573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowicka, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randles, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasov, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarasova, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamazaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, K. J.</span></span> <span> </span><span class="NLM_article-title">Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15540</span>, <span class="refDoi"> DOI: 10.1038/ncomms15540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fncomms15540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28598414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmslSiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15540&author=X.+Luauthor=U.+Nowickaauthor=V.+Sridharanauthor=F.+Liuauthor=L.+Randlesauthor=D.+Hymelauthor=M.+Dybaauthor=S.+G.+Tarasovauthor=N.+I.+Tarasovaauthor=X.+Z.+Zhaoauthor=J.+Hamazakiauthor=S.+Murataauthor=T.+R.+Burkeauthor=K.+J.+Walters&title=Structure+of+the+Rpn13-Rpn2+complex+provides+insights+for+Rpn13+and+Uch37+as+anticancer+targets&doi=10.1038%2Fncomms15540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets</span></div><div class="casAuthors">Lu Xiuxiu; Nowicka Urszula; Sridharan Vinidhra; Liu Fen; Randles Leah; Walters Kylie J; Hymel David; Zhao Xue Zhi; Burke Terrence R Jr; Dyba Marzena; Dyba Marzena; Tarasov Sergey G; Tarasova Nadya I; Hamazaki Jun; Murata Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15540</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Proteasome-ubiquitin receptor hRpn13/Adrm1 binds and activates deubiquitinating enzyme Uch37/UCHL5 and is targeted by bis-benzylidine piperidone RA190, which restricts cancer growth in mice xenografts.  Here, we solve the structure of hRpn13 with a segment of hRpn2 that serves as its proteasome docking site; a proline-rich C-terminal hRpn2 extension stretches across a narrow canyon of the ubiquitin-binding hRpn13 Pru domain blocking an RA190-binding surface.  Biophysical analyses in combination with cell-based assays indicate that hRpn13 binds preferentially to hRpn2 and proteasomes over RA190. hRpn13 also exists outside of proteasomes where it may be RA190 sensitive.  RA190 does not affect hRpn13 interaction with Uch37, but rather directly binds and inactivates Uch37. hRpn13 deletion from HCT116 cells abrogates RA190-induced accumulation of substrates at proteasomes.  We propose that RA190 targets hRpn13 and Uch37 through parallel mechanisms and at proteasomes, RA190-inactivated Uch37 cannot disassemble hRpn13-bound ubiquitin chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeCgKMDdtGrfh3YQQtAhNufW6udTcc2ea3f6Srs1m9ALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmslSiuw%253D%253D&md5=767c1f12875d0f4a147720707bb7ad7a</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1038%2Fncomms15540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15540%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DNowicka%26aufirst%3DU.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DRandles%26aufirst%3DL.%26aulast%3DHymel%26aufirst%3DD.%26aulast%3DDyba%26aufirst%3DM.%26aulast%3DTarasov%26aufirst%3DS.%2BG.%26aulast%3DTarasova%26aufirst%3DN.%2BI.%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DHamazaki%26aufirst%3DJ.%26aulast%3DMurata%26aufirst%3DS.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DWalters%26aufirst%3DK.%2BJ.%26atitle%3DStructure%2520of%2520the%2520Rpn13-Rpn2%2520complex%2520provides%2520insights%2520for%2520Rpn13%2520and%2520Uch37%2520as%2520anticancer%2520targets%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15540%26doi%3D10.1038%2Fncomms15540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coughlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iizuka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anchoori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marastoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazzaro, M.</span></span> <span> </span><span class="NLM_article-title">Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">4159</span>– <span class="NLM_lpage">4170</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.2904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25784654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2Mnls1Sksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=4159-4170&author=R.+I.+Vogelauthor=K.+Coughlinauthor=A.+Scottiauthor=Y.+Iizukaauthor=R.+Anchooriauthor=R.+B.+Rodenauthor=M.+Marastoniauthor=M.+Bazzaro&title=Simultaneous+inhibition+of+deubiquitinating+enzymes+%28DUBs%29+and+autophagy+synergistically+kills+breast+cancer+cells&doi=10.18632%2Foncotarget.2904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells</span></div><div class="casAuthors">Vogel Rachel Isaksson; Bazzaro Martina; Coughlin Kathleen; Iizuka Yoshie; Bazzaro Martina; Scotti Alessandra; Marastoni Mauro; Anchoori Ravi; Roden Richard B S; Anchoori Ravi; Roden Richard B S; Roden Richard B S</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4159-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the leading causes of cancer death among women in the United States.  Patients expressing the estrogen and progesterone receptor (ER and PR) and human epidermal growth factor 2 (HER-2) tumor markers have favorable prognosis and efficacious therapeutic options.  In contrast, tumors that are negative for these markers (triple-negative) have a disproportionate share of morbidity and mortality due to lack of a validated molecular target.  Deubiquitinating enzymes (DUBs) are a critical component of ubiquitin-proteasome-system degradation and have been shown to be differentially expressed and activated in a number of cancers, including breast, with their aberrant activity linked to cancer prognosis and clinical outcome.  We evaluated the effect of the DUB inhibitors b-AP15 and RA-9 alone and in combination with early- and late-stage lysosomal inhibitors on cell viability in a panel of triple negative breast cancer (TNBC) cell lines.  Our results indicate small-molecule DUB inhibitors have a profound effect on TNBC viability and lead to activation of autophagy as a cellular mechanism to compensate for ubiquitin-proteasome-system stress.  Treatment with sub-optimal doses of DUB and lysosome inhibitors synergistically kills TNBC cells.  This supports the evaluation of DUB inhibition, in combination with lysosomal inhibition, as a therapeutic approach for the treatment of TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvDoMDseirLGhHGZei4OW9fW6udTcc2ebTxmyc2IgH97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mnls1Sksg%253D%253D&md5=4cae506139805133d1a3776a41149aa6</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2904%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DCoughlin%26aufirst%3DK.%26aulast%3DScotti%26aufirst%3DA.%26aulast%3DIizuka%26aufirst%3DY.%26aulast%3DAnchoori%26aufirst%3DR.%26aulast%3DRoden%26aufirst%3DR.%2BB.%26aulast%3DMarastoni%26aufirst%3DM.%26aulast%3DBazzaro%26aufirst%3DM.%26atitle%3DSimultaneous%2520inhibition%2520of%2520deubiquitinating%2520enzymes%2520%2528DUBs%2529%2520and%2520autophagy%2520synergistically%2520kills%2520breast%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D4159%26epage%3D4170%26doi%3D10.18632%2Foncotarget.2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodrasov, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, T. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1043</span>, <span class="refDoi"> DOI: 10.1110/ps.083450408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1110%2Fps.083450408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18424514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1035-1043&author=B.+Nicholsonauthor=C.+A.+Leachauthor=S.+J.+Goldenbergauthor=D.+M.+Francisauthor=M.+P.+Kodrasovauthor=X.+Tianauthor=J.+Shanksauthor=D.+E.+Sternerauthor=A.+Bernalauthor=M.+R.+Matternauthor=K.+D.+Wilkinsonauthor=T.+R.+Butt&title=Characterization+of+ubiquitin+and+ubiquitin-like-protein+isopeptidase+activities&doi=10.1110%2Fps.083450408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities</span></div><div class="casAuthors">Nicholson, Benjamin; Leach, Craig A.; Goldenberg, Seth J.; Francis, Dana M.; Kodrasov, Matthew P.; Tian, Xufan; Shanks, John; Sterner, David E.; Bernal, Alejandro; Mattern, Michael R.; Wilkinson, Keith D.; Butt, Tauseef R.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1035-1043</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Conjugation or deconjugation of ubiquitin (Ub) or ubiquitin-like proteins (UBLs) to or from cellular proteins is a multifaceted and universal means of regulating cellular physiol., controlling the lifetime, localization, and activity of many crit. proteins.  Deconjugation of Ub or UBL from proteins is performed by a class of proteases called isopeptidases.  Herein is described a readily quantifiable novel isopeptidase assay platform consisting of Ub or UBL fused to the reporter enzyme phospholipase A2 (PLA2).  Isopeptidase activity releases PLA2, which cleaves its substrate, generating a signal that is linear with deubiquitylase (DUB) concn. and is able to discriminate DUB, deSUMOylase, deNEDDylase, and deISGylase activities.  The power and sensitivity of the UBL-PLA2 assay are demonstrated by its ability to differentiate the contrasting deISGylase and DUB activities of two coronavirus proteases: severe acute respiratory syndrome papain-like protease (SARS-CoV PLpro) and NL63 CoV papain-like protease 2 (PLP2).  Furthermore, direct comparisons with the current Ub-7-amino-4-methylcoumarin (Ub-AMC) assay demonstrated that the Ub-PLA2 assay is an effective tool for characterizing modulators of isopeptidase activity.  This observation was expanded by profiling the inhibitory activity of the nonselective isopeptidase inhibitor NSC 632839 against DUBs and deSUMOylases.  Taken together, these studies illustrate the utility of the reporter-based approach to measuring isopeptidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8B_bxI25uwbVg90H21EOLACvtfcHk0ljGJ5ai64gYOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFKhtLo%253D&md5=eae8fac2cc0e3c82aa7a75c982c635cd</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1110%2Fps.083450408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.083450408%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DB.%26aulast%3DLeach%26aufirst%3DC.%2BA.%26aulast%3DGoldenberg%26aufirst%3DS.%2BJ.%26aulast%3DFrancis%26aufirst%3DD.%2BM.%26aulast%3DKodrasov%26aufirst%3DM.%2BP.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DShanks%26aufirst%3DJ.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DBernal%26aufirst%3DA.%26aulast%3DMattern%26aufirst%3DM.%2BR.%26aulast%3DWilkinson%26aufirst%3DK.%2BD.%26aulast%3DButt%26aufirst%3DT.%2BR.%26atitle%3DCharacterization%2520of%2520ubiquitin%2520and%2520ubiquitin-like-protein%2520isopeptidase%2520activities%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D1035%26epage%3D1043%26doi%3D10.1110%2Fps.083450408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelissen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Saez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riant, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Re-evaluating the mechanism of action of alpha, beta-unsaturated carbonyl DUB inhibitors b-AP15 and VLX1570: a paradigmatic example of unspecific protein cross-linking with Michael acceptor motif-containing drugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3756</span>– <span class="NLM_lpage">3762</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3756-3762&author=J.+A.+Wardauthor=A.+Pinto-Fernandezauthor=L.+Cornelissenauthor=S.+Bonhamauthor=L.+Diaz-Saezauthor=O.+Riantauthor=K.+V.+M.+Huberauthor=B.+M.+Kesslerauthor=O.+Feronauthor=E.+W.+Tate&title=Re-evaluating+the+mechanism+of+action+of+alpha%2C+beta-unsaturated+carbonyl+DUB+inhibitors+b-AP15+and+VLX1570%3A+a+paradigmatic+example+of+unspecific+protein+cross-linking+with+Michael+acceptor+motif-containing+drugs&doi=10.1021%2Facs.jmedchem.0c00144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs</span></div><div class="casAuthors">Ward, Jennifer A.; Pinto-Fernandez, Adan; Cornelissen, Loic; Bonham, Sarah; Diaz-Saez, Laura; Riant, Olivier; Huber, Kilian V. M.; Kessler, Benedikt M.; Feron, Olivier; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3756-3762</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) are a growing target class across multiple disease states, with several inhibitors now reported. b-AP15 and VLX1570 are two structurally related USP14/UCH-37 inhibitors.  Through a proteomic approach, we demonstrate that these compds. target a diverse range of proteins, resulting in the formation of higher mol. wt. (MW) complexes.  Activity-based proteome profiling identified CIAPIN1 as a submicromolar covalent target of VLX1570, and further anal. demonstrated that high MW complex formation leads to aggregation of CIAPIN1 in intact cells.  Our results suggest that in addn. to DUB inhibition, these compds. induce nonspecific protein aggregation, providing mol. explanation for general cellular toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUJKosQOrcbVg90H21EOLACvtfcHk0ljGJ5ai64gYOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOlt70%253D&md5=05300126a6e9b191ea41d1834837916f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00144%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DJ.%2BA.%26aulast%3DPinto-Fernandez%26aufirst%3DA.%26aulast%3DCornelissen%26aufirst%3DL.%26aulast%3DBonham%26aufirst%3DS.%26aulast%3DDiaz-Saez%26aufirst%3DL.%26aulast%3DRiant%26aufirst%3DO.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DFeron%26aufirst%3DO.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DRe-evaluating%2520the%2520mechanism%2520of%2520action%2520of%2520alpha%252C%2520beta-unsaturated%2520carbonyl%2520DUB%2520inhibitors%2520b-AP15%2520and%2520VLX1570%253A%2520a%2520paradigmatic%2520example%2520of%2520unspecific%2520protein%2520cross-linking%2520with%2520Michael%2520acceptor%2520motif-containing%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3756%26epage%3D3762%26doi%3D10.1021%2Facs.jmedchem.0c00144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sizemore, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharia, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubonja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawes, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivich, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmaier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsherniak, A.</span></span> <span> </span><span class="NLM_article-title">Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1038/ng.3984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fng.3984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29083409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehtrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=1779-1784&author=R.+M.+Meyersauthor=J.+G.+Bryanauthor=J.+M.+McFarlandauthor=B.+A.+Weirauthor=A.+E.+Sizemoreauthor=H.+Xuauthor=N.+V.+Dhariaauthor=P.+G.+Montgomeryauthor=G.+S.+Cowleyauthor=S.+Pantelauthor=A.+Goodaleauthor=Y.+Leeauthor=L.+D.+Aliauthor=G.+Jiangauthor=R.+Lubonjaauthor=W.+F.+Harringtonauthor=M.+Stricklandauthor=T.+Wuauthor=D.+C.+Hawesauthor=V.+A.+Zhivichauthor=M.+R.+Wyattauthor=Z.+Kalaniauthor=J.+J.+Changauthor=M.+Okamotoauthor=K.+Stegmaierauthor=T.+R.+Golubauthor=J.+S.+Boehmauthor=F.+Vazquezauthor=D.+E.+Rootauthor=W.+C.+Hahnauthor=A.+Tsherniak&title=Computational+correction+of+copy+number+effect+improves+specificity+of+CRISPR-Cas9+essentiality+screens+in+cancer+cells&doi=10.1038%2Fng.3984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells</span></div><div class="casAuthors">Meyers, Robin M.; Bryan, Jordan G.; McFarland, James M.; Weir, Barbara A.; Sizemore, Ann E.; Xu, Han; Dharia, Neekesh V.; Montgomery, Phillip G.; Cowley, Glenn S.; Pantel, Sasha; Goodale, Amy; Ali, Levi D.; Jiang, Guozhi; Lubonja, Rakela; Harrington, William F.; Strickland, Matthew; Wu, Ting; Hawes, Derek C.; Zhivich, Victor A.; Wyatt, Meghan R.; Kalani, Zohra; Chang, Jaime J.; Okamoto, Michael; Stegmaier, Kimberly; Golub, Todd R.; Boehm, Jesse S.; Vazquez, Francisca; Root, David E.; Hahn, William C.; Tsherniak, Aviad</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1779-1784</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The CRISPR-Cas9 system has revolutionized gene editing both at single genes and in multiplexed loss-of-function screens, thus enabling precise genome-scale identification of genes essential for proliferation and survival of cancer cells.  However, previous studies have reported that a gene-independent antiproliferative effect of Cas9-mediated DNA cleavage confounds such measurement of genetic dependency, thereby leading to false-pos. results in copy no.-amplified regions.  We developed CERES, a computational method to est. gene-dependency levels from CRISPR-Cas9 essentiality screens while accounting for the copy no.-specific effect.  In our efforts to define a cancer dependency map, we performed genome-scale CRISPR-Cas9 essentiality screens across 342 cancer cell lines and applied CERES to this data set.  We found that CERES decreased false-pos. results and estd. sgRNA activity for both this data set and previously published screens performed with different sgRNA libraries.  We further demonstrate the utility of this collection of screens, after CERES correction, for identifying cancer-type-specific vulnerabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8iODR9NtDbVg90H21EOLACvtfcHk0lj6NAz_g9p7dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehtrjI&md5=539e8fb16958480ce2d430a7f8e6cddf</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fng.3984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3984%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DR.%2BM.%26aulast%3DBryan%26aufirst%3DJ.%2BG.%26aulast%3DMcFarland%26aufirst%3DJ.%2BM.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DSizemore%26aufirst%3DA.%2BE.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DMontgomery%26aufirst%3DP.%2BG.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DPantel%26aufirst%3DS.%26aulast%3DGoodale%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DAli%26aufirst%3DL.%2BD.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DLubonja%26aufirst%3DR.%26aulast%3DHarrington%26aufirst%3DW.%2BF.%26aulast%3DStrickland%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DHawes%26aufirst%3DD.%2BC.%26aulast%3DZhivich%26aufirst%3DV.%2BA.%26aulast%3DWyatt%26aufirst%3DM.%2BR.%26aulast%3DKalani%26aufirst%3DZ.%26aulast%3DChang%26aufirst%3DJ.%2BJ.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DVazquez%26aufirst%3DF.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DTsherniak%26aufirst%3DA.%26atitle%3DComputational%2520correction%2520of%2520copy%2520number%2520effect%2520improves%2520specificity%2520of%2520CRISPR-Cas9%2520essentiality%2520screens%2520in%2520cancer%2520cells%26jtitle%3DNat.%2520Genet.%26date%3D2017%26volume%3D49%26spage%3D1779%26epage%3D1784%26doi%3D10.1038%2Fng.3984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haigis, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span> <span> </span><span class="NLM_article-title">A role for mitochondrial translation in promotion of viability in K-Ras mutant cells</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2017.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.celrep.2017.06.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28700943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKhtrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=427-438&author=T.+D.+Martinauthor=D.+R.+Cookauthor=M.+Y.+Choiauthor=M.+Z.+Liauthor=K.+M.+Haigisauthor=S.+J.+Elledge&title=A+role+for+mitochondrial+translation+in+promotion+of+viability+in+K-Ras+mutant+cells&doi=10.1016%2Fj.celrep.2017.06.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells</span></div><div class="casAuthors">Martin, Timothy D.; Cook, Danielle R.; Choi, Mei Yuk; Li, Mamie Z.; Haigis, Kevin M.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-438</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activating mutations in the KRAS oncogene are highly prevalent in tumors, esp. those of the colon, lung, and pancreas.  To better understand the genetic dependencies that K-Ras mutant cells rely upon for their growth, we employed whole-genome CRISPR loss-of-function screens in two isogenic pairs of cell lines.  Since loss of essential genes is uniformly toxic in CRISPR-based screens, we also developed a small hairpin RNA (shRNA) library targeting essential genes.  These approaches uncovered a large set of proteins whose loss results in the selective redn. of K-Ras mutant cell growth.  Pathway anal. revealed that many of these genes function in the mitochondria.  For validation, we generated isogenic pairs of cell lines using CRISPR-based genome engineering, which confirmed the dependency of K-Ras mutant cells on these mitochondrial pathways.  Finally, we found that mitochondrial inhibitors reduce the growth of K-Ras mutant tumors in vivo, aiding in the advancement of strategies to target K-Ras-driven malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Fr6oDktcerVg90H21EOLACvtfcHk0lj6NAz_g9p7dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKhtrzN&md5=cac8a6a7e0b3b44dff54734c2d293eb9</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2017.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2017.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DT.%2BD.%26aulast%3DCook%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DM.%2BY.%26aulast%3DLi%26aufirst%3DM.%2BZ.%26aulast%3DHaigis%26aufirst%3DK.%2BM.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DA%2520role%2520for%2520mitochondrial%2520translation%2520in%2520promotion%2520of%2520viability%2520in%2520K-Ras%2520mutant%2520cells%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D20%26spage%3D427%26epage%3D438%26doi%3D10.1016%2Fj.celrep.2017.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkepang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthi, V.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin receptor RPN13 mediates the inhibitory interaction of diphenyldihaloketones CLEFMA and EF24 with the 26S proteasome</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">392</span>, <span class="refDoi"> DOI: 10.3389/fchem.2018.00392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3389%2Ffchem.2018.00392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30280096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaitrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=392&author=G.+Raoauthor=G.+Nkepangauthor=J.+Xuauthor=H.+Yariauthor=H.+Housonauthor=C.+Tengauthor=V.+Awasthi&title=Ubiquitin+receptor+RPN13+mediates+the+inhibitory+interaction+of+diphenyldihaloketones+CLEFMA+and+EF24+with+the+26S+proteasome&doi=10.3389%2Ffchem.2018.00392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin receptor RPN13 mediates the inhibitory interaction of diphenyldihaloketones CLEFMA and EF24 with the 26S proteasome</span></div><div class="casAuthors">Rao, Geeta; Nkepang, Gregory; Xu, Jian; Yari, Hooman; Houson, Hailey; Teng, Chengwen; Awasthi, Vibhudutta</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">392/1-392/13</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The proteasome is a validated target in drug discovery for diseases assocd. with unusual proteasomal activity.  Here we report that two diphenyldihaloketones, CLEFMA and EF24, inhibit the peptidase activity of the 26S proteasome.  The objective of this study was to investigate interaction of these compds. with the proteasome and identify a putative target within the protein components of the 26S proteasome.  We employed std. fluorogenic peptide-based proteasome activity assay for trypsinlike, chymotrypsin-like, and caspase-like activities of human purified 26S proteasome in cell-free conditions.  GFPu-1 and HUVEC cells were used as proteasome reporter cells.  Direct binding studies used purified 19S, 20S, 26S, and recombinant RPN13-Pru for interaction with biotinylated analogs of CLEFMA and EF24.  The reaction mixts. were subjected to horizontal gel electrophoresis, streptavidin-blotting, pull-down assays, and immunoblotting.  The identity of the interacting protein was detd. by 2D gel electrophoresis and LC-MS/MS.  Drug affinity responsive target stability technique was utilized to examine if CLEFMA binding confers protection to RPN13 against thermolysincatalyzed proteolysis.  We found that trypsin-and chymotrypsin-like activities of the 26S proteasome were reduced significantly by both compds.  The compds. also reduced the proteolytic activity in GFPu-1 and HUVEC cells, resulting in accumulation of ubiquitinated proteins without affecting the autophagy process.  From direct binding assays a 43 kDa protein in the 26S proteasome was found to be the interacting partner.  This protein was identified by tandem mass spectroscopy as regulatory particle subunit 13 (RPN13), a ubiquitin receptor in the 19S regulatory particle.  Furthermore, binding of CLEFMA to RPN13 did not protect latter from thermolysin-mediated proteolysis.  Together, this study showed diphenyldihaloketones as potential proteasome inhibitors for treatment of diseases with perturbed proteasome function.  The results also unraveled RPN13 as a unique target of CLEFMA and EF24.  As a result, these compds. inhibit both trypsin-like and chymotrypsin-like proteasome activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1KhmCHlo637Vg90H21EOLACvtfcHk0lj5QPUswGpm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaitrzN&md5=3638c6bdd16d4b7dff38fe5cbb27740a</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2018.00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2018.00392%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DG.%26aulast%3DNkepang%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYari%26aufirst%3DH.%26aulast%3DHouson%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DC.%26aulast%3DAwasthi%26aufirst%3DV.%26atitle%3DUbiquitin%2520receptor%2520RPN13%2520mediates%2520the%2520inhibitory%2520interaction%2520of%2520diphenyldihaloketones%2520CLEFMA%2520and%2520EF24%2520with%2520the%252026S%2520proteasome%26jtitle%3DFront.%2520Chem.%26date%3D2018%26volume%3D6%26spage%3D392%26doi%3D10.3389%2Ffchem.2018.00392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Amponsa, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tandon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, K. J.</span></span> <span> </span><span class="NLM_article-title">Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquitinated proteins and RA190 cytotoxicity</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>, <span class="NLM_elocation-id">e00122</span> <span class="refDoi"> DOI: 10.1128/MCB.00122-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1128%2FMCB.00122-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=32631902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFyks7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&author=V.+Osei-Amponsaauthor=V.+Sridharanauthor=M.+Tandonauthor=C.+N.+Evansauthor=K.+Klarmannauthor=K.+T.+Chengauthor=J.+Lackauthor=R.+Chariauthor=K.+J.+Walters&title=Impact+of+losing+hRpn13+Pru+or+UCHL5+on+proteasome+clearance+of+ubiquitinated+proteins+and+RA190+cytotoxicity&doi=10.1128%2FMCB.00122-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of losing hRpn13 Pru or UCHL5 on proteasome clearance of ubiquitinated proteins and RA190 cytotoxicity</span></div><div class="casAuthors">Osei-Amponsa, Vasty; Sridharan, Vinidhra; Tandon, Mayank; Evans, Christine N.; Klarmann, Kimberly; Cheng, Kwong Tai; Lack, Justin; Chari, Raj; Walters, Kylie J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">e00122-20</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">1098-5549</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HRpn13/ADRM1 links substrate recruitment with deubiquitination at the proteasome through its proteasome- and ubiquitin-binding Pru domain and DEUBAD domain, which binds and activates deubiquitinating enzyme (DUB) UCHL5/Uch37.  Here, we edit the HCT116 colorectal cancer cell line to delete part of the hRpn13 Pru, producing cells that express truncated hRpn13 (trRpn13), which is competent for UCHL5 binding but defective for proteasome interaction. trRpn13 cells demonstrate reduced levels of proteasome-bound ubiquitinated proteins, indicating that the loss of hRpn13 function at proteasomes cannot be fully compensated for by the two other dedicated substrate receptors (hRpn1 and hRpn10).  Previous studies indicated that the loss of full-length hRpn13 causes a corresponding redn. of UCHL5.  We find UCHL5 levels unaltered in trRpn13 cells, but hRpn11 is elevated in ΔhRpn13 and trRpn13 cells, perhaps from cell stress.  Despite the ∼90 DUBs in human cells, including two others in addn. to UCHL5 at the proteasome, we found deletion of UCHL5 from HCT116 cells to cause increased levels of ubiquitinated proteins in whole-cell ext. and at proteasomes, suggesting that UCHL5 activity cannot be fully assumed by other DUBs.  We also report anticancer mol. RA190, which binds covalently to hRpn13 and UCHL5, to require hRpn13 Pru and not UCHL5 for cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSMEdwHoTb9bVg90H21EOLACvtfcHk0lj5QPUswGpm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFyks7zJ&md5=03295ca7bf229dd637c0822c3a1d9189</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1128%2FMCB.00122-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00122-20%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Amponsa%26aufirst%3DV.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DTandon%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DC.%2BN.%26aulast%3DKlarmann%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DK.%2BT.%26aulast%3DLack%26aufirst%3DJ.%26aulast%3DChari%26aufirst%3DR.%26aulast%3DWalters%26aufirst%3DK.%2BJ.%26atitle%3DImpact%2520of%2520losing%2520hRpn13%2520Pru%2520or%2520UCHL5%2520on%2520proteasome%2520clearance%2520of%2520ubiquitinated%2520proteins%2520and%2520RA190%2520cytotoxicity%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2020%26volume%3D40%26doi%3D10.1128%2FMCB.00122-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brnjic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2271</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1089/ars.2013.5322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1089%2Fars.2013.5322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24011031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKltrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=2271-2285&author=S.+Brnjicauthor=M.+Mazurkiewiczauthor=M.+Fryknasauthor=C.+Sunauthor=X.+Zhangauthor=R.+Larssonauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=Induction+of+tumor+cell+apoptosis+by+a+proteasome+deubiquitinase+inhibitor+is+associated+with+oxidative+stress&doi=10.1089%2Fars.2013.5322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Tumor Cell Apoptosis by a Proteasome Deubiquitinase Inhibitor Is Associated with Oxidative Stress</span></div><div class="casAuthors">Brnjic, Slavica; Mazurkiewicz, Magdalena; Fryknaes, Marten; Sun, Chao; Zhang, Xiaonan; Larsson, Rolf; D'Arcy, Padraig; Linder, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2271-2285</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: b-AP15 is a recently described inhibitor of the USP14/UCHL5 deubiquitinases (DUBs) of the 19S proteasome.  Exposure to b-AP15 results in blocking of proteasome function and accumulation of polyubiquitinated protein substrates in cells.  This novel mechanism of proteasome inhibition may potentially be exploited for cancer therapy, in particular for treatment of malignancies resistant to currently used proteasome inhibitors.  The aim of the present study was to characterize the cellular response to b-AP15-mediated proteasome DUB inhibition.  Results: We report that b-AP15 elicits a similar, but yet distinct, cellular response as the clin. used proteasome inhibitor bortezomib. b-AP15 induces a rapid apoptotic response, assocd. with enhanced induction of oxidative stress and rapid activation of Jun-N-terminal kinase 1/2 (JNK)/activating protein-1 signaling.  Scavenging of reactive oxygen species and pharmacol. inhibition of JNK reduced b-AP15-induced apoptosis.  We further report that endoplasmic reticulum (ER) stress is induced by b-AP15 and is involved in apoptosis induction.  In contrast to bortezomib, ER stress is assocd. with induction of α-subunit of eukaryotic initiation factor 2 phosphorylation.  Innovation: The findings establish that different modes of proteasome inhibition result in distinct cellular responses, a finding of potential therapeutic importance.  Conclusion: Our data show that enhanced oxidative stress and ER stress are major determinants of the strong apoptotic response elicited by the 19S DUB inhibitor b-AP15.  Antioxid. Redox Signal. 21, 2271-2285.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGossfQ3ZNXfWrVg90H21EOLACvtfcHk0lj5QPUswGpm6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKltrzJ&md5=b66cecc85c4f3b1981ff84d7078bcf5f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1089%2Fars.2013.5322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2013.5322%26sid%3Dliteratum%253Aachs%26aulast%3DBrnjic%26aufirst%3DS.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DFryknas%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DInduction%2520of%2520tumor%2520cell%2520apoptosis%2520by%2520a%2520proteasome%2520deubiquitinase%2520inhibitor%2520is%2520associated%2520with%2520oxidative%2520stress%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D21%26spage%3D2271%26epage%3D2285%26doi%3D10.1089%2Fars.2013.5322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, M. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of bisbenzylidenedioxotetrahydrothiopranones as activators of endoplasmic reticulum (ER) stress signaling pathways and apoptotic cell death in acute promyelocytic leukemic cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5904</span>– <span class="NLM_lpage">5918</span>, <span class="refDoi"> DOI: 10.1021/jm401352a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401352a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVentLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5904-5918&author=K.+L.+Tanauthor=A.+Aliauthor=Y.+Duauthor=H.+Fuauthor=H.+X.+Jinauthor=T.+M.+Chinauthor=M.+Khanauthor=M.+L.+Go&title=Synthesis+and+evaluation+of+bisbenzylidenedioxotetrahydrothiopranones+as+activators+of+endoplasmic+reticulum+%28ER%29+stress+signaling+pathways+and+apoptotic+cell+death+in+acute+promyelocytic+leukemic+cells&doi=10.1021%2Fjm401352a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Bisbenzylidenedioxotetrahydrothiopranones as Activators of Endoplasmic Reticulum (ER) Stress Signaling Pathways and Apoptotic Cell Death in Acute Promyelocytic Leukemic Cells</span></div><div class="casAuthors">Tan, Kheng-Lin; Ali, Azhar; Du, Yuhong; Fu, Hainan; Jin, Hai-Xiao; Chin, Tan-Min; Khan, Matiullah; Go, Mei-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5904-5918</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Curcumin is known to trigger ER-stress induced cell death of acute promyelocytic leukemic (APL) cells by intercepting the degrdn. of nuclear co-repressor (N-CoR) protein which has a key role in the pathogenesis of APL.  Replacing the heptadienedione moiety of curcumin with a monocarbonyl cross-conjugated dienone embedded in a tetrahydrothiopyranone dioxide ring resulted in thiopyranone dioxides that were more resilient to hydrolysis and had greater growth inhibitory activities than curcumin on APL cells.  Several members intercepted the degrdn. of misfolded N-CoR and triggered the signaling cascade in the unfolded protein response (UPR) which led to apoptotic cell death.  Microarray anal. showed that genes involved in protein processing pathways that were germane to the activation of the UPR were preferentially up-regulated in treated APL cells, supporting the notion that the UPR was a consequential mechanistic pathway affected by thiopyranone dioxides.  The Michael acceptor reactivity of the scaffold may have a role in exacerbating ER stress in APL cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL70rFGCpFeLVg90H21EOLACvtfcHk0lgsH3DL5gZ5qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVentLbP&md5=2dc7244e25775db0258697e3f347b732</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm401352a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401352a%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DK.%2BL.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%2BX.%26aulast%3DChin%26aufirst%3DT.%2BM.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DGo%26aufirst%3DM.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bisbenzylidenedioxotetrahydrothiopranones%2520as%2520activators%2520of%2520endoplasmic%2520reticulum%2520%2528ER%2529%2520stress%2520signaling%2520pathways%2520and%2520apoptotic%2520cell%2520death%2520in%2520acute%2520promyelocytic%2520leukemic%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5904%26epage%3D5918%26doi%3D10.1021%2Fjm401352a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafiei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span> <span> </span><span class="NLM_article-title">3,5-Bis(3-dimethylaminomethyl-4-hydroxybenzylidene)-4-piperidone and related compounds induce glutathione oxidation and mitochondria-mediated cell death in HCT-116 colon cancer cells</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3669</span>– <span class="NLM_lpage">3673</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bmcl.2017.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28716495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3669-3673&author=E.+Addalaauthor=H.+Rafieiauthor=S.+Dasauthor=B.+Bandyauthor=U.+Dasauthor=S.+S.+Karkiauthor=J.+R.+Dimmock&title=3%2C5-Bis%283-dimethylaminomethyl-4-hydroxybenzylidene%29-4-piperidone+and+related+compounds+induce+glutathione+oxidation+and+mitochondria-mediated+cell+death+in+HCT-116+colon+cancer+cells&doi=10.1016%2Fj.bmcl.2017.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Bis(3-dimethylaminomethyl-4-hydroxybenzylidene)-4-piperidone and related compounds induce glutathione oxidation and mitochondria-mediated cell death in HCT-116 colon cancer cells</span></div><div class="casAuthors">Addala, Eshwari; Rafiei, Hossein; Das, Swagatika; Bandy, Brian; Das, Umashankar; Karki, Subhas S.; Dimmock, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3669-3673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study aims at investigating the cytotoxicity and some of the modes of action of 3,5-bis(3-dimethylamino-4-hydroxybenzylidene)-4-piperidone trihydrochloride 3 and two related compds. 2 (which lacks the dimethylaminomethyl groups) and 4 (which has an addnl. dimethylaminoethyl substituent in both aryl rings) in order to ascertain the contribution of dimethylaminoethyl substituent to bioactivity.  The bioactivities of 2-4 were compared with curcumin 5.  Both 2 and 3 displayed submicromolar GI50 values towards HCT-116 cells and were significantly more potent than 4, 5 and 5-fluorouracil (5-FU).  All of the compds. displayed greater toxicity towards HCT-116 cells than human CRL-1790 non-malignant colon cells.  In HCT-116 cells, the compds. 2, 3 and 5 increased the ratio of oxidised to reduced glutathione and destabilized the mitochondrial membrane potential.  Both 2 and 5 produced an increase in mitochondrial superoxide and a burst in intracellular reactive oxygen species in HCT 116 cells.  In addn., 2 and 4 stimulated respiration in rat liver mitochondria while 2 and 5 induced mitochondrial swelling.  The results suggest that 2 and 5 cause oxidn. or crosslinking of the thiols which control the mitochondrial permeability transition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpurPa-Lnc4gLVg90H21EOLACvtfcHk0lgsH3DL5gZ5qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2ktrvP&md5=ae2e7638f6e54ac66dbfbf63db89b7c9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DAddala%26aufirst%3DE.%26aulast%3DRafiei%26aufirst%3DH.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DBandy%26aufirst%3DB.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DKarki%26aufirst%3DS.%2BS.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26atitle%3D3%252C5-Bis%25283-dimethylaminomethyl-4-hydroxybenzylidene%2529-4-piperidone%2520and%2520related%2520compounds%2520induce%2520glutathione%2520oxidation%2520and%2520mitochondria-mediated%2520cell%2520death%2520in%2520HCT-116%2520colon%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3669%26epage%3D3673%26doi%3D10.1016%2Fj.bmcl.2017.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khalid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehman, M. F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustaqeem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleem, M.</span></span> <span> </span><span class="NLM_article-title">Exploration of noncovalent interactions, chemical reactivity, and nonlinear optical properties of piperidone derivatives: a concise theoretical approach</span>. <i>ACS omega</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13236</span>– <span class="NLM_lpage">13249</span>, <span class="refDoi"> DOI: 10.1021/acsomega.0c01273</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.0c01273" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVSgtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=13236-13249&author=M.+Khalidauthor=A.+Aliauthor=M.+F.+U.+Rehmanauthor=M.+Mustaqeemauthor=S.+Aliauthor=M.+U.+Khanauthor=S.+Asimauthor=N.+Ahmadauthor=M.+Saleem&title=Exploration+of+noncovalent+interactions%2C+chemical+reactivity%2C+and+nonlinear+optical+properties+of+piperidone+derivatives%3A+a+concise+theoretical+approach&doi=10.1021%2Facsomega.0c01273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Noncovalent Interactions, Chemical Reactivity, and Nonlinear Optical Properties of Piperidone Derivatives: A Concise Theoretical Approach</span></div><div class="casAuthors">Khalid, Muhammad; Ali, Akbar; Rehman, Muhammad Fayyaz Ur; Mustaqeem, Muhammad; Ali, Shehbaz; Khan, Muhammad Usman; Asim, Sumreen; Ahmad, Naseeb; Saleem, Muhammad</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13236-13249</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The org. compds. with a π-bond system lead to elec. charge delocalization which enables them to reveal fascinating nonlinear optical properties.  Mono-carbonyl curcuminoids also have an appealing skeleton from the conjugation view point.  Interesting chem. structures of the 3,5-bis(arylidene)-N-benzenesulfonyl-4-piperidone derivs. motivated us to perform d. functional theory (DFT)-based studies.  Therefore, computations using the B3LYP/6-311G(d,p) functional of DFT were executed to explore geometric parameters, HOMO-LUMO energies, and natural bond orbital (NBO) analyses.  Moreover, three different functionals such as HF, B3LYP, and M06 with the 6-311G(d,p) basis set were used to investigate the av. polarizability 〈α〉 and first hyperpolarizability (βtot)-based properties of all compds.  A good concurrence among calcd. and exptl. parameters was obtained through root mean square error calcns.  The mol. stability of piperidone derivs. was examd. using the Hirshfeld surface and NBO analyses.  Natural population anal. was also performed to obtain insights about at. charges.  Calcd. HOMO-LUMO energies showed that charge transfer interactions take place within the mols.  Moreover, global reactivity parameters including electronegativity, chem. hardness, softness, ionization potential, and electrophilicity were calcd. using the HOMO and LUMO energies.  The av. polarizability 〈α〉 and first hyperpolarizability (βtot) values of all compds. were obsd. to be larger in magnitude at the aforesaid functional than the std. compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeiTHPtk4V_7Vg90H21EOLACvtfcHk0lgsH3DL5gZ5qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVSgtL7O&md5=97b4e9b58233a0e6b6cb7d1031b3873a</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Facsomega.0c01273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.0c01273%26sid%3Dliteratum%253Aachs%26aulast%3DKhalid%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DRehman%26aufirst%3DM.%2BF.%2BU.%26aulast%3DMustaqeem%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DM.%2BU.%26aulast%3DAsim%26aufirst%3DS.%26aulast%3DAhmad%26aufirst%3DN.%26aulast%3DSaleem%26aufirst%3DM.%26atitle%3DExploration%2520of%2520noncovalent%2520interactions%252C%2520chemical%2520reactivity%252C%2520and%2520nonlinear%2520optical%2520properties%2520of%2520piperidone%2520derivatives%253A%2520a%2520concise%2520theoretical%2520approach%26jtitle%3DACS%2520omega%26date%3D2020%26volume%3D5%26spage%3D13236%26epage%3D13249%26doi%3D10.1021%2Facsomega.0c01273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narlawar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span> <span> </span><span class="NLM_article-title">Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">30754</span>– <span class="NLM_lpage">30765</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.056010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.M109.056010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19740743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlequ7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=30754-30765&author=K.+Bernardauthor=W.+Wangauthor=R.+Narlawarauthor=B.+Schmidtauthor=K.+L.+Kirk&title=Curcumin+cross-links+cystic+fibrosis+transmembrane+conductance+regulator+%28CFTR%29+polypeptides+and+potentiates+CFTR+channel+activity+by+distinct+mechanisms&doi=10.1074%2Fjbc.M109.056010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Curcumin Cross-links Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Polypeptides and Potentiates CFTR Channel Activity by Distinct Mechanisms</span></div><div class="casAuthors">Bernard, Karen; Wang, Wei; Narlawar, Rajeshwar; Schmidt, Boris; Kirk, Kevin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">30754-30765</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cystic fibrosis (CF) is caused by loss-of-function mutations in the CFTR chloride channel.  Wild type and mutant CFTR channels can be activated by curcumin, a well tolerated dietary compd. with some appeal as a prospective CF therapeutic.  However, we show here that curcumin has the unexpected effect of crosslinking CFTR polypeptides into SDS-resistant oligomers.  This effect occurred for CFTR channels in microsomes as well as in intact cells and at the same concns. that are effective for promoting CFTR channel activity (5-50 μM).  Both mature CFTR polypeptides at the cell surface and immature CFTR protein in the endoplasmic reticulum were cross-linked by curcumin, although the latter pool was more susceptible to this modification.  Curcumin cross-linked two CF mutant channels (ΔF508 and G551D) as well as a variety of deletion constructs that lack the major cytoplasmic domains.  In vitro crosslinking could be prevented by high concns. of oxidant scavengers (i.e. reduced glutathione and sodium azide) indicating a possible oxidn. reaction with the CFTR polypeptide.  Importantly, cyclic derivs. of curcumin that lack the reactive β diketone moiety had no crosslinking activity.  One of these cyclic derivs. stimulated the activities of wild type CFTR channels, Δ1198-CFTR channels, and G551D-CFTR channels in excised membrane patches.  Like the parent compd., the cyclic deriv. irreversibly activated CFTR channels in excised patches during prolonged exposure (>5 min).  Our results raise a note of caution about secondary biochem. effects of reactive compds. like curcumin in the treatment of CF.  Cyclic curcumin derivs. may have better therapeutic potential in this regard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9dPRDUXYDpbVg90H21EOLACvtfcHk0lgIzYl_ckSaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlequ7vN&md5=fcf4df6b19c9a5ef163c801856dfceb3</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.056010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.056010%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DCurcumin%2520cross-links%2520cystic%2520fibrosis%2520transmembrane%2520conductance%2520regulator%2520%2528CFTR%2529%2520polypeptides%2520and%2520potentiates%2520CFTR%2520channel%2520activity%2520by%2520distinct%2520mechanisms%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D30754%26epage%3D30765%26doi%3D10.1074%2Fjbc.M109.056010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuspa, S. H.</span></span> <span> </span><span class="NLM_article-title">The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4950</span>– <span class="NLM_lpage">4956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=7585535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK2MXptFKhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=4950-4956&author=C.+Stanwellauthor=T.+R.+Burkeauthor=S.+H.+Yuspa&title=The+erbstatin+analogue+methyl+2%2C5-dihydroxycinnamate+cross-links+proteins+and+is+cytotoxic+to+normal+and+neoplastic+epithelial+cells+by+a+mechanism+independent+of+tyrosine+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The erbstatin analog methyl 2,5-dihydroxycinnamate crosslinks proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition</span></div><div class="casAuthors">Stanwell, Caroline; Burke, Terrence R., Jr.; Yuspa, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4950-6</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Differentiation therapy is an attractive option for the treatment of superficial, localized neoplastic lesions of the skin.  Topical application of agents that induce differentiation could selectively inhibit tumor cell growth, inducing a program of cell death with the prodn. of crosslinked protein envelopes as the terminal event of this process at the skin surface, effectively eliminating the neoplastic phenotype.  The nonspecific kinase inhibitor staurosporine induces cornified envelope assembly in neoplastic keratinocytes and causes tumor regression (A. A. Dlugosz and S. H. Yuspa, Cancer Res., 51: 4677-4684, 1991).  In pursuit of less toxic agents, specific tyrosine kinase inhibitors were tested for the ability to induce differentiation in keratinocyte-derived cells.  Of a range of inhibitors tested, only Me 2,5-dihydroxycinnamate (MC) was able to induce crosslinked protein and consequent cell death in mouse and human primary normal keratinocytes, 308 neoplastic mouse keratinocytes, HPV-18-infected immortalized human keratinocytes, and human lines SQCC-Y1 (squamous carcinoma) and A431 (epidermoid carcinoma).  MC increased crosslinked protein in a dose-dependent manner (0.05-1 mM).  To confirm differentiation, MC-treated mouse primary normal keratinocytes were tested for activation of the endogenous crosslinking enzyme transglutaminase, but no assocn. was found between transglutaminase activity and MC-induced protein crosslinking.  MC also induced protein crosslinking in the fibroblast cell line NIH3T3 and in B16 melanoma cells, in which cornified envelope assembly is not part of the differentiation process.  This crosslinking occurred at 4°, suggesting a nonphysiol. process.  Western blot anal. of an in vitro assay with purified EGF receptor showed that MC was able to crosslink the receptor.  As in NIH3T3 cells, DTT inhibited crosslinking, suggesting that oxidn. of MC or an acceptor group may be required for this effect.  Thus, MC does not induce differentiation by a physiol. mechanism in epithelial cells but causes chem. protein crosslinking into cornified envelope-like structures at high concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2GZcAqbBSeLVg90H21EOLACvtfcHk0lgIzYl_ckSaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptFKhsrs%253D&md5=7a82b2377da1147615d2cd51f9a75bf2</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanwell%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DYuspa%26aufirst%3DS.%2BH.%26atitle%3DThe%2520erbstatin%2520analogue%2520methyl%25202%252C5-dihydroxycinnamate%2520cross-links%2520proteins%2520and%2520is%2520cytotoxic%2520to%2520normal%2520and%2520neoplastic%2520epithelial%2520cells%2520by%2520a%2520mechanism%2520independent%2520of%2520tyrosine%2520kinase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D4950%26epage%3D4956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuspa, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Cell protein cross-linking by erbstatin and related compounds</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">480</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(96)00250-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2F0006-2952%2896%2900250-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=8687502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1Ogurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=475-480&author=C.+Stanwellauthor=B.+Yeauthor=S.+H.+Yuspaauthor=T.+R.+Burke&title=Cell+protein+cross-linking+by+erbstatin+and+related+compounds&doi=10.1016%2F0006-2952%2896%2900250-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Cell protein crosslinking by erbstatin and related compounds</span></div><div class="casAuthors">Stanwell, Caroline; Ye, Bin; Yuspa, Stuart H.; Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">475-480</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The protein-tyrosine kinase inhibitor and stable erbstatin analog Me 2,5-dihydroxycinnamate (4) cross-links cell proteins by a non-physiol. chem. mechanism (Stanwell et al., Cancer Res 55: 4950-4956, 1995).  To det. the structural requirements for this effect, erbstatin and fifteen related compds., including caffeic acid phenylethyl ester were synthesized and examd. for their ability to induce crosslinking of cellular protein at concns. ranging from low micromolar up to 1000 μM.  Tests were conducted in NIH3T3 fibroblasts as well as mouse keratinocytes.  Potent crosslinking of cellular protein was obsd. for a no. of analogs, including erbstatin, at concns. as low as 10-50 μM.  The inactivity of methoxy and fluoro as compared with their corresponding dihydroxylated counterparts indicated that free arom. hydroxyls were essential for crosslinking.  Addnl., compds. contg. Ph rings with 1,4-dihydroxy substituents were more potent than those having 1,2-dihydroxylated patterns.  As with the prototype compd. 4, crosslinking was induced at both 37° and 4°, suggesting a chem. rather than physiol. mechanism.  Consistent with the data, a mechanism of action is proposed which involves initial oxidn. to reactive quinone intermediates that subsequently cross-link protein nucleophiles via multiple 1,4-Michael-type addns.  Similar alkylation of protein by protein-tyrosine kinase inhibitors, such as herbimycin A, has been invoked.  While the latter benzoquinoid ansamycin antibiotics contain preformed quinone moieties, results of the present study suggest that other hydroxylated kinase inhibitors can potentially participate in similar phenomena.  A large no. of potential therapeutics, including HIV integrase inhibitors, possess polyhydroxylated nuclei.  The non-specific nature of the protein crosslinking reaction demonstrated for these erbstatin analogs, and the fact that crosslinking can occur at micromolar concns., may limit the therapeutic usefulness of such compds. to specific applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqalvwfi9wR37Vg90H21EOLACvtfcHk0lgIzYl_ckSaXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1Ogurc%253D&md5=870f60adfebc883cffbab6f911019b64</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2896%2900250-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252896%252900250-X%26sid%3Dliteratum%253Aachs%26aulast%3DStanwell%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DYuspa%26aufirst%3DS.%2BH.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DCell%2520protein%2520cross-linking%2520by%2520erbstatin%2520and%2520related%2520compounds%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D52%26spage%3D475%26epage%3D480%26doi%3D10.1016%2F0006-2952%2896%2900250-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mace, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drouet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bony, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boidot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draoui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobysheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martherus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deraedt, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schicke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delvaux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriegsheim, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quetin-Leclercq, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riant, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, O.</span></span> <span> </span><span class="NLM_article-title">A new ER-specific photosensitizer unravels O-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">3976</span>– <span class="NLM_lpage">3985</span>, <span class="refDoi"> DOI: 10.1038/onc.2015.474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fonc.2015.474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26686091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGnsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=3976-3985&author=A.+Pintoauthor=Y.+Maceauthor=F.+Drouetauthor=E.+Bonyauthor=R.+Boidotauthor=N.+Draouiauthor=I.+Lobyshevaauthor=C.+Corbetauthor=F.+Poletauthor=R.+Martherusauthor=Q.+Deraedtauthor=J.+Rodriguezauthor=C.+Lamyauthor=O.+Schickeauthor=D.+Delvauxauthor=C.+Louisauthor=R.+Kissauthor=A.+V.+Kriegsheimauthor=C.+Dessyauthor=B.+Eliasauthor=J.+Quetin-Leclercqauthor=O.+Riantauthor=O.+Feron&title=A+new+ER-specific+photosensitizer+unravels+O-driven+protein+oxidation+and+inhibition+of+deubiquitinases+as+a+generic+mechanism+for+cancer+PDT&doi=10.1038%2Fonc.2015.474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT</span></div><div class="casAuthors">Pinto, A.; Mace, Y.; Drouet, F.; Bony, E.; Boidot, R.; Draoui, N.; Lobysheva, I.; Corbet, C.; Polet, F.; Martherus, R.; Deraedt, Q.; Rodriguez, J.; Lamy, C.; Schicke, O.; Delvaux, D.; Louis, C.; Kiss, R.; Kriegsheim, A. V.; Dessy, C.; Elias, B.; Quetin-Leclercq, J.; Riant, O.; Feron, O.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">3976-3985</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Photosensitizers (PS) are ideally devoid of any activity in the absence of photoactivation, and rely on mol. oxygen for the formation of singlet oxygen (1O2) to produce cellular damage.  Off-targets and tumor hypoxia therefore represent obstacles for the use of PS for cancer photodynamic therapy.  Herein, we describe the characterization of OR141, a benzophenazine compd. identified through a phenotypic screening for its capacity to be strictly activated by light and to kill a large variety of tumor cells under both normoxia and hypoxia.  This new class of PS unraveled an unsuspected common mechanism of action for PS that involves the combined inhibition of the mammalian target of rapamycin (mTOR) signaling pathway and proteasomal deubiquitinases (DUBs) USP14 and UCH37.  Oxidn. of mTOR and other endoplasmic reticulum (ER)-assocd. proteins drives the early formation of high mol. wt. (MW) complexes of multimeric proteins, the concomitant blockade of DUBs preventing their degrdn. and pptg. cell death.  Furthermore, we validated the antitumor effects of OR141 in vivo and documented its highly selective accumulation in the ER, further increasing the ER stress resulting from 1O2 generation upon light activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNwQORDD1qDrVg90H21EOLACvtfcHk0liuExGYxYEp2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGnsr7O&md5=fbb8efe6d7a70c798cd48e7629b09456</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.474%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DMace%26aufirst%3DY.%26aulast%3DDrouet%26aufirst%3DF.%26aulast%3DBony%26aufirst%3DE.%26aulast%3DBoidot%26aufirst%3DR.%26aulast%3DDraoui%26aufirst%3DN.%26aulast%3DLobysheva%26aufirst%3DI.%26aulast%3DCorbet%26aufirst%3DC.%26aulast%3DPolet%26aufirst%3DF.%26aulast%3DMartherus%26aufirst%3DR.%26aulast%3DDeraedt%26aufirst%3DQ.%26aulast%3DRodriguez%26aufirst%3DJ.%26aulast%3DLamy%26aufirst%3DC.%26aulast%3DSchicke%26aufirst%3DO.%26aulast%3DDelvaux%26aufirst%3DD.%26aulast%3DLouis%26aufirst%3DC.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKriegsheim%26aufirst%3DA.%2BV.%26aulast%3DDessy%26aufirst%3DC.%26aulast%3DElias%26aufirst%3DB.%26aulast%3DQuetin-Leclercq%26aufirst%3DJ.%26aulast%3DRiant%26aufirst%3DO.%26aulast%3DFeron%26aufirst%3DO.%26atitle%3DA%2520new%2520ER-specific%2520photosensitizer%2520unravels%2520O-driven%2520protein%2520oxidation%2520and%2520inhibition%2520of%2520deubiquitinases%2520as%2520a%2520generic%2520mechanism%2520for%2520cancer%2520PDT%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D3976%26epage%3D3985%26doi%3D10.1038%2Fonc.2015.474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ying, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, G.</span></span> <span> </span><span class="NLM_article-title">EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">18050</span>– <span class="NLM_lpage">18064</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.7633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26919110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC28jks1Krug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=18050-18064&author=P.+Zouauthor=Y.+Xiaauthor=W.+Chenauthor=X.+Chenauthor=S.+Yingauthor=Z.+Fengauthor=T.+Chenauthor=Q.+Yeauthor=Z.+Wangauthor=C.+Qiuauthor=S.+Yangauthor=G.+Liang&title=EF24+induces+ROS-mediated+apoptosis+via+targeting+thioredoxin+reductase+1+in+gastric+cancer+cells&doi=10.18632%2Foncotarget.7633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells</span></div><div class="casAuthors">Zou Peng; Yang Shulin; Zou Peng; Chen Weiqian; Chen Xi; Ying Shilong; Feng Zhiguo; Chen Tongke; Ye Qingqing; Wang Zhe; Qiu Chenyu; Liang Guang; Xia Yiqun</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">18050-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gastric cancer (GC) is one of the leading causes of cancer mortality in the world, and finding novel agents for the treatment of advanced gastric cancer is of urgent need.  Diphenyl difluoroketone (EF24), a molecule having structural similarity to curcumin, exhibits potent anti-tumor activities by arresting cell cycle and inducing apoptosis.  Although EF24 demonstrates potent anticancer efficacy in numerous types of human cancer cells, the cellular targets of EF24 have not been fully dei(logical not)ned.  We report here that EF24 may interact with the thioredoxin reductase 1 (TrxR1), an important selenocysteine (Sec)-containing antioxidant enzyme, to induce reactive oxygen species (ROS)-mediated apoptosis in human gastric cancer cells.  By inhibiting TrxR1 activity and increasing intracellular ROS levels, EF24 induces a lethal endoplasmic reticulum stress in human gastric cancer cells.  Importantly, knockdown of TrxR1 sensitizes cells to EF24 treatment.  In vivo, EF24 treatment markedly reduces the TrxR1 activity and tumor cell burden, and displays synergistic lethality with 5-FU against gastric cancer cells.  Targeting TrxR1 with EF24 thus discloses a previously unrecognized mechanism underlying the biological activity of EF24, and reveals that TrxR1 is a good target for gastric cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB4hk6rM5szxBrI9DTGjC0fW6udTcc2eaF6SXndI3XbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jks1Krug%253D%253D&md5=98d603d2001ba782c1d2b695c17d51f9</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7633%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DP.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYing%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DG.%26atitle%3DEF24%2520induces%2520ROS-mediated%2520apoptosis%2520via%2520targeting%2520thioredoxin%2520reductase%25201%2520in%2520gastric%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D18050%26epage%3D18064%26doi%3D10.18632%2Foncotarget.7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skoupa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzickova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlejnek, P.</span></span> <span> </span><span class="NLM_article-title">Apoptosis induced by the curcumin analogue EF-24 is neither mediated by oxidative stress-related mechanisms nor affected by expression of main drug transporters ABCB1 and ABCG2 in human leukemia cells</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2289</span>, <span class="refDoi"> DOI: 10.3390/ijms18112289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3390%2Fijms18112289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOgurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2289&author=N.+Skoupaauthor=P.+Dolezelauthor=E.+Ruzickovaauthor=P.+Mlejnek&title=Apoptosis+induced+by+the+curcumin+analogue+EF-24+is+neither+mediated+by+oxidative+stress-related+mechanisms+nor+affected+by+expression+of+main+drug+transporters+ABCB1+and+ABCG2+in+human+leukemia+cells&doi=10.3390%2Fijms18112289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis induced by the curcumin analogue EF-24 is neither mediated by oxidative stress-related mechanisms nor affected by expression of main drug transporters ABCB1 and ABCG2 in human leukemia cells</span></div><div class="casAuthors">Skoupa, Nikola; Dolezel, Petr; Ruzickova, Eliska; Mlejnek, Petr</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2289/1-2289/18</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The synthetic curcumin analog, 3,5-bis[(2-fluorophenyl)methylene]-4-piperidinone (EF-24), suppresses NF-κB activity and exhibits antiproliferative effects against a variety of cancer cells in vitro.  Recently, it was reported that EF-24-induced apoptosis was mediated by a redox-dependent mechanism.  Here, we studied the effects of N-acetylcysteine (NAC) on EF-24-induced cell death.  We also addressed the question of whether the main drug transporters, ABCB1 and ABCG2, affect the cytotoxic of EF-24.  We obsd. that EF-24 induced cell death with apoptotic hallmarks in human leukemia K562 cells.  Importantly, the loss of cell viability was preceded by prodn. of reactive oxygen species (ROS), and by a decrease of reduced glutathione (GSH).  However, neither ROS prodn. nor the decrease in GSH predominantly contributed to the EF-24-induced cell death.  We found that EF-24 formed an adduct with GSH, which is likely the mechanism contributing to the decrease of GSH.  Although NAC abrogated ROS prodn., decreased GSH and prevented cell death, its protective effect was mainly due to a rapid conversion of intra- and extra-cellular EF-24 into the EF-24-NAC adduct without cytotoxic effects.  Furthermore, we found that neither overexpression of ABCB1 nor ABCG2 reduced the antiproliferative effects of EF-24.  In conclusion, a redox-dependent-mediated mechanism only marginally contributes to the EF-24-induced apoptosis in K562 cells.  The main mechanism of NAC protection against EF-24-induced apoptosis is conversion of cytotoxic EF-24 into the noncytotoxic EF-24-NAC adduct.  Neither ABCB1 nor ABCG2 mediated resistance to EF-24.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-qKzLF0ko57Vg90H21EOLACvtfcHk0liuExGYxYEp2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOgurbF&md5=1917a4a73abca627fbcaa6b395d87474</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3390%2Fijms18112289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18112289%26sid%3Dliteratum%253Aachs%26aulast%3DSkoupa%26aufirst%3DN.%26aulast%3DDolezel%26aufirst%3DP.%26aulast%3DRuzickova%26aufirst%3DE.%26aulast%3DMlejnek%26aufirst%3DP.%26atitle%3DApoptosis%2520induced%2520by%2520the%2520curcumin%2520analogue%2520EF-24%2520is%2520neither%2520mediated%2520by%2520oxidative%2520stress-related%2520mechanisms%2520nor%2520affected%2520by%2520expression%2520of%2520main%2520drug%2520transporters%2520ABCB1%2520and%2520ABCG2%2520in%2520human%2520leukemia%2520cells%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D2289%26doi%3D10.3390%2Fijms18112289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rundlof, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S.</span></span> <span> </span><span class="NLM_article-title">Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1089/152308604771978336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1089%2F152308604771978336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=14980055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FptVGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=41-52&author=A.+K.+Rundlofauthor=E.+S.+Arner&title=Regulation+of+the+mammalian+selenoprotein+thioredoxin+reductase+1+in+relation+to+cellular+phenotype%2C+growth%2C+and+signaling+events&doi=10.1089%2F152308604771978336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events</span></div><div class="casAuthors">Rundlof Anna-Klara; Arner Elias S J</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-52</span>
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    </div><div class="casAbstract">Reactive oxygen species (ROS) are generated as toxic by-products of aerobic metabolism, but are also essential biomolecules in cell signaling.  The thioredoxin (Trx) system is a major enzymatic system modulating ROS levels and is important for redox regulation of cellular function.  It consists of Trx and thioredoxin reductase (TrxR), which reduces Trx using NADPH.  Most, if not all, of the functions of Trx depend on the activity of TrxR.  Mammalian TrxR enzymes are selenoproteins with broad substrate specificities, and alteration of cytosolic TrxR1 expression and activity is likely to be an important determinant for the control of cellular redox regulation.  TrxR1 activity in cells seems to be modulated by an intricate interplay, involving a housekeeping type promoter in combination with alternative splice variants and transcriptional start sites, posttranscriptional regulation through AU-rich elements, inactivation by electrophilic agents and by itself modulating the effects of several key signaling molecules.  TrxR1 activity is also intimately linked with several aspects of selenium metabolism, and hence selenoprotein function in general.  Here, we summarize the current knowledge of these different levels of TrxR1 regulation in diverse cell types and in response to growth and signaling events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGPTOqFKV0pyCEBeYuoi7AfW6udTcc2eZgKjARc7MIyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FptVGnsw%253D%253D&md5=56df701d5a86ad1c74df9423afd2ee86</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1089%2F152308604771978336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F152308604771978336%26sid%3Dliteratum%253Aachs%26aulast%3DRundlof%26aufirst%3DA.%2BK.%26aulast%3DArner%26aufirst%3DE.%2BS.%26atitle%3DRegulation%2520of%2520the%2520mammalian%2520selenoprotein%2520thioredoxin%2520reductase%25201%2520in%2520relation%2520to%2520cellular%2520phenotype%252C%2520growth%252C%2520and%2520signaling%2520events%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2004%26volume%3D6%26spage%3D41%26epage%3D52%26doi%3D10.1089%2F152308604771978336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress induced by the deubiquitinase Inhibitor b-AP15 is associated with mitochondrial impairment</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>2019</i></span>,  <span class="NLM_fpage">1659468</span>, <span class="refDoi"> DOI: 10.1155/2019/1659468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1155%2F2019%2F1659468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=31281566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3MzkvFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&pages=1659468&author=X.+Zhangauthor=B.+Espinosaauthor=A.+A.+Saeiauthor=P.+D%E2%80%99Arcyauthor=R.+A.+Zubarevauthor=S.+Linder&title=Oxidative+stress+induced+by+the+deubiquitinase+Inhibitor+b-AP15+is+associated+with+mitochondrial+impairment&doi=10.1155%2F2019%2F1659468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment</span></div><div class="casAuthors">Zhang Xiaonan; Linder Stig; Espinosa Belen; Saei Amir Ata; Zubarev Roman A; D'Arcy Padraig; Linder Stig</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">2019</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1659468</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibitors of the 20S proteasome such as bortezomib are cytotoxic to tumor cells and have been proven to be valuable for the clinical management of multiple myeloma.  The therapeutic efficacy of bortezomib is, however, hampered by the emergence of acquired resistance.  Available data suggest that blocking proteasome activity at the level of proteasome-associated deubiquitinases (DUBs) provides a mechanism to overcome resistance to bortezomib and also to other cancer therapies.  The small molecule b-AP15 is an inhibitor of proteasome-associated DUB activity that induces both proteotoxic stress and increases in the levels of reactive oxygen species (ROS) in tumor cells.  Antioxidants have been shown to decrease apoptosis induction by b-AP15 and we here addressed the question of the mechanism of redox perturbation by this compound.  We show that oxidative stress induction by b-AP15 is abrogated in cells deprived of mitochondrial DNA (ρ(0) cells).  We also show associations between the level of proteotoxic stress, the degree of mitochondrial dysfunction, and the extent of induction of hemeoxygenase-1 (HO-1), a target of the redox-regulated Nrf-2 transcription factor.  Decreased expression of COX5b (cytochrome c oxidase subunit 5b) and TOMM34 (translocase of outer mitochondrial membrane 34) was observed in b-AP15-treated cells.  These findings suggest a mitochondrial origin of the increased levels of ROS observed in cells exposed to the DUB inhibitor b-AP15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2QtG6nKnyx8ULxIEhxUjPfW6udTcc2eZgKjARc7MIyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzkvFKlsg%253D%253D&md5=9ea850d717dca2979aada651565b8da3</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1155%2F2019%2F1659468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2019%252F1659468%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DEspinosa%26aufirst%3DB.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DZubarev%26aufirst%3DR.%2BA.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DOxidative%2520stress%2520induced%2520by%2520the%2520deubiquitinase%2520Inhibitor%2520b-AP15%2520is%2520associated%2520with%2520mitochondrial%2520impairment%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2019%26volume%3D2019%26spage%3D1659468%26doi%3D10.1155%2F2019%2F1659468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McConkey, D. J.</span></span> <span> </span><span class="NLM_article-title">The integrated stress response and proteotoxicity in cancer therapy</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>482</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.11.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.bbrc.2016.11.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28212730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislOls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2017&pages=450-453&author=D.+J.+McConkey&title=The+integrated+stress+response+and+proteotoxicity+in+cancer+therapy&doi=10.1016%2Fj.bbrc.2016.11.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The integrated stress response and proteotoxicity in cancer therapy</span></div><div class="casAuthors">McConkey, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">482</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-453</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A variety of different forms of cellular stress can cause protein misfolding and aggregation and proteotoxicity.  The cytoprotective response to proteotoxicity is termed the integrated stress response and involves 4 distinct serine/threonine protein kinases that converge on the translation initiation factor eIF2α, resulting in phosphorylation at S51, cell cycle arrest, and a general inhibition of global protein synthesis.  Phosphorylation of eIF2α also promotes translation of ATF4 and the expression of ATF4 target genes that ameliorate proteotoxic stress but can also promote apoptosis.  This mini review provides a general overview of these mechanisms and discusses how the inter-tumor heterogeneity that involves them affects sensitivity and resistance to proteasome inhibitors, a new class of cancer therapeutics that promotes tumor cell killing via proteotoxic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY5ozOt66h4LVg90H21EOLACvtfcHk0liog_gqeYs6AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislOls7c%253D&md5=a431bf879aee79b0a557c91fcd301990</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.11.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.11.047%26sid%3Dliteratum%253Aachs%26aulast%3DMcConkey%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520integrated%2520stress%2520response%2520and%2520proteotoxicity%2520in%2520cancer%2520therapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D482%26spage%3D450%26epage%3D453%26doi%3D10.1016%2Fj.bbrc.2016.11.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheaff, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitherman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clurman, B. E.</span></span> <span> </span><span class="NLM_article-title">Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80435-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2FS1097-2765%2800%2980435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10882081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslyhtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=403-410&author=R.+J.+Sheaffauthor=J.+D.+Singerauthor=J.+Swangerauthor=M.+Smithermanauthor=J.+M.+Robertsauthor=B.+E.+Clurman&title=Proteasomal+turnover+of+p21Cip1+does+not+require+p21Cip1+ubiquitination&doi=10.1016%2FS1097-2765%2800%2980435-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination</span></div><div class="casAuthors">Sheaff, Robert J.; Singer, Jeffrey D.; Swanger, Jherek; Smitherman, Matthew; Roberts, James M.; Clurman, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-410</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Cdk inhibitor p21Cip1 is an unstable protein.  Pharmacol. inhibition of the proteasome increases the half-life of p21 from less than 30 min to more than 2 h and results in the accumulation of p21-ubiquitin conjugates.  To det. whether ubiquitination was required for proteasomal degrdn. of p21, we constructed mutant versions of p21 that were not ubiquitinated in vivo.  Remarkably, these mutants remained unstable and increased in abundance upon proteasome inhibition, indicating that direct ubiquitination of p21 is not necessary for its turnover by the proteasome.  The frequently obsd. correlation between protein ubiquitination and proteasomal degrdn. is insufficient to conclude that ubiquitination is a prerequisite for degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-UG8R_ulhbVg90H21EOLACvtfcHk0liog_gqeYs6AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslyhtb0%253D&md5=7febf859b6a71afe9488bbbcb12be8e2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980435-9%26sid%3Dliteratum%253Aachs%26aulast%3DSheaff%26aufirst%3DR.%2BJ.%26aulast%3DSinger%26aufirst%3DJ.%2BD.%26aulast%3DSwanger%26aufirst%3DJ.%26aulast%3DSmitherman%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DClurman%26aufirst%3DB.%2BE.%26atitle%3DProteasomal%2520turnover%2520of%2520p21Cip1%2520does%2520not%2520require%2520p21Cip1%2520ubiquitination%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D5%26spage%3D403%26epage%3D410%26doi%3D10.1016%2FS1097-2765%2800%2980435-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldeeb, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahlman, R. P.</span></span> <span> </span><span class="NLM_article-title">The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2714</span>– <span class="NLM_lpage">2722</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.1931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.1931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24798867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2cjgtVyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2714-2722&author=M.+A.+Eldeebauthor=R.+P.+Fahlman&title=The+anti-apoptotic+form+of+tyrosine+kinase+Lyn+that+is+generated+by+proteolysis+is+degraded+by+the+N-end+rule+pathway&doi=10.18632%2Foncotarget.1931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathway</span></div><div class="casAuthors">Eldeeb Mohamed A; Fahlman Richard P</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2714-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activation of apoptotic pathways results in the caspase cleavage of the Lyn tyrosine kinase to generate the N-terminal truncated LynΔN.  This LynΔN fragment has been demonstrated to exert negative feedback on imatinib induced apoptosis in chronic myelogenous leukemia (CML) K562 cells.  Our investigations focus on LynΔN stability and how reduced stability reduces imatinib resistance.  As the proteolytical generated LynΔN has a leucine as an N-terminal amino acid, we hypothesized that LynΔN would be degraded by the N-end rule pathway.  We demonstrated that LynΔN is unstable and that its stability is dependent on the identity of its N-terminus.  Additionally we established that LynΔN degradation could be inhibited by inhibiting either the proteasome or knocking down the UBR1 and UBR2 ubiquitin E3 ligases.  Importantly, we also demonstrate that LynΔN degradation by the N-end rule counters the imatinib resistance of K562 cells provided by LynΔN expression.  Together our data suggest a possible mechanism for the N-end rule pathway having a link to imatinib resistance in CML.  With LynΔN being an N-end rule substrate, it provides the first example that this pathway can also provide a pro-apoptotic function as previous reports have currently only demonstrated anti-apoptotic roles for the N-end rule pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuCHvDMYE2QxKDYG3bNImrfW6udTcc2ebyMDg-XzuUWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjgtVyksw%253D%253D&md5=f6b2fcb56e0cf4d9637a2b47daca1701</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.1931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.1931%26sid%3Dliteratum%253Aachs%26aulast%3DEldeeb%26aufirst%3DM.%2BA.%26aulast%3DFahlman%26aufirst%3DR.%2BP.%26atitle%3DThe%2520anti-apoptotic%2520form%2520of%2520tyrosine%2520kinase%2520Lyn%2520that%2520is%2520generated%2520by%2520proteolysis%2520is%2520degraded%2520by%2520the%2520N-end%2520rule%2520pathway%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D2714%26epage%3D2722%26doi%3D10.18632%2Foncotarget.1931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Pianzola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sierra, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Pomar, R.</span></span> <span> </span><span class="NLM_article-title">Internal ribosome entry site drives cap-independent translation of reaper and heat shock protein 70 mRNAs in Drosophila embryos</span>. <i>RNA</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1783</span>– <span class="NLM_lpage">1797</span>, <span class="refDoi"> DOI: 10.1261/rna.7154104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1261%2Frna.7154104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15496524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1783-1797&author=G.+Hernandezauthor=P.+Vazquez-Pianzolaauthor=J.+M.+Sierraauthor=R.+Rivera-Pomar&title=Internal+ribosome+entry+site+drives+cap-independent+translation+of+reaper+and+heat+shock+protein+70+mRNAs+in+Drosophila+embryos&doi=10.1261%2Frna.7154104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Internal ribosome entry site drives cap-independent translation of reaper and heat shock protein 70 mRNAs in Drosophila embryos</span></div><div class="casAuthors">Hernandez, Greco; Vazquez-Pianzola, Paula; Sierra, Jose M.; Rivera-Pomar, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">RNA</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1783-1797</span>CODEN:
                <span class="NLM_cas:coden">RNARFU</span>;
        ISSN:<span class="NLM_cas:issn">1355-8382</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Translation is a sensitive regulatory step during cellular stress and the apoptosis response.  Under such conditions, cap-dependent translation is reduced and internal ribosome entry site (IRES)-dependent translation plays a major role.  However, many aspects of how mRNAs are translated under stress remain to be elucidated.  Here we report that reaper mRNA, a pro-apoptotic gene from Drosophila melanogaster, is translated in a cap-independent manner.  In Drosophila mutant embryos devoid of the eukaryotic initiation factor 4E (eIF4E), reaper transcription is induced and apoptosis proceeds.  In vitro translation expts. using wild-type and eIF4E mutant embryonic exts. show that reporter mRNA bearing reaper 5' untranslated region (UTR) is effectively translated in a cap-independent manner.  The 5'UTR of reaper exhibits a high degree of similarity with that of Drosophila heat shock protein 70 mRNA, and both display IRES activity.  Studies of mRNA assocn. to polysomes in embryos indicate that both reaper and heat shock protein 70 mRNAs are recruited to polysomes under apoptosis or thermal stress.  Our data suggest that heat shock protein 70 and reaper, two antagonizing factors in apoptosis, use a similar mechanism for protein synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD460bVM8BDbVg90H21EOLACvtfcHk0ljk7JF3I8xazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOksb4%253D&md5=2e03fa37ee026975f001d15eac90bf81</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1261%2Frna.7154104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1261%252Frna.7154104%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DG.%26aulast%3DVazquez-Pianzola%26aufirst%3DP.%26aulast%3DSierra%26aufirst%3DJ.%2BM.%26aulast%3DRivera-Pomar%26aufirst%3DR.%26atitle%3DInternal%2520ribosome%2520entry%2520site%2520drives%2520cap-independent%2520translation%2520of%2520reaper%2520and%2520heat%2520shock%2520protein%252070%2520mRNAs%2520in%2520Drosophila%2520embryos%26jtitle%3DRNA%26date%3D2004%26volume%3D10%26spage%3D1783%26epage%3D1797%26doi%3D10.1261%2Frna.7154104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faustini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mofers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ternerot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span> <span> </span><span class="NLM_article-title">Induction of ER stress in acute lymphoblastic leukemia cells by the deubiquitinase inhibitor VLX1570</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4757</span>, <span class="refDoi"> DOI: 10.3390/ijms21134757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3390%2Fijms21134757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvF2gsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=4757&author=P.+Pellegriniauthor=K.+Selvarajuauthor=E.+Faustiniauthor=A.+Mofersauthor=X.+Zhangauthor=J.+Ternerotauthor=A.+Schubertauthor=S.+Linderauthor=P.+D%E2%80%99Arcy&title=Induction+of+ER+stress+in+acute+lymphoblastic+leukemia+cells+by+the+deubiquitinase+inhibitor+VLX1570&doi=10.3390%2Fijms21134757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of ER stress in acute lymphoblastic leukemia cells by the deubiquitinase inhibitor VLX1570</span></div><div class="casAuthors">Pellegrini, Paola; Selvaraju, Karthik; Faustini, Elena; Mofers, Arjan; Zhang, Xiaonan; Ternerot, Jens; Schubert, Alice; Linder, Stig; D'Arcy, Padraig</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4757</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The proteasome is a validated target of cancer therapeutics.  Defects in the UPR response has been reported to result in altered sensitivity of tumor cells to proteasome inhibitors.  Here, we characterized the effects of the deubiquitinase (DUB) inhibitor VLX1570 on protein homeostasis, both at the level of the UPR and on protein translation, in acute lymphoblastic leukemia (ALL).  Similar to the 20S inhibitor bortezomib, VLX1570 induced accumulation of polyubiquitinated proteins and increased expression of the chaperone Grp78/Bip in ALL cells.  Both compds. induced cleavage of PARP (Poly (ADP-ribose) polymerase) in ALL cells, consistent with induction of apoptosis.  However, and in contrast to bortezomib, VLX1570 treatment resulted in limited induction of the proapoptotic CHOP protein.  Translational inhibition was obsd. by both bortezomib and VLX1570.  We report that in distinction to bortezomib, suppression of translation by VXL1570 occurred at the level of elongation.  Increased levels of Hsc70/Hsp70 proteins were obsd. on polysomes following exposure to VLX1570, possibly suggesting defects in nascent protein folding.  Our findings demonstrate apoptosis induction in ALL cells that appears to be uncoupled from CHOP induction, and show that VLX1570 suppresses protein translation by a mechanism distinct from that of bortezomib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVZghJ89hltLVg90H21EOLACvtfcHk0ljk7JF3I8xazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvF2gsLrM&md5=d4fdc0c9159cc67138e679ec5971e358</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.3390%2Fijms21134757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21134757%26sid%3Dliteratum%253Aachs%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DFaustini%26aufirst%3DE.%26aulast%3DMofers%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTernerot%26aufirst%3DJ.%26aulast%3DSchubert%26aufirst%3DA.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26atitle%3DInduction%2520of%2520ER%2520stress%2520in%2520acute%2520lymphoblastic%2520leukemia%2520cells%2520by%2520the%2520deubiquitinase%2520inhibitor%2520VLX1570%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D4757%26doi%3D10.3390%2Fijms21134757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baccarani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masszi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digumarti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benichou, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akard, L.</span></span> <span> </span><span class="NLM_article-title">Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors</span>. <i>Leuk. Lymphoma</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.3109/10428194.2014.889826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.3109%2F10428194.2014.889826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=24650054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Cnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=120-127&author=H.+J.+Khouryauthor=J.+Cortesauthor=M.+Baccaraniauthor=M.+Wetzlerauthor=T.+Massziauthor=R.+Digumartiauthor=A.+Craigauthor=A.+C.+Benichouauthor=L.+Akard&title=Omacetaxine+mepesuccinate+in+patients+with+advanced+chronic+myeloid+leukemia+with+resistance+or+intolerance+to+tyrosine+kinase+inhibitors&doi=10.3109%2F10428194.2014.889826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors</span></div><div class="casAuthors">Khoury, H. Jean; Cortes, Jorge; Baccarani, Michele; Wetzler, Meir; Masszi, Tamas; Digumarti, Raghunadharao; Craig, Adam; Benichou, Annie-Claude; Akard, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-127</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1029-2403</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Omacetaxine mepesuccinate promotes apoptosis by inhibiting the prodn. of short-lived oncoproteins.  The efficacy and safety of omacetaxine in patients with advanced chronic myeloid leukemia (CML) previously treated with tyrosine kinase inhibitors were assessed in two phase II trials (CML-202 and CML-203).  Fifty-one patients in accelerated phase (AP-CML) and 44 in myeloid blast phase (BP-CML) received s.c. omacetaxine 1.25 mg/m2 twice daily days 1-14 every 28 days until hematol. response/improvement or any cytogenetic response, then days 1-7 every 28 days until disease progression.  The primary endpoint was maintenance or attainment of a major hematol. response (MHR).  Cytogenetic responses were also evaluated.  MHR was 37% in patients with AP-CML and 9% with BP-CML (22% and 5% in those with a history of T315I).  Most grade 3/4 adverse events were related to myelosuppression, and were generally manageable.  Omacetaxine demonstrates activity and an acceptable safety profile in pretreated patients with advanced CML, irresp. of mutational status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDKeSVnLwULbVg90H21EOLACvtfcHk0ljidEn9ZNMk-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Cnu78%253D&md5=1eb6327e31fec17474705e16e3a166ec</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.3109%2F10428194.2014.889826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428194.2014.889826%26sid%3Dliteratum%253Aachs%26aulast%3DKhoury%26aufirst%3DH.%2BJ.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DBaccarani%26aufirst%3DM.%26aulast%3DWetzler%26aufirst%3DM.%26aulast%3DMasszi%26aufirst%3DT.%26aulast%3DDigumarti%26aufirst%3DR.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DBenichou%26aufirst%3DA.%2BC.%26aulast%3DAkard%26aufirst%3DL.%26atitle%3DOmacetaxine%2520mepesuccinate%2520in%2520patients%2520with%2520advanced%2520chronic%2520myeloid%2520leukemia%2520with%2520resistance%2520or%2520intolerance%2520to%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DLeuk.%2520Lymphoma%26date%3D2015%26volume%3D56%26spage%3D120%26epage%3D127%26doi%3D10.3109%2F10428194.2014.889826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikuttyamma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmock, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span> <span> </span><span class="NLM_article-title">NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">65</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-8-65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2F1476-4598-8-65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19703310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD1MnhtVWmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=65&author=P.+Selvakumarauthor=A.+Lakshmikuttyammaauthor=U.+Dasauthor=H.+N.+Patiauthor=J.+R.+Dimmockauthor=R.+K.+Sharma&title=NC2213%3A+a+novel+methionine+aminopeptidase+2+inhibitor+in+human+colon+cancer+HT29+cells&doi=10.1186%2F1476-4598-8-65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells</span></div><div class="casAuthors">Selvakumar Ponniah; Lakshmikuttyamma Ashakumary; Das Umashankar; Pati Hari N; Dimmock Jonathan R; Sharma Rajendra K</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Methionine aminopeptidase 2 (MetAP2) is a bifunctional protein that plays a critical role in the regulation of post-translational processing and protein synthesis.  MetAP2 is overexpressed in human colon cancer.  In this report we screened various MetAP2 inhibitors and treated HT29 cells with various concentrations of compounds.  We evaluated the expression of MetAP2 and pp60c-src expressions in HT29 cells.  In addition we also carried out the cell proliferation and cell cycle analysis in the MetAP2 inhibitor-treated HT29 cells.  The cell cycle analysis of HT29 treated with 1.0 microM of NC2213 showed an arrest in the G2 phase followed by an induction in the percentage of cells undergoing apoptosis in the sub-G1 phase.  Western blot analysis revealed that the MetAP2 expression was dose-dependently decreased when the HT29 cells were treated with the 3,5-bis(benzylidene)-4-piperidone derivative (NC2213).  In addition, phosphorylation of Src, a myristoylated oncoprotein was significantly decreased by 1.0 microM of NC2213 as revealed by Western blot analysis.  Furthermore, NC2213 also inhibits the expression of pp60c-src in HT29 cells.  Interestingly, this compound also inhibits the phosphorylation at Tyr416 of pp60c-src while increasing the phosphorylation at Tyr527 of pp60c-src.  NC2213 inhibits the growth of HT29 cells by inducing apoptosis and might be useful for the treatment of human colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3GexXt5buJoUSrryheKE6fW6udTcc2eYgKU_ZTb-IDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnhtVWmsg%253D%253D&md5=a394a79edc860725073dce736e94c2e2</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-8-65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-8-65%26sid%3Dliteratum%253Aachs%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DLakshmikuttyamma%26aufirst%3DA.%26aulast%3DDas%26aufirst%3DU.%26aulast%3DPati%26aufirst%3DH.%2BN.%26aulast%3DDimmock%26aufirst%3DJ.%2BR.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26atitle%3DNC2213%253A%2520a%2520novel%2520methionine%2520aminopeptidase%25202%2520inhibitor%2520in%2520human%2520colon%2520cancer%2520HT29%2520cells%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26spage%3D65%26doi%3D10.1186%2F1476-4598-8-65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giglione, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fieulaine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinnel, T.</span></span> <span> </span><span class="NLM_article-title">N-terminal protein modifications: Bringing back into play the ribosome</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2014.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.biochi.2014.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25450248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2015&pages=134-146&author=C.+Giglioneauthor=S.+Fieulaineauthor=T.+Meinnel&title=N-terminal+protein+modifications%3A+Bringing+back+into+play+the+ribosome&doi=10.1016%2Fj.biochi.2014.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">N-terminal protein modifications: Bringing back into play the ribosome</span></div><div class="casAuthors">Giglione, Carmela; Fieulaine, Sonia; Meinnel, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134-146</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  N-terminal protein modifications correspond to the first modifications which in principle any protein may undergo, before translation is completed by the ribosome.  This class of essential modifications can have different nature or function and be catalyzed by a variety of dedicated enzymes.  Here, we review the current state of the major N-terminal co-translational modifications, with a particular emphasis to their catalysts, which belong to metalloprotease and acyltransferase clans.  The earliest of these modifications corresponds to the N-terminal methionine excision, an ubiquitous and essential process leading to the removal of the first methionine.  N-alpha acetylation occurs also in all Kingdoms although its extent appears to be significantly increased in higher eukaryotes.  Finally, N-myristoylation is a crucial pathway existing only in eukaryotes.  Recent studies dealing on how some of these co-translational modifiers might work in close vicinity of the ribosome is starting to provide new information on when these modifications exactly take place on the elongating nascent chain and the interplay with other ribosome biogenesis factors taking in charge the nascent chains.  Here a comprehensive overview of the recent advances in the field of N-terminal protein modifications is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7hWM170y6XbVg90H21EOLACvtfcHk0ljidEn9ZNMk-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgs7bL&md5=f872bd9f355dc93f16963f633996fc74</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2014.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2014.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DGiglione%26aufirst%3DC.%26aulast%3DFieulaine%26aufirst%3DS.%26aulast%3DMeinnel%26aufirst%3DT.%26atitle%3DN-terminal%2520protein%2520modifications%253A%2520Bringing%2520back%2520into%2520play%2520the%2520ribosome%26jtitle%3DBiochimie%26date%3D2015%26volume%3D114%26spage%3D134%26epage%3D146%26doi%3D10.1016%2Fj.biochi.2014.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghazizadeh, M.</span></span> <span> </span><span class="NLM_article-title">Methionine aminopeptidase 2 as a potential therapeutic target for human Non-Small-Cell Lung Cancers</span>. <i>Adv. clin exp med</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.17219/acem/60715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.17219%2Facem%2F60715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26935506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC28jmt1ymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=117-128&author=H.+Shimizuauthor=S.+Yamagishiauthor=H.+Chibaauthor=M.+Ghazizadeh&title=Methionine+aminopeptidase+2+as+a+potential+therapeutic+target+for+human+Non-Small-Cell+Lung+Cancers&doi=10.17219%2Facem%2F60715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers</span></div><div class="casAuthors">Shimizu Hajime; Yamagishi Shigeki; Chiba Hideki; Ghazizadeh Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Advances in clinical and experimental medicine : official organ Wroclaw Medical University</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-28</span>
        ISSN:<span class="NLM_cas:issn">1899-5276</span>.
    </div><div class="casAbstract">BACKGROUND:  Methionine aminopeptidase 2 (MetAP2) is a bi-functional protein that plays a critical role in the regulation of post-translational processing and protein synthesis.  OBJECTIVES:  We studied whether MetAP2 is activated and expressed in human non-small-cell lung cancer (NSCLC) tissues and whether inactivation of MetAP2 activity, with its specific inhibitor fumagillin, potentially inhibits proliferation of NSCLC cells.  MATERIAL AND METHODS:  The expression and function of MetAP2 were evaluated in NSCLC tissues, primary cell cultures and cell lines using immunohistochemistry, RT-PCR, Western blot, aminopeptidase activity assay and flow cytometry.  MetAP2 expression was also studied in relation to clinicopathological factors.  RESULTS:  MetAP2 expression in NSCLS, including adenocarcinoma (ADC) and squamous cell carcinoma (SCC), showed a moderate to strong positive reaction while normal appearing bronchial epithelium showed weak staining and normal alveolar epithelial cells were widely negative.  A high MetAP2 mRNA and protein expression was found in NSCLC tissues.  The aminopeptidase activity in NSCLC was 2-fold higher than that in normal lung tissues.  In a series of 41 ADC patients, MetAP2 expression was significantly correlated with patient's outcome or survival time.  Inhibition of MetAP2 by fumagillin in SCC cell lines revealed a significant increase in caspase-3 activity as compared to the control (p = 0.001).  CONCLUSIONS:  Our results indicate that MetAP2 is involved in NSCLC and is an important regulator of proliferative and apoptotic targets.  Thus inhibition of MetAP2, such as by fumagillin, may be a potential therapeutic modality for prevention of tumor cell growth, development and progression in NSCLC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZdBShAtFS45Pq5LRczm8ffW6udTcc2eZwJDXFZUW9TLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jmt1ymsw%253D%253D&md5=9e1837c67441b54ad779aa5a53d75d3f</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.17219%2Facem%2F60715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.17219%252Facem%252F60715%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DYamagishi%26aufirst%3DS.%26aulast%3DChiba%26aufirst%3DH.%26aulast%3DGhazizadeh%26aufirst%3DM.%26atitle%3DMethionine%2520aminopeptidase%25202%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520human%2520Non-Small-Cell%2520Lung%2520Cancers%26jtitle%3DAdv.%2520clin%2520exp%2520med%26date%3D2016%26volume%3D25%26spage%3D117%26epage%3D128%26doi%3D10.17219%2Facem%2F60715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheok, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, D. P.</span></span> <span> </span><span class="NLM_article-title">Reactivation of p53: from peptides to small molecules</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2010.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.tips.2010.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=21145600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=53-62&author=C.+J.+Brownauthor=C.+F.+Cheokauthor=C.+S.+Vermaauthor=D.+P.+Lane&title=Reactivation+of+p53%3A+from+peptides+to+small+molecules&doi=10.1016%2Fj.tips.2010.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of p53: from peptides to small molecules</span></div><div class="casAuthors">Brown, Christopher J.; Cheok, Chit F.; Verma, Chandra S.; Lane, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Approx. 27 million people are living with a tumor in which the tumor suppressing activity of p53 has been inactivated.  In half of these tumors, p53 itself is not mutated but the pathway is partially abrogated.  Mechanisms include the overexpression of neg. regulators of p53, such as MDM2 and MDM4, and deletion or epigenetic inactivation of the pos. regulators of p53 such as ARF.  In the other half of tumors, in which p53 is inactivated, p53 is mutated and ∼95% of these mutations lie in the core DNA-binding domain, which reflects the key role of p53 as a transcriptional activator.  Reactivation of the tumor suppressive properties of p53 is a key therapeutic goal, and the use of peptides in p53 research has led directly to the development of two alternative small mol. approaches: stabilization of mutant p53 to rescue its DNA-binding activity and inhibition of MDM2 or MDM4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEwC8b8rPel7Vg90H21EOLACvtfcHk0ljXucKmsjDwgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFyqug%253D%253D&md5=7db8e66bc56b36244aa359d22451f43d</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DC.%2BJ.%26aulast%3DCheok%26aufirst%3DC.%2BF.%26aulast%3DVerma%26aufirst%3DC.%2BS.%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3DReactivation%2520of%2520p53%253A%2520from%2520peptides%2520to%2520small%2520molecules%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D53%26epage%3D62%26doi%3D10.1016%2Fj.tips.2010.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgorbissa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manfredini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trimarco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frezzato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trentin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenzato, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">45429</span>– <span class="NLM_lpage">45443</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.9742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.9742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=27259251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FmtlCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=45429-45443&author=A.+Tomasellaauthor=R.+Piccoauthor=S.+Ciottiauthor=A.+Sgorbissaauthor=E.+Bianchiauthor=R.+Manfrediniauthor=F.+Benedettiauthor=V.+Trimarcoauthor=F.+Frezzatoauthor=L.+Trentinauthor=G.+Semenzatoauthor=D.+Deliaauthor=C.+Brancolini&title=The+isopeptidase+inhibitor+2cPE+triggers+proteotoxic+stress+and+ATM+activation+in+chronic+lymphocytic+leukemia+cells&doi=10.18632%2Foncotarget.9742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells</span></div><div class="casAuthors">Tomasella Andrea; Picco Raffaella; Ciotti Sonia; Sgorbissa Andrea; Brancolini Claudio; Bianchi Elisa; Manfredini Rossella; Brancolini Claudio; Benedetti Fabio; Trimarco Valentina; Frezzato Federica; Trentin Livio; Semenzato Gianpietro; Delia Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">45429-45443</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Relapse after treatment is a common and unresolved problem for patients suffering of the B-cell chronic lymphocytic leukemia (B-CLL).  Here we investigated the ability of the isopeptidase inhibitor 2cPE to trigger apoptosis in leukemia cells in comparison with bortezomib, another inhibitor of the ubiquitin-proteasome system (UPS).  Both inhibitors trigger apoptosis in CLL B cells and gene expression profiles studies denoted how a substantial part of genes up-regulated by these compounds are elements of adaptive responses, aimed to sustain cell survival. 2cPE treatment elicits the up-regulation of chaperones, proteasomal subunits and elements of the anti-oxidant response.  Selective inhibition of these responses augments apoptosis in response to 2cPE treatment.  We have also observed that the product of the ataxia telangiectasia mutated gene (ATM) is activated in 2cPE treated cells.  Stimulation of ATM signaling is possibly dependent on the alteration of the redox homeostasis.  Importantly ATM inhibition, mutations or down-modulation increase cell death in response to 2cPE.  Overall this work suggests that 2cPE could offer new opportunities for the treatment of B-CLL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXcM3Hnwm7KB0LsK7uFuY7fW6udTcc2eZwJDXFZUW9TLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FmtlCisQ%253D%253D&md5=e5e8637e4f46ea547f2671bc7e99f1bf</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.9742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.9742%26sid%3Dliteratum%253Aachs%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DPicco%26aufirst%3DR.%26aulast%3DCiotti%26aufirst%3DS.%26aulast%3DSgorbissa%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DE.%26aulast%3DManfredini%26aufirst%3DR.%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DTrimarco%26aufirst%3DV.%26aulast%3DFrezzato%26aufirst%3DF.%26aulast%3DTrentin%26aufirst%3DL.%26aulast%3DSemenzato%26aufirst%3DG.%26aulast%3DDelia%26aufirst%3DD.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DThe%2520isopeptidase%2520inhibitor%25202cPE%2520triggers%2520proteotoxic%2520stress%2520and%2520ATM%2520activation%2520in%2520chronic%2520lymphocytic%2520leukemia%2520cells%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D45429%26epage%3D45443%26doi%3D10.18632%2Foncotarget.9742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavin, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Person, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paull, T. T.</span></span> <span> </span><span class="NLM_article-title">ATM activation by oxidative stress</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1126/science.1192912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1126%2Fscience.1192912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20966255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSjsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=517-521&author=Z.+Guoauthor=S.+Kozlovauthor=M.+F.+Lavinauthor=M.+D.+Personauthor=T.+T.+Paull&title=ATM+activation+by+oxidative+stress&doi=10.1126%2Fscience.1192912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">ATM activation by oxidative stress</span></div><div class="casAuthors">Guo, Zhi; Kozlov, Sergei; Lavin, Martin F.; Person, Maria D.; Paull, Tanya T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6003</span>),
    <span class="NLM_cas:pages">517-521</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  The ataxia-telangiectasia mutated (ATM) protein kinase is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex and orchestrates signaling cascades that initiate the DNA damage response.  Cells lacking ATM are also hypersensitive to insults other than DSBs, particularly oxidative stress.  We show that oxidn. of ATM directly induces ATM activation in the absence of DNA DSBs and the MRN complex.  The oxidized form of ATM is a disulfide-crosslinked dimer, and mutation of a crit. cysteine residue involved in disulfide bond formation specifically blocked activation through the oxidn. pathway.  Identification of this pathway explains observations of ATM activation under conditions of oxidative stress and shows that ATM is an important sensor of reactive oxygen species in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQRoS4m9lFAbVg90H21EOLACvtfcHk0lgOb894v5Ngcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSjsbrO&md5=e491c99d5f4f09e270d8df52af316102</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1126%2Fscience.1192912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1192912%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DKozlov%26aufirst%3DS.%26aulast%3DLavin%26aufirst%3DM.%2BF.%26aulast%3DPerson%26aufirst%3DM.%2BD.%26aulast%3DPaull%26aufirst%3DT.%2BT.%26atitle%3DATM%2520activation%2520by%2520oxidative%2520stress%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D517%26epage%3D521%26doi%3D10.1126%2Fscience.1192912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landais, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddingh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarroll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoatlin, M. E.</span></span> <span> </span><span class="NLM_article-title">Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">133</span>, <span class="refDoi"> DOI: 10.1186/1476-4598-8-133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1186%2F1476-4598-8-133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20043851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FjtFWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=133&author=I.+Landaisauthor=S.+Hiddinghauthor=M.+McCarrollauthor=C.+Yangauthor=A.+Sunauthor=M.+S.+Turkerauthor=J.+P.+Snyderauthor=M.+E.+Hoatlin&title=Monoketone+analogs+of+curcumin%2C+a+new+class+of+Fanconi+anemia+pathway+inhibitors&doi=10.1186%2F1476-4598-8-133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors</span></div><div class="casAuthors">Landais Igor; Hiddingh Sanne; McCarroll Matthew; Yang Chao; Sun Aiming; Turker Mitchell S; Snyder James P; Hoatlin Maureen E</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Fanconi anemia (FA) pathway is a multigene DNA damage response network implicated in the repair of DNA lesions that arise during replication or after exogenous DNA damage.  The FA pathway displays synthetic lethal relationship with certain DNA repair genes such as ATM (Ataxia Telangectasia Mutated) that are frequently mutated in tumors.  Thus, inhibition of FANCD2 monoubiquitylation (FANCD2-Ub), a key step in the FA pathway, might target tumor cells defective in ATM through synthetic lethal interaction.  Curcumin was previously identified as a weak inhibitor of FANCD2-Ub.  The aim of this study is to identify derivatives of curcumin with better activity and specificity.  RESULTS:  Using a replication-free assay in Xenopus extracts, we screened monoketone analogs of curcumin for inhibition of FANCD2-Ub and identified analog EF24 as a strong inhibitor.  Mechanistic studies suggest that EF24 targets the FA pathway through inhibition of the NF-kB pathway kinase IKK.  In HeLa cells, nanomolar concentrations of EF24 inhibited hydroxyurea (HU)-induced FANCD2-Ub and foci in a cell-cycle independent manner.  Survival assays revealed that EF24 specifically sensitizes FA-competent cells to the DNA crosslinking agent mitomycin C (MMC).  In addition, in contrast with curcumin, ATM-deficient cells are twofold more sensitive to EF24 than matched wild-type cells, consistent with a synthetic lethal effect between FA pathway inhibition and ATM deficiency.  An independent screen identified 4H-TTD, a compound structurally related to EF24 that displays similar activity in egg extracts and in cells.  CONCLUSIONS:  These results suggest that monoketone analogs of curcumin are potent inhibitors of the FA pathway and constitute a promising new class of targeted anticancer compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNk4F0MtY8P669lAbTj9rGfW6udTcc2eYFNhyZfj-zk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FjtFWgtQ%253D%253D&md5=5c1d2ac76d4b6b5707b608ec4e215afb</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-8-133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-8-133%26sid%3Dliteratum%253Aachs%26aulast%3DLandais%26aufirst%3DI.%26aulast%3DHiddingh%26aufirst%3DS.%26aulast%3DMcCarroll%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DTurker%26aufirst%3DM.%2BS.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DHoatlin%26aufirst%3DM.%2BE.%26atitle%3DMonoketone%2520analogs%2520of%2520curcumin%252C%2520a%2520new%2520class%2520of%2520Fanconi%2520anemia%2520pathway%2520inhibitors%26jtitle%3DMol.%2520Cancer%26date%3D2009%26volume%3D8%26spage%3D133%26doi%3D10.1186%2F1476-4598-8-133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsello, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natoli, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubelli, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asiedu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahr, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberzon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzechowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enache, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrcic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosains, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardlie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenside, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read-Button, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doench, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span> <span> </span><span class="NLM_article-title">A next generation connectivity map: L1000 platform and the first 1,000,000 profiles</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1452</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.10.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.cell.2017.10.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29195078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2017&pages=1437-1452&author=A.+Subramanianauthor=R.+Narayanauthor=S.+M.+Corselloauthor=D.+D.+Peckauthor=T.+E.+Natoliauthor=X.+Luauthor=J.+Gouldauthor=J.+F.+Davisauthor=A.+A.+Tubelliauthor=J.+K.+Asieduauthor=D.+L.+Lahrauthor=J.+E.+Hirschmanauthor=Z.+Liuauthor=M.+Donahueauthor=B.+Julianauthor=M.+Khanauthor=D.+Waddenauthor=I.+C.+Smithauthor=D.+Lamauthor=A.+Liberzonauthor=C.+Toderauthor=M.+Bagulauthor=M.+Orzechowskiauthor=O.+M.+Enacheauthor=F.+Piccioniauthor=S.+A.+Johnsonauthor=N.+J.+Lyonsauthor=A.+H.+Bergerauthor=A.+F.+Shamjiauthor=A.+N.+Brooksauthor=A.+Vrcicauthor=C.+Flynnauthor=J.+Rosainsauthor=D.+Y.+Takedaauthor=R.+Huauthor=D.+Davisonauthor=J.+Lambauthor=K.+Ardlieauthor=L.+Hogstromauthor=P.+Greensideauthor=N.+S.+Grayauthor=P.+A.+Clemonsauthor=S.+Silverauthor=X.+Wuauthor=W.+N.+Zhaoauthor=W.+Read-Buttonauthor=X.+Wuauthor=S.+J.+Haggartyauthor=L.+V.+Roncoauthor=J.+S.+Boehmauthor=S.+L.+Schreiberauthor=J.+G.+Doenchauthor=J.+A.+Bittkerauthor=D.+E.+Rootauthor=B.+Wongauthor=T.+R.+Golub&title=A+next+generation+connectivity+map%3A+L1000+platform+and+the+first+1%2C000%2C000+profiles&doi=10.1016%2Fj.cell.2017.10.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A next generation connectivity map: L1000 platform and the first 1,000,000 profiles</span></div><div class="casAuthors">Subramanian, Aravind; Narayan, Rajiv; Corsello, Steven M.; Peck, David D.; Natoli, Ted E.; Lu, Xiaodong; Gould, Joshua; Davis, John F.; Tubelli, Andrew A.; Asiedu, Jacob K.; Lahr, David L.; Hirschman, Jodi E.; Liu, Zihan; Donahue, Melanie; Julian, Bina; Khan, Mariya; Wadden, David; Smith, Ian C.; Lam, Daniel; Liberzon, Arthur; Toder, Courtney; Bagul, Mukta; Orzechowski, Marek; Enache, Oana M.; Piccioni, Federica; Johnson, Sarah A.; Lyons, Nicholas J.; Berger, Alice H.; Shamji, Alykhan F.; Brooks, Angela N.; Vrcic, Anita; Flynn, Corey; Rosains, Jacqueline; Takeda, David Y.; Hu, Roger; Davison, Desiree; Lamb, Justin; Ardlie, Kristin; Hogstrom, Larson; Greenside, Peyton; Gray, Nathanael S.; Clemons, Paul A.; Silver, Serena; Wu, Xiaoyun; Zhao, Wen-Ning; Read-Button, Willis; Wu, Xiaohua; Haggarty, Stephen J.; Ronco, Lucienne V.; Boehm, Jesse S.; Schreiber, Stuart L.; Doench, John G.; Bittker, Joshua A.; Root, David E.; Wong, Bang; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1437-1452.e17</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures.  Here, we report more than a 1000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000.  We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts.  We further show that the expanded CMap can be used to discover mechanism of action of small mols., functionally annotate genetic variants of disease genes, and inform clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIWrWy5IxY-rVg90H21EOLACvtfcHk0lgOb894v5Ngcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsbrE&md5=d2b13f2b80fe94021ac03f6a8c859a4a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.10.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.10.049%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DNarayan%26aufirst%3DR.%26aulast%3DCorsello%26aufirst%3DS.%2BM.%26aulast%3DPeck%26aufirst%3DD.%2BD.%26aulast%3DNatoli%26aufirst%3DT.%2BE.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DGould%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DJ.%2BF.%26aulast%3DTubelli%26aufirst%3DA.%2BA.%26aulast%3DAsiedu%26aufirst%3DJ.%2BK.%26aulast%3DLahr%26aufirst%3DD.%2BL.%26aulast%3DHirschman%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDonahue%26aufirst%3DM.%26aulast%3DJulian%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DWadden%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DI.%2BC.%26aulast%3DLam%26aufirst%3DD.%26aulast%3DLiberzon%26aufirst%3DA.%26aulast%3DToder%26aufirst%3DC.%26aulast%3DBagul%26aufirst%3DM.%26aulast%3DOrzechowski%26aufirst%3DM.%26aulast%3DEnache%26aufirst%3DO.%2BM.%26aulast%3DPiccioni%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DLyons%26aufirst%3DN.%2BJ.%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DBrooks%26aufirst%3DA.%2BN.%26aulast%3DVrcic%26aufirst%3DA.%26aulast%3DFlynn%26aufirst%3DC.%26aulast%3DRosains%26aufirst%3DJ.%26aulast%3DTakeda%26aufirst%3DD.%2BY.%26aulast%3DHu%26aufirst%3DR.%26aulast%3DDavison%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DArdlie%26aufirst%3DK.%26aulast%3DHogstrom%26aufirst%3DL.%26aulast%3DGreenside%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DSilver%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DW.%2BN.%26aulast%3DRead-Button%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DRonco%26aufirst%3DL.%2BV.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DDoench%26aufirst%3DJ.%2BG.%26aulast%3DBittker%26aufirst%3DJ.%2BA.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DA%2520next%2520generation%2520connectivity%2520map%253A%2520L1000%2520platform%2520and%2520the%2520first%25201%252C000%252C000%2520profiles%26jtitle%3DCell%26date%3D2017%26volume%3D171%26spage%3D1437%26epage%3D1452%26doi%3D10.1016%2Fj.cell.2017.10.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mootha, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span> <span> </span><span class="NLM_article-title">Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15550</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506580102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1073%2Fpnas.0506580102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16199517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=15545-15550&author=A.+Subramanianauthor=P.+Tamayoauthor=V.+K.+Moothaauthor=S.+Mukherjeeauthor=B.+L.+Ebertauthor=M.+A.+Gilletteauthor=A.+Paulovichauthor=S.+L.+Pomeroyauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=J.+P.+Mesirov&title=Gene+set+enrichment+analysis%3A+a+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles&doi=10.1073%2Fpnas.0506580102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span></div><div class="casAuthors">Subramanian, Aravind; Tamayo, Pablo; Mootha, Vamsi K.; Mukherjee, Sayan; Ebert, Benjamin L.; Gillette, Michael A.; Paulovich, Amanda; Pomeroy, Scott L.; Golub, Todd R.; Lander, Eric S.; Mesirov, Jill P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15545-15550</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although genomewide RNA expression anal. has become a routine tool in biomedical research, extg. biol. insight from such information remains a major challenge.  Here, we describe a powerful anal. method called Gene Set Enrichment Anal. (GSEA) for interpreting gene expression data.  The method derives its power by focusing on gene sets, i.e., groups of genes that share common biol. function, chromosomal location, or regulation.  We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer.  Notably, where single-gene anal. finds little similarity between two independent studies of patients survival in lung cancer, GSEA reveals many biol. pathways in common.  The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biol. defined gene sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH2_E6gWd0yrVg90H21EOLACvtfcHk0lhTgXJ_NXTVzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO&md5=ca2eb221010f20379199e6442c65fc2e</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506580102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506580102%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGillette%26aufirst%3DM.%2BA.%26aulast%3DPaulovich%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26atitle%3DGene%2520set%2520enrichment%2520analysis%253A%2520a%2520knowledge-based%2520approach%2520for%2520interpreting%2520genome-wide%2520expression%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D15545%26epage%3D15550%26doi%3D10.1073%2Fpnas.0506580102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brnjic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saei, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mofers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubarev, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>448</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2019.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.canlet.2019.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30768956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2019&pages=70-83&author=E.+K.+Hillertauthor=S.+Brnjicauthor=X.+Zhangauthor=M.+Mazurkiewiczauthor=A.+A.+Saeiauthor=A.+Mofersauthor=K.+Selvarajuauthor=R.+Zubarevauthor=S.+Linderauthor=P.+D%E2%80%99Arcy&title=Proteasome+inhibitor+b-AP15+induces+enhanced+proteotoxicity+by+inhibiting+cytoprotective+aggresome+formation&doi=10.1016%2Fj.canlet.2019.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation</span></div><div class="casAuthors">Hillert, Ellin-Kristina; Brnjic, Slavica; Zhang, Xiaonan; Mazurkiewicz, Magdalena; Saei, Amir Ata; Mofers, Arjan; Selvaraju, Karthik; Zubarev, Roman; Linder, Stig; D'Arcy, Padraig</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Proteasome inhibitors have been shown to induce cell death in cancer cells by triggering an acute proteotoxic stress response characterized by accumulation of poly-ubiquitinated proteins, ER stress and the prodn. of reactive oxygen species.  The aggresome pathway has been described as an escape mechanism from proteotoxicity by sequestering toxic cellular aggregates.  Here we show that b-AP15, a small-mol. inhibitor of proteasomal deubiquitinase activity, induces poly-ubiquitin accumulation in absence of aggresome formation. b-AP15 was found to affect organelle transport in treated cells, raising the possibility that microtubule-transport of toxic protein aggregates is inhibited, leading to enhanced cytotoxicity.  In contrast to the antiproliferative effects of the clin. used proteasome inhibitor bortezomib, the effects of b-AP15 are not further enhanced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).  Our results suggest an inhibitory effect of b-AP15 on the transport of misfolded proteins, resulting in a lack of aggresome formation, and a strong proteotoxic stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAsKIith5aTrVg90H21EOLACvtfcHk0lhTgXJ_NXTVzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbg%253D&md5=29b6a15a8926a57b43f3ad0980a22a27</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2019.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2019.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DBrnjic%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DSaei%26aufirst%3DA.%2BA.%26aulast%3DMofers%26aufirst%3DA.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DZubarev%26aufirst%3DR.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26atitle%3DProteasome%2520inhibitor%2520b-AP15%2520induces%2520enhanced%2520proteotoxicity%2520by%2520inhibiting%2520cytoprotective%2520aggresome%2520formation%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D448%26spage%3D70%26epage%3D83%26doi%3D10.1016%2Fj.canlet.2019.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simms-Waldrip, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K. M.</span></span> <span> </span><span class="NLM_article-title">Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2557</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-5989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F0008-5472.CAN-07-5989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=18413721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Git7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2557-2560&author=A.+Rodriguez-Gonzalezauthor=T.+Linauthor=A.+K.+Ikedaauthor=T.+Simms-Waldripauthor=C.+Fuauthor=K.+M.+Sakamoto&title=Role+of+the+aggresome+pathway+in+cancer%3A+targeting+histone+deacetylase+6-dependent+protein+degradation&doi=10.1158%2F0008-5472.CAN-07-5989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6-Dependent Protein Degradation</span></div><div class="casAuthors">Rodriguez-Gonzalez, Agustin; Lin, Tara; Ikeda, Alan K.; Simms-Waldrip, Tiffany; Fu, Cecilia; Sakamoto, Kathleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2557-2560</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Misfolded or aggregated proteins have two fates: they are either refolded with the help of chaperones or degraded by the proteasome.  Cells also have an alternative pathway that involves intracellular "storage bins" for misfolded intracellular proteins known as aggresomes.  Aggresomes recruit motor proteins that transport misfolded or aggregated proteins to chaperones and proteasomes for subsequent destruction.  There is emerging evidence that inhibiting the aggresome pathway leads to accumulation of misfolded proteins and apoptosis in tumor cells through autophagy.  We discuss the role of aggresomes in cancer and the potential to target this pathway for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO2L35Ht3RbVg90H21EOLACvtfcHk0lifqai9QVgxQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Git7o%253D&md5=1e811e9d6cbc801be733fbb74e5fa2f3</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5989%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Gonzalez%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DA.%2BK.%26aulast%3DSimms-Waldrip%26aufirst%3DT.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26atitle%3DRole%2520of%2520the%2520aggresome%2520pathway%2520in%2520cancer%253A%2520targeting%2520histone%2520deacetylase%25206-dependent%2520protein%2520degradation%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2557%26epage%3D2560%26doi%3D10.1158%2F0008-5472.CAN-07-5989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cajone, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crescente, M.</span></span> <span> </span><span class="NLM_article-title">In vitro activation of heat shock transcription factor by 4-hydroxynonenal</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/0009-2797(92)90071-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2F0009-2797%2892%2990071-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1394624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK3sXit12i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1992&pages=97-112&author=F.+Cajoneauthor=M.+Crescente&title=In+vitro+activation+of+heat+shock+transcription+factor+by+4-hydroxynonenal&doi=10.1016%2F0009-2797%2892%2990071-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activation of heat shock transcription factor by 4-hydroxynonenal</span></div><div class="casAuthors">Cajone, Francesco; Crescente, Melchiorre</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-112</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    </div><div class="casAbstract">The in vitro activation of heat shock factor (HSF) by treating at 0° a HeLa cell-free system with the aldehyde 4-hydroxynonenal (HNE), a highly cytotoxic product of lipid peroxidn. was investigated.  The in vitro activation of HSF by HNE occurred only if some components of the cell-free system were not sedimented at 100,000 × g.  The reason for this is unclear but the release of active HSF from nuclei of unshocked cells and the involvement of Ca2+ contained in the mitochondria and ER have been excluded.  Although HNE is known to be a sulfhydryl blocking agent, the results obtained with N-ethylmaleimide suggest that different mechanisms might be involved in the in vitro activation of HSF by HNE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUevonBZf3gbVg90H21EOLACvtfcHk0lifqai9QVgxQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12i&md5=9d38c1e5d92b7149cc5b7a7e2792f7a7</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2F0009-2797%2892%2990071-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-2797%252892%252990071-R%26sid%3Dliteratum%253Aachs%26aulast%3DCajone%26aufirst%3DF.%26aulast%3DCrescente%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520activation%2520of%2520heat%2520shock%2520transcription%2520factor%2520by%25204-hydroxynonenal%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D1992%26volume%3D84%26spage%3D97%26epage%3D112%26doi%3D10.1016%2F0009-2797%2892%2990071-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anton, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norbury, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yewdell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennink, J. R.</span></span> <span> </span><span class="NLM_article-title">Rapid degradation of a large fraction of newly synthesized proteins by proteasomes</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>404</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1038/35008096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2F35008096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10783891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVamtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=404&publication_year=2000&pages=770-774&author=U.+Schubertauthor=L.+C.+Antonauthor=J.+Gibbsauthor=C.+C.+Norburyauthor=J.+W.+Yewdellauthor=J.+R.+Bennink&title=Rapid+degradation+of+a+large+fraction+of+newly+synthesized+proteins+by+proteasomes&doi=10.1038%2F35008096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid degradation of a large fraction of newly synthesized proteins by proteasomes</span></div><div class="casAuthors">Schubert, Ulrich; Anton, Luis C.; Gibbs, James; Norbury, Christopher C.; Yewdell, Jonathan W.; Bennink, Jack R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">404</span>
        (<span class="NLM_cas:issue">6779</span>),
    <span class="NLM_cas:pages">770-774</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MHC class I mols. function to present peptides eight to ten residues long to the immune system.  These peptides originate primarily from a cytosolic pool of proteins through the actions of proteasomes, and are transported into the endoplasmic reticulum, where they assemble with nascent class I mols.  Most peptides are generated from proteins that are apparently metabolically stable.  To explain this, we previously proposed that peptides arise from proteasomal degrdn. of defective ribosomal products (DRiPs).  DRiPs are polypeptides that never attain native structure owing to errors in translation or post-translational processes necessary for proper protein folding.  Here we show, first, that DRiPs constitute upwards of 30% of newly synthesized proteins as detd. in a variety of cell types; second, that at least some DRiPs represent ubiquitinated proteins; and last, that ubiquitinated DRiPs are formed from human immunodeficiency virus Gag polyprotein, a long-lived viral protein that serves as a source of antigenic peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIZmF6WIlRkbVg90H21EOLACvtfcHk0lhNl9REME4Dxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVamtbs%253D&md5=939730948ac7e6819a540336b06b1ee6</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2F35008096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35008096%26sid%3Dliteratum%253Aachs%26aulast%3DSchubert%26aufirst%3DU.%26aulast%3DAnton%26aufirst%3DL.%2BC.%26aulast%3DGibbs%26aufirst%3DJ.%26aulast%3DNorbury%26aufirst%3DC.%2BC.%26aulast%3DYewdell%26aufirst%3DJ.%2BW.%26aulast%3DBennink%26aufirst%3DJ.%2BR.%26atitle%3DRapid%2520degradation%2520of%2520a%2520large%2520fraction%2520of%2520newly%2520synthesized%2520proteins%2520by%2520proteasomes%26jtitle%3DNature%26date%3D2000%26volume%3D404%26spage%3D770%26epage%3D774%26doi%3D10.1038%2F35008096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roboti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puumalainen, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hult, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">High, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanton, E.</span></span> <span> </span><span class="NLM_article-title">Elevation of proteasomal substrate levels sensitizes cells to apoptosis induced by inhibition of proteasomal deubiquitinases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e108839</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0108839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0108839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25286379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjs7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=C.+Sunauthor=P.+Robotiauthor=M.+R.+Puumalainenauthor=M.+Fryknasauthor=X.+Wangauthor=P.+D%E2%80%99Arcyauthor=M.+Hultauthor=S.+Highauthor=S.+Linderauthor=E.+Swanton&title=Elevation+of+proteasomal+substrate+levels+sensitizes+cells+to+apoptosis+induced+by+inhibition+of+proteasomal+deubiquitinases&doi=10.1371%2Fjournal.pone.0108839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Elevation of proteasomal substrate levels sensitizes cells to apoptosis induced by inhibition of proteasomal deubiquitinases</span></div><div class="casAuthors">Sun, Chao; Roboti, Peristera; Puumalainen, Marjo-Riitta; Fryknaes, Maarten; Wang, Xin; D'Arcy, Padraig; Hult, Malin; High, Stephen; Linder, Stig; Swanton, Eileithyia</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e108839/1-e108839/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Inhibitors of the catalytic activity of the 20S proteasome are cytotoxic to tumor cells and are currently in clin. use for treatment of multiple myeloma, while the deubiquitinase activity assocd. with the 19S regulatory subunit of the proteasome is also a valid target for anti-cancer drugs.  The mechanisms underlying the therapeutic efficacy of these drugs and their selective toxicity towards cancer cells are not known.  Here, we show that increasing the cellular levels of proteasome substrates using an inhibitor of Sec61-mediated protein translocation significantly increases the extent of apoptosis that is induced by inhibition of proteasomal deubiquitinase activity in both cancer derived and non-transformed cell lines.  Our results suggest that increased generation of misfolded proteasome substrates may contribute to the mechanism(s) underlying the increased sensitivity of tumor cells to inhibitors of the ubiquitin-proteasome system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv3i0iiIVLWbVg90H21EOLACvtfcHk0lhNl9REME4Dxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjs7jK&md5=998aad975eb148f0a4a0e73362d80ae3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0108839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0108839%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%26aulast%3DRoboti%26aufirst%3DP.%26aulast%3DPuumalainen%26aufirst%3DM.%2BR.%26aulast%3DFryknas%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DHult%26aufirst%3DM.%26aulast%3DHigh%26aufirst%3DS.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DSwanton%26aufirst%3DE.%26atitle%3DElevation%2520of%2520proteasomal%2520substrate%2520levels%2520sensitizes%2520cells%2520to%2520apoptosis%2520induced%2520by%2520inhibition%2520of%2520proteasomal%2520deubiquitinases%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0108839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harant, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberhauser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquardt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dascher-Nadel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindley, I. J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>436</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1038/nature03670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnature03670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16015337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVeku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=290-293&author=J.+Besemerauthor=H.+Harantauthor=S.+Wangauthor=B.+Oberhauserauthor=K.+Marquardtauthor=C.+A.+Fosterauthor=E.+P.+Schreinerauthor=J.+E.+de+Vriesauthor=C.+Dascher-Nadelauthor=I.+J.+Lindley&title=Selective+inhibition+of+cotranslational+translocation+of+vascular+cell+adhesion+molecule+1&doi=10.1038%2Fnature03670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1</span></div><div class="casAuthors">Besemer, Juergen; Harant, Hanna; Wang, Shirley; Oberhauser, Berndt; Marquardt, Katharina; Foster, Carolyn A.; Schreiner, Erwin P.; de Vries, Jan E.; Dascher-Nadel, Christiane; Lindley, Ivan J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7048</span>),
    <span class="NLM_cas:pages">290-293</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increased expression of vascular cell adhesion mol. 1 (VCAM1) is assocd. with a variety of chronic inflammatory conditions, making its expression and function a target for therapeutic intervention.  The authors have recently identified CAM741, a deriv. of a fungus-derived cyclopeptolide that acts as a selective inhibitor of VCAM1 synthesis in endothelial cells.  Here the authors show that the compd. represses the biosynthesis of VCAM1 in cells by blocking the process of cotranslational translocation, which is dependent on the signal peptide of VCAM1.  CAM741 does not inhibit targeting of the VCAM1 nascent chains to the translocon channel but prevents translocation to the luminal side of the endoplasmic reticulum (ER), through a process that involves the translocon component Sec61β.  Consequently, the VCAM1 precursor protein is synthesized towards the cytosolic compartment of the cells, where it is degraded.  Our results indicate that the inhibition of cotranslational translocation with low-mol.-mass compds., using specificity conferred by signal peptides, can modulate the biosynthesis of certain secreted and/or membrane proteins.  In addn., they highlight cotranslational translocation at the ER membrane as a potential target for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe18k16JGYwrVg90H21EOLACvtfcHk0lhNl9REME4Dxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVeku7c%253D&md5=6f0bf182517369a03787dcae708e35a9</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Fnature03670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03670%26sid%3Dliteratum%253Aachs%26aulast%3DBesemer%26aufirst%3DJ.%26aulast%3DHarant%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DOberhauser%26aufirst%3DB.%26aulast%3DMarquardt%26aufirst%3DK.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DSchreiner%26aufirst%3DE.%2BP.%26aulast%3Dde%2BVries%26aufirst%3DJ.%2BE.%26aulast%3DDascher-Nadel%26aufirst%3DC.%26aulast%3DLindley%26aufirst%3DI.%2BJ.%26atitle%3DSelective%2520inhibition%2520of%2520cotranslational%2520translocation%2520of%2520vascular%2520cell%2520adhesion%2520molecule%25201%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D290%26epage%3D293%26doi%3D10.1038%2Fnature03670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, R. G.</span></span> <span> </span><span class="NLM_article-title">Protein quality control degradation in the nucleus</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">725</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-062917-012730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1146%2Fannurev-biochem-062917-012730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29925261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=725-749&author=C.+Enamauthor=Y.+Geffenauthor=T.+Ravidauthor=R.+G.+Gardner&title=Protein+quality+control+degradation+in+the+nucleus&doi=10.1146%2Fannurev-biochem-062917-012730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Quality Control Degradation in the Nucleus</span></div><div class="casAuthors">Enam, Charisma; Geffen, Yifat; Ravid, Tommer; Gardner, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">725-749</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Nuclear proteins participate in diverse cellular processes, many of which are essential for cell survival and viability.  To maintain optimal nuclear physiol., the cell employs the ubiquitin-proteasome system to eliminate damaged and misfolded proteins in the nucleus that could otherwise harm the cell.  In this review, we highlight the current knowledge about the major ubiquitin-protein ligases involved in protein quality control degrdn. (PQCD) in the nucleus and how they orchestrate their functions to eliminate misfolded proteins in different nuclear subcompartments.  Many human disorders are causally linked to protein misfolding in the nucleus, hence we discuss major concepts that still need to be clarified to better understand the basis of the nuclear misfolded proteins' toxic effects.  Addnl., we touch upon potential strategies for manipulating nuclear PQCD pathways to ameliorate diseases assocd. with protein misfolding and aggregation in the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGrwGXTr8ZLVg90H21EOLACvtfcHk0lhY-YJLBumIww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrrI&md5=5a4bce377874dbbbd1072b04f08e41da</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-062917-012730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-062917-012730%26sid%3Dliteratum%253Aachs%26aulast%3DEnam%26aufirst%3DC.%26aulast%3DGeffen%26aufirst%3DY.%26aulast%3DRavid%26aufirst%3DT.%26aulast%3DGardner%26aufirst%3DR.%2BG.%26atitle%3DProtein%2520quality%2520control%2520degradation%2520in%2520the%2520nucleus%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26spage%3D725%26epage%3D749%26doi%3D10.1146%2Fannurev-biochem-062917-012730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seckinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hose, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haefeli, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burhenne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J.</span></span> <span> </span><span class="NLM_article-title">Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1007/s00280-014-2643-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs00280-014-2643-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=25477008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2gtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=281-291&author=J.+Clemensauthor=A.+Seckingerauthor=D.+Hoseauthor=D.+Theileauthor=M.+Longoauthor=W.+E.+Haefeliauthor=J.+Burhenneauthor=J.+Weiss&title=Cellular+uptake+kinetics+of+bortezomib+in+relation+to+efficacy+in+myeloma+cells+and+the+influence+of+drug+transporters&doi=10.1007%2Fs00280-014-2643-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters</span></div><div class="casAuthors">Clemens, Jannick; Seckinger, Anja; Hose, Dirk; Theile, Dirk; Longo, Magdalena; Haefeli, Walter Emil; Burhenne, Juergen; Weiss, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-291</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Despite overall successful application to multiple myeloma patients, clin. efficacy of the proteasome inhibitor bortezomib is typically challenged by primary and secondary resistance of unknown origin.  So far, the potential impact of intracellular concns. on drug efficacy of bortezomib and the influence of drug transporters are unknown.  Methods: We detd. cellular bortezomib kinetics in nine myeloma cell lines using ultrahigh-performance liq. chromatog. coupled to tandem mass spectrometry.  The potential influence of drug transporters on the uptake kinetics obsd. in these cell lines was investigated by testing substrate characteristics of bortezomib for several transporters in over-expressing model cells.  Addnl., transporter mRNA expression was quantified in myeloma cell lines by real-time polymerase chain reaction (RT-PCR).  Results: All myeloma cells revealed an extensive intracellular bortezomib accumulation (47.5-183 ng/mL) exceeding extracellular concns. (0.04-0.17 ng/mL) by more than factor 1,000.  Only org. anion-transporting polypeptide 1B1 facilitated the uptake in over-expressing cells, however, to a negligible extent (factor 1.36).  Bortezomib efflux via P-glycoprotein was confirmed by demonstrating reduced sensitivity (IC50 11.6 vs. 2.8 ng/mL) and intracellular concns. (-56.1 %) in over-expressing cells compared to controls.  RT-PCR revealed a varying but overall weak transporter expression in the studied myeloma cells without any correlation to intracellular concns.  Although principally valid as demonstrated in the P-glycoprotein over-expressing cell model, there was no significant correlation between intracellular concns. and bortezomib efficacy in myeloma cell lines.  Conclusion: Differences in intracellular concns. in myeloma cell lines neither result from variable transporter expression nor represent the main factor detg. bortezomib efficacy in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Hx5lUe6yULVg90H21EOLACvtfcHk0lhY-YJLBumIww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2gtL3N&md5=d7af0098f6411bd69213589f0fe1ef50</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1007%2Fs00280-014-2643-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-014-2643-1%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DSeckinger%26aufirst%3DA.%26aulast%3DHose%26aufirst%3DD.%26aulast%3DTheile%26aufirst%3DD.%26aulast%3DLongo%26aufirst%3DM.%26aulast%3DHaefeli%26aufirst%3DW.%2BE.%26aulast%3DBurhenne%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DJ.%26atitle%3DCellular%2520uptake%2520kinetics%2520of%2520bortezomib%2520in%2520relation%2520to%2520efficacy%2520in%2520myeloma%2520cells%2520and%2520the%2520influence%2520of%2520drug%2520transporters%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2015%26volume%3D75%26spage%3D281%26epage%3D291%26doi%3D10.1007%2Fs00280-014-2643-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menendez-Benito, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoef, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masucci, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantuma, N. P.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum stress compromises the ubiquitin-proteasome system</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2787</span>– <span class="NLM_lpage">2799</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddi312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Fhmg%2Fddi312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=16103128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWnt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=2787-2799&author=V.+Menendez-Benitoauthor=L.+G.+Verhoefauthor=M.+G.+Masucciauthor=N.+P.+Dantuma&title=Endoplasmic+reticulum+stress+compromises+the+ubiquitin-proteasome+system&doi=10.1093%2Fhmg%2Fddi312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic reticulum stress compromises the ubiquitin-proteasome system</span></div><div class="casAuthors">Menendez-Benito, Victoria; Verhoef, Lisette G. G. C.; Masucci, Maria G.; Dantuma, Nico P.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2787-2799</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The presence of endoplasmic reticulum (ER) stress and impaired ubiquitin-proteasome system (UPS) activity has been independently implicated in the pathophysiol. of conformational diseases.  Here, we reveal a link between ER stress and the functionality of the UPS.  Treatment of cells with different ER stressors delayed the degrdn. of an ER reporter substrate and caused a subtle but consistent accumulation of three independent nuclear/cytosolic UPS reporter substrates.  A similar signature increase was obsd. upon induction of ER stress in transgenic mice expressing a reporter substrate.  Cells undergoing ER stress failed to clear efficiently UBB+1, an aberrant ubiquitin found in conformational diseases, which in turn caused general impairment of the UPS.  We conclude that ER stress has a general inhibitory effect on the UPS.  The compromised UPS during ER stress may explain the long-term gradual accumulation of misfolded proteins as well as the selective vulnerability of particular cell populations in conformational diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr82G8RTTmfY7Vg90H21EOLACvtfcHk0lhY-YJLBumIww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWnt7jO&md5=dabc18061d0fb7bdd246708ffdbc1532</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddi312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddi312%26sid%3Dliteratum%253Aachs%26aulast%3DMenendez-Benito%26aufirst%3DV.%26aulast%3DVerhoef%26aufirst%3DL.%2BG.%26aulast%3DMasucci%26aufirst%3DM.%2BG.%26aulast%3DDantuma%26aufirst%3DN.%2BP.%26atitle%3DEndoplasmic%2520reticulum%2520stress%2520compromises%2520the%2520ubiquitin-proteasome%2520system%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2005%26volume%3D14%26spage%3D2787%26epage%3D2799%26doi%3D10.1093%2Fhmg%2Fddi312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span> <span> </span><span class="NLM_article-title">Quantitative chemoproteomics for site-specific analysis of protein alkylation by 4-hydroxy-2-nonenal in cells</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2535</span>– <span class="NLM_lpage">2541</span>, <span class="refDoi"> DOI: 10.1021/ac504685y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac504685y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit12msLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=2535-2541&author=J.+Yangauthor=K.+A.+Tallmanauthor=N.+A.+Porterauthor=D.+C.+Liebler&title=Quantitative+chemoproteomics+for+site-specific+analysis+of+protein+alkylation+by+4-hydroxy-2-nonenal+in+cells&doi=10.1021%2Fac504685y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Chemoproteomics for Site-Specific Analysis of Protein Alkylation by 4-Hydroxy-2-Nonenal in Cells</span></div><div class="casAuthors">Yang, Jing; Tallman, Keri A.; Porter, Ned A.; Liebler, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2535-2541</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein alkylation by 4-hydroxy-2-nonenal (HNE), an endogenous lipid derived electrophile, contributes to stress signaling and cellular toxicity.  Although previous work has identified protein targets for HNE alkylation, the sequence specificity of alkylation and dynamics in a cellular context remain largely unexplored.  The authors developed a new quant. chemoproteomic platform, which uses isotopically tagged, photocleavable azido-biotin reagents to selectively capture and quantify the cellular targets labeled by the alkynyl analog of HNE (aHNE).  The authors' analyses site-specifically identified and quantified 398 aHNE protein alkylation events (386 cysteine sites and 12 histidine sites) in intact cells.  This data set expands by at least an order of magnitude the no. of such modification sites previously reported.  Although adducts formed by Michael addn. are thought to be largely irreversible, most aHNE modifications are lost rapidly in situ.  Moreover, aHNE adduct turnover occurs only in intact cells and loss rates are site-selective.  This quant. chemoproteomics platform provides a versatile general approach to map bioorthogonal-chem. engineered post-translational modifications and their cellular dynamics in a site-specific and unbiased manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKhDp3eK6t4bVg90H21EOLACvtfcHk0lgORsavKqbhFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit12msLY%253D&md5=da2595e75c2f67c0ad0ef233c53cf284</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fac504685y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac504685y%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DTallman%26aufirst%3DK.%2BA.%26aulast%3DPorter%26aufirst%3DN.%2BA.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26atitle%3DQuantitative%2520chemoproteomics%2520for%2520site-specific%2520analysis%2520of%2520protein%2520alkylation%2520by%25204-hydroxy-2-nonenal%2520in%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2015%26volume%3D87%26spage%3D2535%26epage%3D2541%26doi%3D10.1021%2Fac504685y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regazzoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altomare, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldini, G.</span></span> <span> </span><span class="NLM_article-title">Enzymatic and non-enzymatic detoxification of 4-hydroxynonenal: methodological aspects and biological consequences</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2017.01.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.freeradbiomed.2017.01.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28161307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1Wkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2017&pages=328-344&author=M.+Molauthor=L.+Regazzoniauthor=A.+Altomareauthor=G.+Deganiauthor=M.+Cariniauthor=G.+Vistoliauthor=G.+Aldini&title=Enzymatic+and+non-enzymatic+detoxification+of+4-hydroxynonenal%3A+methodological+aspects+and+biological+consequences&doi=10.1016%2Fj.freeradbiomed.2017.01.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic and non-enzymatic detoxification of 4-hydroxynonenal: Methodological aspects and biological consequences</span></div><div class="casAuthors">Mol, Marco; Regazzoni, Luca; Altomare, Alessandra; Degani, Genny; Carini, Marina; Vistoli, Giulio; Aldini, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">328-344</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  4-Hydroxynonenal (HNE), an electrophilic end-product deriving from lipid peroxidn., undergoes a heterogeneous set of biotransformations including enzymic and non-enzymic reactions.  The former mostly involve red-ox reactions on the HNE oxygenated functions (phase I metab.) and GSH conjugations (phase II) while the latter are due to the HNE capacity to spontaneously condense with nucleophilic sites within endogenous mols. such as proteins, nucleic acids and phospholipids.  The overall metabolic fate of HNE has recently attracted great interest not only because it clearly dets. the HNE disposal, but esp. because the generated metabolites and adducts are not inactive mols. (as initially believed) but show biol. activities even more pronounced than those of the parent compd. as exemplified by potent pro-inflammatory stimulus induced by GSH conjugates.  Similarly, several studies revealed that the non-enzymic reactions, initially considered as damaging processes randomly involving all endogenous nucleophilic reactants, are in fact quite selective in terms of both reactivity of the nucleophilic sites and stability of the generated adducts.  Even though many formed adducts retain the expected toxic consequences, some adducts exhibit well-defined beneficial roles as documented by the protective effects of sublethal concns. of HNE against toxic concns. of HNE.  Clearly, future investigations are required to gain a more detailed understanding of the metabolic fate of HNE as well as to identify novel targets involved in the biol. activity of the HNE metabolites.  These studies are and will be permitted by the continuous progress in the anal. for the identification and quantitation of novel HNE metabolites as well as for proteomic analyses able to offer a comprehensive picture of the HNE-induced adducted targets.  On these grounds, the present review will focus on the major enzymic and non-enzymic HNE biotransformations discussing both the mol. mechanisms involved and the biol. effects elicited.  The review will also describe the most important anal. enhancements that have permitted the here discussed advancements in the authors' understanding of the HNE metabolic fate and which will permit in a near future an even better knowledge of this enigmatic mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKk4UUjc_R7rVg90H21EOLACvtfcHk0lgORsavKqbhFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1Wkurs%253D&md5=048cab6f29c0710fdfcfea3c20d2d446</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2017.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2017.01.036%26sid%3Dliteratum%253Aachs%26aulast%3DMol%26aufirst%3DM.%26aulast%3DRegazzoni%26aufirst%3DL.%26aulast%3DAltomare%26aufirst%3DA.%26aulast%3DDegani%26aufirst%3DG.%26aulast%3DCarini%26aufirst%3DM.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DAldini%26aufirst%3DG.%26atitle%3DEnzymatic%2520and%2520non-enzymatic%2520detoxification%2520of%25204-hydroxynonenal%253A%2520methodological%2520aspects%2520and%2520biological%2520consequences%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2017%26volume%3D111%26spage%3D328%26epage%3D344%26doi%3D10.1016%2Fj.freeradbiomed.2017.01.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maisonneuve, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoueiry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lignon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talla, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukan, S.</span></span> <span> </span><span class="NLM_article-title">Rules governing selective protein carbonylation</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e7269</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0007269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1371%2Fjournal.pone.0007269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19802390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD1Mnmsl2nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=E.+Maisonneuveauthor=A.+Ducretauthor=P.+Khoueiryauthor=S.+Lignonauthor=S.+Longhiauthor=E.+Tallaauthor=S.+Dukan&title=Rules+governing+selective+protein+carbonylation&doi=10.1371%2Fjournal.pone.0007269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Rules governing selective protein carbonylation</span></div><div class="casAuthors">Maisonneuve Etienne; Ducret Adrien; Khoueiry Pierre; Lignon Sabrina; Longhi Sonia; Talla Emmanuel; Dukan Sam</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e7269</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Carbonyl derivatives are mainly formed by direct metal-catalysed oxidation (MCO) attacks on the amino-acid side chains of proline, arginine, lysine and threonine residues.  For reasons unknown, only some proteins are prone to carbonylation.  METHODOLOGY/PRINCIPAL FINDINGS:  we used mass spectrometry analysis to identify carbonylated sites in: BSA that had undergone in vitro MCO, and 23 carbonylated proteins in Escherichia coli.  The presence of a carbonylated site rendered the neighbouring carbonylatable site more prone to carbonylation.  Most carbonylated sites were present within hot spots of carbonylation.  These observations led us to suggest rules for identifying sites more prone to carbonylation.  We used these rules to design an in silico model (available at http://www.lcb.cnrs-mrs.fr/CSPD/), allowing an effective and accurate prediction of sites and of proteins more prone to carbonylation in the E. coli proteome.  CONCLUSIONS/SIGNIFICANCE:  We observed that proteins evolve to either selectively maintain or lose predicted hot spots of carbonylation depending on their biological function.  As our predictive model also allows efficient detection of carbonylated proteins in Bacillus subtilis, we believe that our model may be extended to direct MCO attacks in all organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj4ywhhj4VNGZyxfu64m4ffW6udTcc2ebxrv7CbtRCpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mnmsl2nsQ%253D%253D&md5=17d8e3d6e60f8a109b31f7aba0dc3bd4</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007269%26sid%3Dliteratum%253Aachs%26aulast%3DMaisonneuve%26aufirst%3DE.%26aulast%3DDucret%26aufirst%3DA.%26aulast%3DKhoueiry%26aufirst%3DP.%26aulast%3DLignon%26aufirst%3DS.%26aulast%3DLonghi%26aufirst%3DS.%26aulast%3DTalla%26aufirst%3DE.%26aulast%3DDukan%26aufirst%3DS.%26atitle%3DRules%2520governing%2520selective%2520protein%2520carbonylation%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0007269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, D. J.</span></span> <span> </span><span class="NLM_article-title">Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2135</span>– <span class="NLM_lpage">2139</span>, <span class="refDoi"> DOI: 10.1002/pmic.201200289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fpmic.201200289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=23606334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlGgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2135-2139&author=S.+Marconeauthor=D.+J.+Fitzgerald&title=Proteomic+identification+of+the+candidate+target+proteins+of+15-deoxy-delta12%2C14-prostaglandin+J2&doi=10.1002%2Fpmic.201200289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2S</span></div><div class="casAuthors">Marcone, Simone; Fitzgerald, Desmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2135-2139</span>CODEN:
                <span class="NLM_cas:coden">PROTC7</span>;
        ISSN:<span class="NLM_cas:issn">1615-9853</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">15-Deoxy-delta12, 14-prostaglandin J2 (15d-PGJ2) is an endogenous anti-inflammatory lipid derived from PGD2.  One potential mechanism for its activity is the covalent modification of cellular proteins, via a reactive α,β-unsatd. carbonyl group in its cyclopentenone ring, which in turn alters protein function.  In order to identify the candidate target proteins covalently modified by 15d-PGJ2 in human aortic endothelial cell (EC), EC was treated with biotinylated-15d-PGJ2, the modified proteins extd. by Neutravidin affinity-purifn. and the proteins identified by LTQ Orbitrap mass spectrometer.  Classification of the 358 identified proteins was performed using PANTHER classification system (www.pantherdb.org), showing that the proteins mapped to metabolic process, cellular process, and transport activity.  This protein data set highlights the potential for 15d-PGJ2 to covalently modify cellular proteins and provides a source of data that will aid further studies on the mechanism of action of this endogenous regulator of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJlCCjyM7kY7Vg90H21EOLACvtfcHk0lhPHtyHNtfWqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlGgs7o%253D&md5=aefebb28d27b1e7166c95d85243be831</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2Fpmic.201200289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.201200289%26sid%3Dliteratum%253Aachs%26aulast%3DMarcone%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DD.%2BJ.%26atitle%3DProteomic%2520identification%2520of%2520the%2520candidate%2520target%2520proteins%2520of%252015-deoxy-delta12%252C14-prostaglandin%2520J2%26jtitle%3DProteomics%26date%3D2013%26volume%3D13%26spage%3D2135%26epage%3D2139%26doi%3D10.1002%2Fpmic.201200289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">25284</span>– <span class="NLM_lpage">25290</span>, <span class="refDoi"> DOI: 10.1074/jbc.M414645200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.M414645200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15879598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFyqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25284-25290&author=J.+Fangauthor=J.+Luauthor=A.+Holmgren&title=Thioredoxin+reductase+is+irreversibly+modified+by+curcumin%3A+a+novel+molecular+mechanism+for+its+anticancer+activity&doi=10.1074%2Fjbc.M414645200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Thioredoxin Reductase Is Irreversibly Modified by Curcumin: a novel molecular mechanism for its anticancer activity</span></div><div class="casAuthors">Fang, Jianguo; Lu, Jun; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">25284-25290</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The thioredoxin reductase (TrxR) isoenzymes, TrxR1 in cytosol or nucleus and TrxR2 in mitochondria, are essential mammalian selenocysteine (Sec)-contg. flavoenzymes with a -Gly-Cys-Sec-Gly active site.  TrxRs are the only enzymes catalyzing the NADPH-dependent redn. of the active site disulfide in thioredoxins (Trxs), which play essential roles in substrate redns., defense against oxidative stress, and redox regulation by thiol redox control.  TrxRs have been found to be overexpressed by a no. of human tumors.  Curcumin, which is consumed daily by millions of people, is a polyphenol derived from the plant Curcuma longa.  This phytochem. has well known anticancer and antiangiogenic properties.  In this study we report that rat TrxR1 activity in Trx-dependent disulfide redn. was inhibited by curcumin.  The IC50 value for the enzyme was 3.6 μM after incubation at room temp. for 2 h in vitro.  The inhibition occurred with enzyme only in the presence of NADPH and persisted after removal of curcumin.  By using mass spectrometry and blotting anal., we proved that this irreversible inhibition by curcumin was caused by alkylation of both residues in the catalytically active site (Cys496/Sec497) of the enzyme.  However, the curcumin-modified enzyme showed a strongly induced NADPH oxidase activity to produce reactive oxygen species.  Inhibition of TrxR by curcumin added to cultured HeLa cells was also obsd. with an IC50 of around 15 μM.  Modification of TrxR by curcumin provides a possible mechanistic explanation for its cancer preventive activity, shifting the enzyme from an antioxidant to a prooxidant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWrKagjmS1sLVg90H21EOLACvtfcHk0lhPHtyHNtfWqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFyqtbw%253D&md5=373d0ddf866fdab1c60f811c75a200d7</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M414645200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M414645200%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520reductase%2520is%2520irreversibly%2520modified%2520by%2520curcumin%253A%2520a%2520novel%2520molecular%2520mechanism%2520for%2520its%2520anticancer%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25284%26epage%3D25290%26doi%3D10.1074%2Fjbc.M414645200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangpoengtrakul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyokuni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">23787</span>– <span class="NLM_lpage">23793</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.34.23787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.274.34.23787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10446139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=23787-23793&author=K.+Okadaauthor=C.+Wangpoengtrakulauthor=T.+Osawaauthor=S.+Toyokuniauthor=K.+Tanakaauthor=K.+Uchida&title=4-Hydroxy-2-nonenal-mediated+impairment+of+intracellular+proteolysis+during+oxidative+stress.+Identification+of+proteasomes+as+target+molecules&doi=10.1074%2Fjbc.274.34.23787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules</span></div><div class="casAuthors">Okada, Kunihiko; Wangpoengtrakul, Chantima; Osawa, Toshihiko; Toyokuni, Shinya; Tanaka, Keiji; Uchida, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">23787-23793</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Oxidative stress is assocd. with important pathophysiol. events in a variety of diseases.  It has been postulated that free radicals and lipid peroxidn. products generated during the process may be responsible for these effects because of their ability to damage cellular components such as membranes, proteins, and DNA.  In the present study, we provide evidence that oxidative stress causes a transient impairment of intracellular proteolysis via covalent binding of 4-hydroxy-2-nonenal (HNE), a major end product of lipid peroxidn., to proteasomes.  A single i.p. treatment with the renal carcinogen, ferric nitrilotriacetate, caused oxidative stress, as monitored by accumulation of lipid peroxidn. products and 8-hydroxy-2'-deoxyguanosine, in the kidney of mice.  In addn., transient accumulation of HNE-modified proteins in the kidney was also found by competitive ELISA and immunohistochem. analyses.  This and the observation that the HNE-modified proteins were significantly ubiquitinated suggested a crucial role of proteasomes in the metab. of HNE-modified proteins.  In vitro incubation of the kidney homogenates with HNE indeed resulted in a transient accumulation of HNE-modified proteins, whereas the proteasome inhibitor significantly suppressed the time-dependent elimination of HNE-modified proteins.  We found that, among three proteolytic activities (trypsin, chymotrypsin, and peptidylglutamyl peptide hydrolase activities) of proteasomes, both trypsin and peptidylglutamyl peptide hydrolase activities in the kidney were transiently diminished in accordance with the accumulation of HNE-modified proteins during oxidative stress.  The loss of proteasome activities was partially ascribed to the direct attachment of HNE to the protein, based on the detection of HNE-proteasome conjugates by an immunopptn. technique.  These results suggest that HNE may contribute to the enhanced accumulation of oxidatively modified proteins via an impairment of ubiquitin/proteasome-dependent intracellular proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopxKQt5H6rxLVg90H21EOLACvtfcHk0lhPHtyHNtfWqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOnsLg%253D&md5=8d0e2faf6a7e649a82b3e211195dd0db</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.34.23787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.34.23787%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DWangpoengtrakul%26aufirst%3DC.%26aulast%3DOsawa%26aufirst%3DT.%26aulast%3DToyokuni%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DUchida%26aufirst%3DK.%26atitle%3D4-Hydroxy-2-nonenal-mediated%2520impairment%2520of%2520intracellular%2520proteolysis%2520during%2520oxidative%2520stress.%2520Identification%2520of%2520proteasomes%2520as%2520target%2520molecules%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D23787%26epage%3D23793%26doi%3D10.1074%2Fjbc.274.34.23787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szweda, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, F.</span></span> <span> </span><span class="NLM_article-title">Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1424</span>– <span class="NLM_lpage">1426</span>, <span class="refDoi"> DOI: 10.1096/fj.04-1743fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1096%2Ffj.04-1743fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15247152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlKlu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1424-1426&author=C.+Marquesauthor=P.+Pereiraauthor=A.+Taylorauthor=J.+N.+Liangauthor=V.+N.+Reddyauthor=L.+I.+Szwedaauthor=F.+Shang&title=Ubiquitin-dependent+lysosomal+degradation+of+the+HNE-modified+proteins+in+lens+epithelial+cells&doi=10.1096%2Ffj.04-1743fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells</span></div><div class="casAuthors">Marques, Carla; Pereira, Paulo; Taylor, Allen; Liang, Jack N.; Reddy, Venkat N.; Szweda, Luke I.; Shang, Fu</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1424-1426, 10.1096/fj.04-1743fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">4-Hydroxynonenal (HNE), a highly reactive lipid peroxidn. product, may adversely modify proteins.  Accumulation of HNE-modified proteins may be responsible for pathol. lesions assocd. with oxidative stress.  The objective of this work was to det. how HNE-modified proteins are removed from cells.  The data showed that αB-crystallin modified by HNE was ubiquitinated at a faster rate than that of native αB-crystallin in a cell-free system.  However, its susceptibility to proteasome-dependent degrdn. in the cell-free system did not increase.  When delivered into cultured lens epithelial cells, HNE-modified αB-crystallin was degraded at a faster rate than that of unmodified αB-crystallin.  Inhibition of the lysosomal activity stabilized HNE-modified αB-crystallin, but inhibition of the proteasome activity alone had little effect.  To det. if other HNE-modified proteins are also degraded in a ubiquitin-dependent lysosomal pathway, lens epithelial cells were treated with HNE and the removal of HNE-modified proteins in the cells was monitored.  The levels of HNE-modified proteins in the cell decreased rapidly upon removal of HNE from the medium.  Depletion of ATP or the presence of MG132, a proteasome/lysosome inhibitor, resulted in stabilization of HNE-modified proteins.  However, proteasome-specific inhibitors, lactacystin-β-lactone and epoxomicin, could not stabilize HNE-modified proteins in the cells.  In contrast, chloroquine, a lysosome inhibitor, stabilized HNE-modified proteins.  The enrichment of HNE-modified proteins in the fraction of ubiquitin conjugates suggests that HNE-modified proteins are preferentially ubiquitinated.  Taken together, these findings show that HNE-modified proteins are degraded via a novel ubiquitin and lysosomal-dependent but proteasome-independent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLnpjgJoSdy7Vg90H21EOLACvtfcHk0lhPHtyHNtfWqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlKlu7w%253D&md5=11ec46c217186f08a18bc8b612cd82fd</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-1743fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-1743fje%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DC.%26aulast%3DPereira%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DJ.%2BN.%26aulast%3DReddy%26aufirst%3DV.%2BN.%26aulast%3DSzweda%26aufirst%3DL.%2BI.%26aulast%3DShang%26aufirst%3DF.%26atitle%3DUbiquitin-dependent%2520lysosomal%2520degradation%2520of%2520the%2520HNE-modified%2520proteins%2520in%2520lens%2520epithelial%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1424%26epage%3D1426%26doi%3D10.1096%2Ffj.04-1743fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. P.</span></span> <span> </span><span class="NLM_article-title">Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1111/jnc.13957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1111%2Fjnc.13957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28095639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislWnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=941-954&author=S.+Zhangauthor=E.+Eitanauthor=M.+P.+Mattson&title=Early+involvement+of+lysosome+dysfunction+in+the+degeneration+of+cerebral+cortical+neurons+caused+by+the+lipid+peroxidation+product+4-hydroxynonenal&doi=10.1111%2Fjnc.13957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal</span></div><div class="casAuthors">Zhang, Shi; Eitan, Erez; Mattson, Mark P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-954</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Free radical-mediated oxidative damage to proteins, lipids, and DNA occurs in neurons during acute brain injuries and in neurodegenerative disorders.  Membrane lipid peroxidn. contributes to neuronal dysfunction and death, in part by disrupting neuronal ion homeostasis and cellular bioenergetics.  Emerging findings suggest that 4-hydroxynonenal (HNE), an aldehyde produced during lipid peroxidn., impairs the function of various proteins involved in neuronal homeostasis.  Here we tested the hypothesis that HNE impairs the cellular system that removes damaged proteins and organelles, the autophagy-lysosome pathway in rat primary cortical neurons.  We found that HNE, at a concn. that causes apoptosis over a 48-72 h period, increases protein levels of LC3 II and p62 and within 1 and 4 h of exposure, resp.; LC3 II and p62 immunoreactive puncta were obsd. in the cytoplasm of HNE-treated neurons at 6 h.  The extent of up-regulation of p62 and LC3 II in response to HNE was not affected by co-treatment with the lysosome inhibitor bafilomycin A1, suggesting that the effects of HNE on autophagy were secondary to lysosome inhibition.  Indeed, we found that neurons exposed to HNE exhibit elevated pH levels, and decreased protein substrate hydrolysis and cathepsin B activity.  Neurons exposed to HNE also exhibited the accumulation of K63-linked polyubiquitinated proteins, which are substrates targeted for lysosomal degrdn.  Moreover, we found that the levels of LAMP2a and constitutively active heat-shock protein 70, and nos. of LAMP2a-pos. lysosomes, are decreased in neurons exposed to HNE.  Our findings demonstrate that the lipid peroxidn. product HNE causes early impairment of lysosomes which may contribute to the accumulation of damaged and dysfunctional proteins and organelles and consequent neuronal death.  Because impaired lysosome function is increasingly recognized as an early event in the neuronal death that occurs in neurodegenerative disorders, our findings suggest a role for HNE in such lysosomal dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq6NywODZ6XrVg90H21EOLACvtfcHk0lgu5UIlif6S9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislWnsb4%253D&md5=8344befc0d840a6bc38a0fe9dea9ecc2</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13957%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DEitan%26aufirst%3DE.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DEarly%2520involvement%2520of%2520lysosome%2520dysfunction%2520in%2520the%2520degeneration%2520of%2520cerebral%2520cortical%2520neurons%2520caused%2520by%2520the%2520lipid%2520peroxidation%2520product%25204-hydroxynonenal%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D140%26spage%3D941%26epage%3D954%26doi%3D10.1111%2Fjnc.13957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dayton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvendiran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meduru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span> <span> </span><span class="NLM_article-title">Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1032</span>, <span class="refDoi"> DOI: 10.4161/cbt.10.10.13250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.4161%2Fcbt.10.10.13250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20798598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1egsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1027-1032&author=A.+Daytonauthor=K.+Selvendiranauthor=M.+L.+Kuppusamyauthor=B.+K.+Riveraauthor=S.+Meduruauthor=T.+Kalaiauthor=K.+Hidegauthor=P.+Kuppusamy&title=Cellular+uptake%2C+retention+and+bioabsorption+of+HO-3867%2C+a+fluorinated+curcumin+analog+with+potential+antitumor+properties&doi=10.4161%2Fcbt.10.10.13250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties</span></div><div class="casAuthors">Dayton, Alex; Selvendiran, Karuppaiyah; Kuppusamy, M. Lakshmi; Rivera, Brian K.; Meduru, Sarath; Kalai, Tamas; Hideg, Kalman; Kuppusamy, Periannan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1027-1032</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Curcumin, a naturally-occurring compd. found in the rhizome of Curcuma longa plant, is known for its antitumor activities.  However, its clin. efficacy is limited due to poor bioabsorption.  A new class of synthetic analogs of curcumin, namely diarylidenylpiperidone (DAP), has been developed with substantially higher anticancer activity than curcumin.  However, its cellular uptake and bioabsorption have riot been evaluated.  In this study we have detd. the absorption of a representative DAP compd., HO-3867, using optical and ESR spectrometry.  The cellular uptake of HO-3867 was measured in a variety of cancer cell lines.  HO-3867 was taken in cells within 15 min of exposure and its uptake was more than 100-fold higher than curcumin.  HO-3867 was also retained in cells in an active form for 72 h and possibly longer.  HO-3867 was substantially cytotoxic to all the cancer cells tested.  However, there was no direct correlation between cellular uptake and cytotoxicity suggesting that the cytotoxic mechanisms could be cell-type specific.  When administered to rats by i.p. injection, significantly high levels of HO-3867 were found in the liver, kidney, stomach and blood after 3 h.  Also, significant accumulation of HO-3867 was found in murine tumor xenografts with a dose-dependent inhibition of tumor growth.  The results suggest that the curcumin analog has substantially higher bioabsorption when compared to curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHVmuXcv8U7Vg90H21EOLACvtfcHk0lgu5UIlif6S9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1egsr0%253D&md5=10edc00c082ff97ba8e0d28d116155e8</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.4161%2Fcbt.10.10.13250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.10.10.13250%26sid%3Dliteratum%253Aachs%26aulast%3DDayton%26aufirst%3DA.%26aulast%3DSelvendiran%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DM.%2BL.%26aulast%3DRivera%26aufirst%3DB.%2BK.%26aulast%3DMeduru%26aufirst%3DS.%26aulast%3DKalai%26aufirst%3DT.%26aulast%3DHideg%26aufirst%3DK.%26aulast%3DKuppusamy%26aufirst%3DP.%26atitle%3DCellular%2520uptake%252C%2520retention%2520and%2520bioabsorption%2520of%2520HO-3867%252C%2520a%2520fluorinated%2520curcumin%2520analog%2520with%2520potential%2520antitumor%2520properties%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D1027%26epage%3D1032%26doi%3D10.4161%2Fcbt.10.10.13250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Cellular processing of platinum anticancer drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nrd1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fnrd1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15789122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=307-320&author=D.+Wangauthor=S.+J.+Lippard&title=Cellular+processing+of+platinum+anticancer+drugs&doi=10.1038%2Fnrd1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular processing of platinum anticancer drugs</span></div><div class="casAuthors">Wang, Dong; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-320</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy.  Platinum-DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs.  This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signaling of DNA damage, cell-cycle checkpoints and arrest, DNA repair and cell death.  Such knowledge of the cellular processing of cisplatin adducts with DNA provides valuable clues for the rational design of more efficient platinum-based drugs as well as the development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHJfZNaqwy67Vg90H21EOLACvtfcHk0lgu5UIlif6S9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVart7c%253D&md5=e44a8e87683ba5cfe3e165f9f4229fee</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fnrd1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1691%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DCellular%2520processing%2520of%2520platinum%2520anticancer%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D307%26epage%3D320%26doi%3D10.1038%2Fnrd1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havelka, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoshan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1002/ijc.22132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1002%2Fijc.22132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=17044026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BD28nltVyktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=175-180&author=M.+Berndtssonauthor=M.+Haggauthor=T.+Panaretakisauthor=A.+M.+Havelkaauthor=M.+C.+Shoshanauthor=S.+Linder&title=Acute+apoptosis+by+cisplatin+requires+induction+of+reactive+oxygen+species+but+is+not+associated+with+damage+to+nuclear+DNA&doi=10.1002%2Fijc.22132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA</span></div><div class="casAuthors">Berndtsson Maria; Hagg Maria; Panaretakis Theocharis; Havelka Aleksandra Mandic; Shoshan Maria C; Linder Stig</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-80</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Cisplatin is a broad-spectrum anticancer drug that is also widely used in experimental studies on DNA damage-induced apoptosis.  Induction of apoptosis within 24-48 hr requires cisplatin concentrations that are at least one order of magnitude higher than the IC(50).  Here, we show that such high, apoptosis-inducing cisplatin concentrations induce cellular superoxide formation and that apoptosis is inhibited by superoxide scavengers.  The same concentration limit and the requirement for superoxide are also true for induction of caspase activation in enucleated cells (cytoplasts), showing that cisplatin-induced apoptosis occurs independently of nuclear DNA damage.  In contrast, lower cisplatin concentrations, which do not induce acute apoptosis, are sufficient for induction of DNA damage signaling.  We propose that the antiproliferative effects of cisplatin at IC(50) doses involve premature senescence and secondary, nonstress-induced apoptosis.  The higher doses currently used in in vitro studies lead to acute, stress-induced apoptosis that involves induction of superoxide but is largely DNA damage-independent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5_jtJBSbIKPSAs_PE1QvifW6udTcc2ebGsSMh9bIzUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nltVyktw%253D%253D&md5=a7861d675ec983eddfd53d85a031beec</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1002%2Fijc.22132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22132%26sid%3Dliteratum%253Aachs%26aulast%3DBerndtsson%26aufirst%3DM.%26aulast%3DHagg%26aufirst%3DM.%26aulast%3DPanaretakis%26aufirst%3DT.%26aulast%3DHavelka%26aufirst%3DA.%2BM.%26aulast%3DShoshan%26aufirst%3DM.%2BC.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DAcute%2520apoptosis%2520by%2520cisplatin%2520requires%2520induction%2520of%2520reactive%2520oxygen%2520species%2520but%2520is%2520not%2520associated%2520with%2520damage%2520to%2520nuclear%2520DNA%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D120%26spage%3D175%26epage%3D180%26doi%3D10.1002%2Fijc.22132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. B.,  IV</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbiser, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, J. P.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00832-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2FS0960-894X%2802%2900832-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=12467629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Cqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=115-117&author=T.+P.+Robinsonauthor=T.+Ehlersauthor=R.+B.+Hubbardauthor=X.+Baiauthor=J.+L.+Arbiserauthor=D.+J.+Goldsmithauthor=J.+P.+Bowen&title=Design%2C+synthesis%2C+and+biological+evaluation+of+angiogenesis+inhibitors%3A+aromatic+enone+and+dienone+analogues+of+curcumin&doi=10.1016%2FS0960-894X%2802%2900832-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin</span></div><div class="casAuthors">Robinson, Thomas Philip; Ehlers, Tedman; Hubbard, Richard B.; Bai, Xianhe; Arbiser, Jack L.; Goldsmith, David J.; Bowen, J. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-117</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The quest to find new antitumor compds. is an ongoing research endeavor in many labs. around the world.  The use of small-mol. angiogenesis inhibitors promises to be a potentially effective method for cancer treatment and possible prevention.  Many antiangiogenic compds. are in various stages of lab. evaluations and clin. trials.  Curcumin is a natural product that has exhibited potent antiangiogenic properties.  Based on a simple pharmacophore model, using std. drug design concepts, arom. enone and arom. dienone analogs of curcumin were prepd. and/or obtained com.  These compds. were screened for antiangiogenic properties via an in vitro SVR assay and were found to inhibit cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7aewmjUsjirVg90H21EOLACvtfcHk0lihss5bjwRflA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Cqu7o%253D&md5=2a05b0fc5afd81d5f4142231c0e2d08d</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900832-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900832-6%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DT.%2BP.%26aulast%3DEhlers%26aufirst%3DT.%26aulast%3DHubbard%26aufirst%3DR.%2BB.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DArbiser%26aufirst%3DJ.%2BL.%26aulast%3DGoldsmith%26aufirst%3DD.%2BJ.%26aulast%3DBowen%26aufirst%3DJ.%2BP.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520angiogenesis%2520inhibitors%253A%2520aromatic%2520enone%2520and%2520dienone%2520analogues%2520of%2520curcumin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D115%26epage%3D117%26doi%3D10.1016%2FS0960-894X%2802%2900832-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thackaberry, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopytek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherratt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trouba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, B.</span></span> <span> </span><span class="NLM_article-title">Comprehensive investigation of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-beta-cyclodextrin for use in general toxicology studies</span>. <i>Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1093/toxsci/kfq207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1093%2Ftoxsci%2Fkfq207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=20643750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyltb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2010&pages=485-492&author=E.+A.+Thackaberryauthor=S.+Kopytekauthor=P.+Sherrattauthor=K.+Troubaauthor=B.+McIntyre&title=Comprehensive+investigation+of+hydroxypropyl+methylcellulose%2C+propylene+glycol%2C+polysorbate+80%2C+and+hydroxypropyl-beta-cyclodextrin+for+use+in+general+toxicology+studies&doi=10.1093%2Ftoxsci%2Fkfq207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive Investigation of Hydroxypropyl Methylcellulose, Propylene Glycol, Polysorbate 80, and Hydroxypropyl-Beta-Cyclodextrin for use in General Toxicology Studies</span></div><div class="casAuthors">Thackaberry, Evan A.; Kopytek, Stephen; Sherratt, Phillip; Trouba, Kevin; McIntyre, Barry</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">485-492</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">This study was conducted to assess the safety and tolerability of the alternative formulation vehicles polysorbate 80 (PS80), propylene glycol (PG), and hydroxypropyl-beta-cyclodextrin (HPβCD) in general toxicol. studies in the mouse, rat, dog, and monkey.  Twenty (20) mg/kg of hydroxypropyl methylcellulose (MC, control), 10 mg/kg PS80, 1000 mg/kg PG, 500 mg/kg HPβCD, or 1000 mg/kg HPβCD were administered by oral gavage to mice, rats, dogs, and cynomolgus monkeys for approx. 90 days.  The effects of these formulations on clin. observations, body wt. and food consumption parameters, clin. pathol., and histopathol. were evaluated across all species.  The suitability of formulations contg. up to 20 mg/kg MC, 10 mg/kg PS80, and 1000 mg/kg PG for use in preclin. safety studies was confirmed by a lack of effects on all parameters examd.  However, formulations contg. HPβCD produced elevated transaminase (aspartate and alanine aminotransferase) levels in rats and mice and fecal changes (loose and soft stool) in large animals.  Although the etiol. and toxicol. significance of the transaminase elevations in rats and mice is uncertain, this finding could represent a significant liability for a preclin. formulation because of the crit. importance of these biomarkers in the risk assessment of novel therapeutic agents.  Based on these data, PS80 and PG are considered to be practical alternatives to MC in preclin. toxicol. studies.  However, formulations contg. HPβCD should be used with caution because of the elevations in rodent transaminase levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQeX-9u3aWf7Vg90H21EOLACvtfcHk0lihss5bjwRflA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyltb7F&md5=afd1e4fa16a34edefb0ac0ff79da673f</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq207%26sid%3Dliteratum%253Aachs%26aulast%3DThackaberry%26aufirst%3DE.%2BA.%26aulast%3DKopytek%26aufirst%3DS.%26aulast%3DSherratt%26aufirst%3DP.%26aulast%3DTrouba%26aufirst%3DK.%26aulast%3DMcIntyre%26aufirst%3DB.%26atitle%3DComprehensive%2520investigation%2520of%2520hydroxypropyl%2520methylcellulose%252C%2520propylene%2520glycol%252C%2520polysorbate%252080%252C%2520and%2520hydroxypropyl-beta-cyclodextrin%2520for%2520use%2520in%2520general%2520toxicology%2520studies%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D117%26spage%3D485%26epage%3D492%26doi%3D10.1093%2Ftoxsci%2Fkfq207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowinsky, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdeja, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paba-Prada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venugopal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porkka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullbo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loskog, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landgren, O.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1453</span>, <span class="refDoi"> DOI: 10.1007/s10637-020-00915-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1007%2Fs10637-020-00915-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=32125598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslykurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=1448-1453&author=E.+K.+Rowinskyauthor=A.+Panerauthor=J.+G.+Berdejaauthor=C.+Paba-Pradaauthor=P.+Venugopalauthor=K.+Porkkaauthor=J.+Gullboauthor=S.+Linderauthor=A.+Loskogauthor=P.+G.+Richardsonauthor=O.+Landgren&title=Phase+1+study+of+the+protein+deubiquitinase+inhibitor+VLX1570+in+patients+with+relapsed+and%2For+refractory+multiple+myeloma&doi=10.1007%2Fs10637-020-00915-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma</span></div><div class="casAuthors">Rowinsky, Eric K.; Paner, Agne; Berdeja, Jesus G.; Paba-Prada, Claudia; Venugopal, Parameswaran; Porkka, Kimmo; Gullbo, Joachim; Linder, Stig; Loskog, Angelica; Richardson, Paul G.; Landgren, Ola</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1448-1453</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Summary: This phase 1 study sought to characterize the safety, tolerability, and pharmacokinetic behavior of VLX1570, a small mol. inhibitor of the deubiquitinases (DUBs) that remove sterically bulky ubiquitin chains from proteins during processing in the19S regulatory subunit of the proteasome, in patients with relapsed and refractory multiple myeloma (MM).  Fourteen patients were treated with escalating doses of VLX1570 ranging from 0.05 to 1.2 mg/kg as a brief i.v. (IV) infusion on Days 1, 2, 8, 9, 15, and 16 of a 28-day cycle.  Due to its poor aq. soly., VLX1570 was formulated in polyethylene glycol, polyoxyethylated castor oil, and polysorbate 80 and administered as a brief i.v. (IV) infusion via a central venous catheter.  Anti-myeloma effects were noted at doses at or above 0.6 mg/kg, however, two patients treated at the 1.2 mg/kg dose level experienced severe, abrupt, and progressive respiratory insufficiency, which was assocd. with diffuse pulmonary infiltrates on imaging studies, similar to those rarely noted with bortezomib and other inhibitors of the 20S proteasome, culminating in death.  Although the contribution of VLX1570's formulation to the pulmonary toxicity could not be ruled out, the severity and precipitous nature of the toxicity and the steep relationship between dose and toxicity, the study was discontinued.  Despite the severe pulmonary toxicity noted with VLX1570, efforts directed at identifying DUB inhibitors with greater therapeutic indexes appear warranted based on the unique mechanism of action, robustness of preclin. antitumor activity, and activity of the DUB inhibitors in MM resistant to PIs targeting the 20S proteasome subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6mUOQ3zhPrVg90H21EOLACvtfcHk0lhvH_ONcE0DMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslykurs%253D&md5=ecde1e0e66c08aa1d3602cc89a7b05c7</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1007%2Fs10637-020-00915-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-020-00915-4%26sid%3Dliteratum%253Aachs%26aulast%3DRowinsky%26aufirst%3DE.%2BK.%26aulast%3DPaner%26aufirst%3DA.%26aulast%3DBerdeja%26aufirst%3DJ.%2BG.%26aulast%3DPaba-Prada%26aufirst%3DC.%26aulast%3DVenugopal%26aufirst%3DP.%26aulast%3DPorkka%26aufirst%3DK.%26aulast%3DGullbo%26aufirst%3DJ.%26aulast%3DLinder%26aufirst%3DS.%26aulast%3DLoskog%26aufirst%3DA.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DLandgren%26aufirst%3DO.%26atitle%3DPhase%25201%2520study%2520of%2520the%2520protein%2520deubiquitinase%2520inhibitor%2520VLX1570%2520in%2520patients%2520with%2520relapsed%2520and%252For%2520refractory%2520multiple%2520myeloma%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2020%26volume%3D38%26spage%3D1448%26epage%3D1453%26doi%3D10.1007%2Fs10637-020-00915-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uprety, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belur, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhakal, A.</span></span> <span> </span><span class="NLM_article-title">Bortezomib-Induced Pulmonary Toxicity: A case report and review of literature</span>. <i>Case Rep. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">2913124</span>, <span class="refDoi"> DOI: 10.1155/2018/2913124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1155%2F2018%2F2913124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=30595697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BB3cnms1yiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=2913124&author=P.+Kharelauthor=D.+Upretyauthor=A.+B.+Chandraauthor=Y.+Huauthor=A.+A.+Belurauthor=A.+Dhakal&title=Bortezomib-Induced+Pulmonary+Toxicity%3A+A+case+report+and+review+of+literature&doi=10.1155%2F2018%2F2913124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature</span></div><div class="casAuthors">Kharel Prakash; Uprety Deekchha; Chandra Abhinav B; Hu Yirui; Belur Anuradha Avinash; Dhakal Ajay</div><div class="citationInfo"><span class="NLM_cas:title">Case reports in medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2913124</span>
        ISSN:<span class="NLM_cas:issn">1687-9627</span>.
    </div><div class="casAbstract">Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma.  Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports.  The objective of this study is to report a case of bortezomib-induced lung injury, review current literature, and perform exploratory analysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsDA0LaTEnU7YtC3U5jeOifW6udTcc2eZTo3KT6Kvmmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnms1yiug%253D%253D&md5=5b4a198b273c85d181c6dd830a987bed</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1155%2F2018%2F2913124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F2913124%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DP.%26aulast%3DUprety%26aufirst%3DD.%26aulast%3DChandra%26aufirst%3DA.%2BB.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBelur%26aufirst%3DA.%2BA.%26aulast%3DDhakal%26aufirst%3DA.%26atitle%3DBortezomib-Induced%2520Pulmonary%2520Toxicity%253A%2520A%2520case%2520report%2520and%2520review%2520of%2520literature%26jtitle%3DCase%2520Rep.%2520Med.%26date%3D2018%26volume%3D2018%26spage%3D2913124%26doi%3D10.1155%2F2018%2F2913124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alnemri, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amelio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annicchiarico-Petruzzelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehrecke, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlev, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernassola, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagosklonny, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanella, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona-Gutierrez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecconi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chipuk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cidlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cubillos-Ruiz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabotar, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Angiolella, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Laurenzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Daniele, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Virgilio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckett, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynlacht, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elrod, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimia, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Saez, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavathiotis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golstein, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajnoczky, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengartner, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaattela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juin, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitsis, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemasters, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockshin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malorni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marine, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Pinedo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panaretakis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pervaiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacentini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prehn, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puthalakath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzuto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, C. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorrano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistigu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabadkai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tait, S. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavernarakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virgin, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vousden, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakeri, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitvogel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/s41418-017-0012-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1038%2Fs41418-017-0012-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=29362479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=486-541&author=L.+Galluzziauthor=I.+Vitaleauthor=S.+A.+Aaronsonauthor=J.+M.+Abramsauthor=D.+Adamauthor=P.+Agostinisauthor=E.+S.+Alnemriauthor=L.+Altucciauthor=I.+Amelioauthor=D.+W.+Andrewsauthor=M.+Annicchiarico-Petruzzelliauthor=A.+V.+Antonovauthor=E.+Aramaauthor=E.+H.+Baehreckeauthor=N.+A.+Barlevauthor=N.+G.+Bazanauthor=F.+Bernassolaauthor=M.+J.+M.+Bertrandauthor=K.+Bianchiauthor=M.+V.+Blagosklonnyauthor=K.+Blomgrenauthor=C.+Bornerauthor=P.+Boyaauthor=C.+Brennerauthor=M.+Campanellaauthor=E.+Candiauthor=D.+Carmona-Gutierrezauthor=F.+Cecconiauthor=F.+K.-M.+Chanauthor=N.+S.+Chandelauthor=E.+H.+Chengauthor=J.+E.+Chipukauthor=J.+A.+Cidlowskiauthor=A.+Ciechanoverauthor=G.+M.+Cohenauthor=M.+Conradauthor=J.+R.+Cubillos-Ruizauthor=P.+E.+Czabotarauthor=V.+D%E2%80%99Angiolellaauthor=T.+M.+Dawsonauthor=V.+L.+Dawsonauthor=V.+De+Laurenziauthor=R.+De+Mariaauthor=K.-M.+Debatinauthor=R.+J.+DeBerardinisauthor=M.+Deshmukhauthor=N.+Di+Danieleauthor=F.+Di+Virgilioauthor=V.+M.+Dixitauthor=S.+J.+Dixonauthor=C.+S.+Duckettauthor=B.+D.+Dynlachtauthor=W.+S.+El-Deiryauthor=J.+W.+Elrodauthor=G.+M.+Fimiaauthor=S.+Fuldaauthor=A.+J.+Garcia-Saezauthor=A.+D.+Gargauthor=C.+Garridoauthor=E.+Gavathiotisauthor=P.+Golsteinauthor=E.+Gottliebauthor=D.+R.+Greenauthor=L.+A.+Greeneauthor=H.+Gronemeyerauthor=A.+Grossauthor=G.+Hajnoczkyauthor=J.+M.+Hardwickauthor=I.+S.+Harrisauthor=M.+O.+Hengartnerauthor=C.+Hetzauthor=H.+Ichijoauthor=M.+Jaattelaauthor=B.+Josephauthor=P.+J.+Jostauthor=P.+P.+Juinauthor=W.+J.+Kaiserauthor=M.+Karinauthor=T.+Kaufmannauthor=O.+Keppauthor=A.+Kimchiauthor=R.+N.+Kitsisauthor=D.+J.+Klionskyauthor=R.+A.+Knightauthor=S.+Kumarauthor=S.+W.+Leeauthor=J.+J.+Lemastersauthor=B.+Levineauthor=A.+Linkermannauthor=S.+A.+Liptonauthor=R.+A.+Lockshinauthor=C.+Lopez-Otinauthor=S.+W.+Loweauthor=T.+Lueddeauthor=E.+Lugliauthor=M.+MacFarlaneauthor=F.+Madeoauthor=M.+Malewiczauthor=W.+Malorniauthor=G.+Manicauthor=J.-C.+Marineauthor=S.+J.+Martinauthor=J.-C.+Martinouauthor=J.+P.+Medemaauthor=P.+Mehlenauthor=P.+Meierauthor=S.+Melinoauthor=E.+A.+Miaoauthor=J.+D.+Molkentinauthor=U.+M.+Mollauthor=C.+Munoz-Pinedoauthor=S.+Nagataauthor=G.+Nunezauthor=A.+Oberstauthor=M.+Orenauthor=M.+Overholtzerauthor=M.+Paganoauthor=T.+Panaretakisauthor=M.+Pasparakisauthor=J.+M.+Penningerauthor=D.+M.+Pereiraauthor=S.+Pervaizauthor=M.+E.+Peterauthor=M.+Piacentiniauthor=P.+Pintonauthor=J.+H.+M.+Prehnauthor=H.+Puthalakathauthor=G.+A.+Rabinovichauthor=M.+Rehmauthor=R.+Rizzutoauthor=C.+M.+P.+Rodriguesauthor=D.+C.+Rubinszteinauthor=T.+Rudelauthor=K.+M.+Ryanauthor=E.+Sayanauthor=L.+Scorranoauthor=F.+Shaoauthor=Y.+Shiauthor=J.+Silkeauthor=H.-U.+Simonauthor=A.+Sistiguauthor=B.+R.+Stockwellauthor=A.+Strasserauthor=G.+Szabadkaiauthor=S.+W.+G.+Taitauthor=D.+Tangauthor=N.+Tavernarakisauthor=A.+Thorburnauthor=Y.+Tsujimotoauthor=B.+Turkauthor=T.+Vanden+Bergheauthor=P.+Vandenabeeleauthor=M.+G.+Vander+Heidenauthor=A.+Villungerauthor=H.+W.+Virginauthor=K.+H.+Vousdenauthor=D.+Vucicauthor=E.+F.+Wagnerauthor=H.+Walczakauthor=D.+Wallachauthor=Y.+Wangauthor=J.+A.+Wellsauthor=W.+Woodauthor=J.+Yuanauthor=Z.+Zakeriauthor=B.+Zhivotovskyauthor=L.+Zitvogelauthor=G.+Melinoauthor=G.+Kroemer&title=Molecular+mechanisms+of+cell+death%3A+recommendations+of+the+Nomenclature+Committee+on+Cell+Death+2018&doi=10.1038%2Fs41418-017-0012-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</span></div><div class="casAuthors">Galluzzi Lorenzo; Galluzzi Lorenzo; Cubillos-Ruiz Juan R; Galluzzi Lorenzo; Kepp Oliver; Kroemer Guido; Vitale Ilio; Campanella Michelangelo; Cecconi Francesco; Manic Gwenola; Piacentini Mauro; Vitale Ilio; Campanella Michelangelo; Manic Gwenola; Aaronson Stuart A; Chipuk Jerry E; Abrams John M; Adam Dieter; Agostinis Patrizia; Garg Abhishek D; Alnemri Emad S; Altucci Lucia; Amelio Ivano; Antonov Alexey V; Knight Richard A; MacFarlane Marion; Malewicz Michal; Melino Gerry; Andrews David W; Andrews David W; Andrews David W; Annicchiarico-Petruzzelli Margherita; Candi Eleonora; Arama Eli; Kimchi Adi; Baehrecke Eric H; Barlev Nickolai A; Bazan Nicolas G; Bernassola Francesca; Candi Eleonora; Melino Gerry; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bertrand Mathieu J M; Vanden Berghe Tom; Vandenabeele Peter; Bianchi Katiuscia; Blagosklonny Mikhail V; Blomgren Klas; Kroemer Guido; Blomgren Klas; Borner Christoph; Borner Christoph; Boya Patricia; Brenner Catherine; Brenner Catherine; Campanella Michelangelo; Campanella Michelangelo; Carmona-Gutierrez Didac; Madeo Frank; Cecconi Francesco; Cecconi Francesco; Chan Francis K-M; Chandel Navdeep S; Cheng Emily H; Cidlowski John A; Ciechanover Aaron; Gottlieb Eyal; Cohen Gerald M; Conrad Marcus; Cubillos-Ruiz Juan R; Czabotar Peter E; Strasser Andreas; Czabotar Peter E; Silke John; D'Angiolella Vincenzo; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Valina L; Dawson Ted M; Dawson Ted M; Dawson Valina L; Dawson Valina L; De Laurenzi Vincenzo; De Maria Ruggero; Sistigu Antonella; Debatin Klaus-Michael; DeBerardinis Ralph J; Deshmukh Mohanish; Di Daniele Nicola; Di Virgilio Francesco; Pinton Paolo; Dixit Vishva M; Dixon Scott J; Duckett Colin S; Dynlacht Brian D; Dynlacht Brian D; Pagano Michele; El-Deiry Wafik S; El-Deiry Wafik S; Elrod John W; Fimia Gian Maria; Piacentini Mauro; Fimia Gian Maria; Fulda Simone; Fulda Simone; Fulda Simone; Garcia-Saez Ana J; Garrido Carmen; Garrido Carmen; Garrido Carmen; Gavathiotis Evripidis; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Gavathiotis Evripidis; Kitsis Richard N; Golstein Pierre; Gottlieb Eyal; Ryan Kevin M; Tait Stephen W G; Green Douglas R; Greene Lloyd A; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gronemeyer Hinrich; Gross Atan; Hajnoczky Gyorgy; Hardwick J Marie; Harris Isaac S; Yuan Junying; Hengartner Michael O; Hetz Claudio; Hetz Claudio; Hetz Claudio; Ichijo Hidenori; Jaattela Marja; Joseph Bertrand; Zhivotovsky Boris; Jost Philipp J; Juin Philippe P; Juin Philippe P; Juin Philippe P; Juin Philippe P; Kaiser William J; Karin Michael; Karin Michael; Karin Michael; Karin Michael; Kaufmann Thomas; Simon Hans-Uwe; Kepp Oliver; Zitvogel Laurence; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kepp Oliver; Kroemer Guido; Kitsis Richard N; Kitsis Richard N; Klionsky Daniel J; Klionsky Daniel J; Kumar Sharad; Lee Sam W; Lemasters John J; Lemasters John J; Levine Beth; Levine Beth; Levine Beth; Linkermann Andreas; Lipton Stuart A; Lipton Stuart A; Lipton Stuart A; Lockshin Richard A; Lockshin Richard A; Lopez-Otin Carlos; Lowe Scott W; Lowe Scott W; Luedde Tom; Lugli Enrico; Lugli Enrico; Madeo Frank; Malorni Walter; Marine Jean-Christophe; Marine Jean-Christophe; Martin Seamus J; Martinou Jean-Claude; Medema Jan Paul; Medema Jan Paul; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Mehlen Patrick; Meier Pascal; Melino Sonia; Miao Edward A; Miao Edward A; Miao Edward A; Molkentin Jeffery D; Moll Ute M; Munoz-Pinedo Cristina; Nagata Shigekazu; Nunez Gabriel; Nunez Gabriel; Oberst Andrew; Oberst Andrew; Oren Moshe; Overholtzer Michael; Pagano Michele; Pagano Michele; Panaretakis Theocharis; Panaretakis Theocharis; Pasparakis Manolis; Pasparakis Manolis; Penninger Josef M; Pereira David M; Pervaiz Shazib; Pervaiz Shazib; Pervaiz Shazib; Peter Marcus E; Peter Marcus E; Pinton Paolo; Pinton Paolo; Prehn Jochen H M; Puthalakath Hamsa; Rabinovich Gabriel A; Rabinovich Gabriel A; Rehm Markus; Rehm Markus; Rizzuto Rosario; Szabadkai Gyorgy; Rodrigues Cecilia M P; Rubinsztein David C; Rudel Thomas; Sayan Emre; Scorrano Luca; Scorrano Luca; Shao Feng; Shi Yufang; Shi Yufang; Shi Yufang; Silke John; Sistigu Antonella; Stockwell Brent R; Stockwell Brent R; Szabadkai Gyorgy; Szabadkai Gyorgy; Vousden Karen H; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tang Daolin; Tavernarakis Nektarios; Thorburn Andrew; Tsujimoto Yoshihide; Turk Boris; Turk Boris; Vander Heiden Matthew G; Vander Heiden Matthew G; Vander Heiden Matthew G; Villunger Andreas; Virgin Herbert W; Vucic Domagoj; Wagner Erwin F; Walczak Henning; Wallach David; Wang Ying; Wells James A; Wood Will; Yuan Junying; Zakeri Zahra; Zhivotovsky Boris; Zitvogel Laurence; Zitvogel Laurence; Zitvogel Laurence; Kroemer Guido</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">486-541</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives.  Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process.  As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes.  The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVakKpC8MvO-R_TJajKxJDfW6udTcc2eaT_Fkxk27fVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvjsFKgug%253D%253D&md5=4f2b2e5757ae4448c16f7114cd494a7c</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fs41418-017-0012-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-017-0012-4%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26aulast%3DAbrams%26aufirst%3DJ.%2BM.%26aulast%3DAdam%26aufirst%3DD.%26aulast%3DAgostinis%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DAmelio%26aufirst%3DI.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26aulast%3DAnnicchiarico-Petruzzelli%26aufirst%3DM.%26aulast%3DAntonov%26aufirst%3DA.%2BV.%26aulast%3DArama%26aufirst%3DE.%26aulast%3DBaehrecke%26aufirst%3DE.%2BH.%26aulast%3DBarlev%26aufirst%3DN.%2BA.%26aulast%3DBazan%26aufirst%3DN.%2BG.%26aulast%3DBernassola%26aufirst%3DF.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%2BM.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26aulast%3DBlomgren%26aufirst%3DK.%26aulast%3DBorner%26aufirst%3DC.%26aulast%3DBoya%26aufirst%3DP.%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DCampanella%26aufirst%3DM.%26aulast%3DCandi%26aufirst%3DE.%26aulast%3DCarmona-Gutierrez%26aufirst%3DD.%26aulast%3DCecconi%26aufirst%3DF.%26aulast%3DChan%26aufirst%3DF.%2BK.-M.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DChipuk%26aufirst%3DJ.%2BE.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DCubillos-Ruiz%26aufirst%3DJ.%2BR.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DD%25E2%2580%2599Angiolella%26aufirst%3DV.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDe%2BLaurenzi%26aufirst%3DV.%26aulast%3DDe%2BMaria%26aufirst%3DR.%26aulast%3DDebatin%26aufirst%3DK.-M.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DM.%26aulast%3DDi%2BDaniele%26aufirst%3DN.%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26aulast%3DDynlacht%26aufirst%3DB.%2BD.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26aulast%3DElrod%26aufirst%3DJ.%2BW.%26aulast%3DFimia%26aufirst%3DG.%2BM.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DGarcia-Saez%26aufirst%3DA.%2BJ.%26aulast%3DGarg%26aufirst%3DA.%2BD.%26aulast%3DGarrido%26aufirst%3DC.%26aulast%3DGavathiotis%26aufirst%3DE.%26aulast%3DGolstein%26aufirst%3DP.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DHajnoczky%26aufirst%3DG.%26aulast%3DHardwick%26aufirst%3DJ.%2BM.%26aulast%3DHarris%26aufirst%3DI.%2BS.%26aulast%3DHengartner%26aufirst%3DM.%2BO.%26aulast%3DHetz%26aufirst%3DC.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJaattela%26aufirst%3DM.%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DJost%26aufirst%3DP.%2BJ.%26aulast%3DJuin%26aufirst%3DP.%2BP.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DT.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKimchi%26aufirst%3DA.%26aulast%3DKitsis%26aufirst%3DR.%2BN.%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26aulast%3DKnight%26aufirst%3DR.%2BA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DLemasters%26aufirst%3DJ.%2BJ.%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26aulast%3DLockshin%26aufirst%3DR.%2BA.%26aulast%3DLopez-Otin%26aufirst%3DC.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26aulast%3DLuedde%26aufirst%3DT.%26aulast%3DLugli%26aufirst%3DE.%26aulast%3DMacFarlane%26aufirst%3DM.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DMalewicz%26aufirst%3DM.%26aulast%3DMalorni%26aufirst%3DW.%26aulast%3DManic%26aufirst%3DG.%26aulast%3DMarine%26aufirst%3DJ.-C.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DMartinou%26aufirst%3DJ.-C.%26aulast%3DMedema%26aufirst%3DJ.%2BP.%26aulast%3DMehlen%26aufirst%3DP.%26aulast%3DMeier%26aufirst%3DP.%26aulast%3DMelino%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DE.%2BA.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26aulast%3DMoll%26aufirst%3DU.%2BM.%26aulast%3DMunoz-Pinedo%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DOberst%26aufirst%3DA.%26aulast%3DOren%26aufirst%3DM.%26aulast%3DOverholtzer%26aufirst%3DM.%26aulast%3DPagano%26aufirst%3DM.%26aulast%3DPanaretakis%26aufirst%3DT.%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DPereira%26aufirst%3DD.%2BM.%26aulast%3DPervaiz%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26aulast%3DPiacentini%26aufirst%3DM.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DPrehn%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DRabinovich%26aufirst%3DG.%2BA.%26aulast%3DRehm%26aufirst%3DM.%26aulast%3DRizzuto%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DC.%2BM.%2BP.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26aulast%3DRudel%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DK.%2BM.%26aulast%3DSayan%26aufirst%3DE.%26aulast%3DScorrano%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DH.-U.%26aulast%3DSistigu%26aufirst%3DA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DSzabadkai%26aufirst%3DG.%26aulast%3DTait%26aufirst%3DS.%2BW.%2BG.%26aulast%3DTang%26aufirst%3DD.%26aulast%3DTavernarakis%26aufirst%3DN.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DTsujimoto%26aufirst%3DY.%26aulast%3DTurk%26aufirst%3DB.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DVandenabeele%26aufirst%3DP.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DVirgin%26aufirst%3DH.%2BW.%26aulast%3DVousden%26aufirst%3DK.%2BH.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DE.%2BF.%26aulast%3DWalczak%26aufirst%3DH.%26aulast%3DWallach%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DWood%26aufirst%3DW.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZakeri%26aufirst%3DZ.%26aulast%3DZhivotovsky%26aufirst%3DB.%26aulast%3DZitvogel%26aufirst%3DL.%26aulast%3DMelino%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMolecular%2520mechanisms%2520of%2520cell%2520death%253A%2520recommendations%2520of%2520the%2520Nomenclature%2520Committee%2520on%2520Cell%2520Death%25202018%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2018%26volume%3D25%26spage%3D486%26epage%3D541%26doi%3D10.1038%2Fs41418-017-0012-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the ubiquitin-proteasome system are not all alike: identification of a new necrotic pathway</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.4161/auto.5.4.8169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.4161%2Fauto.5.4.8169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19270488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVyrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=543-545&author=C.+Fotiauthor=F.+Demarchiauthor=C.+Brancolini&title=Inhibitors+of+the+ubiquitin-proteasome+system+are+not+all+alike%3A+identification+of+a+new+necrotic+pathway&doi=10.4161%2Fauto.5.4.8169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the ubiquitin-proteasome system are not all alike: identification of a new necrotic pathway</span></div><div class="casAuthors">Foti, Carmela; Demarchi, Francesca; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-545</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">An addendum to the author's earlier paper (J Biol Chem 2009; 284:8369-81).  In response to stress, cells can not only activate survival pathways, but also death pathways, when the stresses are ungovernable.  The case of proteasome impairment is emblematic in this respect.  Autophagy is induced, as a prosurvival response, which antagonizes apoptosis.  As an addnl. option, cells can activate necrosis.  We have found that certain inhibitors of the ubiquitin-proteasome system can activate a rather peculiar type of necrotic death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNa3SJqhYDbVg90H21EOLACvtfcHk0lgNRLDkmQdy9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVyrsbo%253D&md5=88e9d073c6e2c5224c95b1230b91e372</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.4161%2Fauto.5.4.8169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.5.4.8169%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DDemarchi%26aufirst%3DF.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520the%2520ubiquitin-proteasome%2520system%2520are%2520not%2520all%2520alike%253A%2520identification%2520of%2520a%2520new%2520necrotic%2520pathway%26jtitle%3DAutophagy%26date%3D2009%26volume%3D5%26spage%3D543%26epage%3D545%26doi%3D10.4161%2Fauto.5.4.8169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florean, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzutto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncaglia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustincich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3140</span>– <span class="NLM_lpage">3150</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1158%2F1535-7163.MCT-09-0431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19887551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3140-3150&author=C.+Fotiauthor=C.+Floreanauthor=A.+Pezzuttoauthor=P.+Roncagliaauthor=A.+Tomasellaauthor=S.+Gustincichauthor=C.+Brancolini&title=Characterization+of+caspase-dependent+and+caspase-independent+deaths+in+glioblastoma+cells+treated+with+inhibitors+of+the+ubiquitin-proteasome+system&doi=10.1158%2F1535-7163.MCT-09-0431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system</span></div><div class="casAuthors">Foti, Carmela; Florean, Cristina; Pezzutto, Antonio; Roncaglia, Paola; Tomasella, Andrea; Gustincich, Stefano; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3140-3150</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The regulation of the necrotic death and its relevance in anticancer therapy are largely unknown.  Here, we have investigated the proapoptotic and pronecrotic activities of two ubiquitin-proteasome system inhibitors: bortezomib and G5.  The present study points out that the glioblastoma cell lines U87MG and T98G are useful models to study the susceptibility to apoptosis and necrosis in response to ubiquitin-proteasome system inhibitors.  U87MG cells show resistance to apoptosis induced by bortezomib and G5, but they are more susceptible to necrosis induced by G5.  Conversely, T98G cells are more susceptible to apoptosis induced by both inhibitors but show some resistance to G5-induced necrosis.  No overt differences in the induction of Noxa and Mcl-1 or in the expression levels of other components of the apoptotic machinery were obsd. between U87MG and T98G cells.  Instead, by comparing the transcriptional profiles of the two cell lines, we have found that the resistance to G5-induced necrosis could arise from differences in glutathione synthesis/utilization and in the microenvironment.  In particular, collagen IV, which is highly expressed in T98G cells, and fibronectin, whose adhesive function is counteracted by tenascin-C in U87MG cells, can restrain the necrotic response to G5.  Collectively, our results provide an initial characterization of the mol. signals governing cell death by necrosis in glioblastoma cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom1sxLYUap7LVg90H21EOLACvtfcHk0lgNRLDkmQdy9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlyrt7zM&md5=089096f305ec8b5694415dd11152929f</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0431%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DFlorean%26aufirst%3DC.%26aulast%3DPezzutto%26aufirst%3DA.%26aulast%3DRoncaglia%26aufirst%3DP.%26aulast%3DTomasella%26aufirst%3DA.%26aulast%3DGustincich%26aufirst%3DS.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DCharacterization%2520of%2520caspase-dependent%2520and%2520caspase-independent%2520deaths%2520in%2520glioblastoma%2520cells%2520treated%2520with%2520inhibitors%2520of%2520the%2520ubiquitin-proteasome%2520system%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D3140%26epage%3D3150%26doi%3D10.1158%2F1535-7163.MCT-09-0431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontanini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crivellato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maestro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demarchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancolini, C.</span></span> <span> </span><span class="NLM_article-title">The isopeptidase inhibitor G5 triggers a caspase-independent necrotic death in cells resistant to apoptosis: a comparative study with the proteasome inhibitor bortezomib</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">8369</span>– <span class="NLM_lpage">8381</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806113200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1074%2Fjbc.M806113200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=19139105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8369-8381&author=A.+Fontaniniauthor=C.+Fotiauthor=H.+Potuauthor=E.+Crivellatoauthor=R.+Maestroauthor=P.+Bernardiauthor=F.+Demarchiauthor=C.+Brancolini&title=The+isopeptidase+inhibitor+G5+triggers+a+caspase-independent+necrotic+death+in+cells+resistant+to+apoptosis%3A+a+comparative+study+with+the+proteasome+inhibitor+bortezomib&doi=10.1074%2Fjbc.M806113200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: a comparative study with the proteasome inhibitor bortezomib</span></div><div class="casAuthors">Fontanini, Alessandra; Foti, Carmela; Potu, Harish; Crivellato, Enrico; Maestro, Roberta; Bernardi, Paolo; Demarchi, Francesca; Brancolini, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">8369-8381</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Inhibitors of the ubiquitin-proteasome system (UPSIs) promote apoptosis of cancer cells and show encouraging anti-tumor activities in vivo.  In this study, we evaluated the death activities of two different UPSIs: bortezomib and the isopeptidase inhibitor G5.  To unveil whether these compds. elicit different types of death, we compared their effect both on apoptosis-proficient wild type mouse embryo fibroblasts and on cells defective for apoptosis (double-deficient Bax/Bak mouse embryo fibroblasts) (double knockout; DKO).  We have discovered that (i) both inhibitors induce apoptosis in a Bax and Bak-dependent manner, (ii) both inhibitors elicit autophagy in WT and DKO cells, and (iii) only G5 can kill apoptosis-resistant DKO cells by activating a necrotic response.  The induction of necrosis was confirmed by different exptl. approaches, including time lapse anal., HMGB1 release, and electron microscopy studies.  Neither treatment with antinecrotic agents, such as antioxidants, poly(ADP-ribose) polymerase and JNK inhibitors, necrostatin, and the intracellular Ca2+ chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester, nor overexpression of Bcl-2 and Bcl-xL prevented necrosis induced by G5.  This necrotic death is characterized by the absence of protein oxidn. and by the rapid cyclosporin A-independent dissipation of the mitochondrial membrane potential.  Notably, a peculiar feature of the G5-induced necrosis is an early and dramatic reorganization of the actin cytoskeleton, coupled to an alteration of cell adhesion.  The importance of cell adhesion impairment in the G5-induced necrotic death of DKO cells was confirmed by the antagonist effect of the extracellular matrix-adhesive components, collagen and fibronectin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUlFWDM_c67bVg90H21EOLACvtfcHk0lgNRLDkmQdy9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSisLs%253D&md5=dc56d684f7b32c0ab2a51938ecd7e82c</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806113200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806113200%26sid%3Dliteratum%253Aachs%26aulast%3DFontanini%26aufirst%3DA.%26aulast%3DFoti%26aufirst%3DC.%26aulast%3DPotu%26aufirst%3DH.%26aulast%3DCrivellato%26aufirst%3DE.%26aulast%3DMaestro%26aufirst%3DR.%26aulast%3DBernardi%26aufirst%3DP.%26aulast%3DDemarchi%26aufirst%3DF.%26aulast%3DBrancolini%26aufirst%3DC.%26atitle%3DThe%2520isopeptidase%2520inhibitor%2520G5%2520triggers%2520a%2520caspase-independent%2520necrotic%2520death%2520in%2520cells%2520resistant%2520to%2520apoptosis%253A%2520a%2520comparative%2520study%2520with%2520the%2520proteasome%2520inhibitor%2520bortezomib%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8369%26epage%3D8381%26doi%3D10.1074%2Fjbc.M806113200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Belle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredesen, D. E.</span></span> <span> </span><span class="NLM_article-title">An alternative, nonapoptotic form of programmed cell death</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">14376</span>– <span class="NLM_lpage">14381</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.26.14376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1073%2Fpnas.97.26.14376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=11121041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=14376-14381&author=S.+Sperandioauthor=I.+de+Belleauthor=D.+E.+Bredesen&title=An+alternative%2C+nonapoptotic+form+of+programmed+cell+death&doi=10.1073%2Fpnas.97.26.14376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">An alternative, nonapoptotic form of programmed cell death</span></div><div class="casAuthors">Sperandio, Sabina; De Belle, Ian; Bredesen, Dale E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">14376-14381</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The term apoptosis often has been used interchangeably with the term programmed cell death.  Here we describe a form of programmed cell death that is distinct from apoptosis by the criteria of morphol., biochem., and response to apoptosis inhibitors.  Morphol., this alternative form of programmed cell death appears during development and in some cases of neuro-degeneration.  Despite its lack of response to caspase inhibitors and Bcl-xL, we show that this form of cell death is driven by an alternative caspase-9 activity that is Apaf-1-independent.  Characterization of this alternative form of programmed cell death should lead to new insight into cell death programs and their roles in development and degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4H2cvUAMyLVg90H21EOLACvtfcHk0lj909R8IW5f4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVCktw%253D%253D&md5=6f69e53b6ba4cfd765a3560fe22f9232</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.26.14376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.26.14376%26sid%3Dliteratum%253Aachs%26aulast%3DSperandio%26aufirst%3DS.%26aulast%3Dde%2BBelle%26aufirst%3DI.%26aulast%3DBredesen%26aufirst%3DD.%2BE.%26atitle%3DAn%2520alternative%252C%2520nonapoptotic%2520form%2520of%2520programmed%2520cell%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D14376%26epage%3D14381%26doi%3D10.1073%2Fpnas.97.26.14376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nijhawan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zack, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamothe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsherniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besche, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbluh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shehata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span> <span> </span><span class="NLM_article-title">Cancer vulnerabilities unveiled by genomic loss</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.07.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1016%2Fj.cell.2012.07.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=22901813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Sktb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=842-854&author=D.+Nijhawanauthor=T.+I.+Zackauthor=Y.+Renauthor=M.+R.+Stricklandauthor=R.+Lamotheauthor=S.+E.+Schumacherauthor=A.+Tsherniakauthor=H.+C.+Bescheauthor=J.+Rosenbluhauthor=S.+Shehataauthor=G.+S.+Cowleyauthor=B.+A.+Weirauthor=A.+L.+Goldbergauthor=J.+P.+Mesirovauthor=D.+E.+Rootauthor=S.+N.+Bhatiaauthor=R.+Beroukhimauthor=W.+C.+Hahn&title=Cancer+vulnerabilities+unveiled+by+genomic+loss&doi=10.1016%2Fj.cell.2012.07.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Vulnerabilities Unveiled by Genomic Loss</span></div><div class="casAuthors">Nijhawan, Deepak; Zack, Travis I.; Ren, Yin; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Tsherniak, Aviad; Besche, Henrike C.; Rosenbluh, Joseph; Shehata, Shyemaa; Cowley, Glenn S.; Weir, Barbara A.; Goldberg, Alfred L.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">842-854</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Due to genome instability, most cancers exhibit loss of regions contg. tumor suppressor genes and collateral loss of other genes.  To identify cancer-specific vulnerabilities that are the result of copy no. losses, we performed integrated analyses of genome-wide copy no. and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy no. loss of that gene.  These CYCLOPS (copy no. alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components.  One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome.  Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression.  Cells harboring partial PSMC2 copy no. loss lack this complex and die after PSMC2 suppression.  These observations define a distinct class of cancer-specific liabilities resulting from genome instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoohXVIvmqAsLVg90H21EOLACvtfcHk0lj909R8IW5f4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Sktb7I&md5=0349098aaa4a6626abbabf0eddea1f5c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.07.023%26sid%3Dliteratum%253Aachs%26aulast%3DNijhawan%26aufirst%3DD.%26aulast%3DZack%26aufirst%3DT.%2BI.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DStrickland%26aufirst%3DM.%2BR.%26aulast%3DLamothe%26aufirst%3DR.%26aulast%3DSchumacher%26aufirst%3DS.%2BE.%26aulast%3DTsherniak%26aufirst%3DA.%26aulast%3DBesche%26aufirst%3DH.%2BC.%26aulast%3DRosenbluh%26aufirst%3DJ.%26aulast%3DShehata%26aufirst%3DS.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26atitle%3DCancer%2520vulnerabilities%2520unveiled%2520by%2520genomic%2520loss%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D842%26epage%3D854%26doi%3D10.1016%2Fj.cell.2012.07.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birsoy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupczak, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of essential genes in the human genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1101</span>, <span class="refDoi"> DOI: 10.1126/science.aac7041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1126%2Fscience.aac7041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=26472758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFamtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&pages=1096-1101&author=T.+Wangauthor=K.+Birsoyauthor=N.+W.+Hughesauthor=K.+M.+Krupczakauthor=Y.+Postauthor=J.+J.+Weiauthor=E.+S.+Landerauthor=D.+M.+Sabatini&title=Identification+and+characterization+of+essential+genes+in+the+human+genome&doi=10.1126%2Fscience.aac7041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of essential genes in the human genome</span></div><div class="casAuthors">Wang, Tim; Birsoy, Kivanc; Hughes, Nicholas W.; Krupczak, Kevin M.; Post, Yorick; Wei, Jenny J.; Lander, Eric S.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">6264</span>),
    <span class="NLM_cas:pages">1096-1101</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Large-scale genetic anal. of lethal phenotypes has elucidated the mol. underpinnings of many biol. processes.  Using the bacterial clustered regularly interspaced short palindromic repeats (CRISPR) system, we constructed a genome-wide single-guide RNA library to screen for genes required for proliferation and survival in a human cancer cell line.  Our screen revealed the set of cell-essential genes, which was validated with an orthogonal gene-trap-based screen and comparison with yeast gene knockouts.  This set is enriched for genes that encode components of fundamental pathways, are expressed at high levels, and contain few inactivating polymorphisms in the human population.  We also uncovered a large group of uncharacterized genes involved in RNA processing, a no. of whose products localize to the nucleolus.  Last, screens in addnl. cell lines showed a high degree of overlap in gene essentiality but also revealed differences specific to each cell line and cancer type that reflect the developmental origin, oncogenic drivers, paralogous gene expression pattern, and chromosomal structure of each line.  These results demonstrate the power of CRISPR-based screens and suggest a general strategy for identifying liabilities in cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonjG02K7R4iLVg90H21EOLACvtfcHk0lj909R8IW5f4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFamtL3F&md5=61273ba03938104748f0458f662a3c34</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac7041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac7041%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBirsoy%26aufirst%3DK.%26aulast%3DHughes%26aufirst%3DN.%2BW.%26aulast%3DKrupczak%26aufirst%3DK.%2BM.%26aulast%3DPost%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DJ.%2BJ.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520essential%2520genes%2520in%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2015%26volume%3D350%26spage%3D1096%26epage%3D1101%26doi%3D10.1126%2Fscience.aac7041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ode, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Identification of simple compounds with microtubule-binding activity that inhibit cancer cell growth with high potency</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1021/ml200195s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200195s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlylt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=35-38&author=W.+S.+Yangauthor=K.+Shimadaauthor=D.+Delvaauthor=M.+Patelauthor=E.+Odeauthor=R.+Skoutaauthor=B.+R.+Stockwell&title=Identification+of+simple+compounds+with+microtubule-binding+activity+that+inhibit+cancer+cell+growth+with+high+potency&doi=10.1021%2Fml200195s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency</span></div><div class="casAuthors">Yang, Wan Seok; Shimada, Kenichi; Delva, Darnelle; Patel, Milesh; Ode, Egberamwen; Skouta, Rachid; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-38</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We analyzed more than 1 million small mols. with the goal of finding simple synthetic compds. that potently inhibit cancer cell growth.  We identified three such compds. with unknown mechanisms of action.  Subsequent studies revealed that all three of these small mols. target microtubules.  These three scaffolds can serve as templates for developing new microtubule-targeted agents, overcoming the limits of existing microtubule-inhibiting drugs derived from complex natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcL7aucy03LVg90H21EOLACvtfcHk0ljyvsY06dUUVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlylt7fM&md5=14be45185e15c7ffe594492e756c1f25</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fml200195s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200195s%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DDelva%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DOde%26aufirst%3DE.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DIdentification%2520of%2520simple%2520compounds%2520with%2520microtubule-binding%2520activity%2520that%2520inhibit%2520cancer%2520cell%2520growth%2520with%2520high%2520potency%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D35%26epage%3D38%26doi%3D10.1021%2Fml200195s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazurkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillert, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, S.</span></span> <span> </span><span class="NLM_article-title">Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">21115</span>– <span class="NLM_lpage">21127</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.15501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.18632%2Foncotarget.15501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=28423502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A280%3ADC%252BC1cvpt1ajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=21115-21127&author=M.+Mazurkiewiczauthor=E.+K.+Hillertauthor=X.+Wangauthor=P.+Pellegriniauthor=M.+H.+Olofssonauthor=K.+Selvarajuauthor=P.+D%E2%80%99Arcyauthor=S.+Linder&title=Acute+lymphoblastic+leukemia+cells+are+sensitive+to+disturbances+in+protein+homeostasis+induced+by+proteasome+deubiquitinase+inhibition&doi=10.18632%2Foncotarget.15501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition</span></div><div class="casAuthors">Mazurkiewicz Magdalena; Hillert Ellin-Kristina; Olofsson Maria Hagg; Linder Stig; Wang Xin; Pellegrini Paola; Selvaraju Karthik; D'Arcy Padraig; Linder Stig</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">21115-21127</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The non-genotoxic nature of proteasome inhibition makes it an attractive therapeutic option for the treatment of pediatric malignancies.  We recently described the small molecule VLX1570 as an inhibitor of proteasome deubiquitinase (DUB) activity that induces proteotoxic stress and apoptosis in cancer cells.  Here we show that acute lymphoblastic leukemia (ALL) cells are highly sensitive to treatment with VLX1570, resulting in the accumulation of polyubiquitinated proteasome substrates and loss of cell viability.  VLX1570 treatment increased the levels of a number of proteins, including the chaperone HSP70B', the oxidative stress marker heme oxygenase-1 (HO-1) and the cell cycle regulator p21Cip1.  Unexpectedly, polybiquitin accumulation was found to be uncoupled from ER stress in ALL cells.  Thus, increased phosphorylation of eIF2α occurred only at supra-pharmacological VLX1570 concentrations and did not correlate with polybiquitin accumulation.  Total cellular protein synthesis was found to decrease in the absence of eIF2α phosphorylation.  Furthermore, ISRIB (Integrated Stress Response inhibitor) did not overcome the inhibition of protein synthesis.  We finally show that VLX1570 can be combined with L-asparaginase for additive or synergistic antiproliferative effects on ALL cells.  We conclude that ALL cells are highly sensitive to the proteasome DUB inhibitor VLX1570 suggesting a novel therapeutic option for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0Sy6WJkt3Igqdek-gHSrIfW6udTcc2eYNbdqYig8tyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvpt1ajsg%253D%253D&md5=c120ebf5961057717aed171c6a09f61b</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.15501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.15501%26sid%3Dliteratum%253Aachs%26aulast%3DMazurkiewicz%26aufirst%3DM.%26aulast%3DHillert%26aufirst%3DE.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPellegrini%26aufirst%3DP.%26aulast%3DOlofsson%26aufirst%3DM.%2BH.%26aulast%3DSelvaraju%26aufirst%3DK.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DP.%26aulast%3DLinder%26aufirst%3DS.%26atitle%3DAcute%2520lymphoblastic%2520leukemia%2520cells%2520are%2520sensitive%2520to%2520disturbances%2520in%2520protein%2520homeostasis%2520induced%2520by%2520proteasome%2520deubiquitinase%2520inhibition%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D21115%26epage%3D21127%26doi%3D10.18632%2Foncotarget.15501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">7130</span>– <span class="NLM_lpage">7139</span>, <span class="refDoi"> DOI: 10.1128/MCB.24.16.7130-7139.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=10.1128%2FMCB.24.16.7130-7139.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=15282312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=7130-7139&author=A.+Kobayashiauthor=M.+I.+Kangauthor=H.+Okawaauthor=M.+Ohtsujiauthor=Y.+Zenkeauthor=T.+Chibaauthor=K.+Igarashiauthor=M.+Yamamoto&title=Oxidative+stress+sensor+Keap1+functions+as+an+adaptor+for+Cul3-based+E3+ligase+to+regulate+proteasomal+degradation+of+Nrf2&doi=10.1128%2FMCB.24.16.7130-7139.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2</span></div><div class="casAuthors">Kobayashi, Akira; Kang, Moon-Il; Okawa, Hiromi; Ohtsuji, Makiko; Zenke, Yukari; Chiba, Tomoki; Igarashi, Kazuhiko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7130-7139</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transcription factor Nrf2 is a major regulator of genes encoding phase 2 detoxifying enzymes and antioxidant stress proteins in response to electrophilic agents and oxidative stress.  In the absence of such stimuli, Nrf2 is inactive owing to its cytoplasmic retention by Keap1 and rapid degrdn. through the proteasome system.  We examd. the contribution of Keap1 to the rapid turnover of Nrf2 (half-life of less than 20 min) and found that a direct assocn. between Keap1 and Nrf2 is required for Nrf2 degrdn.  In a series of domain function analyses of Keap1, we found that both the BTB and intervening-region (IVR) domains are crucial for Nrf2 degrdn., implying that these two domains act to recruit ubiquitin-proteasome factors.  Indeed, Cullin 3 (Cul3), a subunit of the E3 ligase complex, was found to interact specifically with Keap1 in vivo.  Keap1 assocs. with the N-terminal region of Cul3 through the IVR domain and promotes the ubiquitination of Nrf2 in cooperation with the Cul3-Roc1 complex.  These results thus provide solid evidence that Keap1 functions as an adaptor of Cul3-based E3 ligase.  To our knowledge, Nrf2 and Keap1 are the first reported mammalian substrate and adaptor, resp., of the Cul3-based E3 ligase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrut4YvhAuZKrVg90H21EOLACvtfcHk0ljyvsY06dUUVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlOjt7w%253D&md5=3d6e356865cd6f33c800bf9124d7c8da</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1128%2FMCB.24.16.7130-7139.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.24.16.7130-7139.2004%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DM.%2BI.%26aulast%3DOkawa%26aufirst%3DH.%26aulast%3DOhtsuji%26aufirst%3DM.%26aulast%3DZenke%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DOxidative%2520stress%2520sensor%2520Keap1%2520functions%2520as%2520an%2520adaptor%2520for%2520Cul3-based%2520E3%2520ligase%2520to%2520regulate%2520proteasomal%2520degradation%2520of%2520Nrf2%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2004%26volume%3D24%26spage%3D7130%26epage%3D7139%26doi%3D10.1128%2FMCB.24.16.7130-7139.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e1737-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00812">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23602"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00812?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00812</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Table 1 listing selective antiproliferative activity to tumor cells, as verified by other laboratories (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00812/suppl_file/jm0c00812_si_001.pdf">jm0c00812_si_001.pdf (56.56 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00812&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00812%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00812" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0fc14be0324b2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
